{"id":"00046980","next":"https:\/\/symplectic.leeds.ac.uk:8091\/secure-api\/v6.13\/users\/pid-00046980\/publications?detail=full&modified-since=2025-10-22T15%3A20%3A01.180&after-id=865828","publications":{"selected_publication":[],"favourites":[],"journal_article":[{"html":"

Smolen JS; Edwards CJ; Konzett V; Laskou F; Aletaha D; Caporali R; D\u00f6rner T; Hyrich KL; Mateus E; Pope JE; Primdahl J; de Souza S; Stamm T; Takeuchi T; van der Heijde D; Verschueren P; Winthrop KL; Alvaro-Gracia JM; Askling J; Bathon J; Buch MH; Burmester GR; Codreanu C; Conaghan PG; Cutolo M; Fautrel B; Fonseca J; Gossec L; Haavardsholm E; Hetland ML; Iagnocco A; Juge P-A; Li Z; Moe RH; Nash P; Po\u00f3r G; Rubbert-Roth A; Sobrin RDS; Schulze-Koops H; Shumnalieva R; Senolt L; Silva-Fernandez L; Strangfeld A; Taylor P; Turesson C; van Duuren E; de Wit M; Xavier R; Kerschbaumer A; Landew\u00e9 RBM<\/span> (2026)<\/span> EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update<\/span>. Ann Rheum Dis<\/span>, 24<\/span>, (4)<\/span>, pp. S0003-4967(26)00075-0-158<\/span>. <\/a><\/p>","publicationid":"381757","date":"2026-03-12","publicationtype":"Journal article","isfavourite":"0"},{"html":"

De Marco G; Hensor EMA; McGonagle D; Tan AL; Coates LC; Emery P; Helliwell PS; Marzo-Ortega H<\/span> (2026)<\/span> PASDAS test-retest reliability in early, untreated PsA: data from the GOLMePsA clinical trial<\/span>. Rheumatology (Oxford)<\/span>, 65<\/span>, (1)<\/span>, pp. keaf507<\/span>. <\/a><\/p>","publicationid":"1106434","date":"2026-01-08","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bixio R; Di Donato S; Lommano MG; Smerilli G; Farah S; \u00c7olak S; Minerba M; Pistillo F; Wakefield RJ; Salaffi F; Viapiana O; De Angelis R; Rossini M; Cipolletta E; Filippucci E; Idolazzi L; Emery P; Del Galdo F; Di Matteo A<\/span> (2025)<\/span> Multimodal ultrasound in the assessment of muscle involvement in systemic sclerosis patients: results from a bicentric study<\/span>. Rheumatology (Oxford)<\/span>, 64<\/span>, (12)<\/span>, pp. 6159-6167<\/span>. <\/a> <\/a><\/p>","publicationid":"1092798","date":"2025-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fitton J; Melville A; Di Matteo A; Nam J; Dass S; Saleem B; Shukla R; Emery P; Wakefield RJ; Hensor EMA; Buch MH<\/span> (2025)<\/span> Neither ultrasound synovitis nor clinical-ultrasound phenotypes of established rheumatoid arthritis predict response to targeted therapy<\/span>. Rheumatology (Oxford)<\/span>, 64<\/span>, (12)<\/span>, pp. 6079-6089<\/span>. <\/a><\/p>","publicationid":"1058433","date":"2025-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; Harnden K; Sharrack S; Abacar K; Sahin D; Okano T; Horvath R; Hurnakova J; Voulgari PV; Yerolatsite M; de Agust\u00edn JJ; Trallero-Aragu\u00e1s E; Di Geso L; Wakefield RJ; Filippucci E; Emery P; Mankia K<\/span> (2025)<\/span> Ultrasound-detected inflammation and structural changes in the joints, tendons and entheses of patients with cancer who developed arthritis or arthralgia after exposure to immune checkpoint inhibitors<\/span>. RMD Open<\/span>, 11<\/span>, (4)<\/span>, pp. e005879<\/span>. <\/a> <\/a><\/p>","publicationid":"1110328","date":"2025-10-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Donato S; Smerilli G; Becciolini A; Camarda F; Cauli A; Cazenave T; Cipolletta E; Corradini D; de Agustin de Oro JJ; Destro Castaniti GM; Di Donato E; Duran E; Farisogullari B; Fornaro M; Francioso F; Giorgis P; Granel A; Hernandez Diaz C; Horvath R; Hurnakova J; Jesus D; Karadag O; Li L; Li Y; Lommano MG; Marin J; Martire MV; Michelena X; Muntean L; Piga M; Rosemffet MG; Rovisco J; Salaffi F; Saraiva L; Scioscia C; Tamas M-M; Tanimura S; Venetsanopoulou AI; Ventura Rios L; Villota O; Villota-Eraso C; Voulgari PV; Vukatana G; Zacariaz Hereter J; Del Galdo F; Emery P; McGonagle D; Filippucci E; Di Matteo A<\/span> (2025)<\/span> Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study<\/span>. Semin Arthritis Rheum<\/span>, 74<\/span>, pp. 152823<\/span>. <\/a> <\/a><\/p>","publicationid":"1101530","date":"2025-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Harnden K; Sidhu N; Rowbotham E; Duquenne L; Sharrack S; Howell K; Bertham D; Abacar K; Emery P; McGonagle D; Mankia K<\/span> (2025)<\/span> Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study<\/span>. Lancet Rheumatol<\/span>, 7<\/span>, (10)<\/span>, pp. e697-e707<\/span>. <\/a> <\/a><\/p>","publicationid":"1043375","date":"2025-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sharrack S; Di Matteo A; Mankia K; Dass S; Emery P<\/span> (2025)<\/span> Remission is the ambition: can remission rates for new patients with rheumatoid arthritis finally be improved, at minimal cost?<\/span> Rheumatology (Oxford)<\/span>, 64<\/span>, (7)<\/span>, pp. 4107-4109<\/span>. <\/a><\/p>","publicationid":"989824","date":"2025-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Shukla RR; Wakefield RJ; Ho P; Tan AL; Emery P; Plant D; Buch MH<\/span> (2025)<\/span> Baseline synovitis-tenosynovitis is associated with remission in early rheumatoid arthritis, but discordance with disease activity is a changeable state<\/span>. Rheumatology (Oxford)<\/span>, 64<\/span>, (6)<\/span>, pp. 3468-3477<\/span>. <\/a> <\/a><\/p>","publicationid":"971996","date":"2025-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mahmoud K; Md Yusof MY; Teh LS; Khan S; Yee C-S; D'Cruz D; Isenberg D; Ciurtin C; Conaghan PG; Emery P; Edwards CJ; Hensor EMA; Vital EM<\/span> (2025)<\/span> Improving the arthritis component of the SLEDAI-2K<\/span>. Rheumatology (Oxford)<\/span>, 64<\/span>, (6)<\/span>, pp. 3556-3562<\/span>. <\/a> <\/a><\/p>","publicationid":"919574","date":"2025-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Siddle HJ; Wilson M; Nam JL; Garcia-Montoya L; Duquenne L; Mankia K; Emery P; Hensor EMA<\/span> (2025)<\/span> A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary care<\/span>. Rheumatology (Oxford)<\/span>, 64<\/span>, (6)<\/span>, pp. 3947-3956<\/span>. <\/a> <\/a><\/p>","publicationid":"891484","date":"2025-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

James L; Helliwell PS; Hensor EMA; Conaghan PG; Emery P; Coates LC<\/span> (2025)<\/span> Tight Control and Radiological Progression: The Radiographic Outcomes of the TICOPA Study<\/span>. J Rheumatol<\/span>, 52<\/span>, (5)<\/span>, pp. 527<\/span>. <\/a> <\/a><\/p>","publicationid":"982409","date":"2025-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

James L; Helliwell PS; Hensor EMA; Conaghan PG; Emery P; Coates LC<\/span> (2025)<\/span> Tight Control and Radiological Progression: The Radiographic Outcomes of the TICOPA Study<\/span>. J Rheumatol<\/span>, 52<\/span>, (5)<\/span>, pp. 460-465<\/span>. <\/a> <\/a><\/p>","publicationid":"938819","date":"2025-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

D'Ignazio E; Corradini D; Cazenave T; Bixio R; Baldi C; Ubhi HK; Smith K; Wakefield RJ; Emery P; Di Matteo A<\/span> (2025)<\/span> Ultrasound Beyond Joints: A Review of Extra-Articular Applications in Rheumatology<\/span>. Curr Rheumatol Rep<\/span>, 27<\/span>, (1)<\/span>, pp. 20<\/span>. <\/a><\/p>","publicationid":"987953","date":"2025-03-04","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Westhovens R; Winthrop KL; Kavanaugh A; Greenwald M; Dagna L; Cseuz R; Besuyen R; de Vries D; Modgill V; Le LH; Genovese MC; Emery P; Verschueren P; Alten R<\/span> (2025)<\/span> Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study<\/span>. RMD Open<\/span>, 11<\/span>, (1)<\/span>, pp. e004857<\/span>. <\/a> <\/a><\/p>","publicationid":"956859","date":"2025-01-30","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Patel J; Emery P; Vital E; Yusof MYM<\/span> (2025)<\/span> RITUXIMAB SUPER-RESPONDERS: CHARACTERISTICS OF PATIENTS WITH MORE THAN 3 YEARS RESPONSE TO A SINGLE CYCLE OF TREATMENT<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, 52<\/span>, (Suppl 1)<\/span>, pp. 247<\/span>. <\/a><\/p>","publicationid":"1043610","date":"2025-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Soo CY; Duquenne L; Thornton L; Anderton T; Tomoaia R; Lwin M; Asad M; Kamani C; Chowdhary A; Thirunavukarasu S; Procter H; Kotha S; Giannoudi M; Levelt E; Bissell L-A; Emery P; Saleem B; Wakefield R; Mankia K; Plein S; Jex N<\/span> (2025)<\/span> Rheumatoid arthritis is associated with sub-clinical abnormalities in myocardial energetics, myocardial oedema, fibrosis, and quantitative perfusion<\/span>. Journal of Cardiovascular Magnetic Resonance<\/span>, 27<\/span>, pp. 101632<\/span>. <\/a><\/p>","publicationid":"971175","date":"2025-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sahin D; Di Matteo A; Emery P<\/span> (2025)<\/span> Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: A comprehensive review<\/span>. Ann Clin Biochem<\/span>, 62<\/span>, (1)<\/span>, pp. 3-21<\/span>. <\/a> <\/a><\/p>","publicationid":"832619","date":"2025-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

DI Matteo A; Emery P<\/span> (2024)<\/span> Rheumatoid arthritis: a review of the key clinical features and ongoing challenges of the disease<\/span>. Panminerva Med<\/span>, 66<\/span>, (4)<\/span>, pp. 427-442<\/span>. <\/a><\/p>","publicationid":"906841","date":"2024-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rooney CM; Jeffery IB; Mankia K; Wilcox MH; Emery P<\/span> (2024)<\/span> Dynamics of the gut microbiome in individuals at risk of rheumatoid arthritis: a cross-sectional and longitudinal observational study<\/span>. Ann Rheum Dis<\/span>, 84<\/span>, (4)<\/span>, pp. ard-2024-226362-574<\/span>. <\/a><\/p>","publicationid":"884302","date":"2024-11-08","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Aletaha D; Combe BG; Tanaka Y; Caporali R; Schulze-Koops H; Takeuchi T; Gottenberg J-E; Blanco R; Verschueren P; Zubrzycka-Sienkiewicz A; De Leonardis F; Ekoka Omoruyi EV; Rajendran V; Emery P<\/span> (2024)<\/span> Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study<\/span>. RMD Open<\/span>, 10<\/span>, (4)<\/span>, pp. e004476<\/span>. <\/a><\/p>","publicationid":"867963","date":"2024-10-24","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Deane KD; Holers VM; Emery P; Mankia K; El-Gabalawy H; Sparks JA; Costenbader KH; Schett G; van der Helm-van Mil A; van Schaardenburg D; Thomas R; Cope AP<\/span> (2024)<\/span> Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease<\/span>. Ann Rheum Dis<\/span>, 84<\/span>, (1)<\/span>, pp. ard-2023-224211-28<\/span>. <\/a> <\/a><\/p>","publicationid":"832618","date":"2024-09-24","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; De Lorenzis E; Duquenne L; Nam JL; Garcia-Montoya L; Harnden K; Chowdhury R; Wakefield RJ; Emery P; Mankia K<\/span> (2024)<\/span> Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction<\/span>. Rheumatology (Oxford)<\/span>, 63<\/span>, (8)<\/span>, pp. 2213-2221<\/span>. <\/a><\/p>","publicationid":"635898","date":"2024-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brady S; Mott A; Carlisle K; Abhishek A; Adamson J; Coates L; van Duren B; Emery P; Goodman SM; Hewitt C; Li J; Mandefield L; Parkinson G; Marzo-Ortega H; Maxwell J; Nanchahal J; Rangan A; Richards D; Ronaldson S; Shepherd S; Taylor J; Wilkinson JM; Pandit H; Mankia KS<\/span> (2024)<\/span> PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study<\/span>. BMJ Open<\/span>, 14<\/span>, (6)<\/span>, pp. e084997<\/span>. <\/a> <\/a><\/p>","publicationid":"771323","date":"2024-06-23","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sparks JA; Dieud\u00e9 P; Hoffmann-Vold A-M; Burmester GR; Walsh SL; Kreuter M; Stock C; Sambevski S; Alves M; Emery P<\/span> (2024)<\/span> Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis<\/span>. BMC Rheumatol<\/span>, 8<\/span>, (1)<\/span>, pp. 19<\/span>. <\/a><\/p>","publicationid":"657662","date":"2024-05-21","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Anioke I; Duquenne L; Parmar R; Mankia K; Shuweihdi F; Emery P; Ponchel F<\/span> (2024)<\/span> Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals<\/span>. Rheumatology (Oxford)<\/span>, 63<\/span>, (6)<\/span>, pp. 1720-1732<\/span>. <\/a> <\/a><\/p>","publicationid":"629136","date":"2024-05-03","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gul H; Di Matteo A; Anioke I; Shuweidhi F; Mankia K; Ponchel F; Emery P<\/span> (2024)<\/span> Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy<\/span>. ACR Open Rheumatol<\/span>, 6<\/span>, (5)<\/span>, pp. 294-303<\/span>. <\/a> <\/a><\/p>","publicationid":"646456","date":"2024-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pontarini E; Sciacca E; Chowdhury F; Grigoriadou S; Rivellese F; Murray-Brown WJ; Lucchesi D; Fossati-Jimack L; Nerviani A; Jaworska E; Ghirardi GM; Giacomassi C; Emery P; Ng WF; Sutcliffe N; Everett C; Fernandez C; Tappuni A; Seror R; Mariette X; Porcher R; Cavallaro G; Pulvirenti A; Verstappen GM; de Wolff L; Arends S; Bootsma H; Lewis MJ; Pitzalis C; Bowman SJ; Bombardieri M; Trial for Anti\u2013B Cell Therapy in Patients With Primary Sj\u00f6gren Syndrome Study Research Group<\/span> (2024)<\/span> Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sj\u00f6gren Syndrome (CRESS) and Sj\u00f6gren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sj\u00f6gren Syndrome (TRACTISS)<\/span>. Arthritis Rheumatol<\/span>, 76<\/span>, (5)<\/span>, pp. 763-776<\/span>. <\/a> <\/a><\/p>","publicationid":"640210","date":"2024-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston J; Marzetti M; Larkman N; Rowbotham E; Emery P; Grainger A<\/span> (2024)<\/span> Whole-body MRI for the investigation of joint involvement in inflammatory arthritis<\/span>. Skeletal Radiol<\/span>, 53<\/span>, (5)<\/span>, pp. 935-945<\/span>. <\/a> <\/a><\/p>","publicationid":"638262","date":"2024-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; Mankia K; Garcia-Montoya L; Sharrack S; Duquenne L; Nam JL; Mahler M; Emery P<\/span> (2024)<\/span> Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test<\/span>. RMD Open<\/span>, 10<\/span>, (2)<\/span>, pp. e003927<\/span>. <\/a> <\/a><\/p>","publicationid":"650870","date":"2024-04-10","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hen O; Di Matteo A; Dubash SR; De Marco G; Tan AL; Emery P; Wakefield RJ; McGonagle DG; Helliwell P; Marzo-Ortega H<\/span> (2024)<\/span> High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort<\/span>. RMD Open<\/span>, 10<\/span>, (2)<\/span>, pp. e003841<\/span>. <\/a> <\/a><\/p>","publicationid":"650614","date":"2024-04-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

David P; Di Matteo A; Hen O; Dass S; Marzo-Ortega H; Wakefield RJ; Bissell L-A; Nam J; Mankia K; Emery P; Saleem B; McGonagle D<\/span> (2024)<\/span> Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes<\/span>. Arthritis Rheumatol<\/span>, 76<\/span>, (4)<\/span>, pp. 510-521<\/span>. <\/a> <\/a><\/p>","publicationid":"639153","date":"2024-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zhao SS; Rogers K; Kearsley-Fleet L; Watson K; Bosworth A; Galloway J; Verstappen S; Plant D; BSRBR-RA Contributors Group, BRAGGSS Collaborators; Barton A; Hyrich KL; Humphreys JH<\/span> (2024)<\/span> Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 63<\/span>, (3)<\/span>, pp. 648-656<\/span>. <\/a> <\/a><\/p>","publicationid":"648376","date":"2024-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hemgren C; Martinsson K; Rooney C; Wetter\u00f6 J; Mankia K; Emery P; Kastbom A<\/span> (2024)<\/span> Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis<\/span>. J Rheumatol<\/span>, 51<\/span>, (2)<\/span>, pp. 134-138<\/span>. <\/a> <\/a><\/p>","publicationid":"645454","date":"2024-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Garcia-Montoya L; Kang J; Duquenne L; Di Matteo A; Nam JL; Harnden K; Chowdhury R; Mankia K; Emery P<\/span> (2024)<\/span> Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study<\/span>. Lancet Rheumatol<\/span>, 6<\/span>, (2)<\/span>, pp. e72-e80<\/span>. <\/a> <\/a><\/p>","publicationid":"643511","date":"2024-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Curtis JR; Emery P; Downie B; Zhong Y; Liu J; Han L; Hawtin RE; Burmester GR<\/span> (2024)<\/span> Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis<\/span>. Rheumatol Ther<\/span>, 11<\/span>, (1)<\/span>, pp. 177-189<\/span>. <\/a> <\/a><\/p>","publicationid":"639154","date":"2024-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Ouwerkerk L; Verschueren P; Boers M; Emery P; de Jong PHP; Landew\u00e9 RB; Lems W; Smolen JS; Huizinga TW; Allaart CF; Bergstra SA<\/span> (2024)<\/span> Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?<\/span> Ann Rheum Dis<\/span>, 83<\/span>, (1)<\/span>, pp. 65-71<\/span>. <\/a><\/p>","publicationid":"628492","date":"2024-01-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gottenberg JE; Buch MH; Aletaha D; Caporali R; Combe B; Schultze-Koops H; Tanaka Y; Blanco R; Takeuchi T; Ekoka Omoruyi EV; Van Beneden K; Rajendran V; Watson C; De Leonardis F; Emery P<\/span> (2023)<\/span> Efficacit\u00e9 du filgotinib chez des patients atteints de polyarthrite rhumato\u00efde\u00a0: r\u00e9sultats \u00e0 la Semaine 156\u00a0d\u2019une \u00e9tude d\u2019extension long terme<\/span>. Revue du Rhumatisme<\/span>, 90<\/span>, pp. A148-A149<\/span>. <\/a><\/p>","publicationid":"1103342","date":"2023-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; Bathon JM; Emery P<\/span> (2023)<\/span> Rheumatoid arthritis<\/span>. Lancet<\/span>, 402<\/span>, (10416)<\/span>, pp. 2019-2033<\/span>. <\/a> <\/a><\/p>","publicationid":"639193","date":"2023-11-25","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pitaksalee R; Parmar R; Hodgett R; Emery P; Ponchel F<\/span> (2023)<\/span> DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms<\/span>. Cells<\/span>, 12<\/span>, (19)<\/span>, pp. 2376<\/span>. <\/a> <\/a><\/p>","publicationid":"630741","date":"2023-09-28","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gouze H; Backhaus M; Balint P; Di Matteo A; Grassi W; Iagnocco A; Naredo E; Wakefield RJ; \u00d8stergaard M; Emery P; D'Agostino M-A<\/span> (2023)<\/span> Ultrasound in the Management of Patients With Psoriatic Arthritis: Systematic Literature Review and Novel Algorithms for Pragmatic Use<\/span>. J Rheumatol<\/span>, 51<\/span>, (1)<\/span>, pp. jrheum.2023-jrheum.0091<\/span>. <\/a><\/p>","publicationid":"630243","date":"2023-09-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Curtis JR; Emery P; Kricorian G; Yen PK; Collier DH; Bykerk V; Haraoui B<\/span> (2023)<\/span> Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis<\/span>. J Rheumatol<\/span>, 50<\/span>, (9)<\/span>, pp. 1114-1120<\/span>. <\/a><\/p>","publicationid":"617217","date":"2023-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

David T; Su L; Cheng Y; Gordon C; Parker B; Isenberg D; Reynolds JA; Bruce IN; International Collaborating Clinics Consortium; MASTERPLANS Consortium<\/span> (2023)<\/span> Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort<\/span>. Lupus<\/span>, 32<\/span>, (9)<\/span>, pp. 1043-1055<\/span>. <\/a><\/p>","publicationid":"1039492","date":"2023-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Duquenne L; Hensor EM; Wilson M; Garcia-Montoya L; Nam JL; Wu J; Harnden K; Anioke IC; Di Matteo A; Chowdhury R; Sidhu N; Ponchel F; Mankia K; Emery P<\/span> (2023)<\/span> Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification<\/span>. Ann Intern Med<\/span>, 176<\/span>, (8)<\/span>, pp. 1027-1036<\/span>. <\/a> <\/a><\/p>","publicationid":"626405","date":"2023-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tuttle J; Emery P; Nirula A<\/span> (2023)<\/span> Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. Reply<\/span>. N Engl J Med<\/span>, 389<\/span>, (4)<\/span>, pp. 378-379<\/span>. <\/a><\/p>","publicationid":"626623","date":"2023-07-27","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Matteson EL; Matucci-Cerinic M; Kreuter M; Burmester GR; Dieud\u00e9 P; Emery P; Allanore Y; Pope J; Khanna D<\/span> (2023)<\/span> Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review<\/span>. RMD Open<\/span>, 9<\/span>, (3)<\/span>, pp. e003059<\/span>. <\/a> <\/a><\/p>","publicationid":"626622","date":"2023-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Tanaka Y; Bykerk VP; Huizinga TWJ; Citera G; Bingham CO; Banerjee S; Soule BP; Nys M; Connolly SE; Lozenski KL; Zhuo J; Wong R; Huang K-HG; Fleischmann R<\/span> (2023)<\/span> Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis<\/span>. Rheumatol Ther<\/span>, 10<\/span>, (3)<\/span>, pp. 707-727<\/span>. <\/a><\/p>","publicationid":"614663","date":"2023-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hum RM; Ho P; Nair N; Jani M; Morgan AW; Isaacs JD; Wilson AG; Hyrich KL; Plant D; Barton A; BRAGGSS Collaborators<\/span> (2023)<\/span> Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 62<\/span>, (6)<\/span>, pp. 2090-2097<\/span>. <\/a> <\/a><\/p>","publicationid":"594663","date":"2023-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aletaha D; Kerschbaumer A; Kastrati K; Dejaco C; Dougados M; McInnes IB; Sattar N; Stamm TA; Takeuchi T; Trauner M; van der Heijde D; Voshaar M; Winthrop KL; Ravelli A; Betteridge N; Burmester G-RR; Bijlsma JW; Bykerk V; Caporali R; Choy EH; Codreanu C; Combe B; Crow MK; de Wit M; Emery P; Fleischmann RM; Gabay C; Hetland ML; Hyrich KL; Iagnocco A; Isaacs JD; Kremer JM; Mariette X; Merkel PA; Mysler EF; Nash P; Nurmohamed MT; Pavelka K; Poor G; Rubbert-Roth A; Schulze-Koops H; Strangfeld A; Tanaka Y; Smolen JS<\/span> (2023)<\/span> Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update<\/span>. Ann Rheum Dis<\/span>, 82<\/span>, (6)<\/span>, pp. 773-787<\/span>. <\/a> <\/a><\/p>","publicationid":"591686","date":"2023-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tuttle J; Drescher E; Sim\u00f3n-Campos JA; Emery P; Greenwald M; Kivitz A; Rha H; Yachi P; Kiley C; Nirula A<\/span> (2023)<\/span> A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis<\/span>. N Engl J Med<\/span>, 388<\/span>, (20)<\/span>, pp. 1853-1862<\/span>. <\/a> <\/a><\/p>","publicationid":"618949","date":"2023-05-18","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Carter LM; Alase A; Wigston Z; Psarras A; Burska A; Sutton E; Yusof MYM; Reynolds JA; MASTERPLANS Consortium; McHugh N; Emery P; Wittmann M; Bruce IN; Vital EM<\/span> (2023)<\/span> Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry-Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus<\/span>. Arthritis Rheumatol<\/span>, 75<\/span>, (5)<\/span>, pp. 697-710<\/span>. <\/a> <\/a><\/p>","publicationid":"597666","date":"2023-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Tanaka Y; Bykerk VP; Bingham CO; Huizinga TWJ; Citera G; Huang K-HG; Wu C; Connolly SE; Elbez Y; Wong R; Lozenski K; Fleischmann R<\/span> (2023)<\/span> The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study<\/span>. Arthritis Res Ther<\/span>, 25<\/span>, (1)<\/span>, pp. 67<\/span>. <\/a><\/p>","publicationid":"617218","date":"2023-04-22","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2023)<\/span> Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis<\/span>. Journal of Rheumatology<\/span>, 50<\/span>, (9)<\/span>, pp. 1114-1120<\/span>. <\/a> <\/a><\/p>","publicationid":"635337","date":"2023-04-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Siddle HJ; Bradley SH; Anderson AM; Mankia K; Emery P; Richards SH<\/span> (2023)<\/span> Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice<\/span>. Br J Gen Pract<\/span>, 73<\/span>, (729)<\/span>, pp. 152-154<\/span>. <\/a> <\/a><\/p>","publicationid":"615791","date":"2023-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Ouwerkerk L; Boers M; Emery P; de Jong PH; Landew\u00e9 RB; Lems W; Smolen JS; Verschueren P; Huizinga TW; Allaart CF; Bergstra SA<\/span> (2023)<\/span> Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 82<\/span>, (4)<\/span>, pp. 468-475<\/span>. <\/a> <\/a><\/p>","publicationid":"609840","date":"2023-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Volkmann ER; Sparks JA; Hoffmann-Vold A-M; Doyle TJ; Emery P; Dieud\u00e9 P<\/span> (2023)<\/span> Preclinical\/subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences<\/span>. Lancet Rheumatol<\/span>, 5<\/span>, (3)<\/span>, pp. e116-e118<\/span>. <\/a> <\/a><\/p>","publicationid":"614668","date":"2023-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rabin T; De Marco G; Dubash SR; Shuweihdi F; Marzo-Ortega H; Emery P; Ponchel F; Goeb V<\/span> (2023)<\/span> Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis<\/span>. Clin Exp Rheumatol<\/span>, 41<\/span>, (3)<\/span>, pp. 694-703<\/span>. <\/a> <\/a><\/p>","publicationid":"589713","date":"2023-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P<\/span> (2023)<\/span> Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study<\/span>. Lancet Rheumatol<\/span>, 5<\/span>, (2)<\/span>, pp. e88-e98<\/span>. <\/a> <\/a><\/p>","publicationid":"611101","date":"2023-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Martinsson K; Di Matteo A; \u00d6hman C; Johansson A; Sv\u00e4rd A; Mankia K; Emery P; Kastbom A<\/span> (2023)<\/span> Antibodies to leukotoxin A from the periodontal pathogen Aggregatibacter actinomycetemcomitans in patients at an increased risk of rheumatoid arthritis<\/span>. Front Med (Lausanne)<\/span>, 10<\/span>, pp. 1176165<\/span>. <\/a><\/p>","publicationid":"628297","date":"2023-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Curtis JR; Stolshek B; Emery P; Haraoui B; Karis E; Kricorian G; Collier DH; Yen PK; Bykerk VP<\/span> (2023)<\/span> Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA Trial<\/span>. J Clin Rheumatol<\/span>, 29<\/span>, (1)<\/span>, pp. 16-22<\/span>. <\/a> <\/a><\/p>","publicationid":"609148","date":"2023-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Biglands JD; Erhayiem B; Fent G; Greenwood JP; Dumitru RB; Andrews J; Emery P; Buch MH; Plein S<\/span> (2023)<\/span> No differences in myocardial perfusion between treatment-naive, early rheumatoid arthritis patients and healthy controls<\/span>. Arthritis Rheumatol<\/span>, 75<\/span>, (1)<\/span>, pp. 141-142<\/span>. <\/a> <\/a><\/p>","publicationid":"592765","date":"2023-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gavan SP; Bruce IN; Payne K; MASTERPLANS Consortium<\/span> (2023)<\/span> Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases<\/span>. Value Health<\/span>, 26<\/span>, (1)<\/span>, pp. 115-122<\/span>. <\/a><\/p>","publicationid":"592259","date":"2023-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gul HL; Di Matteo A; Mankia K; Wu J; Ponchel F; Emery P<\/span> (2023)<\/span> Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?<\/span> Clin Exp Rheumatol<\/span>, 41<\/span>, (1)<\/span>, pp. 126-136<\/span>. <\/a> <\/a><\/p>","publicationid":"588359","date":"2023-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wu C; Hu Y; Schafer P; Connolly SE; Wong R; Nielsen SH; Bay-Jensen A-C; Emery P; Tanaka Y; Bykerk VP; Bingham CO; Huizinga TW; Fleischmann R; Liu J<\/span> (2022)<\/span> Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis<\/span>. RMD Open<\/span>, 8<\/span>, (2)<\/span>, pp. e002683<\/span>. <\/a><\/p>","publicationid":"610350","date":"2022-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ponchel F; Duquenne L; Xie X; Corscadden D; Shuweihdi F; Mankia K; Trouw LA; Emery P<\/span> (2022)<\/span> Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals<\/span>. RMD Open<\/span>, 8<\/span>, (2)<\/span>, pp. e002512<\/span>. <\/a> <\/a><\/p>","publicationid":"609839","date":"2022-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Taylor CA; Watson RA; Tong O; Ye W; Nassiri I; Gilchrist JJ; de Los Aires AV; Sharma PK; Koturan S; Cooper RA; Woodcock VK; Jungkurth E; Shine B; Coupe N; Payne MJ; Church DN; Naranbhai V; Groha S; Emery P; Mankia K; Freedman ML; Choueiri TK; Middleton MR; Gusev A; Fairfax BP<\/span> (2022)<\/span> IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma<\/span>. Nat Med<\/span>, 28<\/span>, (12)<\/span>, pp. 2592-2600<\/span>. <\/a> <\/a><\/p>","publicationid":"609657","date":"2022-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Robinson JI; Md Yusof MY; Davies V; Wild D; Morgan M; Taylor JC; El-Sherbiny Y; Morris DL; Liu L; Rawstron AC; Buch MH; Plant D; Cordell HJ; Isaacs JD; Bruce IN; Emery P; Barton A; Vyse TJ; Barrett JH; Vital EM; Morgan AW; MATURA Consortia; MASTERPLANS Consortia<\/span> (2022)<\/span> Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity<\/span>. EBioMedicine<\/span>, 86<\/span>, pp. 104343<\/span>. <\/a> <\/a><\/p>","publicationid":"597403","date":"2022-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cooles FAH; Tarn J; Lendrem DW; Naamane N; Lin CM; Millar B; Maney NJ; Anderson AE; Thalayasingam N; Diboll J; Bondet V; Duffy D; Barnes MR; Smith GR; Ng S; Watson D; Henkin R; Cope AP; Reynard LN; Pratt AG; RA-MAP Consortium; Isaacs JD<\/span> (2022)<\/span> Interferon-\u03b1-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming<\/span>. Ann Rheum Dis<\/span>, 81<\/span>, (9)<\/span>, pp. 1214-1223<\/span>. <\/a> <\/a><\/p>","publicationid":"591971","date":"2022-08-11","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; Duquenne L; Cipolletta E; Nam JL; Garcia-Montoya L; Wakefield RJ; Mahler M; Mankia K; Emery P<\/span> (2022)<\/span> Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum<\/span>. Rheumatology (Oxford)<\/span>, 61<\/span>, (8)<\/span>, pp. 3192-3200<\/span>. <\/a> <\/a><\/p>","publicationid":"574889","date":"2022-08-03","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pepple S; Arnold J; Vital EM; Rawstron AC; Pease CT; Dass S; Emery P; Md Yusof MY<\/span> (2022)<\/span> Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sj\u00f6gren Syndrome<\/span>. ACR Open Rheumatol<\/span>, 4<\/span>, (8)<\/span>, pp. 689-699<\/span>. <\/a> <\/a><\/p>","publicationid":"587739","date":"2022-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schreiber S; Puig L; Gon\u00e7alves J; Mease PJ; Panaccione R; Emery P<\/span> (2022)<\/span> Critical appraisal and future outlook on anti-inflammatory biosimilar use in chronic immune-mediated inflammatory diseases<\/span>. Semin Arthritis Rheum<\/span>, 55<\/span>, pp. 152023<\/span>. <\/a> <\/a><\/p>","publicationid":"585903","date":"2022-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bertham DP; Tan AL; Booth A; Paton L; Emery P; Biglands J; Farrow M<\/span> (2022)<\/span> Repeatability of quantitative MRI in patients with rheumatoid arthritis<\/span>. Radiography (Lond)<\/span>, 28<\/span>, (3)<\/span>, pp. 831-837<\/span>. <\/a> <\/a><\/p>","publicationid":"577757","date":"2022-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2022)<\/span> Interferon-\u03b1-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming<\/span>. Annals of the Rheumatic Diseases<\/span>.<\/p>","publicationid":"598317","date":"2022-06-09","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; O'Dwyer J; Meads D; Emery P; Conaghan PG; Helliwell PS<\/span> (2022)<\/span> Treat-to-target in psoriatic arthritis-cost-effective in the biosimilar era<\/span>. Lancet Rheumatol<\/span>, 4<\/span>, (6)<\/span>, pp. e390-e391<\/span>. <\/a> <\/a><\/p>","publicationid":"584076","date":"2022-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Myasoedova E; Athreya AP; Crowson CS; Davis JM; Warrington KJ; Walchak RC; Carlson E; Kalari KR; Bongartz T; Tak PP; van Vollenhoven RF; Padyukov L; Emery P; Morgan A; Wang L; Weinshilboum RM; Matteson EL; Pharmacogenetics of Methotrexate in Rheumatoid Arthritis Consortium<\/span> (2022)<\/span> Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach<\/span>. Arthritis Care Res (Hoboken)<\/span>, 74<\/span>, (6)<\/span>, pp. 879-888<\/span>. <\/a> <\/a><\/p>","publicationid":"575221","date":"2022-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; Mankia K; Wakefield RJ; Emery P<\/span> (2022)<\/span> Response to: 'Pisotriquetral arthritis: 'forgotten' joint in ultrasound imaging of the wrist' by Becciolini et al<\/span>. Ann Rheum Dis<\/span>, 81<\/span>, (6)<\/span>, pp. e98<\/span>. <\/a> <\/a><\/p>","publicationid":"527637","date":"2022-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

RA-MAP Consortium<\/span> (2022)<\/span> RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients<\/span>. Sci Data<\/span>, 9<\/span>, (1)<\/span>, pp. 196<\/span>. <\/a> <\/a><\/p>","publicationid":"586265","date":"2022-05-09","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dubash S; Alabas OA; Michelena X; Garcia-Montoya L; Wakefield RJ; Helliwell PS; Emery P; McGonagle DG; Tan AL; Marzo-Ortega H<\/span> (2022)<\/span> Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis<\/span>. Ann Rheum Dis<\/span>, 81<\/span>, (4)<\/span>, pp. 490-495<\/span>. <\/a> <\/a><\/p>","publicationid":"573636","date":"2022-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Green L; Eng S; Emery P; Del Galdo F<\/span> (2022)<\/span> Nailfold Microvascular Imaging by Dynamic Optical Coherence Tomography in Systemic Sclerosis: A Case-Controlled Pilot Study<\/span>. J Invest Dermatol<\/span>, 142<\/span>, (4)<\/span>, pp. 1050-1057<\/span>. <\/a> <\/a><\/p>","publicationid":"568557","date":"2022-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Ross RL; Bissell L-A; Aslam A; Mankia K; Duquenne L; Corsadden D; Carter C; Hughes P; Nadat FA; Mulipa P; Lobb M; Clarke B; Mbara K; Morton R; Dibb S; Chowdhury R; Newton D; Pike A; Kakkar V; Savic S; DelGaldo F; Emery P<\/span> (2022)<\/span> Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses<\/span>. RMD Open<\/span>, 8<\/span>, (1)<\/span>, pp. e002050<\/span>. <\/a> <\/a><\/p>","publicationid":"584256","date":"2022-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Ross RL; Duquenne L; Hughes P; Emery P<\/span> (2022)<\/span> COVID-19 vaccine-induced T-cell responses in patients with rheumatoid arthritis: preferential induction by ChAdOx1<\/span>. Lancet Rheumatol<\/span>, 4<\/span>, (3)<\/span>, pp. e171-e172<\/span>. <\/a> <\/a><\/p>","publicationid":"579367","date":"2022-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ahmad HA; Baker JF; Conaghan PG; Emery P; Huizinga TWJ; Elbez Y; Banerjee S; \u00d8stergaard M<\/span> (2022)<\/span> Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept<\/span>. Arthritis Res Ther<\/span>, 24<\/span>, (1)<\/span>, pp. 47<\/span>. <\/a> <\/a><\/p>","publicationid":"576323","date":"2022-02-16","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Shukla R; Emery P; Buch MH<\/span> (2022)<\/span> Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the 'VEDERA' trial<\/span>. Rheumatology (Oxford)<\/span>, 61<\/span>, (2)<\/span>, pp. 868-869<\/span>. <\/a> <\/a><\/p>","publicationid":"570379","date":"2022-02-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Siddle HJ; Chapman LS; Mankia K; Z\u0103b\u0103lan C; Kouloumas M; Raza K; Falahee M; Kerry J; Kerschbaumer A; Aletaha D; Emery P; Richards SH<\/span> (2022)<\/span> Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies<\/span>. Ann Rheum Dis<\/span>, 81<\/span>, (2)<\/span>, pp. 159-168<\/span>. <\/a> <\/a><\/p>","publicationid":"569340","date":"2022-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Garcia-Montoya L; Nam JL; Duquenne L; Villota-Eraso C; Di Matteo A; Hartley C; Mankia K; Emery P<\/span> (2022)<\/span> Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study<\/span>. Arthritis Res Ther<\/span>, 24<\/span>, (1)<\/span>, pp. 26<\/span>. <\/a> <\/a><\/p>","publicationid":"577772","date":"2022-01-18","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fitton J; Melville A; Naraghi K; Nam J; Dass S; Emery P; Buch MH<\/span> (2022)<\/span> Single-centre experience of refractory rheumatoid arthritis<\/span>. Rheumatol Adv Pract<\/span>, 6<\/span>, (2)<\/span>, pp. rkac057<\/span>. <\/a><\/p>","publicationid":"591535","date":"2022-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wouters F; Maurits MP; van Boheemen L; Verstappen M; Mankia K; Matthijssen XME; Dorj\u00e9e AL; Emery P; Knevel R; van Schaardenburg D; Toes REM; van der Helm-van Mil AHM<\/span> (2022)<\/span> Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 81<\/span>, (1)<\/span>, pp. 48-55<\/span>. <\/a> <\/a><\/p>","publicationid":"564408","date":"2022-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tinazzi I; Mulipa P; Colato C; Abignano G; Ballarin A; Biasi D; Emery P; Ross RL; Del Galdo F<\/span> (2021)<\/span> SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker<\/span>. J Clin Med<\/span>, 10<\/span>, (24)<\/span>, pp. 5820<\/span>. <\/a> <\/a><\/p>","publicationid":"575561","date":"2021-12-13","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Downie B; Liu J; Hawtin RE; Curtis J; Burmester GR; Combe B<\/span> (2021)<\/span> Le filgotinib a d\u00e9montr\u00e9 une efficacit\u00e9 clinique dans la polyarthrite rhumato\u00efde ind\u00e9pendamment du statut tabagique\u00a0: analyse post-hoc en sous-groupes de 3\u00a0essais cliniques de phase 3<\/span>. Revue du Rhumatisme<\/span>, 88<\/span>, pp. A137-A138<\/span>. <\/a><\/p>","publicationid":"1103350","date":"2021-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mahmoud K; Zayat AS; Yusof MYM; Dutton K; Teh LS; Yee C-S; D'Cruz D; Ng N; Isenberg D; Ciurtin C; Conaghan PG; Emery P; Edwards CJ; Hensor EMA; Vital EM<\/span> (2021)<\/span> Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study<\/span>. Rheumatology (Oxford)<\/span>, 60<\/span>, (11)<\/span>, pp. 5194-5204<\/span>. <\/a> <\/a><\/p>","publicationid":"553430","date":"2021-11-03","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Garcia-Montoya L; Emery P<\/span> (2021)<\/span> Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials<\/span>. Expert Opin Investig Drugs<\/span>, 30<\/span>, (11)<\/span>, pp. 1109-1124<\/span>. <\/a> <\/a><\/p>","publicationid":"574618","date":"2021-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Siddle HJ; Kerschbaumer A; Alpizar Rodriguez D; Catrina AI; Ca\u00f1ete JD; Cope AP; Daien CI; Deane KD; El Gabalawy H; Finckh A; Holers VM; Koloumas M; Ometto F; Raza K; Zabalan C; van der Helm-van Mil A; van Schaardenburg D; Aletaha D; Emery P<\/span> (2021)<\/span> EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 80<\/span>, (10)<\/span>, pp. 1286-1298<\/span>. <\/a> <\/a><\/p>","publicationid":"564628","date":"2021-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Siddle H; Di Matteo A; Alp\u00edzar-Rodr\u00edguez D; Kerry J; Kerschbaumer A; Aletaha D; Emery P<\/span> (2021)<\/span> A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis<\/span>. RMD Open<\/span>, 7<\/span>, (3)<\/span>, pp. e001768<\/span>. <\/a> <\/a><\/p>","publicationid":"568543","date":"2021-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fitton J; Melville AR; Emery P; Nam JL; Buch MH<\/span> (2021)<\/span> Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway<\/span>. Rheumatology (Oxford)<\/span>, 60<\/span>, (9)<\/span>, pp. 4048-4054<\/span>. <\/a> <\/a><\/p>","publicationid":"546459","date":"2021-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Arnold J; Winthrop K; Emery P<\/span> (2021)<\/span> COVID-19 vaccination and antirheumatic therapy<\/span>. Rheumatology (Oxford)<\/span>, 60<\/span>, (8)<\/span>, pp. 3496-3502<\/span>. <\/a> <\/a><\/p>","publicationid":"553421","date":"2021-08-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Harrison SR; Burska AN; Emery P; Marzo-Ortega H; Ponchel F<\/span> (2021)<\/span> Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot study<\/span>. Rheumatology (Oxford)<\/span>, 60<\/span>, (8)<\/span>, pp. 3607-3616<\/span>. <\/a><\/p>","publicationid":"549104","date":"2021-08-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Melville AR; Md Yusof MY; Fitton J; Garcia-Montoya L; Bailey L; Dass S; Emery P; Buch MH; Saleem B<\/span> (2021)<\/span> Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 60<\/span>, (8)<\/span>, pp. 3679-3688<\/span>. <\/a> <\/a><\/p>","publicationid":"545712","date":"2021-08-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rooney CM; Mankia K; Mitra S; Moura IB; Emery P; Wilcox MH<\/span> (2021)<\/span> Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 60<\/span>, (7)<\/span>, pp. 3380-3387<\/span>. <\/a> <\/a><\/p>","publicationid":"544214","date":"2021-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; Mankia K; Nam JL; Cipolletta E; Garcia-Montoya L; Duquenne L; Rowbotham E; Emery P<\/span> (2021)<\/span> In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis<\/span>. Rheumatology (Oxford)<\/span>, 60<\/span>, (7)<\/span>, pp. 3156-3164<\/span>. <\/a> <\/a><\/p>","publicationid":"541753","date":"2021-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Emery P<\/span> (2021)<\/span> Should we aim for personalized prevention in individuals at risk of rheumatoid arthritis?<\/span> Int J Rheum Dis<\/span>, 24<\/span>, (5)<\/span>, pp. 621-622<\/span>. <\/a> <\/a><\/p>","publicationid":"547134","date":"2021-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Xu C; Rafique A; Potocky T; Paccaly A; Nolain P; Lu Q; Iglesias-Rodriguez M; St John G; Nivens MC; Kanamaluru V; Fairhurst J; Ishii T; Maldonado R; Choy E; Emery P<\/span> (2021)<\/span> Differential Binding of Sarilumab and Tocilizumab to IL-6R\u03b1 and Effects of Receptor Occupancy on Clinical Parameters<\/span>. J Clin Pharmacol<\/span>, 61<\/span>, (5)<\/span>, pp. 714-724<\/span>. <\/a> <\/a><\/p>","publicationid":"547070","date":"2021-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Curtis JR; Emery P; Karis E; Haraoui B; Bykerk V; Yen PK; Kricorian G; Chung JB<\/span> (2021)<\/span> Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission<\/span>. Arthritis Rheumatol<\/span>, 73<\/span>, (5)<\/span>, pp. 759-768<\/span>. <\/a><\/p>","publicationid":"545819","date":"2021-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Curtis JR; Emery P; Karis E; Haraoui B; Bykerk V; Yen PK; Kricorian G; Chung JB<\/span> (2021)<\/span> Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission<\/span>. Arthritis and Rheumatology<\/span>, 73<\/span>, (5)<\/span>, pp. 759-768<\/span>. <\/a> <\/a><\/p>","publicationid":"544210","date":"2021-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Farrow M; Biglands J; Tanner S; Hensor EMA; Buch MH; Emery P; Tan AL<\/span> (2021)<\/span> Muscle deterioration due to rheumatoid arthritis: assessment by quantitative MRI and strength testing<\/span>. Rheumatology (Oxford)<\/span>, 60<\/span>, (3)<\/span>, pp. 1216-1225<\/span>. <\/a> <\/a><\/p>","publicationid":"531325","date":"2021-03-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Psarras A; Antanaviciute A; Alase A; Carr I; Wittmann M; Emery P; Tsokos GC; Vital EM<\/span> (2021)<\/span> TNF-\u03b1 Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-\u03b1 Production and Enhancing T Cell Activation<\/span>. J Immunol<\/span>, 206<\/span>, (4)<\/span>, pp. 785-796<\/span>. <\/a> <\/a><\/p>","publicationid":"549400","date":"2021-02-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Corradini D; Di Matteo A; Emery P; Mankia K<\/span> (2021)<\/span> How should we treat palindromic rheumatism? A systematic literature review<\/span>. Semin Arthritis Rheum<\/span>, 51<\/span>, (1)<\/span>, pp. 266-277<\/span>. <\/a> <\/a><\/p>","publicationid":"545680","date":"2021-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cheng Z; Do T; Mankia K; Meade J; Hunt L; Clerehugh V; Speirs A; Tugnait A; Emery P; Devine D<\/span> (2021)<\/span> Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 80<\/span>, (2)<\/span>, pp. 162-168<\/span>. <\/a> <\/a><\/p>","publicationid":"538319","date":"2021-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Farrow M; Biglands J; Tanner SF; Clegg A; Brown L; Hensor EMA; O'Connor P; Emery P; Tan AL<\/span> (2021)<\/span> The effect of ageing on skeletal muscle as assessed by quantitative MR imaging: an association with frailty and muscle strength<\/span>. Aging Clin Exp Res<\/span>, 33<\/span>, (2)<\/span>, pp. 291-301<\/span>. <\/a> <\/a><\/p>","publicationid":"521389","date":"2021-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Gul H; Emery P<\/span> (2021)<\/span> Treating rheumatoid arthritis to an imaging target produces better outcomes, or does it?<\/span> Rheumatology (Oxford)<\/span>, 60<\/span>, (1)<\/span>, pp. 3-4<\/span>. <\/a> <\/a><\/p>","publicationid":"534541","date":"2021-01-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Durez P; Hueber AJ; de la Torre I; Larsson E; Holzk\u00e4mper T; Tanaka Y<\/span> (2021)<\/span> Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis-a comprehensive review<\/span>. Arthritis Res Ther<\/span>, 23<\/span>, (1)<\/span>, pp. 3<\/span>. <\/a> <\/a><\/p>","publicationid":"546458","date":"2021-01-04","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dubash SR; Alabas OA; Michelena X; Garcia-Montoya L; De Marco G; Merashli M; Wakefield RJ; Emery P; McGonagle D; Tan AL; Marzo-Ortega H<\/span> (2021)<\/span> Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-na\u00efve early psoriatic arthritis<\/span>. Rheumatol Adv Pract<\/span>, 5<\/span>, (3)<\/span>, pp. rkab086<\/span>. <\/a> <\/a><\/p>","publicationid":"576032","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Arnold J; Vital EM; Dass S; Aslam A; Rawstron AC; Savic S; Emery P; Md Yusof MY<\/span> (2021)<\/span> A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis<\/span>. Front Immunol<\/span>, 12<\/span>, pp. 803175<\/span>. <\/a> <\/a><\/p>","publicationid":"575246","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

RA-MAP Consortium<\/span> (2021)<\/span> Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study<\/span>. Ther Adv Musculoskelet Dis<\/span>, 13<\/span>, pp. 1759720X211043977-17<\/span>. <\/a> <\/a><\/p>","publicationid":"571166","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Breedveld F; Campos-Alberto E; Szumski AE; Hirose T<\/span> (2021)<\/span> Clinical, radiologic, and functional outcomes following methotrexate withdrawal in etanercept-treated patients with active early rheumatoid arthritis: A subanalysis of comet year 2 by week 52 das28 status<\/span>. Open Rheumatology Journal<\/span>, 15<\/span>, (1)<\/span>, pp. 31-38<\/span>. <\/a> <\/a><\/p>","publicationid":"563420","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bagnato G; Pigatto E; Bitto A; Pizzino G; Irrera N; Abignano G; Ferrera A; Sciortino D; Wilson M; Squadrito F; Buch MH; Emery P; Zanatta E; Gangemi S; Saitta A; Cozzi F; Roberts WN; Del Galdo F<\/span> (2021)<\/span> The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis<\/span>. Front Med (Lausanne)<\/span>, 8<\/span>, (1)<\/span>, pp. 651748<\/span>. <\/a> <\/a><\/p>","publicationid":"551964","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kim H; Alten R; Cummings F; Danese S; D'Haens G; Emery P; Ghosh S; Gilletta de Saint Joseph C; Lee J; Lindsay JO; Nikiphorou E; Parker B; Schreiber S; Simoens S; Westhovens R; Jeong JH; Peyrin-Biroulet L<\/span> (2021)<\/span> Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters<\/span>. MAbs<\/span>, 13<\/span>, (1)<\/span>, pp. 1868078<\/span>. <\/a> <\/a><\/p>","publicationid":"551826","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nash P; Kerschbaumer A; D\u00f6rner T; Dougados M; Fleischmann RM; Geissler K; McInnes I; Pope JE; van der Heijde D; Stoffer-Marx M; Takeuchi T; Trauner M; Winthrop KL; de Wit M; Aletaha D; Baraliakos X; Boehncke W-H; Emery P; Isaacs JD; Kremer J; Lee EB; Maksymowych WP; Voshaar M; Tam L-S; Tanaka Y; van den Bosch F; Westhovens R; Xavier R; Smolen JS<\/span> (2021)<\/span> Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement<\/span>. Ann Rheum Dis<\/span>, 80<\/span>, (1)<\/span>, pp. 71-87<\/span>. <\/a> <\/a><\/p>","publicationid":"544213","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Farrow M; Biglands JD; Grainger AJ; O'Connor P; Hensor EMA; Ladas A; Tanner SF; Emery P; Tan AL<\/span> (2021)<\/span> Quantitative MRI in myositis patients: comparison with healthy volunteers and radiological visual assessment<\/span>. Clin Radiol<\/span>, 76<\/span>, (1)<\/span>, pp. 81.e1-81.e10<\/span>. <\/a> <\/a><\/p>","publicationid":"538316","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ponchel F; van Delft MAM; Xie X; Burska AN; Duquenne L; Trouw LA; Emery P<\/span> (2021)<\/span> Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?<\/span> Clin Exp Rheumatol<\/span>, 39<\/span>, (1)<\/span>, pp. 146-150<\/span>. <\/a> <\/a><\/p>","publicationid":"526052","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burska AN; El-Jawhari JJ; Wu J; Wakefield RJ; Marzo-Ortega H; Conaghan PG; Emery P; Ponchel F; Freeston JE<\/span> (2021)<\/span> Receptor activator of nuclear factor kappa-\u0392 ligand (RANKL) serum levels are associated with progression to seropositive\/negative rheumatoid arthritis<\/span>. Clin Exp Rheumatol<\/span>, 39<\/span>, (3)<\/span>, pp. 456-462<\/span>. <\/a> <\/a><\/p>","publicationid":"526049","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ponchel F; Churchman S; El-Jawhari JJ; Burska AN; Chambers P; Vital EM; El-Sherbiny YM; Jones E; Conaghan PG; Goeb V; Emery P<\/span> (2021)<\/span> Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium<\/span>. Clin Exp Rheumatol<\/span>, 39<\/span>, (2)<\/span>, pp. 253-262<\/span>. <\/a> <\/a><\/p>","publicationid":"523012","date":"2021-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pachai C; Connolly S; Landis J; Tanaka Y; Bykerk V; Huizinga T; Citera G; Bingham C; Wong R; Huang K; Du S; Hayes W; Wu C; Fleischmann R; Gervais E; Emery P<\/span> (2020)<\/span> Impact du score d\u2019\u00e9rosion \u00e0 l\u2019inclusion sur la r\u00e9ponse th\u00e9rapeutique et l\u2019\u00e9volution radiographique de l\u2019atteinte structurale dans AVERT-2\u00a0: un essai randomis\u00e9 de phase IIIB avec l\u2019abatacept chez des patients atteints de PR r\u00e9cente, na\u00effs de MTX et ACPA+<\/span>. Revue du Rhumatisme<\/span>, 87<\/span>, pp. A145-A146<\/span>. <\/a><\/p>","publicationid":"1103358","date":"2020-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Psarras A; Alase A; Antanaviciute A; Carr IM; Md Yusof MY; Wittmann M; Emery P; Tsokos GC; Vital EM<\/span> (2020)<\/span> Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity<\/span>. Nat Commun<\/span>, 11<\/span>, (1)<\/span>, pp. 6149<\/span>. <\/a> <\/a><\/p>","publicationid":"543110","date":"2020-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Biglands JD; Grainger AJ; Robinson P; Tanner SF; Tan AL; Feiweier T; Evans R; Emery P; O'Connor P<\/span> (2020)<\/span> MRI in acute muscle tears in athletes: can quantitative T2 and DTI predict return to play better than visual assessment?<\/span> Eur Radiol<\/span>, 30<\/span>, (12)<\/span>, pp. 6603-6613<\/span>. <\/a> <\/a><\/p>","publicationid":"525637","date":"2020-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Calabrese LH; Emery P; Kivitz AJ; Tesser JRP<\/span> (2020)<\/span> Evolving treatment paradigms for rheumatoid arthritis: Translating comprehensive patient evaluations into personalized therapy<\/span>. Semin Arthritis Rheum<\/span>, 50<\/span>, (6)<\/span>, pp. 1549<\/span>. <\/a> <\/a><\/p>","publicationid":"493389","date":"2020-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Plein S; Erhayiem B; Fent G; Horton S; Dumitru RB; Andrews J; Greenwood JP; Emery P; Hensor EM; Baxter P; Pavitt S; Buch MH<\/span> (2020)<\/span> Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-na\u00efve, early rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (11)<\/span>, pp. 1414-1422<\/span>. <\/a> <\/a><\/p>","publicationid":"539311","date":"2020-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; van Hoogstraten H; Thangavelu K; Mangan E; St John G; Verschueren P<\/span> (2020)<\/span> Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open-Label Extension of a Randomized Clinical Trial<\/span>. ACR Open Rheumatol<\/span>, 2<\/span>, (11)<\/span>, pp. 672-680<\/span>. <\/a> <\/a><\/p>","publicationid":"538525","date":"2020-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; Mankia K; Duquenne L; Mahler M; Corscadden D; Mbara K; Garcia-Montoya L; Nam JL; Emery P<\/span> (2020)<\/span> Third-Generation Anti-Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis<\/span>. Arthritis Rheumatol<\/span>, 72<\/span>, (11)<\/span>, pp. 1820-1828<\/span>. <\/a> <\/a><\/p>","publicationid":"525981","date":"2020-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Iqbal K; Darby M; Lettieri G; Vital EM; Beirne P; Dass S; Emery P; Kelly C<\/span> (2020)<\/span> Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis<\/span>. Rheumatology (Oxford)<\/span>, 59<\/span>, (10)<\/span>, pp. 2838-2846<\/span>. <\/a> <\/a><\/p>","publicationid":"516261","date":"2020-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Suh C-H; Weinblatt ME; Smolen JS; Keystone EC; Genovese M; Vencovsky J; Kay J; Hong E; Baek Y; Ghil J<\/span> (2020)<\/span> Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis<\/span>. Scand J Rheumatol<\/span>, 49<\/span>, (5)<\/span>, pp. 361-370<\/span>. <\/a><\/p>","publicationid":"526622","date":"2020-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Helliwell PS; Coates LC; Chew NS; Lettieri G; Moverley AR; Freeston JE; Nam J; Waxman R; Emery P; Conaghan PG<\/span> (2020)<\/span> Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA Trial<\/span>. J Rheumatol<\/span>, 47<\/span>, (9)<\/span>, pp. 1338-1343<\/span>. <\/a> <\/a><\/p>","publicationid":"511053","date":"2020-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Kang YM; Yoo W-H; Emery P; Weinblatt ME; Keystone EC; Genovese MC; Myung G; Baek I; Ghil J<\/span> (2020)<\/span> Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis<\/span>. Arthritis Res Ther<\/span>, 22<\/span>, (1)<\/span>, pp. 188<\/span>. <\/a> <\/a><\/p>","publicationid":"534515","date":"2020-08-14","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; O'Donnell JS; Sharif K; Emery P; Bridgewood C<\/span> (2020)<\/span> Pulmonary intravascular coagulopathy in COVID-19 pneumonia - Authors' reply<\/span>. Lancet Rheumatol<\/span>, 2<\/span>, (8)<\/span>, pp. e460-e461<\/span>. <\/a> <\/a><\/p>","publicationid":"533973","date":"2020-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Burmester GR; Naredo E; Sinigaglia L; Lagunes I; Koenigsbauer F; Conaghan PG<\/span> (2020)<\/span> Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (8)<\/span>, pp. 1023-1030<\/span>. <\/a> <\/a><\/p>","publicationid":"524255","date":"2020-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Garcia-Montoya L; Villota-Eraso C; Yusof MYM; Vital EM; Emery P<\/span> (2020)<\/span> Lessons for rituximab therapy in patients with rheumatoid arthritis<\/span>. Lancet Rheumatol<\/span>, 2<\/span>, (8)<\/span>, pp. e497-e509<\/span>. <\/a> <\/a><\/p>","publicationid":"519147","date":"2020-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Tanaka Y; Cardillo T; Schlichting D; Rooney T; Beattie S; Helt C; Smolen JS<\/span> (2020)<\/span> Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis<\/span>. Arthritis Res Ther<\/span>, 22<\/span>, (1)<\/span>, pp. 166<\/span>. <\/a> <\/a><\/p>","publicationid":"533531","date":"2020-07-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Di Matteo A; Mankia K; Duquenne L; Cipolletta E; Wakefield RJ; Garcia-Montoya L; Nam JL; Emery P<\/span> (2020)<\/span> Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (7)<\/span>, pp. 901-907<\/span>. <\/a> <\/a><\/p>","publicationid":"524305","date":"2020-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; O'Donnell JS; Sharif K; Emery P; Bridgewood C<\/span> (2020)<\/span> Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia<\/span>. Lancet Rheumatol<\/span>, 2<\/span>, (7)<\/span>, pp. e437-e445<\/span>. <\/a> <\/a><\/p>","publicationid":"524264","date":"2020-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Vital EM; Emery P; Savic S<\/span> (2020)<\/span> Reply<\/span>. Arthritis Rheumatol<\/span>, 72<\/span>, (7)<\/span>, pp. 1231-1233<\/span>. <\/a> <\/a><\/p>","publicationid":"521475","date":"2020-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ahmad HA; Baker JF; \u00d8stergaard M; Emery P; Durez P; Ye J; Banerjee S; Conaghan PG<\/span> (2020)<\/span> Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis<\/span>. Arthritis Care Res (Hoboken)<\/span>, 72<\/span>, (7)<\/span>, pp. 959-964<\/span>. <\/a> <\/a><\/p>","publicationid":"508237","date":"2020-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alfuraih AM; Tan AL; O'Connor P; Emery P; Wakefield RJ<\/span> (2020)<\/span> Muscle stiffness in rheumatoid arthritis is not altered or associated with muscle weakness: A shear wave elastography study<\/span>. Mod Rheumatol<\/span>, 30<\/span>, (4)<\/span>, pp. 617-625<\/span>. <\/a> <\/a><\/p>","publicationid":"502330","date":"2020-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; D'Agostino M-A; Murillo-Gonz\u00e1lez J; Grainger A; Emery P<\/span> (2020)<\/span> Response to: 'Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?' by Deng et al<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (7)<\/span>, pp. e84<\/span>. <\/a> <\/a><\/p>","publicationid":"498806","date":"2020-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Rigby W; Tanaka Y; Ignacio Vargas J; Damjanov N; Jain M; Song Y; Khan N; Enejosa JJ; Cohen SB<\/span> (2020)<\/span> THU0213\u2005UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 84 WEEKS FROM THE SELECT-MONOTHERAPY STUDY<\/span>. Annals of the Rheumatic Diseases<\/span>, 79<\/span>, pp. 331-332<\/span>. <\/a><\/p>","publicationid":"1103360","date":"2020-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Tanaka Y; Bykerk V; Bingham C; Huizinga T; Citera G; Huang KHG; Connolly S; Elbez Y; Wong R; Lozenski K; Fleischmann R<\/span> (2020)<\/span> FRI0090\u2005MAINTENANCE OF CLINICAL RESPONSE WITH ABATACEPT IN COMBINATION WITH MTX IN INDIVIDUAL PATIENTS WITH EARLY RA WHO ARE MTX-NA\u00cfVE AND ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+: RESULTS FROM THE INDUCTION PERIOD OF AVERT-2, A RANDOMISED PHASE IIIB STUDY<\/span>. Annals of the Rheumatic Diseases<\/span>, 79<\/span>, pp. 623<\/span>. <\/a><\/p>","publicationid":"1103359","date":"2020-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; \u01festergaard M; Coates LC; Deodhar A; Quebe-Fehling E; Pellet P; Pricop L; Gaillez C; Van den Bosch F<\/span> (2020)<\/span> THU0373\u2005SECUKINUMAB DOSE ESCALATION ON ACR RESPONSES IN ANTI-TUMOUR NECROSIS FACTOR NA\u00cfVE PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 FUTURE 4 AND FUTURE 5 STUDIES<\/span>. Annals of the Rheumatic Diseases<\/span>, 79<\/span>, pp. 418-419<\/span>. <\/a><\/p>","publicationid":"1103351","date":"2020-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Duquenne L<\/span> (2020)<\/span> It's never too soon to treat rheumatoid arthritis: finally, some supportive evidence<\/span>. Lancet Rheumatol<\/span>, 2<\/span>, (6)<\/span>, pp. e311-e313<\/span>. <\/a> <\/a><\/p>","publicationid":"526270","date":"2020-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Landew\u00e9 RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg J-E; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; M\u00fcller-Ladner U; Mysler EF; da Silva JAP; Po\u00f3r G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D<\/span> (2020)<\/span> EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (6)<\/span>, pp. 685-699<\/span>. <\/a> <\/a><\/p>","publicationid":"517906","date":"2020-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Di Matteo A; Emery P<\/span> (2020)<\/span> Prevention and cure: The major unmet needs in the management of rheumatoid arthritis<\/span>. J Autoimmun<\/span>, 110<\/span>, pp. 102399<\/span>. <\/a> <\/a><\/p>","publicationid":"516251","date":"2020-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Tanaka Y; Cardillo T; Schlichting D; Rooney T; Beattie S; Helt C; Smolen JS<\/span> (2020)<\/span> Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis<\/span>. Arthritis Res Ther<\/span>, 22<\/span>, (1)<\/span>, pp. 115<\/span>. <\/a> <\/a><\/p>","publicationid":"525860","date":"2020-05-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

El-Sherbiny YM; Md Yusof MY; Psarras A; Hensor EMA; Kabba KZ; Dutton K; Mohamed AAA; Elewaut D; McGonagle D; Tooze R; Doody G; Wittmann M; Emery P; Vital EM<\/span> (2020)<\/span> B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus<\/span>. Arthritis Rheumatol<\/span>, 72<\/span>, (5)<\/span>, pp. 769-779<\/span>. <\/a> <\/a><\/p>","publicationid":"514911","date":"2020-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pitaksalee R; Burska AN; Ajaib S; Rogers J; Parmar R; Mydlova K; Xie X; Droop A; Nijjar JS; Chambers P; Emery P; Hodgett R; McInnes IB; Ponchel F<\/span> (2020)<\/span> Differential CpG DNA methylation in peripheral na\u00efve CD4+ T-cells in early rheumatoid arthritis patients<\/span>. Clin Epigenetics<\/span>, 12<\/span>, (1)<\/span>, pp. 54<\/span>. <\/a> <\/a><\/p>","publicationid":"521471","date":"2020-04-07","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Melville A; Buch M; Nam J; Emery P; Saleem B; Dass S<\/span> (2020)<\/span> P12\u2003Clinical responses, B cell depletion and treatment outcomes following rituximab biosimilar switch in RA: is there value in switching back?<\/span> Rheumatology<\/span>, 59<\/span>, (Supplement_2)<\/span>, pp. keaa111.011<\/span>. <\/a><\/p>","publicationid":"1103363","date":"2020-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Yusof YM; Dutton K1; Teh LS; Yee C-S; D'Cruz D; Ng N; Isenberg D; Ciurtin C; Conaghan P; Emery P; Edwards C; Hensor E; Vital EM<\/span> (2020)<\/span> P174 USEFUL I: musculoskeletal ultrasound to identify patients with lupus arthritis with better response to therapy<\/span>. Rheumatology<\/span>, 59<\/span>, (Supplement_2)<\/span>, pp. keaa111.169<\/span>. <\/a><\/p>","publicationid":"732935","date":"2020-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fautrel B; Zhu B; Taylor PC; van de Laar M; Emery P; De Leonardis F; Kannowski CL; Nicolay C; Kadziola Z; De La Torre I; Fleischmann R<\/span> (2020)<\/span> Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are na\u00efve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison<\/span>. RMD Open<\/span>, 6<\/span>, (1)<\/span>, pp. e001131<\/span>. <\/a> <\/a><\/p>","publicationid":"521479","date":"2020-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Horton S; Dumitru RB; Naraghi K; van der Heijde D; Wakefield RJ; Hensor EMA; Buch MH<\/span> (2020)<\/span> Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (4)<\/span>, pp. 464-471<\/span>. <\/a> <\/a><\/p>","publicationid":"517003","date":"2020-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Mahmood F; Freeston J; Emery P; Conaghan PG; Helliwell PS<\/span> (2020)<\/span> Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial<\/span>. Rheumatology (Oxford)<\/span>, 59<\/span>, (4)<\/span>, pp. 807-810<\/span>. <\/a> <\/a><\/p>","publicationid":"502724","date":"2020-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vlahos B; Szczypa P; Thakur M; Jones HE; Woolcott J; Santos Estrella PV; Rolland C; Gibofsky A; Citera G; Sockalingam S; Marshall L<\/span> (2020)<\/span> Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis<\/span>. J Rheumatol<\/span>, 47<\/span>, (4)<\/span>, pp. 493-501<\/span>. <\/a> <\/a><\/p>","publicationid":"499728","date":"2020-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kay J; D\u00f6rner T; Emery P; Kvien TK; Breedveld FC<\/span> (2020)<\/span> Clinical trial and 'real-world' data support switching from a bio-originator to its biosimilar<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (4)<\/span>, pp. e44-+<\/span>. <\/a> <\/a><\/p>","publicationid":"489162","date":"2020-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Furst DE; Kirchner P; Melega S; Lacey S; Lehane PB<\/span> (2020)<\/span> Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data<\/span>. Rheumatol Ther<\/span>, 7<\/span>, (1)<\/span>, pp. 121-131<\/span>. <\/a> <\/a><\/p>","publicationid":"513758","date":"2020-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gul HL; Eugenio G; Rabin T; Burska A; Parmar R; Wu J; Ponchel F; Emery P<\/span> (2020)<\/span> Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes<\/span>. Rheumatology (Oxford)<\/span>, 59<\/span>, (3)<\/span>, pp. 613-621<\/span>. <\/a> <\/a><\/p>","publicationid":"502659","date":"2020-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; D'Agostino M-A; Emery P<\/span> (2020)<\/span> Response to: 'Ultrasound findings in palindromic rheumatism' by Sanmarti et al<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (3)<\/span>, pp. e31<\/span>. <\/a> <\/a><\/p>","publicationid":"487466","date":"2020-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ponchel F; Burska AN; Hunt L; Gul H; Rabin T; Parmar R; Buch MH; Conaghan PG; Emery P<\/span> (2020)<\/span> T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum:\u00a0implications for management<\/span>. Sci Rep<\/span>, 10<\/span>, (1)<\/span>, pp. 3669<\/span>. <\/a> <\/a><\/p>","publicationid":"517598","date":"2020-02-28","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Briggs C; Emery P<\/span> (2020)<\/span> How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies-positive Patients Who Do Not Have Arthritis?<\/span> J Rheumatol<\/span>, 47<\/span>, (2)<\/span>, pp. 305-306<\/span>. <\/a> <\/a><\/p>","publicationid":"505012","date":"2020-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Duquenne L; Chowdhury R; Mankia K; Emery P<\/span> (2020)<\/span> The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on \"At-Risk\" Individuals<\/span>. Front Med (Lausanne)<\/span>, 7<\/span>, pp. 587827<\/span>. <\/a> <\/a><\/p>","publicationid":"544211","date":"2020-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hassan SU; Md Yusof MY; Emery P; Dass S; Vital EM<\/span> (2020)<\/span> Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab<\/span>. Front Med (Lausanne)<\/span>, 7<\/span>, pp. 498<\/span>. <\/a> <\/a><\/p>","publicationid":"540880","date":"2020-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rooney CM; Mankia K; Emery P<\/span> (2020)<\/span> The Role of the Microbiome in Driving RA-Related Autoimmunity<\/span>. Front Cell Dev Biol<\/span>, 8<\/span>, pp. 538130<\/span>. <\/a> <\/a><\/p>","publicationid":"540530","date":"2020-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lamana A; Villares R; Seoane IV; Andr\u00e9s N; Lucas P; Emery P; Vital EM; Triguero-Mart\u00ednez A; Marquez A; Ortiz AM; Maxime R; Mart\u00ednez C; Mart\u00edn J; Gomariz RP; Ponchel F; Gonz\u00e1lez-\u00c1lvaro I; Mellado M<\/span> (2020)<\/span> Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity<\/span>. Front Immunol<\/span>, 11<\/span>, pp. 1336<\/span>. <\/a> <\/a><\/p>","publicationid":"533932","date":"2020-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Choe J-Y; Weinblatt ME; Emery P; Keystone E; Genovese MC; Myung G; Hong E; Baek I; Ghil J<\/span> (2020)<\/span> Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis<\/span>. RMD Open<\/span>, 6<\/span>, (1)<\/span>, pp. e001096<\/span>. <\/a> <\/a><\/p>","publicationid":"517002","date":"2020-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mease PJ; Smolen JS; Behrens F; Nash P; Liu Leage S; Li L; Tahir H; Gooderham M; Krishnan E; Liu-Seifert H; Emery P; Pillai SG; Helliwell PS; SPIRIT H2H study group<\/span> (2020)<\/span> A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-na\u00efve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial<\/span>. Ann Rheum Dis<\/span>, 79<\/span>, (1)<\/span>, pp. 123-131<\/span>. <\/a> <\/a><\/p>","publicationid":"509195","date":"2020-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hamann PDH; Pauling JD; McHugh N; Shaddick G; Hyrich K; BSRBR-RA Contributors Group<\/span> (2019)<\/span> Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (12)<\/span>, pp. 2162-2169<\/span>. <\/a> <\/a><\/p>","publicationid":"516024","date":"2019-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alfuraih AM; Tan AL; O'Connor P; Emery P; Wakefield RJ<\/span> (2019)<\/span> The effect of ageing on shear wave elastography muscle stiffness in adults<\/span>. Aging Clin Exp Res<\/span>, 31<\/span>, (12)<\/span>, pp. 1755-1763<\/span>. <\/a> <\/a><\/p>","publicationid":"489047","date":"2019-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Emery P<\/span> (2019)<\/span> Palindromic rheumatism as part of the rheumatoid arthritis continuum<\/span>. Nat Rev Rheumatol<\/span>, 15<\/span>, (11)<\/span>, pp. 687-695<\/span>. <\/a> <\/a><\/p>","publicationid":"500728","date":"2019-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Vital EM; McElvenny DM; Hensor EMA; Das S; Dass S; Rawstron AC; Buch MH; Emery P; Savic S<\/span> (2019)<\/span> Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases<\/span>. Arthritis Rheumatol<\/span>, 71<\/span>, (11)<\/span>, pp. 1812-1823<\/span>. <\/a> <\/a><\/p>","publicationid":"499581","date":"2019-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burska AN; Thu A; Parmar R; Bzoma I; Samans B; Raschke E; Olek S; Conaghan PG; Emery P; Ponchel F<\/span> (2019)<\/span> Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (11)<\/span>, pp. 2015-2024<\/span>. <\/a> <\/a><\/p>","publicationid":"495690","date":"2019-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tarn JR; Howard-Tripp N; Lendrem DW; Mariette X; Saraux A; Devauchelle-Pensec V; Seror R; Skelton AJ; James K; McMeekin P; Al-Ali S; Hackett KL; Lendrem BC; Hargreaves B; Casement J; Mitchell S; Bowman SJ; Price E; Pease CT; Emery P; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Johnsen SJA; Norheim KB; Omdal R; Stocken D; Everett C; Fernandez C; Leeds CTRU; Isaacs JD; Gottenberg J-E; French ASSESS cohort; Ng W-F; UK Primary Sj\u00f6gren's Syndrome Registry<\/span> (2019)<\/span> Symptom-based stratification of patients with primary Sj\u00f6gren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials<\/span>. Lancet Rheumatol<\/span>, 1<\/span>, (2)<\/span>, pp. e85-e94<\/span>. <\/a> <\/a><\/p>","publicationid":"519333","date":"2019-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Britton J; Edward S; Hensor EMA; Goodfield MJ; Laws PM; Emery P; Wittmann M; Vital EM<\/span> (2019)<\/span> Validity and sensitivity to change of laser Doppler imaging as a novel objective outcome measure for cutaneous lupus erythematosus<\/span>. Lupus<\/span>, 28<\/span>, (11)<\/span>, pp. 1320-1328<\/span>. <\/a> <\/a><\/p>","publicationid":"508223","date":"2019-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alfuraih AM; Tan AL; O'Connor P; Emery P; Mackie S; Wakefield RJ<\/span> (2019)<\/span> Reduction in stiffness of proximal leg muscles during the first 6 months of glucocorticoid therapy for giant cell arteritis: A pilot study using shear wave elastography<\/span>. Int J Rheum Dis<\/span>, 22<\/span>, (10)<\/span>, pp. 1891-1899<\/span>. <\/a> <\/a><\/p>","publicationid":"503183","date":"2019-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Air\u00f2 P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E; EUSTAR Collaborators<\/span> (2019)<\/span> Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis<\/span>. Arthritis Rheumatol<\/span>, 71<\/span>, (9)<\/span>, pp. 1553-1570<\/span>. <\/a> <\/a><\/p>","publicationid":"506219","date":"2019-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kitas GD; Nightingale P; Armitage J; Sattar N; Belch JJF; Symmons DPM; TRACE RA Consortium<\/span> (2019)<\/span> A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis<\/span>. Arthritis Rheumatol<\/span>, 71<\/span>, (9)<\/span>, pp. 1437-1449<\/span>. <\/a> <\/a><\/p>","publicationid":"503259","date":"2019-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Farrow M; Grainger AJ; Tan AL; Buch MH; Emery P; Ridgway JP; Feiweier T; Tanner SF; Biglands J<\/span> (2019)<\/span> Normal values and test-retest variability of stimulated-echo diffusion tensor imaging and fat fraction measurements in the muscle<\/span>. Br J Radiol<\/span>, 92<\/span>, (1101)<\/span>, pp. 20190143<\/span>. <\/a> <\/a><\/p>","publicationid":"500987","date":"2019-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Michaud K; Pope JE; Emery P; Zhu B; Gaich CL; DeLozier AM; Zhang X; Dickson CL; Smolen JS<\/span> (2019)<\/span> Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial<\/span>. Rheumatol Ther<\/span>, 6<\/span>, (3)<\/span>, pp. 409-419<\/span>. <\/a> <\/a><\/p>","publicationid":"500732","date":"2019-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ahmad HA; Baker JF; \u00d8stergaard M; Ye J; Emery P; Conaghan PG<\/span> (2019)<\/span> Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial<\/span>. Adv Ther<\/span>, 36<\/span>, (9)<\/span>, pp. 2384-2393<\/span>. <\/a> <\/a><\/p>","publicationid":"500357","date":"2019-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mortimer I; Bissell L-A; Hensor EMA; Kozera L; Mackie SL; Burska AN; Nam JL; Keen H; Villeneuve E; Donica H; Buch MH; Conaghan PG; Emery P; Morgan AW; Andrews J<\/span> (2019)<\/span> Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (9)<\/span>, pp. 1684-1686<\/span>. <\/a> <\/a><\/p>","publicationid":"492021","date":"2019-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alfuraih AM; O'Connor P; Tan AL; Hensor EMA; Ladas A; Emery P; Wakefield RJ<\/span> (2019)<\/span> Muscle shear wave elastography in idiopathic inflammatory myopathies: a case-control study with MRI correlation<\/span>. Skeletal Radiol<\/span>, 48<\/span>, (8)<\/span>, pp. 1209-1219<\/span>. <\/a> <\/a><\/p>","publicationid":"492296","date":"2019-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fent G; Mankia K; Erhayiem B; Hunt L; Nam JL; Bissell L-A; Foley JR; Chew PG; Brown LE; Greenwood JP; Emery P; Plein S; Buch MH<\/span> (2019)<\/span> First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis<\/span>. Ann Rheum Dis<\/span>, 78<\/span>, (8)<\/span>, pp. 1138-1140<\/span>. <\/a> <\/a><\/p>","publicationid":"491801","date":"2019-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Peterfy C; DiCarlo J; Emery P; Genovese MC; Keystone EC; Taylor PC; Schlichting DE; Beattie SD; Luchi M; Macias W<\/span> (2019)<\/span> MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis<\/span>. J Rheumatol<\/span>, 46<\/span>, (8)<\/span>, pp. 887-895<\/span>. <\/a> <\/a><\/p>","publicationid":"484942","date":"2019-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Romagnoni A; J\u00e9gou S; Van Steen K; Wainrib G; Hugot J-P; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC)<\/span> (2019)<\/span> Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data<\/span>. Sci Rep<\/span>, 9<\/span>, (1)<\/span>, pp. 10351<\/span>. <\/a><\/p>","publicationid":"503000","date":"2019-07-17","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Al-Laith M; Jasenecova M; Abraham S; Bosworth A; Bruce IN; Buckley CD; Ciurtin C; D'Agostino M-A; Emery P; Gaston H; Isaacs JD; Filer A; Fisher BA; Huizinga TWJ; Ho P; Jacklin C; Lempp H; McInnes IB; Pratt AG; \u00d6stor A; Raza K; Taylor PC; van Schaardenburg D; Shivapatham D; Wright AJ; Vasconcelos JC; Kelly J; Murphy C; Prevost AT; Cope AP<\/span> (2019)<\/span> Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol<\/span>. Trials<\/span>, 20<\/span>, (1)<\/span>, pp. 429<\/span>. <\/a> <\/a><\/p>","publicationid":"502308","date":"2019-07-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P<\/span> (2019)<\/span> The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis<\/span>. Arthritis Res Ther<\/span>, 21<\/span>, (1)<\/span>, pp. 164<\/span>. <\/a> <\/a><\/p>","publicationid":"501836","date":"2019-07-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P<\/span> (2019)<\/span> The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis<\/span>. Arthritis Research and Therapy<\/span>, 21<\/span>, (1)<\/span>, pp. 164<\/span>. <\/a> <\/a><\/p>","publicationid":"499680","date":"2019-07-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N; UKMyonet contributors<\/span> (2019)<\/span> Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients<\/span>. J Autoimmun<\/span>, 101<\/span>, pp. 48-55<\/span>. <\/a> <\/a><\/p>","publicationid":"501835","date":"2019-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Elhai M; Boubaya M; Distler O; Smith V; Matucci-Cerinic M; Alegre Sancho JJ; Truchetet M-E; Braun-Moscovici Y; Iannone F; Novikov PI; Lescoat A; Siegert E; Castellv\u00ed I; Air\u00f3 P; Vettori S; De Langhe E; Hachulla E; Erler A; Ananieva L; Krusche M; L\u00f3pez-Longo FJ; Distler JHW; Hunzelmann N; Hoffmann-Vold A-M; Riccieri V; Hsu VM; Pozzi MR; Ancuta C; Rosato E; Mihai C; Kuwana M; Saketkoo LA; Chizzolini C; Hesselstrand R; Ullman S; Yavuz S; Rednic S; Caimmi C; Bloch-Queyrat C; Allanore Y; for EUSTAR network<\/span> (2019)<\/span> Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study<\/span>. Ann Rheum Dis<\/span>, 78<\/span>, (7)<\/span>, pp. 979-987<\/span>. <\/a><\/p>","publicationid":"501303","date":"2019-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Taylor PC; Lee YC; Fleischmann R; Takeuchi T; Perkins EL; Fautrel B; Zhu B; Quebe AK; Gaich CL; Zhang X; Dickson CL; Schlichting DE; Patel H; Durand F; Emery P<\/span> (2019)<\/span> Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial<\/span>. J Clin Med<\/span>, 8<\/span>, (6)<\/span>, pp. E831-831<\/span>. <\/a> <\/a><\/p>","publicationid":"499689","date":"2019-06-12","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Pangan AL; Emery P; Rigby W; Tanaka Y; Vargas JI; Zhang Y; Damjanov N; Friedman A; Othman AA; Camp HS; Cohen S<\/span> (2019)<\/span> Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study<\/span>. Lancet<\/span>, 393<\/span>, (10188)<\/span>, pp. 2303-2311<\/span>. <\/a> <\/a><\/p>","publicationid":"491622","date":"2019-06-08","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Cheng Z; Do T; Hunt L; Meade J; Kang J; Clerehugh V; Speirs A; Tugnait A; Hensor EMA; Nam JL; Devine DA; Emery P<\/span> (2019)<\/span> Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis<\/span>. JAMA Netw Open<\/span>, 2<\/span>, (6)<\/span>, pp. e195394<\/span>. <\/a> <\/a><\/p>","publicationid":"499726","date":"2019-06-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Cheng Z; Do T; Hunt L; Meade J; Kang J; Clerehugh V; Speirs A; Tugnait A; Hensor EMA; Nam JL; Devine DA; Emery P<\/span> (2019)<\/span> Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti\u2013Cyclic Citrullinated Protein Antibody\u2013Positive At-Risk Adults Without Arthritis<\/span>. JAMA Network Open<\/span>, 2<\/span>, (6)<\/span>, pp. e195394<\/span>. <\/a> <\/a><\/p>","publicationid":"496811","date":"2019-06-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Rigby W; Tanaka Y; Vargas JI; Damjanov N; Jain M; Sui Y; Enejosa J; Pangan A; Camp H; Cohen SB<\/span> (2019)<\/span> THU0191\u2005UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-MONOTHERAPY STUDY<\/span>. Annals of the Rheumatic Diseases<\/span>, 78<\/span>, pp. 371-372<\/span>. <\/a><\/p>","publicationid":"1103371","date":"2019-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Weinblatt ME; Emery P; Choe J-Y; Kay J; Lee J; Myung G; Seo H; Ghil J<\/span> (2019)<\/span> SAT0162\u2005A POOLED ANALYSIS OF 1-YEAR CLINICAL OUTCOMES AMONG 6-MONTH RESPONDERS AND NON-RESPONDERS FROM THREE RANDOMISED CONTROLLED STUDIES OF TNF INHIBITOR BIOSIMILARS IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. Annals of the Rheumatic Diseases<\/span>, 78<\/span>, pp. 1153-1154<\/span>. <\/a><\/p>","publicationid":"1103370","date":"2019-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Briggs C; Emery P<\/span> (2019)<\/span> SAT0100\u2005IN THE ABSENCE OF GUIDELINES, HOW ARE RHEUMATOLOGISTS MANAGING ANTI-CCP POSITIVE PATIENTS WITHOUT CLINICAL SYNOVITIS?<\/span> Annals of the Rheumatic Diseases<\/span>, 78<\/span>, pp. 1116<\/span>. <\/a><\/p>","publicationid":"1103369","date":"2019-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; D'Agostino M-A; Rowbotham E; Hensor EM; Hunt L; M\u00f6ller I; Miguel M; M\u00e9rida-Velasco JR; Murillo-Gonz\u00e1lez J; Naredo E; Nam JL; Tan AL; Freeston JE; Grainger A; Emery P<\/span> (2019)<\/span> MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis<\/span>. Ann Rheum Dis<\/span>, 78<\/span>, (6)<\/span>, pp. 781-786<\/span>. <\/a> <\/a><\/p>","publicationid":"493442","date":"2019-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bykerk VP; Burmester GR; Combe BG; Furst DE; Huizinga TWJ; Ahmad HA; Emery P<\/span> (2019)<\/span> Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis<\/span>. Rheumatol Int<\/span>, 39<\/span>, (5)<\/span>, pp. 945<\/span>. <\/a> <\/a><\/p>","publicationid":"490888","date":"2019-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Braun J; Baraliakos X; Deodhar A; Poddubnyy D; Emery P; Delicha EM; Talloczy Z; Porter B<\/span> (2019)<\/span> Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (5)<\/span>, pp. 859-868<\/span>. <\/a> <\/a><\/p>","publicationid":"487467","date":"2019-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Rondon J; Parrino J; Lin Y; Pena-Rossi C; van Hoogstraten H; Graham NMH; Liu N; Paccaly A; Wu R; Spindler A<\/span> (2019)<\/span> Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (5)<\/span>, pp. 849-858<\/span>. <\/a> <\/a><\/p>","publicationid":"481735","date":"2019-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Cohen S; Emery P; Rigby W; Tanaka Y; Zhang Y; Friedman A; Othman AA; Camp HS; Pangan AL<\/span> (2019)<\/span> 060\u2003Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez106.059<\/span>. <\/a><\/p>","publicationid":"1103376","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Dudler J; Smolen J; Zerbini C; Burmester G; Fautrel B; van der Laar M; Fleischmann R; Fakhouri W; Leonardis FD; Zhu B; Kadziola Z; Torre IDL; Perrier C; Taylor PC<\/span> (2019)<\/span> 074\u2003Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez106.073<\/span>. <\/a><\/p>","publicationid":"1103375","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Curtis JR; John GS; Pannucci M; Lin Y; Maldonado-Cocco JA; Huizinga T; Stanislav M; Wilson E; Emery P<\/span> (2019)<\/span> 078\u2003Reductions in absolute neutrophil count with sarilumab resulting in dose delays or dose decreases: effects on efficacy and safety<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez106.077<\/span>. <\/a><\/p>","publicationid":"1103374","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fitton J; Dass S; Emery P; Nam J; Buch MH<\/span> (2019)<\/span> 087\u2003Janus kinase inhibitors demonstrate effectiveness in a real-world multi-biologic DMARD refractory rheumatoid arthritis population<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez106.086<\/span>. <\/a><\/p>","publicationid":"1103373","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Baraliakos X; Braun J; Deodhar A; Poddubnyy D; Delicha E-M; Talloczy Z; Porter B<\/span> (2019)<\/span> 264\u2003Secukinumab demonstrates low radiographic progression and sustained efficacy through 4 years in patients with active ankylosing spondylitis<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez107.080<\/span>. <\/a><\/p>","publicationid":"1103372","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Bailey L; Montoya LG; Yusof Y; Vital EM; Emery P; Nam JL; Dass S; Buch M<\/span> (2019)<\/span> 191\u2003Effectiveness and safety of switch to rituximab biosimilar with rheumatoid arthritis. a single centre experience<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez107.007<\/span>. <\/a><\/p>","publicationid":"1039513","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Yuzaiful M; Yusof M; Wittmann M; Fernandez C; Wilson D; Edward S; Abignano G; Alase A; Sharples L; Laws P; Goodfield M; Vital EM; Emery P<\/span> (2019)<\/span> 244\u2003Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez107.060<\/span>. <\/a><\/p>","publicationid":"1039511","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fitton J; Naraghi K; Nam J; Dass S; Emery P; Buch MH<\/span> (2019)<\/span> 089\u2003Single centre cohort of refractory rheumatoid arthritis also identifies a rare subgroup of multiple targeted therapy class non-response<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez106.088<\/span>. <\/a><\/p>","publicationid":"739491","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Carriero A; Abignano G; Hutchinson M; Ballard K; Eng S; Emery P; Buch MH; Galdo FD<\/span> (2019)<\/span> 231\u2003Serum interferon score predicts clinical outcome at 12 months in diffuse cutaneous systemic sclerosis as measured by Global Ranked Composite Score (GRCS) and Composite Response Index in SSc (CRISS)<\/span>. Rheumatology<\/span>, 58<\/span>, (Supplement_3)<\/span>, pp. kez107.047<\/span>. <\/a><\/p>","publicationid":"702975","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Oldroyd A; Sergeant JC; New P; McHugh NJ; Betteridge Z; Lamb JA; Ollier WE; Cooper RG; Chinoy H; UKMyoNet<\/span> (2019)<\/span> The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (4)<\/span>, pp. 650-655<\/span>. <\/a> <\/a><\/p>","publicationid":"497852","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Savage L; Goodfield M; Horton L; Watad A; Hensor E; Emery P; Wakefield R; Wittmann M; McGonagle D<\/span> (2019)<\/span> Regression of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated With Ustekinumab for\u00a0Moderate-to-Severe Chronic Plaque Psoriasis: A Fifty-Two-Week, Prospective, Open-Label Feasibility Study<\/span>. Arthritis Rheumatol<\/span>, 71<\/span>, (4)<\/span>, pp. 626-631<\/span>. <\/a> <\/a><\/p>","publicationid":"484723","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fisher BA; Emery P; Pitzalis C; Bombardieri M; Bowman SJ<\/span> (2019)<\/span> Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sj\u00f6gren's syndrome?<\/span> Ann Rheum Dis<\/span>, 78<\/span>, (4)<\/span>, pp. e28<\/span>. <\/a> <\/a><\/p>","publicationid":"464096","date":"2019-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hensor EMA; McKeigue P; Ling SF; Colombo M; Barrett JH; Nam JL; Freeston J; Buch MH; Spiliopoulou A; Agakov F; Kelly S; Lewis MJ; Verstappen SMM; MacGregor AJ; Viatte S; Barton A; Pitzalis C; Emery P; Conaghan PG; Morgan AW<\/span> (2019)<\/span> Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (8)<\/span>, pp. 1400-1409<\/span>. <\/a> <\/a><\/p>","publicationid":"487505","date":"2019-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Bissell L-A; Dumitru RB; Eng S; Allanore Y; Avouac J; Bosello S; Denton CP; Distler O; Ferraccioli G; Jordan S; Matucci-Cerinic M; Ong V; Messenger M; Hutchinson M; Buch MH; Emery P; Del Galdo F<\/span> (2019)<\/span> European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (2)<\/span>, pp. 254-259<\/span>. <\/a> <\/a><\/p>","publicationid":"479803","date":"2019-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zayat AS; Mahmoud K; Md Yusof MY; Mukherjee S; D'Agostino M-A; Hensor EMA; Wakefield RJ; Conaghan PG; Edwards CJ; Emery P; Vital EM<\/span> (2019)<\/span> Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (2)<\/span>, pp. 304-312<\/span>. <\/a> <\/a><\/p>","publicationid":"472457","date":"2019-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mahmoud K; Zayat AS; Yusof Y; Hensor E; Conaghan PG; Emery P; Vital EM<\/span> (2019)<\/span> Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus<\/span>. Rheumatology (Oxford)<\/span>, 58<\/span>, (8)<\/span>, pp. 1353-1360<\/span>. <\/a> <\/a><\/p>","publicationid":"482860","date":"2019-01-03","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Traylor M; Knevel R; Cui J; Taylor J; Harm-Jan W; Conaghan PG; Cope AP; Curtis C; Emery P; Newhouse S; Patel H; Steer S; Gregersen P; Shadick NA; Weinblatt ME; Van Der Helm-van Mil A; Barrett JH; Morgan AW; Lewis CM; Scott IC<\/span> (2019)<\/span> Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases<\/span>. PLoS One<\/span>, 14<\/span>, (10)<\/span>, pp. e0223246<\/span>. <\/a> <\/a><\/p>","publicationid":"508047","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ridgley LA; Anderson AE; Maney NJ; Naamane N; Skelton AJ; Lawson CA; Emery P; Isaacs JD; Carmody RJ; Pratt AG<\/span> (2019)<\/span> IL-6 Mediated Transcriptional Programming of Na\u00efve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function<\/span>. Front Immunol<\/span>, 10<\/span>, (JULY)<\/span>, pp. 1535<\/span>. <\/a> <\/a><\/p>","publicationid":"500359","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pan Y; Norton S; Gwinnutt JM; Kearsley-Fleet L; Symmons DPM; Lunt M; Young A; BSRBR-RA Control Centre Consortium; Hyrich KL; Verstappen SMM<\/span> (2019)<\/span> Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity<\/span>. PLoS One<\/span>, 14<\/span>, (5)<\/span>, pp. e0215999<\/span>. <\/a> <\/a><\/p>","publicationid":"500227","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van der Heijde D; Schiff M; Tanaka Y; Xie L; Meszaros G; Ishii T; Casillas M; Ortmann RA; Emery P<\/span> (2019)<\/span> Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis<\/span>. RMD Open<\/span>, 5<\/span>, (1)<\/span>, pp. e000898<\/span>. <\/a> <\/a><\/p>","publicationid":"499574","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hackett KL; Davies K; Tarn J; Bragg R; Hargreaves B; Miyamoto S; McMeekin P; Mitchell S; Bowman S; Price EJ; Pease C; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Vadivelu S; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Lendrem DW; Ng W-F<\/span> (2019)<\/span> Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sj\u00f6gren's syndrome<\/span>. RMD Open<\/span>, 5<\/span>, (1)<\/span>, pp. e000885<\/span>. <\/a> <\/a><\/p>","publicationid":"495128","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Burmester GR; Bykerk VP; Combe BG; Furst DE; Maldonado MA; Huizinga TW<\/span> (2019)<\/span> Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study<\/span>. RMD Open<\/span>, 5<\/span>, (1)<\/span>, pp. e000840<\/span>. <\/a> <\/a><\/p>","publicationid":"491643","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Duquenne L; Gul H; Emery P<\/span> (2019)<\/span> Safety evaluation of adalimumab in immune-mediated inflammatory disorders: a rheumatological point of view<\/span>. Expert Opin Drug Saf<\/span>, 18<\/span>, (1)<\/span>, pp. 11-19<\/span>. <\/a> <\/a><\/p>","publicationid":"484005","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Conaghan PG; D'Agostino M-A; Maksymowych W; Naredo E; Ostergaard M; Schett G; Emery P<\/span> (2019)<\/span> Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities<\/span>. Eur J Rheumatol<\/span>, 6<\/span>, (1)<\/span>, pp. 38-47<\/span>. <\/a> <\/a><\/p>","publicationid":"481734","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; D'Agostino M-A; Wakefield RJ; Nam JL; Mahmood W; Grainger AJ; Emery P<\/span> (2019)<\/span> Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism<\/span>. Ann Rheum Dis<\/span>, 78<\/span>, (1)<\/span>, pp. 43-50<\/span>. <\/a> <\/a><\/p>","publicationid":"481261","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Lubrano E; Perrotta FM; Emery P; Conaghan PG; Helliwell PS<\/span> (2019)<\/span> What Should Be the Primary Target of \"Treat to Target\" in Psoriatic Arthritis?<\/span> J Rheumatol<\/span>, 46<\/span>, (1)<\/span>, pp. 38-42<\/span>. <\/a> <\/a><\/p>","publicationid":"472452","date":"2019-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bykerk VP; Burmester GR; Combe BG; Furst DE; Huizinga TWJ; Ahmad HA; Emery P<\/span> (2018)<\/span> On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis<\/span>. Rheumatol Int<\/span>, 38<\/span>, (12)<\/span>, pp. 2225-2231<\/span>. <\/a> <\/a><\/p>","publicationid":"482737","date":"2018-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tanaka Y; McInnes IB; Taylor PC; Byers NL; Chen L; de Bono S; Issa M; Macias WM; Rogai V; Rooney TP; Schlichting DE; Zuckerman SH; Emery P<\/span> (2018)<\/span> Characterization and changes of lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis: an integrated analysis<\/span>. Arthritis and Rheumatology<\/span>, 70<\/span>, (12)<\/span>, pp. 1923-1932<\/span>. <\/a> <\/a><\/p>","publicationid":"472488","date":"2018-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tanaka Y; McInnes IB; Taylor PC; Byers NL; Chen L; de Bono S; Issa M; Macias WL; Rogai V; Rooney TP; Schlichting DE; Zuckerman SH; Emery P<\/span> (2018)<\/span> Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis<\/span>. Arthritis Rheumatol<\/span>, 70<\/span>, (12)<\/span>, pp. 1923-1932<\/span>. <\/a> <\/a><\/p>","publicationid":"347732","date":"2018-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cohen SB; Burgos-Vargas R; Emery P; Jin B; Cronenberger C; V\u00e1zquez-Abad M-D<\/span> (2018)<\/span> Extension Study of PF-05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis<\/span>. Arthritis Care Res (Hoboken)<\/span>, 70<\/span>, (11)<\/span>, pp. 1598-1606<\/span>. <\/a> <\/a><\/p>","publicationid":"465564","date":"2018-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Dudler J; Zerbini C; Walid F; Nicolay C; de La Torre I; Burmester G<\/span> (2018)<\/span> PMS5 - A NETWORK META-ANALYSIS TO EVALUATE THE EFFICACY OF BARICITINIB AND OTHER TREATMENTS OF RHEUMATOID ARTHRITIS IN PATIENTS WHO ARE INADEQUATE RESPONDERS TO METHOTREXATE<\/span>. Value in Health<\/span>, 21<\/span>, pp. S288<\/span>. <\/a><\/p>","publicationid":"1103385","date":"2018-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

El-Sherbiny YM; Psarras A; Md Yusof MY; Hensor EMA; Tooze R; Doody G; Mohamed AAA; McGonagle D; Wittmann M; Emery P; Vital EM<\/span> (2018)<\/span> Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features<\/span>. Sci Rep<\/span>, 8<\/span>, (1)<\/span>, pp. 14846<\/span>. <\/a> <\/a><\/p>","publicationid":"480679","date":"2018-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Pope JE; Kruger K; Lippe R; DeMasi R; Lula S; Kola B<\/span> (2018)<\/span> Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review<\/span>. Adv Ther<\/span>, 35<\/span>, (10)<\/span>, pp. 1535-1563<\/span>. <\/a> <\/a><\/p>","publicationid":"475501","date":"2018-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Psarras A; El-Sherbiny YM; Hensor EMA; Dutton K; Ul-Hassan S; Zayat AS; Shalbaf M; Alase A; Wittmann M; Emery P; Vital EM<\/span> (2018)<\/span> Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status<\/span>. Ann Rheum Dis<\/span>, 77<\/span>, (10)<\/span>, pp. 1432-1439<\/span>. <\/a> <\/a><\/p>","publicationid":"468297","date":"2018-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Van Keep M; Beard S; Graham C; Miles L; Jugl SM; Gunda P; Halliday A; Marzo-Ortega H<\/span> (2018)<\/span> Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK<\/span>. Pharmacoeconomics<\/span>, 36<\/span>, (8)<\/span>, pp. 1015-1027<\/span>. <\/a> <\/a><\/p>","publicationid":"468363","date":"2018-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Conaghan PG; D'Agostino MA; De Wit M; FitzGerald O; Kvien TK; Lories R; Mease P; Nash P; Schett G; Soriano ER; Emery P<\/span> (2018)<\/span> Remission in psoriatic arthritis-where are we now?<\/span> Rheumatology (Oxford)<\/span>, 57<\/span>, (8)<\/span>, pp. 1321-1331<\/span>. <\/a> <\/a><\/p>","publicationid":"447262","date":"2018-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Taylor JC; Bongartz T; Massey J; Mifsud B; Spiliopoulou A; Scott IC; Wang J; Morgan M; Plant D; Colombo M; Orchard P; Twigg S; McInnes IB; Porter D; Freeston JE; Nam JL; Cordell HJ; Isaacs JD; Strathdee JL; Arnett D; de Hair MJH; Tak PP; Aslibekyan S; van Vollenhoven RF; Padyukov L; Bridges SL; Pitzalis C; Cope AP; Verstappen SMM; Emery P; Barnes MR; Agakov F; McKeigue P; Mushiroda T; Kubo M; Weinshilboum R; Barton A; Morgan AW; Barrett JH; MATURA; and PAMERA; Consortia<\/span> (2018)<\/span> Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients<\/span>. Pharmacogenomics J<\/span>, 18<\/span>, (4)<\/span>, pp. 528-538<\/span>. <\/a> <\/a><\/p>","publicationid":"461337","date":"2018-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Taylor PC; Kremer JM; Emery P; Zuckerman SH; Ruotolo G; Zhong J; Chen L; Witt S; Saifan C; Kurzawa M; Otvos JD; Connelly MA; Macias WL; Schlichting DE; Rooney TP; de Bono S; McInnes IB<\/span> (2018)<\/span> Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies<\/span>. Ann Rheum Dis<\/span>, 77<\/span>, (7)<\/span>, pp. 988-995<\/span>. <\/a> <\/a><\/p>","publicationid":"457512","date":"2018-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Weinblatt M; Emery P; Keystone E; Genovese M; Myung G; Hong E; Baek I; Lee S; Ghil J<\/span> (2018)<\/span> THU0201\u2005A pooled analysis of three tnf-\u0391 inhibitor biosimilar studies in patients with rheumatoid arthritis comparing radiographic progression by disease activity states<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 319-320<\/span>. <\/a><\/p>","publicationid":"1103384","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vlahos B; Szczypa P; Thakur M; Jones HE; Woolcott J; Santos Estrella PV; Gibofsky A; Rolland C; Citera G; Marshall L<\/span> (2018)<\/span> AB0460\u2005Long-term drug survival of etanercept vs other tnf inhibitor therapies in patients with rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 1391-1392<\/span>. <\/a><\/p>","publicationid":"1103383","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Weinblatt M; Smolen JS; Keystone E; Genovese M; Vencovsky J; Kay J; Hong E; Baek Y; Ghil J<\/span> (2018)<\/span> THU0184\u2005Impact of immunogenicity on clinical efficacy and administration related reaction in tnf inhibitors: a pooled-analysis from three biosimilar studies in patients with rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 310-311<\/span>. <\/a><\/p>","publicationid":"1103382","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pope J; Michaud K; Emery P; Zhu B; Gaich C; DeLozier A; Zhang X; Dickson C; Smolen JS<\/span> (2018)<\/span> AB0240\u2005Reduction in fatigue and pain are associated with improved work productivity in patients with ra<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 1302<\/span>. <\/a><\/p>","publicationid":"1103381","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen J; Cohen S; Emery P; Rigby W; Tanaka Y; Zhang Y; Friedman A; Othman A; Camp H; Pangan A<\/span> (2018)<\/span> OP0035\u2005Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 67-68<\/span>. <\/a><\/p>","publicationid":"1103380","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

de Vlam K; Fautrel B; van de Laar M; Kirkham BW; Alten R; Beneden KV; de Leonardis F; Lopez-Romero P; Gaich C; Quebe A; Cardoso A; Fleischmann R; Emery P<\/span> (2018)<\/span> AB0258\u2005Impact of controlling disease activity on regaining normal physical function, and achieving no or limited pain in patients with rheumatoid arthritis treated with baricitinib<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 1310-1311<\/span>. <\/a><\/p>","publicationid":"1103379","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Verschueren P; Emery P; van Hoogstraten H; Dong Q; Mangan EK; den Broeder A<\/span> (2018)<\/span> THU0215\u2005Efficacy of sarilumab in patients with rheumatoid arthritis with and without previous response to tocilizumab<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 327-328<\/span>. <\/a><\/p>","publicationid":"1103378","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Braun J; Deodhar A; Poddubny D; Emery P; Delicha EM; Talloczy Z; Porter B<\/span> (2018)<\/span> SAT0268\u2005Secukinumab demonstrates low radiographic progression and sustained efficacy through 4 years in patients with active ankylosing spondylitis<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 997-998<\/span>. <\/a><\/p>","publicationid":"1103377","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Wittmann M; Fernandez C; Wilson D; Edward S; Abignano G; Alase A; Sharples L; Laws P; Goodfield MJ; Vital EM; Emery P<\/span> (2018)<\/span> FRI0328\u2005Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): first results from a proof-of-concept phase 2 trial<\/span>. Annals of the Rheumatic Diseases<\/span>, 77<\/span>, pp. 700-701<\/span>. <\/a><\/p>","publicationid":"1039515","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Oldroyd AGS; Symmons DPM; Sergeant JC; Kearsley-Fleet L; Watson K; Lunt M; Hyrich KL; BSRBR-RA Contributors Group<\/span> (2018)<\/span> Long-term persistence with rituximab in patients with rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 57<\/span>, (6)<\/span>, pp. 1089-1096<\/span>. <\/a> <\/a><\/p>","publicationid":"469954","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown S; Everett CC; Naraghi K; Davies C; Dawkins B; Hulme C; McCabe C; Pavitt S; Emery P; Sharples L; Buch MH<\/span> (2018)<\/span> Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT<\/span>. Health Technol Assess<\/span>, 22<\/span>, (34)<\/span>, pp. 1-280<\/span>. <\/a> <\/a><\/p>","publicationid":"469685","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gillespie J; Ross RL; Corinaldesi C; Esteves F; Derrett-Smith E; McDermott MF; Doody GM; Denton CP; Emery P; Del Galdo F<\/span> (2018)<\/span> Transforming Growth Factor \u03b2 Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2<\/span>. Arthritis Rheumatol<\/span>, 70<\/span>, (6)<\/span>, pp. 932-942<\/span>. <\/a> <\/a><\/p>","publicationid":"456527","date":"2018-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

El-Sherbiny YM; Psarras A; Md Yusof MY; Hensor EMA; Tooze R; Doody G; Mohamed AAA; McGonagle D; Wittmann M; Emery P; Vital EM<\/span> (2018)<\/span> A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features<\/span>. Sci Rep<\/span>, 8<\/span>, (1)<\/span>, pp. 5793<\/span>. <\/a> <\/a><\/p>","publicationid":"464025","date":"2018-04-11","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2018)<\/span> i137\u2003A new early intervention clinic with work as the main outcome<\/span>. Rheumatology<\/span>, 57<\/span>, (suppl_3)<\/span>, pp. key075.137<\/span>. <\/a><\/p>","publicationid":"1103387","date":"2018-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Combe B; Balsa A; Winthrop K; Tony H-P; Genovese MC; Harigai M; Smolen JS; Emery P; Dudler J; Hall S; Zerbini CA; Van Den Bosch F; Durand F; Arthanari S; Rogai V; Zhong J; Meszaros G; Dougados M<\/span> (2018)<\/span> 219\u2003Safety summary results of baricitinib focusing on serious infections events and preselected comorbidities<\/span>. Rheumatology<\/span>, 57<\/span>, (suppl_3)<\/span>, pp. key075.443<\/span>. <\/a><\/p>","publicationid":"1103386","date":"2018-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bagnato G; Pigatto E; Bitto A; Pizzino C; Irrera N; Abignano G; Hutchinson M; Ferrera A; Zanatta E; Squadrito F; Buch M; Emery P; Saitta A; Cozzi F; Del Galdo F<\/span> (2018)<\/span> O18\u2003The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) score: the first validated combined index predictive of future weight loss in systemic sclerosis<\/span>. Rheumatology<\/span>, 57<\/span>, (suppl_3)<\/span>, pp. key075.200<\/span>. <\/a><\/p>","publicationid":"702979","date":"2018-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Eng S; Buch M; Emery P; Khanna D; Del Galdo F<\/span> (2018)<\/span> 207\u2003Correlation of the American College of Rheumatology provisional composite response index in systemic sclerosis with serum biomarkers of fibrogenesis in an observational cohort<\/span>. Rheumatology<\/span>, 57<\/span>, (suppl_3)<\/span>, pp. key075.431<\/span>. <\/a><\/p>","publicationid":"702978","date":"2018-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Daniel A; Green L; Eng S; Emery P; Del Galdo F<\/span> (2018)<\/span> 208\u2003Microvascular flow assessed by dynamic optical coherence tomography: first non-invasive quantitative outcome measure of microvascular disease in systemic sclerosis<\/span>. Rheumatology<\/span>, 57<\/span>, (suppl_3)<\/span>, pp. key075.432<\/span>. <\/a><\/p>","publicationid":"702977","date":"2018-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Eng S; Bagnato G; Buch M; Emery P; Del Galdo F<\/span> (2018)<\/span> 209\u2003Normalisation of the American College of Rheumatology provisional composite response index in systemic sclerosis numerator for baseline data offers a measure of magnitude of response: results from a real-life observational study<\/span>. Rheumatology<\/span>, 57<\/span>, (suppl_3)<\/span>, pp. key075.433<\/span>. <\/a><\/p>","publicationid":"702976","date":"2018-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Twigg S; Pentony PE; Hensor EMA; Nam JL; Hunt L; Mankia K; Emery P<\/span> (2018)<\/span> O11\u2003Change in function, fatigue and pain in anti-CCP positive at-risk individuals predict progression to inflammatory arthritis<\/span>. Rheumatology<\/span>, 57<\/span>, (suppl_3)<\/span>, pp. key075.193<\/span>. <\/a><\/p>","publicationid":"671535","date":"2018-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Curtis JR; Trivedi M; Haraoui B; Emery P; Park GS; Collier DH; Aras GA; Chung J<\/span> (2018)<\/span> Defining and characterizing sustained remission in patients with rheumatoid arthritis<\/span>. Clin Rheumatol<\/span>, 37<\/span>, (4)<\/span>, pp. 885-893<\/span>. <\/a> <\/a><\/p>","publicationid":"452131","date":"2018-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fisher BA; Everett CC; Rout J; O'Dwyer JL; Emery P; Pitzalis C; Ng W-F; Carr A; Pease CT; Price EJ; Sutcliffe N; Makdissi J; Tappuni AR; Gendi NST; Hall FC; Ruddock SP; Fernandez C; Hulme CT; Davies KA; Edwards CJ; Lanyon PC; Moots RJ; Roussou E; Richards A; Sharples LD; Bombardieri M; Bowman SJ<\/span> (2018)<\/span> Effect of rituximab on a salivary gland ultrasound score in primary Sj\u00f6gren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy<\/span>. Ann Rheum Dis<\/span>, 77<\/span>, (3)<\/span>, pp. 412-416<\/span>. <\/a> <\/a><\/p>","publicationid":"453766","date":"2018-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F<\/span> (2018)<\/span> Scleroderma fibroblasts suppress angiogenesis via TGF-\u03b2\/caveolin-1 dependent secretion of pigment epithelium-derived factor<\/span>. Ann Rheum Dis<\/span>, 77<\/span>, (3)<\/span>, pp. 431-440<\/span>. <\/a> <\/a><\/p>","publicationid":"453366","date":"2018-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Girolomoni G; Feldman SR; Emery P; Ghil J; Keum JW; Cheong SY; Hong E<\/span> (2018)<\/span> Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study<\/span>. Br J Dermatol<\/span>, 178<\/span>, (3)<\/span>, pp. e215-e216<\/span>. <\/a> <\/a><\/p>","publicationid":"440003","date":"2018-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

O'Dwyer JL; Meads DM; Hulme CT; Mcparland L; Brown S; Coates LC; Moverley AR; Emery P; Conaghan PG; Helliwell PS<\/span> (2018)<\/span> Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial<\/span>. Arthritis Care Res (Hoboken)<\/span>, 70<\/span>, (3)<\/span>, pp. 462-468<\/span>. <\/a> <\/a><\/p>","publicationid":"380633","date":"2018-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Twigg S; Hensor EMA; Freeston J; Tan AL; Emery P; Tennant A; Morgan AW; YEAR and IACON Consortia<\/span> (2018)<\/span> Effect of Fatigue, Older Age, Higher Body Mass Index, and Female Sex on Disability in Early Rheumatoid Arthritis in the Treatment-to-Target Era<\/span>. Arthritis Care Res (Hoboken)<\/span>, 70<\/span>, (3)<\/span>, pp. 361-368<\/span>. <\/a> <\/a><\/p>","publicationid":"380574","date":"2018-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Burmester GR; Naredo E; Zhou Y; Hojnik M; Conaghan PG<\/span> (2018)<\/span> Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)<\/span>. BMJ Open<\/span>, 8<\/span>, (2)<\/span>, pp. e019007<\/span>. <\/a> <\/a><\/p>","publicationid":"455039","date":"2018-02-28","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Aletaha D; Barton A; Burmester GR; Emery P; Firestein GS; Kavanaugh A; McInnes IB; Solomon DH; Strand V; Yamamoto K<\/span> (2018)<\/span> Rheumatoid arthritis<\/span>. Nat Rev Dis Primers<\/span>, 4<\/span>, (1)<\/span>, pp. 18001<\/span>. <\/a> <\/a><\/p>","publicationid":"457509","date":"2018-02-08","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh A; van Vollenhoven RF; Fleischmann R; Emery P; Sainsbury I; Florentinus S; Chen S; Gu\u00e9rette B; Kupper H; Smolen JS<\/span> (2018)<\/span> Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 77<\/span>, (2)<\/span>, pp. 289-292<\/span>. <\/a> <\/a><\/p>","publicationid":"448386","date":"2018-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kay J; Schoels MM; D\u00f6rner T; Emery P; Kvien TK; Smolen JS; Breedveld FC; Task Force on the Use of Biosimilars to Treat Rheumatological Diseases<\/span> (2018)<\/span> Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases<\/span>. Ann Rheum Dis<\/span>, 77<\/span>, (2)<\/span>, pp. 165-174<\/span>. <\/a> <\/a><\/p>","publicationid":"438145","date":"2018-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alfuraih AM; O'Connor P; Hensor E; Tan AL; Emery P; Wakefield RJ<\/span> (2018)<\/span> The effect of unit, depth, and probe load on the reliability of muscle shear wave elastography: Variables affecting reliability of SWE<\/span>. J Clin Ultrasound<\/span>, 46<\/span>, (2)<\/span>, pp. 108-115<\/span>. <\/a> <\/a><\/p>","publicationid":"437176","date":"2018-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cope AP; Barnes MR; Belson A; Binks M; Brockbank S; Bonachela-Capdevila F; Carini C; Fisher BA; Goodyear CS; Emery P; Ehrenstein MR; Gozzard N; Harris R; Hollis S; Keidel S; Levesque M; Lindholm C; McDermott MF; McInnes IB; Mela CM; Parker G; Read S; Pedersen AW; Ponchel F; Porter D; Rao R; Rowe A; Schulze-Knappe P; Sleeman MA; Symmons D; Taylor PC; Tom B; Tsuji W; Verbeeck D; Isaacs JD; RA-MAP Consortium<\/span> (2018)<\/span> Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaboration<\/span>. Nat Rev Rheumatol<\/span>, 14<\/span>, (2)<\/span>, pp. 119<\/span>. <\/a> <\/a><\/p>","publicationid":"511264","date":"2018-01-24","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lilleker JB; Vencovsky J; Wang G; Wedderburn LR; Diederichsen LP; Schmidt J; Oakley P; Benveniste O; Danieli MG; Danko K; Thuy NTP; Vazquez-Del Mercado M; Andersson H; De Paepe B; deBleecker JL; Maurer B; McCann LJ; Pipitone N; McHugh N; Betteridge ZE; New P; Cooper RG; Ollier WE; Lamb JA; Krogh NS; Lundberg IE; Chinoy H; all EuroMyositis contributors<\/span> (2018)<\/span> The EuroMyositis registry: an international collaborative tool to facilitate myositis research<\/span>. Ann Rheum Dis<\/span>, 77<\/span>, (1)<\/span>, pp. 30-39<\/span>. <\/a><\/p>","publicationid":"1103392","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

RA-MAP Consortium<\/span> (2018)<\/span> Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data<\/span>. RMD Open<\/span>, 4<\/span>, (2)<\/span>, pp. e000721<\/span>. <\/a> <\/a><\/p>","publicationid":"489119","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Psarras A; Alase A; Antanaviciute A; Carr I; Md Yusof MY; Wittmann M; Emery P; Tsokos G; Vital E<\/span> (2018)<\/span> Plasmacytoid dendritic cells are functionally exhausted while non-haematopoietic sources of type I interferon dominate human autoimmunity<\/span>. pp. 502047<\/span>. <\/a><\/p>","publicationid":"488462","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Garcia-Montoya L; Gul H; Emery P<\/span> (2018)<\/span> Recent advances in ankylosing spondylitis: understanding the disease and management<\/span>. F1000Res<\/span>, 7<\/span>, pp. F1000 Faculty Rev-1512-1512<\/span>. <\/a> <\/a><\/p>","publicationid":"482553","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Pedersen R; Bukowski J; Marshall L<\/span> (2018)<\/span> Predictors of remission maintenance after etanercept tapering or withdrawal in early rheumatoid arthritis: Results from the PRIZE study<\/span>. Open Rheumatology Journal<\/span>, 12<\/span>, (1)<\/span>, pp. 179-188<\/span>. <\/a> <\/a><\/p>","publicationid":"481684","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van der Heijde D; Dougados M; Chen Y-C; Greenwald M; Drescher E; Klar R; Xie L; de la Torre I; Rooney TP; Witt SL; Schlichting DE; de Bono S; Emery P<\/span> (2018)<\/span> Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs<\/span>. RMD Open<\/span>, 4<\/span>, (1)<\/span>, pp. e000662<\/span>. <\/a> <\/a><\/p>","publicationid":"467537","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jansen DTSL; Emery P; Smolen JS; Westhovens R; Le Bars M; Connolly SE; Ye J; Toes REM; Huizinga TWJ<\/span> (2018)<\/span> Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study<\/span>. RMD Open<\/span>, 4<\/span>, (1)<\/span>, pp. e000564<\/span>. <\/a> <\/a><\/p>","publicationid":"465488","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dumusc A; Ng W-F; James K; Griffiths B; Price E; Pease C; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Gupta M; McLaren J; Cooper A; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman S<\/span> (2018)<\/span> Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sj\u00f6gren's syndrome: examination of data from the UK Primary Sj\u00f6gren's Syndrome Registry<\/span>. Swiss Med Wkly<\/span>, 148<\/span>, (5-6)<\/span>, pp. w14588<\/span>. <\/a> <\/a><\/p>","publicationid":"457364","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Twigg S; Nikiphorou E; Nam JL; Hunt L; Mankia K; Pentony PE; Freeston JE; Tan AL; Emery P<\/span> (2018)<\/span> Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis<\/span>. Front Med (Lausanne)<\/span>, 5<\/span>, (FEB)<\/span>, pp. 35<\/span>. <\/a> <\/a><\/p>","publicationid":"455759","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cope AP; Barnes MR; Belson A; Binks M; Brockbank S; Bonachela-Capdevila F; Carini C; Fisher BA; Goodyear CS; Emery P; Ehrenstein MR; Gozzard N; Harris R; Hollis S; Keidel S; Levesque M; Lindholm C; McDermott MF; McInnes IB; Mela CM; Parker G; Read S; Pedersen AW; Ponchel F; Porter D; Rao R; Rowe A; Schulz-Knappe P; Sleeman MA; Symmons D; Taylor PC; Tom B; Tsuji W; Verbeeck D; Isaacs JD; RA-MAP Consortium<\/span> (2018)<\/span> The RA-MAP Consortium: a working model for academia-industry collaboration<\/span>. Nat Rev Rheumatol<\/span>, 14<\/span>, (1)<\/span>, pp. 53-60<\/span>. <\/a> <\/a><\/p>","publicationid":"452624","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Sch\u00f6ls M; Braun J; Dougados M; FitzGerald O; Gladman DD; Kavanaugh A; Landew\u00e9 R; Mease P; Sieper J; Stamm T; Wit MD; Aletaha D; Baraliakos X; Betteridge N; Bosch FVD; Coates LC; Emery P; Gensler LS; Gossec L; Helliwell P; Jongkees M; Kvien TK; Inman RD; McInnes IB; Maccarone M; Machado PM; Molto A; Ogdie A; Poddubnyy D; Ritchlin C; Rudwaleit M; Tanew A; Thio B; Veale D; Vlam KD; van der Heijde D<\/span> (2018)<\/span> Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force<\/span>. Ann Rheum Dis<\/span>, 77<\/span>, (1)<\/span>, pp. 3-17<\/span>. <\/a> <\/a><\/p>","publicationid":"435633","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burska AN; Neilan J; Chisman RE; Pitaksalee R; Hodgett R; Marzo-Ortega H; Conaghan PG; West R; Emery P; Ponchel F<\/span> (2018)<\/span> Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria<\/span>. Clin Exp Rheumatol<\/span>, 36<\/span>, (1)<\/span>, pp. 115-120<\/span>. <\/a> <\/a><\/p>","publicationid":"429136","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Takase-Minegishi K; Horita N; Kobayashi K; Yoshimi R; Kirino Y; Ohno S; Kaneko T; Nakajima H; Wakefield RJ; Emery P<\/span> (2018)<\/span> Diagnostic test accuracy of ultrasound for synovitis in rheumatoid arthritis: systematic review and meta-analysis<\/span>. Rheumatology (Oxford)<\/span>, 57<\/span>, (1)<\/span>, pp. 49-58<\/span>. <\/a> <\/a><\/p>","publicationid":"371582","date":"2018-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ouboussad L; Hunt L; Hensor EMA; Nam JL; Barnes NA; Emery P; McDermott MF; Buch MH<\/span> (2017)<\/span> Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis<\/span>. Arthritis Res Ther<\/span>, 19<\/span>, (1)<\/span>, pp. 288<\/span>. <\/a> <\/a><\/p>","publicationid":"453903","date":"2017-12-22","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Orr C; Vieira-Sousa E; Boyle DL; Buch MH; Buckley CD; Ca\u00f1ete JD; Catrina AI; Choy EHS; Emery P; Fearon U; Filer A; Gerlag D; Humby F; Isaacs JD; Just SA; Lauwerys BR; Goff BL; Manzo A; McGarry T; McInnes IB; Najm A; Pitzalis C; Pratt A; Smith M; Tak PP; Tas SW; Thurlings R; Fonseca JE; Veale DJ<\/span> (2017)<\/span> Corrigendum: Synovial tissue research: a state-of-the-art review<\/span>. Nat Rev Rheumatol<\/span>, 14<\/span>, (1)<\/span>, pp. 60<\/span>. <\/a><\/p>","publicationid":"1103388","date":"2017-12-19","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gul HL; Garcia-Montoya L; Duquenne LM; Pentony P; Oliveira L; Emery P<\/span> (2017)<\/span> Predicting Successful Tapering of Biologic Therapy for Patients with Rheumatoid Arthritis in Remission \u2013 Why are we still using clinical remission criteria to inform decisions?<\/span> Reviews Press<\/span>, 1<\/span>, (1)<\/span>, pp. 6-18<\/span>. <\/a> <\/a><\/p>","publicationid":"453127","date":"2017-12-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Oni C; Mitchell S; James K; Ng W-F; Griffiths B; Hindmarsh V; Price E; Pease CT; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Hunter J; Gupta M; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman SJ<\/span> (2017)<\/span> Eligibility for clinical trials in primary Sj\u00f6gren's syndrome: lessons from the UK Primary Sj\u00f6gren's Syndrome Registry<\/span>. Rheumatology (Oxford)<\/span>, 56<\/span>, (12)<\/span>, pp. 2255<\/span>. <\/a> <\/a><\/p>","publicationid":"440560","date":"2017-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vencovsk\u00fd J; Sylwestrzak A; Leszczynski P; Porawska W; Baranauskaite A; Tseluyko V; Zhdan VM; Stasiuk B; Milasiene R; Barrera Rodriguez AA; Cheong SY; Ghil J<\/span> (2017)<\/span> 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 56<\/span>, (12)<\/span>, pp. 2093-2101<\/span>. <\/a> <\/a><\/p>","publicationid":"362733","date":"2017-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alfuraih AM; O'Connor P; Tan AL; Hensor E; Emery P; Wakefield RJ<\/span> (2017)<\/span> An investigation into the variability between different shear wave elastography systems in muscle<\/span>. Med Ultrason<\/span>, 19<\/span>, (4)<\/span>, pp. 392-400<\/span>. <\/a> <\/a><\/p>","publicationid":"436296","date":"2017-11-29","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vencovsk\u00fd J; Sylwestrzak A; Leszczy\u0144ski P; Porawska W; Stasiuk B; Hilt J; Mosterova Z; Cheong SY; Ghil J<\/span> (2017)<\/span> Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (12)<\/span>, pp. 1986-1991<\/span>. <\/a> <\/a><\/p>","publicationid":"429486","date":"2017-11-13","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pentony P; Duquenne L; Dutton K; Mankia K; Gul H; Vital E; Emery P<\/span> (2017)<\/span> The initiation of autoimmunity at epithelial surfaces: a focus on rheumatoid arthritis and systemic lupus erythematosus<\/span>. Discov Med<\/span>, 24<\/span>, (133)<\/span>, pp. 191-200<\/span>. <\/a><\/p>","publicationid":"453902","date":"2017-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

\u00d8stergaard M; Peterfy CG; Bird P; Gandjbakhch F; Glinatsi D; Eshed I; Haavardsholm EA; Lillegraven S; B\u00f8yesen P; Ejbjerg B; Foltz V; Emery P; Genant HK; Conaghan PG<\/span> (2017)<\/span> The OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging (MRI) Scoring System: Updated Recommendations by the OMERACT MRI in Arthritis Working Group<\/span>. J Rheumatol<\/span>, 44<\/span>, (11)<\/span>, pp. 1706-1712<\/span>. <\/a> <\/a><\/p>","publicationid":"437319","date":"2017-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lau CS; Gibofsky A; Damjanov N; Lula S; Marshall L; Jones H; Emery P<\/span> (2017)<\/span> Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review<\/span>. Rheumatol Int<\/span>, 37<\/span>, (11)<\/span>, pp. 1789-1798<\/span>. <\/a> <\/a><\/p>","publicationid":"435688","date":"2017-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Shaw D; El-Sherbiny YM; Dunn E; Rawstron AC; Emery P; Vital EM<\/span> (2017)<\/span> Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (11)<\/span>, pp. 1829-1836<\/span>. <\/a> <\/a><\/p>","publicationid":"429507","date":"2017-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Glinatsi D; Bird P; Gandjbakhch F; Haavardsholm EA; Peterfy CG; Vital EM; Emery P; Conaghan PG; \u00d8stergaard M<\/span> (2017)<\/span> Development and Validation of the OMERACT Rheumatoid Arthritis Magnetic Resonance Tenosynovitis Scoring System in a Multireader Exercise<\/span>. J Rheumatol<\/span>, 44<\/span>, (11)<\/span>, pp. 1688-1693<\/span>. <\/a> <\/a><\/p>","publicationid":"380459","date":"2017-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bezzina OM; Gallagher P; Mitchell S; Bowman SJ; Griffiths B; Hindmarsh V; Hargreaves B; Price EJ; Pease CT; Emery P; Lanyon P; Bombardieri M; Sutcliffe N; Pitzalis C; Hunter J; Gupta M; McLaren J; Cooper AM; Regan M; Giles IP; Isenberg DA; Saravanan V; Coady D; Dasgupta B; McHugh NJ; Young-Min SA; Moots RJ; Gendi N; Akil M; MacKay K; Ng WF; Robinson LJ; UK Primary Sj\u00f6gren's Syndrome Registry<\/span> (2017)<\/span> Subjective and Objective Measures of Dryness Symptoms in Primary Sj\u00f6gren's Syndrome: Capturing the Discrepancy<\/span>. Arthritis Care Res (Hoboken)<\/span>, 69<\/span>, (11)<\/span>, pp. 1714-1723<\/span>. <\/a> <\/a><\/p>","publicationid":"370940","date":"2017-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Weinblatt ME; Bingham CO; Burmester G-R; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; VanLunen B; Ecoffet C; Cioffi C; Emery P<\/span> (2017)<\/span> A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis<\/span>. Arthritis Rheumatol<\/span>, 69<\/span>, (10)<\/span>, pp. 1937-1948<\/span>. <\/a> <\/a><\/p>","publicationid":"435634","date":"2017-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

George MD; \u00d8stergaard M; Conaghan PG; Emery P; Baker DG; Baker JF<\/span> (2017)<\/span> Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (10)<\/span>, pp. 1743-1746<\/span>. <\/a> <\/a><\/p>","publicationid":"429190","date":"2017-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Mahmood F; Emery P; Conaghan PG; Helliwell PS<\/span> (2017)<\/span> The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (10)<\/span>, pp. 1688-1692<\/span>. <\/a> <\/a><\/p>","publicationid":"380572","date":"2017-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Emery P<\/span> (2017)<\/span> Imminent rheumatoid arthritis can be identified in primary care<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (10)<\/span>, pp. e42<\/span>. <\/a> <\/a><\/p>","publicationid":"374870","date":"2017-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Psarras A; Emery P; Vital EM<\/span> (2017)<\/span> Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy<\/span>. Rheumatology (Oxford)<\/span>, 56<\/span>, (10)<\/span>, pp. 1662-1675<\/span>. <\/a> <\/a><\/p>","publicationid":"367551","date":"2017-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Orr C; Vieira-Sousa E; Boyle DL; Buch MH; Buckley CD; Ca\u00f1ete JD; Catrina AI; Choy EHS; Emery P; Fearon U; Filer A; Gerlag D; Humby F; Isaacs JD; Just SA; Lauwerys BR; Le Goff B; Manzo A; McGarry T; McInnes IB; Najm A; Pitzalis C; Pratt A; Smith M; Tak PP; Thurlings R; Fonseca JE; Veale DJ<\/span> (2017)<\/span> Synovial tissue research: a state-of-the-art review<\/span>. Nat Rev Rheumatol<\/span>, 13<\/span>, (10)<\/span>, pp. 630<\/span>. <\/a><\/p>","publicationid":"1103390","date":"2017-09-22","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alfuraih AM; O'Connor P; Tan AL; Hensor E; Emery P; Wakefield R<\/span> (2017)<\/span> Does unit of reporting, depth and probe load influence the reliability of muscle shear wave elastography?<\/span> Clinical Radiology<\/span>, 72<\/span>, pp. S12<\/span>. <\/a><\/p>","publicationid":"849167","date":"2017-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alfuraih AM; O'Connor P; Tan AL; Hensor E; Emery P; Wakefield R<\/span> (2017)<\/span> An investigation into the reliability of shear wave elastography acquisition methods in muscle<\/span>. Clinical Radiology<\/span>, 72<\/span>, pp. S11-S12<\/span>. <\/a><\/p>","publicationid":"849166","date":"2017-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW; Yorkshire Early Arthritis Register Consortium<\/span> (2017)<\/span> Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register<\/span>. J Rheumatol<\/span>, 44<\/span>, (9)<\/span>, pp. 1331-1340<\/span>. <\/a> <\/a><\/p>","publicationid":"380004","date":"2017-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Orr C; Vieira-Sousa E; Boyle DL; Buch MH; Buckley CD; Ca\u00f1ete JD; Catrina AI; Choy EHS; Emery P; Fearon U; Filer A; Gerlag D; Humby F; Isaacs JD; Just SA; Lauwerys BR; Le Goff B; Manzo A; McGarry T; McInnes IB; Najm A; Pitzalis C; Pratt A; Smith M; Tak PP; Thurlings R; Fonseca JE; Veale DJ; Tas SW<\/span> (2017)<\/span> Synovial tissue research: a state-of-the-art review<\/span>. Nat Rev Rheumatol<\/span>, 13<\/span>, (8)<\/span>, pp. 463-475<\/span>. <\/a> <\/a><\/p>","publicationid":"435931","date":"2017-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P<\/span> (2017)<\/span> Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre<\/span>. Rheumatology (Oxford)<\/span>, 56<\/span>, (8)<\/span>, pp. 1348-1357<\/span>. <\/a> <\/a><\/p>","publicationid":"380095","date":"2017-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fleischmann R; Mysler E; Hall S; Kivitz AJ; Moots RJ; Luo Z; DeMasi R; Soma K; Zhang R; Takiya L; Tatulych S; Mojcik C; Krishnaswami S; Menon S; Smolen JS; ORAL Strategy investigators<\/span> (2017)<\/span> Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b\/4, double-blind, head-to-head, randomised controlled trial<\/span>. Lancet<\/span>, 390<\/span>, (10093)<\/span>, pp. 457-468<\/span>. <\/a><\/p>","publicationid":"1103397","date":"2017-07-29","publicationtype":"Journal article","isfavourite":"0"},{"html":"

De Marco G; Helliwell P; McGonagle D; Emery P; Coates LC; Hensor EMA; Marzo-Ortega H<\/span> (2017)<\/span> The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes<\/span>. BMC Musculoskelet Disord<\/span>, 18<\/span>, (1)<\/span>, pp. 303<\/span>. <\/a> <\/a><\/p>","publicationid":"435945","date":"2017-07-18","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Arumugakani G; Stephenson SJ; Newton DJ; Rawstron A; Emery P; Doody GM; McGonagle D; Tooze RM<\/span> (2017)<\/span> Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition<\/span>. J Immunol<\/span>, 198<\/span>, (12)<\/span>, pp. 4618-4628<\/span>. <\/a> <\/a><\/p>","publicationid":"379981","date":"2017-06-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Simon JB; Colin CE; John LO; Paul E; Costantino P; Wan\u2010Fai N; Colin TP; Elizabeth JP; Nurhan S; Nagui STG; Frances CH; Sharon PR; Catherine F; Catherine R; Claire TH; Kevin AD; Christopher JE; Peter CL; Robert JM; Euthalia R; Ian PG; Linda DS; Michele B<\/span> (2017)<\/span> Randomized Controlled Trial of Rituximab and Cost\u2010Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sj\u00f6gren's Syndrome<\/span>. Arthritis & Rheumatology<\/span>, 69<\/span>, (7)<\/span>, pp. 1440-1450<\/span>. <\/a> <\/a><\/p>","publicationid":"377592","date":"2017-06-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ayd\u0131n SZ; Castillo-Gallego C; Nam J; Freeston J; Horton S; Wakefield RJ; Emery P<\/span> (2017)<\/span> The new ACR\/EULAR criteria for rheumatoid arthritis can identify patients with same disease activity but less damage by ultrasound<\/span>. Eur J Rheumatol<\/span>, 4<\/span>, (2)<\/span>, pp. 118-121<\/span>. <\/a> <\/a><\/p>","publicationid":"434556","date":"2017-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Braun J; Baraliakos X; Deodhar A; Baeten D; Sieper J; Emery P; Readie A; Martin R; Mpofu S; Richards HB; MEASURE 1 study group<\/span> (2017)<\/span> Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (6)<\/span>, pp. 1070-1077<\/span>. <\/a> <\/a><\/p>","publicationid":"370941","date":"2017-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Combe B; Landewe R; Daien CI; Hua C; Aletaha D; \u00c1lvaro-Gracia JM; Bakkers M; Brodin N; Burmester GR; Codreanu C; Conway R; Dougados M; Emery P; Ferraccioli G; Fonseca J; Raza K; Silva-Fern\u00e1ndez L; Smolen JS; Skingle D; Szekanecz Z; Kvien TK; van der Helm-van Mil A; van Vollenhoven R<\/span> (2017)<\/span> 2016 update of the EULAR recommendations for the management of early arthritis<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (6)<\/span>, pp. 948-959<\/span>. <\/a> <\/a><\/p>","publicationid":"369829","date":"2017-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Nam J; Emery P<\/span> (2017)<\/span> Identifying arthralgia suspicious for progression to rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (6)<\/span>, pp. e14<\/span>. <\/a> <\/a><\/p>","publicationid":"369163","date":"2017-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Landew\u00e9 R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg J-E; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Po\u00f3r G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D<\/span> (2017)<\/span> EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (6)<\/span>, pp. 960-977<\/span>. <\/a> <\/a><\/p>","publicationid":"203717","date":"2017-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Castillo-Gallego C; Green MJ; Aydin SZ; Nizam S; Emery P; Marzo-Ortega H<\/span> (2017)<\/span> Long term follow up of an early oligoarthritis cohort shows that early aggressive intervention leads to drug free remission after 10 years: results from the LOTO study<\/span>. International Journal of Clinical Rheumatology<\/span>, 12<\/span>, (2)<\/span>, pp. 12-15<\/span>. <\/a><\/p>","publicationid":"378041","date":"2017-04-29","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; van Hoogstraten H; Mangan EK; van Adelsberg J; Fan C; Kivitz A; Pinheiro GDRC; Huizinga TW<\/span> (2017)<\/span> 229.\u2003CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. Rheumatology<\/span>, 56<\/span>, (suppl_2)<\/span>. <\/a><\/p>","publicationid":"1103391","date":"2017-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; D'Agostino MA; Wakefield R; Horton L; Nam J; Grainger A; Emery P<\/span> (2017)<\/span> 267.\u2003FIRST DEMONSTRATION OF A CHANGING IMAGING PHENOTYPE DURING FLARES OF PALINDROMIC RHEUMATISM<\/span>. Rheumatology<\/span>, 56<\/span>, (suppl_2)<\/span>. <\/a><\/p>","publicationid":"849165","date":"2017-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Emery P; Conaghan PG; Helliwell PS<\/span> (2017)<\/span> 075.\u2003WHAT SHOULD BE THE PRIMARY TARGET OF TREAT TO TARGET IN PSORIATIC ARTHRITIS?<\/span> Rheumatology<\/span>, 56<\/span>, (suppl_2)<\/span>. <\/a><\/p>","publicationid":"829447","date":"2017-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mahmood FS; Coates LC; Emery P; Conaghan P; Helliwell PS<\/span> (2017)<\/span> 116.\u2003THE KINETICS OF RESPONSE MEASURED BY SEVERAL COMPOSITE OUTCOME TOOLS IN THE TIGHT CONTROL OF INFLAMMATION IN EARLY PSORIATIC ARTHRITIS TRIAL<\/span>. Rheumatology<\/span>, 56<\/span>, (suppl_2)<\/span>. <\/a><\/p>","publicationid":"829446","date":"2017-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Halliday A; Jugl S; Mokashi S; Porter B; Martin R; Sherif B; Williams N; Marzo-Ortega H<\/span> (2017)<\/span> 107.\u2003LONG-TERM EFFICACY OF SECUKINUMAB CONDITIONAL ON RESPONSE STATUS AT WEEK 12: ANALYSIS IN TUMOUR NECROSIS FACTOR \u03b1 INHIBITOR\u2013NA\u00cfVE AND TUMOUR NECROSIS FACTOR \u03b1 INHIBITOR INADEQUATE RESPONDER PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS<\/span>. Rheumatology<\/span>, 56<\/span>, (suppl_2)<\/span>. <\/a><\/p>","publicationid":"666884","date":"2017-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Allen PB; Olivera P; Emery P; Moulin D; Jouzeau J-Y; Netter P; Danese S; Feagan B; Sandborn WJ; Peyrin-Biroulet L<\/span> (2017)<\/span> Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis<\/span>. Aliment Pharmacol Ther<\/span>, 45<\/span>, (8)<\/span>, pp. 1058-1072<\/span>. <\/a> <\/a><\/p>","publicationid":"377290","date":"2017-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Low ASL; Symmons DPM; Lunt M; Mercer LK; Gale CP; Watson KD; Dixon WG; Hyrich KL; British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) and the BSRBR Control Centre Consortium<\/span> (2017)<\/span> Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (4)<\/span>, pp. 654-660<\/span>. <\/a> <\/a><\/p>","publicationid":"374358","date":"2017-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ng W-F; Miller A; Bowman SJ; Price EJ; Kitas GD; Pease C; Emery P; Lanyon P; Hunter J; Gupta M; Giles I; Isenberg D; McLaren J; Regan M; Cooper A; Young-Min SA; McHugh N; Vadivelu S; Moots RJ; Coady D; MacKay K; Dasgupta B; Sutcliffe N; Bombardieri M; Pitzalis C; Griffiths B; Mitchell S; Miyamoto ST; Trenell M; UK Primary Sj\u00f6gren\u2019s Syndrome Registry<\/span> (2017)<\/span> Physical activity but not sedentary activity is reduced in primary Sj\u00f6gren's syndrome<\/span>. Rheumatol Int<\/span>, 37<\/span>, (4)<\/span>, pp. 623-631<\/span>. <\/a> <\/a><\/p>","publicationid":"371131","date":"2017-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

FitzGerald JM; Emery P<\/span> (2017)<\/span> Modifying the trajectory of asthma-are there lessons from the use of biologics in rheumatology?<\/span> Lancet<\/span>, 389<\/span>, (10074)<\/span>, pp. 1082-1084<\/span>. <\/a> <\/a><\/p>","publicationid":"378311","date":"2017-03-18","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pitaksalee R; Burska AN; Rogers J; Emery P; Hodgett R; Ponchel F<\/span> (2017)<\/span> 02.17\u2005Rheumatoid arthritis driven alteration in t-cell epigenetic programing<\/span>. Annals of the Rheumatic Diseases<\/span>, 76<\/span>, pp. A15<\/span>. <\/a><\/p>","publicationid":"1103389","date":"2017-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Kapadia A; Lettieri G; Goodfield M; Emery P; McGonagle D; Del Galdo F; Mikeljevic J<\/span> (2017)<\/span> Use of optical coherence tomography for the diagnosis of preclinical lesions of circumscribed palmar hypokeratosis<\/span>. Clin Exp Dermatol<\/span>, 42<\/span>, (2)<\/span>, pp. 192-195<\/span>. <\/a> <\/a><\/p>","publicationid":"371439","date":"2017-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker JF; Conaghan PG; Emery P; Baker DG; Ostergaard M<\/span> (2017)<\/span> Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (3)<\/span>, pp. 486-490<\/span>. <\/a> <\/a><\/p>","publicationid":"360701","date":"2017-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Clowse MEB; Wallace DJ; Furie RA; Petri MA; Pike MC; Leszczy\u0144ski P; Neuwelt CM; Hobbs K; Keiserman M; Duca L; Kalunian KC; Galateanu C; Bongardt S; Stach C; Beaudot C; Kilgallen B; Gordon C; EMBODY Investigator Group<\/span> (2017)<\/span> Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials<\/span>. Arthritis Rheumatol<\/span>, 69<\/span>, (2)<\/span>, pp. 362-375<\/span>. <\/a><\/p>","publicationid":"1103507","date":"2017-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Mankia K; Nam JL<\/span> (2017)<\/span> Individuals at risk of rheumatoid arthritis - The evolving story<\/span>. Best Pract Res Clin Rheumatol<\/span>, 31<\/span>, (1)<\/span>, pp. 1-2<\/span>. <\/a> <\/a><\/p>","publicationid":"452067","date":"2017-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Emery P<\/span> (2017)<\/span> What can palindromic rheumatism tell us?<\/span> Best Pract Res Clin Rheumatol<\/span>, 31<\/span>, (1)<\/span>, pp. 90-98<\/span>. <\/a> <\/a><\/p>","publicationid":"447689","date":"2017-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cheng Z; Meade J; Mankia K; Emery P; Devine DA<\/span> (2017)<\/span> Periodontal disease and periodontal bacteria as triggers for rheumatoid arthritis<\/span>. Best Pract Res Clin Rheumatol<\/span>, 31<\/span>, (1)<\/span>, pp. 19-30<\/span>. <\/a> <\/a><\/p>","publicationid":"436853","date":"2017-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sellam J; Rivi\u00e8re E; Courties A; Rouzaire P-O; Tolusso B; Vital EM; Emery P; Ferracioli G; Soubrier M; Ly B; Chavez HH; Taoufik Y; Dougados M; Mariette X<\/span> (2017)<\/span> Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis<\/span>. Arthritis Res Ther<\/span>, 19<\/span>, (1)<\/span>, pp. 11<\/span>. <\/a> <\/a><\/p>","publicationid":"373792","date":"2017-01-23","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Emery P; Conaghan PG; Helliwell PS<\/span> (2017)<\/span> WHAT SHOULD BE THE PRIMARY TARGET OF TREAT TO TARGET IN PSORIATIC ARTHRITIS?<\/span> RHEUMATOLOGY<\/span>, 56<\/span>, pp. 78<\/span>.<\/p>","publicationid":"493458","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Savic S; Mistry A; Wilson AG; Barcenas-Morales G; Doffinger R; Emery P; McGonagle D<\/span> (2017)<\/span> Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases<\/span>. RMD Open<\/span>, 3<\/span>, (2)<\/span>, pp. e000550<\/span>. <\/a> <\/a><\/p>","publicationid":"448239","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone EC; Breedveld FC; van der Heijde D; van Vollenhoven RF; Emery P; Smolen JS; Sainsbury I; Florentinus S; Kupper H; Chen K; Kavanaugh A<\/span> (2017)<\/span> Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone<\/span>. RMD Open<\/span>, 3<\/span>, (2)<\/span>, pp. e000445<\/span>. <\/a> <\/a><\/p>","publicationid":"447233","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Gunal EK; Ozata M; Keskin H; Ozturk AB; Emery P; D'Agostino MA<\/span> (2017)<\/span> Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission<\/span>. Clin Exp Rheumatol<\/span>, 35<\/span>, (5)<\/span>, pp. 853-856<\/span>. <\/a><\/p>","publicationid":"434096","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Tan AL; Wakefield RJ; Freeston JE; Buch MH; Emery P<\/span> (2017)<\/span> Ultrasound-detectable grey scale synovitis predicts future fulfilment of the 2010 ACR\/EULAR RA classification criteria in patients with new-onset undifferentiated arthritis<\/span>. RMD Open<\/span>, 3<\/span>, (1)<\/span>, pp. e000394<\/span>. <\/a> <\/a><\/p>","publicationid":"379539","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Blanco R; Maldonado Cocco J; Chen Y-C; Gaich CL; DeLozier AM; de Bono S; Liu J; Rooney T; Chang CH-C; Dougados M<\/span> (2017)<\/span> Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis<\/span>. RMD Open<\/span>, 3<\/span>, (1)<\/span>, pp. e000410<\/span>. <\/a> <\/a><\/p>","publicationid":"379130","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jani M; Dixon WG; Kersley-Fleet L; Bruce IN; Chinoy H; Barton A; Lunt M; Watson K; BSRBR-RA*; BSRBR-RA Control Centre Consortium*; Symmons DP; Hyrich KL<\/span> (2017)<\/span> Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA<\/span>. RMD Open<\/span>, 3<\/span>, (1)<\/span>, pp. e000314<\/span>. <\/a> <\/a><\/p>","publicationid":"374359","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Pay S; Inanc N; Kamali S; Karadag O; Emery P; D'Agostino M-A; Targeted Ultrasound Initiative (TUI) Steering Committee<\/span> (2017)<\/span> Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience<\/span>. Clin Exp Rheumatol<\/span>, 35<\/span>, (3)<\/span>, pp. 508-511<\/span>. <\/a><\/p>","publicationid":"372686","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker JF; \u00d8stergaard M; Emery P; Baker DG; Conaghan PG<\/span> (2017)<\/span> Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression<\/span>. Clin Exp Rheumatol<\/span>, 35<\/span>, (4)<\/span>, pp. 607-613<\/span>. <\/a><\/p>","publicationid":"370788","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

D'Agostino MA; Boers M; Wakefield RJ; Emery P; Conaghan PG<\/span> (2017)<\/span> Is it time to revisit the role of ultrasound in rheumatoid arthritis management?<\/span> Ann Rheum Dis<\/span>, 76<\/span>, (1)<\/span>, pp. 7-8<\/span>. <\/a> <\/a><\/p>","publicationid":"367554","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; van der Heijde D; Chen Y-C; Greenwald M; Drescher E; Liu J; Beattie S; Witt S; de la Torre I; Gaich C; Rooney T; Schlichting D; de Bono S; Emery P<\/span> (2017)<\/span> Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (1)<\/span>, pp. 88-95<\/span>. <\/a> <\/a><\/p>","publicationid":"365426","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jani M; Isaacs JD; Morgan AW; Wilson AG; Plant D; Hyrich KL; Chinoy H; Barton A; BRAGGSS<\/span> (2017)<\/span> High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (1)<\/span>, pp. 208-213<\/span>. <\/a> <\/a><\/p>","publicationid":"356435","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Hensor EMA; Rakieh C; Freeston JE; Middleton E; Horton S; Das S; Peterfy C; Tan AL; Wakefield RJ; Emery P<\/span> (2017)<\/span> Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study<\/span>. Rheumatology (Oxford)<\/span>, 56<\/span>, (1)<\/span>, pp. 58-67<\/span>. <\/a> <\/a><\/p>","publicationid":"351354","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME<\/span> (2017)<\/span> Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-na\u00efve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (1)<\/span>, pp. 96-104<\/span>. <\/a> <\/a><\/p>","publicationid":"351350","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vencovsk\u00fd J; Sylwestrzak A; Leszczy\u0144ski P; Porawska W; Baranauskaite A; Tseluyko V; Zhdan VM; Stasiuk B; Milasiene R; Barrera Rodriguez AA; Cheong SY; Ghil J<\/span> (2017)<\/span> A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy<\/span>. Ann Rheum Dis<\/span>, 76<\/span>, (1)<\/span>, pp. 51-57<\/span>. <\/a> <\/a><\/p>","publicationid":"329763","date":"2017-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sellam J; Rivi\u00e8re E; Courties A; Rouzaire P-O; Tolusso B; Vital EM; Emery P; Ferraccioli G; Soubrier M; Ly B; Hendel Chavez H; Taoufik Y; Dougados M; Mariette X<\/span> (2016)<\/span> Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis<\/span>. Arthritis Res Ther<\/span>, 18<\/span>, (1)<\/span>, pp. 294<\/span>. <\/a> <\/a><\/p>","publicationid":"369056","date":"2016-12-13","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Bissell L-A; Emery P; Del Galdo F; Buch MH<\/span> (2016)<\/span> Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?<\/span> Rheumatology (Oxford)<\/span>, 55<\/span>, (12)<\/span>, pp. 2273-2275<\/span>. <\/a> <\/a><\/p>","publicationid":"367610","date":"2016-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kremer JM; Emery P; Camp HS; Friedman A; Wang L; Othman AA; Khan N; Pangan AL; Jungerwirth S; Keystone EC<\/span> (2016)<\/span> A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy<\/span>. Arthritis Rheumatol<\/span>, 68<\/span>, (12)<\/span>, pp. 2867-2877<\/span>. <\/a> <\/a><\/p>","publicationid":"360872","date":"2016-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bissell L-A; Hensor EMA; Kozera L; Mackie SL; Burska AN; Nam JL; Keen H; Villeneuve E; Donica H; Buch MH; Conaghan PG; Andrews J; Emery P; Morgan AW<\/span> (2016)<\/span> Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study<\/span>. Rheumatology (Oxford)<\/span>, 55<\/span>, (12)<\/span>, pp. 2181-2190<\/span>. <\/a> <\/a><\/p>","publicationid":"351083","date":"2016-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Hensor EMA; Hunt L; Conaghan PG; Wakefield RJ; Emery P<\/span> (2016)<\/span> Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (12)<\/span>, pp. 2060-2067<\/span>. <\/a> <\/a><\/p>","publicationid":"343554","date":"2016-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Silva-Fern\u00e1ndez L; Lunt M; Kearsley-Fleet L; Watson KD; Dixon WG; Symmons DPM; Hyrich KL; British Society for Rheumatology Biologics Register (BSRBR) Control Centre Consortium<\/span> (2016)<\/span> The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis<\/span>. Rheumatology (Oxford)<\/span>, 55<\/span>, (11)<\/span>, pp. 2033-2039<\/span>. <\/a> <\/a><\/p>","publicationid":"370105","date":"2016-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

D'Agostino MA; Terslev L; Wakefield R; \u00d8stergaard M; Balint P; Naredo E; Iagnocco A; Backhaus M; Grassi W; Emery P<\/span> (2016)<\/span> Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (11)<\/span>, pp. 1902-1908<\/span>. <\/a> <\/a><\/p>","publicationid":"361474","date":"2016-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Bingham CO; Burmester GR; Bykerk VP; Furst DE; Mariette X; Heijde DVD; Vollenhoven RV; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME<\/span> (2016)<\/span> Response to: 'Let's stop fooling ourselves. In RA, only ACR\/EULAR criteria define remission and equate with absence of disease!' by Boers<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (10)<\/span>, pp. e69-E69<\/span>. <\/a> <\/a><\/p>","publicationid":"360871","date":"2016-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vencovsk\u00fd J; Ghil J; Cheong SY; Rho YH<\/span> (2016)<\/span> Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: response to letter by Scheinberg and Azevedo<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (10)<\/span>, pp. e65-E65<\/span>. <\/a> <\/a><\/p>","publicationid":"360866","date":"2016-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hunt L; Hensor EM; Nam J; Burska AN; Parmar R; Emery P; Ponchel F<\/span> (2016)<\/span> T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (10)<\/span>, pp. 1884-1889<\/span>. <\/a> <\/a><\/p>","publicationid":"344807","date":"2016-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

D'Agostino M-A; Wakefield RJ; Berner-Hammer H; Vittecoq O; Filippou G; Balint P; M\u00f6ller I; Iagnocco A; Naredo E; \u00d8stergaard M; Boers M; Gaillez C; Van Holder K; Le Bars M; OMERACT-EULAR-Ultrasound Task Force<\/span> (2016)<\/span> Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (10)<\/span>, pp. 1763-1769<\/span>. <\/a> <\/a><\/p>","publicationid":"342113","date":"2016-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vencovsk\u00fd J; Ghil J; Kang JW<\/span> (2016)<\/span> Response to: 'Lower anti-drug antibodies with etanercept biosimilar: Can Ctrough explain the differences' by Shah<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (9)<\/span>, pp. e61-E61<\/span>. <\/a> <\/a><\/p>","publicationid":"361111","date":"2016-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bissell L-A; Abignano G; Emery P; Del Galdo F; Buch MH<\/span> (2016)<\/span> Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon<\/span>. BMC Musculoskelet Disord<\/span>, 17<\/span>, (1)<\/span>, pp. 342<\/span>. <\/a> <\/a><\/p>","publicationid":"362120","date":"2016-08-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton L; Emery P; Marshall P<\/span> (2016)<\/span> Development and assessment of inter- and intra-rater reliability of a novel ultrasound tool for scoring tendon and sheath disease - A pilot study<\/span>. Ultrasound<\/span>, 24<\/span>, (3)<\/span>, pp. 134-141<\/span>. <\/a> <\/a><\/p>","publicationid":"364939","date":"2016-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nadesalingam K; Goodfield M; Emery P<\/span> (2016)<\/span> Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy<\/span>. Oxf Med Case Reports<\/span>, 2016<\/span>, (8)<\/span>, pp. omw027-156<\/span>. <\/a> <\/a><\/p>","publicationid":"362121","date":"2016-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schett G; Emery P; Tanaka Y; Burmester G; Pisetsky DS; Naredo E; Fautrel B; van Vollenhoven R<\/span> (2016)<\/span> Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (8)<\/span>, pp. 1428-1437<\/span>. <\/a> <\/a><\/p>","publicationid":"355439","date":"2016-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Smolen JS; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Kavanaugh A<\/span> (2016)<\/span> Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate<\/span>. Rheumatology (Oxford)<\/span>, 55<\/span>, (8)<\/span>, pp. 1458-1465<\/span>. <\/a> <\/a><\/p>","publicationid":"350470","date":"2016-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Peterfy C; Burmester GR; Bykerk VP; Combe BG; DiCarlo JC; Furst DE; Huizinga TWJ; Wong DA; Conaghan PG; Emery P<\/span> (2016)<\/span> Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (8)<\/span>, pp. 1501-1505<\/span>. <\/a> <\/a><\/p>","publicationid":"346189","date":"2016-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Hunt L; Hensor EMA; Emery P<\/span> (2016)<\/span> Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms - a cohort study<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (8)<\/span>, pp. 1452-1456<\/span>. <\/a> <\/a><\/p>","publicationid":"331623","date":"2016-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cohen S; Emery P; Greenwald M; Yin D; Becker J-C; Melia LA; Li R; Gumbiner B; Thomas D; Spencer-Green G; Meng X<\/span> (2016)<\/span> A phase I pharmacokinetics trial comparing PF-05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis<\/span>. Br J Clin Pharmacol<\/span>, 82<\/span>, (1)<\/span>, pp. 129-138<\/span>. <\/a> <\/a><\/p>","publicationid":"372106","date":"2016-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vencovsk\u00fd J; Kang JW; Ghil J<\/span> (2016)<\/span> Confirmation on the immunogenicity assay used in the SB4 phase III study: response to the comments by Meacci et al<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (7)<\/span>, pp. e40-E40<\/span>. <\/a> <\/a><\/p>","publicationid":"356283","date":"2016-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vencovsk\u00fd J; Ghil J; Kang JW<\/span> (2016)<\/span> Response to: 'Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration' by Marshall et al<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (7)<\/span>, pp. e38-e39<\/span>. <\/a> <\/a><\/p>","publicationid":"350050","date":"2016-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Tan AL; Freeston JE; Wakefield RJ; Buch MH; Emery P<\/span> (2016)<\/span> Discordance between the predictors of clinical and imaging remission in patients with early rheumatoid arthritis in clinical practice: implications for the use of ultrasound within a treatment-to-target strategy<\/span>. Rheumatology (Oxford)<\/span>, 55<\/span>, (7)<\/span>, pp. 1177-1187<\/span>. <\/a> <\/a><\/p>","publicationid":"343541","date":"2016-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Cassamoali H; Hawkins T; Rawstron A; Dunn E; Emery P; Vital EM<\/span> (2016)<\/span> OP0042\u2005Humanised Anti-CD20 Antibodies Improve Depletion and Response in Sle Patients with Resistance To Rituximab: Results from The First 100 Patients at A Single Centre<\/span>. Annals of the Rheumatic Diseases<\/span>, 75<\/span>, pp. 69<\/span>. <\/a><\/p>","publicationid":"1039521","date":"2016-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Hunt L; Hensor E; Nam J; Clerehugh V; Speirs A; Tugnait A; Do T; Devine D; Emery P<\/span> (2016)<\/span> OP0246\u2005Increased Prevalence of Periodontal Disease in Anti-CCP Positive Individuals at Risk of Progression To Inflammatory Arthritis: A Target for Prevention?<\/span> Annals of the Rheumatic Diseases<\/span>, 75<\/span>, pp. 151<\/span>. <\/a><\/p>","publicationid":"672551","date":"2016-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante EJB; Churchill M; Park W; Pons-Estel B; Han C; Gathany TA; Xu S; Zhou Y; Leu JH; Hsia EC<\/span> (2016)<\/span> Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial<\/span>. Arthritis Care Res (Hoboken)<\/span>, 68<\/span>, (6)<\/span>, pp. 744-752<\/span>. <\/a> <\/a><\/p>","publicationid":"338076","date":"2016-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker JF; Conaghan PG; Emery P; Baker DG; \u00d8stergaard M<\/span> (2016)<\/span> Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (6)<\/span>, pp. 1114-1119<\/span>. <\/a> <\/a><\/p>","publicationid":"327422","date":"2016-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Emery P<\/span> (2016)<\/span> A new window of opportunity in rheumatoid arthritis: targeting at-risk individuals<\/span>. Curr Opin Rheumatol<\/span>, 28<\/span>, (3)<\/span>, pp. 260-266<\/span>. <\/a> <\/a><\/p>","publicationid":"350875","date":"2016-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2016)<\/span> Introduction: the future of rheumatoid arthritis management<\/span>. Curr Opin Rheumatol<\/span>, 28<\/span>, (3)<\/span>, pp. 259<\/span>. <\/a> <\/a><\/p>","publicationid":"347764","date":"2016-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Vencovsk\u00fd J; Ghil J<\/span> (2016)<\/span> Response to: 'Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required' by Moots et al<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (5)<\/span>, pp. e25-EU4<\/span>. <\/a> <\/a><\/p>","publicationid":"344991","date":"2016-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Krogulec M; Alonso RB; Rossini M; Raeman F; Walker D; Ghizdavescu AP; Irto I; Rentero ML; Casillas M; de la Torre I; Dougados M<\/span> (2016)<\/span> O51\u2003Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to <sc>cs<\/sc>Dmards: Summary Results from the 24-Week Phase III RA-Build Study<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i60<\/span>. <\/a><\/p>","publicationid":"1103409","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Deodhar A; Sieper J; Andersson M; Richards H<\/span> (2016)<\/span> O05\u2003Secukinumab Significantly Improves Physical Function, Quality of Life, Fatigue and Work Productivity in Subjects with Active Ankylosing Spondylitis Treated for Up to 52 Weeks in the Phase III Measure 2 Study<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i35<\/span>. <\/a><\/p>","publicationid":"1103408","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Latif ZP; Stack RJ; Keenan A-M; Mankia K; Gul H; Emery P; Raza K<\/span> (2016)<\/span> 112\u2003A Qualitative Exploration of the Symptoms Experienced by People with Palindromic Rheumatism<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i108-i109<\/span>. <\/a><\/p>","publicationid":"1103407","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bykerk V; Burmester G; Combe B; Furst DE; Huizinga T; Wong D; Emery P<\/span> (2016)<\/span> 087\u2003On Drug and Drug-Free Remission by Baseline Disease Duration in the Avert Trial: Abatacept Versus Methotrexate Comparison in Patients with Early Rheumatoid Arthritis<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i97-i98<\/span>. <\/a><\/p>","publicationid":"1103406","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Burmester G; Bykerk V; Combe B; Furst DE; Maldonado M; Huizinga T<\/span> (2016)<\/span> 079\u2003Abatacept Plus Methotrexate can Effectively and Safely Regain the Target of Remission Following Re-Treatment for Flares after Drug-Free Withdrawal in Patients with Early Rheumatoid Arthritis<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i93-i94<\/span>. <\/a><\/p>","publicationid":"1103403","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Buch M; O'Reilly D; Sheeran T; Keidel S; Chitale S; Emery P<\/span> (2016)<\/span> 083\u2003The Impact of Treat to Target on 1-Year Real-World Outcomes in Patients with Rheumatoid Arthritis<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i95-i96<\/span>. <\/a><\/p>","publicationid":"1103402","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Buch M; O'Reilly D; Sheeran T; Keidel S; Chitale S; Emery P<\/span> (2016)<\/span> 084\u2003Predictors of Outcome at 1-Year in Patients with Rheumatoid Arthritis: Results from the UK Treat-to-Target Audit<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i96<\/span>. <\/a><\/p>","publicationid":"1103401","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Yusof Y; Iqbal K; Emery P; Kelly C; Dass S<\/span> (2016)<\/span> 101\u2003Safety of Rituximab in Patients with Rheumatoid Arthritis Associated with Bronchiectasis: Results from a Multicentre Cohort<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i103-i104<\/span>. <\/a><\/p>","publicationid":"1103400","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Iqbal K; Yuzaiful YM; Emery P; Dass S; Kelly C<\/span> (2016)<\/span> 103\u2003Efficacy of Rituximab in Patients with Rheumatoid Arthritis Associated with Bronchiectasis: Results from a Multicentre Cohort<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i104<\/span>. <\/a><\/p>","publicationid":"1103399","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Bissell LA; Dumitru RB; Eng S; Calder N; Messenger M; Buch M; Emery P; Del Galdo F<\/span> (2016)<\/span> 253\u2003Complementary Value of the ELF Test and NT-proBNP in Reflecting Fibrosis and Vasculopathy in Systemic Sclerosis<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i164<\/span>. <\/a><\/p>","publicationid":"702983","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Yusof YM; Mohamed AA; El-Sherbiny YM; Psarras A; Cassamoali H; Wittmann M; Vital EM; Emery P<\/span> (2016)<\/span> 270\u2003Patients with Early Incomplete Lupus have Elevated Type 1 Interferon Activity<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i170<\/span>. <\/a><\/p>","publicationid":"681629","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Blagojevic J; Abignano G; Hensor EMA; Guiducci S; Randone SB; Bruni C; Lepri G; Romano E; Mazzotta C; Calder NJ; Messenger MP; Buch M; Emery P; Matucci-Cerinic M; Del Galdo F<\/span> (2016)<\/span> Young Investigator AwardO30\u2003The Scleroderma Fibrotic Score: A Useful Serum Test in the Diagnosis of Early Scleroderma<\/span>. Rheumatology<\/span>, 55<\/span>, (suppl_1)<\/span>, pp. i49<\/span>. <\/a><\/p>","publicationid":"671536","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Emery P<\/span> (2016)<\/span> Preclinical Rheumatoid Arthritis: Progress Toward Prevention<\/span>. Arthritis Rheumatol<\/span>, 68<\/span>, (4)<\/span>, pp. 779-788<\/span>. <\/a> <\/a><\/p>","publicationid":"343546","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kang T; Wakefield RJ; Emery P<\/span> (2016)<\/span> Musculoskeletal ultrasound in rheumatology in Korea: targeted ultrasound initiative survey<\/span>. Int J Rheum Dis<\/span>, 19<\/span>, (4)<\/span>, pp. 335-342<\/span>. <\/a><\/p>","publicationid":"328883","date":"2016-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ramiro S; Smolen JS; Landew\u00e9 R; van der Heijde D; Dougados M; Emery P; de Wit M; Cutolo M; Oliver S; Gossec L<\/span> (2016)<\/span> Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (3)<\/span>, pp. 490-498<\/span>. <\/a> <\/a><\/p>","publicationid":"342029","date":"2016-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gossec L; Smolen JS; Ramiro S; de Wit M; Cutolo M; Dougados M; Emery P; Landew\u00e9 R; Oliver S; Aletaha D; Betteridge N; Braun J; Burmester G; Ca\u00f1ete JD; Damjanov N; FitzGerald O; Haglund E; Helliwell P; Kvien TK; Lories R; Luger T; Maccarone M; Marzo-Ortega H; McGonagle D; McInnes IB; Olivieri I; Pavelka K; Schett G; Sieper J; van den Bosch F; Veale DJ; Wollenhaupt J; Zink A; van der Heijde D<\/span> (2016)<\/span> European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (3)<\/span>, pp. 499-510<\/span>. <\/a> <\/a><\/p>","publicationid":"341215","date":"2016-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zayat AS; Md Yusof MY; Wakefield RJ; Conaghan PG; Emery P; Vital EM<\/span> (2016)<\/span> The role of ultrasound in assessing musculoskeletal symptoms of systemic lupus erythematosus: a systematic literature review<\/span>. Rheumatology (Oxford)<\/span>, 55<\/span>, (3)<\/span>, pp. 485-494<\/span>. <\/a> <\/a><\/p>","publicationid":"338074","date":"2016-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Combe B; Furst DE; Keystone EC; van der Heijde D; Luijtens K; Ionescu L; Goel N; Emery P<\/span> (2016)<\/span> Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre-Specified Analysis of Two Phase III Trials<\/span>. Arthritis Care Res (Hoboken)<\/span>, 68<\/span>, (3)<\/span>, pp. 299-307<\/span>. <\/a> <\/a><\/p>","publicationid":"332008","date":"2016-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Oni C; Mitchell S; James K; Ng W-F; Griffiths B; Hindmarsh V; Price E; Pease CT; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Hunter J; Gupta M; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman SJ; UK Primary Sj\u00f6gren\u2019s Syndrome Registry<\/span> (2016)<\/span> Eligibility for clinical trials in primary Sj\u00f6gren's syndrome: lessons from the UK Primary Sj\u00f6gren's Syndrome Registry<\/span>. Rheumatology (Oxford)<\/span>, 55<\/span>, (3)<\/span>, pp. 544-552<\/span>. <\/a> <\/a><\/p>","publicationid":"331625","date":"2016-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dumitru RB; Horton S; Hodgson R; Wakefield RJ; Hensor EMA; Emery P; Buch MH<\/span> (2016)<\/span> A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA)<\/span>. BMC Musculoskelet Disord<\/span>, 17<\/span>, (1)<\/span>, pp. 61<\/span>. <\/a> <\/a><\/p>","publicationid":"346192","date":"2016-02-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ferreira JF; Ahmed Mohamed AA; Emery P<\/span> (2016)<\/span> Glucocorticoids and Rheumatoid Arthritis<\/span>. Rheum Dis Clin North Am<\/span>, 42<\/span>, (1)<\/span>, pp. 33-vii<\/span>. <\/a> <\/a><\/p>","publicationid":"343726","date":"2016-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Borah B; Braun J; Baeten D; Laurent D; Sieper J; Emery P; McInnes IB; van Laar JM; Wordsworth P; Wollenhaupt J; Kellner H; Colin L; Vandenhende F; Radford K; Hueber W<\/span> (2016)<\/span> Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (2)<\/span>, pp. 408-412<\/span>. <\/a> <\/a><\/p>","publicationid":"332009","date":"2016-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rowbotham EL; Freeston JE; Emery P; Grainger AJ<\/span> (2016)<\/span> The prevalence of tenosynovitis of the interosseous tendons of the hand in patients with rheumatoid arthritis<\/span>. Eur Radiol<\/span>, 26<\/span>, (2)<\/span>, pp. 444-450<\/span>. <\/a> <\/a><\/p>","publicationid":"326367","date":"2016-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kang T; Wakefield RJ; Emery P<\/span> (2016)<\/span> Recent Trends of Ultrasound in Rheumatology<\/span>. Journal of Rheumatic Diseases<\/span>, 23<\/span>, (1)<\/span>, pp. 11<\/span>. <\/a><\/p>","publicationid":"849178","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burska AN; Neilan J; Chisman RE; West R; Emery P; Ponchel F<\/span> (2016)<\/span> SERUM IL-7 AS DIAGNOSTIC BIOMARKER FOR RHEUMATOID ARTHRITIS, VALIDATION WITH EULAR-2010 DIAGNOSTIC CRITERIA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 75<\/span>, pp. A25-A26<\/span>. <\/a><\/p>","publicationid":"588101","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Krogulec M; Alonso RB; Rossini M; Raeman F; Walker D; Ghizdavescu AP; Irto I; Rentero ML; Casillas M; De la Torre I; Dougados M; Larsson E<\/span> (2016)<\/span> Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inappropriate response to conventional disease-modifying anti-rheumatic drugs: 24-week phase 3 RA-BUILD study summary results<\/span>. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY<\/span>, 45<\/span>, pp. 20-21<\/span>.<\/p>","publicationid":"372105","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Braun J; Baraliakos X; Deodhar A; Baeten D; Sieper J; Emery P; Talloczy Z; Martin R; Richards HB<\/span> (2016)<\/span> EFFECT OF SECUKINUMAB ON SPINAL RADIOGRAPHIC CHANGES THROUGH 2 YEARS IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF THE PHASE 3 STUDY, MEASURE-1<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 34<\/span>, (4)<\/span>, pp. 781-782<\/span>.<\/p>","publicationid":"372104","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bykerk VP; Emery P; Weinblatt ME; Burmester G; Furst DE; Mariette X; van Vollenhoven R; Ralston P; Purcaru O; Bingham C<\/span> (2016)<\/span> CLINICAL RESPONSES AND IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES ARE ASSOCIATED WITH INCREASED PRODUCTIVITY IN THE WORKPLACE AND AT HOME IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL<\/span>. VALUE IN HEALTH<\/span>, 19<\/span>, (7)<\/span>, pp. A545<\/span>. <\/a> <\/a><\/p>","publicationid":"368253","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Howard Tripp N; Tarn J; Natasari A; Gillespie C; Mitchell S; Hackett KL; Bowman SJ; Price E; Pease CT; Emery P; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg DA; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Lendrem DW; Ng W-F<\/span> (2016)<\/span> Fatigue in primary Sj\u00f6gren's syndrome is associated with lower levels of proinflammatory cytokines<\/span>. RMD Open<\/span>, 2<\/span>, (2)<\/span>, pp. e000282<\/span>. <\/a> <\/a><\/p>","publicationid":"361760","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Heldmann F; Baraliakos X; Kiltz U; Brandt J; van der Horst-Bruinsma IE; Landew\u00e9 R; Sieper J; Burmester GR; van den Bosch F; de Vlam K; Gaston H; Gruenke M; Witt M; Appelboom T; Emery P; Dougados M; Leirisalo-Repo M; Breban M; Braun J<\/span> (2016)<\/span> Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety<\/span>. Clin Exp Rheumatol<\/span>, 34<\/span>, (2)<\/span>, pp. 184-190<\/span>.<\/p>","publicationid":"350614","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Oni C; Mitchell S; James K; Ng W-F; Griffiths B; Hindmarsh V; Prices E; Pease CT; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Hunter J; Gupta M; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman SJ<\/span> (2016)<\/span> Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry<\/span>. RHEUMATOLOGY<\/span>, 55<\/span>, (3)<\/span>, pp. 544-552<\/span>. <\/a><\/p>","publicationid":"350580","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ramiro S; Smolen JS; Landewe R; van der Heijde D; Dougados M; Emery P; de Wit M; Cutolo M; Oliver S; Gossec L<\/span> (2016)<\/span> Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 75<\/span>, (3)<\/span>, pp. 490-498<\/span>. <\/a><\/p>","publicationid":"348510","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bierkarre H; Harder J; Cuthbert R; Emery P; Leuschner I; Mrowietz U; Hedderich J; McGonagle D; Gl\u00e4ser R<\/span> (2016)<\/span> Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity<\/span>. Scand J Rheumatol<\/span>, 45<\/span>, (3)<\/span>, pp. 188-196<\/span>. <\/a> <\/a><\/p>","publicationid":"337955","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Breedveld FC; Burmester GR; Bykerk V; Dougados M; Emery P; Kvien TK; Navarro-Comp\u00e1n MV; Oliver S; Schoels M; Scholte-Voshaar M; Stamm T; Stoffer M; Takeuchi T; Aletaha D; Andreu JL; Aringer M; Bergman M; Betteridge N; Bijlsma H; Burkhardt H; Cardiel M; Combe B; Durez P; Fonseca JE; Gibofsky A; Gomez-Reino JJ; Graninger W; Hannonen P; Haraoui B; Kouloumas M; Landewe R; Martin-Mola E; Nash P; Ostergaard M; \u00d6st\u00f6r A; Richards P; Sokka-Isler T; Thorne C; Tzioufas AG; Van Vollenhoven R; De Wit M; Van Der Heijde D<\/span> (2016)<\/span> Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force<\/span>. Annals of the Rheumatic Diseases<\/span>, 75<\/span>, (1)<\/span>, pp. 3-15<\/span>. <\/a> <\/a><\/p>","publicationid":"327303","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Stoffer MA; Schoels MM; Smolen JS; Aletaha D; Breedveld FC; Burmester G; Bykerk V; Dougados M; Emery P; Haraoui B; Gomez-Reino J; Kvien TK; Nash P; Navarro-Comp\u00e1n V; Scholte-Voshaar M; van Vollenhoven R; van der Heijde D; Stamm TA<\/span> (2016)<\/span> Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (1)<\/span>, pp. 16-22<\/span>. <\/a> <\/a><\/p>","publicationid":"324526","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Peterfy C; Emery P; Tak PP; \u00d8stergaard M; DiCarlo J; Otsa K; Navarro Sarabia F; Pavelka K; Bagnard M-A; Gylvin LH; Bernasconi C; Gabriele A<\/span> (2016)<\/span> MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (1)<\/span>, pp. 170-177<\/span>. <\/a> <\/a><\/p>","publicationid":"307721","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Breedveld FC; Burmester GR; Bykerk V; Dougados M; Emery P; Kvien TK; Navarro-Comp\u00e1n MV; Oliver S; Schoels M; Scholte-Voshaar M; Stamm T; Stoffer M; Takeuchi T; Aletaha D; Andreu JL; Aringer M; Bergman M; Betteridge N; Bijlsma H; Burkhardt H; Cardiel M; Combe B; Durez P; Fonseca JE; Gibofsky A; Gomez-Reino JJ; Graninger W; Hannonen P; Haraoui B; Kouloumas M; Landewe R; Martin-Mola E; Nash P; Ostergaard M; \u00d6st\u00f6r A; Richards P; Sokka-Isler T; Thorne C; Tzioufas AG; van Vollenhoven R; de Wit M; van der Heijde D<\/span> (2016)<\/span> Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force<\/span>. Ann Rheum Dis<\/span>, 75<\/span>, (1)<\/span>, pp. 3-15<\/span>. <\/a> <\/a><\/p>","publicationid":"236258","date":"2016-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baeten D; Sieper J; Braun J; Baraliakos X; Dougados M; Emery P; Deodhar A; Porter B; Martin R; Andersson M; Mpofu S; Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group<\/span> (2015)<\/span> Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis<\/span>. N Engl J Med<\/span>, 373<\/span>, (26)<\/span>, pp. 2534-2548<\/span>. <\/a> <\/a><\/p>","publicationid":"342794","date":"2015-12-24","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Moverley AR; McParland L; Brown S; Navarro-Coy N; O'Dwyer JL; Meads DM; Emery P; Conaghan PG; Helliwell PS<\/span> (2015)<\/span> Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial<\/span>. Lancet<\/span>, 386<\/span>, (10012)<\/span>, pp. 2489-2498<\/span>. <\/a> <\/a><\/p>","publicationid":"324963","date":"2015-12-19","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Emery P<\/span> (2015)<\/span> Anti-Porphyromonas gingivalis Antibodies in Rheumatoid Arthritis: Comment on the Article by Seror et al<\/span>. Arthritis Rheumatol<\/span>, 67<\/span>, (12)<\/span>, pp. 3329-3330<\/span>. <\/a> <\/a><\/p>","publicationid":"334668","date":"2015-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mackie SL; Pease CT; Fukuba E; Harris E; Emery P; Hodgson R; Freeston J; McGonagle D<\/span> (2015)<\/span> Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids<\/span>. Ann Rheum Dis<\/span>, 74<\/span>, (12)<\/span>, pp. 2188-2192<\/span>. <\/a> <\/a><\/p>","publicationid":"330000","date":"2015-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

\u00d8stergaard M; Bird P; Gandjbakhch F; Eshed I; Haugen IK; Haavardsholm EA; Lillegraven S; Foltz V; Glinatsi D; Peterfy C; Ejbjerg B; B\u00f8yesen P; Mease PJ; Hermann K-G; Emery P; Genant HK; Conaghan PG<\/span> (2015)<\/span> The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research Priorities<\/span>. J Rheumatol<\/span>, 42<\/span>, (12)<\/span>, pp. 2470-2472<\/span>. <\/a> <\/a><\/p>","publicationid":"319834","date":"2015-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Kavanaugh A; Bao Y; Ganguli A; Mulani P<\/span> (2015)<\/span> Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?<\/span> Ann Rheum Dis<\/span>, 74<\/span>, (12)<\/span>, pp. 2165-2174<\/span>. <\/a> <\/a><\/p>","publicationid":"294351","date":"2015-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Weinblatt ME; Fleischmann R; van Vollenhoven RF; Emery P; Huizinga TWJ; Cutolo M; van der Heijde D; Duncan B; Davies O; Luijtens K; Dougados M<\/span> (2015)<\/span> Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population<\/span>. Arthritis Res Ther<\/span>, 17<\/span>, (1)<\/span>, pp. 325<\/span>. <\/a> <\/a><\/p>","publicationid":"338073","date":"2015-11-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hawkins T; Emery P<\/span> (2015)<\/span> Biosimilar medicines in rheumatology<\/span>. Clinical Pharmacist<\/span>, 7<\/span>, (10)<\/span>. <\/a> <\/a><\/p>","publicationid":"341422","date":"2015-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Solem C; Majer I; Cappelleri JC; Tarallo M<\/span> (2015)<\/span> A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization<\/span>. Rheumatol Int<\/span>, 35<\/span>, (11)<\/span>, pp. 1837-1849<\/span>. <\/a> <\/a><\/p>","publicationid":"329762","date":"2015-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gvozdenovi\u0107 E; Wolterbeek R; Allaart CF; Brenol C; Dougados M; Emery P; Ferraccioli G; van der Heijde D; Huizinga TW; Kay J; Martin Mola E; Moots RJ; da Silva JAP; Smolen J; Veale D; Landew\u00e9 RB<\/span> (2015)<\/span> Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database<\/span>. J Clin Rheumatol<\/span>, 21<\/span>, (7)<\/span>, pp. 349-354<\/span>. <\/a> <\/a><\/p>","publicationid":"331628","date":"2015-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Weinblatt ME; Mease P; Mysler E; Takeuchi T; Drescher E; Berman A; Xing J; Zilberstein M; Banerjee S; Emery P<\/span> (2015)<\/span> The efficacy and safety of subcutaneous clazakizumab in patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate: results from a multinational, phase IIb, randomized, double-blind, placebo\/active-controlled, dose-ranging study<\/span>. Arthritis Rheumatol<\/span>, 67<\/span>, (10)<\/span>, pp. 2591-2600<\/span>. <\/a> <\/a><\/p>","publicationid":"328918","date":"2015-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mankia K; Emery P<\/span> (2015)<\/span> Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for prevention<\/span>. Discov Med<\/span>, 20<\/span>, (109)<\/span>, pp. 129-135<\/span>. <\/a><\/p>","publicationid":"338075","date":"2015-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Vital EM; Das S; Dass S; Arumugakani G; Savic S; Rawstron AC; Emery P<\/span> (2015)<\/span> Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions<\/span>. Ann Rheum Dis<\/span>, 74<\/span>, (9)<\/span>, pp. 1734-1738<\/span>. <\/a> <\/a><\/p>","publicationid":"335908","date":"2015-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rakieh C; Nam JL; Hunt L; Hensor EMA; Das S; Bissell L-A; Villeneuve E; McGonagle D; Hodgson R; Grainger A; Wakefield RJ; Conaghan PG; Emery P<\/span> (2015)<\/span> Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study<\/span>. Annals of the rheumatic diseases<\/span>, 74<\/span>, (9)<\/span>, pp. 1659-1666<\/span>. <\/a> <\/a><\/p>","publicationid":"283068","date":"2015-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Genovese MC; Silverman GJ; Emery P; Gupta RC; Gill A; Veenhuizen M; Xie L; Komocsar WJ; Berclaz P-Y; Lee C<\/span> (2015)<\/span> Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)<\/span>. J Clin Rheumatol<\/span>, 21<\/span>, (5)<\/span>, pp. 231-238<\/span>. <\/a> <\/a><\/p>","publicationid":"331185","date":"2015-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ramiro S; Smolen JS; Landew\u00e9 R; van der Heijde D; Dougados M; Emery P; De Wit M; Cutolo M; Oliver S; Gossec L<\/span> (2015)<\/span> THU0412\u2005Pharmacological Treatment of Psoriatic Arthritis (PSA): Systematic Literature Review for the Update of the Eular Recommendations for the Management of PSA<\/span>. Annals of the Rheumatic Diseases<\/span>, 74<\/span>, pp. 346<\/span>. <\/a><\/p>","publicationid":"1103520","date":"2015-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gottenberg JE; Rubbert-Roth A; Sarzi-Puttini P; Choquette D; Taboada VMM; Barile-Fabris L; Moots RJ; Ostor A; Andrianakos A; Gemmen E; Mpofu C; Chung C; Gylvin LH; Finckh A<\/span> (2015)<\/span> Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study<\/span>. Ann Rheum Dis<\/span>, 74<\/span>, (6)<\/span>, pp. 979-984<\/span>. <\/a> <\/a><\/p>","publicationid":"329622","date":"2015-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Silva-Fernandez L; Carmona L; Aletaha D; Christensen R; Combe B; Emery P; Ferraccioli G; Guillemin F; Kvien TK; Landewe R; Pavelka K; Saag K; Smolen JS; Symmons D; Van Der Heijde D; Welling J; Wells G; Westhovens R; Zink A; Boers M<\/span> (2015)<\/span> Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology<\/span>. Annals of the Rheumatic Diseases<\/span>, 74<\/span>, (6)<\/span>, pp. 963-969<\/span>. <\/a> <\/a><\/p>","publicationid":"327478","date":"2015-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Wittmann M; Edward S; Md Yusof MY; MacIver H; Pease CT; Goodfield M; Emery P<\/span> (2015)<\/span> Brief report: responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus<\/span>. Arthritis Rheumatol<\/span>, 67<\/span>, (6)<\/span>, pp. 1586-1591<\/span>. <\/a> <\/a><\/p>","publicationid":"320653","date":"2015-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Silva-Fernandez L; Carmona L; Aletaha D; Christensen R; Combe B; Emery P; Ferraccioli G; Guillemin F; Kvien TK; Landewe R; Pavelka K; Saag K; Smolen JS; Symmons D; van der Heijde D; Welling J; Wells G; Westhovens R; Zink A; Boers M; European League Against Rheumatism (EULAR)<\/span> (2015)<\/span> Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology<\/span>. Annals of the rheumatic diseases<\/span>, 74<\/span>, (6)<\/span>, pp. 963-969<\/span>. <\/a><\/p>","publicationid":"286023","date":"2015-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mercer LK; Lunt M; Low ALS; Dixon WG; Watson KD; Symmons DPM; Hyrich KL; BSRBR Control Centre Consortium<\/span> (2015)<\/span> Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis<\/span>. Ann Rheum Dis<\/span>, 74<\/span>, (6)<\/span>, pp. 1087-1093<\/span>. <\/a><\/p>","publicationid":"283243","date":"2015-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Dass S; Buch MH; Rawstron AC; Emery P<\/span> (2015)<\/span> An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial<\/span>. Ann Rheum Dis<\/span>, 74<\/span>, (6)<\/span>, pp. 1195-1201<\/span>. <\/a> <\/a><\/p>","publicationid":"277236","date":"2015-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Ferraccioli GF; Samborski W; Berenbaum F; Davies OR; Koetse W; Purcaru O; Bennett B; Burkhardt H<\/span> (2015)<\/span> Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial<\/span>. Ann Rheum Dis<\/span>, 74<\/span>, (5)<\/span>, pp. 843-850<\/span>. <\/a> <\/a><\/p>","publicationid":"323167","date":"2015-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jani M; Chinoy H; Warren RB; Griffiths CEM; Plant D; Fu B; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Barton A; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Collaborators<\/span> (2015)<\/span> Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis<\/span>. Arthritis Rheumatol<\/span>, 67<\/span>, (8)<\/span>, pp. 2011-2019<\/span>. <\/a><\/p>","publicationid":"319337","date":"2015-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zayat AS; Ellegaard K; Conaghan PG; Terslev L; Hensor EMA; Freeston JE; Emery P; Wakefield RJ<\/span> (2015)<\/span> The specificity of ultrasound-detected bone erosions for rheumatoid arthritis<\/span>. Annals of the rheumatic diseases<\/span>, 74<\/span>, (5)<\/span>, pp. 897-903<\/span>. <\/a> <\/a><\/p>","publicationid":"276932","date":"2015-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Burmester GR; Bykerk VP; Combe BG; Furst DE; Karyekar CS; Wong DA; Huizinga TWJ<\/span> (2015)<\/span> O12.\u2003Predictors of Drug-Free Remission Following Treatment with Abatacept (In Combination with Methotrexate or as Monotherapy) in Early Rheumatoid Arthritis<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i28-i29<\/span>. <\/a><\/p>","publicationid":"1103412","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nadesalingam K; Goodfield M; Emery P<\/span> (2015)<\/span> 012.\u2003Halo Naevi, Vitiligo and Diffuse Alopecia Areata Associated with Tocilizumab Therapy<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i54<\/span>. <\/a><\/p>","publicationid":"1103411","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cartlidge C; Bowman S; Ng W-F; James K; Griffiths B; Price E; Prease C; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S<\/span> (2015)<\/span> 213.\u2003Eligibility for Clinical Trials in Primary Sj\u00f6gren\u2019s Syndrome: Lessons from the UK Primary Sj\u00f6gren\u2019s Registry<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i131-i132<\/span>. <\/a><\/p>","publicationid":"1103410","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ferreira JCF; Yusof YM; Das S; Vital EM; Emery P<\/span> (2015)<\/span> 061.\u2003Rituximab-Associated Neutropaenia: Safety of Retreatment Rituximab Therapy<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i74<\/span>. <\/a><\/p>","publicationid":"1039518","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kabia AR; Yusof YM; Dass S; Vital EM; Beirne P; Emery P<\/span> (2015)<\/span> 092.\u2003Efficacy and Safety of Rituximab in Rheumatoid Arthritis Patients with Concomitant Interstitial Lung Disease: 10-Year Experience at Single Centre<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i86<\/span>. <\/a><\/p>","publicationid":"1039516","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Peterfy C; Burmester GR; Bykerk VP; Combe BG; DiCarlo JC; Furst DE; Huizinga TWJ; Karyekar CS; Wong DA; Conaghan P; Emery P<\/span> (2015)<\/span> 060.\u2003Sustained Improvements in Magnetic Resonance Imaging Outcomes with Abatacept following the withdrawal of all Treatment in Patients with Early Rheumatoid Arthritis<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i73-i74<\/span>. <\/a><\/p>","publicationid":"829451","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zayat AS; Edwards CJ; Yusof YM; Mukherjee S; Wakefield RJ; Emery P; Vital EM<\/span> (2015)<\/span> O24.\u2003The Role of Musculoskeletal Ultrasound in the Stratification of SLE: A Multicentre Cross-Sectional Study<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i34-i35<\/span>. <\/a><\/p>","publicationid":"732954","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

El-Sherbiny Y; Ponchel F; Rawstron AC; Emery P; Vital EM<\/span> (2015)<\/span> 078.\u2003A Paradoxical Relationship Between BAFF and B Cells Revealed by Rituximab Therapy for Rheumatoid Arthritis<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i81<\/span>. <\/a><\/p>","publicationid":"681630","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mohamed AAA; El-Sherbiny YM; Yusof YM; Vital EM; Emery P<\/span> (2015)<\/span> 295.\u2003Flow-Based Cell-Specific Interferon Signature as a Biomarker in Systemic Lupus Erythematosus<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i164<\/span>. <\/a><\/p>","publicationid":"681628","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gul HL; Porto MJI; Ponchel F; Hensor EMA; Emery P<\/span> (2015)<\/span> O04.\u2003Defining the Characteristics of Remission and Low Disease Activity State in Patients with Rheumatoid Arthritis: Clinical, Imaging, Functional and Immunological Characteristics<\/span>. Rheumatology<\/span>, 54<\/span>, (suppl_1)<\/span>, pp. i23-i24<\/span>. <\/a><\/p>","publicationid":"671538","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lendrem D; Mitchell S; McMeekin P; Gompels L; Hackett K; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng W-F; UK primary Sj\u00f6gren\u2019s Syndrome Registry<\/span> (2015)<\/span> Do the EULAR Sj\u00f6gren's syndrome outcome measures correlate with health status in primary Sj\u00f6gren's syndrome?<\/span> Rheumatology (Oxford)<\/span>, 54<\/span>, (4)<\/span>, pp. 655-659<\/span>. <\/a> <\/a><\/p>","publicationid":"306216","date":"2015-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2015)<\/span> Rheumatoid arthritis in 2014: Exciting times for RA research<\/span>. Nat Rev Rheumatol<\/span>, 11<\/span>, (2)<\/span>, pp. 69-70<\/span>. <\/a><\/p>","publicationid":"310347","date":"2015-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Hammoudeh M; Combe B<\/span> (2015)<\/span> Etanercept tapering in rheumatoid arthritis<\/span>. N Engl J Med<\/span>, 372<\/span>, (5)<\/span>, pp. 489-490<\/span>. <\/a><\/p>","publicationid":"320483","date":"2015-01-29","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Graudal N; J\u00fcrgens G<\/span> (2015)<\/span> Etanercept tapering in rheumatoid arthritis<\/span>. N Engl J Med<\/span>, 372<\/span>, (5)<\/span>, pp. 489-490<\/span>. <\/a><\/p>","publicationid":"318870","date":"2015-01-29","publicationtype":"Journal article","isfavourite":"0"},{"html":"

El-Sherbiny Y; Mohamed AA; Yusof YM; Vital E; Emery P<\/span> (2015)<\/span> FLOW-BASED CELL-SPECIFIC INTERFERON SIGNATURE AS A BIOMARKER IN SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 74<\/span>, pp. 562-563<\/span>. <\/a><\/p>","publicationid":"370762","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Rondon J; Garg A; van Hoogstraten H; Graham N; Liu M; Parrino J; Spindler AJ; Liu N<\/span> (2015)<\/span> Safety and Tolerability of Subcutaneous Sarilumab Compared to Intravenous Tocilizumab in Patients with RA<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347733","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Deodhar AA; Braun J; Baeten D; Dougados M; Sieper J; Emery P; Readie A; Martin R; Mpofu S; Richards H<\/span> (2015)<\/span> Effect of Interleukin-17A Inhibition on Spinal Radiographic Changes through 2 Years in Patients with Active Ankylosing Spondylitis: Results of a Phase 3 Study with Secukinumab<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347731","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann R; Xu S; Hsia EC<\/span> (2015)<\/span> Treatment Target Status at 6 Months and Long-Term Outcomes at 5 Years: Analysis of Methotrexate-Naive Patients with Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347730","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Baranauskaite A; Tseluyko V; Zhdan V; Stasiuk B; Milasiene R; Barrera Rodriguez AA; Cheong SY; Ghil J; Emery P<\/span> (2015)<\/span> A Phase III, Randomized, Double-Blind Clinical Study Comparing SB4, an Etanercept Biosimilar, with Etanercept Reference Product (Enbrel\u00ae) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy (52-week Results)<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347729","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Weinblatt M; Bingham C; Burmester G; Bykerk VP; Furst DE; Mariette X; van der Heijde D; Tatla D; Arendt C; Mountian I; VanLunen B; Emery P<\/span> (2015)<\/span> Early Response As a Predictor of Long-Term Remission in DMARD-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis Treated with Certolizumab Pegol in Combination with Methotrexate<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347728","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kremer J; Dougados M; Genovese MC; Emery P; Yang L; de Bono S; Holzkaemper T; Iikuni N; Schlichting DE; Smolen JS<\/span> (2015)<\/span> Response to Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347727","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mohamed AAA; Yusof MYM; El-Sherbiny Y; Emery P; Vital EM<\/span> (2015)<\/span> Interferon Activity in Early and Established SLE: Interferon Score Is Lower in Early Disease and Not Seen without Antibodies to Extractable Nuclear Antigens<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347726","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Bykerk VP; Burmester G; Combe BG; Huizinga TWJ; Alemao E; Johnsen A; Emery P<\/span> (2015)<\/span> Evaluation of Patient-Reported Outcomes By Baseline Disease Duration: 6-Month Data from Two Clinical Trials of Patients with Early Rheumatoid Arthritis Treated with Abatacept<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347725","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bykerk VP; Bingham C; Burmester G; Furst DE; Mariette X; Purcaru O; VanLunen B; Weinblatt M; Emery P<\/span> (2015)<\/span> Reduction of Disease Burden on Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in DMARD-Naive Patients with Active, Severe, Progressive Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347724","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kremer JM; Keystone EC; Emery P; Camp HS; Friedman A; Wang L; Othman AA; Khan N; Jungerwirth S<\/span> (2015)<\/span> Safety and Efficacy of ABT-494, a Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Anti-TNF Biologic Therapy<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347723","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bykerk VP; Burmester G; Combe BG; Furst DE; Huizinga TWJ; Wong DA; Emery P<\/span> (2015)<\/span> On Drug and Drug-Free Remission By Baseline Disease Duration: Abatacept Versus Methotrexate Comparison in Patients with Early Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347722","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Burmester G; Bykerk VP; Combe B; Furst DE; Maldonado M; Huizinga TWJ<\/span> (2015)<\/span> Abatacept Plus Methotrexate Can Effectively and Safely Regain the Target of Remission Following Re-Treatment for Flares after Drug-Free Withdrawal in Patients with Early Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347721","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Huizinga TWJ; Connolly SE; Johnsen A; Zhu J; Furst DE; Bykerk VP; Burmester G; Combe BG; Wong DA; Trouw LA; Toes REM; Emery P<\/span> (2015)<\/span> Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347720","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Weinblatt M; Bingham C; Burmester G; Bykerk VP; Furst DE; Mariette X; van der Heijde D; Tatla D; Arendt C; Mountian I; VanLunen B; Emery P<\/span> (2015)<\/span> Certolizumab Pegol in Combination with Methotrexate in DMARD-Naive Patients with Active, Severe, Progressive Rheumatoid Arthritis: Results from a Randomized, Double-Blind, Controlled Phase 3 Study<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347719","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gaich CL; DeLozier AM; De Bono S; Liu J; Chang C; Dougados M<\/span> (2015)<\/span> Patient-Reported Outcomes from a Phase 3 Study of Baricitinib in Patients with Rheumatoid Arthritis with Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347718","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Erhayiem B; McDiarmid A; Swoboda P; Kidambi A; Ripley D; Musa T; Dobson L; Garg P; Horton S; Dumitru R; Andrews J; Greenwood J; Emery P; Plein S; Buch MH<\/span> (2015)<\/span> Treatment-Naive, Early Rheumatoid Arthritis Patients Demonstrate Abnormalities of Vascular and Myocardial Function on Cardiac MRI<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347715","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bowes MA; Guillard G; Vincent GR; Freeston JE; Vital EM; Emery P; Conaghan PG<\/span> (2015)<\/span> Quantitative MRI Measurement of Tenosynovitis Demonstrates Differing Responses of Synovitis and Tenosynovitis after RA Treatment<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347713","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker J; Ostergaard M; Baker D; Emery P; Conaghan PG<\/span> (2015)<\/span> Defining an Acceptable Level of MRI Inflammation in Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347712","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker J; Conaghan PG; Baker D; Emery P; Ostergaard M<\/span> (2015)<\/span> MRI Measures of Disease Activity and Joint Damage Are Associated with Patient-Reported Outcomes in Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 67<\/span>.<\/p>","publicationid":"347708","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

James K; Al-Ali S; Tarn J; Cockell SJ; Gillespie CS; Hindmarsh V; Locke J; Mitchell S; Lendrem D; Bowman S; Price E; Pease CT; Emery P; Lanyon P; Hunter JA; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; UK Primary Sj\u00f6gren\u2019s Syndrome registry; Wipat A; Newton J; Jones DE; Isaacs J; Hallinan J; Ng W-F<\/span> (2015)<\/span> A Transcriptional Signature of Fatigue Derived from Patients with Primary Sj\u00f6gren's Syndrome<\/span>. PLoS One<\/span>, 10<\/span>, (12)<\/span>, pp. e0143970<\/span>. <\/a><\/p>","publicationid":"342030","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zayat AS; Edwards CJ; Yusof MM; Mukherjee S; Philip CG; Wakefield RJ; Emery P; Vital EM<\/span> (2015)<\/span> The role of musculoskeletal ultrasound in the stratification of SLE; a multicenter crosssectionalstudy<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 33<\/span>, (3)<\/span>, pp. S74-S75<\/span>.<\/p>","publicationid":"335517","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Shaw DJ; Yusof MYM; Savic S; Emery P; Vital EM<\/span> (2015)<\/span> Long-term safety of rituximab in systemic lupus erythematosus: Repeat cycles are associated with low rates of hypogammaglobulinaemia<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 33<\/span>, (3)<\/span>, pp. S29<\/span>.<\/p>","publicationid":"335487","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Yusof MYM; Shaw D; El-Sherbiny Y; Dass S; Savic S; Rawstron AC; Vital EM; Emery P<\/span> (2015)<\/span> Management of primary and secondary non-responders to B cell depletion therapy in systemic lupus erythematosus: Results from the first 100 patients at a single centre<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 33<\/span>, (3)<\/span>, pp. S28<\/span>.<\/p>","publicationid":"335486","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ponchel F; Burska AN; Hensor EMA; Raja R; Campbell M; Emery P; Conaghan PG<\/span> (2015)<\/span> Changes in peripheral blood immune cell composition in osteoarthritis<\/span>. OSTEOARTHRITIS AND CARTILAGE<\/span>, 23<\/span>, (11)<\/span>, pp. 1870-1878<\/span>. <\/a> <\/a><\/p>","publicationid":"331261","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gul HL; Ferreira JF; Emery P<\/span> (2015)<\/span> Remission in rheumatoid arthritis: is it all the same?<\/span> Expert Rev Clin Pharmacol<\/span>, 8<\/span>, (5)<\/span>, pp. 575-586<\/span>. <\/a> <\/a><\/p>","publicationid":"328837","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Erhayiem B; Bissell L-A; McDiarmid AK; Swoboda PP; Kidambi A; Ripley DP; Musa TA; Dobson LE; Garg P; Emery P; Andrews J; Greenwood JP; Buch MH; Plein S<\/span> (2015)<\/span> Abnormal left ventricular geometry is prevalent in asymptomatic patients with established rheumatoid arthritis compared with those with early disease and healthy controls<\/span>. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance<\/span>, 17<\/span>, (Suppl 1)<\/span>, pp. P297<\/span>. <\/a><\/p>","publicationid":"323865","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2015)<\/span> Rheumatoid arthritis in 2014: Exciting times for RA research<\/span>. Nature Reviews Rheumatology<\/span>, 11<\/span>, (2)<\/span>, pp. 69-70<\/span>. <\/a><\/p>","publicationid":"320445","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Burmester GR; Bykerk VP; Combe BG; Furst DE; Barr\u00e9 E; Karyekar CS; Wong DA; Huizinga TWJ<\/span> (2015)<\/span> Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24\u2005months, with a 12-month, double-blind treatment period<\/span>. Ann Rheum Dis<\/span>, 74<\/span>, (1)<\/span>, pp. 19-26<\/span>. <\/a><\/p>","publicationid":"308162","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Fukuba E; Halliday NA; Tanner SF; Emery P; McGonagle D<\/span> (2015)<\/span> High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis<\/span>. Ann Rheum Dis<\/span>, 74<\/span>, (1)<\/span>, pp. 185-189<\/span>. <\/a> <\/a><\/p>","publicationid":"306558","date":"2015-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Navarro Coy NC; Brown S; Bosworth A; Davies CT; Emery P; Everett CC; Fernandez C; Gray JC; Hartley S; Hulme C; Keenan A-M; McCabe C; Redmond A; Reynolds C; Scott D; Sharples LD; Pavitt S; Buch MH<\/span> (2014)<\/span> The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug<\/span>. BMC Musculoskelet Disord<\/span>, 15<\/span>, (1)<\/span>, pp. 452<\/span>. <\/a> <\/a><\/p>","publicationid":"310394","date":"2014-12-23","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Churchman SM; El-Jawhari JJ; Burska AN; Parmar R; Go\u00ebb V; Conaghan PG; Emery P; Ponchel F<\/span> (2014)<\/span> Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis<\/span>. Arthritis Res Ther<\/span>, 16<\/span>, (6)<\/span>, pp. 511<\/span>. <\/a> <\/a><\/p>","publicationid":"310360","date":"2014-12-23","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Hammoudeh M; FitzGerald O; Combe B; Martin-Mola E; Buch MH; Krogulec M; Williams T; Gaylord S; Pedersen R; Bukowski J; Vlahos B<\/span> (2014)<\/span> Sustained remission with etanercept tapering in early rheumatoid arthritis<\/span>. N Engl J Med<\/span>, 371<\/span>, (19)<\/span>, pp. 1781-1792<\/span>. <\/a><\/p>","publicationid":"308163","date":"2014-11-06","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker JF; Smolen JS; Aletaha D; Shults J; Conaghan PG; Emery P; Baker DG; Ostergaard M<\/span> (2014)<\/span> Reply: To PMID 24757132<\/span>. Arthritis Rheumatol<\/span>, 66<\/span>, (11)<\/span>, pp. 3245-3246<\/span>. <\/a><\/p>","publicationid":"309998","date":"2014-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker JF; Ostergaard M; George M; Shults J; Emery P; Baker DG; Conaghan PG<\/span> (2014)<\/span> Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2\u2005years<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (11)<\/span>, pp. 1923-1928<\/span>. <\/a><\/p>","publicationid":"293784","date":"2014-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ponchel F; Go\u00ebb V; Parmar R; El-Sherbiny Y; Boissinot M; El Jawhari J; Burska A; Vital EM; Harrison S; Conaghan PG; Hensor E; Emery P<\/span> (2014)<\/span> An immunological biomarker to predict MTX response in early RA<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (11)<\/span>, pp. 2047-2053<\/span>. <\/a> <\/a><\/p>","publicationid":"264970","date":"2014-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker JF; Ostergaard M; Emery P; Hsia EC; Lu J; Baker DG; Conaghan PG<\/span> (2014)<\/span> Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (11)<\/span>, pp. 1968-1974<\/span>. <\/a><\/p>","publicationid":"264595","date":"2014-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ndosi M; Lewis M; Hale C; Quinn H; Ryan S; Emery P; Bird H; Hill J<\/span> (2014)<\/span> The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (11)<\/span>, pp. 1975-1982<\/span>. <\/a> <\/a><\/p>","publicationid":"165812","date":"2014-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Landew\u00e9 RBM; Smolen JS; Weinblatt ME; Emery P; Dougados M; Fleischmann R; Aletaha D; Kavanaugh A; van der Heijde D<\/span> (2014)<\/span> Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (10)<\/span>, pp. 1755-1760<\/span>. <\/a><\/p>","publicationid":"294352","date":"2014-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Md Yusof MY; Emery P<\/span> (2014)<\/span> Choosing the right rituximab dose for the right patient: comment on the article by Bredemeier et al<\/span>. Arthritis care & research<\/span>, 66<\/span>, (10)<\/span>, pp. 1591-1593<\/span>. <\/a> <\/a><\/p>","publicationid":"287338","date":"2014-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Heldmann F; Callhoff J; Listing J; Appelboom T; Brandt J; Van den Bosch F; Breban M; Burmester G; Dougados M; Emery P; Gaston H; Grunke M; Van Der Horst-Bruinsma IE; Landew\u00e9 R; Leirisalo-Repo M; Sieper J; De Vlam K; Pappas D; Kiltz U; Van Der Heijde D; Braun J<\/span> (2014)<\/span> Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (10)<\/span>, pp. 1819-1825<\/span>. <\/a><\/p>","publicationid":"264602","date":"2014-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kang T; Abignano G; Lettieri G; Wakefield RJ; Emery P; Del Galdo F<\/span> (2014)<\/span> Skin imaging in systemic sclerosis<\/span>. Eur J Rheumatol<\/span>, 1<\/span>, (3)<\/span>, pp. 111-116<\/span>. <\/a><\/p>","publicationid":"365973","date":"2014-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE<\/span> (2014)<\/span> Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets<\/span>. Rheumatology (Oxford, England)<\/span>, 53<\/span>, (9)<\/span>, pp. 1560-1569<\/span>. <\/a><\/p>","publicationid":"321878","date":"2014-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Hsia EC; Xu S; Zhou Y; Baker D<\/span> (2014)<\/span> Efficacy of golimumab plus methotrexate in methotrexate-na\u00efve patients with severe active rheumatoid arthritis<\/span>. Clinical Rheumatology<\/span>, 33<\/span>, (9)<\/span>, pp. 1239-1246<\/span>. <\/a><\/p>","publicationid":"294991","date":"2014-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gallo G; Boyd H; Morgan CL; Currie CJ; Poole CD; Nab HW<\/span> (2014)<\/span> Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs<\/span>. Clinical and experimental rheumatology<\/span>, 32<\/span>, (5)<\/span>, pp. 653-660<\/span>.<\/p>","publicationid":"294847","date":"2014-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Hsia EC; Xu S; Zhou Y; Baker D<\/span> (2014)<\/span> Efficacy of golimumab plus methotrexate in methotrexate-na\u00efve patients with severe active rheumatoid arthritis<\/span>. Clinical rheumatology<\/span>, 33<\/span>, (9)<\/span>, pp. 1239-1246<\/span>. <\/a><\/p>","publicationid":"292156","date":"2014-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hunt L; Emery P<\/span> (2014)<\/span> Defining populations at risk of rheumatoid arthritis: the first steps to prevention<\/span>. Nature reviews. Rheumatology<\/span>, 10<\/span>, (9)<\/span>, pp. 521-530<\/span>. <\/a><\/p>","publicationid":"290075","date":"2014-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Takase K; Horton SC; Ganesha A; Das S; McHugh A; Emery P; Savic S; Buch MH<\/span> (2014)<\/span> What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (9)<\/span>, pp. 1695-1699<\/span>. <\/a><\/p>","publicationid":"281367","date":"2014-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Emery P<\/span> (2014)<\/span> Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets<\/span>. Rheumatology (Oxford, England)<\/span>, 53<\/span>, (9)<\/span>, pp. 1560-1569<\/span>. <\/a><\/p>","publicationid":"276054","date":"2014-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fechtenbaum M; Nam JL; Emery P<\/span> (2014)<\/span> Biologics in rheumatoid arthritis: where are we going?<\/span> Br J Hosp Med (Lond)<\/span>, 75<\/span>, (8)<\/span>, pp. 448-456<\/span>. <\/a><\/p>","publicationid":"307819","date":"2014-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Vital EM; Emery P<\/span> (2014)<\/span> Biologics in systemic lupus erythematosus: current options and future perspectives<\/span>. Br J Hosp Med (Lond)<\/span>, 75<\/span>, (8)<\/span>, pp. 440-447<\/span>. <\/a> <\/a><\/p>","publicationid":"307818","date":"2014-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Scott N; Wollheim FA; Emery P; Buch MH; Del Galdo F<\/span> (2014)<\/span> Collagenous colitis in systemic sclerosis: an overlooked and treatable complication<\/span>. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases<\/span>, 20<\/span>, (5)<\/span>, pp. 278-282<\/span>. <\/a><\/p>","publicationid":"292476","date":"2014-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Backhouse MR; Pickles DA; Mathieson HR; Edgson L; Emery P; Helliwell PS; Redmond AC<\/span> (2014)<\/span> Diurnal variation of gait in patients with rheumatoid arthritis: The DIVIGN study<\/span>. Clinical biomechanics (Bristol, Avon)<\/span>, 29<\/span>, (7)<\/span>, pp. 811-814<\/span>. <\/a> <\/a><\/p>","publicationid":"289970","date":"2014-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lendrem D; Mitchell S; McMeekin P; Bowman S; Price E; T Pease C; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Vadivelu S; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng WF<\/span> (2014)<\/span> Health-related utility values of patients with primary Sj\u00f6gren's syndrome and its predictors<\/span>. Annals of the Rheumatic Diseases<\/span>, 73<\/span>, (7)<\/span>, pp. 1362-1368<\/span>. <\/a><\/p>","publicationid":"294468","date":"2014-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lendrem D; Mitchell S; McMeekin P; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Vadivelu S; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng W-F; UK primary Sj\u00f6gren's Syndrome Registry<\/span> (2014)<\/span> Health-related utility values of patients with primary Sj\u00f6gren's syndrome and its predictors<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (7)<\/span>, pp. 1362-1368<\/span>. <\/a><\/p>","publicationid":"263680","date":"2014-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Laar JM; Farge D; Sont JK; Naraghi K; Marjanovic Z; Larghero J; Schuerwegh AJ; Marijt EWA; Vonk MC; Schattenberg AV; Matucci-Cerinic M; Voskuyl AE; van de Loosdrecht AA; Daikeler T; K\u00f6tter I; Schmalzing M; Martin T; Lioure B; Weiner SM; Kreuter A; Deligny C; Durand J-M; Emery P; Machold KP; Sarrot-Reynauld F; Warnatz K; Adoue DFP; Constans J; Tony H-P; Del Papa N; Fassas A; Himsel A; Launay D; Lo Monaco A; Philippe P; Qu\u00e9r\u00e9 I; Rich \u00c9; Westhovens R; Griffiths B; Saccardi R; van den Hoogen FH; Fibbe WE; Soci\u00e9 G; Gratwohl A; Tyndall A; EBMT\/EULAR Scleroderma Study Group<\/span> (2014)<\/span> Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial<\/span>. JAMA<\/span>, 311<\/span>, (24)<\/span>, pp. 2490-2498<\/span>. <\/a> <\/a><\/p>","publicationid":"292245","date":"2014-06-25","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tran G; Emery P<\/span> (2014)<\/span> Role of golimumab for the treatment of rheumatoid arthritis<\/span>. International Journal of Clinical Rheumatology<\/span>, 9<\/span>, (3)<\/span>, pp. 245-258<\/span>. <\/a><\/p>","publicationid":"294469","date":"2014-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kremer JM; Peterfy C; Russell AS; Emery P; Abud-Mendoza C; Sibilia J; Becker J-C; Westhovens R; Genant HK<\/span> (2014)<\/span> Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial<\/span>. The Journal of rheumatology<\/span>, 41<\/span>, (6)<\/span>, pp. 1077-1087<\/span>. <\/a><\/p>","publicationid":"283670","date":"2014-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fechtenbaum M; Md Yusof MY; Emery P<\/span> (2014)<\/span> Certolizumab pegol in rheumatoid arthritis: current update<\/span>. Expert opinion on biological therapy<\/span>, 14<\/span>, (6)<\/span>, pp. 841-850<\/span>. <\/a> <\/a><\/p>","publicationid":"281414","date":"2014-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Dass S; Buch MH; Rawstron AC; Emery P<\/span> (2014)<\/span> Response to Dr Bredemeier's letter<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (6)<\/span>, pp. e34-E34<\/span>. <\/a><\/p>","publicationid":"281407","date":"2014-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Villeneuve E; Hensor EMA; Wakefield RJ; Conaghan PG; Green MJ; Gough A; Quinn M; Reece R; Cox SR; Buch MH; van der Heijde DM; Emery P<\/span> (2014)<\/span> A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (6)<\/span>, pp. 1027-1036<\/span>. <\/a> <\/a><\/p>","publicationid":"281378","date":"2014-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mathews RJ; Robinson JI; Battellino M; Wong C; Taylor JC; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS); Eyre S; Churchman SM; Wilson AG; Isaacs JD; Hyrich K; Barton A; Plant D; Savic S; Cook GP; Sarzi-Puttini P; Emery P; Barrett JH; Morgan AW; McDermott MF<\/span> (2014)<\/span> Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (6)<\/span>, pp. 1202-1210<\/span>. <\/a> <\/a><\/p>","publicationid":"258107","date":"2014-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Juarez M; Toms TE; de Pablo P; Mitchell S; Bowman S; Nightingale P; Price EJ; Griffiths B; Hunter J; Gupta M; Bombardieri M; Sutdliffe N; Pitzalis C; Pease C; Andrews J; Emery P; Regan M; Giles I; Isenberg D; Moots R; Collins KS; Ng WF; Kitas GD; UK Primary Sj\u00f6gren\u2019s Syndrome Registry<\/span> (2014)<\/span> Cardiovascular risk factors in women with primary Sj\u00f6gren's syndrome: United Kingdom primary Sj\u00f6gren's syndrome registry results<\/span>. Arthritis Care Res (Hoboken)<\/span>, 66<\/span>, (5)<\/span>, pp. 757-764<\/span>. <\/a><\/p>","publicationid":"290067","date":"2014-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Juarez M; Toms TE; de Pablo P; Mitchell S; Bowman S; Nightingale P; Price EJ; Griffiths B; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; Pease C; Andrews J; Emery P; Regan M; Giles I; Isenberg D; Moots R; Collins KS; Ng WF; Kitas GD<\/span> (2014)<\/span> Cardiovascular Risk Factors in Women With Primary Sj\u00f6gren's Syndrome: United Kingdom Primary Sj\u00f6gren's Syndrome Registry Results<\/span>. Arthritis Care & Research<\/span>, 66<\/span>, (5)<\/span>, pp. 757-764<\/span>. <\/a><\/p>","publicationid":"284474","date":"2014-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Savic S; Ouboussad L; Dickie LJ; Geiler J; Wong C; Doody GM; Churchman SM; Ponchel F; Emery P; Cook GP; Buch MH; Tooze RM; McDermott MF<\/span> (2014)<\/span> TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes<\/span>. J Autoimmun<\/span>, 50<\/span>, (100)<\/span>, pp. 59-66<\/span>. <\/a> <\/a><\/p>","publicationid":"275818","date":"2014-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Das S; Vital EM; Horton S; Bryer D; El-Sherbiny Y; Rawstron AC; Ponchel F; Emery P; Buch MH<\/span> (2014)<\/span> Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (5)<\/span>, pp. 909-912<\/span>. <\/a> <\/a><\/p>","publicationid":"275519","date":"2014-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; van Vollenhoven RF; Fleischmann R; Emery P; Florentinus S; Rathmann SS; Cardoso A; Kupper H; Kavanaugh A<\/span> (2014)<\/span> 88.\u2003Efficacy of Adalimumab Plus Methotrexate Therapy in Rheumatoid Arthritis Non-Responders Receiving Methotrexate Monotherapy or Adalimumab Combination Therapy: Results from the Optima Trial<\/span>. Rheumatology<\/span>, 53<\/span>, (suppl_1)<\/span>, pp. i89<\/span>. <\/a><\/p>","publicationid":"1103415","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone E; Fleischmann RM; Furst DE; Hessey EW; Mehbob A; Lehane PB<\/span> (2014)<\/span> 106.\u2003Long-Term Safety of Rituximab: Pooled Analysis of the Rheumatoid Arthritis Global Clinical Trial Programme Over 11 Years<\/span>. Rheumatology<\/span>, 53<\/span>, (suppl_1)<\/span>, pp. i97-i98<\/span>. <\/a><\/p>","publicationid":"1103414","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

James K; Lendrem D; Mitchell S; Hindmarsh V; Bowman S; Price EJ; Pease CT; Emery P; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles IP; Isenberg DA; Vadivelu S; Coady D; Dasgupta B; McHugh N; Griffiths B; Ng W-F<\/span> (2014)<\/span> 205.\u2003The UK Primary Sj\u00f6gren\u2019s Syndrome Registry (UKPSSR): A Valuable Resource for Future Sj\u00f6gren\u2019s Syndrom Research<\/span>. Rheumatology<\/span>, 53<\/span>, (suppl_1)<\/span>, pp. i136<\/span>. <\/a><\/p>","publicationid":"1103413","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2014)<\/span> I72.\u2003Early Arthritis<\/span>. Rheumatology<\/span>, 53<\/span>, (suppl_1)<\/span>, pp. i16<\/span>. <\/a><\/p>","publicationid":"1103405","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Smolen J; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Mahinda Karunaratne P; Kavanaugh A<\/span> (2014)<\/span> 60.\u2003Work Related Outcomes in Early Rheumatoid Arthritis Patients with Elevated Risk of Employment Loss: Results from Two Randomized Clinical Trials (Optima and Prowd) on the Effect of Adalimumab and Methotrexate Combination Therapy Versus Methotrexate Monotherapy Over 6 Months of Treatment<\/span>. Rheumatology<\/span>, 53<\/span>, (suppl_1)<\/span>, pp. i78<\/span>. <\/a><\/p>","publicationid":"1103404","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Bissell L-A; Britton J; Woods D; Buch M; McGonagle D; Emery P; Galdo FD<\/span> (2014)<\/span> O41.\u2003Longitudinal Assessment of Scleroderma Skin by Optical Coherence Tomography: Preliminary Validation of Sensitivity to Change Over-Time<\/span>. Rheumatology<\/span>, 53<\/span>, (suppl_1)<\/span>, pp. i46-i47<\/span>. <\/a><\/p>","publicationid":"702982","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ikeda K; Koike T; Wakefield R; Emery P<\/span> (2014)<\/span> Is the glass half full or half empty? Comment on the article by G\u00e4rtner et Al<\/span>. Arthritis Rheumatol<\/span>, 66<\/span>, (4)<\/span>, pp. 1055-1056<\/span>. <\/a> <\/a><\/p>","publicationid":"284475","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker JF; Conaghan PG; Smolen JS; Aletaha D; Shults J; Emery P; Baker DG; Ostergaard M<\/span> (2014)<\/span> Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and radiographic progression<\/span>. Arthritis Rheumatol<\/span>, 66<\/span>, (4)<\/span>, pp. 794-802<\/span>. <\/a> <\/a><\/p>","publicationid":"283784","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Arumugakani G; Vital EM; Md Yusof MY; McGonagle DG; Emery P<\/span> (2014)<\/span> Response to: 'Which B-cell subset should we target in lupus?' by Ferraccioli and Houssiau<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (4)<\/span>, pp. e20-E20<\/span>. <\/a> <\/a><\/p>","publicationid":"275876","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Moore RA; Derry S; Simon LS; Emery P<\/span> (2014)<\/span> Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk<\/span>. Pain Pract<\/span>, 14<\/span>, (4)<\/span>, pp. 378-395<\/span>. <\/a><\/p>","publicationid":"265323","date":"2014-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sokoll KB; Batuca J; Lopez LR; Hensor E; Emery P; Delgado Alves J; Ames PRJ<\/span> (2014)<\/span> Effects of Atorvastatin on Atherosclerosis and Atherogenesis in Systemic Lupus Erythematosus: A Pilot Study<\/span>. ISRN Immunology<\/span>, 2014<\/span>, (1)<\/span>, pp. 1-7<\/span>. <\/a><\/p>","publicationid":"1103484","date":"2014-03-19","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston JE; Coates LC; Nam JL; Moverley AR; Hensor EMA; Wakefield RJ; Emery P; Helliwell PS; Conaghan PG<\/span> (2014)<\/span> Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power doppler ultrasound<\/span>. Arthritis Care and Research<\/span>, 66<\/span>, (3)<\/span>, pp. 432-439<\/span>. <\/a><\/p>","publicationid":"282359","date":"2014-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan MD; Al-Shaarawy N; Martin S; Robinson JI; Twigg S; YEAR Consortium; Magdy AA; Omar AS; Ghattas MH; Emery P; Barrett JH; Morgan AW<\/span> (2014)<\/span> MTHFR functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis<\/span>. Pharmacogenomics<\/span>, 15<\/span>, (4)<\/span>, pp. 467-475<\/span>. <\/a><\/p>","publicationid":"281415","date":"2014-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Ramiro S; Gaujoux-Viala C; Takase K; Leon-Garcia M; Emery P; Gossec L; Landewe R; Smolen JS; Buch MH<\/span> (2014)<\/span> Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 73<\/span>, (3)<\/span>, pp. 516-528<\/span>. <\/a><\/p>","publicationid":"280319","date":"2014-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Landew\u00e9 R; Breedveld FC; Buch M; Burmester G; Dougados M; Emery P; Gaujoux-Viala C; Gossec L; Nam J; Ramiro S; Winthrop K; de Wit M; Aletaha D; Betteridge N; Bijlsma JWJ; Boers M; Buttgereit F; Combe B; Cutolo M; Damjanov N; Hazes JMW; Kouloumas M; Kvien TK; Mariette X; Pavelka K; van Riel PLCM; Rubbert-Roth A; Scholte-Voshaar M; Scott DL; Sokka-Isler T; Wong JB; van der Heijde D<\/span> (2014)<\/span> EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update<\/span>. Annals of the Rheumatic Diseases<\/span>, 73<\/span>, (3)<\/span>, pp. 492-509<\/span>. <\/a><\/p>","publicationid":"280317","date":"2014-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Ramiro S; Gaujoux-Viala C; Takase K; Leon-Garcia M; Emery P; Gossec L; Landewe R; Smolen JS; Buch MH<\/span> (2014)<\/span> Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (3)<\/span>, pp. 516-528<\/span>. <\/a><\/p>","publicationid":"275901","date":"2014-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nakamura J; Halliday NA; Fukuba E; Radjenovic A; Tanner SF; Emery P; McGonagle D; Tan AL<\/span> (2014)<\/span> The microanatomic basis of finger clubbing - a high-resolution magnetic resonance imaging study<\/span>. The Journal of rheumatology<\/span>, 41<\/span>, (3)<\/span>, pp. 523-527<\/span>. <\/a><\/p>","publicationid":"275877","date":"2014-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Landew\u00e9 R; Breedveld FC; Buch M; Burmester G; Dougados M; Emery P; Gaujoux-Viala C; Gossec L; Nam J; Ramiro S; Winthrop K; de Wit M; Aletaha D; Betteridge N; Bijlsma JWJ; Boers M; Buttgereit F; Combe B; Cutolo M; Damjanov N; Hazes JMW; Kouloumas M; Kvien TK; Mariette X; Pavelka K; van Riel PLCM; Rubbert-Roth A; Scholte-Voshaar M; Scott DL; Sokka-Isler T; Wong JB; van der Heijde D<\/span> (2014)<\/span> EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (3)<\/span>, pp. 492-509<\/span>. <\/a><\/p>","publicationid":"270722","date":"2014-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Rigby W; Tak PP; Dor\u0308ner T; Olech E; Martin C; Millar L; Travers H; Fisheleva E<\/span> (2014)<\/span> Safety with ocrelizumab in rheumatoid arthritis: Results from the ocrelizumab phase III program<\/span>. Plos One<\/span>, 9<\/span>, (2)<\/span>. <\/a><\/p>","publicationid":"282661","date":"2014-02-03","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mistretta F; Ferlet JF; Soubrier M; Antunez A; Balint P; Balsa A; Buch M; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Kay J; Luo S; Kurucz R; Maciel G; Martin Mola E; Montecucco CM; Mc Innes I; Radner H; Smolen J; Song Y; Van de Laar M; Winthrop K; Dougados M<\/span> (2014)<\/span> \u00c9tude transversale internationale de la pr\u00e9valence des comorbidit\u00e9s dans la polyarthrite rhumato\u00efde (PR) et \u00e9valuation de leur suivi (COMORA study\u00a0: COMOrbidities in Rheumatoid Arthritis)<\/span>. Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique<\/span>, 62<\/span>, pp. S14<\/span>. <\/a><\/p>","publicationid":"1103489","date":"2014-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates L; Moverley A; McParland L; Brown S; Collier H; Brown SR; Navarro-Coy N; Emery P; Conaghan P; Helliwell P<\/span> (2014)<\/span> Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a multicentre, open-label, randomised controlled trial<\/span>. The Lancet<\/span>, 383<\/span>, pp. S36<\/span>. <\/a><\/p>","publicationid":"694113","date":"2014-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McInnes IB; Sieper J; Braun J; Emery P; Van Der Heijde D; Isaacs JD; Dahmen G; Wollenhaupt J; Schulze-Koops H; Kogan J; Ma S; Schumacher MM; Bertolino AP; Hueber W; Tak PP<\/span> (2014)<\/span> Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: A 24-week, randomised, double-blind, placebo-controlled, phase ii proof-of-concept trial<\/span>. Annals of the Rheumatic Diseases<\/span>, 73<\/span>, (2)<\/span>, pp. 349-356<\/span>. <\/a><\/p>","publicationid":"277400","date":"2014-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Cuomo G; Buch MH; Rosenberg WM; Valentini G; Emery P; Del Galdo F<\/span> (2014)<\/span> The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (2)<\/span>, pp. 420-427<\/span>. <\/a> <\/a><\/p>","publicationid":"277198","date":"2014-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gandjbakhch F; Haavardsholm EA; Conaghan PG; Ejbjerg B; Foltz V; Brown AK; D\u00f8hn UM; Lassere M; Freeston JE; Olsen IC; B\u00f8yesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; H\u00f8rslev-Petersen K; Kvien TK; McQueen FM; \u00d8stergaard M<\/span> (2014)<\/span> Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity<\/span>. The Journal of rheumatology<\/span>, 41<\/span>, (2)<\/span>, pp. 398-406<\/span>. <\/a><\/p>","publicationid":"274876","date":"2014-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; McQueen FM; Bird P; Peterfy C; Haavardsholm E; Gandjbakhch F; Eshed I; Haugen IK; Lillegraven S; D\u00f8hn UM; Ejbjerg B; Foltz V; Coates L; B\u00f8yesen P; Hermann K-G; Freeston J; Lassere M; O'Connor P; Emery P; Genant H; \u00d8stergaard M<\/span> (2014)<\/span> Update on the OMERACT magnetic resonance imaging task force: research and future directions<\/span>. The Journal of rheumatology<\/span>, 41<\/span>, (2)<\/span>, pp. 383-385<\/span>. <\/a><\/p>","publicationid":"273657","date":"2014-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McInnes IB; Sieper J; Braun J; Emery P; van der Heijde D; Isaacs JD; Dahmen G; Wollenhaupt J; Schulze-Koops H; Kogan J; Ma S; Schumacher MM; Bertolino AP; Hueber W; Tak PP<\/span> (2014)<\/span> Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (2)<\/span>, pp. 349-356<\/span>. <\/a><\/p>","publicationid":"250166","date":"2014-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Fleischmann R; van Vollenhoven RF; Pavelka K; Durez P; Gu\u00e9rette B; Kupper H; Redden L; Arora V; Kavanaugh A<\/span> (2014)<\/span> Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial<\/span>. Lancet<\/span>, 383<\/span>, (9914)<\/span>, pp. 321-332<\/span>. <\/a><\/p>","publicationid":"270721","date":"2014-01-25","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Becker J-CP; Yin D; Melia LA; Li R; Gumbiner B; Thomas D; Spencer-Green G; Meng X<\/span> (2014)<\/span> A Phase I Trial Comparing PF-05280586 (A Potential Biosimilar) and Rituximab in Subjects with Active Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S660-S661<\/span>.<\/p>","publicationid":"473197","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Erhayiem B; Bissell L-A; McDiarmid AK; Kidambi A; Ripley DP; Greenwood JP; Sourbron S; Galdo FD; Emery P; Andrews J; Buch M; Plein S<\/span> (2014)<\/span> Characterisation of sub-clinical primary myocardial disease in systemic sclerosis - preliminary findings from a cardiac magnetic resonance study<\/span>. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance<\/span>, 16<\/span>, (Suppl 1)<\/span>, pp. P335<\/span>. <\/a><\/p>","publicationid":"441320","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aslam A; Nam J; Hunt L; Rakieh C; Morgan A; Emery P<\/span> (2014)<\/span> Emergence of proinflammatory autoreactive T-cell responses in preclinical rheumatoid arthritis<\/span>. LANCET<\/span>, 383<\/span>, pp. 22<\/span>. <\/a><\/p>","publicationid":"335882","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alemao EA; Joo S; Banerjee S; Emery P; Weinblatt M<\/span> (2014)<\/span> Impact of Rapid Attainment of Stringent Measures of Efficacy in Rheumatoid Arthritis on Patient-Reported Outcomes<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S599<\/span>.<\/p>","publicationid":"319154","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Liakouli V; Scarcia M; Abignano G; Derrett-Smith EC; Gillespie J; Cipriani P; Emery P; Denton CP; Giacomolli R; Mavria G; Del Galdo F<\/span> (2014)<\/span> Transforming Growth Factor Beta Induces anti Angio and Vasculo-Genesis Phenotype in Dermal Fibroblasts through Secretion of Pigment Epithelium Derived Factor<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S337<\/span>.<\/p>","publicationid":"319153","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gillespie J; Derrett-Smith EC; McDermott M; Emery P; Denton CP; Del Galdo F<\/span> (2014)<\/span> Priming of WNT Signalling during Fibrosis Is Mediated By TGF-\u03b2 Induced Axin-2 Downregulation<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S431<\/span>.<\/p>","publicationid":"319152","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burmester G; Furst DE; Combe BG; Huizinga TWJ; Bykerk VP; Wong D; Karyekar CS; Emery P<\/span> (2014)<\/span> Stringent Criteria for Low Disease Activity and Remission after 12 Months of Treatment, and after Treatment Withdrawal, with Abatacept Monotherapy, Abatacept with Methotrexate or Methotrexate Alone in Early Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S1076<\/span>.<\/p>","publicationid":"319151","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baeten DL; Braun J; Baraliakos X; Sieper J; Dougados M; Emery P; Deodhar AA; Porter B; Martin R; Mpofu S; Richards H<\/span> (2014)<\/span> Secukinumab, a Monoclonal Antibody to Interleukin-17A, Significantly Improves Signs and Symptoms of Active Ankylosing Spondylitis: Results of a 52-Week Phase 3 Randomized Placebo-Controlled Trial with Intravenous Loading and Subcutaneous Maintenance Dosing<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S360<\/span>.<\/p>","publicationid":"319150","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Deodhar AA; Baeten DL; Braun J; Baraliakos X; Sieper J; Dougados M; Emery P; Porter B; Martin R; Mpofu S; Richards H<\/span> (2014)<\/span> Secukinumab, a Monoclonal Antibody to Interleukin-17A, Significantly Improves Physical Function and Quality of Life in Subjects with Active Ankylosing Spondylitis: Results of a Phase 3 Randomized, Placebo-Controlled Trial with Intravenous Loading and Subcutaneous Maintenance Dosing<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S233-S234<\/span>.<\/p>","publicationid":"319149","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sieper J; Braun J; Baraliakos X; Baeten DL; Dougados M; Emery P; Deodhar AA; Porter B; Andersson M; Mpofu S; Richards H<\/span> (2014)<\/span> Secukinumab, a Monoclonal Antibody to Interleukin-17A, Significantly Improves Signs and Symptoms of Active Ankylosing Spondylitis: Results of a Phase 3, Randomized, Placebo-Controlled Trial with Subcutaneous Loading and Maintenance Dosing<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S232<\/span>.<\/p>","publicationid":"319147","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Burmester G; Bykerk VP; Combe B; Furst DE; Barre E; Karyekar CS; Wong D; Huizinga TWJ<\/span> (2014)<\/span> Predictors of Drug-Free Remission Following Treatment with Abatacept (in Combination with Methotrexate or as Monotherapy) in Early Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S1084<\/span>.<\/p>","publicationid":"319146","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Han C; Keystone EC; Fleischmann R; Smolen JS; Matteson EL; Emery P; Genovese MC; Gathany TA; Hsia EC<\/span> (2014)<\/span> Impact of Golimumab on Physical Function and Employability of Patients with Rheumatoid Arthritis: 5-Year Data from 3 Phase III Clinical Trials<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S1090<\/span>.<\/p>","publicationid":"319145","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alemao EA; Joo S; Banerjee S; Allison P; Emery P; Weinblatt M; Liao KP<\/span> (2014)<\/span> Validation of a Prognostic Model to Predict Structural Damage Assessed By X-Ray in Patients with RA Using MRI Data from a Clinical Trial<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S164<\/span>.<\/p>","publicationid":"319144","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aslam A; Nam JL; Hunt L; Rakieh C; Morgan AW; Emery P<\/span> (2014)<\/span> Citrullinated-Vimentin-Specific Regulatory T-Cell Responses Associate with ACPA Positive Individuals with Non-Specific Musculoskeletal Symptoms<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S191-S192<\/span>.<\/p>","publicationid":"319143","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Huizinga TWJ; Connolly SE; Furst DE; Bykerk VP; Burmester G; Combe BG; Karyekar CS; Wong D; Trouw L; Toes REM; Emery P<\/span> (2014)<\/span> The Impact on Anti-Citrullinated Protein Antibody Isotypes and Epitope Fine Specificity in Patients with Early RA Treated with Abatacept and Methotrexate<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S666<\/span>.<\/p>","publicationid":"319142","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Pedersen R; Bukowski J; Marshall L<\/span> (2014)<\/span> Early Response to Full-Dose Etanercept-Plus-Methotrexate Induction Therapy Predicts Sustained Remission with Reduced-Dose Combination Therapy in Early Rheumatoid Arthritis Patients<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S1094<\/span>.<\/p>","publicationid":"319141","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Bykerk VP; Burmester G; Combe B; Huizinga TWJ; Alemao E; Wong D; Karyekar CS; Emery P<\/span> (2014)<\/span> Patient-Reported Outcomes Following 12 Months of Therapy with Abatacept (Plus Methotrexate or as Monotherapy) or Methotrexate and up to 6 Months after Treatment Withdrawal in Patients with Early Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S1084-S1085<\/span>.<\/p>","publicationid":"319140","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Peterfy C; Burmester G; Bykerk VP; Combe BG; DiCarlo JC; Furst DE; Huizinga TWJ; Karyekar CS; Wong D; Conaghan PG; Emery P<\/span> (2014)<\/span> Sustained Improvements in Magnetic Resonance Imaging Outcomes with Abatacept Following the Withdrawal of All Treatment in Patients with Early Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S669<\/span>.<\/p>","publicationid":"319119","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker J; Conaghan PG; Emery P; Baker D; Ostergaard M<\/span> (2014)<\/span> Early MRI Endpoints Provide a Valid Measure of Structural Damage While Reducing Study Duration and Participant Numbers in Rheumatoid Arthritis Clinical Trials<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S832<\/span>.<\/p>","publicationid":"319115","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mackie S; Pease CT; Fukuba E; Emery P; Hodgson RJ; Freeston JE; McGonagle D<\/span> (2014)<\/span> Whole-Body MRI Reveals Characteristic Extracapsular Pattern of Inflammation in Polymyalgia Rheumatica<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S1211<\/span>.<\/p>","publicationid":"319071","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hayashi M; Nam JL; Hunt L; Hensor E; Kanamono T; Kojima T; Ishiguro N; Emery P<\/span> (2014)<\/span> In Palindromic Rheumatism, Older Age, Shorter Interval Between Attacks and Positive Anti-CCP Antibodies May Predict Progression to RA<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S162<\/span>.<\/p>","publicationid":"319028","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Hunt L; Hensor EMA; Conaghan PG; Wakefield RJ; Emery P<\/span> (2014)<\/span> Ultrasound Power Doppler Findings in the Wrists and Hands Joints of Anti-CCP Antibody Positive Individuals with Non-Specific Musculoskeletal Symptoms and the Development of Inflammatory Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, 66<\/span>, pp. S53<\/span>.<\/p>","publicationid":"319025","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hunt L; Emery P<\/span> (2014)<\/span> Defining populations at risk of rheumatoid arthritis: The first steps to prevention<\/span>. Nature Reviews Rheumatology<\/span>, 10<\/span>, (9)<\/span>, pp. 521-530<\/span>. <\/a><\/p>","publicationid":"307646","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Westhovens R; Kremer JM; Emery P; Russell AS; Alten R; Barr\u00e9 E; Dougados M<\/span> (2014)<\/span> Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study<\/span>. Clin Exp Rheumatol<\/span>, 32<\/span>, (4)<\/span>, pp. 553-562<\/span>.<\/p>","publicationid":"293926","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Scott N; Wollheim FA; Emery P; Buch MH; Del Galdo F<\/span> (2014)<\/span> Collagenous colitis in systemic sclerosis: An overlooked and treatable complication<\/span>. Journal of Clinical Rheumatology<\/span>, 20<\/span>, (5)<\/span>, pp. 278-282<\/span>. <\/a><\/p>","publicationid":"293924","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Takase K; Horton SC; Ganesha A; Das S; McHugh A; Emery P; Savic S; Buch MH<\/span> (2014)<\/span> What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 73<\/span>, (9)<\/span>, pp. 1695-1699<\/span>. <\/a> <\/a><\/p>","publicationid":"293747","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2014)<\/span> Why is there persistent disease despite biologic therapy? Importance of early intervention<\/span>. Arthritis Res Ther<\/span>, 16<\/span>, (3)<\/span>, pp. 115<\/span>. <\/a><\/p>","publicationid":"292244","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Liakouli V; Mavria G; Gillespie J; Scarcia M; Cipriani P; Giacomelli R; Emery P; Del Galdo F<\/span> (2014)<\/span> PIGMENT EPITHELIUM DERIVED FACTOR SECRETED BY SSC FIBROBLASTS INHIBITS ANGIO AND VASCULOGENESIS IN VITRO<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 32<\/span>, (2)<\/span>, pp. S11-S12<\/span>.<\/p>","publicationid":"290066","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gillespie J; Giuseppina A; Emery P; McDermott MF; Del Galdo F<\/span> (2014)<\/span> SECRETED FRIZZLED-RELATED PROTEIN 4 CAN BE INDUCED BY TRANSFORMING GROWTH FACTOR-BETA, IS REGULATED BY CAVEOLIN-1 AND CAN INDUCE NON-CANONICAL WNT SIGNALING IN FIBROBLASTS<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 32<\/span>, (2)<\/span>, pp. S58-S59<\/span>.<\/p>","publicationid":"290065","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bissell L; Erhayiem B; Greenwood JP; Del Galdo F; Emery P; Andrews J; Plein S; Buch MH<\/span> (2014)<\/span> CHARACTERISATION OF SUB-CLINICAL PRIMARY MYOCARDIAL DISEASE IN SYSTEMIC SCLEROSIS - PRELIMINARY FINDINGS FROM A CARDIAC MAGNETIC RESONANCE AND ELECTROPHYSIOLOGICAL STUDY<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 32<\/span>, (2)<\/span>, pp. S93-S94<\/span>.<\/p>","publicationid":"290025","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Bissell LA; Britton J; Woods D; Buch M; Mcgonagle D; Emery P; Del Galdo F<\/span> (2014)<\/span> LONGITUDINAL ASSESSMENT OF SCLERODERMA SKIN BY OPTICAL COHERENCE TOMOGRAPHY: PRELIMINARY VALIDATION OF SENSITIVITY TO CHANGE OVER-TIME<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 32<\/span>, (2)<\/span>, pp. S108<\/span>.<\/p>","publicationid":"289997","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Dass S; Buch MH; Rawstron AC; Emery P<\/span> (2014)<\/span> Response to Dr Bredemeier's letter<\/span>. Annals of the Rheumatic Diseases<\/span>, 73<\/span>, (6)<\/span>, pp. e34<\/span>. <\/a><\/p>","publicationid":"286128","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan MD; Al-Shaarawy N; Martin S; Robinson JI; Twigg S; Magdy AA; Omar AS; Ghattas MH; Emery P; Barrett JH; Morgan AW<\/span> (2014)<\/span> MTHFR<\/i> functional genetic variation and methotrexate treatment response in rheumatoid arthritis: a meta-analysis<\/span>. PHARMACOGENOMICS<\/span>, 15<\/span>, (4)<\/span>, pp. 467-475<\/span>. <\/a><\/p>","publicationid":"285206","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Moore RA; Derry S; Simon LS; Emery P<\/span> (2014)<\/span> Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk<\/span>. Pain Practice<\/span>, 14<\/span>, (4)<\/span>, pp. 378-395<\/span>. <\/a><\/p>","publicationid":"283247","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burska AN; Hunt L; Boissinot M; Strollo R; Ryan BJ; Vital E; Nissim A; Winyard PG; Emery P; Ponchel F<\/span> (2014)<\/span> Autoantibodies to posttranslational modifications in rheumatoid arthritis<\/span>. Mediators Inflamm<\/span>, 2014<\/span>, (1)<\/span>, pp. 492873-19<\/span>. <\/a> <\/a><\/p>","publicationid":"281862","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kang T; Emery P; Wakefield RJ<\/span> (2014)<\/span> A brief history of ultrasound in rheumatology: where we are now<\/span>. Clinical and experimental rheumatology<\/span>, 32<\/span>, (1 Suppl 80)<\/span>, pp. S7-11<\/span>. <\/a><\/p>","publicationid":"280195","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Fleischmann R; van Vollenhoven RF; Pavelka K; Durez P; Gu\u00e9rette B; Kupper H; Redden L; Arora V; Kavanaugh A<\/span> (2014)<\/span> Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial<\/span>. The Lancet<\/span>, 383<\/span>, (9914)<\/span>, pp. 321-332<\/span>. <\/a><\/p>","publicationid":"277825","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Rigby W; Tak PP; D\u00f6rner T; Olech E; Martin C; Millar L; Travers H; Fisheleva E<\/span> (2014)<\/span> Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program<\/span>. PloS one<\/span>, 9<\/span>, (2)<\/span>, pp. e87379<\/span>. <\/a><\/p>","publicationid":"277612","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown S; Navarro Coy N; Pitzalis C; Emery P; Pavitt S; Gray J; Hulme C; Hall F; Busch R; Smith P; Dawson L; Bombardieri M; Wan-Fai N; Pease C; Price E; Sutcliffe N; Woods C; Ruddock S; Everett C; Reynolds C; Skinner E; Poveda-Gallego A; Rout J; Macleod I; Rauz S; Bowman S; TRACTISS trial team<\/span> (2014)<\/span> The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sj\u00f6gren's Syndrome<\/span>. BMC musculoskeletal disorders<\/span>, 15<\/span>, (1)<\/span>, pp. 21<\/span>. <\/a> <\/a><\/p>","publicationid":"277302","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; Soubrier M; Antunez A; Balint P; Balsa A; Buch MH; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Luo SF; Kurucz R; Maciel G; Mola EM; Montecucco CM; McInnes I; Radner H; Smolen JS; Song YW; Vonkeman HE; Winthrop K; Kay J<\/span> (2014)<\/span> Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: Results of an international, cross-sectional study (COMORA)<\/span>. Annals of the Rheumatic Diseases<\/span>, 73<\/span>, (1)<\/span>, pp. 62-68<\/span>. <\/a><\/p>","publicationid":"275057","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Braun J; Dougados M; Emery P; FitzGerald O; Helliwell P; Kavanaugh A; Kvien TK; Landew\u00e9 R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Schoels M; Sieper J; De Wit M; Baraliakos X; Betteridge N; Burgos-Vargas R; Collantes-Estevez E; Deodhar A; Elewaut D; Gossec L; Jongkees M; Maccarone M; Redlich K; Van Den Bosch F; Cheng-Chung Wei J; Winthrop K; Van Der Heijde D<\/span> (2014)<\/span> Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force<\/span>. Annals of the Rheumatic Diseases<\/span>, 73<\/span>, (1)<\/span>, pp. 6-16<\/span>. <\/a><\/p>","publicationid":"275056","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schoels MM; Braun J; Dougados M; Emery P; Fitzgerald O; Kavanaugh A; Kvien TK; Landew\u00e9 R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Sieper J; Smolen JS; De Wit M; Van Der Heijde D<\/span> (2014)<\/span> Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: Results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 73<\/span>, (1)<\/span>, pp. 238-242<\/span>. <\/a><\/p>","publicationid":"275055","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan CL; Emery P; Porter D; Reynolds A; Young A; Boyd H; Poole CD; Currie CJ<\/span> (2014)<\/span> Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data<\/span>. Rheumatology (Oxford, England)<\/span>, 53<\/span>, (1)<\/span>, pp. 186-194<\/span>. <\/a><\/p>","publicationid":"269037","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; Soubrier M; Antunez A; Balint P; Balsa A; Buch MH; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Luo S-F; Kurucz R; Maciel G; Mola EM; Montecucco CM; McInnes I; Radner H; Smolen JS; Song Y-W; Vonkeman HE; Winthrop K; Kay J<\/span> (2014)<\/span> Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (1)<\/span>, pp. 62-68<\/span>. <\/a><\/p>","publicationid":"268363","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Villeneuve E; Hensor EMA; Conaghan PG; Keen HI; Buch MH; Gough AK; Green MJ; Helliwell PS; Keenan AM; Morgan AW; Quinn M; Reece R; van der Heijde DM; Wakefield RJ; Emery P<\/span> (2014)<\/span> Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)<\/span>. Annals of the rheumatic diseases<\/span>, 73<\/span>, (1)<\/span>, pp. 75-85<\/span>. <\/a> <\/a><\/p>","publicationid":"263835","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schoels MM; Braun J; Dougados M; Emery P; Fitzgerald O; Kavanaugh A; Kvien TK; Landew\u00e9 R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Sieper J; Smolen JS; Wit MD; van der Heijde D<\/span> (2014)<\/span> Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (1)<\/span>, pp. 238-242<\/span>. <\/a><\/p>","publicationid":"263681","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Braun J; Dougados M; Emery P; Fitzgerald O; Helliwell P; Kavanaugh A; Kvien TK; Landew\u00e9 R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Schoels M; Sieper J; Wit MD; Baraliakos X; Betteridge N; Burgos-Vargas R; Collantes-Estevez E; Deodhar A; Elewaut D; Gossec L; Jongkees M; Maccarone M; Redlich K; van den Bosch F; Wei JC-C; Winthrop K; van der Heijde D<\/span> (2014)<\/span> Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force<\/span>. Ann Rheum Dis<\/span>, 73<\/span>, (1)<\/span>, pp. 6-16<\/span>. <\/a><\/p>","publicationid":"263576","date":"2014-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2013)<\/span> PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases<\/span>. Pediatric Rheumatology<\/span>, 11<\/span>, (S2)<\/span>, pp. i27<\/span>. <\/a><\/p>","publicationid":"1103505","date":"2013-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Sebba A; Huizinga TWJ<\/span> (2013)<\/span> Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, (12)<\/span>, pp. 1897-1904<\/span>. <\/a><\/p>","publicationid":"274082","date":"2013-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Sebba A; Huizinga TWJ<\/span> (2013)<\/span> Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis<\/span>. Annals of the rheumatic diseases<\/span>, 72<\/span>, (12)<\/span>, pp. 1897-1904<\/span>. <\/a><\/p>","publicationid":"264468","date":"2013-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baeten D; Baraliakos X; Braun J; Sieper J; Emery P; van der Heijde D; McInnes I; van Laar JM; Landew\u00e9 R; Wordsworth P; Wollenhaupt J; Kellner H; Paramarta J; Wei J; Brachat A; Bek S; Laurent D; Li Y; Wang YA; Bertolino AP; Gsteiger S; Wright AM; Hueber W<\/span> (2013)<\/span> Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial<\/span>. Lancet<\/span>, 382<\/span>, (9906)<\/span>, pp. 1705-1713<\/span>. <\/a><\/p>","publicationid":"266693","date":"2013-11-23","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh A; Smolen JS; Emery P; Keystone E; Strand V; Purcaru O; van Vollenhoven R<\/span> (2013)<\/span> Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis: Results from the Open-Label Extension Study of Rapid1<\/span>. Value in Health<\/span>, 16<\/span>, (7)<\/span>, pp. A570<\/span>. <\/a><\/p>","publicationid":"1103566","date":"2013-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Solem CT; Macahilig CP; Corman S; Majer IM; McGuire M; Cappelleri JC; Tarallo M<\/span> (2013)<\/span> Rationale for Initiating and Switching Biologic Therapy in Patients with Rheumatoid Arthritis: Results of a European Chart Review Study<\/span>. Value in Health<\/span>, 16<\/span>, (7)<\/span>, pp. A573<\/span>. <\/a><\/p>","publicationid":"274084","date":"2013-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Solem CT; Macahilig CP; Majer IM; Stephens JM; Cappelleri JC; Tarallo M<\/span> (2013)<\/span> Improvement in Disease Activity Scores Associated with Early Versus Late Initiation of Biologic Therapy in Patients with Rheumatoid Arthritis: Results of a European Chart Review Study<\/span>. Value in Health<\/span>, 16<\/span>, (7)<\/span>, pp. A557<\/span>. <\/a><\/p>","publicationid":"274083","date":"2013-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Aydin SZ; Castillo-Gallego C; Liakouli V; Woods D; Meekings A; Wakefield RJ; McGonagle DG; Emery P; Del Galdo F<\/span> (2013)<\/span> Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (11)<\/span>, pp. 1845-1851<\/span>. <\/a> <\/a><\/p>","publicationid":"268343","date":"2013-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Doyle MK; Strusberg I; Durez P; Nash P; Amante E; Churchill M; Park W; Pons-Estel B; Xu W; Xu S; Wu Z; Hsia EC<\/span> (2013)<\/span> Golimumab, a human anti\u2013tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function findings of a phase III, multicenter, randomized, double-blind, placebo-controlled study<\/span>. Arthritis care & research<\/span>, 65<\/span>, (11)<\/span>, pp. 1732-1742<\/span>. <\/a><\/p>","publicationid":"262817","date":"2013-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2013)<\/span> Adjusting therapy in rheumatoid arthritis based on achievement of stable low disease activity<\/span>. Lancet<\/span>.<\/p>","publicationid":"266456","date":"2013-10-31","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Teare MD; Knevel R; Morgan MD; Kleszcz A; Emery P; Moore DJ; Conaghan P; Huizinga TWJ; Morgan AW; van der Helm-van Mil AHM; Wilson AG<\/span> (2013)<\/span> Allele-dose association of the C5orf30 rs26232 variant with joint damage in rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 65<\/span>, (10)<\/span>, pp. 2555-2561<\/span>. <\/a><\/p>","publicationid":"268364","date":"2013-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hunt L; Emery P<\/span> (2013)<\/span> Etanercept in the treatment of rheumatoid arthritis<\/span>. Expert opinion on biological therapy<\/span>, 13<\/span>, (10)<\/span>, pp. 1441-1450<\/span>. <\/a><\/p>","publicationid":"266284","date":"2013-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kouroupis D; Churchman SM; English A; Emery P; Giannoudis PV; McGonagle D; Jones EA<\/span> (2013)<\/span> Assessment of umbilical cord tissue as a source of mesenchymal stem cell\/endothelial cell mixtures for bone regeneration<\/span>. Regenerative medicine<\/span>, 8<\/span>, (5)<\/span>, pp. 569-581<\/span>. <\/a><\/p>","publicationid":"266276","date":"2013-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone EC; Fleischmann RM; Furst DE; Tyson N; Collinson N; Lehane PB<\/span> (2013)<\/span> Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, (9)<\/span>, pp. 1496-1502<\/span>. <\/a><\/p>","publicationid":"265322","date":"2013-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Castillo-Gallego C; Aydin SZ; Emery P; McGonagle DG; Marzo-Ortega H<\/span> (2013)<\/span> Magnetic resonance imaging assessment of axial psoriatic arthritis: extent of disease relates to HLA-B27<\/span>. Arthritis and rheumatism<\/span>, 65<\/span>, (9)<\/span>, pp. 2274-2278<\/span>. <\/a><\/p>","publicationid":"260026","date":"2013-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone EC; Fleischmann RM; Furst DE; Tyson N; Collinson N; Lehane PB<\/span> (2013)<\/span> Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (9)<\/span>, pp. 1496-1502<\/span>. <\/a><\/p>","publicationid":"229092","date":"2013-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Emery P<\/span> (2013)<\/span> Is there a place for initial treatment with biological DMARDs in the early phase of RA?<\/span> Best Practice and Research: Clinical Rheumatology<\/span>, 27<\/span>, (4)<\/span>, pp. 537-554<\/span>. <\/a><\/p>","publicationid":"275058","date":"2013-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Emery P<\/span> (2013)<\/span> Is there a place for initial treatment with biological DMARDs in the early phase of RA?<\/span> Best Pract Res Clin Rheumatol<\/span>, 27<\/span>, (4)<\/span>, pp. 537-554<\/span>. <\/a><\/p>","publicationid":"270723","date":"2013-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Vital EMJ; Emery P<\/span> (2013)<\/span> B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress<\/span>. Expert review of clinical immunology<\/span>, 9<\/span>, (8)<\/span>, pp. 761-772<\/span>. <\/a> <\/a><\/p>","publicationid":"264999","date":"2013-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Strollo R; Ponchel F; Malmstr\u00f6m V; Rizzo P; Bombardieri M; Wenham CY; Landy R; Perret D; Watt F; Corrigall VM; Winyard PG; Pozzilli P; Conaghan PG; Panayi GS; Klareskog L; Emery P; Nissim A<\/span> (2013)<\/span> Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 65<\/span>, (7)<\/span>, pp. 1702-1712<\/span>. <\/a><\/p>","publicationid":"263032","date":"2013-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Taylor LH; Twigg S; Worthington J; Emery P; Morgan AW; Wilson AG; Teare MD<\/span> (2013)<\/span> Metaanalysis of the association of smoking and PTPN22 R620W genotype on autoantibody status and radiological erosions in rheumatoid arthritis<\/span>. The Journal of rheumatology<\/span>, 40<\/span>, (7)<\/span>, pp. 1048-1053<\/span>. <\/a><\/p>","publicationid":"257426","date":"2013-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Kay J; Emery P<\/span> (2013)<\/span> Rituximab biosimilars<\/span>. Expert opinion on biological therapy<\/span>, 13<\/span>, (7)<\/span>, pp. 1049-1062<\/span>. <\/a><\/p>","publicationid":"257167","date":"2013-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Hammoudeh M; FitzGerald O; Combe B; Martin Mola E; Bukowski J; Pedersen R; Williams T; Gaylord S; Vlahos B<\/span> (2013)<\/span> FRI0089\u2005Assessing maintenance of remission with reduced dose etanercept plus methotrexate, methotrexate alone, or placebo in patients with early rheumatoid arthritis who achieved remission with etanercept and methotrextate: the prize study<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A399<\/span>. <\/a><\/p>","publicationid":"1103619","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Wiland P; Dudler J; Ionescu RM; Vlahos B; Bukowski J; Pedersen R; Williams T; Gaylord S; Kotak S<\/span> (2013)<\/span> SAT0543\u2005Reduced\/Withdrawn Dose of Etanercept-Methotrexate Therapy of Early Rheumatoid Arthritis has a Favorable Impact on Patient-Reported Outcomes Compared with MTX Alone or Placebo: the Prize Study<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A765-A766<\/span>. <\/a><\/p>","publicationid":"1103610","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone E; Fleischmann RM; Furst D; Hessey EW; Vashishtha A; Mehbob A; Lehane PB<\/span> (2013)<\/span> SAT0131\u2005Long-Term Safety of Rituximab: Pooled Analysis of the Rheumatoid Arthritis Global Clinical Trial Programme Over 11 Years<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A625-A626<\/span>. <\/a><\/p>","publicationid":"1103595","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hunt L; Nam JL; Rakieh C; Emery P; Ponchel F<\/span> (2013)<\/span> THU0032\u2005Predicting the Evolution of Inflammatory Arthritis in ACPA-Positive Individuals: can T-Cell Subset Help?<\/span> Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A175<\/span>. <\/a><\/p>","publicationid":"1103567","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante E; Churchill M; Park W; Pons-Estel B; Han C; Gathany T; Zhou Y; Xu S; Hsia EC<\/span> (2013)<\/span> FRI0178\u2005Five-year safety and efficacy of golimumab in methotrexate-na\u00efve patients with rheumatoid arthritis: final study results of the phase 3, randomized, placebo-controlled go-before trial<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A432<\/span>. <\/a><\/p>","publicationid":"1103558","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Braun J; Laurent D; Baeten D; van der Heijde D; Sieper J; Emery P; McInnes I; van Laar J; Landewe R; Wordsworth P; Wollenhaupt J; Kellner H; Wright A; Vandenhende F; Radford K; Borah B; Hueber W<\/span> (2013)<\/span> FRI0420\u2005Long term inhibition of IL-17a with secukinumab reduces spinal inflammation but has no influence on fatty lesions as assessed by magnetic resonance imaging in patients with ankylosing spondylitis<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A516<\/span>. <\/a><\/p>","publicationid":"1103556","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Park Y-J; Cho C-S; Emery P; Kim W-U<\/span> (2013)<\/span> SAT0042\u2005Low-Density Lipoprotein Cholesterolemia as a Novel Risk Factor for Radiographic Progression of Rheumatoid Arthritis: A Single Centered Prospective Study<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A594<\/span>. <\/a><\/p>","publicationid":"1103547","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Solem CT; McGuire MB; Majer I; Hensen M; Stephens JM; Tarallo M<\/span> (2013)<\/span> SAT0542\u2005European Chart Review Study on Early Rheumatoid Arthritis (RA): Patient Profile and Biologic Treatment Patterns<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A765<\/span>. <\/a><\/p>","publicationid":"1103517","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ng W-F; Miller A; Bowman S; Price E; Kitas G; Pease C; Emery P; Lanyon P; Hunter J; Gupta M; Giles I; Isenberg D; MaClaren J; Regan M; Cooper A; Young-Min S; Bombardieri M; Sutcliffe N; Pitzalis C; Vadivelu S; Coady D; MacKay K; Moots R; Mitchell S; Mchugh N; Dasgupta B; Trenell M<\/span> (2013)<\/span> FRI0323\u2005Level of physical activity in primary sj\u00f6gren's syndrome and its predictors<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A483-A484<\/span>. <\/a><\/p>","publicationid":"1103515","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keenan A-M; White J; Pearson D; McSorely P; Andrews J; Taylor Y; Emery P<\/span> (2013)<\/span> OP0236-HPR\u2005The Implementation of a Novel Software Application (Midatabank) to Record, Triage and Manage Telephone Calls to the Leeds Rheumatology Outpatient's Department<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A132<\/span>. <\/a><\/p>","publicationid":"1103501","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Szumski A; Bukowski J; Bananis E; Marshall L<\/span> (2013)<\/span> SAT0071\u2005Early Initiated Etanercept Plus Methotrexate Treatment Induces Remission in Patients with Either Moderate or Severe Rheumatoid Arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A603-A604<\/span>. <\/a><\/p>","publicationid":"1103494","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Szumski A; Jones H<\/span> (2013)<\/span> FRI0090\u2005Radiographic progression in patients with early rheumatoid arthritis treated with etanercept: results from the prize study<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A399-A400<\/span>. <\/a><\/p>","publicationid":"1103491","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Takase K; Horton SC; Ganesha A; Das S; Emery P; Savic S; Buch MH<\/span> (2013)<\/span> AB0274\u2005What is the utility of routine ana testing in predicting development of biological dmard-induced lupus\/vasculitis in patients with rheumatoid arthritis?<\/span> Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A870<\/span>. <\/a><\/p>","publicationid":"1103490","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; Soubrier M; Antunez A; Balint P; Balsa A; Buch M; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Kay J; Luo S-F; Kurucz R; Maciel G; Martin Mola E; Montecucco CM; Mc Innes I; Radner H; Smolen J; Song Y-W; Van de Laar M; Winthrop K<\/span> (2013)<\/span> SAT0061\u2005Prevalence of Co-Morbidities in Rheumatoid Arthritis (RA) and Evaluation of their Monitoring: Results of an International, Cross-Sectional Study (Comora)<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A600<\/span>. <\/a><\/p>","publicationid":"1103485","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Das S; Takase K; Dass S; Buch MH; Vital E; Emery P<\/span> (2013)<\/span> AB0333\u2005Overall response pattern of rituximab in ra-single centre experience<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A889<\/span>. <\/a><\/p>","publicationid":"1039523","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Braun J; Dougados M; Emery P; FitzGerald O; Helliwell P; Kavanaugh A; Kvien TK; Landew\u00e9 R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Schoels M; Sieper J; de Wit M; van der Heijde D<\/span> (2013)<\/span> OP0110\u2005Treat-To-Target Recommendations for Spondyloarthritis, Including Ankylosing Spondylitis and Psoriatic Arthritis: A Consensus of an International Task Force<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A88-A89<\/span>. <\/a><\/p>","publicationid":"881541","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rakieh C; Saleem B; Takase K; Nam JL; Keen H; Wakefield RJ; Emery P<\/span> (2013)<\/span> THU0136\u2005Long Term Outcomes of Stopping Tumour Necrosis Factor Inhibitors (TNFI) in Patients with Established Rheumatoid Arthritis (RA) Who are in Sustained Remission: Is it Worth the Risk?<\/span> Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A208-A209<\/span>. <\/a><\/p>","publicationid":"849179","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Gallego CC; Nam J; Freeston J; Horton S; Wakefield RJ; Emery P<\/span> (2013)<\/span> OP0135\u2005The New ACR\/EULAR Criteria for Rheumatoid Arthritis is Able to Identify Patients with Same Disease Activity but Less Damage by Ultrasound<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A97<\/span>. <\/a><\/p>","publicationid":"849173","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker J; \u00d8stergaard M; Emery P; Hsia EC; Lu JD; Baker D; Conaghan PG<\/span> (2013)<\/span> SAT0486\u2005Early MRI Measures Independently Predict 1- and 2- Year X-Ray Progression: Results from a Large Clinical Trial<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A746<\/span>. <\/a><\/p>","publicationid":"829462","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bissell L-A; Burska A; Horton SC; Donica H; Freeston JE; Buch MH; Emery P; Andrews J<\/span> (2013)<\/span> FRI0156\u2005Cardiovascular risk factors are prevalent in early inflammatory arthritis regardless of fulfilment of the acr criteria for rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A423<\/span>. <\/a><\/p>","publicationid":"753395","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rakieh C; Nam JL; Hunt L; Villeneuve E; Bissell L-A; Das S; Conaghan PG; McGonagle D; Wakefield RJ; Emery P<\/span> (2013)<\/span> OP0180\u2005Risk of Developing Clinical Synovitis in ACPA Positive Patients with Non-Specific Musculoskeletal Symptoms<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A114<\/span>. <\/a><\/p>","publicationid":"753374","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Cuomo G; Buch M; Rosenberg WM; Valentini G; Emery P; Del Galdo F<\/span> (2013)<\/span> FRI0405\u2005Sub-analysis of elf score biomarkers components indicates a specific correlation with different organ involvement in systemic sclerosis<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A510-A511<\/span>. <\/a><\/p>","publicationid":"702987","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Redmond A; Alcacer-Pitarch B; Gray J; Denton C; Herrick A; Navarro-Coy N; Collier H; Loughrey L; Pavitt S; Siddle H; Wright J; Helliwell P; Emery P; Buch M<\/span> (2013)<\/span> FRI0390\u2005Effects of pressure relieving insoles for foot problems in people with ssc: the pisces randomized controlled trial<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A505<\/span>. <\/a><\/p>","publicationid":"671243","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; El-Sherbiny Y; Freeston J; Brown A; Reece R; Dass S; Buch M; Ponchel F; Emery P<\/span> (2013)<\/span> OP0045\u2005Synovial B Cell Status Determines Intensity of Rituximab Therapy Required in Rheumatoid Arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A64-A65<\/span>. <\/a><\/p>","publicationid":"370768","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Israelsson L; Nogueira L; Malmstr\u00f6m V; El-Sherbiny Y; Rawstron A; Serre G; Klareskog L; Ponchel F; Emery P<\/span> (2013)<\/span> FRI0227\u2005Acpa fine specificity is associated with increased plasmablast numbers and worse clinical response to rituximab in rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A450<\/span>. <\/a><\/p>","publicationid":"370767","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Wakefield RJ; Tan AL; Freeston JE; Buch MH; Emery P<\/span> (2013)<\/span> SAT0011\u2005What is Undifferentiated Arthritis (UA) in 2013, and can Progression to Rheumatoid Arthritis (RA) be Predicted?<\/span> Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. A582<\/span>. <\/a><\/p>","publicationid":"366519","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Go\u00ebb V; Aegerter P; Parmar R; Fardellone P; Vittecoq O; Conaghan PG; Emery P; Le Lo\u00ebt X; Ponchel F<\/span> (2013)<\/span> Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels<\/span>. Annals of the rheumatic diseases<\/span>, 72<\/span>, (6)<\/span>, pp. 1032-1036<\/span>. <\/a><\/p>","publicationid":"223227","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Ash ZR; Tinazzi I; Castillo-Gallego C; Kwok C; Wilson C; Goodfield M; Gisondi P; Tan AL; Marzo-Ortega H; Emery P; Wakefield RJ; McGonagle DG<\/span> (2013)<\/span> The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (6)<\/span>, pp. 992-995<\/span>. <\/a> <\/a><\/p>","publicationid":"217565","date":"2013-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gabay C; Emery P; van Vollenhoven R; Dikranian A; Alten R; Pavelka K; Klearman M; Musselman D; Agarwal S; Green J; Kavanaugh A; ADACTA Study Investigators<\/span> (2013)<\/span> Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial<\/span>. Lancet<\/span>, 381<\/span>, (9877)<\/span>, pp. 1541-1550<\/span>. <\/a><\/p>","publicationid":"255245","date":"2013-05-04","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone EC; Cohen SB; Emery P; Kremer JM; Dougados M; Loveless JE; Chung C; Wong P; Lehane PB; Tyrrell H<\/span> (2013)<\/span> Dr. Keystone, et al, reply<\/span>. J Rheumatol<\/span>, 40<\/span>, (5)<\/span>, pp. 732-733<\/span>. <\/a><\/p>","publicationid":"258304","date":"2013-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wagner C; Chen D; Fan H; Hsia EC; Mack M; Emery P; Fleischmann RM<\/span> (2013)<\/span> Evaluation of serum biomarkers associated with radiographic progression in methotrexate-naive rheumatoid arthritis patients treated with methotrexate or golimumab<\/span>. The Journal of rheumatology<\/span>, 40<\/span>, (5)<\/span>, pp. 590-598<\/span>. <\/a><\/p>","publicationid":"253229","date":"2013-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Tanner SF; Waller ML; Hensor EMA; Burns A; Jeavons AP; Bury RF; Emery P; McGonagle D<\/span> (2013)<\/span> High-resolution [18F]fluoride positron emission tomography of the distal interphalangeal joint in psoriatic arthritis--a bone-enthesis-nail complex<\/span>. Rheumatology (Oxford, England)<\/span>, 52<\/span>, (5)<\/span>, pp. 898-904<\/span>. <\/a><\/p>","publicationid":"248729","date":"2013-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mehta P; Holder S; Fisher B; Vincent T; Nadesalingam K; Maciver H; Shingler W; Bakshi J; Hassan S; D'Cruz D; Chan A; Litwic AE; McCrae F; Seth R; McCrae F; Nandagudi A; Jury E; Isenberg D; Karjigi U; Paul A; Rees F; O'Dowd E; Kinnear W; Johnson S; Lanyon P; Bakshi J; Stevens R; Narayan N; Marguerie C; Robinson H; Ffolkes L; Worsnop F; Ostlere L; Kiely P; Dharmapalaiah C; Hassan N; Nandagudi A; Bharadwaj A; Skibinska M; Gendi N; Davies EJ; Akil M; Kilding R; Ramachandran Nair J; Walsh M; Farrar W; Thompson RN; Borukhson L; McFadyen C; Singh D; Rajagopal V; Chan AML; Wearn Koh L; Christie JD; Croot L; Gayed M; Disney B; Singhal S; Grindulis K; Reynolds TD; Conway K; Williams D; Quin J; Dean G; Churchill D; Walker-Bone KE; Goff I; Reynolds G; Grove M; Patel P; Lazarus MN; Roncaroli F; Gabriel C; Kinderlerer AR; Nikiphorou E; Hall FC; Bruce E; Gray L; Krutikov M; Wig S; Bruce I; D'Agostino MA; Wakefield R; Berner Hammer H; Vittecoq O; Galeazzi M; Balint P; Filippucci E; Moller I; Iagnocco A; Naredo E; Ostergaard M; Gaillez C; Kerselaers W; Van Holder K; Le Bars M; Stone MA; Williams F; Wolber L; Karppinen J; Maatta J; Thompson B; Atchia I; Lorenzi A; Raftery G; Platt P; Platt PN; Pratt A; Turmezei TD; Treece GM; Gee AH; Poole KE; Chandratre PN; Roddy E; Clarson L; Richardson J; Hider S; Mallen C; Lieberman A; Prouse PJ; Mahendran P; Samarawickrama A; Churchill D; Walker-Bone KE; Ottery FD; Yood R; Wolfson M; Ang A; Riches P; Thomson J; Nuki G; Humphreys J; Verstappen SM; Chipping J; Hyrich K; Marshall T; Symmons DP; Roy M; Kirwan JR; Marshall RW; Matcham F; Scott IC; Rayner L; Hotopf M; Kingsley GH; Scott DL; Steer S; Ma MH; Dahanayake C; Scott IC; Kingsley G; Cope A; Scott DL; Dahanayake C; Ma MH; Scott IC; Kingsley GH; Cope A; Scott DL; Wernham A; Ward L; Carruthers D; Deeming A; Buckley C; Raza K; De Pablo P; Nikiphorou E; Carpenter L; Jayakumar K; Solymossy C; Dixey J; Young A; Singh A; Penn H; Ellerby N; Mattey DL; Packham J; Dawes P; Hider SL; Ng N; Humby F; Bombardieri M; Kelly S; Di Cicco M; Dadoun S; Hands R; Rocher V; Kidd B; Pyne D; Pitzalis C; Poore S; Hutchinson D; Low A; Lunt M; Mercer L; Galloway J; Davies R; Watson K; Dixon W; Symmons D; Hyrich K; Mercer L; Lunt M; Low A; Galloway J; Watson KD; Dixon WG; Symmons D; Hyrich KL; Low A; Lunt M; Mercer L; Bruce E; Dixon W; Hyrich K; Symmons D; Malik SP; Kelly C; Hamilton J; Heycock C; Saravanan V; Rynne M; Harris HE; Tweedie F; Skaparis Y; White M; Scott N; Samson K; Mercieca C; Clarke S; Warner AJ; Humphreys J; Lunt M; Marshall T; Symmons D; Verstappen S; Chan E; Kelly C; Woodhead FA; Nisar M; Arthanari S; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A; Kelly C; Chan E; Ahmad Y; Woodhead FA; Nisar M; Arthanari S; Dawson J; Sathi N; Koduri G; Young A; Cumming J; Stannett P; Hull R; Metsios G; Stavropoulos Kalinoglou A; Veldhuijzen van Zanten JJ; Nightingale P; Koutedakis Y; Kitas GD; Nikiphorou E; Dixey J; Williams P; Kiely P; Walsh D; Carpenter L; Young A; Perry E; Kelly C; de-Soyza A; Moullaali T; Eggleton P; Hutchinson D; Veldhuijzen van Zanten JJ; Metsios G; Stavropoulos-Kalinoglou A; Sandoo A; Kitas GD; de Pablo P; Maggs F; Carruthers D; Faizal A; Pugh M; Jobanputra P; Kehoe O; Cartwright A; Askari A; El Haj A; Middleton J; Aynsley S; Hardy J; Veale D; Fearon U; Wilson G; Muthana M; Fossati G; Healy L; Nesbitt A; Becerra E; Leandro MJ; De La Torre I; Cambridge G; Nelson PN; Roden D; Shaw M; Davari Ejtehadi H; Nevill A; Freimanis G; Hooley P; Bowman S; Alavi A; Axford J; Veitch AM; Tugnet N; Rylance PB; Hawtree S; Muthana M; Aynsley S; Mark Wilkinson J; Wilson AG; Woon Kam N; Filter A; Buckley C; Pitzalis C; Bombardieri M; Croft AP; Naylor A; Zimmermann B; Hardie D; Desanti G; Jaurez M; Muller-Ladner U; Filer A; Neumann E; Buckley C; Movahedi M; Lunt M; Ray DW; Dixon WG; Burmester GR; Matucci-Cerinic M; Navarro-Blasco F; Kary S; Unnebrink K; Kupper H; Mukherjee S; Cornell P; Richards S; Rahmeh F; Thompson PW; Westlake SL; Javaid MK; Batra R; Chana J; Round G; Judge A; Taylor P; Patel S; Cooper C; Ravindran V; Bingham CO; Weinblatt ME; Mendelsohn A; Kim L; Mack M; Lu J; Baker D; Westhovens R; Hewitt J; Han C; Keystone EC; Fleischmann R; Smolen J; Emery P; Genovese M; Doyle M; Hsia EC; Hart JC; Lazarus MN; Kinderlerer AR; Harland D; Gibbons C; Pang H; Huertas C; Diamantopoulos A; Dejonckheere F; Clowse M; Wolf D; Stach C; Kosutic G; Williams S; Terpstra I; Mahadevan U; Smolen J; Emery P; Ferraccioli G; Samborski W; Berenbaum F; Davies O; Koetse W; Bennett B; Burkhardt H; Weinblatt ME; Fleischmann R; Davies O; Luijtens K; van der Heijde D; Mariette X; van Vollenhoven RF; Bykerk V; de Longueville M; Arendt C; Luijtens K; Cush J; Khan A; Maclaren Z; Dubash S; Chalam VC; Sheeran T; Price T; Baskar S; Mulherin D; Molloy C; Keay F; Heritage C; Douglas B; Fleischmann R; Weinblatt ME; Schiff MH; Khanna D; Furst DE; Maldonado MA; Li W; Sasso EH; Emerling D; Cavet G; Ford K; Mackenzie-Green B; Collins D; Price E; Williamson L; Golla J; Vagadia V; Morrison E; Tierney A; Wilson H; Hunter J; Ma MH; Scott DL; Reddy V; Moore S; Ehrenstein M; Benson C; Wray M; Cairns A; Wright G; Pendleton A; McHenry M; Taggart A; Bell A; Bosworth A; Cox M; Johnston G; Shah P; O'Brien A; Jones P; Sargeant I; Bukhari M; Nusslein H; Alten R; Galeazzi M; Lorenz HM; Boumpas D; Nurmohamed MT; Bensen W; Burmester GR; Peter H-H; Rainer F; Pavelka K; Chartier M; Poncet C; Rauch C; Le Bars M; Lempp H; Hofmann D; Adu A; Congreve C; Dobson J; Rose D; Simpson C; Wykes T; Cope A; Scott DL; Ibrahim F; Schiff M; Alten R; Weinblatt ME; Nash P; Fleischmann R; Durez P; Kaine J; Delaet I; Kelly S; Maldonado M; Patel S; Genovese M; Jones G; Sebba A; Lepley D; Devenport J; Bernasconi C; Smart D; Mpofu C; Gomez-Reino JJ; Verma I; Kaur J; Syngle A; Krishan P; Vohra K; Kaur L; Garg N; Chhabara M; Gibson K; Woodburn J; Telfer S; Buckley F; Finckh A; Huizinga TW; Dejonckheere F; Jansen JP; Genovese M; Sebba A; Rubbert-Roth A; Scali JJ; Alten R; Kremer JM; Pitts L; Vernon E; van Vollenhoven RF; Sharif MI; Das S; Emery P; Maciver H; Shingler W; Helliwell P; Sokoll K; Vital EM<\/span> (2013)<\/span> Case Reports * 1. A Late Presentation of Loeys-Dietz Syndrome: Beware of TGF\u00a0 Receptor Mutations in Benign Joint Hypermobility<\/span>. Rheumatology<\/span>, 52<\/span>, (suppl 1)<\/span>, pp. i56-i94<\/span>. <\/a><\/p>","publicationid":"1103611","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fleischmann R; van Vollenhoven RF; Smolen J; Emery P; Florentinus S; Rathmann S; Kupper H; Kavanaugh A; Taylor P; Genovese M; Keystone EC; Drescher E; Berclaz P-Y; Lee C; Fidelus-Gort R; Schlichting D; Beattie S; Luchi M; Macias W; Kavanaugh A; Emery P; van Vollenhoven RF; Dikranian AH; Alten R; Klearman M; Musselman D; Agarwal S; Green J; Gabay C; Weinblatt ME; Schiff MH; Fleischmann R; Valente R; van der Heijde D; Citera G; Zhao C; Maldonado MA; Rakieh C; Nam JL; Hunt L; Villeneuve E; Bissell L-A; Das S; Conaghan P; McGonagle D; Wakefield RJ; Emery P; Wright HL; Thomas HB; Moots R; Edwards SW; Hamann P; Heward J; McHugh N; Lindsay MA; Haroon M; Giles JT; Winchester R; FitzGerald O; Karaderi T; Cohen CJ; Keidel S; Appleton LH; Macfarlane GJ; Siebert S; Evans D; Paul Wordsworth B; Plant D; Bowes J; Orozco G; Morgan AW; Wilson AG; Isaacs J; Barton A; Williams FM; Livshits G; Spector T; MacGregor A; Williams FM; Scollen S; Cao D; Memari Y; Hyde CL; Zhang B; Sidders B; Ziemek D; Shi Y; Harris J; Harrow I; Dougherty B; Malarstig A; McEwen R; Stephens JL; Patel K; Shin S-Y; Surdulescu G; He W; Jin X; McMahon SB; Soranzo N; John S; Wang J; Spector TD; Baker J; Litherland GJ; Rowan AD; Kite KA; Bayley R; Yang P; Smith JP; Williams J; Harper L; Kitas GD; Buckley C; Young SP; Fitzpatrick MA; Young SP; McGettrick HM; Filer A; Raza K; Nash G; Buckley C; Muthana M; Davies H; Khetan S; Adeleke G; Hawtree S; Tazzyman S; Morrow F; Ciani B; Wilson G; Quirke A-M; Lugli E; Wegner N; Charles P; Hamilton B; Chowdhury M; Ytterberg J; Potempa J; Fisher B; Thiele G; Mikuls T; Venables P; Adebajo AO; Kavanaugh A; Mease P; Gomez-Reino JJ; Wollenhaupt J; Hu C; Stevens R; Sieper J; van der Heijde D; Dougados M; Van den Bosch F; Goupille P; Rathmann SS; Pangan AL; van der Heijde D; Sieper J; Maksymowych WP; Brown MA; Rathmann S; Pangan AL; Sieper J; van der Heijde D; Elewaut D; Pangan AL; Anderson J; Haroon M; Ramasamy P; O'Rourke M; Murphy C; Fitzgerald O; Jani M; Moore S; Mirjafari H; Macphie E; Chinoy H; Rao C; McLoughlin Y; Preeti S<\/span> (2013)<\/span> Oral Abstracts 7: RA Clinical * O37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatment Approach<\/span>. Rheumatology<\/span>, 52<\/span>, (suppl 1)<\/span>, pp. i44-i55<\/span>. <\/a><\/p>","publicationid":"729485","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gayed M; Leone F; Toescu V; Bruce I; Giles I; Teh L-S; McHugh N; Edwards C; Akil M; Khamashta M; Gordon C; Parker B; Urowitz M; Gladman D; Lunt M; Bruce I; Redmond A; Alcacer-Pitarch B; Gray J; Denton C; Herrick A; Navarro-Coy N; Collier H; Loughrey L; Pavitt S; Siddle H; Wright J; Helliwell P; Emery P; Buch M; Abrol E; Pulido CG; Isenberg DA; Kia S; Patil P; Williams M; Adizie T; Christidis D; Gordon T; Borg FA; Jain S; Dasgupta B; Robson J; Doll H; Yew S; Flossmann O; Suppiah R; Harper L; Hoglund P; Jayne D; Mukhtyar C; Westman K; Luqmani R; Al-Mossawi MH; Ridley A; Wong I; Kollnberger S; Shaw J; Bowness P; Di Cicco M; Humby F; Kelly S; Ng N; Hands R; Dadoun S; Buckley C; McInnes IB; Taylor P; Bombardieri M; Pitzalis C; Mansour S; Tocheva A; Goulston L; Platten H; Edwards C; Cooper C; Gadola SD; Lugli E; Lundberg K; Bracke K; Brusselle G; Venables PJ; Sanchez-Blanco C; Cornish G; Burn G; Saini M; Brownlie R; Klavinskis L; Williams R; Thompson S; Svensson L; Zamoyska R; Cope A; Hong CF; Khan K; Alade R; Nihtyanova SI; Ong VH; Denton CP; Scott DL; Ibrahim F; Kelly C; Birrell F; Chakravarty K; Walker D; Maddison P; Kingsley G; Cohen C; Karaderi T; Appleton L; Keidel S; Pointon J; Ridley A; Bowness P; Wordsworth P; Williams MA; Heine PJ; McConkey C; Lord J; Dosanjh S; Williamson E; Adams J; Underwood M; Lamb SE<\/span> (2013)<\/span> Oral Abstracts 1: Connective Tissue Disease * O1. Long-Term Outcomes of Children Born to Mothers with SLE<\/span>. Rheumatology<\/span>, 52<\/span>, (suppl 1)<\/span>, pp. i26-i32<\/span>. <\/a><\/p>","publicationid":"671239","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Karrar S; Shiwen X; Nikotorowicz-Buniak J; Abraham DJ; Denton C; Stratton R; Bayley R; Kite KA; Clay E; Smith JP; Kitas GD; Buckley C; Young SP; Ye L; Zhang L; Goodall J; Gaston H; Xu H; Lutalo PM; Zhao Y; Meng Choong L; Sangle S; Spencer J; D'Cruz D; Rysnik OJ; McHugh K; Bowness P; Rump-Goodrich L; Mattey D; Kehoe O; Middleton J; Cartwright A; Schmutz C; Askari A; Middleton J; Gardner DH; Jeffery LE; Raza K; Sansom DM; Clay E; Bayley R; Fitzpatrick M; Wallace G; Young S; Shaw J; Hatano H; Cauli A; Giles JL; McHugh K; Mathieu A; Bowness P; Kollnberger S; Webster S; Ellis L; O'Brien LM; Fitzmaurice TJ; Gaston H; Goodall J; Nazeer Moideen A; Evans L; Osgood L; Williams A; Jones S; Thomas C; O'Donnell V; Nowell M; Ouboussad L; Savic S; Dickie LJ; Hintze J; Wong CH; Cook GP; Buch M; Emery P; McDermott MF; Hardcastle SA; Gregson CL; Deere K; Davey Smith G; Dieppe P; Tobias JH; Dennison E; Edwards M; Bennett J; Coggon D; Palmer K; Cooper C; McWilliams D; Young A; Kiely PD; Walsh D; Taylor HJ; Harding I; Hutchinson J; Nelson I; Blom A; Tobias J; Clark E; Parker J; Bukhari M; McWilliams D; Jayakumar K; Young A; Kiely P; Walsh D; Diffin J; Lunt M; Marshall T; Chipping J; Symmons D; Verstappen S; Taylor HJ; Harding I; Hutchinson J; Nelson I; Tobias J; Clark E; Bluett J; Bowes J; Ho P; McHugh N; Buden D; Fitzgerald O; Barton A; Glossop JR; Nixon NB; Emes RD; Dawes PT; Farrell WE; Mattey DL; Scott IC; Steer S; Seegobin S; Hinks AM; Eyre S; Morgan A; Wilson AG; Hocking L; Wordsworth P; Barton A; Worthington J; Cope A; Lewis CM; Guerra S; Ahmed BA; Denton C; Abraham D; Fonseca C; Robinson J; Taylor J; Haroon Rashid L; Flynn E; Eyre S; Worthington J; Barton A; Isaacs J; Bowes J; Wilson AG; Barrett JH; Morgan A; Kingston B; Ahmed M; Kirwan JR; Marshall R; Chapman K; Pearson R; Heycock C; Kelly C; Rynne M; Saravanan V; Hamilton J; Saeed A; Coughlan R; Carey JJ; Farah Z; Matthews W; Bell C; Petford S; Tibbetts L-M; Douglas KMJ; Holden W; Ledingham J; Fletcher M; Winfield R; Price Z; Mackay K; Dixon C; Oppong R; Jowett S; Nicholls E; Whitehurst D; Hill S; Hammond A; Hay E; Dziedzic K; Righetti C; Lebmeier M; Manning VL; Hurley M; Scott DL; Choy E; Bearne L; Nikiphorou E; Morris S; James D; Kiely P; Walsh D; Young A; Wong EC; Long J; Fletcher A; Fletcher M; Holmes S; Hockey P; Abbas M; Chattopadhyay C; Flint J; Gayed M; Schreiber K; Arthanari S; Nisar M; Khamashta M; Gordon C; Giles I; Robson J; Kiran A; Maskell J; Arden N; Hutchings A; Emin A; Culliford D; Dasgupta B; Hamilton W; Luqmani R; Jethwa H; Rowczenio D; Trojer H; Russell T; Loeffler J; Hawkins P; Lachmann H; Verma I; Syngle A; Krishan P; Garg N; Flint J; Gayed M; Schreiber K; Arthanari S; Nisar M; Khamashta M; Gordon C; Giles I; McGowan SP; Gerrard DT; Chinoy H; Ollier WE; Cooper RG; Lamb JA; Taborda L; Correia Azevedo P; Isenberg D; Leyland KM; Kiran A; Judge A; Hunter D; Hart D; Javaid MK; Arden N; Cooper C; Edwards MH; Litwic AE; Jameson KA; Deeg D; Cooper C; Dennison E; Edwards MH; Jameson KA; Cushnaghan J; Aihie Sayer A; Deeg D; Cooper C; Dennison E; Jagannath D; Parsons C; Cushnaghan J; Cooper C; Edwards MH; Dennison E; Stoppiello L; Mapp P; Ashraf S; Wilson D; Hill R; Scammell B; Walsh D; Wenham C; Shore P; Hodgson R; Grainger A; Aaron J; Hordon L; Conaghan P; Bar-Ziv Y; Beer Y; Ran Y; Benedict S; Halperin N; Drexler M; Mor A; Segal G; Lahad A; Haim A; Rath U; Morgensteren DM; Salai M; Elbaz A; Vasishta VG; Derrett-Smith E; Hoyles R; Khan K; Abraham DJ; Denton C; Ezeonyeji A; Takhar G; Denton C; Ong V; Loughrey L; Bissell L-A; Hensor E; Abignano G; Redmond A; Buch M; Del Galdo F; Hall FC; Malaviya A; Nisar M; Baker S; Furlong A; Mitchell A; Godfrey AL; Ruddlesden M; Hadjinicolaou A; Hughes M; Moore T; O'Leary N; Tracey A; Ennis H; Dinsdale G; Roberts C; Herrick A; Denton CP; Guillevin L; Hunsche E; Rosenberg D; Schwierin B; Scott M; Krieg T; Anderson M; Hall FC; Herrick A; McHugh N; Matucci-Cerinic M; Alade R; Khan K; Xu S; Denton C; Ong V; Nihtyanova S; Ong V; Denton CP; Clark KE; Tam FWK; Unwin R; Khan K; Abraham DJ; Denton C; Stratton RJ; Nihtyanova S; Schreiber B; Ong V; Denton CP; Seng Edwin Lim C; Dasgupta B; Corsiero E; Sutcliffe N; Wardemann H; Pitzalis C; Bombardieri M; Tahir H; Donnelly S; Greenwood M; Smith TO; Easton V; Bacon H; Jerman E; Armon K; Poland F; Macgregor A; van der Heijde D; Sieper J; Elewaut D; Pangan AL; Nguyen D; Badenhorst C; Kirby S; White D; Harrison A; Garcia JA; Stebbings S; MacKay JW; Aboelmagd S; Gaffney K; van der Heijde D; Deodhar A; Braun J; Mack M; Hsu B; Gathany T; Han C; Inman RD; Cooper-Moss N; Packham J; Strauss V; Freeston JE; Coates L; Nam J; Moverley AR; Helliwell P; Hensor E; Wakefield R; Emery P; Conaghan P; Mease P; Fleischmann R; Wollenhaupt J; Deodhar A; Kielar D; Woltering F; Stach C; Hoepken B; Arledge T; van der Heijde D; Gladman D; Fleischmann R; Coteur G; Woltering F; Mease P; Kavanaugh A; Gladman D; van der Heijde D; Purcaru O; Mease P; McInnes I; Kavanaugh A; Gottlieb AB; Puig L; Rahman P; Ritchlin C; Li S; Wang Y; Mendelsohn A; Doyle M; Tillett W; Jadon D; Shaddick G; Cavill C; Robinson G; Sengupta R; Korendowych E; de Vries C; McHugh N; Thomas RC; Shuto T; Busquets-Perez N; Marzo-Ortega H; McGonagle D; Tillett W; Richards G; Cavill C; Sengupta R; Shuto T; Marzo-Ortega H; Thomas RC; Bingham S; Coates L; Emery P; John Hamlin P; Adshead R; Cambridge S; Donnelly S; Tahir H; Suppiah P; Cullinan M; Nolan A; Thompson WM; Stebbings S; Mathieson HR; Mackie SL; Bryer D; Buch M; Emery P; Marzo-Ortega H; Krutikov M; Gray L; Bruce E; Ho P; Marzo-Ortega H; Busquets-Perez N; Thomas RC; Gaffney K; Keat A; Innes W; Pandit R; Kay L; Lapshina S; Myasoutova L; Erdes S; Wallis D; Waldron N; McHugh N; Korendowych E; Thorne I; Harris C; Keat A; Garg N; Syngle A; Vohra K; Khinchi D; Verma I; Kaur L; Jones A; Harrison N; Harris D; Jones T; Rees J; Bennett A; Fazal S; Tugnet N; Barkham N; Basu N; McClean A; Harper L; Amft EN; Dhaun N; Luqmani RA; Little MA; Jayne DR; Flossmann O; McLaren J; Kumar V; Reid DM; Macfarlane GJ; Jones G; Yates M; Watts RA; Igali L; Mukhtyar C; Macgregor A; Robson J; Doll H; Yew S; Flossmann O; Suppiah R; Harper L; Hoglund P; Jayne D; Mukhtyar C; Westman K; Luqmani R; Win Maw W; Patil P; Williams M; Adizie T; Christidis D; Borg F; Dasgupta B; Robertson A; Croft AP; Smith S; Carr S; Youssouf S; Salama A; Pusey C; Harper L; Morgan M<\/span> (2013)<\/span> Basic Science * 208. Stem Cell Factor Expression is Increased in the Skin of Patients with Systemic Sclerosis and Promotes Proliferation and Migration of Fibroblasts in vitro<\/span>. Rheumatology<\/span>, 52<\/span>, (suppl 1)<\/span>, pp. i135-i172<\/span>. <\/a><\/p>","publicationid":"666895","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Keystone EC; So AK; Braun J; Breedveld FC; Burmester GR; De Benedetti F; D\u00f6rner T; Emery P; Fleischmann R; Gibofsky A; Kalden JR; Kavanaugh A; Kirkham B; Mease P; Rubbert-Roth A; Sieper J; Singer NG; Smolen JS; Van Riel PLCM; Weisman MH; Winthrop KL<\/span> (2013)<\/span> Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, pp. ii2-ii34<\/span>. <\/a><\/p>","publicationid":"257399","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kang T; Horton L; Emery P; Wakefield RJ<\/span> (2013)<\/span> Value of ultrasound in rheumatologic diseases<\/span>. Journal of Korean medical science<\/span>, 28<\/span>, (4)<\/span>, pp. 497-507<\/span>. <\/a> <\/a><\/p>","publicationid":"256223","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Villeneuve E; Nam JL; Bell MJ; Deighton CM; Felson DT; Hazes JM; McInnes IB; Silman AJ; Solomon DH; Thompson AE; White PHP; Bykerk VP; Emery P<\/span> (2013)<\/span> A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis<\/span>. Postgrad Med J<\/span>, 89<\/span>, (1050)<\/span>, pp. 231-240<\/span>. <\/a><\/p>","publicationid":"255202","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Schoels MM; Nishimoto N; Breedveld FC; Burmester GR; Dougados M; Emery P; Ferraccioli G; Gabay C; Gibofsky A; Gomez-Reino JJ; Jones G; Kvien TK; Murakami M; Betteridge N; Bingham CO; Bykerk V; Choy EH; Combe B; Cutolo M; Graninger W; Lanas A; Martin-Mola E; Montecucco C; Ostergaard M; Pavelka K; Rubbert-Roth A; Sattar N; Scholte-Voshaar M; Tanaka Y; Trauner M; Valentini G; Winthrop KL; De Wit M; Van Der Heijde D<\/span> (2013)<\/span> Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, (4)<\/span>, pp. 482-492<\/span>. <\/a><\/p>","publicationid":"253894","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van der Heijde D; van der Helm-van Mil AHM; Aletaha D; Bingham CO; Burmester GR; Dougados M; Emery P; Felson D; Knevel R; Kvien TK; Landew\u00e9 RBM; Lukas C; McInnes I; Silman AJ; Smolen JS; Stanislawska-Biernat E; Zink A; Combe B<\/span> (2013)<\/span> EULAR definition of erosive disease in light of the 2010 ACR\/EULAR rheumatoid arthritis classification criteria<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (4)<\/span>, pp. 479-481<\/span>. <\/a><\/p>","publicationid":"250156","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Schoels MM; Nishimoto N; Breedveld FC; Burmester GR; Dougados M; Emery P; Ferraccioli G; Gabay C; Gibofsky A; Gomez-Reino JJ; Jones G; Kvien TK; Murakami M; Betteridge N; Bingham CO; Bykerk V; Choy EH; Combe B; Cutolo M; Graninger W; Lanas A; Martin-Mola E; Montecucco C; Ostergaard M; Pavelka K; Rubbert-Roth A; Sattar N; Scholte-Voshaar M; Tanaka Y; Trauner M; Valentini G; Winthrop KL; de Wit M; van der Heijde D<\/span> (2013)<\/span> Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (4)<\/span>, pp. 482-492<\/span>. <\/a><\/p>","publicationid":"245280","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schoels MM; van der Heijde D; Breedveld FC; Burmester GR; Dougados M; Emery P; Ferraccioli G; Gabay C; Gibofsky A; Gomez-Reino JJ; Jones G; Kvien TK; Murakami M; Nishimoto N; Smolen JS<\/span> (2013)<\/span> Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (4)<\/span>, pp. 583-589<\/span>. <\/a><\/p>","publicationid":"236262","date":"2013-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Navarro-Coy N; Brown SR; Brown S; McParland L; Collier H; Skinner E; Law J; Moverley A; Pavitt S; Hulme C; Emery P; Conaghan PG; Helliwell PS<\/span> (2013)<\/span> The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis<\/span>. BMC musculoskeletal disorders<\/span>, 14<\/span>, (1)<\/span>, pp. 101<\/span>. <\/a> <\/a><\/p>","publicationid":"255094","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Pavitt S; Parmar M; Emery P<\/span> (2013)<\/span> Creative trial design in RA: Optimizing patient outcomes<\/span>. Nature Reviews Rheumatology<\/span>, 9<\/span>, (3)<\/span>, pp. 183-194<\/span>. <\/a><\/p>","publicationid":"254362","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Busquets-Perez N; Marzo-Ortega H; Emery P<\/span> (2013)<\/span> Emerging drugs for axial spondyloarthritis including ankylosing spondylitis<\/span>. Expert Opin Emerg Drugs<\/span>, 18<\/span>, (1)<\/span>, pp. 71-86<\/span>. <\/a><\/p>","publicationid":"254359","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Md Yusof MY; Emery P<\/span> (2013)<\/span> Targeting interleukin-6 in rheumatoid arthritis<\/span>. Drugs<\/span>, 73<\/span>, (4)<\/span>, pp. 341-356<\/span>. <\/a> <\/a><\/p>","publicationid":"253230","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Das S; Fernandez Matilla M; Dass S; Buch MH; Rawstron AC; Vital EM; Emery P<\/span> (2013)<\/span> Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, (3)<\/span>, pp. 463-464<\/span>. <\/a><\/p>","publicationid":"251507","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Pavitt S; Parmar M; Emery P<\/span> (2013)<\/span> Creative trial design in RA: optimizing patient outcomes<\/span>. Nature reviews. Rheumatology<\/span>, 9<\/span>, (3)<\/span>, pp. 183-194<\/span>. <\/a><\/p>","publicationid":"249937","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Das S; Fernandez Matilla M; Dass S; Buch MH; Rawstron AC; Vital EM; Emery P<\/span> (2013)<\/span> Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis<\/span>. Annals of the rheumatic diseases<\/span>, 72<\/span>, (3)<\/span>, pp. 463-464<\/span>. <\/a><\/p>","publicationid":"229036","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lanni S; Wood M; Ravelli A; Magni Manzoni S; Emery P; Wakefield RJ<\/span> (2013)<\/span> Towards a role of ultrasound in children with juvenile idiopathic arthritis<\/span>. Rheumatology (Oxford, England)<\/span>, 52<\/span>, (3)<\/span>, pp. 413-420<\/span>. <\/a><\/p>","publicationid":"229030","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Davies R; Dixon WG; Watson KD; Lunt M; BSRBR Control Centre Consortium; Symmons DPM; Hyrich KL; BSRBR<\/span> (2013)<\/span> Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (3)<\/span>, pp. 461-462<\/span>. <\/a><\/p>","publicationid":"223291","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Isaacs JD; Cohen SB; Emery P; Tak PP; Wang J; Lei G; Williams S; Lal P; Read SJ<\/span> (2013)<\/span> Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (3)<\/span>, pp. 329-336<\/span>. <\/a><\/p>","publicationid":"213630","date":"2013-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tarn JR; Natasari A; Mitchell S; Bowman S; Price E; Pease C; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; McLaren J; Hunter J; Gupta M; Regan M; Cooper A; Giles I; Isenberg D; Young D; Lendrem D; Downie C; Foggo H; Stocks P; Edgar S; Ng WF<\/span> (2013)<\/span> Soluble molecule profiling and network analysis of primary Sj\u00f6gren's Syndrome patient serum<\/span>. BMC Musculoskeletal Disorders<\/span>, 14<\/span>, (S1)<\/span>, pp. a2<\/span>. <\/a><\/p>","publicationid":"1103398","date":"2013-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Shuto T; Thomas R; Bingham S; Coates L; Emery P; Marzo-Ortega H; Hamlin PJ<\/span> (2013)<\/span> P575 Caseload and impact of the Leeds Combined Rheumatology and Gastroenterology Clinic<\/span>. Journal of Crohn's and Colitis<\/span>, 7<\/span>, (Supplement_1)<\/span>, pp. S241<\/span>. <\/a><\/p>","publicationid":"666891","date":"2013-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

El Zorkany B; Alwahshi HA; Hammoudeh M; Al Emadi S; Benitha R; Al Awadhi A; Bouajina E; Laatar A; El Badawy S; Al Badi M; Al-Maini M; Al Saleh J; Alswailem R; Ally MMTM; Batha W; Djoudi H; El Garf A; El Hadidi K; El Marzouqi M; Hadidi M; Maharaj AB; Masri AF; Mofti A; Nahar I; Pettipher CA; Spargo CE; Emery P<\/span> (2013)<\/span> Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?<\/span> Clin Rheumatol<\/span>, 32<\/span>, (2)<\/span>, pp. 151-159<\/span>. <\/a><\/p>","publicationid":"246757","date":"2013-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ndosi M; Lewis M; Hale C; Bird H; Ryan S; Quinn H; McIvor L; Taylor J; Burbage G; Bond D; White J; Chagadama D; Green S; Kay L; Pace AV; Bejarano V; Emery P; Hill J<\/span> (2013)<\/span> CLINICAL OUTCOMES OF NURSE-LED CARE FOR PEOPLE WITH RA: A MULTICENTRE RCT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 71<\/span>, pp. 120<\/span>. <\/a><\/p>","publicationid":"286067","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Braun J; Laurent D; Baeten D; van der Heijde D; Sieper J; Emery P; McInnes I; van Laar J; Landewe R; Wordsworth P; Wollenhaupt J; Kellner H; Wright A; Vandenhende F; Radford K; Borah B; Hueber W<\/span> (2013)<\/span> Long term IL-17A inhibition by secukinumab leads to reduced spinal inflammation and unchanged fatty lesions in patients with ankylosing spondylitis<\/span>. ZEITSCHRIFT FUR RHEUMATOLOGIE<\/span>, 72<\/span>, pp. 129<\/span>.<\/p>","publicationid":"282668","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Szumski A; Bukowski J; Bananis E; Marshall L<\/span> (2013)<\/span> EARLY INITIATED ETANERCEPT PLUS METHOTREXATE TREATMENT INDUCES REMISSION IN PATIENTS WITH EITHER MODERATE OR SEVERE RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 603-604<\/span>.<\/p>","publicationid":"281576","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Solem CT; McGuire MB; Majer I; Hensen M; Stephens JM; Tarallo M<\/span> (2013)<\/span> EUROPEAN CHART REVIEW STUDY ON EARLY RHEUMATOID ARTHRITIS (RA): PATIENT PROFILE AND BIOLOGIC TREATMENT PATTERNS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 765<\/span>.<\/p>","publicationid":"281575","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ng W-F; Miller A; Bowman S; Price E; Kitas G; Pease C; Emery P; Lanyon P; Hunter J; Gupta M; Giles I; Isenberg D; MaClaren J; Regan M; Cooper A; Young-Min S; Bombardieri M; Sutcliffe N; Pitzalis C; Vadivelu S; Coady D; MacKay K; Moots R; Mitchell S; Mchugh N; Dasgupta B; Trenell M<\/span> (2013)<\/span> LEVEL OF PHYSICAL ACTIVITY IN PRIMARY SJOGREN'S SYNDROME AND ITS PREDICTORS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 483-484<\/span>.<\/p>","publicationid":"281574","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Das S; Takase K; Dass S; Buch MH; Vital E; Emery P<\/span> (2013)<\/span> OVERALL RESPONSE PATTERN OF RITUXIMAB IN RA-SINGLE CENTRE EXPERIENCE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 889<\/span>.<\/p>","publicationid":"281573","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; Soubrier M; Antunez A; Balint P; Balsa A; Buch M; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Kay J; Luo S-F; Kurucz R; Maciel G; Martin Mola E; Montecucco CM; Mc Innes I; Radner H; Smolen J; Song Y-W; Van de Laar M; Winthrop K<\/span> (2013)<\/span> PREVALENCE OF CO-MORBIDITIES IN RHEUMATOID ARTHRITIS (RA) AND EVALUATION OF THEIR MONITORING: RESULTS OF AN INTERNATIONAL, CROSS-SECTIONAL STUDY (COMORA)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 600<\/span>.<\/p>","publicationid":"281571","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone E; Fleischmann RM; Furst D; Hessey EW; Vashishtha A; Mehbob A; Lehane B<\/span> (2013)<\/span> LONG-TERM SAFETY OF RITUXIMAB: POOLED ANALYSIS OF THE RHEUMATOID ARTHRITIS GLOBAL CLINICAL TRIAL PROGRAMME OVER 11 YEARS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 625-626<\/span>.<\/p>","publicationid":"281570","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Szumski A; Jones H<\/span> (2013)<\/span> RADIOGRAPHIC PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS TREATED WITH ETANERCEPT: RESULTS FROM THE PRIZE STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 399-400<\/span>.<\/p>","publicationid":"281569","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Park Y-J; Cho C-S; Emery P; Kim W-U<\/span> (2013)<\/span> LOW-DENSITY LIPOPROTEIN CHOLESTEROLEMIA AS A NOVEL RISK FACTOR FOR RADIOGRAPHIC PROGRESSION OF RHEUMATOID ARTHRITIS: A SINGLE CENTERED PROSPECTIVE STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 594<\/span>.<\/p>","publicationid":"281568","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante E; Churchill M; Park W; Pons-Estel B; Han C; Gathany T; Zhou Y; Xu S; Hsia EC<\/span> (2013)<\/span> FIVE-YEAR SAFETY AND EFFICACY OF GOLIMUMAB IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL STUDY RESULTS OF THE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED GO-BEFORE TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 432<\/span>.<\/p>","publicationid":"281567","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Braun J; Laurent D; Baeten D; van der Heijde D; Sieper J; Emery P; McInnes I; van Laar J; Landewe R; Wordsworth P; Wollenhaupt J; Kellner H; Wright A; Vandenhende F; Radford K; Borah B; Hueber W<\/span> (2013)<\/span> LONG TERM INHIBITION OF IL-17A WITH SECUKINUMAB REDUCES SPINAL INFLAMMATION BUT HAS NO INFLUENCE ON FATTY LESIONS AS ASSESSED BY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ANKYLOSING SPONDYLITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 516<\/span>.<\/p>","publicationid":"281566","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Hammoudeh M; FitzGerald O; Combe B; Martin Mola E; Bukowski J; Pedersen R; Williams T; Gaylord S; Vlahos B<\/span> (2013)<\/span> ASSESSING MAINTENANCE OF REMISSION WITH REDUCED DOSE ETANERCEPT PLUS METHOTREXATE, METHOTREXATE ALONE, OR PLACEBO IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WHO ACHIEVED REMISSION WITH ETANERCEPT AND METHOTREXTATE: THE PRIZE STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 399<\/span>.<\/p>","publicationid":"281565","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Wiland P; Dudler J; Ionescu RM; Vlahos B; Bukowski J; Pedersen R; Williams T; Gaylord S; Kotak S<\/span> (2013)<\/span> REDUCED\/WITHDRAWN DOSE OF ETANERCEPT-METHOTREXATE THERAPY OF EARLY RHEUMATOID ARTHRITIS HAS A FAVORABLE IMPACT ON PATIENT-REPORTED OUTCOMES COMPARED WITH MTX ALONE OR PLACEBO: THE PRIZE STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 765-766<\/span>.<\/p>","publicationid":"281564","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Cuomo G; Buch M; Rosenberg WM; Valentini G; Emery P; Del Galdo F<\/span> (2013)<\/span> SUB-ANALYSIS OF ELF SCORE BIOMARKERS COMPONENTS INDICATES A SPECIFIC CORRELATION WITH DIFFERENT ORGAN INVOLVEMENT IN SYSTEMIC SCLEROSIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 510-511<\/span>.<\/p>","publicationid":"281563","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baker J; Ostergaard M; Emery P; Hsia EC; Lu JD; Baker D; Conaghan PG<\/span> (2013)<\/span> EARLY MRI MEASURES INDEPENDENTLY PREDICT 1-AND 2-YEAR X-RAY PROGRESSION: RESULTS FROM A LARGE CLINICAL TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 746<\/span>.<\/p>","publicationid":"281559","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keenan A-M; White J; Pearson D; McSorely P; Andrews J; Taylor Y; Emery P<\/span> (2013)<\/span> THE IMPLEMENTATION OF A NOVEL SOFTWARE APPLICATION (MIDATABANK) TO RECORD, TRIAGE AND MANAGE TELEPHONE CALLS TO THE LEEDS RHEUMATOLOGY OUTPATIENT'S DEPARTMENT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 1058<\/span>.<\/p>","publicationid":"281553","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keenan A-M; White J; Pearson D; McSorely P; Andrews J; Taylor Y; Emery P<\/span> (2013)<\/span> THE IMPLEMENTATION OF A NOVEL SOFTWARE APPLICATION (MIDATABANK) TO RECORD, TRIAGE AND MANAGE TELEPHONE CALLS TO THE LEEDS RHEUMATOLOGY OUTPATIENT'S DEPARTMENT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 132<\/span>.<\/p>","publicationid":"281552","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rakieh C; Nam JL; Hunt L; Villeneuve E; Bissell L-A; Das S; Conaghan PG; McGonagle D; Wakefield RJ; Emery P<\/span> (2013)<\/span> RISK OF DEVELOPING CLINICAL SYNOVITIS IN ACPA POSITIVE PATIENTS WITH NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 114<\/span>.<\/p>","publicationid":"281503","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Wakefield RJ; Tan AL; Freeston JE; Buch MH; Emery P<\/span> (2013)<\/span> PROGRESSION TO RHEUMATOID ARTHRITIS (RA) BE PREDICTED?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 582<\/span>.<\/p>","publicationid":"281502","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rakieh C; Saleem B; Takase K; Nam JL; Keen H; Wakefield RJ; Emery P<\/span> (2013)<\/span> LONG TERM OUTCOMES OF STOPPING TUMOUR NECROSIS FACTOR INHIBITORS (TNFI) IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS (RA) WHO ARE IN SUSTAINED REMISSION: IS IT WORTH THE RISK?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 208-209<\/span>.<\/p>","publicationid":"281501","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Gallego CC; Nam J; Freeston J; Horton S; Wakefield RJ; Emery P<\/span> (2013)<\/span> THE NEW ACR\/EULAR CRITERIA FOR RHEUMATOID ARTHRITIS IS ABLE TO IDENTIFY PATIENTS WITH SAME DISEASE ACTIVITY BUT LESS DAMAGE BY ULTRASOUND<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 97<\/span>.<\/p>","publicationid":"281499","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Redmond A; Alcacer-Pitarch B; Gray J; Denton C; Herrick A; Navarro-Coy N; Collier H; Loughrey L; Pavitt S; Siddle H; Wright J; Helliwell P; Emery P; Buch M<\/span> (2013)<\/span> EFFECTS OF PRESSURE RELIEVING INSOLES FOR FOOT PROBLEMS IN PEOPLE WITH SSC: THE PISCES RANDOMIZED CONTROLLED TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 505<\/span>.<\/p>","publicationid":"281468","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Braun J; Dougados M; Emery P; FitzGerald O; Helliwell P; Kavanaugh A; Kvien TK; Landewe R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Schoels M; Sieper J; de Wit M; van der Heijde D<\/span> (2013)<\/span> TREAT-TO-TARGET RECOMMENDATIONS FOR SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A CONSENSUS OF AN INTERNATIONAL TASK FORCE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 72<\/span>, pp. 88-89<\/span>.<\/p>","publicationid":"281464","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Tan AL; Hodsgon R; Grainger A; Emery P; Wakefield RJ; McGonagle D<\/span> (2013)<\/span> Comparison of ultrasonography and magnetic resonance imaging for the assessment of clinically defined knee enthesitis in spondyloarthritis<\/span>. Clin Exp Rheumatol<\/span>, 31<\/span>, (6)<\/span>, pp. 933-936<\/span>. <\/a><\/p>","publicationid":"277636","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh A; Smolen JS; Emery P; Keystone E; Strand V; Purcaru O; van Vollenhoven R<\/span> (2013)<\/span> LONG-TERM BENEFITS OVER MORE THAN 4 YEARS OF CERTOLIZUMAB PEGOL COMBINATION THERAPY ON WORKPLACE AND HOUSEHOLD PRODUCTIVITY, AND PARTICIPATION IN SOCIAL ACTIVITIES IN RHEUMATOID ARTHRITIS: RESULTS FROM THE OPEN-LABEL EXTENSION STUDY OF RAPID1<\/span>. VALUE IN HEALTH<\/span>, 16<\/span>, (7)<\/span>, pp. A570<\/span>.<\/p>","publicationid":"274085","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baeten D; Baraliakos X; Braun J; Sieper J; Emery P; Van Der Heijde D; McInnes I; Van Laar JM; Landew\u00e9 R; Wordsworth P; Wollenhaupt J; Kellner H; Paramarta J; Wei J; Brachat A; Bek S; Laurent D; Li Y; Wang YA; Bertolino AP; Gsteiger S; Wright AM; Hueber W<\/span> (2013)<\/span> Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: A randomised, double-blind, placebo-controlled trial<\/span>. Lancet<\/span>, 382<\/span>, (9906)<\/span>, pp. 1705-1713<\/span>. <\/a><\/p>","publicationid":"274006","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tanaka Y; Hirata S; Saleem B; Emery P<\/span> (2013)<\/span> Discontinuation of biologics in patients with rheumatoid arthritis<\/span>. Clin Exp Rheumatol<\/span>, 31<\/span>, (4 Suppl 78)<\/span>, pp. S22-S27<\/span>.<\/p>","publicationid":"273101","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tanaka Y; Hirata S; Saleem B; Emery P<\/span> (2013)<\/span> Discontinuation of biologics in patients with rheumatoid arthritis<\/span>. Clinical and Experimental Rheumatology<\/span>, 31<\/span>, (4 Suppl 78)<\/span>, pp. s22-s27<\/span>.<\/p>","publicationid":"270724","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Park Y-J; Cho C-S; Emery P; Kim W-U<\/span> (2013)<\/span> LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study<\/span>. PLoS One<\/span>, 8<\/span>, (7)<\/span>, pp. e68975<\/span>. <\/a><\/p>","publicationid":"263679","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fabris M; Quartuccio L; Vital E; Pontarini E; Salvin S; Fabro C; Zabotti A; Benucci M; Manfredi M; Ravagnani V; Biasi D; Atzeni F; Sarzi-Puttini P; Morassi P; Fischetti F; Bazzicchi L; Saracco M; Pellerito R; Cimmino M; Carraro V; Semeraro A; Schiavon F; Caporali R; Bortolotti R; Govoni M; Fogolari F; Tonutti E; Bombardieri S; Emery P; De Vita S<\/span> (2013)<\/span> The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers<\/span>. Arthritis Rheum<\/span>, 65<\/span>, (1)<\/span>, pp. 88-97<\/span>. <\/a><\/p>","publicationid":"248488","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh A; Fleischmann RM; Emery P; Kupper H; Redden L; Guerette B; Santra S; Smolen JS<\/span> (2013)<\/span> Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study<\/span>. Annals of the Rheumatic Diseases<\/span>, 72<\/span>, (1)<\/span>, pp. 64-71<\/span>. <\/a><\/p>","publicationid":"246581","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Villeneuve E; Nam JL; Bell MJ; Deighton CM; Felson DT; Hazes JM; McInnes IB; Silman AJ; Solomon DH; Thompson AE; White PHP; Bykerk VP; Emery P<\/span> (2013)<\/span> A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis<\/span>. Annals of the rheumatic diseases<\/span>, 72<\/span>, (1)<\/span>, pp. 13-22<\/span>. <\/a><\/p>","publicationid":"246302","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh A; Fleischmann RM; Emery P; Kupper H; Redden L; Guerette B; Santra S; Smolen JS<\/span> (2013)<\/span> Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study<\/span>. Ann Rheum Dis<\/span>, 72<\/span>, (1)<\/span>, pp. 64-71<\/span>. <\/a><\/p>","publicationid":"212060","date":"2013-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kang T; Lanni S; Nam J; Emery P; Wakefield RJ<\/span> (2012)<\/span> The evolution of ultrasound in rheumatology<\/span>. Ther Adv Musculoskelet Dis<\/span>, 4<\/span>, (6)<\/span>, pp. 399-411<\/span>. <\/a><\/p>","publicationid":"259313","date":"2012-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mariette X; Reynolds AV; Emery P<\/span> (2012)<\/span> Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, (12)<\/span>, pp. e2<\/span>. <\/a><\/p>","publicationid":"229077","date":"2012-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mariette X; Reynolds AV; Emery P<\/span> (2012)<\/span> Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors<\/span>. Ann Rheum Dis<\/span>, 71<\/span>, (12)<\/span>, pp. e2-E2<\/span>. <\/a><\/p>","publicationid":"221683","date":"2012-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone EC; Cohen SB; Emery P; Kremer JM; Dougados M; Loveless JE; Chung C; Wong P; Lehane PB; Tyrrell H<\/span> (2012)<\/span> Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX study<\/span>. The Journal of rheumatology<\/span>, 39<\/span>, (12)<\/span>, pp. 2238-2246<\/span>. <\/a><\/p>","publicationid":"221603","date":"2012-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wenham CYJ; Hensor EMA; Grainger AJ; Hodgson R; Balamoody S; Dor\u00e9 CJ; Emery P; Conaghan PG<\/span> (2012)<\/span> A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis<\/span>. Rheumatology (Oxford, England)<\/span>, 51<\/span>, (12)<\/span>, pp. 2286-2294<\/span>. <\/a><\/p>","publicationid":"219204","date":"2012-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Weinblatt ME; Fleischmann R; Huizinga TWJ; Emery P; Pope J; Massarotti EM; van Vollenhoven RF; Wollenhaupt J; Bingham CO; Duncan B; Goel N; Davies OR; Dougados M<\/span> (2012)<\/span> Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study<\/span>. Rheumatology (Oxford, England)<\/span>, 51<\/span>, (12)<\/span>, pp. 2204-2214<\/span>. <\/a><\/p>","publicationid":"217915","date":"2012-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dickie LJ; Aziz AM; Savic S; Lucherini OM; Cantarini L; Geiler J; Wong CH; Coughlan R; Lane T; Lachmann HJ; Hawkins PN; Robinson PA; Emery P; McGonagle D; McDermott MF<\/span> (2012)<\/span> Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome<\/span>. Annals of the rheumatic diseases<\/span>, 71<\/span>, (12)<\/span>, pp. 2035-2043<\/span>. <\/a><\/p>","publicationid":"213113","date":"2012-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Newton JL; Frith J; Powell D; Hackett K; Wilton K; Bowman S; Price E; Pease C; Andrews J; Emery P; Hunter J; Gupta M; Vadivelu S; Giles I; Isenberg D; Lanyon P; Jones A; Regan M; Cooper A; Moots R; Sutcliffe N; Bombardieri M; Pitzalis C; McLaren J; Young-Min S; Dasgupta B; Griffiths B; Lendrem D; Mitchell S; Ng W-F; UK primary Sj\u00f6gren's syndrome registry<\/span> (2012)<\/span> Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome<\/span>. Ann Rheum Dis<\/span>, 71<\/span>, (12)<\/span>, pp. 1973-1979<\/span>. <\/a><\/p>","publicationid":"212058","date":"2012-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coulthard LR; Geiler J; Mathews RJ; Church LD; Dickie LJ; Cooper DL; Wong C; Savic S; Bryer D; Buch MH; Emery P; Morgan AW; McDermott MF<\/span> (2012)<\/span> Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients<\/span>. Clin Exp Immunol<\/span>, 170<\/span>, (1)<\/span>, pp. 36-46<\/span>. <\/a><\/p>","publicationid":"219520","date":"2012-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Strand V; Burmester GR; Ogale S; Devenport J; John A; Emery P<\/span> (2012)<\/span> Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study<\/span>. Rheumatology (Oxford, England)<\/span>, 51<\/span>, (10)<\/span>, pp. 1860-1869<\/span>. <\/a><\/p>","publicationid":"214226","date":"2012-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston JE; Coates LC; Helliwell PS; Hensor EMA; Wakefield RJ; Emery P; Conaghan PG<\/span> (2012)<\/span> Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power doppler ultrasound<\/span>. Arthritis care & research<\/span>, 64<\/span>, (10)<\/span>, pp. 1617-1621<\/span>. <\/a><\/p>","publicationid":"212472","date":"2012-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Conaghan PG; Emery P; Green MJ; Ibrahim G; MacIver H; Helliwell PS<\/span> (2012)<\/span> Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis<\/span>. Arthritis and rheumatism<\/span>, 64<\/span>, (10)<\/span>, pp. 3150-3155<\/span>. <\/a><\/p>","publicationid":"211848","date":"2012-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mackie SL; Taylor JC; Twigg S; Martin SG; Steer S; Worthington J; Barton A; Wilson AG; Hocking L; Young A; Emery P; Barrett JH; Morgan AW<\/span> (2012)<\/span> Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional study<\/span>. Annals of the rheumatic diseases<\/span>, 71<\/span>, (10)<\/span>, pp. 1640-1645<\/span>. <\/a><\/p>","publicationid":"208764","date":"2012-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A<\/span> (2012)<\/span> IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522)<\/span>. Semin Arthritis Rheum<\/span>, 42<\/span>, (2)<\/span>, pp. 131-139<\/span>. <\/a><\/p>","publicationid":"208300","date":"2012-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ash Z; Emery P<\/span> (2012)<\/span> The role of tocilizumab in the management of rheumatoid arthritis<\/span>. Expert opinion on biological therapy<\/span>, 12<\/span>, (9)<\/span>, pp. 1277-1289<\/span>. <\/a><\/p>","publicationid":"215741","date":"2012-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; D'Agostino MA; Naredo E; Buch MH; Iagnocco A; Terslev L; Ostergaard M; Backhaus M; Grassi W; Dougados M; Burmester GR; Saleem B; de Miguel E; Estrach C; Ikeda K; Gutierrez M; Thompson R; Balint P; Emery P<\/span> (2012)<\/span> After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?<\/span> Postgraduate medical journal<\/span>, 88<\/span>, (1042)<\/span>, pp. 482-486<\/span>. <\/a><\/p>","publicationid":"215723","date":"2012-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Churchman SM; Ponchel F; Boxall SA; Cuthbert R; Kouroupis D; Roshdy T; Giannoudis PV; Emery P; McGonagle D; Jones EA<\/span> (2012)<\/span> Transcriptional profile of native CD271+ multipotential stromal cells: evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activity<\/span>. Arthritis and rheumatism<\/span>, 64<\/span>, (8)<\/span>, pp. 2632-2643<\/span>. <\/a><\/p>","publicationid":"207440","date":"2012-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Brown AK; Quinn M; Karim Z; Hensor EMA; Conaghan P; Peterfy C; Wakefield RJ; Emery P<\/span> (2012)<\/span> Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study<\/span>. Annals of the rheumatic diseases<\/span>, 71<\/span>, (8)<\/span>, pp. 1316-1321<\/span>. <\/a><\/p>","publicationid":"181018","date":"2012-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hinks A; Cobb J; Sudman M; Eyre S; Martin P; Flynn E; Packham J; Childhood Arthritis Prospective Study (CAPS); UK RA Genetics (UKRAG) Consortium; British Society of Paediatric and Adolescent Rheumatology (BSPAR) Study Group; Barton A; Worthington J; Langefeld CD; Glass DN; Thompson SD; Thomson W<\/span> (2012)<\/span> Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap<\/span>. Ann Rheum Dis<\/span>, 71<\/span>, (7)<\/span>, pp. 1117-1121<\/span>. <\/a><\/p>","publicationid":"215327","date":"2012-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hodgson RJ; Menon N; Grainger AJ; O'Connor PJ; McGonagle D; Helliwell P; Emery P; Robson MD<\/span> (2012)<\/span> Quantitative MRI measurements of the Achilles tendon in spondyloarthritis using ultrashort echo times<\/span>. The British journal of radiology<\/span>, 85<\/span>, (1015)<\/span>, pp. e293-e299<\/span>. <\/a><\/p>","publicationid":"214211","date":"2012-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2012)<\/span> Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment<\/span>. Rheumatology (Oxford, England)<\/span>, 51 Suppl 5<\/span>, (SUPPL.5)<\/span>, pp. v22-v30<\/span>. <\/a><\/p>","publicationid":"214208","date":"2012-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gore M; Sadosky AB; Leslie DL; Tai K-S; Emery P<\/span> (2012)<\/span> Therapy switching, augmentation, and discontinuation in patients with osteoarthritis and chronic low back pain<\/span>. Pain practice : the official journal of World Institute of Pain<\/span>, 12<\/span>, (6)<\/span>, pp. 457-468<\/span>. <\/a><\/p>","publicationid":"166032","date":"2012-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Cohen SB; Emery P; Kremer JM; Dougados M; Loveless JE; Chung C; Wong P; Lehane PB; Tyrrell H<\/span> (2012)<\/span> AB0526\u2005Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 668<\/span>. <\/a><\/p>","publicationid":"1103622","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann R; Hsia EC; Xu S; Xu W; Baker D<\/span> (2012)<\/span> AB0485\u2005Golimumab's efficacy in patients with very active disease in methotrexate-na\u00cfve rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 665<\/span>. <\/a><\/p>","publicationid":"1103612","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Das S; Bryer D; Emery P; Buch MH<\/span> (2012)<\/span> AB0573\u2005Tocilizumab use in a diverse patient population: Single-centre tertiary experience<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 671<\/span>. <\/a><\/p>","publicationid":"1103601","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gottenberg J-E; Mpofu C; Bensen W; Rubbert-Roth A; Irazoque F; Mart\u00ednez Taboada V; Chung C; Hinsch-Gylvin L; Ferri C; Emery P<\/span> (2012)<\/span> AB0541\u2005Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 669<\/span>. <\/a><\/p>","publicationid":"1103585","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Keystone E; Fleischmann R; Genovese M; Klareskog L; Xu S; Han C; Hsia EC<\/span> (2012)<\/span> AB0486\u2005New, provisional american college of rheumatology and european league against rheumatism remission criteria: Results from 2 randomized, controlled golimumab trials in patients with rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 665<\/span>. <\/a><\/p>","publicationid":"1103542","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh A; Emery P; van Vollenhoven R; Cifaldi M; Shaw J; Chen N; Smolen J<\/span> (2012)<\/span> AB0450\u2005Effect of adalimumab discontinuation on patient-reported outcomes and work productivity in early rheumatoid arthritis patients who achieved low disease activity following 26 weeks of treatment: Data from the optima study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 663<\/span>. <\/a><\/p>","publicationid":"1103516","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Das S; Vital E; Dass S; Buch MH; Rawstron AC; Emery P<\/span> (2012)<\/span> AB0527\u2005Prediction of improving responses on repeat cycles of rituximab using B cell biomarkers<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 668<\/span>. <\/a><\/p>","publicationid":"737886","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital E; Rawstron AC; Arumugakani G; McGonagle D; Emery P<\/span> (2012)<\/span> AB0042\u2005Associations of plasmablasts with disease activity and therapies for rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 640<\/span>. <\/a><\/p>","publicationid":"737882","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mackie SL; Taylor JC; Twigg S; Martin SG; Steer S; Worthington J; Barton A; Wilson AG; Hocking LJ; Young A; Emery P; Barrett JH; Morgan AW<\/span> (2012)<\/span> AB0180\u2005Relationship between area level socio-economic deprivation and autoantibody status in rheumatoid arthritis patients: Multicentre cross-sectional study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 647<\/span>. <\/a><\/p>","publicationid":"691862","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Battellino M; Mathews RJ; Churchman SM; Wong C; Hintze J; Cook GP; Sarzi-Puttini P; Emery P; McDermott MF<\/span> (2012)<\/span> AB0066\u2005Expression of NLRP3-inflammasome-related transcripts in peripheral blood of rheumatoid arthritis patients treated with infliximab<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 641<\/span>. <\/a><\/p>","publicationid":"511218","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Cohen SB; Emery P; Kremer JM; Dougados M; Loveless JE; Chung C; Wong P; Lehane PB; Tyrrell H<\/span> (2012)<\/span> FRI0183\u2005Sustained inhibition of structural damage in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors prior to rituximab treatment: 5-year data from the reflex study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 374<\/span>. <\/a><\/p>","publicationid":"286071","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Taylor LH; Twigg S; Worthington JJ; Emery P; Morgan AW; Wilson AG; Teare MD<\/span> (2012)<\/span> THU0008\u2005Meta-analysis of the association of smoking and PTPN22 R620W genotype on autoantibody status and radiological erosions in rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 156<\/span>. <\/a><\/p>","publicationid":"286070","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh AF; Emery P; van Vollenhoven R; Cifaldi MA; Shaw JW; Chen N; Smolen JS<\/span> (2012)<\/span> FRI0153\u2005Comparisons of work productivity and patient-reported outcomes through 78 weeks among optima study arms 2, 4, and 5<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 362-363<\/span>. <\/a><\/p>","publicationid":"286069","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gabay C; Emery P; van Vollenhoven R; Dikranian A; Alten R; Klearman M; Musselman D; Agarwal S; Green J; Kavanaugh A<\/span> (2012)<\/span> LB0003\u2005Tocilizumab (TCZ) monotherapy is superior to adalimumab (ADA) monotherapy in reducing disease activity in patients with rheumatoid arthritis (RA): 24-week data from the phase 4 adacta trial<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 152<\/span>. <\/a><\/p>","publicationid":"286068","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tarn J; Mitchell S; Bowman S; Price E; Pease C; Sutcliffe N; Emery P; Andrews J; Bombardieri M; Pitzalis C; Lanyon P; Hunter J; Gupta M; Regan M; Cooper A; Giles I; Isenberg D; Young D; Lendrem D; McLaren J; Downie C; Foggo H; Stocks P; Edgar S; Ng W-F<\/span> (2012)<\/span> SAT0166\u2005Serum cytokine and chemokine profiling in primary sj\u00f6gren's syndrome<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 527-528<\/span>. <\/a><\/p>","publicationid":"286066","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ng W-F; Mitchell S; Lendrem D; Bowman S; Price E; Pease C; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; Hunter J; Gupta M; McLaren J; Regan M; Cooper A; Giles I; Isenberg D; Vadivelu S; Coady D; Griffiths B<\/span> (2012)<\/span> SAT0242\u2005How good are the eular sj\u00f6gren's syndrome disease activity index (ESSDAI), and EULAR sj\u00f6gren's syndrome patients reported index (ESSPRI) in predicting health status in primary sj\u00f6gren's syndrome?<\/span> Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 553-554<\/span>. <\/a><\/p>","publicationid":"286065","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Das S; Horton S; Vital E; Bryer D; Emery P; Buch M<\/span> (2012)<\/span> THU0089\u2005Response to abatacept and tocilizumab in patients who had failed rituximab\u2013 initial single centre experience<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 183<\/span>. <\/a><\/p>","publicationid":"286064","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gottenberg J-E; Sarzi-Puttini P; Moots RJ; Choquette D; Finckh A; \u00d6st\u00f6r A; Andrianakos A; Barile-Fabris L; Desjuzeur M-L; Hinsch-Gylvin L; Chung C; Mpofu C<\/span> (2012)<\/span> FRI0200\u2005Relative effectiveness of rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis and an inadequate response to a single previous TNF inhibitor: Results from switch-RA, a global, comparative-effectiveness, observational study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 381<\/span>. <\/a><\/p>","publicationid":"286063","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Westhovens R; Dougados M; Alten R; Gaillez C; Poncet C; Le Bars M; Elegbe A; Genant H<\/span> (2012)<\/span> FRI0199\u2005In patients with established RA, abatacept efficacy is independent of baseline annual radiographic progression rate<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 380-381<\/span>. <\/a><\/p>","publicationid":"286062","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Das S; Fernandez Matilla M; Dass S; Vital E; Emery P<\/span> (2012)<\/span> THU0123\u2005Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 196<\/span>. <\/a><\/p>","publicationid":"286061","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burmester G; Emery P; Signorovitch J; Williams D; Valdes J; Bao Y; Mulani PM<\/span> (2012)<\/span> FRI0145\u2005The effect of adalimumab on risk of major adverse cardiovascular events in rheumatoid arthritis: A meta-analysis of randomized trials<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 359-360<\/span>. <\/a><\/p>","publicationid":"286060","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Heldmann F; Listing J; Schett G; Appelboom T; Brandt J; van den Bosch F; Breban M; Burmester G; Dougados M; Emery P; Gaston H; Gruenke M; van der Horst-Bruinsma I; Landew\u00e9 R; Leirisalo-Repo M; Sieper J; de Vlam K; Braun J<\/span> (2012)<\/span> THU0262\u2005Sclerostin does not predict radiographic progression in patients on anti-tnf therapy \u2013 new results from the european ankylosing spondylitis (AS) infliximab cohort (EASIC)<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 243<\/span>. <\/a><\/p>","publicationid":"286059","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh A; Fleischmann R; Emery P; van Vollenhoven R; Florentinus S; Shaw JW; Santra S; Kupper H; Redden L; Smolen J<\/span> (2012)<\/span> SAT0122\u2005Efficacy of addition, or continuation, of adalimumab in patients who did not achieve stable low disease activity with methotrexate or adalimumab plus methotrexate in the optima study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 511-512<\/span>. <\/a><\/p>","publicationid":"286058","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Heldmann F; Baraliakos X; Brandt J; van der Horst-Bruinsma I; Landew\u00e9 R; Sieper J; Burmester GR; van den Bosch F; de Vlam K; Gaston H; Gr\u00fcnke M; Appelboom T; Emery P; Dougados M; Leirisalo-Repo M; Breban M; Braun J<\/span> (2012)<\/span> THU0270\u2005European ankylosing spondylitis (AS) infliximab cohort (EASIC) long-term extension: Efficacy and safety of infliximab over a time period of more than 7 years in patients with AS<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 246<\/span>. <\/a><\/p>","publicationid":"286057","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Fleischmann R; van Vollenhoven R; Florentinus S; Santra S; Kupper H; Kavanaugh A<\/span> (2012)<\/span> SAT0134\u2005Biologic free disease control (BFDC) in early RA: Predictors of successful withdrawal of adalimumab (ADA) after achieving stable low disease activity with ada plus methotrexate (MTX) \u2013 data from the optima study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 516<\/span>. <\/a><\/p>","publicationid":"286056","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Ferraccioli G; Samborski W; Berenbaum F; Davies O; Koetse W; Bennett B; Burkhardt H<\/span> (2012)<\/span> FRI0150\u2005Maintenance of remission in rheumatoid arthritis patients with low-moderate disease activity following withdrawal of certolizumab PEGOL treatment: Week 52 results from the certain study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 361-362<\/span>. <\/a><\/p>","publicationid":"286055","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Smolen JS; Fleischmann R; van Vollenhoven R; Florentinus S; Santra S; Kupper H; Redden L; Kavanaugh A<\/span> (2012)<\/span> FRI0171\u2005Achieving long-term comprehensive disease control with adalimumab and methotrexate in patients with early rheumatoid arthritis in the optima study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 369-370<\/span>. <\/a><\/p>","publicationid":"286053","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Hermes H; Esteves F; Gillespie J; Chang HY; Jimenez SA; Emery P; Del Galdo F<\/span> (2012)<\/span> SAT0022\u2005Palmoplantar specific long NCRNA hotair drives myofibroblasts specific signature in systemic sclerosis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 478<\/span>. <\/a><\/p>","publicationid":"286052","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ng W-F; Lendrem D; Mitchell S; Bowman S; Price E; Pease C; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; Hunter J; Gupta M; McLaren J; Regan M; Cooper A; Giles I; Isenberg D; Vadivelu S; Coady D; Griffiths B<\/span> (2012)<\/span> FRI0448\u2005Evaluating health status of 620 patients with primary sj\u00d6gren's syndrome using EQ-5D<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 466<\/span>. <\/a><\/p>","publicationid":"286051","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Heldmann F; Callhoff J; Listing J; Appelboom T; Brandt J; van den Bosch F; Breban M; Burmester G; Dougados M; Emery P; Pappas D; Gaston H; Sieper J; de Vlam K; Braun J<\/span> (2012)<\/span> OP0172\u2005Inflammation and fatty degeneration are of similar importance for new bone formation in patients with ankylosing spondylitis treated with infliximab or other anti-TNF agents over 5 years<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 113<\/span>. <\/a><\/p>","publicationid":"286050","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone E; Fleischmann R; Furst DE; Tyson N; Mehbob A; Lehane PB<\/span> (2012)<\/span> THU0120\u2005Long-term safety of rituximab: 10-year follow-up in the rheumatoid arthritis global clinical trial programme<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 195<\/span>. <\/a><\/p>","publicationid":"286049","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Haavardsholm EA; Gandjbakhch F; Conaghan P; Ejbjerg BJ; Foltz V; Brown A; D\u00f8hn UM; Lassere M; Freeston J; B\u00f8yesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; H\u00f8rslev-Petersen K; Olsen IC; \u00d8stergaard M<\/span> (2012)<\/span> OP0274\u2005Towards imaging remission: Determining a MRI inflammatory activity acceptable state in rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 149<\/span>. <\/a><\/p>","publicationid":"286037","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Aydin S; Castillo-Gallego C; Woods D; Meekings A; McGonagle D; Emery P; Del Galdo F<\/span> (2012)<\/span> OP0228\u2005Optical coherence tomography validation: A new quantitative imaging biomarker for affected skin in scleroderma<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 133<\/span>. <\/a><\/p>","publicationid":"285983","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dickie LJ; Aziz AM; Savic S; Emery P; McGonagle D; McDermott MF<\/span> (2012)<\/span> OP0256\u2005Involvement of unfolded protein response and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor- associated periodic syndrome (TRAPS)<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 142-143<\/span>. <\/a><\/p>","publicationid":"285981","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Villeneuve E; Hodgson R; Grainger AJ; Das S; Bissell L-A; Wakefield RJ; McGonagle DG; Conaghan PG; Emery P<\/span> (2012)<\/span> SAT0095\u2005MRI findings are prevalent in ACPA positive patients with musculoskeletal symptoms<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 502<\/span>. <\/a><\/p>","publicationid":"285979","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Freeston JE; Rakieh C; Middleton E; Tan AL; Pickles D; Ward J; Horton S; Das S; Wakefield R; Emery P<\/span> (2012)<\/span> THU0114\u2005Abatacept as an effective treatment in the management of poor prognosis ACPA negative undifferentiated arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 193<\/span>. <\/a><\/p>","publicationid":"285953","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Castillo-Gallego C; Green MJ; Aydin S; Nizam S; Emery P; Marzo-Ortega H<\/span> (2012)<\/span> FRI0275\u2005Long term follow up of an early oligoarthritis cohort shows that early aggressive intervention leads to drug free remission after 10 years: Results from the loto study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 407<\/span>. <\/a><\/p>","publicationid":"285927","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Ash ZR; Tinazzi I; Castillo-Gallego C; Kwok C; Wilson C; Goodfield M; Gisondi P; Tan AL; Marzo-Ortega H; Emery P; Wakefield R; McGonagle D<\/span> (2012)<\/span> SAT0313\u2005The link between enthesitis and arthritis in psoriatic arthritis: A switch to a vascular phenotype at insertions may play a role in arthritis development<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 578<\/span>. <\/a><\/p>","publicationid":"285926","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Castillo-Gallego C; Aydin S; Emery P; McGonagle D; Marzo-Ortega H<\/span> (2012)<\/span> SAT0289\u2005Mri assessment of spinal involvement in psoriatic arthritis: Extent of disease relates to HLA-B27<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 569<\/span>. <\/a><\/p>","publicationid":"285924","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan MD; Twigg S; Hensor EMA; Conaghan PG; Worthington J; Emery P; Barrett JH; Morgan AW<\/span> (2012)<\/span> THU0016\u2005Investigation of RA genetic susceptibility loci contribution to response outcomes following conventional DMARD treatment in early RA<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 159<\/span>. <\/a><\/p>","publicationid":"285901","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan MD; Twigg S; Conaghan PG; Hensor EMA; Worthington J; van der Heijde D; Emery P; Barrett JH; Morgan AW<\/span> (2012)<\/span> SAT0005\u2005RA genetic susceptibility loci are associated with baseline radiographic joint damage in early RA<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 472<\/span>. <\/a><\/p>","publicationid":"285900","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bissell L-A; Mackie SL; Kozera L; Nam J; Burska A; Hensor EM; Keen H; Villeneuve E; Donica H; Conaghan P; Andrews J; Emery P; Morgan AW<\/span> (2012)<\/span> FRI0119\u2005Improvement in some, but not all, surrogate measures of cardiovascular disease following intensive treatment of early rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 350<\/span>. <\/a><\/p>","publicationid":"285899","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Twigg S; Pickles D; Hensor E; Freeston JE; Tan AL; Wakefield RJ; Emery P; Buch MH; Consortium Y<\/span> (2012)<\/span> FRI0130\u2005Change in disease outcomes after implementation of treat to target, including evaluation of power doppler ultrasound remission<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 354<\/span>. <\/a><\/p>","publicationid":"285898","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Villeneuve E; Hensor EMA; Conaghan PG; Keen HI; Gough AK; Green MJ; Helliwell P; Keenan A-M; Morgan AW; Quinn M; Reece R; van der Heijde DM; Wakefield RJ; Emery P<\/span> (2012)<\/span> OP0156\u2005Inhibition of structural damage with two intensive treatment strategies using infliximab or high dose intravenous steroid followed by treat to target in DMARD na\u00cfve rheumatoid arthritis (the idea study) \u2013 a preliminary report<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, pp. 106-107<\/span>. <\/a><\/p>","publicationid":"285835","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Han C; Keystone E; Fleischmann R; Smolen JS; Emery P; Genovese M; Doyle M; Hsia E<\/span> (2012)<\/span> PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism: Analysis Based on Patient Reported Outcomes from 3 Phase III Clinical Trials of Golimumab<\/span>. Value in Health<\/span>, 15<\/span>, (4)<\/span>, pp. A43<\/span>. <\/a><\/p>","publicationid":"213491","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mercer LK; Green AC; Galloway JB; Davies R; Lunt M; Dixon WG; Watson KD; British Society for Rheumatology Biologics Register Control Centre Consortium; Symmons DPM; Hyrich KL; British Society for Rheumatology Biologics Register<\/span> (2012)<\/span> The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register<\/span>. Ann Rheum Dis<\/span>, 71<\/span>, (6)<\/span>, pp. 869-874<\/span>. <\/a><\/p>","publicationid":"212514","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Kvien TK; Combe B; Freundlich B; Robertson D; Ferdousi T; Bananis E; Pedersen R; Koenig AS<\/span> (2012)<\/span> Combination etanercept and methotrexate provides better disease control in very early (\u22644 months) versus early rheumatoid arthritis (>4 months and <2 years): Post hoc analyses from the COMET study<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, (6)<\/span>, pp. 989-992<\/span>. <\/a><\/p>","publicationid":"212513","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; D'Agostino MA; Naredo E; Buch MH; Iagnocco A; Terslev L; Ostergaard M; Backhaus M; Grassi W; Dougados M; Burmester GR; Saleem B; de Miguel E; Estrach C; Ikeda K; Gutierrez M; Thompson R; Balint P; Emery P<\/span> (2012)<\/span> After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?<\/span> Annals of the rheumatic diseases<\/span>, 71<\/span>, (6)<\/span>, pp. 799-803<\/span>. <\/a><\/p>","publicationid":"212510","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Dass S; Emery P<\/span> (2012)<\/span> Concomitant cyclophosphamide and oral immunosuppressants with rituximab for systemic lupus erythematosus<\/span>. Rheumatology (Oxford, England)<\/span>, 51<\/span>, (6)<\/span>, pp. 1131-1132<\/span>. <\/a><\/p>","publicationid":"209282","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Kvien TK; Combe B; Freundlich B; Robertson D; Ferdousi T; Bananis E; Pedersen R; Koenig AS<\/span> (2012)<\/span> Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study<\/span>. Annals of the rheumatic diseases<\/span>, 71<\/span>, (6)<\/span>, pp. 989-992<\/span>. <\/a><\/p>","publicationid":"207827","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; Marzo-Ortega H; Tan AL; Hensor EMA; Green M; Emery P; McGonagle D<\/span> (2012)<\/span> Ten-year follow-up of SpA-related oligoarthritis involving the knee: the presence of psoriasis but not HLA-B27 or baseline MRI bone oedema predicts outcome<\/span>. Rheumatology (Oxford, England)<\/span>, 51<\/span>, (6)<\/span>, pp. 1099-1106<\/span>. <\/a><\/p>","publicationid":"183162","date":"2012-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Harris C; Remedios D; Aptowitzer T; Keat A; Hamilton L; Guile G; Belkhiri A; Newman D; Toms A; Macgregor A; Gaffney K; Morton L; Jones GT; MacDonald AG; Downham C; Macfarlane GJ; Tillett W; Jadon D; Wallis D; Costa L; Waldron N; Griffith N; Cavill C; Korendowych E; de Vries C; McHugh N; Iaremenko O; Fedkov D; Emery P; Baeten D; Sieper J; Braun J; van der Heijde D; McInnes I; Van Laar J; Landewe R; Wordsworth BP; Wollenhaupt J; Kellner H; Paramarta I; Bertolino A; Wright AM; Hueber W; Sofat N; Smee C; Hermansson M; Wajed J; Sanyal K; Kiely P; Howard M; Howe FA; Barrick TR; Abraham AM; Pearce MS; Mann KD; Francis RM; Birrell F; Carr A; Macleod I; Ng W-F; Kavanaugh A; van der Heijde D; Chattopadhyay C; Gladman D; Mease P; McInnes I; Krueger G; Xu W; Goldstein N; Beutler A; Van Laar J; Baraliakos X; Braun J; Laurent DD; Baeten D; van der Heijde D; Sieper J; Emery P; McInnes I; Landewe R; Wordsworth BP; Wollenhaupt J; Kellner H; Wright AM; Gsteiger S; Hueber W; Conaghan PG; Peterfy CG; DiCarlo J; Olech E; Alberts AR; Alper JA; Devenport J; Anisfeld AM; Troum OM; Cooper P; Gimpel M; Deakin G; Jameson K; Godtschailk M; Gadola S; Stokes M; Cooper C; Gordon C; Kalunian K; Petri M; Strand V; Kilgallen B; Barry A; Wallace D; Flurey CA; Morris M; Pollock J; Hughes R; Richards P; Hewlett S<\/span> (2012)<\/span> Oral abstracts 1: Spondyloarthropathies * O1. Detecting axial spondyloarthritis amongst primary care back pain referrals<\/span>. Rheumatology<\/span>, 51<\/span>, (suppl 3)<\/span>, pp. iii19-iii26<\/span>. <\/a><\/p>","publicationid":"1103584","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Williams D; Khamashta M; Ostensen M; Nelson-Piercy C; Emery P; Parmar M; Barton A; Clinch J; Silman AJ; Grahame R; Hakim A; Lemmey A; Hurkmans E; Knittle K; Vlieland TV; Manning V; Frith J; Bearne L; Macfarlane GJ; MacGregor A; Silman AJ; Dixon W; Maffulli N; Hughes C; Bull A; Longo UG; Maffulli N; Diamond B; Isenberg D; Isaacs J; Denton CP; Rahman A; Hill J; Foster NE; Hewlett S; Sanderson T; Conaghan P<\/span> (2012)<\/span> Reproductive issues in rheumatology: do you know how to advise your patients? * I1. Is pregnancy a stress test for subsequent development of autoimmunity?<\/span> Rheumatology<\/span>, 51<\/span>, (suppl 3)<\/span>, pp. iii1-iii6<\/span>. <\/a><\/p>","publicationid":"1103574","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Heathfield S; Parker B; Zeef L; Bruce I; Alexander Y; Collins F; Stone M; Wang E; Williams AS; Wright HL; Thomas HB; Moots RJ; Edwards SW; Bullock C; Chapman V; Walsh DA; Mobasheri A; Kendall D; Kelly S; Bayley R; Buckley CD; Young SP; Rump-Goodrich L; Middleton J; Chen L; Fisher R; Kollnberger S; Shastri N; Kessler BM; Bowness P; Nazeer Moideen A; Evans L; Osgood L; Williams AS; Jones SA; Nowell MA; Mahadik Y; Young S; Morgan M; Gordon C; Harper L; Giles JL; Paul Morgan B; Harris CL; Rysnik OJ; McHugh K; Kollnberger S; Payeli S; Marroquin O; Shaw J; Renner C; Bowness P; Nayar S; Cloake T; Bombardieri M; Pitzalis C; Buckley C; Barone F; Barone F; Nayar S; Cloake T; Lane P; Coles M; Buckley C; Williams EL; Edwards CJ; Cooper C; Oreffo RO; Dunn S; Crawford A; Wilkinson M; Le Maitre C; Bunning R; Daniels J; Phillips KLE; Chiverton N; Le Maitre CL; Kollnberger S; Shaw J; Ridley A; Wong-Baeza I; McHugh K; Keidel S; Chan A; Bowness P; Gullick NJ; Abozaid HS; Jayaraj DM; Evans HG; Scott DL; Choy EH; Taams LS; Hickling M; Golor G; Jullion A; Shaw S; Kretsos K; Bari SF; Rhys-Dillon B; Amos N; Siebert S; Phillips KLE; Chiverton N; Bunning RD; Haddock G; Cross AK; Le Maitre CL; Kate I; Phillips E; Cross A; Chiverton N; Haddock G; Bunning RAD; Le Maitre CL; Ceeraz S; Spencer J; Choy E; Corrigall V; Crilly A; Palmer H; Lockhart J; Plevin R; Ferrell WR; McInnes I; Hutchinson D; Perry L; DiCicco M; Humby F; Kelly S; Hands R; Buckley C; McInnes I; Taylor P; Bombardieri M; Pitzalis C; Mehta P; Mitchell A; Tysoe C; Caswell R; Owens M; Vincent T; Hashmi TM; Price-Forbes A; Sharp CA; Murphy H; Wood EF; Doherty T; Sheldon J; Sofat N; Goff I; Platt PN; Abdulkader R; Clunie G; Ismajli M; Nikiphorou E; Young A; Tugnet N; Dixey J; Banik S; Alcorn D; Hunter J; Win Maw W; Patil P; Hayes F; Main Wong W; Borg FA; Dasgupta B; Malaviya AP; Ostor AJ; Chana JK; Ahmed AA; Edmonds S; Hayes F; Coward L; Borg F; Heaney J; Amft N; Simpson J; Dhillon V; Ayalew Y; Khattak F; Gayed M; Amarasena RI; McKenna F; Amarasena RI; McKenna F; Mc Laughlin M; Baburaj K; Fattah Z; Ng N; Wilson J; Colaco B; Williams MR; Adizie T; Dasgupta B; Casey M; Lip S; Tan S; Anderson D; Robertson C; Devanny I; Field M; Walker D; Robinson S; Ryan S; Hassell A; Bateman J; Allen M; Davies D; Crouch C; Walker-Bone K; Gainsborough N; Gullick NJ; Lutalo PM; Davies UM; Walker-Bone K; Mckew JR; Millar AM; Wright SA; Bell AL; Thapper M; Roussou T; Cumming J; Hull RG; Thapper M; Roussou T; McKeogh J; O'Connor MB; Hassan AI; Bond U; Swan J; Phelan MJ; Coady D; Kumar N; Farrow L; Bukhari M; Oldroyd AG; Greenbank C; McBeth J; Duncan R; Brown D; Horan M; Pendleton N; Littlewood A; Cordingley L; Mulvey M; Curtis EM; Cole ZA; Crozier SR; Georgia N; Robinson SM; Godfrey KM; Sayer AA; Inskip HM; Cooper C; Harvey NC; Davies R; Mercer L; Galloway J; Low A; Watson K; Lunt M; Symmons D; Hyrich K; Chitale S; Estrach C; Moots RJ; Goodson NJ; Rankin E; Jiang CQ; Cheng KK; Lam TH; Adab P; Ling S; Chitale S; Moots RJ; Estrach C; Goodson NJ; Humphreys J; Ellis C; Bunn D; Verstappen SM; Symmons D; Fluess E; Macfarlane GJ; Bond C; Jones GT; Scott IC; Steer S; Lewis CM; Cope A; Mulvey MR; Macfarlane GJ; Symmons D; Lovell K; Keeley P; Woby S; Beasley M; McBeth J; Viatte S; Plant D; Lunt M; Fu B; Parker B; Galloway J; Solymossy C; Worthington J; Symmons D; Dixey J; Young A; Barton A; Williams FM; Osei-Bordom D-C; Popham M; MacGregor A; Spector T; Little J; Herrick A; Pushpakom S; Ennis H; McBurney H; Worthington J; Newman W; Ibrahim I; Plant D; Hyrich K; Morgan A; Wilson A; Isaacs J; Barton A; Sanderson T; Hewlett S; Calnan M; Morris M; Raza K; Kumar K; Cardy CM; Pauling JD; Jenkins J; Brown SJ; McHugh N; Nikiphorou E; Mugford M; Davies C; Cooper N; Brooksby A; Bunn D; Symmons D; MacGregor A; Dures E; Ambler N; Fletcher D; Pope D; Robinson F; Rooke R; Hewlett S; Gorman CL; Reynolds P; Hakim AJ; Bosworth A; Weaver D; Kiely PD; Skeoch S; Jani M; Amarasena R; Rao C; Macphie E; McLoughlin Y; Shah P; Else S; Semenova O; Thompson H; Ogunbambi O; Kallankara S; Patel Y; Baguley E; Jani M; Halsey J; Severn A; Bukhari M; Selvan S; Price E; Husain MJ; Brophy S; Phillips CJ; Cooksey R; Irvine E; Siebert S; Lendrem D; Mitchell S; Bowman S; Price E; Pease CT; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; Hunter J; Gupta M; McLaren J; Regan M; Cooper A; Giles I; Isenberg D; Griffiths B; Foggo H; Edgar S; Vadivelu S; Coady D; McHugh N; Ng W-F; Dasgupta B; Taylor P; Iqbal I; Heron L; Pilling C; Marks J; Hull R; Ledingham J; Han C; Gathany T; Tandon N; Hsia E; Taylor P; Strand V; Sensky T; Harta N; Fleming S; Kay L; Rutherford M; Nicholl K; Kay L; Rutherford M; Nicholl K; Eyre T; Wilson G; Johnson P; Russell M; Timoshanko J; Duncan G; Spandley A; Roskell S; Coady D; West L; Adshead R; Donnelly SP; Ashton S; Tahir H; Patel D; Darroch J; Goodson NJ; Boulton J; Ellis B; Finlay R; Lendrem D; Mitchell S; Bowman S; Price E; Pease CT; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; Hunter J; Gupta M; McLaren J; Regan M; Cooper A; Giles I; Isenberg D; Vadivelu S; Coady D; McHugh N; Griffiths B; Foggo H; Edgar S; Ng W-F; Murray-Brown W; Priori R; Tappuni T; Vartoukian S; Seoudi N; Picarelli G; Fortune F; Valesini G; Pitzalis C; Bombardieri M; Ball E; Rooney M; Bell A; Merida AA; Isenberg D; Tarelli E; Axford J; Giles I; Pericleous C; Pierangeli SS; Ioannou J; Rahman A; Alavi A; Hughes M; Evans B; Bukhari M; Parker B; Zaki A; Alexander Y; Bruce I; Hui M; Garner R; Rees F; Bavakunji R; Daniel P; Varughese S; Srikanth A; Andres M; Pearce F; Leung J; Lim K; Regan M; Lanyon P; Oomatia A; Petri M; Fang H; Birnbaum J; Amissah-Arthur M; Gayed M; Stewart K; Jennens H; Braude S; Gordon C; Sutton EJ; Watson KD; Gordon C; Yee C-S; Lanyon P; Jayne D; Isenberg D; Rahman A; Akil M; McHugh N; Ahmad Y; Amft N; D'Cruz D; Edwards CJ; Griffiths B; Khamashta M; Teh L-S; Zoma A; Bruce I; Dey ID; Kenu E; Isenberg D; Pericleous C; Garza-Garcia A; Murfitt L; Driscoll PC; Isenberg D; Pierangeli S; Giles I; Ioannou Y; Rahman A; Reynolds JA; Ray DW; O'Neill T; Alexander Y; Bruce I; Segeda I; Shevchuk S; Kuvikova I; Brown N; Bruce I; Venning M; Mehta P; Dhanjal M; Mason J; Nelson-Piercy C; Basu N; Paudyal P; Stockton M; Lawton S; Dent C; Kindness K; Meldrum G; John E; Arthur C; West L; Macfarlane MV; Reid DM; Jones GT; Macfarlane GJ; Yates M; Loke Y; Watts R; MacGregor A; Adizie T; Christidis D; Dasgupta B; Williams M; Sivakumar R; Misra R; Danda D; Mahendranath KM; Bacon PA; Mackie SL; Pease CT<\/span> (2012)<\/span> Basic science * 232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function<\/span>. Rheumatology<\/span>, 51<\/span>, (suppl 3)<\/span>, pp. iii140-iii184<\/span>. <\/a><\/p>","publicationid":"1103506","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Campbell R; Hofmann D; Hatch S; Gordon P; Lempp H; Das L; Blumbergs P; Limaye V; Vermaak E; McHugh N; Edwards MH; Jameson K; Sayer AA; Dennison E; Cooper C; Salvador FB; Huertas C; Isenberg D; Jackson EJ; Middleton A; Churchill D; Walker-Bone K; Worsley PR; Mottram S; Warner M; Morrissey D; Gadola S; Carr A; Cooper C; Stokes M; Srivastava RN; Sanghi D; Srivastava RN; Sanghi D; Elbaz A; Mor A; Segal G; Drexler M; Norman D; Peled E; Rozen N; Goryachev Y; Debbi EM; Haim A; Rozen N; Wolf A; Debi R; Mor A; Segal G; Debbi EM; Cohen MS; Igolnikov I; Bar Ziv Y; Benkovich V; Bernfeld B; Rozen N; Elbaz A; Collins J; Moots RJ; Clegg PD; Milner PI; Ejtehadi HD; Nelson PN; Wenham C; Balamoody S; Hodgson R; Conaghan P; Wilkie R; Blagojevic M; Jordan KP; Mcbeth J; Peffers MJ; Beynon RJ; Thornton DJ; Clegg PD; Chapman R; Chapman V; Walsh D; Kelly S; Hui M; Zhang W; Doherty S; Rees F; Muir K; Maciewicz R; Doherty M; Snelling S; Davidson RK; Swingler T; Price A; Clark I; Stockley E; Hathway G; Faas H; Auer D; Chapman V; Hirsch G; Hale E; Kitas G; Klocke R; Abraham A; Pearce MS; Mann KD; Francis RM; Birrell F; Tucker M; Mellon SJ; Jones L; Price AJ; Dieppe PA; Gill HS; Ashraf S; Chapman V; Walsh DA; McCollum D; McCabe C; Grieve S; Shipley J; Gorodkin R; Oldroyd AG; Evans B; Greenbank C; Bukhari M; Rajak R; Bennett C; Williams A; Martin JC; Abdulkader R; MacNicol C; Brixey K; Stephenson S; Clunie G; Andrews RN; Oldroyd AG; Evans B; Greenbank C; Bukhari M; Clark EM; Gould VC; Carter L; Morrison L; Tobias JH; Pye SR; Vanderschueren D; O'Neill TW; Lee DM; Jans I; Billen J; Gielen E; Laurent M; Claessens F; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi I; Kula K; Lean ME; Pendleton N; Punab M; Wu FC; Boonen S; Mercieca C; Webb J; Shipley J; Bhalla A; Fairbanks S; Moss KE; Collins C; Sedgwick P; Clark EM; Gould VC; Morrison L; Tobias JH; Parker J; Greenbank C; Evans B; Oldroyd AG; Bukhari M; Harvey NC; Cole ZA; Crozier SR; Ntani G; Mahon PA; Robinson SM; Inskip HM; Godfrey KM; Dennison EM; Cooper C; Bridges M; Ruddick S; Holroyd CR; Mahon P; Crozier SR; Godfrey K; Inskip HM; Cooper C; Harvey NC; Bridges M; Ruddick S; McNeilly T; McNally C; Beringer T; Finch M; Coda A; Davidson J; Walsh J; Fowlie P; Carline T; Santos D; Patil P; Rawcliffe C; Olaleye A; Moore S; Fox A; Sen D; Ioannou Y; Nisar S; Rankin K; Birch M; Finnegan S; Rooney M; Gibson DS; Malviya A; Ferris CM; Rushton SP; Foster HE; Hanson H; Muthumayandi K; Deehan DJ; Birt L; Poland F; MacGregor A; Armon K; Pfeil M; McErlane F; Beresford MW; Baildam EM; Thomson W; Hyrich K; Chieng A; Davidson J; Foster HE; Gardner-Medwin J; Lunt M; Wedderburn L; Gibson DS; Finnegan S; Newell K; Evans A; Manning G; Scaife C; McAllister C; Pennington SR; Duncan M; Moore T; Rooney M; Pericleous C; Croca SC; Giles I; Alber K; Yong H; Isenberg D; Midgely A; Beresford MW; Rahman A; Ioannou Y; Rzewuska M; Mallen C; Strauss VY; Belcher J; Peat G; Byng-Maddick R; Wijendra M; Penn H; Roddy E; Muller S; Hayward R; Mallen C; Kamlow F; Pakozdi A; Jawad A; Green DJ; Muller S; Mallen C; Hider SL; Singh Bawa S; Bawa S; Turton A; Palmer M; Grieve S; Lewis J; Moss T; McCabe C; Goodchild CE; Tang N; Scott D; Salkovskis P; Selvan S; Williamson L; Selvan S; Williamson L; Thalayasingam N; Higgins M; Saravanan V; Rynne M; Hamilton JD; Heycock C; Kelly C; Norton S; Sacker A; Done J; Young A; Smolen JS; Fleischmann RM; Emery P; van Vollenhoven RF; Guerette B; Santra S; Kupper H; Redden L; Kavanaugh A; Keystone EC; van der Heijde D; Weinblatt ME; Mozaffarian N; Guerette B; Kupper H; Liu S; Kavanaugh A; Zhang N; Wilkinson S; Riaz M; Ostor AJ; Nisar MK; Burmester G; Mariette X; Navarro-Blasco F; Oezer U; Kary S; Unnebrink K; Kupper H; Jobanputra P; Maggs F; Deeming A; Carruthers D; Rankin E; Jordan A; Faizal A; Goddard C; Pugh M; Bowman S; Brailsford S; Nightingale P; Tugnet N; Cooper SC; Douglas KM; Edwin Lim CS; Bee Lian Low S; Joy C; Hill L; Davies P; Mukherjee S; Cornell P; Westlake SL; Richards S; Rahmeh F; Thompson PW; Breedveld F; Keystone E; van der Heijde D; Landewe R; Smolen JS; Guerette B; McIlraith M; Kupper H; Liu S; Kavanaugh A; Byng-Maddick R; Penn H; Abdulkader R; Dharmapalaiah C; Shand L; Rose G; Clunie G; Watts R; Eldashan A; Dasgupta B; Borg FA; Bell GM; Anderson AE; Harry RA; Stoop JN; Hilkens CM; Isaacs J; Dickinson A; McColl E; Banik S; Smith L; France J; Bawa S; Rutherford A; Scott Russell A; Smith J; Jassim I; Withrington R; Bacon P; De Lord D; McGregor L; Morrison I; Stirling A; Porter DR; Saunders SA; Else S; Semenova O; Thompson H; Ogunbambi O; Kallankara S; Baguley E; Patel Y; Alzabin S; Abraham S; Taher TE; Palfeeman A; Hull D; McNamee K; Jawad A; Pathan E; Kinderlerer A; Taylor P; Williams RO; Mageed RA; Iaremenko O; Mikitenko G; Ferrari M; Kamalati T; Pitzalis C; Tugnet N; Pearce F; Tosounidou S; Obrenovic K; Erb N; Packham J; Sandhu R; White C; Cardy CM; Justice E; Frank M; Li L; Lloyd M; Ahmed A; Readhead S; Ala A; Fittall M; Manson J; Ioannou Y; Sibilia J; Marc Flipo R; Combe B; Gaillez C; Le Bars M; Poncet C; Elegbe A; Westhovens R; Hassanzadeh R; Mangan C; France J; Bawa S; Weinblatt ME; Fleischmann R; van Vollenhoven R; Emery P; Huizinga TWJ; Goldermann R; Duncan B; Timoshanko J; Luijtens K; Davies O; Dougados M; Hewitt J; Owlia M; Dougados M; Gaillez C; Le Bars M; Poncet C; Elegbe A; Schiff M; Alten R; Kaine JL; Keystone E; Nash PT; Delaet I; Qi K; Genovese MC; Clark J; Kardash S; Wong E; Hull R; McCrae F; Shaban R; Thomas L; Young-Min S; Ledingham J; Genovese MC; Covarrubias Cobos A; Leon G; Mysler EF; Keiserman MW; Valente RM; Nash PT; Abraham Simon Campos J; Porawska W; Box JH; Legerton CW; Nasonov EL; Durez P; Pappu R; Delaet I; Teng J; Alten R; Edwards CJ; Arden N; Campbell J; van Staa T; Housden C; Sargeant I; Edwards CJ; Arden N; Campbell J; van Staa T; Housden C; Sargeant I; Choy E; McAuliffe S; Roberts K; Sargeant I; Emery P; Sarzi-Puttini P; Moots RJ; Andrianakos A; Sheeran TP; Choquette D; Finckh A; Desjuzeur M-L; Gemmen EK; Mpofu C; Gottenberg J-E; Bukhari M; Shah P; Kitas G; Cox M; Nye A; O'Brien A; Jones P; Sargeant I; Jones GT; Paudyal P; MacPherson H; Sim J; Doherty M; Ernst E; Fisken M; Lewith G; Tadman J; Macfarlane GJ; Mariette X; Bertin P; Arendt C; Terpstra I; VanLunen B; de Longueville M; Zhou H; Cai A; Lacy E; Kay J; Keystone E; Matteson E; Hu C; Hsia E; Doyle M; Rahman M; Shealy D; Scott DL; Ibrahim F; Abozaid H; Choy E; Hassell A; Plant M; Richards S; Walker D; Simpson G; Kowalczyk A; Prouse P; Brown A; George M; Kumar N; Mackay K; Marshall S; Nash PT; Ludivico CL; Delaet I; Qi K; Murthy B; Corbo M; Kaine JL; Emery P; Smolen JS; Samborski W; Berenbaum F; Davies O; Ambrugeat J; Bennett B; Burkhardt H; Prouse P; Brown A; George M; Kumar N; Mackay K; Marshall S; Bykerk V; Ostor AJ; Roman Ivorra J; Wollenhaupt J; Stancati A; Bernasconi C; Sibilia J; Scott DGI; Claydon P; Ellis C; Buchan S; Pope J; Fleischmann R; Dougados M; Bingham CO; Massarotti EM; Wollenhaupt J; Duncan B; Coteur G; Weinblatt M; Hull D; Ball C; Abraham S; Ainsworth T; Kermik J; Woodham J; Haq I; Quesada-Masachs E; Carolina Diaz A; Avila G; Acosta I; Sans X; Alegre C; Marsal S; McWilliams D; Kiely PD; Young A; Walsh DA; Fleischmann R; Bolce R; Wang J; Ingham M; Dehoratius R; Decktor D; Rao V; Pavlov A; Klearman M; Musselman D; Giles J; Bathon J; Sattar N; Lee J; Baxter D; McLaren JS; Gordon M-M; Thant KZ; Williams EL; Earl S; White P; Williams J; Westlake SL; Ledingham J; Jan AK; Bhatti AI; Stafford C; Carolan M; Ramakrishnan SA<\/span> (2012)<\/span> Muscle disorders * 111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study<\/span>. Rheumatology<\/span>, 51<\/span>, (suppl 3)<\/span>, pp. iii93-iii139<\/span>. <\/a><\/p>","publicationid":"1103481","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McErlane F; Beresford MW; Baildam EM; Thomson W; Hyrich K; Chieng A; Davidson J; Foster HE; Gardner-Medwin J; Lunt M; Wedderburn L; Nikiphorou E; Carpenter L; Kiely P; Walsh D; Dixey J; Young A; Kapoor SR; Filer A; Fitzpatrick M; Fisher BA; Taylor PC; Buckley C; McInnes I; Raza K; Young SP; Dougados M; Kissel K; Amital H; Conaghan P; Martin-Mola E; Nasonov E; Schett G; Troum O; Veldi T; Bernasconi C; Huizinga T; Durez P; Genovese MC; Richards HB; Supronik J; Dokoupilova E; Aelion JA; Lee S-H; Codding CE; Kellner H; Ikawa T; Hugot S; Ligozio G; Mpofu S; Kavanaugh A; Emery P; Fleischmann R; Van Vollenhoven R; Pavelka K; Durez P; Guerette B; Santra S; Redden L; Kupper H; Smolen JS; Wilkie R; Tajar A; McBeth J; Hooper LS; Bowen CJ; Gates L; Culliford D; Edwards CJ; Arden NK; Adams J; Ryan S; Haywood H; Pain H; Siddle HJ; Redmond AC; Waxman R; Dagg AR; Alcacer-Pitarch B; Wilkins RA; Helliwell PS; Norton S; Kiely P; Walsh D; Williams R; Young A; Halls S; Law R-J; Jones J; Markland D; Maddison P; Thom J; Parker B; Urowitz MB; Gladman DD; Bruce I; Croca SC; Pericleous C; Yong H; Isenberg D; Giles I; Rahman A; Ioannou Y; Warrell CE; Dobarro D; Handler C; Denton CP; Schreiber BE; Coghlan JG; Betteridge ZE; Woodhead F; Bunn C; Denton CP; Abraham D; Desai S; du Bois R; Wells A; McHugh N; Abignano G; Aydin S; Castillo-Gallego C; Woods D; Meekings A; McGonagle D; Emery P; Del Galdo F; Vila J; Mitchell S; Bowman S; Price E; Pease CT; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; Hunter J; Gupta M; McLaren J; Regan M; Cooper A; Giles I; Isenberg D; Vadivelu S; Coady D; Griffiths B; Lendrem D; Foggo H; Tarn J; Ng W-F; Goodhead C; Shekar P; Kelly C; Francis G; Bailey A-M; Thompson L; Hamilton J; Salisbury C; Foster NE; Bishop A; Coast J; Franchini A; Hall J; Hollinghurst S; Hopper C; Grove S; Kaur S; Montgomery A; Paskins Z; Sanders T; Croft PR; Hassell AB; Coxon DE; Frisher M; Jordan KP; Jinks C; Peat G; Monk HL; Muller S; Mallen C; Hider SL; Roddy E; Muller S; Hayward R; Mallen C<\/span> (2012)<\/span> Oral abstracts 3: RA Treatment and outcomes * O13. Validation of jadas in all subtypes of juvenile idiopathic arthritis in a clinical setting<\/span>. Rheumatology<\/span>, 51<\/span>, (suppl 3)<\/span>, pp. iii27-iii38<\/span>. <\/a><\/p>","publicationid":"662043","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Go\u00ebb V; Walsh CAE; Reece RJ; Emery P; Ponchel F<\/span> (2012)<\/span> Potential role of arthroscopy in the management of inflammatory arthritis<\/span>. Clinical and experimental rheumatology<\/span>, 30<\/span>, (3)<\/span>, pp. 429-435<\/span>.<\/p>","publicationid":"213965","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Buch MH<\/span> (2012)<\/span> Towards an optimum strategy in rheumatoid arthritis<\/span>. Lancet (London, England)<\/span>, 379<\/span>, (9827)<\/span>, pp. 1682-1684<\/span>. <\/a><\/p>","publicationid":"212065","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gerlag DM; Raza K; van Baarsen LGM; Brouwer E; Buckley CD; Burmester GR; Gabay C; Catrina AI; Cope AP; Cornelis F; Dahlqvist SR; Emery P; Eyre S; Finckh A; Gay S; Hazes JM; van der Helm-van Mil A; Huizinga TWJ; Klareskog L; Kvien TK; Lewis C; Machold KP; R\u00f6nnelid J; van Schaardenburg D; Schett G; Smolen JS; Thomas S; Worthington J; Tak PP<\/span> (2012)<\/span> EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis<\/span>. Ann Rheum Dis<\/span>, 71<\/span>, (5)<\/span>, pp. 638-641<\/span>. <\/a><\/p>","publicationid":"210319","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gerlag DM; Raza K; van Baarsen LGM; Brouwer E; Buckley CD; Burmester GR; Gabay C; Catrina AI; Cope AP; Cornelis F; Dahlqvist SR; Emery P; Eyre S; Finckh A; Gay S; Hazes JM; van der Helm-van Mil A; Huizinga TWJ; Klareskog L; Kvien TK; Lewis C; Machold KP; R\u00f6nnelid J; van Schaardenburg D; Schett G; Smolen JS; Thomas S; Worthington J; Tak PP<\/span> (2012)<\/span> EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 71<\/span>, (5)<\/span>, pp. 638-641<\/span>. <\/a><\/p>","publicationid":"208308","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zayat AS; Freeston JE; Conaghan PG; Hensor EMA; Emery P; Wakefield RJ<\/span> (2012)<\/span> Does joint position affect US findings in inflammatory arthritis?<\/span> Rheumatology (Oxford, England)<\/span>, 51<\/span>, (5)<\/span>, pp. 921-925<\/span>. <\/a><\/p>","publicationid":"166521","date":"2012-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Theakston K; de Vries J<\/span> (2012)<\/span> Introduction<\/span>. Journal of Clinical Rheumatology\n<\/span>, 11<\/span>, (3 Suppl)<\/span>, pp. S37-38<\/span>. <\/a><\/p>","publicationid":"117069","date":"2012-04-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Keystone EC; Braun J; Breedveld FC; Burmester GR; De Benedetti F; D\u00f6rner T; Emery P; Fleischmann R; Gibofsky A; Kalden JR; Kavanaugh A; Kirkham B; Mease P; Sieper J; Singer NG; Smolen JS; Van Riel PLCM; Weisman MH; Winthrop K<\/span> (2012)<\/span> Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011<\/span>. Ann Rheum Dis<\/span>, 71 Suppl 2<\/span>, pp. i2-45<\/span>. <\/a><\/p>","publicationid":"211205","date":"2012-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kotyla PJ; Owczarek A; Rakoczy J; Lewicki M; Kucharz EJ; Emery P<\/span> (2012)<\/span> Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide<\/span>. The Journal of rheumatology<\/span>, 39<\/span>, (4)<\/span>, pp. 701-706<\/span>. <\/a><\/p>","publicationid":"184321","date":"2012-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Robinson JI; Carr IM; Cooper DL; Rashid LH; Martin SG; Emery P; Isaacs JD; Barton A; BRAGGSS; Wilson AG; Barrett JH; Morgan AW<\/span> (2012)<\/span> Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis<\/span>. Human mutation<\/span>, 33<\/span>, (4)<\/span>, pp. 741-749<\/span>. <\/a> <\/a><\/p>","publicationid":"180937","date":"2012-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ash ZR; Tinazzi I; Gallego CC; Kwok C; Wilson C; Goodfield M; Gisondi P; Tan AL; Marzo-Ortega H; Emery P; Wakefield RJ; McGonagle DG; Aydin SZ<\/span> (2012)<\/span> Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails<\/span>. Annals of the rheumatic diseases<\/span>, 71<\/span>, (4)<\/span>, pp. 553-556<\/span>. <\/a><\/p>","publicationid":"164589","date":"2012-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

D\u00edaz-Lagares C; Croca S; Sangle S; Vital EM; Catapano F; Mart\u00ednez-Berriotxoa A; Garc\u00eda-Hern\u00e1ndez F; Callejas-Rubio J-L; Rasc\u00f3n J; D'Cruz D; Jayne D; Ruiz-Irastorza G; Emery P; Isenberg D; Ramos-Casals M; Khamashta MA; UK-BIOGEAS Registry<\/span> (2012)<\/span> Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts<\/span>. Autoimmun Rev<\/span>, 11<\/span>, (5)<\/span>, pp. 357-364<\/span>. <\/a><\/p>","publicationid":"206021","date":"2012-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ash Z; Gaujoux-Viala C; Gossec L; Hensor EMA; FitzGerald O; Winthrop K; van der Heijde D; Emery P; Smolen JS; Marzo-Ortega H<\/span> (2012)<\/span> A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis<\/span>. Annals of the rheumatic diseases<\/span>, 71<\/span>, (3)<\/span>, pp. 319-326<\/span>. <\/a><\/p>","publicationid":"146529","date":"2012-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Elhai M; Guerini H; Bazeli R; Avouac J; Freire V; Drape J-L; Kahan A; Allanore Y; Abignano G; Cuomo G; Buch M; Rosenberg WM; Valentini G; Emery P; Del Galdo F; Martin P; Teodoro WR; Velosa AP; Carrasco S; de Morais J; Christmann RB; Parras ER; Capelozzi VL; Yoshinari NH; Cuomo G; Zappia M; Iudici M; Abignao G; Valentini G<\/span> (2012)<\/span> S.7.1 Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biological and radiographic findings<\/span>. Rheumatology<\/span>, 51<\/span>, (suppl 2)<\/span>, pp. ii14-ii15<\/span>. <\/a><\/p>","publicationid":"702985","date":"2012-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hommes D; Colombel J-F; Emery P; Greco M; Sandborn WJ<\/span> (2012)<\/span> Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life<\/span>. J Crohns Colitis<\/span>, 6 Suppl 2<\/span>, (SUPPL.2)<\/span>, pp. S224-S234<\/span>. <\/a><\/p>","publicationid":"208954","date":"2012-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alcacer-Pitarch B; Buch MH; Gray J; Denton CP; Herrick A; Navarro-Coy N; Collier H; Loughrey L; Pavitt S; Siddle HJ; Wright J; Helliwell PS; Emery P; Redmond AC<\/span> (2012)<\/span> Pressure and pain in systemic sclerosis\/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol<\/span>. BMC musculoskeletal disorders<\/span>, 13<\/span>, (1)<\/span>, pp. 11<\/span>. <\/a> <\/a><\/p>","publicationid":"181591","date":"2012-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton S; Walsh C; Emery P<\/span> (2012)<\/span> Certolizumab pegol for the treatment of rheumatoid arthritis<\/span>. Expert opinion on biological therapy<\/span>, 12<\/span>, (2)<\/span>, pp. 235-249<\/span>. <\/a><\/p>","publicationid":"164600","date":"2012-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gillespie J; Savic S; Wong C; Hempshall A; Inman M; Emery P; Grigg R; McDermott MF<\/span> (2012)<\/span> Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients<\/span>. Arthritis and rheumatism<\/span>, 64<\/span>, (2)<\/span>, pp. 418-422<\/span>. <\/a><\/p>","publicationid":"152257","date":"2012-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mackie SL; Taylor JC; Martin SG; YEAR Consortium; UKRAG Consortium; Wordsworth P; Steer S; Wilson AG; Worthington J; Emery P; Barrett JH; Morgan AW<\/span> (2012)<\/span> A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population<\/span>. Genes and immunity<\/span>, 13<\/span>, (2)<\/span>, pp. 120-128<\/span>. <\/a><\/p>","publicationid":"148968","date":"2012-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zhang W; Sun H; Emery P; Sato R; Singh A; Freundlich B; Anis AH<\/span> (2012)<\/span> Does achieving clinical response prevent work stoppage or work absence among employed patients with early rheumatoid arthritis?<\/span> Rheumatology (Oxford, England)<\/span>, 51<\/span>, (2)<\/span>, pp. 270-274<\/span>. <\/a><\/p>","publicationid":"143780","date":"2012-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Covic T; Cumming SR; Pallant JF; Manolios N; Emery P; Conaghan PG; Tennant A<\/span> (2012)<\/span> Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS)<\/span>. BMC Psychiatry<\/span>, 12<\/span>, (1)<\/span>, pp. 6<\/span>. <\/a><\/p>","publicationid":"207487","date":"2012-01-24","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery<\/span> (2012)<\/span> The Effects of Golimumab on Radiographic Progression in Rheumatoid Arthritis Results of Randomized Controlled Studies of Golimumab Before Methotrexate Therapy and Golimumab After Methotrexate Therapy (vol 63, pg 1200, 2011)<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, 64<\/span>, (4)<\/span>, pp. 1045<\/span>. <\/a><\/p>","publicationid":"829470","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Castillo-Gallego C; Ash ZR; Marzo-Ortega H; Emery P; Wakefield RJ; Wittmann M; McGonagle D<\/span> (2012)<\/span> Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy<\/span>. Dermatology<\/span>, 225<\/span>, (3)<\/span>, pp. 231-235<\/span>. <\/a><\/p>","publicationid":"250926","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Baeten D; Sieper J; Braun J; van der Heijde D; McInnes I; van Laar J; Landewe R; Wordsworth P; Wollenhaupt J; Kellner H; Paramarta J; Bertolino A; Gsteiger S; Wright A; Hueber W<\/span> (2012)<\/span> SECUKINUMAB SIGNIFICANTLY IMPROVES ASAS20 RESPONSES VERSUS PLACEBO IN MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS PATIENTS<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 30<\/span>, (4)<\/span>, pp. 609<\/span>.<\/p>","publicationid":"223382","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Braun J; Laurent DD; Baeten D; van der Heijde D; Sieper J; Emery P; McInnes I; van Laar J; Landewe R; Wordsworth P; Wollenhaupt J; Kellner H; Wright AM; Gsteiger S; Hueber W<\/span> (2012)<\/span> SECUKINUMAB REDUCES SPINAL INFLAMMATION AS EARLY AS WEEK 6, AS DETECTED BY MRI - RESULTS OF A DOUBLE-BLIND, PHASE II PROOF-OF-CONCEPT STUDY IN PATIENTS WITH ANKYLOSING SPONDYLITIS<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 30<\/span>, (4)<\/span>, pp. 632<\/span>.<\/p>","publicationid":"223381","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Castillo-Gallego C; Ash ZR; Abignano G; Emery P; Marzo-Ortega H; Wakefield RJ; Del Galdo F; McGonagle D<\/span> (2012)<\/span> SUPERIORITY OF OPTICAL COHERENCE TOMOGRAPHY OVER ULTRASOUND FOR THE ASSESSMENT OF NAIL DISEASE IN PSORIASIS AND PSORIATIC ARTHRITIS<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 30<\/span>, (4)<\/span>, pp. 630<\/span>.<\/p>","publicationid":"223378","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McInnes I; Sieper J; Braun J; Emery P; van der Heijde D; Isaacs J; Dahmen G; Wollenhaupt J; Schulze-Koops H; Gsteiger S; Bertolino AP; Hueber W; Tak PP<\/span> (2012)<\/span> SECUKINUMAB IMPROVES SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS: A 24-WEEK, DOUBLE-BLIND, TRIAL<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 30<\/span>, (4)<\/span>, pp. 619<\/span>.<\/p>","publicationid":"223377","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Heldmann F; Listing P; Schett G; van Verde M; Appelboom T; Brandt J; van den Bosch F; Breban M; Burmester G; Dougados M; Emery P; Gaston H; Gruenke M; van der Horst-Bruinsma I; van Tubergen A; Leirisalo-Repo M; Sieper J; de Vlam K; Braun J<\/span> (2012)<\/span> SCLEROSTIN DOES NOT PREDICT RADIOGRAPHIC PROGRESSION IN PATIENTS ON ANTI-TNF THERAPY - NEW RESULTS FROM THE EUROPEAN ANKYLOSING SPONDYLITIS (AS) INFLIXIMAB COHORT (EASIC)<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 30<\/span>, (4)<\/span>, pp. 628-629<\/span>.<\/p>","publicationid":"223366","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Baraliakos X; Heldmann F; Listing J; Appelboom T; Brandt J; van den Bosch F; Breban M; Burmester G; Dougados M; Emery P; Gaston H; Gruenke M; van der Horst-Bruinsma I; Landewe R; Leirisalo-Repo M; Sieper J; de Vlam K; Braun J<\/span> (2012)<\/span> INFLAMMATION AND FATTY DEGENERATION ARE OF SIMILAR IMPORTANCE FOR NEW BONE FORMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH INFLIXIMAB OR OTHER ANTI-TNF AGENTS OVER 5 YEARS<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 30<\/span>, (4)<\/span>, pp. 628<\/span>.<\/p>","publicationid":"223364","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Castillo-Gallego C; Aydin SZ; Emery P; McGonagle D; Marzo-Ortega H<\/span> (2012)<\/span> MRI ASSESSMENT OF SPINAL INVOLVEMENT IN PSA: EXTENT OF DISEASE RELATES TO HLA-B27<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 30<\/span>, (4)<\/span>, pp. 630<\/span>.<\/p>","publicationid":"223357","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gore M; Sadosky AB; Leslie DL; Tai KS; Emery P<\/span> (2012)<\/span> Therapy Switching, Augmentation, and Discontinuation in Patients with Osteoarthritis and Chronic Low Back Pain<\/span>. Pain Practice<\/span>, 12<\/span>, (6)<\/span>, pp. 457-468<\/span>. <\/a><\/p>","publicationid":"215382","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Emery P<\/span> (2012)<\/span> Biological therapy for rheumatoid arthritis: where are we now?<\/span> Br J Hosp Med (Lond)<\/span>, 73<\/span>, (1)<\/span>, pp. 12-18<\/span>. <\/a><\/p>","publicationid":"206661","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gossec L; Smolen JS; Gaujoux-Viala C; Ash Z; Marzo-Ortega H; van der Heijde D; FitzGerald O; Aletaha D; Balint P; Boumpas D; Braun J; Breedveld FC; Burmester G; Ca\u00f1ete JD; de Wit M; Dagfinrud H; de Vlam K; Dougados M; Helliwell P; Kavanaugh A; Kvien TK; Landew\u00e9 R; Luger T; Maccarone M; McGonagle D; McHugh N; McInnes IB; Ritchlin C; Sieper J; Tak PP; Valesini G; Vencovsky J; Winthrop KL; Zink A; Emery P; European League Against Rheumatism<\/span> (2012)<\/span> European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies<\/span>. Ann Rheum Dis<\/span>, 71<\/span>, (1)<\/span>, pp. 4-12<\/span>. <\/a> <\/a><\/p>","publicationid":"166522","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Conaghan PG; Fleischmann R; van der Heijde D; Keystone EC; Genovese MC; Hsia EC; Xu W; Beutler A; Baratelle A; Rahman MU<\/span> (2012)<\/span> Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al Reply<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, 64<\/span>, (4)<\/span>, pp. 1298-1299<\/span>. <\/a><\/p>","publicationid":"166035","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cooper DL; Martin SG; Robinson JI; Mackie SL; Charles CJ; Nam J; YEAR Consortium; Isaacs JD; Emery P; Morgan AW<\/span> (2012)<\/span> Fc\u03b3RIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy<\/span>. PLoS One<\/span>, 7<\/span>, (1)<\/span>, pp. e28918<\/span>. <\/a><\/p>","publicationid":"165752","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Churchman SM; Geiler J; Parmar R; Horner EA; Church LD; Emery P; Buch MH; McDermott MF; Ponchel F<\/span> (2012)<\/span> Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor<\/span>. Clin Exp Rheumatol<\/span>, 30<\/span>, (4)<\/span>, pp. 534-542<\/span>.<\/p>","publicationid":"165720","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Maksymowych WP; Bennett AN; McGonagle D; Emery P; Marzo-Ortega H<\/span> (2012)<\/span> Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years<\/span>. Annals of the rheumatic diseases<\/span>, 71<\/span>, (1)<\/span>, pp. 56-60<\/span>. <\/a><\/p>","publicationid":"159015","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bejarano V; Hensor E; Green M; Haugeberg G; Brown AK; Buch MH; Emery P; Conaghan PG<\/span> (2012)<\/span> Relationship between early bone mineral density changes and long-term function and radiographic progression in rheumatoid arthritis<\/span>. Arthritis care & research<\/span>, 64<\/span>, (1)<\/span>, pp. 66-70<\/span>. <\/a><\/p>","publicationid":"144854","date":"2012-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Emery P<\/span> (2011)<\/span> Remission in inflammatory arthritis: Past, present, and future<\/span>. International Journal of Advances in Rheumatology<\/span>, 9<\/span>, (3)<\/span>, pp. 77-83<\/span>.<\/p>","publicationid":"215592","date":"2011-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P<\/span> (2011)<\/span> Infliximab: 12 years of experience<\/span>. Arthritis Research & Therapy<\/span>, 13<\/span>, (S1)<\/span>. <\/a><\/p>","publicationid":"204621","date":"2011-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

\u00d8stergaard M; Emery P; Conaghan PG; Fleischmann R; Hsia EC; Xu W; Rahman MU<\/span> (2011)<\/span> Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients<\/span>. Arthritis Rheum<\/span>, 63<\/span>, (12)<\/span>, pp. 3712-3722<\/span>. <\/a><\/p>","publicationid":"165250","date":"2011-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; D\u00f6rner T<\/span> (2011)<\/span> Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response<\/span>. Annals of the rheumatic diseases<\/span>, 70<\/span>, (12)<\/span>, pp. 2063-2070<\/span>. <\/a><\/p>","publicationid":"155734","date":"2011-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Mease PJ; Rubbert-Roth A; Curtis JR; M\u00fcller-Ladner U; Gaylis NB; Williams S; Reynard M; Tyrrell H<\/span> (2011)<\/span> Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis<\/span>. Rheumatology (Oxford, England)<\/span>, 50<\/span>, (12)<\/span>, pp. 2223-2232<\/span>. <\/a><\/p>","publicationid":"151571","date":"2011-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; van der Heijde D; Ostergaard M; Conaghan PG; Genovese MC; Keystone EC; Fleischmann R; Hsia EC; Xu W; Xu S; Rahman MU<\/span> (2011)<\/span> Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis<\/span>. Annals of the rheumatic diseases<\/span>, 70<\/span>, (12)<\/span>, pp. 2126-2130<\/span>. <\/a><\/p>","publicationid":"151491","date":"2011-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keen HI; Redmond A; Wakefield RJ; Freeston J; Grainger AJ; Hensor EMA; Emery P; Conaghan PG<\/span> (2011)<\/span> An ultrasonographic study of metatarsophalangeal joint pain: synovitis, structural pathology and their relationship to symptoms and function<\/span>. Annals of the rheumatic diseases<\/span>, 70<\/span>, (12)<\/span>, pp. 2140-2143<\/span>. <\/a><\/p>","publicationid":"148545","date":"2011-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alcacer-Pitarch B; Siddle HJ; Buch MH; Emery P; Hashmi F; Redmond AC<\/span> (2011)<\/span> Foot health needs in people with systemic sclerosis: an audit of foot health care provision<\/span>. Clinical rheumatology<\/span>, 30<\/span>, (12)<\/span>, pp. 1611-1615<\/span>. <\/a> <\/a><\/p>","publicationid":"142461","date":"2011-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Dougados M; Tak PP; Kavanaugh A; Choy E; Rubbert-Roth A<\/span> (2011)<\/span> Treat to target - Tailoring therapy in rheumatoid arthritis<\/span>. European Musculoskeletal Review<\/span>, 6<\/span>, (4)<\/span>, pp. 211-217<\/span>.<\/p>","publicationid":"222161","date":"2011-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Emery P; Ostergaard M; Keystone EC; Genovese MC; Hsia EC; Xu WC; Rahman MU<\/span> (2011)<\/span> Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial<\/span>. ANN RHEUM DIS<\/span>, 70<\/span>, (11)<\/span>, pp. 1968-1974<\/span>. <\/a><\/p>","publicationid":"208114","date":"2011-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Haraoui B; Smolen JS; Aletaha D; Breedveld FC; Burmester G; Codreanu C; Da Silva JP; de Wit M; Dougados M; Durez P; Emery P; Fonseca JE; Gibofsky A; Gomez-Reino J; Graninger W; Hamuryudan V; Jannaut Pe\u00f1a MJ; Kalden J; Kvien TK; Laurindo I; Martin-Mola E; Montecucco C; Santos Moreno P; Pavelka K; Poor G; Cardiel MH; Stanislawska-Biernat E; Takeuchi T; van der Heijde D; Treat to Target Taskforce<\/span> (2011)<\/span> Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire<\/span>. Ann Rheum Dis<\/span>, 70<\/span>, (11)<\/span>, pp. 1999-2002<\/span>. <\/a><\/p>","publicationid":"155774","date":"2011-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mariette X; Matucci-Cerinic M; Pavelka K; Taylor P; van Vollenhoven R; Heatley R; Walsh C; Lawson R; Reynolds A; Emery P<\/span> (2011)<\/span> Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis<\/span>. Ann Rheum Dis<\/span>, 70<\/span>, (11)<\/span>, pp. 1895-1904<\/span>. <\/a><\/p>","publicationid":"155773","date":"2011-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Das S; Emery P<\/span> (2011)<\/span> Certolizumab pegol in rheumatoid arthritis: a review of Phase III clinical trials and its role in real-life clinical practice<\/span>. International Journal of Clinical Rheumatology<\/span>, 6<\/span>, (5)<\/span>, pp. 517-527<\/span>. <\/a><\/p>","publicationid":"205634","date":"2011-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kremer JM; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Westhovens R; Li T; Zhou X; Becker J-C; Aranda R; Peterfy C; Genant HK<\/span> (2011)<\/span> Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial<\/span>. Ann Rheum Dis<\/span>, 70<\/span>, (10)<\/span>, pp. 1826-1830<\/span>. <\/a><\/p>","publicationid":"151927","date":"2011-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zayat AS; Conaghan PG; Sharif M; Freeston JE; Wenham C; Hensor EMA; Emery P; Wakefield RJ<\/span> (2011)<\/span> Do non-steroidal anti-inflammatory drugs have a significant effect on detection and grading of ultrasound-detected synovitis in patients with rheumatoid arthritis? Results from a randomised study<\/span>. ANN RHEUM DIS<\/span>, 70<\/span>, (10)<\/span>, pp. 1746-1751<\/span>. <\/a><\/p>","publicationid":"146528","date":"2011-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Dass S; Buch MH; Henshaw K; Pease CT; Martin MF; Ponchel F; Rawstron AC; Emery P<\/span> (2011)<\/span> B Cell Biomarkers of Rituximab Responses in Systemic Lupus Erythematosus<\/span>. ARTHRITIS RHEUM-US<\/span>, 63<\/span>, (10)<\/span>, pp. 3038-3047<\/span>. <\/a><\/p>","publicationid":"141819","date":"2011-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Boers M; Abadie EC; Breedveld FC; Emery P; Bardin T; Goel N; Ethgen DJ; Avouac BP; Durez P; Flamion B; Laslop A; Miossec P; Reiter S; Reginster JY; Task Force Grp Respect Ethics & Ex<\/span> (2011)<\/span> Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis<\/span>. RHEUMATOLOGY<\/span>, 50<\/span>, (10)<\/span>, pp. 1732-1736<\/span>. <\/a><\/p>","publicationid":"133306","date":"2011-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gore M; Sadosky A; Leslie D; Tai K-S; Emery P<\/span> (2011)<\/span> T220 THERAPY SWITCHING, AUGMENTATION AND DISCONTINUATION IN PATIENTS WITH CHRONIC LOW BACK PAIN IN THE UNITED KINGDOM<\/span>. European Journal of Pain Supplements<\/span>, 5<\/span>, (S1)<\/span>, pp. 42<\/span>. <\/a><\/p>","publicationid":"1103540","date":"2011-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sadosky A; Bushmakin A; Cappelleri J; Taylor-Stokes G; Sayers J; Carroll D; Gosden T; Emery P<\/span> (2011)<\/span> 446 ASSOCIATION OF PATIENT-REPORTED OSTEOARTHRITIS SEVERITY WITH OTHER PATIENT-REPORTED OUTCOMES IN THE EUROPEAN CLINICAL SETTING<\/span>. Osteoarthritis and Cartilage<\/span>, 19<\/span>, pp. S207<\/span>. <\/a><\/p>","publicationid":"294449","date":"2011-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gore M; Sadosky A; Leslie D; Tai K-S; Emery P<\/span> (2011)<\/span> 497 THERAPY SWITCHING, ADD-ON, AND DISCONTINUATION IN PATIENTS WITH OSTEOARTHRITIS IN THE UNITED KINGDOM<\/span>. Osteoarthritis and Cartilage<\/span>, 19<\/span>, pp. S230<\/span>. <\/a><\/p>","publicationid":"294448","date":"2011-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gandjbakhch F; Conaghan PG; Ejbjerg B; Haavardsholm EA; Foltz V; Brown AK; Dohn UM; Lassere M; Freeston J; Boyesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; Horslev-Petersen K; Kvien TK; McQueen F; Ostergaard M<\/span> (2011)<\/span> Synovitis and Osteitis Are Very Frequent in Rheumatoid Arthritis Clinical Remission: Results from an MRI Study of 294 Patients in Clinical Remission or Low Disease Activity State<\/span>. J RHEUMATOL<\/span>, 38<\/span>, (9)<\/span>, pp. 2039-2044<\/span>. <\/a><\/p>","publicationid":"149293","date":"2011-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; McQueen FM; Bird P; Peterfy CG; Haavardsholm EA; Gandjbakhch F; Boyesen P; Coates L; Ejbjerg B; Eshed I; Foltz V; Hermann KG; Freeston J; Lillegraven S; Lassere M; Wiell C; Anandarajah A; Duer-Jensen A; O'Connor P; Genant HK; Emery P; Ostergaard M<\/span> (2011)<\/span> Update on Research and Future Directions of the OMERACT MRI Inflammatory Arthritis Group<\/span>. J RHEUMATOL<\/span>, 38<\/span>, (9)<\/span>, pp. 2031-2033<\/span>. <\/a><\/p>","publicationid":"149065","date":"2011-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Emery P; Peterfy CG<\/span> (2011)<\/span> Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies (Annals of the Rheumatic Diseases (2009) 68, (216-221))<\/span>. Annals of the Rheumatic Diseases<\/span>, 70<\/span>, (8)<\/span>, pp. 1519<\/span>. <\/a><\/p>","publicationid":"204776","date":"2011-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton SC; Walsh CAE; Emery P<\/span> (2011)<\/span> Established rheumatoid arthritis: rationale for best practice: physicians' perspective of how to realise tight control in clinical practice<\/span>. Best practice & research. Clinical rheumatology<\/span>, 25<\/span>, (4)<\/span>, pp. 509-521<\/span>. <\/a><\/p>","publicationid":"159038","date":"2011-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ndosi M; Lewis M; Hale C; Quinn H; Ryan S; Emery P; Bird H; Hill J<\/span> (2011)<\/span> A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: Study protocol of an ongoing nationwide multi-centre study<\/span>. INT J NURS STUD<\/span>, 48<\/span>, (8)<\/span>, pp. 995-1001<\/span>. <\/a> <\/a><\/p>","publicationid":"135651","date":"2011-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Chaplin S; Hawkins T; Emery P<\/span> (2011)<\/span> NSAIDs for RA, osteoarthritis and ankylosing spondylitis<\/span>. Prescriber<\/span>, 22<\/span>, (12)<\/span>, pp. 26-29<\/span>. <\/a><\/p>","publicationid":"1103523","date":"2011-06-19","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Braun J; van den Berg R; Baraliakos X; Boehm H; Burgos-Vargas R; Collantes-Estevez E; Dagfinrud H; Dijkmans B; Dougados M; Emery P; Geher P; Hammoudeh M; Inman RD; Jongkees M; Khan MA; Kiltz U; Kvien T; Leirisalo-Repo M; Maksymowych WP; Olivieri I; Pavelka K; Sieper J; Stanislawska-Biernat E; Wendling D; Ozgocmen S; van Drogen C; van Royen B; van der Heijde D<\/span> (2011)<\/span> 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis<\/span>. Ann Rheum Dis<\/span>, 70<\/span>, (6)<\/span>, pp. 896-904<\/span>. <\/a><\/p>","publicationid":"141707","date":"2011-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Aletaha D; Emery P; Smolen JS<\/span> (2011)<\/span> Reporting of long-term extension studies: lack of consistency calls for consensus<\/span>. ANN RHEUM DIS<\/span>, 70<\/span>, (6)<\/span>, pp. 886-890<\/span>. <\/a><\/p>","publicationid":"137285","date":"2011-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Smolen JS; Betteridge N; Breedveld FC; Burmester G; Dorner T; Ferraccioli G; Gottenberg JE; Isaacs J; Kvien TK; Mariette X; Martin-Mola E; Pavelka K; Tak PP; van der Heijde D; van Vollenhoven RF; Emery P; Rituximab Consensus Expert Comm<\/span> (2011)<\/span> Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis<\/span>. ANN RHEUM DIS<\/span>, 70<\/span>, (6)<\/span>, pp. 909-920<\/span>. <\/a><\/p>","publicationid":"137284","date":"2011-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hodgson RJ; Grainger AJ; O'Connor PJ; Evans R; Coates L; Marzo-Ortega H; Helliwell P; McGonagle D; Emery P; Robson MD<\/span> (2011)<\/span> Imaging of the Achilles tendon in spondyloarthritis: a comparison of ultrasound and conventional, short and ultrashort echo time MRI with and without intravenous contrast<\/span>. EUR RADIOL<\/span>, 21<\/span>, (6)<\/span>, pp. 1144-1152<\/span>. <\/a><\/p>","publicationid":"132745","date":"2011-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P<\/span> (2011)<\/span> Infliximab: 12 years of experience<\/span>. Arthritis Res Ther<\/span>, 13 Suppl 1<\/span>, (Suppl 1)<\/span>, pp. S2<\/span>. <\/a><\/p>","publicationid":"145086","date":"2011-05-25","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Fleischmann R; Han C; Smolen JS; Emery P; Genovese M; Gathany T; Doyle M; Hsia E<\/span> (2011)<\/span> PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS<\/span>. Value in Health<\/span>, 14<\/span>, (3)<\/span>, pp. A133<\/span>. <\/a><\/p>","publicationid":"184454","date":"2011-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cohen SB; Potter H; Deodhar A; Emery P; Conaghan P; Ostergaard M<\/span> (2011)<\/span> Extremity Magnetic Resonance Imaging in Rheumatoid Arthritis: Updated Literature Review<\/span>. ARTHRIT CARE RES<\/span>, 63<\/span>, (5)<\/span>, pp. 660-665<\/span>. <\/a><\/p>","publicationid":"140127","date":"2011-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hodgson RJ; Evans R; Wright P; Grainger AJ; O'Connor PJ; Helliwell P; McGonagle D; Emery P; Robson MD<\/span> (2011)<\/span> Quantitative magnetization transfer ultrashort echo time imaging of the Achilles tendon<\/span>. Magnetic resonance in medicine<\/span>, 65<\/span>, (5)<\/span>, pp. 1372-1376<\/span>. <\/a><\/p>","publicationid":"139050","date":"2011-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Emery P<\/span> (2011)<\/span> New therapies in the management of rheumatoid arthritis<\/span>. CURR OPIN RHEUMATOL<\/span>, 23<\/span>, (3)<\/span>, pp. 245-251<\/span>. <\/a><\/p>","publicationid":"138039","date":"2011-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann R; van der Heijde D; Keystone EC; Genovese MC; Conaghan PG; Hsia EC; Xu WC; Baratelle A; Beutler A; Rahman MU<\/span> (2011)<\/span> The Effects of Golimumab on Radiographic Progression in Rheumatoid Arthritis Results of Randomized Controlled Studies of Golimumab Before Methotrexate Therapy and Golimumab After Methotrexate Therapy<\/span>. ARTHRITIS RHEUM-US<\/span>, 63<\/span>, (5)<\/span>, pp. 1200-1210<\/span>. <\/a><\/p>","publicationid":"134705","date":"2011-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Wakefield R; Karim Z; Quinn M; Hensor E; Conaghan PG; Emery P<\/span> (2011)<\/span> Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments<\/span>. ANN RHEUM DIS<\/span>, 70<\/span>, (5)<\/span>, pp. 792-798<\/span>. <\/a><\/p>","publicationid":"133305","date":"2011-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hodgson RJ; Evans R; Wright P; Grainger AJ; O'Connor PJ; Helliwell P; McGonagle D; Emery P; Robson MD<\/span> (2011)<\/span> Quantitative Magnetization Transfer Ultrashort Echo Time Imaging of the Achilles Tendon<\/span>. MAGN RESON MED<\/span>, 65<\/span>, (5)<\/span>, pp. 1372-1376<\/span>. <\/a><\/p>","publicationid":"132986","date":"2011-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Castillo-Gallego C; de Miguel Mendieta E; Garcia-Arias M; Plasencia-Rodriguez C; Lojo-Oliveira L; Martin-Mola E; Tillett W; Cavill C; Korendowych E; McHugh N; Coates L; Bhalla AK; Creamer P; Packham J; Hailwood S; Taylor G; Hamilton L; Brooksby A; Leeder J; Gaffney K; Malipeddi AS; Neame R; Francis J; Hassan W; Mease P; Olds M; Kary S; Kupper H; Bell C; Peffers G; Rees F; Lanyon P; Obrenovic K; Sandhu R; Packham J; Erb N; Coates LC; Conaghan P; Emery P; Green M; Ibrahim G; MakIver H; Helliwell P; Giles JL; McHugh K; DiGleria K; Shaw J; Kollnberger S; Maenaka K; Marroquin O; Renner C; Bowness P; Landewe R; Ritchlin C; Olds M; Guerette B; Lavie F; Kavanaugh A; McInnes I; Krueger GG; Gladman D; Zrubek J; Goldstein N; Xu S; Mudivarthy S; Mack M; Prevosto C; McDonald S; De Riva A; Goodman R; Key T; Hill Gaston JS; Deery MJ; Busch R; Fischer R; Wright C; Kessler B; Bowness P; Sheehy C; Jois RN; Leeder J; Kerrigan N; Mills KS; Somerville M; Scott DG; Gaffney K; Kavanaugh A; van der Heijde D; Chattopadhyay C; Gladman D; Mease P; McInnes I; Krueger GG; Xu W; Rahman MU; Zrubek J; Baratelle A; Beutler A; Stober CB; Benham HJ; Goodall JC; Hill Gaston JS; Sanyal K; Walker-Bone K; Coates LC; Conaghan P; Emery P; Green M; Ibrahim G; MakIver H; Helliwell PS; Vastesaeger N; Wang Y; Inman R; Deodhar A; Hsu B; Rahman MU; Dijkmans B; Braun J; Geusens P; Sieper J; van der Heijde D; El Miedany Y; Palmer D; McHugh K; Giles JL; Shaw J; Kollnberger S; Payeli S; Utriainen L; Milling S; Renner C; Bowness P<\/span> (2011)<\/span> Spondylarthropathies (including psoriatic arthritis): 244. Validity of Colour Doppler and Spectral Doppler Ultrasound of Sacroilicac Joints Againts Physical Examination as Gold Standard<\/span>. Rheumatology<\/span>, 50<\/span>, (Supplement 3)<\/span>, pp. iii137-iii145<\/span>. <\/a><\/p>","publicationid":"1103606","date":"2011-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Meek R; Deighton C; Lee J; Remedios D; Watts R; Emery P; Buch M; Moots RJ<\/span> (2011)<\/span> Rheumatologists at training: IP21. Understanding Health Policies, Nice and Guidelines: What every Trainee Needs to Know. A View of Musculoskeletal Health Policy<\/span>. Rheumatology<\/span>, 50<\/span>, (Supplement 3)<\/span>, pp. iii5-iii6<\/span>. <\/a><\/p>","publicationid":"1103581","date":"2011-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Comer C; White D; Conaghan P; Redmond AC; Muller S; Thomas E; Peat G; Backhouse MR; Pickles DA; Mathieson HR; Edgson L; Emery P; Bird H; Helliwell P; Redmond AC; van der Leeden M; Dahmen R; Ursum J; Roorda LD; van Schaardenburg D; Knol DL; Steultjens MP; Dekker J<\/span> (2011)<\/span> Mobility in musculokeletal disease: compromise and compensations: IP76. Why do People with Neurogenic Claudication Like Shopping?<\/span> Rheumatology<\/span>, 50<\/span>, (Supplement 3)<\/span>, pp. iii18-iii19<\/span>. <\/a><\/p>","publicationid":"829459","date":"2011-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Assen S; Elkayam O; Agmon-Levin N; Cervera R; Doran MF; Dougados M; Emery P; Geborek P; Ioannidis JPA; Jayne DRW; Kallenberg CGM; M\u00fcller-Ladner U; Shoenfeld Y; Stojanovich L; Valesini G; Wulffraat NM; Bijl M<\/span> (2011)<\/span> Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases<\/span>. Autoimmun Rev<\/span>, 10<\/span>, (6)<\/span>, pp. 341-352<\/span>. <\/a><\/p>","publicationid":"141452","date":"2011-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Walsh CAE; Emery P<\/span> (2011)<\/span> Remission in inflammatory arthritis: a new immunological target<\/span>. IMMUNOTHERAPY-UK<\/span>, 3<\/span>, (4)<\/span>, pp. 459-463<\/span>. <\/a><\/p>","publicationid":"138501","date":"2011-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2011)<\/span> RHEUMATOID ARTHRITIS International disparities in access to anti-TNF therapy<\/span>. NAT REV RHEUMATOL<\/span>, 7<\/span>, (4)<\/span>, pp. 197-198<\/span>. <\/a><\/p>","publicationid":"138493","date":"2011-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LHD; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landew\u00e9 R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M; American College of Rheumatology; European League Against Rheumatism<\/span> (2011)<\/span> American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials<\/span>. Arthritis Rheum<\/span>, 63<\/span>, (3)<\/span>, pp. 573-586<\/span>. <\/a><\/p>","publicationid":"204170","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Thomson W; Martin SG; Carter AM; Erlich HA; Barton A; Hocking L; Reid DM; Harrison P; Wordsworth P; Steer S; Worthington J; Emery P; Wilson AG; Barrett JH; Yorkshire Early Arthrit Register; UK Rheumatoid Arthrit Genetics<\/span> (2011)<\/span> Reevaluation of the Interaction Between HLA-DRB1 Shared Epitope Alleles, PTPN22, and Smoking in Determining Susceptibility to Autoantibody-Positive and Autoantibody-Negative Rheumatoid Arthritis in a Large UK Caucasian Population (vol 60, pg 2565, 2009)<\/span>. ARTHRITIS RHEUM-US<\/span>, 63<\/span>, (3)<\/span>, pp. 669<\/span>. <\/a><\/p>","publicationid":"144770","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Warren RB; Smith RL; Flynn E; Bowes J; Eyre S; Worthington J; Barton A; Griffiths CEM; UKRAG Consortium<\/span> (2011)<\/span> A systematic investigation of confirmed autoimmune loci in early-onset psoriasis reveals an association with IL2\/IL21<\/span>. BRIT J DERMATOL<\/span>, 164<\/span>, (3)<\/span>, pp. 660-664<\/span>. <\/a><\/p>","publicationid":"144532","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mariette X; Reynolds A; Emery P<\/span> (2011)<\/span> Care needs to be taken when reviewing malignancy data reported from observational studies: comment on the article by Onel and Onel<\/span>. Arthritis Care Res (Hoboken)<\/span>, 63<\/span>, (3)<\/span>, pp. 461-463<\/span>. <\/a><\/p>","publicationid":"138398","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Keystone EC; Braun J; Breedveld FC; Burmester GR; De Benedetti F; D\u00f6rner T; Emery P; Fleischmann R; Gibofsky A; Kalden JR; Kavanaugh A; Kirkham B; Mease P; Sieper J; Singer NG; Smolen JS; Van Riel PLCM; Weisman MH; Winthrop K<\/span> (2011)<\/span> Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010<\/span>. Ann Rheum Dis<\/span>, 70 Suppl 1<\/span>, pp. i2-36<\/span>. <\/a><\/p>","publicationid":"137795","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van de Sande MGH; Gerlag DM; Lodde BM; van Baarsen LGM; Alivernini S; Codullo V; Felea I; Vieira-Sousa E; Fearon U; Reece R; Montecucco C; Veale DJ; Pitzalis C; Emery P; Klareskog L; McInnes IB; Tak PP<\/span> (2011)<\/span> Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials<\/span>. Ann Rheum Dis<\/span>, 70<\/span>, (3)<\/span>, pp. 423-427<\/span>. <\/a><\/p>","publicationid":"137730","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Assen S; Agmon-Levin N; Elkayam O; Cervera R; Doran MF; Dougados M; Emery P; Geborek P; Ioannidis JPA; Jayne DRW; Kallenberg CGM; M\u00fcller-Ladner U; Shoenfeld Y; Stojanovich L; Valesini G; Wulffraat NM; Bijl M<\/span> (2011)<\/span> EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases<\/span>. Ann Rheum Dis<\/span>, 70<\/span>, (3)<\/span>, pp. 414-422<\/span>. <\/a><\/p>","publicationid":"137729","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Orozco G; Eyre S; Hinks A; Bowes J; Morgan AW; Wilson AG; Wordsworth P; Steer S; Hocking L; UKRAG consortium; Thomson W; Worthington J; Barton A<\/span> (2011)<\/span> Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus<\/span>. Ann Rheum Dis<\/span>, 70<\/span>, (3)<\/span>, pp. 463-468<\/span>. <\/a><\/p>","publicationid":"137311","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LHD; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landew\u00e9 R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M<\/span> (2011)<\/span> American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials<\/span>. Ann Rheum Dis<\/span>, 70<\/span>, (3)<\/span>, pp. 404-413<\/span>. <\/a><\/p>","publicationid":"137310","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Rawstron AC; Dass S; Henshaw K; Madden J; Emery P; McGonagle D<\/span> (2011)<\/span> Reduced-Dose Rituximab in Rheumatoid Arthritis Efficacy Depends on Degree of B Cell Depletion<\/span>. ARTHRITIS RHEUM-US<\/span>, 63<\/span>, (3)<\/span>, pp. 603-608<\/span>. <\/a><\/p>","publicationid":"136095","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ash Z; Emery P<\/span> (2011)<\/span> Golimumab - a new tool in the armoury against inflammatory arthritis<\/span>. ANN MED<\/span>, 43<\/span>, (2)<\/span>, pp. 133-141<\/span>. <\/a><\/p>","publicationid":"133310","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Ash ZR; Hodgson RJ; Emery P; Radjenovic A<\/span> (2011)<\/span> MRI for the assessment and monitoring of RA-what can it tell us?<\/span> NAT REV RHEUMATOL<\/span>, 7<\/span>, (3)<\/span>, pp. 185-189<\/span>. <\/a><\/p>","publicationid":"129203","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pountos I; Giannoudis PV; Jones E; English A; Churchman S; Field S; Ponchel F; Bird H; Emery P; McGonagle D<\/span> (2011)<\/span> NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man<\/span>. J CELL MOL MED<\/span>, 15<\/span>, (3)<\/span>, pp. 525-534<\/span>. <\/a><\/p>","publicationid":"72891","date":"2011-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Boers M; Abadie EC; Breedveld FC; Emery P; Bardin T; Goel N; Ethgen DJ; Avouac BP; Dere WH; Durez P; Matucci-Cerinic M; Flamion B; Laslop A; Lekkerkerker FJ; Miossec P; Mitlak BH; Ormarsd\u00f3ttir S; Paolozzi L; Rao R; Reiter S; Tsouderos Y; Reginster J-Y; Group for Respect of Ethics and Excellence in Science (GREES)<\/span> (2011)<\/span> Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA<\/span>. Curr Med Res Opin<\/span>, 27<\/span>, (2)<\/span>, pp. 315-325<\/span>. <\/a><\/p>","publicationid":"137323","date":"2011-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Buch M; Emery P; Del Galdo F<\/span> (2011)<\/span> Biomarkers in the management of scleroderma: an update<\/span>. Current rheumatology reports<\/span>, 13<\/span>, (1)<\/span>, pp. 4-12<\/span>. <\/a><\/p>","publicationid":"129722","date":"2011-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston JE; Garnero P; Wakefield RJ; Hensor EMA; Conaghan PG; Emery P<\/span> (2011)<\/span> Urinary type II collagen C-terminal peptide is associated with synovitis and predicts structural bone loss in very early inflammatory arthritis<\/span>. ANN RHEUM DIS<\/span>, 70<\/span>, (2)<\/span>, pp. 331-333<\/span>. <\/a><\/p>","publicationid":"129689","date":"2011-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ames PRJ; Sokoll KB; MavIver H; Batuca J; Lopez L; Emery P<\/span> (2011)<\/span> Effect of atorvastatin on inflammatory markers, nitric oxide metabolites and carotid intima media thickness in systemic lupus erythematosus. A placebo controlled study<\/span>. JOURNAL OF THROMBOSIS AND HAEMOSTASIS<\/span>, 9<\/span>, pp. 483<\/span>.<\/p>","publicationid":"306642","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Ash Z; Del Galdo F; Marzo-Ortega H; Wakefield RJ; Emery P; McGonagle D<\/span> (2011)<\/span> Optical Coherence Tomography: A New Tool to Assess Nail Disease in Psoriasis?<\/span> DERMATOLOGY<\/span>, 222<\/span>, (4)<\/span>, pp. 311-313<\/span>. <\/a><\/p>","publicationid":"208110","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bushmakin AG; Cappelleri JC; Taylor-Stokes G; Sayers J; Sadosky A; Carroll D; Gosden T; Emery P<\/span> (2011)<\/span> Relationship between patient-reported disease severity and other clinical outcomes in osteoarthritis: a European perspective<\/span>. J Med Econ<\/span>, 14<\/span>, (4)<\/span>, pp. 381-389<\/span>. <\/a><\/p>","publicationid":"204847","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Li T; Wells G; Westhovens R; Emery P; Becker J-C; Tugwell P<\/span> (2011)<\/span> Improvements in participation in usual daily activities in patients with rheumatoid arthritis treated with abatacept<\/span>. Value Health<\/span>, 14<\/span>, (2)<\/span>, pp. 361-370<\/span>. <\/a><\/p>","publicationid":"181007","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Heldmann F; Brandt J; van der Horst-Bruinsma IE; Landewe R; Sieper J; Burmester GR; van den Bosch F; de Vlam K; Geusens P; Gaston H; Schewe S; Appelboom T; Emery P; Dougados M; Leirisalo-Repo M; Breban M; Listing J; Braun J<\/span> (2011)<\/span> The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab<\/span>. Clin Exp Rheumatol<\/span>, 29<\/span>, (4)<\/span>, pp. 672-680<\/span>.<\/p>","publicationid":"155796","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Nash P; Fleischmann R; Emery P; Dougados M; Hall S; Williams S; Reynard M<\/span> (2011)<\/span> MULTIPLE COURSES OF RITUXIMAB PRODUCE SUSTAINED EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS<\/span>. INTERNAL MEDICINE JOURNAL<\/span>, 41<\/span>, pp. 18-19<\/span>.<\/p>","publicationid":"141862","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Van Vollenhoven R; Littlejohn G; Emery P; Bingham C; Keystone E; Fleischmann R; Furst D; Jones G; Tyson N; Collinson N; Lehane P<\/span> (2011)<\/span> LONG-TERM SAFETY OF RITUXIMAB: FOLLOW-UP OF THE RHEUMATOID ARTHRITIS CLINICAL TRIALS AND RETREATMENT POPULATION<\/span>. INTERNAL MEDICINE JOURNAL<\/span>, 41<\/span>, pp. 18<\/span>.<\/p>","publicationid":"141861","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Abignano G; Hermes H; Gillespie J; Jimenez SA; Emery P; Del Galdo F<\/span> (2011)<\/span> MYOFIBROBLAST SPECIFIC GENE EXPRESSION SIGNATURE IN SYSTEMIC SCLEROSIS, MORE THAN TGF-BETA INDUCED ACTIVATION<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 29<\/span>, (1)<\/span>, pp. 168-169<\/span>.<\/p>","publicationid":"138118","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Griffiths B; Emery P; Ryan V; Isenberg D; Akil M; Thompson R; Maddison P; Griffiths ID; Lorenzi A; Miles S; Situnayake D; Teh LS; Plant M; Hallengren C; Nived O; Sturfelt G; Chakravarty K; Tait T; Gordon C<\/span> (2011)<\/span> The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE. (vol 49, pg 723, 2010)<\/span>. RHEUMATOLOGY<\/span>, 50<\/span>, (3)<\/span>, pp. 634<\/span>. <\/a><\/p>","publicationid":"138069","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Haugeberg G; Morton S; Emery P; Conaghan PG<\/span> (2011)<\/span> Effect of intra-articular corticosteroid injections and inflammation on periarticular and generalised bone loss in early rheumatoid arthritis<\/span>. ANN RHEUM DIS<\/span>, 70<\/span>, (1)<\/span>, pp. 184-187<\/span>. <\/a><\/p>","publicationid":"133469","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Villeneuve E; Emery P<\/span> (2011)<\/span> Rheumatoid arthritis: what has changed? (vol 38, pg 109, 2009)<\/span>. SKELETAL RADIOL<\/span>, 40<\/span>, (1)<\/span>, pp. 141<\/span>. <\/a><\/p>","publicationid":"128658","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coulthard LR; Taylor JC; Eyre S; Robinson JI; Wilson AG; Isaacs JD; Hyrich K; Emery P; Barton A; Barrett JH; Morgan AW; McDermott MF; Biol Rheumatoid Arthrit Genetics G<\/span> (2011)<\/span> Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients<\/span>. ANN RHEUM DIS<\/span>, 70<\/span>, (1)<\/span>, pp. 98-103<\/span>. <\/a><\/p>","publicationid":"124276","date":"2011-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam J; Emery P<\/span> (2010)<\/span> Erratum to: Aspects of TNF inhibitor therapy in rheumatoid arthritis<\/span>. Modern Rheumatology<\/span>, 20<\/span>, (6)<\/span>, pp. 643<\/span>. <\/a><\/p>","publicationid":"1103473","date":"2010-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bowes J; Lawrence R; Eyre S; Panoutsopoulou K; Orozco G; Elliott KS; Ke X; Morris AP; UKRAG; Thomson W; Worthington J; Barton A; Zeggini E<\/span> (2010)<\/span> Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritis<\/span>. Hum Genet<\/span>, 128<\/span>, (6)<\/span>, pp. 627-633<\/span>. <\/a><\/p>","publicationid":"549079","date":"2010-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam J; Emery P<\/span> (2010)<\/span> Erratum: Aspects of TNF inhibitor therapy in rheumatoid arthritis (Modern Rheumatology (2010) 20 (325-330) DOI: 10.1007\/s10165-010-0277-7)<\/span>. Modern Rheumatology<\/span>, 20<\/span>, (6)<\/span>, pp. 643<\/span>. <\/a><\/p>","publicationid":"203436","date":"2010-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bykerk V; Emery P<\/span> (2010)<\/span> Delay in receiving rheumatology care leads to long-term harm<\/span>. Arthritis Rheum<\/span>, 62<\/span>, (12)<\/span>, pp. 3519-3521<\/span>. <\/a><\/p>","publicationid":"203345","date":"2010-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Zayat AS; Wakefield RJ; Conaghan PG; Emery P<\/span> (2010)<\/span> Ultrasonography in rheumatic diseases: Can we do without it?<\/span> International Journal of Advances in Rheumatology<\/span>, 8<\/span>, (3)<\/span>, pp. 89-94<\/span>. <\/a><\/p>","publicationid":"144578","date":"2010-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hinks A; Martin P; Flynn E; Eyre S; Packham J; Barton A; Childhood Arthritis Prospective Study (CAPS), UKRAG Consortium, BSPAR study group; Worthington J; Thomson W<\/span> (2010)<\/span> Investigation of type 1 diabetes and coeliac disease susceptibility loci for association with juvenile idiopathic arthritis<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (12)<\/span>, pp. 2169-2172<\/span>. <\/a><\/p>","publicationid":"144533","date":"2010-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Villeneuve E; Hildebrandt L; Emery P<\/span> (2010)<\/span> The Changing Management of Inflammatory Arthritis<\/span>. JCR-J CLIN RHEUMATOL<\/span>, 16<\/span>, (8)<\/span>, pp. 403-407<\/span>. <\/a><\/p>","publicationid":"131171","date":"2010-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam J; Emery P<\/span> (2010)<\/span> Aspects of TNF inhibitor therapy in rheumatoid arthritis (vol 20, pg 325, 2010)<\/span>. MOD RHEUMATOL<\/span>, 20<\/span>, (6)<\/span>, pp. 643<\/span>. <\/a><\/p>","publicationid":"131153","date":"2010-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Orozco G; Hinks A; Eyre S; Ke X; Gibbons LJ; Bowes J; Flynn E; Martin P; Wilson AG; Bax DE; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Barton A; Worthington J<\/span> (2010)<\/span> Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23<\/span>. Human Molecular Genetics<\/span>, 19<\/span>, (22)<\/span>, pp. 4544<\/span>. <\/a><\/p>","publicationid":"202966","date":"2010-11-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hawkins T; Emery P<\/span> (2010)<\/span> CONDOR: time to review our treatment with NSAIDs?<\/span> Prescriber<\/span>, 21<\/span>, (21)<\/span>, pp. 7-8<\/span>. <\/a><\/p>","publicationid":"1103605","date":"2010-11-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Tanner SF; Rhodes LA; Tan AL; Conaghan PG; Hensor EMA; Radjenovic A; O'Connor P; Emery P; McGonagle D<\/span> (2010)<\/span> Erratum<\/span>. Scandinavian Journal of Rheumatology<\/span>, 39<\/span>, (6)<\/span>, pp. 527<\/span>. <\/a><\/p>","publicationid":"203294","date":"2010-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wenham CY; Emery P<\/span> (2010)<\/span> Research Highlights<\/span>. Therapy<\/span>, 7<\/span>, (6)<\/span>, pp. 587-589<\/span>. <\/a><\/p>","publicationid":"203230","date":"2010-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barton A; Eyre S; Ke X; Hinks A; Bowes J; Flynn E; Martin P; Wilson AG; Morgan AW; Emery P; Steer S; Hocking LJ; Reid DM; Harrison P; Wordsworth P; Thomson W; Worthington J<\/span> (2010)<\/span> Corrigendum: Identification of AF4\/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes<\/span>. Human Molecular Genetics<\/span>, 19<\/span>, (22)<\/span>, pp. 4543<\/span>. <\/a><\/p>","publicationid":"202984","date":"2010-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barkham N; Keen HI; Coates LC; O'Connor P; Hensor E; Fraser AD; Cawkwell LS; Bennett A; McGonagle D; Emery P<\/span> (2010)<\/span> Erratum: Clinical and imaging efficacy of infliximab in HLA\u2013B27\u2013positive patients with magnetic resonance imaging\u2013determined early sacroiliitis<\/span>. Arthritis & Rheumatism<\/span>, 62<\/span>, (10)<\/span>, pp. 3005<\/span>. <\/a><\/p>","publicationid":"1103586","date":"2010-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bruyn GAW; Pineda C; Hernandez\u2010Diaz C; Ventura\u2010Rios L; Moya C; Garrido J; Groen H; Pena A; Espinosa R; M\u00f6ller I; Filippucci E; Iagnocco A; Balint PV; Kane D; D'Agostino M; Angulo M; Ponte R; Fernandez\u2010Gallardo JM; Naredo E<\/span> (2010)<\/span> Erratum: Validity of ultrasonography and measures of adult shoulder function and reliability of ultrasonography in detecting shoulder synovitis in patients with rheumatoid arthritis using magnetic resonance imaging as a gold standard<\/span>. Arthritis Care & Research<\/span>, 62<\/span>, (10)<\/span>, pp. 1514<\/span>. <\/a><\/p>","publicationid":"202861","date":"2010-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bejarano V; Conaghan PG; Quinn MA; Saleem B; Emery P<\/span> (2010)<\/span> Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis<\/span>. RHEUMATOLOGY<\/span>, 49<\/span>, (10)<\/span>, pp. 1971-1974<\/span>. <\/a><\/p>","publicationid":"106104","date":"2010-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Hensor EMA; Keenan AM; Morgan AW; Emery P; YEAR Consortium<\/span> (2010)<\/span> Persistently moderate DAS-28 is not benign: loss of function occurs in early RA despite step-up DMARD therapy<\/span>. RHEUMATOLOGY<\/span>, 49<\/span>, (10)<\/span>, pp. 1894-1899<\/span>. <\/a><\/p>","publicationid":"85807","date":"2010-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Moreland LW; Hsia EC; Strusberg I; Durez P; Nash P; Amante EJB; Churchill M; Park W; Pons\u2010Estel BA; Doyle MK; Visvanathan S; Xu W; Rahman MU<\/span> (2010)<\/span> Erratum: Golimumab, a human anti\u2010tumor necrosis factor \u03b1 monoclonal antibody, injected subcutaneously every four weeks in methotrexate\u2010naive patients with active rheumatoid arthritis: Twenty\u2010four\u2010week results of a phase III, multicenter, randomized, double\u2010blind, placebo\u2010controlled study of golimumab before methotrexate as first\u2010line therapy for early\u2010onset rheumatoid arthritis<\/span>. Arthritis & Rheumatism<\/span>, 62<\/span>, (9)<\/span>, pp. 2812<\/span>. <\/a><\/p>","publicationid":"1103613","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Keen H; Goeb V; Parmar R; Nizam S; Hensor EMA; Churchman SM; Quinn M; Wakefield R; Conaghan PG; Ponchel F; Emery P<\/span> (2010)<\/span> Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?<\/span> ANN RHEUM DIS<\/span>, 69<\/span>, (9)<\/span>, pp. 1636-1642<\/span>. <\/a><\/p>","publicationid":"133462","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2010)<\/span> Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23<\/span>. Human molecular genetics<\/span>, 19<\/span>, (22)<\/span>, pp. 4544<\/span>. <\/a><\/p>","publicationid":"131191","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2010)<\/span> Identification of AF4\/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes<\/span>. Human molecular genetics<\/span>, 19<\/span>, (22)<\/span>, pp. 4543<\/span>. <\/a><\/p>","publicationid":"131190","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cohen S; Emery P<\/span> (2010)<\/span> The American College of Rheumatology\/European League Against Rheumatism criteria for the classification of rheumatoid arthritis: a game changer<\/span>. Arthritis Rheum<\/span>, 62<\/span>, (9)<\/span>, pp. 2592-2594<\/span>. <\/a><\/p>","publicationid":"129816","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Neogi T; Aletaha D; Silman AJ; Naden RL; Felson DT; Aggarwal R; Bingham CO; Birnbaum NS; Burmester GR; Bykerk VP; Cohen MD; Combe B; Costenbader KH; Dougados M; Emery P; Ferraccioli G; Hazes JMW; Hobbs K; Huizinga TWJ; Kavanaugh A; Kay J; Khanna D; Kvien TK; Laing T; Liao K; Mease P; M\u00e9nard HA; Moreland LW; Nair R; Pincus T; Ringold S; Smolen JS; Stanislawska-Biernat E; Symmons D; Tak PP; Upchurch KS; Vencovsk\u00fd J; Wolfe F; Hawker G; American College of Rheumatology; European League Against Rheumatism<\/span> (2010)<\/span> The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report<\/span>. Arthritis Rheum<\/span>, 62<\/span>, (9)<\/span>, pp. 2582-2591<\/span>. <\/a><\/p>","publicationid":"129815","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aletaha D; Neogi T; Silman AJ; Funovits J; Felson DT; Bingham CO; Birnbaum NS; Burmester GR; Bykerk VP; Cohen MD; Combe B; Costenbader KH; Dougados M; Emery P; Ferraccioli G; Hazes JMW; Hobbs K; Huizinga TWJ; Kavanaugh A; Kay J; Kvien TK; Laing T; Mease P; M\u00e9nard HA; Moreland LW; Naden RL; Pincus T; Smolen JS; Stanislawska-Biernat E; Symmons D; Tak PP; Upchurch KS; Vencovsk\u00fd J; Wolfe F; Hawker G<\/span> (2010)<\/span> 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative<\/span>. Arthritis Rheum<\/span>, 62<\/span>, (9)<\/span>, pp. 2569-2581<\/span>. <\/a><\/p>","publicationid":"129814","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aletaha D; Neogi T; Silman AJ; Funovits J; Felson DT; Bingham CO; Birnbaum NS; Burmester GR; Bykerk VP; Cohen MD; Combe B; Costenbader KH; Dougados M; Emery P; Ferraccioli G; Hazes JMW; Hobbs K; Huizinga TWJ; Kavanaugh A; Kay J; Kvien TK; Laing T; Mease P; M\u00e9nard HA; Moreland LW; Naden RL; Pincus T; Smolen JS; Stanislawska-Biernat E; Symmons D; Tak PP; Upchurch KS; Vencovsky J; Wolfe F; Hawker G<\/span> (2010)<\/span> 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (9)<\/span>, pp. 1580-1588<\/span>. <\/a><\/p>","publicationid":"124380","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Funovits J; Aletaha D; Bykerk V; Combe B; Dougados M; Emery P; Felson D; Hawker G; Hazes JM; Huizinga T; Kay J; Kvien TK; Smolen JS; Symmons D; Tak PP; Silman A<\/span> (2010)<\/span> The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (9)<\/span>, pp. 1589-1595<\/span>. <\/a><\/p>","publicationid":"124338","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cohen S; Emery P<\/span> (2010)<\/span> The American College of Rheumatology\/European League Against Rheumatism Criteria for the classification of rheumatoid arthritis: a game changer<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (9)<\/span>, pp. 1575-1576<\/span>. <\/a><\/p>","publicationid":"124337","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Deodhar A; Rigby WF; Isaacs JD; Combe B; Racewicz AJ; Latinis K; Abud-Mendoza C; Szczepanski LJ; Roschmann RA; Chen A; Armstrong GK; Douglass W; Tyrrell H<\/span> (2010)<\/span> Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (9)<\/span>, pp. 1629-1635<\/span>. <\/a><\/p>","publicationid":"76684","date":"2010-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2010)<\/span> Time for treatment targets in rheumatoid arthritis<\/span>. BMJ Online<\/span>, 341<\/span>, (7767)<\/span>, pp. 267<\/span>. <\/a><\/p>","publicationid":"202477","date":"2010-08-07","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Treat to Target UK Steering Group; Buch MH; Ost\u00f6r A; Kirkham B; Taylor P; Estrach C; Jenkinson T; McInnes I; Porter D<\/span> (2010)<\/span> Symmetrical polyarthritis. Time for treatment targets in rheumatoid arthritis<\/span>. BMJ<\/span>, 341<\/span>, (aug04 2)<\/span>, pp. c4170<\/span>. <\/a><\/p>","publicationid":"124247","date":"2010-08-04","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hensor EMA; Emery P; Bingham SJ; Conaghan PG; YEAR Consortium<\/span> (2010)<\/span> Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): can they be reduced?<\/span> RHEUMATOLOGY<\/span>, 49<\/span>, (8)<\/span>, pp. 1521-1529<\/span>. <\/a><\/p>","publicationid":"133468","date":"2010-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Eyre S; Hinks A; Flynn E; Martin P; Wilson AG; Maxwell JR; Morgan AW; Emery P; Steer S; Hocking LJ; Reid DM; Harrison P; Wordsworth P; Thomson W; Worthington J; Barton A<\/span> (2010)<\/span> Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (8)<\/span>, pp. 1572-1573<\/span>. <\/a><\/p>","publicationid":"123484","date":"2010-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dickie LJ; Church LD; Coulthard LR; Mathews RJ; Emery P; McDermott MF<\/span> (2010)<\/span> Vitamin D-3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes<\/span>. RHEUMATOLOGY<\/span>, 49<\/span>, (8)<\/span>, pp. 1466-1471<\/span>. <\/a><\/p>","publicationid":"35673","date":"2010-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam J; Emery P<\/span> (2010)<\/span> Aspects of TNF inhibitor therapy in rheumatoid arthritis<\/span>. MOD RHEUMATOL<\/span>, 20<\/span>, (4)<\/span>, pp. 325-330<\/span>. <\/a><\/p>","publicationid":"7147","date":"2010-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Seibold JR; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells A; Matucci Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM<\/span> (2010)<\/span> Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis<\/span>. Arthritis Rheum<\/span>, 62<\/span>, (7)<\/span>, pp. 2101-2108<\/span>. <\/a><\/p>","publicationid":"129747","date":"2010-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Eyre S; Flynn E; Martin P; Hinks A; Wilson AG; Morgan AW; Emery P; Steer S; Hocking LJ; Reid DM; Harrison P; Wordsworth P; Thomson W; Worthington J; Barton A<\/span> (2010)<\/span> No evidence for association of the KLF12 gene with rheumatoid arthritis in a large UK cohort<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (7)<\/span>, pp. 1407-1408<\/span>. <\/a><\/p>","publicationid":"123087","date":"2010-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Haugeberg G; Bennett AN; McGonagle D; Emery P; Marzo-Ortega H<\/span> (2010)<\/span> Bone loss in very early inflammatory back pain in undifferentiated spondyloarthropathy: a 1-year observational study<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (7)<\/span>, pp. 1364-1366<\/span>. <\/a><\/p>","publicationid":"104522","date":"2010-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Davidovici BB; Sattar N; Prinz JC; Puig L; Emery P; Barker JN; van de Kerkhof P; St\u00e5hle M; Nestle FO; Girolomoni G; Krueger JG<\/span> (2010)<\/span> Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions<\/span>. J Invest Dermatol<\/span>, 130<\/span>, (7)<\/span>, pp. 1785-1796<\/span>. <\/a><\/p>","publicationid":"55737","date":"2010-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jones E; English A; Churchman SM; Kouroupis D; Boxall SA; Kinsey S; Giannoudis PG; Emery P; McGonagle D<\/span> (2010)<\/span> Large-Scale Extraction and Characterization of CD271+Multipotential Stromal Cells From Trabecular Bone in Health and Osteoarthritis Implications for Bone Regeneration Strategies Based on Uncultured or Minimally Cultured Multipotential Stromal Cells<\/span>. ARTHRITIS RHEUM-US<\/span>, 62<\/span>, (7)<\/span>, pp. 1944-1954<\/span>. <\/a><\/p>","publicationid":"26135","date":"2010-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ciurtin C; Majeed Y; Naylor J; Sukumar P; English AA; Emery P; Beech DJ<\/span> (2010)<\/span> TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan<\/span>. BMC MUSCULOSKEL DIS<\/span>, 11<\/span>, (1)<\/span>, pp. 111<\/span>. <\/a> <\/a><\/p>","publicationid":"99585","date":"2010-06-04","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dixon WG; Watson KD; Lunt M; Mercer LK; Hyrich KL; Symmons DPM; British Society For Rheumatology Biologics Register Control Centre Consortium; British Society for Rheumatology Biologics Register<\/span> (2010)<\/span> Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register<\/span>. Arthritis Care Res (Hoboken)<\/span>, 62<\/span>, (6)<\/span>, pp. 755-763<\/span>. <\/a><\/p>","publicationid":"202014","date":"2010-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Davey R; Bamford J; Emery P<\/span> (2010)<\/span> The role of endothelial dysfunction in the pathogenesis of neuropsychiatric systemic lupus erythematosus<\/span>. Lupus<\/span>, 19<\/span>, (7)<\/span>, pp. 797-802<\/span>. <\/a><\/p>","publicationid":"97781","date":"2010-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Stahl EA; Raychaudhuri S; Remmers EF; Xie G; Eyre S; Thomson BP; Li Y; Kurreeman FAS; Zhernakova A; Hinks A; Guiducci C; Chen R; Alfredsson L; Amos CI; Ardlie KG; BIRAC Consortium; Barton A; Bowes J; Brouwer E; Burtt NP; Catanese JJ; Coblyn J; Coenen MJH; Costenbader KH; Criswell LA; Crusius JBA; Cui J; de Bakker PIW; De Jager PL; Ding B; Emery P; Flynn E; Harrison P; Hocking LJ; Huizinga TWJ; Kastner DL; Ke X; Lee AT; Liu X; Martin P; Morgan AW; Padyukov L; Posthumus MD; Radstake TRDJ; Reid DM; Seielstad M; Seldin MF; Shadick NA; Steer S; Tak PP; Thomson W; van der Helm-van Mil AHM; van der Horst-Bruinsma IE; van der Schoot CE; van Riel PLCM; Weinblatt ME; Wilson AG; Wolbink GJ; Wordsworth BP; YEAR Consortium; Wijmenga C; Karlson EW; Toes REM; de Vries N; Begovich AB; Worthington J; Siminovitch KA; Gregersen PK; Klareskog L; Plenge RM<\/span> (2010)<\/span> Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci<\/span>. Nat Genet<\/span>, 42<\/span>, (6)<\/span>, pp. 508-514<\/span>. <\/a><\/p>","publicationid":"58546","date":"2010-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Landew\u00e9 R; Breedveld FC; Dougados M; Emery P; Gaujoux-Viala C; Gorter S; Knevel R; Nam J; Schoels M; Aletaha D; Buch M; Gossec L; Huizinga T; Bijlsma JWJW; Burmester G; Combe B; Cutolo M; Gabay C; Gomez-Reino J; Kouloumas M; Kvien TK; Martin-Mola E; McInnes I; Pavelka K; van Riel P; Scholte M; Scott DL; Sokka T; Valesini G; van Vollenhoven R; Winthrop KL; Wong J; Zink A; van der Heijde D<\/span> (2010)<\/span> EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (6)<\/span>, pp. 964-975<\/span>. <\/a><\/p>","publicationid":"58176","date":"2010-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam JL; Winthrop KL; van Vollenhoven RF; Pavelka K; Valesini G; Hensor EMA; Worthy G; Landewe R; Smolen JS; Emery P; Buch MH<\/span> (2010)<\/span> Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (6)<\/span>, pp. 976-986<\/span>. <\/a><\/p>","publicationid":"57847","date":"2010-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Robinson JI; Barrett JH; Taylor JC; Naven M; Corscadden D; Barton A; Wilson AG; Emery P; Isaacs JD; Morgan AW; YEAR Consortium; BRAGGSS<\/span> (2010)<\/span> Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive disease<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (6)<\/span>, pp. 1054-1057<\/span>. <\/a><\/p>","publicationid":"23838","date":"2010-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keen HI; Wakefield RJ; Hensor EMA; Emery P; Conaghan PG<\/span> (2010)<\/span> Response of symptoms and synovitis to intra-muscular methylprednisolone in osteoarthritis of the hand: an ultrasonographic study<\/span>. RHEUMATOLOGY<\/span>, 49<\/span>, (6)<\/span>, pp. 1093-1100<\/span>. <\/a><\/p>","publicationid":"16880","date":"2010-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cohen SB; Keystone E; Genovese MC; Emery P; Peterfy C; Tak PP; Cravets M; Shaw T; Hagerty D<\/span> (2010)<\/span> Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (6)<\/span>, pp. 1158-1161<\/span>. <\/a><\/p>","publicationid":"3939","date":"2010-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; Rehman A; Hensor EMA; Marzo-Ortega H; Emery P; McGonagle D<\/span> (2010)<\/span> The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (5)<\/span>, pp. 891-894<\/span>. <\/a><\/p>","publicationid":"85704","date":"2010-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Orozco G; Eyre S; Hinks A; Ke X; Wellcome Trust Case Control consortium YEAR Consortium; Wilson AG; Bax DE; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Barton A; Worthington J<\/span> (2010)<\/span> Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (5)<\/span>, pp. 813-816<\/span>. <\/a><\/p>","publicationid":"74974","date":"2010-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Dass S; Rawstron AC; Buch MH; Goeb V; Henshaw K; Ponchel F; Emery P<\/span> (2010)<\/span> Management of Nonresponse to Rituximab in Rheumatoid Arthritis Predictors and Outcome of Re-treatment<\/span>. ARTHRITIS RHEUM-US<\/span>, 62<\/span>, (5)<\/span>, pp. 1273-1279<\/span>. <\/a><\/p>","publicationid":"39748","date":"2010-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jadon DR; Cavill C; Waldron N; Barton A; Korendowych E; McHugh NJ; Coates LC; Helliwell PS; van der Heijde D; Emery P; Patra K; Lavie F; Skerrett J; van der Weide I; Barlow J; Keat A; Gladman D; Kavanaugh A; Chattopadhyay C; Mease P; Krueger GG; Zrubek J; Beutler A; Hsu B; Mudivarthy S; Mack M; McInnes IB; Kirkham B; Fitzgerald O; Robertson D; Estojak J; Foehl J; Molta C; Freundlich B; Navarro F; Sueiro JLF; Torre Alonso JC; Queiro R; Gonzalez C; Gratacos J; Loza E; Linares L; Zarco P; Juanola X; Andres Roman Ivorra J; Martin Mola E; Sanmarti R; Mulero J; Diaz G; Alfonso E; Collantes E; Healey EL; Haywood KL; Jordan KP; Garratt AM; Packham JC<\/span> (2010)<\/span> Concurrent Oral 6 - Spondylarthropathies [OP40-OP47]: OP40. Association of IL23R and IL12B Polymorphisms with Psoriatic Arthritis<\/span>. Rheumatology<\/span>, 49<\/span>, (Supplement 1)<\/span>, pp. i17-i20<\/span>. <\/a><\/p>","publicationid":"1103621","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fleischmann R; Burgos-Vargas R; Ambs P; Alecock E; Kremer J; Soliman MM; Ashcroft DM; Watson KD; Lunt M; Symmons DP; Hyrich KL; Tak PP; Rigby W; Rubbert A; Peterfy C; van Vollenhoven RF; Stohl W; Hessey E; Chen A; Tyrrell H; Shaw T; Genovese MC; Breedveld FC; Emery P; Cohen SB; Keystone EC; Matteson EL; Burke LS; Chai A; Reiss WG; Sweetser MT; Shaw TM; Owen SA; Eyre S; Martin P; Hider S; Bruce IN; Barton A; Thomson W; Jones G; Gomez-Reino JJ; Lowenstein MB; Tornero J; Sebba A; Alecock E; Guarin E; Genovese M<\/span> (2010)<\/span> Concurrent Oral 1 - Rheumatoid Arthritis: Treatment [OP4-OP9]: OP4. Inhibition of Radiographic Progression and Improvements in Physical Function at 2 Years, with Increasing Clinical Efficacy Over Time, in Rheumatoid Arthritis (Ra) Patients Treated with Tocilizumab (Tcz): The Lithe Study<\/span>. Rheumatology<\/span>, 49<\/span>, (Supplement 1)<\/span>, pp. i3-i5<\/span>. <\/a><\/p>","publicationid":"1103579","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lloyd M; Makadsi R; Ala A; Connor P; Gwynne C; Rhys Dillon B; Lawson T; Emery P; Mease PJ; Rubbert-Roth A; Curtis JR; Muller-Ladner U; Gaylis N; Armstrong GK; Reynard M; Tyrrell H; Joshi N; Loke Y; MacGregor A; Malaiya R; Rachapalli SM; Parton T; King L; Parker G; Nesbitt A; Schiff M; Sheikzadeh A; Formosa D; Domanska B; Morgan D; van Vollenhoven R; Cifaldi M; Roy S; Chen N; Gotlieb L; Malaise M; Langtree M; Lam M; Malipeddi A; Hassan W; El Miedany Y; El Gaafary M; Palmer D; Dutta S; Breslin A; Ahmad Y; Morcos PN; Zhang X; Grange S; Schmitt C; Malipeddi AS; Neame R; Isaacs JD; Olech E; Tak PP; Deodhar A; Keystone E; Emery P; Yocum D; Hessey E; Read S; Blunn KJ; Williams RB; McDowell JA; Rees DH; Young A; Marks JL; Westlake SL; Baird J; Kiely PD; Ostor AJ; Quinn MA; Taylor PC; Edwards CJ; Vagadia V; Bracewell C; McKay N; Collini A; Kidd E; Wright D; Watson K; Williams E; Mossadegh S; Ledingham J; Combe B; Schwartzman S; Massarotti E; Keystone EC; Luijtens K; van der Heijde D; Mariette X; Kivitz A; Isaacs JD; Stohl W; Tak PP; Jones R; Jahreis A; Armstrong G; Shaw T; Westhovens R; Strand V; Keystone EC; Purcaru O; Khanna D; Smolen J; Kavanaugh A; Keystone EC; Fleischmann RM; Emery P; Dougados M; Baldassare AR; Armstrong GK; Linnik M; Reynard M; Tyrrell H; McInnes IB; Combe B; Burmester G; Schiff M; Keiserman M; Codding C; Songcharoen S; Berman A; Nayiager S; Saldate C; Aranda R; Becker J-C; Zhao C; Le Bars M; Dougados M; Burmester GR; Kary S; Unnebrink K; Guerette B; Oezer U; Kupper H; Dougados M; Keystone EC; Guerette B; Patra K; Lavie F; Gasparyan AY; Sandoo A; Stavropoulos-Kalinoglou A; Kitas GD; Dubash SR; Linton S; Emery P; Genovese MC; Fleischmann RM; Matteson EL; Hsia EC; Xu S; Doyle MK; Rahman MU; Keystone E; Curtis J; Fleischmann R; Mease P; Khanna D; Smolen J; Coteur G; Combe B; van Vollenhoven R; Smolen J; Schiff M; Fleischmann R; Combe B; Goel N; Desai C; Curtis J; Keystone E; Emery P; Choy E; Van Vollenhoven R; Keystone E; Furie R; Blesch A; Wang CD; Curtis JR; Hughes LD; Young A; Done DJ; Treharne G; van Vollenhoven RF; Emery P; Bingham CO; Keystone EC; Fleischmann RM; Furst DE; Macey K; Sweetster MT; Lehane PB; Farmer P; Long SG; Kremer JM; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Becker J-C; Wu G; Westhovens R; Keystone EC; Kavanaugh A; van der Heijde D; Sinisi S; Guerette B; Keystone EC; Fleischmann R; Smolen J; Strand V; Landewe R; Combe B; Mease P; Ansari Z; Goel N; van der Heijde D; Emery P; Alavi A; Fitzgerald O; Collins ES; Fraser O; Tarelli E; Ng VC; Breshnihan B; Veale DJ; Axford JS; Aletaha D; Alasti F; Smolen JS; Keystone EC; Schiff MH; Rovensky J; Taylor M; John AK; Balbir-Gurman A; Hughes LD; Young A; John Done D; Treharne GJ; Ezard C; Willott R; Butt S; Gadsby K; Deighton C; Tsuru T; Terao K; Suzaki M; Nakashima H; Akiyama A; Nishimoto N; Smolen J; Wordsworth P; Doyle MK; Kay J; Matteson EL; Landewe R; Hsia E; Zhou Y; Rahman MU; Van Vollenhoven R; Siri D; Furie R; Krasnow J; Alecock E; Alten R; Nishimoto N; Kawata Y; Aoki C; Mima T; van Vollenhoven RF; Nishimoto N; Yamanaka H; Woodworth T; Schiff MH; Taylor A; Pope JE; Genovese MC; Rubbert A; Keystone EC; Hsia EC; Buchanan J; Klareskog L; Murphy FT; Wu Z; Parasuraman S; Rahman MU; Kay J; Wordsworth P; Doyle MK; Smolen J; Buchanan J; Matteson EL; Hsia EC; Landewe R; Zhou Y; Shreekant P; Rahman MU; Smolen JS; Gomez-Reino JJ; Davies C; Alecock E; Rubbert-Roth A; Emery P<\/span> (2010)<\/span> Rheumatoid Arthritis: Treatment [151-201]: 151. Should we be Looking More Carefully for Methotrexate Induced Liver Disease?<\/span> Rheumatology<\/span>, 49<\/span>, (Supplement 1)<\/span>, pp. i89-i111<\/span>. <\/a><\/p>","publicationid":"1103524","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Arthanari S; Nisar M; Weber H; Lange R; Kuperwasser B; McCann B; Okamoto A; Steup A; Etropolski M; Rauschkolb C; Shapiro D; Buynak R; Okamoto A; Van Hove I; Steup A; Lange B; Haufel T; Etropolski M; Kelly K; Etropolski M; Kuperwasser B; Okamoto A; Steup A; Van Hove I; Lange B; Rauschkolb C; Shark L-K; Chen H; Goodacre J; Soni A; Mudge N; Joshi A; Wyatt M; Williamson L; Cramb D; Grainger A; Hodgson R; Hensor E; Willis K; McGonagle D; Emery P; Jones A; Tan AL; Trivedi B; Marshall M; Roddy E<\/span> (2010)<\/span> Osteoarthritis [119-126]: 119. The Value of HFE Genotyping in Exceptional Osteoarthritis<\/span>. Rheumatology<\/span>, 49<\/span>, (Supplement 1)<\/span>, pp. i78-i80<\/span>. <\/a><\/p>","publicationid":"1103522","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wig S; Bischoff P; Holt M; Collins S; Goodfellow R; Martin J; Rhys-Dillon C; Lyle S; Rowan Phillips J; Mease PJ; Perdok R; Kary S; Kupper H; Humphreys E; Amos N; Nash J; Jones S; McHugh K; Giles J; Kollnberger S; Kuroi K; Maenaka K; Bowness P; El Miedany Y; El Gaafary M; Youssef S; Palmer D; Marshall CL; Harrison PV; Bukhari M; Greenwood MC; Omar F; Hakim AJ; Donnelly SP; Rooney MM; Lanham JG; Tahir H; Mease PJ; Kavanaugh A; Perdok R; Kupper H; Lavie F; Barlow JH; McFarland L; Tindall L; Ravindran J; Perkins P; Ciurtin C; Doufexi D; Bartko J; Roussou E; Phillips JR; Collins S; Lyle S; Goodfellow R; Martin J; Rhys-Dillon C; Thompson B; Rapley T; Broderick W; May C; Kay L; Sandhu J; Packham JC; Healey EL; Jordan K; Garratt AM; Haywood KL; Utriainen L; Cerovic V; McInnes I; Milling S; Ritchlin CT; Mease PJ; Perdok R; Kupper H; Lavie F; Freeston JE; Coates LC; Helliwell PS; Hensor EM; Wakefield RJ; Emery P; Conaghan PG; Skerrett J; van der Weide I; Barlow J; Keat A; van der Heijde D; Braun J; Sieper J; Wishneski C; Vlahos B; Szumski A; Foehl J; Freundlich B; Koenig A; Gatia A; Bartko J; Doufexi D; Roussou E; Kavanaugh A; Gladman D; Chattopadhyay C; Mease P; McInnes IB; Beutler A; Zrubek J; Buchanan J; Parasuraman S; Mack M; Krueger GG; Wazir TU; Cairns AP; Bell A; Giles JL; Shaw J; McHugh K; Ridley A; Bowness P; Kollnberger S; Pritchard GS; Bukhari M; Wilcox L; Freeston JE; Coates LC; Helliwell PS; Hensor EM; Wakefield RJ; Emery P; Conaghan PG; Packham J; Jordan KP; Lebmeier M; Garratt AM; Healey EL; Haywood KL; Ciurtin C; Roussou E; Clarke L; Kay L; Gingold MJ; Bansback N; Guh DP; Cavill C; Porteous R; Kyle SD; Waldron N; Korendowych E; McHugh N; Braun J; van der Heijde AD; Deodhar L; Diekman J; Sieper S-I; Kim A; Beutler M; Mack S; Xu J; Zrubek B; Hsu R; Inman O<\/span> (2010)<\/span> Spondyloarthropathies (Including Psoriatic Arthritis) [40-69]: 40. Eagle's Syndrome: An Unusual Association with Sero-Negative Arthropathy<\/span>. Rheumatology<\/span>, 49<\/span>, (Supplement 1)<\/span>, pp. i48-i59<\/span>. <\/a><\/p>","publicationid":"1103503","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schoels M; Knevel R; Aletaha D; Bijlsma JWJ; Breedveld FC; Boumpas DT; Burmester G; Combe B; Cutolo M; Dougados M; Emery P; van der Heijde D; Huizinga TWJ; Kalden J; Keystone EC; Kvien TK; Martin-Mola E; Montecucco C; de Wit M; Smolen JS<\/span> (2010)<\/span> Evidence for treating rheumatoid arthritis to target: results of a systematic literature search<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (4)<\/span>, pp. 638-643<\/span>. <\/a><\/p>","publicationid":"93512","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Griffiths B; Emery P; Ryan V; Isenberg D; Akil M; Thompson R; Maddison P; Griffiths ID; Lorenzi A; Miles S; Situnayake D; Teh LS; Plant M; Hallengren C; Nived O; Sturfelt G; Chakravarty K; Tait T; Gordon C<\/span> (2010)<\/span> The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE<\/span>. RHEUMATOLOGY<\/span>, 49<\/span>, (4)<\/span>, pp. 723-732<\/span>. <\/a><\/p>","publicationid":"27470","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wellcome Trust Case Control Consortium; Craddock N; Hurles ME; Cardin N; Pearson RD; Plagnol V; Robson S; Vukcevic D; Barnes C; Conrad DF; Giannoulatou E; Holmes C; Marchini JL; Stirrups K; Tobin MD; Wain LV; Yau C; Aerts J; Ahmad T; Andrews TD; Arbury H; Attwood A; Auton A; Ball SG; Balmforth AJ; Barrett JC; Barroso I; Barton A; Bennett AJ; Bhaskar S; Blaszczyk K; Bowes J; Brand OJ; Braund PS; Bredin F; Breen G; Brown MJ; Bruce IN; Bull J; Burren OS; Burton J; Byrnes J; Caesar S; Clee CM; Coffey AJ; Connell JMC; Cooper JD; Dominiczak AF; Downes K; Drummond HE; Dudakia D; Dunham A; Ebbs B; Eccles D; Edkins S; Edwards C; Elliot A; Emery P; Evans DM; Evans G; Eyre S; Farmer A; Ferrier IN; Feuk L; Fitzgerald T; Flynn E; Forbes A; Forty L; Franklyn JA; Freathy RM; Gibbs P; Gilbert P; Gokumen O; Gordon-Smith K; Gray E; Green E; Groves CJ; Grozeva D; Gwilliam R; Hall A; Hammond N; Hardy M; Harrison P; Hassanali N; Hebaishi H; Hines S; Hinks A; Hitman GA; Hocking L; Howard E; Howard P; Howson JMM; Hughes D; Hunt S; Isaacs JD; Jain M; Jewell DP; Johnson T; Jolley JD; Jones IR; Jones LA; Kirov G; Langford CF; Lango-Allen H; Lathrop GM; Lee J; Lee KL; Lees C; Lewis K; Lindgren CM; Maisuria-Armer M; Maller J; Mansfield J; Martin P; Massey DCO; McArdle WL; McGuffin P; McLay KE; Mentzer A; Mimmack ML; Morgan AE; Morris AP; Mowat C; Myers S; Newman W; Nimmo ER; O'Donovan MC; Onipinla A; Onyiah I; Ovington NR; Owen MJ; Palin K; Parnell K; Pernet D; Perry JRB; Phillips A; Pinto D; Prescott NJ; Prokopenko I; Quail MA; Rafelt S; Rayner NW; Redon R; Reid DM; Renwick; Ring SM; Robertson N; Russell E; St Clair D; Sambrook JG; Sanderson JD; Schuilenburg H; Scott CE; Scott R; Seal S; Shaw-Hawkins S; Shields BM; Simmonds MJ; Smyth DJ; Somaskantharajah E; Spanova K; Steer S; Stephens J; Stevens HE; Stone MA; Su Z; Symmons DPM; Thompson JR; Thomson W; Travers ME; Turnbull C; Valsesia A; Walker M; Walker NM; Wallace C; Warren-Perry M; Watkins NA; Webster J; Weedon MN; Wilson AG; Woodburn M; Wordsworth BP; Young AH; Zeggini E; Carter NP; Frayling TM; Lee C; McVean G; Munroe PB; Palotie A; Sawcer SJ; Scherer SW; Strachan DP; Tyler-Smith C; Brown MA; Burton PR; Caulfield MJ; Compston A; Farrall M; Gough SCL; Hall AS; Hattersley AT; Hill AVS; Mathew CG; Pembrey M; Satsangi J; Stratton MR; Worthington J; Deloukas P; Duncanson A; Kwiatkowski DP; McCarthy MI; Ouwehand W; Parkes M; Rahman N; Todd JA; Samani NJ; Donnelly P<\/span> (2010)<\/span> Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls<\/span>. Nature<\/span>, 464<\/span>, (7289)<\/span>, pp. 713-720<\/span>. <\/a><\/p>","publicationid":"25090","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; D'Agostino MA; Le Bars M; Baron G; Schmidely N; Wakefield R; Ravaud P; Grassi W; Martin-Mola E; So A; Backhaus M; Malaise M; Emery P; Dougados M<\/span> (2010)<\/span> Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (4)<\/span>, pp. 644-647<\/span>. <\/a><\/p>","publicationid":"15788","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burr ML; Naseem H; Hinks A; Eyre S; Gibbons LJ; Bowes J; Wilson AG; Maxwell J; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Worthington J; BIRAC Consortium; YEAR Consortium; Barton A<\/span> (2010)<\/span> PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (4)<\/span>, pp. 666-670<\/span>. <\/a><\/p>","publicationid":"5267","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Aletaha D; Bijlsma JWJ; Breedveld FC; Boumpas D; Burmester G; Combe B; Cutolo M; de Wit M; Dougados M; Emery P; Gibofsky A; Gomez-Reino JJ; Haraoui B; Kalden J; Keystone EC; Kvien TK; McInnes I; Martin-Mola E; Montecucco C; Schoels M; van der Heijde D; T2T Expert Committee<\/span> (2010)<\/span> Treating rheumatoid arthritis to target: recommendations of an international task force<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (4)<\/span>, pp. 631-637<\/span>. <\/a><\/p>","publicationid":"824","date":"2010-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hinks A; Eyre S; Ke X; Barton A; Martin P; Flynn E; Packham J; Worthington J; Thomson W; CAPS; UKRAG Consortium; BSPAR Study Grp<\/span> (2010)<\/span> Association of the AFF3 gene and IL2\/IL21 gene region with juvenile idiopathic arthritis<\/span>. GENES IMMUN<\/span>, 11<\/span>, (2)<\/span>, pp. 194-198<\/span>. <\/a><\/p>","publicationid":"144536","date":"2010-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schoels M; Aletaha D; Smolen JS; Bijlsma JWJ; Burmester G; Breedveld FC; Cutolo M; Combe B; Dougados M; Emery P; Kalden J; Keystone EC; Kvien TK; Martin-Mola E; Montecucco C; De Wit M<\/span> (2010)<\/span> Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (3)<\/span>, pp. 575-578<\/span>. <\/a><\/p>","publicationid":"88513","date":"2010-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Breedveld F; van der Heijde D; Ferraccioli G; Dougados M; Robertson D; Pedersen R; Koenig AS; Freundlich B; Combination Methotrexate Etanercep<\/span> (2010)<\/span> Two-Year Clinical and Radiographic Results With Combination Etanercept-Methotrexate Therapy Versus Monotherapy in Early Rheumatoid Arthritis<\/span>. ARTHRITIS RHEUM-US<\/span>, 62<\/span>, (3)<\/span>, pp. 674-682<\/span>. <\/a><\/p>","publicationid":"77051","date":"2010-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Machold KP; Landew\u00e9 R; Smolen JS; Stamm TA; van der Heijde DM; Verpoort KN; Brickmann K; V\u00e1zquez-Mellado J; Karateev DE; Breedveld FC; Emery P; Huizinga TWJ<\/span> (2010)<\/span> The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (3)<\/span>, pp. 495-502<\/span>. <\/a><\/p>","publicationid":"73131","date":"2010-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; Marzo-Ortega H; Rehman A; Emery P; McGonagle D; Leeds Spondyloarthropathy Grp<\/span> (2010)<\/span> The evidence for whole-spine MRI in the assessment of axial spondyloarthropathy<\/span>. RHEUMATOLOGY<\/span>, 49<\/span>, (3)<\/span>, pp. 426-432<\/span>. <\/a><\/p>","publicationid":"72070","date":"2010-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Durez P; Dougados M; Legerton CW; Becker JC; Vratsanos G; Genant HK; Peterfy C; Mitra P; Overfield S; Qi K; Westhovens R<\/span> (2010)<\/span> Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (3)<\/span>, pp. 510-516<\/span>. <\/a><\/p>","publicationid":"28458","date":"2010-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone EC; Fleischmann R; Furst DE; Macey K; Sweetser M; Kelman A; Rao R<\/span> (2010)<\/span> Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials<\/span>. J RHEUMATOL<\/span>, 37<\/span>, (3)<\/span>, pp. 558-567<\/span>. <\/a><\/p>","publicationid":"23179","date":"2010-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Marzo-Ortega H; Bennett AN; Emery P<\/span> (2010)<\/span> Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician<\/span>. Therapeutic advances in musculoskeletal disease<\/span>, 2<\/span>, (1)<\/span>, pp. 37-43<\/span>. <\/a><\/p>","publicationid":"217492","date":"2010-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2010)<\/span> New biologic for treating rheumatoid arthritis: clinical trial experience with tocilizumab<\/span>. International Journal of Clinical Rheumatology<\/span>, 5<\/span>, (1)<\/span>, pp. 17-24<\/span>. <\/a><\/p>","publicationid":"201502","date":"2010-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Haque S; Gordon C; Isenberg D; Rahman A; Lanyon P; Bell A; Emery P; McHugh N; Teh LS; Scott DGI; Akil M; Naz S; Andrews J; Griffiths B; Harris H; Youssef H; McLaren J; Toescu V; Devakumar V; Teir J; Bruce IN<\/span> (2010)<\/span> Risk Factors for Clinical Coronary Heart Disease in Systemic Lupus Erythematosus: The Lupus and Atherosclerosis Evaluation of Risk (LASER) Study<\/span>. J RHEUMATOL<\/span>, 37<\/span>, (2)<\/span>, pp. 322-329<\/span>. <\/a><\/p>","publicationid":"122239","date":"2010-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alten RE; Zerbini C; Jeka S; Irazoque F; Khatib F; Emery P; Bertasso A; Rabbia M; Caulfield JP<\/span> (2010)<\/span> Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (2)<\/span>, pp. 364-367<\/span>. <\/a><\/p>","publicationid":"85626","date":"2010-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston JE; Wakefield RJ; Conaghan PG; Hensor EMA; Stewart SP; Emery P<\/span> (2010)<\/span> A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (2)<\/span>, pp. 417-419<\/span>. <\/a><\/p>","publicationid":"48134","date":"2010-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jones E; Churchman SM; English A; Buch MH; Horner EA; Burgoyne CH; Reece R; Kinsey S; Emery P; McGonagle D; Ponchel F<\/span> (2010)<\/span> Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level<\/span>. ANN RHEUM DIS<\/span>, 69<\/span>, (2)<\/span>, pp. 450-457<\/span>. <\/a><\/p>","publicationid":"21870","date":"2010-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Backhouse M; Pickles D; Mathieson H; Edgson L; Emery P; Bird H; Helliwell P; Redmond A<\/span> (2010)<\/span> Gait velocity exhibits more than 50% diurnal variation in Rheumatoid Arthritis: the divign study<\/span>. Journal of foot and ankle research<\/span>, 3<\/span>, (Suppl 1)<\/span>, pp. P1<\/span>. <\/a><\/p>","publicationid":"441742","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alcacer-Pitarch B; Siddle H; Christie M; Buch M; Emery P; Redmon A<\/span> (2010)<\/span> Unmet foot health needs in people with Systemic Sclerosis: an audit of foot health care provision<\/span>. Journal of foot and ankle research<\/span>, 3<\/span>, (Suppl 1)<\/span>, pp. O2<\/span>. <\/a><\/p>","publicationid":"366170","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Din OS; Dodwell D; Wakefield RJ; Bradburn M; Emery P; Wilson G; Tan AL; O'Connor P; Highland A; Horgan K; Coleman RE<\/span> (2010)<\/span> Investigating Early Features of Aromatase Inhibitor-Induced Arthralgia<\/span>. CANCER RESEARCH<\/span>, 70<\/span>, (24_Supplement)<\/span>, pp. p5-11-18-p5-11-18<\/span>. <\/a><\/p>","publicationid":"356238","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Villeneuve E; Nam J; Emery P<\/span> (2010)<\/span> 2010 ACR-EULAR classification criteria for rheumatoid arthritis<\/span>. REVISTA BRASILEIRA DE REUMATOLOGIA<\/span>, 50<\/span>, (5)<\/span>, pp. 484-486<\/span>.<\/p>","publicationid":"203261","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Villeneuve E; Emery P<\/span> (2010)<\/span> Erratum to: Rheumatoid arthritis: what has changed?<\/span> Skeletal Radiology<\/span>, pp. 1<\/span>. <\/a><\/p>","publicationid":"202833","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Villeneuve E; Nam J; Emery P<\/span> (2010)<\/span> 2010 ACR-EULAR classification criteria for rheumatoid arthritis<\/span>. Rev Bras Reumatol<\/span>, 50<\/span>, (5)<\/span>, pp. 481-483<\/span>. <\/a><\/p>","publicationid":"153813","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton S; Buch MH; Emery P<\/span> (2010)<\/span> Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations<\/span>. Drug, healthcare and patient safety<\/span>, 2<\/span>, (1)<\/span>, pp. 101-119<\/span>. <\/a><\/p>","publicationid":"143770","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tinazzi I; Abignano G; Colato C; Biasi D; Emery P; Del Galdo F<\/span> (2010)<\/span> Comparative analysis of sclerodermoid-graft versus host disease and systemic sclerosis skin tissues reveals insights in the specific pathways involved in bridging immune activation and tissue fibrosis<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 28<\/span>, (5)<\/span>, pp. S79<\/span>.<\/p>","publicationid":"133001","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Purcaru O; Taylor PC; Emery P; Palmer S<\/span> (2010)<\/span> COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM<\/span>. VALUE IN HEALTH<\/span>, 13<\/span>, (7)<\/span>, pp. A310<\/span>. <\/a><\/p>","publicationid":"132772","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Tanner SF; Rhodes LA; Tan AL; Conaghan PG; Hensor EMA; Radjenovic A; O'Connor P; Emery P; McGonagle D<\/span> (2010)<\/span> Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis (vol 38, pg 79, 2009)<\/span>. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY<\/span>, 39<\/span>, (6)<\/span>, pp. 527<\/span>.<\/p>","publicationid":"132621","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Eyre S; Hinks A; Bowes J; Flynn E; Martin P; Wilson AG; Morgan AW; Emery P; Steer S; Hocking LJ; Reid DM; Harrison P; Wordsworth P; Yorkshire Early Arthritis Consortium; Biologics in RA Control Consortium; Thomson W; Worthington J; Barton A<\/span> (2010)<\/span> Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease<\/span>. Arthritis Res Ther<\/span>, 12<\/span>, (5)<\/span>, pp. R175<\/span>. <\/a><\/p>","publicationid":"132263","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barkham N; Coates LC; Keen H; Hensor E; Fraser A; Redmond A; Cawkwell L; Emery P<\/span> (2010)<\/span> Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, 69<\/span>, (11)<\/span>, pp. 1926-1928<\/span>. <\/a><\/p>","publicationid":"129818","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dijkmans B; Emery P; Hakala M<\/span> (2010)<\/span> Etanercept in the longterm treatment of patients with ankylosing spondylitis. (vol 36, pg 1256, 2009)<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, 37<\/span>, (10)<\/span>, pp. 2198<\/span>.<\/p>","publicationid":"129738","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Bennett AN; McGonagle D; Emery P; Maksymowych WP<\/span> (2010)<\/span> VALIDATION OF THE ASAS DEFINITION OF A POSITIVE MRI IN A COHORT OF PATIENTS WITH EARLY SPA FOLLOWED FOR EIGHT YEARS<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 28<\/span>, (4)<\/span>, pp. 608-609<\/span>.<\/p>","publicationid":"127840","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Bennett A; Emery P; McGonagle D; Marzo-Ortega H<\/span> (2010)<\/span> THE NEW ASAS CRITERIA FOR AXIAL SPA DOES NOT PREDICT THE DEVELOPMENT OF MNYC AS AT 8 YEARS IN A COHORT OF VERY EARLY IBP PATIENTS<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 28<\/span>, (4)<\/span>, pp. 629<\/span>.<\/p>","publicationid":"127698","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Wakefield R; Tan AL; Hodgson R; Grainger A; Emery P; McGonagle D<\/span> (2010)<\/span> COMPARISON OF ULTRASONOGRAPHY AND MAGNETIC RESONANCE IMAGING FOR THE ASSESSMENT OF CLINICALLY DEFINED KNEE ENTHESITIS IN SPONDYLOARTHRITIS<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 28<\/span>, (4)<\/span>, pp. 636<\/span>.<\/p>","publicationid":"127634","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barkham N; Keen H; Coates L; O'Connor P; Hensor E; McGonagle D; Marzo-Ortega H; Emery P<\/span> (2010)<\/span> CONTINUED EFFICACY OF INFLIXIMAB IN THE TREATMENT OF HLA B27 POSITIVE VERY EARLY ANKYLOSING SPONDYLITIS FOLLOWING ITS DISCONTINUATION - CLINICAL AND IMAGING RESULTS OF THE 40 WEEK FOLLOW-UP STUDY OF A THREE MONTH, RANDOMISED, PLACEBO-CONTROLLED TRIAL<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 28<\/span>, (4)<\/span>, pp. 606<\/span>.<\/p>","publicationid":"126995","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aydin SZ; Bennett A; Emery P; McGonagle D; Marco-Ortega H<\/span> (2010)<\/span> DISEASE ACTIVITY ASSESSMENT BY ASDAS DOESN'T PREDICT SACROILIAC INFLAMMATION WITH MRI IN AXIAL SPA<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 28<\/span>, (4)<\/span>, pp. 627<\/span>.<\/p>","publicationid":"126720","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ash ZR; Marzo-Ortega H; Buch M; Ogah K; Collyns T; Emery P<\/span> (2010)<\/span> DOES THE ADDITION OF A QUANTIFERON\u00ae TEST REDUCE THE USE OF CHEMOPROPHYLAXIS IN RHEUMATOLOGY PATIENTS COMMENCING ANTI-TUMOUR NECROSIS FACTOR AGENTS?<\/span> CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 28<\/span>, (4)<\/span>, pp. 622-623<\/span>.<\/p>","publicationid":"126719","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sanchez OA; Kissel K; Alecock E; Emery P<\/span> (2010)<\/span> TOCILIZUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN RA PATIENTS WITH INADEQUATE RESPONSE TO PRIOR ANTI-TNF THERAPY: THE RADIATE STUDY<\/span>. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY<\/span>, 16<\/span>, (3)<\/span>, pp. S43<\/span>.<\/p>","publicationid":"123788","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Keystone EC; Fleischmann R; Mease P; Breedveld FC; Smolen JS; Kalden JR; Braun J; Bresnihan B; Burmester GR; De Benedetti F; D\u00f6rner T; Emery P; Gibofsky A; Kavanaugh A; Kirkham B; Schiff MH; Sieper J; Singer N; Van Riel PLCM; Weinblatt ME; Weisman MH; Winthrop K<\/span> (2010)<\/span> Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009<\/span>. Ann Rheum Dis<\/span>, 69 Suppl 1<\/span>, (SUPPL. 2)<\/span>, pp. i2-29<\/span>. <\/a><\/p>","publicationid":"101402","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Robinson JI; Conaghan PG; Martin SG; Hensor EMA; Morgan MD; Steiner L; Erlich HA; Gooi HC; Barton A; Worthington J; Emery P; UKRAG Consortium & Year Consortium<\/span> (2010)<\/span> Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3\/TNFAIP3, STAT4 and TRAF1\/C5 in an inception cohort<\/span>. ARTHRITIS RES THER<\/span>, 12<\/span>, (2)<\/span>, pp. R57<\/span>. <\/a> <\/a><\/p>","publicationid":"86766","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kekow J; Moots RJ; Emery P; Durez P; Koenig A; Singh A; Pedersen R; Robertson D; Freundlich B; Sato R<\/span> (2010)<\/span> Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial<\/span>. Ann Rheum Dis<\/span>, 69<\/span>, (1)<\/span>, pp. 222-225<\/span>. <\/a><\/p>","publicationid":"77267","date":"2010-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aziz A; Wong CH; Emery P; McDermott MF<\/span> (2009)<\/span> Comparison of autoinflammation and autoimmunity using TRAPS and rheumatoid arthritis as prototypes of these conditions<\/span>. International Journal of Clinical Rheumatology<\/span>, 4<\/span>, (6)<\/span>, pp. 681-695<\/span>. <\/a><\/p>","publicationid":"201505","date":"2009-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Raychaudhuri S; Thomson BP; Remmers EF; Eyre S; Hinks A; Guiducci C; Catanese JJ; Xie G; Stahl EA; Chen R; Alfredsson L; Amos CI; Ardlie KG; BIRAC Consortium; Barton A; Bowes J; Burtt NP; Chang M; Coblyn J; Costenbader KH; Criswell LA; Crusius JBA; Cui J; De Jager PL; Ding B; Emery P; Flynn E; Harrison P; Hocking LJ; Huizinga TWJ; Kastner DL; Ke X; Kurreeman FAS; Lee AT; Liu X; Li Y; Martin P; Morgan AW; Padyukov L; Reid DM; Seielstad M; Seldin MF; Shadick NA; Steer S; Tak PP; Thomson W; van der Helm-van Mil AHM; van der Horst-Bruinsma IE; Weinblatt ME; Wilson AG; Wolbink GJ; Wordsworth P; YEAR Consortium; Altshuler D; Karlson EW; Toes REM; de Vries N; Begovich AB; Siminovitch KA; Worthington J; Klareskog L; Gregersen PK; Daly MJ; Plenge RM<\/span> (2009)<\/span> Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk<\/span>. Nat Genet<\/span>, 41<\/span>, (12)<\/span>, pp. 1313-1318<\/span>. <\/a><\/p>","publicationid":"96197","date":"2009-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Haugeberg G; Conaghan PG; Quinn M; Emery P<\/span> (2009)<\/span> Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study<\/span>. Ann Rheum Dis<\/span>, 68<\/span>, (12)<\/span>, pp. 1898-1901<\/span>. <\/a><\/p>","publicationid":"77240","date":"2009-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Genovese MC; Breedveld FC; Emery P; Cohen S; Keystone E; Matteson EL; Baptiste Y; Chai A; Burke L; Reiss W; Sweetser M; Shaw TM<\/span> (2009)<\/span> Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients<\/span>. Ann Rheum Dis<\/span>, 68<\/span>, (12)<\/span>, pp. 1894-1897<\/span>. <\/a><\/p>","publicationid":"26426","date":"2009-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kavanaugh A; Smolen JS; Emery P; Purcaru O; Keystone E; Richard L; Strand V; van Vollenhoven RF<\/span> (2009)<\/span> Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 61<\/span>, (11)<\/span>, pp. 1592-1600<\/span>. <\/a><\/p>","publicationid":"4418","date":"2009-11-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Macaraeg G; Kremer JM; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Becker JC; Wu G; Westhovens R<\/span> (2009)<\/span> P32 Abatacept demonstrates consistent safety and sustained improvements in efficacy through 5 years of treatment in biologic-na\u00efve patients with RA<\/span>. Indian Journal of Rheumatology<\/span>, 4<\/span>, (3)<\/span>, pp. S13-S14<\/span>. <\/a><\/p>","publicationid":"1103510","date":"2009-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McClure A; Lunt M; Eyre S; Ke XY; Thomson W; Hinks A; Bowes J; Gibbons L; Plant D; Wilson AG; Marinou I; Morgan AW; Emery P; Steer S; Hocking LJ; Reid DM; Wordsworth P; Harrison P; Worthington J; Barton A; BIRAC Consortium<\/span> (2009)<\/span> Investigating the viability of genetic screening\/testing for RA susceptibility using combinations of five confirmed risk loci<\/span>. RHEUMATOLOGY<\/span>, 48<\/span>, (11)<\/span>, pp. 1369-1374<\/span>. <\/a><\/p>","publicationid":"76518","date":"2009-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gilworth G; Emery P; Gossec L; Vlieland TPMV; Breedveld FC; Hueber AJ; Schett G; Tennant A<\/span> (2009)<\/span> Adaptation and cross-cultural validation of the rheumatoid arthritis work instability scale (RA-WIS)<\/span>. ANN RHEUM DIS<\/span>, 68<\/span>, (11)<\/span>, pp. 1686-1690<\/span>. <\/a><\/p>","publicationid":"69888","date":"2009-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hyrich KL; Deighton C; Watson KD; BSRBR Control Centre Consortium; Symmons DPM; Lunt M; British Society for Rheumatology Biologics Register<\/span> (2009)<\/span> Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity<\/span>. Rheumatology (Oxford)<\/span>, 48<\/span>, (10)<\/span>, pp. 1323-1327<\/span>. <\/a><\/p>","publicationid":"200441","date":"2009-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam J; Villeneuve E; Emery P<\/span> (2009)<\/span> The role of biomarkers in the management of patients with rheumatoid arthritis<\/span>. Current rheumatology reports<\/span>, 11<\/span>, (5)<\/span>, pp. 371-377<\/span>. <\/a><\/p>","publicationid":"108185","date":"2009-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Anis A; Zhang W; Emery P; Sun HY; Singh A; Freundlich B; Sato R<\/span> (2009)<\/span> The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study<\/span>. RHEUMATOLOGY<\/span>, 48<\/span>, (10)<\/span>, pp. 1283-1289<\/span>. <\/a><\/p>","publicationid":"4567","date":"2009-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; D'Agostino M-A; LeBars M; Baron G; Schmidely N; Wakefield R; Ravaud P; Grassi W; Martin-Mola E; So A; Backhaus M; Malaise M; Emery P; Conaghan PG<\/span> (2009)<\/span> 444 CLINICAL AND ULTRASONOGRAPHIC PREDICTORS OF JOINT REPLACEMENT FOR KNEE OSTEOARTHRITIS: RESULTS FROM A LARGE, 5 YEARS, PROSPECTIVE EULAR STUDY<\/span>. Osteoarthritis and Cartilage<\/span>, 17<\/span>, pp. S237<\/span>. <\/a><\/p>","publicationid":"829467","date":"2009-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jarrett SJ; Sivera F; Cawkwell LS; Marzo-Ortega H; McGonagle D; Hensor E; Coates L; O'Connor PJ; Fraser A; Conaghan PG; Emery P<\/span> (2009)<\/span> MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib<\/span>. ANN RHEUM DIS<\/span>, 68<\/span>, (9)<\/span>, pp. 1466-1469<\/span>. <\/a><\/p>","publicationid":"59406","date":"2009-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Thomson W; Martin SG; Carter AM; Erlich HA; Barton A; Hocking L; Reid DM; Harrison P; Wordsworth P; Steer S; Worthington J; Emery P; Wilson AG; Barrett JH; Yorkshire Early Arthritis Register; UK Rheumatoid Arthritis Genetics C<\/span> (2009)<\/span> Reevaluation of the Interaction Between HLA-DRB1 Shared Epitope Alleles, PTPN22, and Smoking in Determining Susceptibility to Autoantibody-Positive and Autoantibody-Negative Rheumatoid Arthritis in a Large UK Caucasian Population<\/span>. ARTHRITIS RHEUM<\/span>, 60<\/span>, (9)<\/span>, pp. 2565-2576<\/span>. <\/a><\/p>","publicationid":"16314","date":"2009-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Bird P; McQueen F; Peterfy C; Boyesen P; Gandjbakhch F; Duer-Jensen A; Haavardsholm EA; Ejbjerg B; Wiell C; Coates L; Hermann KGA; O'Connor P; Lassere M; Freeston JE; Anandarajah A; Genant H; Emery P; Ostergaard M<\/span> (2009)<\/span> The OMERACT MRI Inflammatory Arthritis Group: Advances and Future Research Priorities<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, 36<\/span>, (8)<\/span>, pp. 1803-1805<\/span>. <\/a><\/p>","publicationid":"45041","date":"2009-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Moreland LW; Hsia EC; Strusberg I; Durez P; Nash P; Amante EJB; Churchill M; Park W; Pons-Estel BA; Doyle MK; Visvanathan S; Xu WC; Rahman MU<\/span> (2009)<\/span> Golimumab, a Human Anti-Tumor Necrosis Factor alpha Monoclonal Antibody, Injected Subcutaneously Every Four Weeks in Methotrexate-Naive Patients With Active Rheumatoid Arthritis Twenty-Four-Week Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Golimumab Before Methotrexate as First-Line Therapy for Early-Onset Rheumatoid Arthritis<\/span>. ARTHRITIS RHEUM<\/span>, 60<\/span>, (8)<\/span>, pp. 2272-2283<\/span>. <\/a><\/p>","publicationid":"38673","date":"2009-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Orozco G; Hinks A; Eyre S; Ke X; Gibbons LJ; Bowes J; Flynn E; Martin P; Wellcome Trust Case Control Consortium; YEAR consortium; Wilson AG; Bax DE; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Barton A; Worthington J<\/span> (2009)<\/span> Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23<\/span>. Hum Mol Genet<\/span>, 18<\/span>, (14)<\/span>, pp. 2693-2699<\/span>. <\/a> <\/a><\/p>","publicationid":"96334","date":"2009-07-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Boyle DL; Rosengren S; Saleem B; Reece RJ; Rhodes LA; Radjenovic A; English A; Tang H; Vratsanos G; O'Connor P; Firestein GS; Emery P<\/span> (2009)<\/span> Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study<\/span>. ANN RHEUM DIS<\/span>, 68<\/span>, (7)<\/span>, pp. 1220-1227<\/span>. <\/a> <\/a><\/p>","publicationid":"108096","date":"2009-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Karim Z; Quinn M; Wakefield R; Hensor E; Conaghan PG; Emery P<\/span> (2009)<\/span> Disease Remission State in Patients Treated With the Combination of Tumor Necrosis Factor Blockade and Methotrexate or With Disease-Modifying Antirheumatic Drugs A Clinical and Imaging Comparative Study<\/span>. ARTHRITIS RHEUM<\/span>, 60<\/span>, (7)<\/span>, pp. 1915-1922<\/span>. <\/a><\/p>","publicationid":"107578","date":"2009-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bracewell C; Isaacs JD; Emery P; Ng WF<\/span> (2009)<\/span> Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis<\/span>. Expert Opin Biol Ther<\/span>, 9<\/span>, (7)<\/span>, pp. 909-919<\/span>. <\/a><\/p>","publicationid":"83892","date":"2009-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Genovese MC; van Vollenhoven R; Sharp JT; Patra K; Sasso EH<\/span> (2009)<\/span> Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis<\/span>. J RHEUMATOL<\/span>, 36<\/span>, (7)<\/span>, pp. 1429-1441<\/span>. <\/a><\/p>","publicationid":"77760","date":"2009-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barton A; Eyre S; Ke X; Hinks A; Bowes J; Flynn E; Martin P; YEAR Consortium; BIRAC Consortium; Wilson AG; Morgan AW; Emery P; Steer S; Hocking LJ; Reid DM; Harrison P; Wordsworth P; Thomson W; Worthington J<\/span> (2009)<\/span> Identification of AF4\/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes<\/span>. Hum Mol Genet<\/span>, 18<\/span>, (13)<\/span>, pp. 2518-2522<\/span>. <\/a><\/p>","publicationid":"25174","date":"2009-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gilworth G; Emery P; Barkham N; Smyth MG; Helliwell P; Tennant A<\/span> (2009)<\/span> Reducing work disability in Ankylosing Spondylitis - development of a work instability scale for AS<\/span>. BMC MUSCULOSKEL DIS<\/span>, 10<\/span>, (1)<\/span>, pp. 68<\/span>. <\/a> <\/a><\/p>","publicationid":"200113","date":"2009-06-16","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Dass S; Buch MH; Rawstron AC; Ponchel F; McGonagle D; Emery P<\/span> (2009)<\/span> Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al<\/span>. ARTHRITIS RHEUM<\/span>, 60<\/span>, (6)<\/span>, pp. 1867<\/span>. <\/a><\/p>","publicationid":"99060","date":"2009-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; Marzo-Ortega H; Emery P; McGonagle D; Leeds Spondyloarthropathy Group<\/span> (2009)<\/span> Diagnosing axial spondyloarthropathy. The new Assessment in SpondyloArthritis international Society criteria: MRI entering centre stage<\/span>. Ann Rheum Dis<\/span>, 68<\/span>, (6)<\/span>, pp. 765-767<\/span>. <\/a><\/p>","publicationid":"84937","date":"2009-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Han C; van der Heijde DMFM; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Aletaha D; Baker D; Han J; Bala M; St Clair EW; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group<\/span> (2009)<\/span> Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade<\/span>. Ann Rheum Dis<\/span>, 68<\/span>, (6)<\/span>, pp. 823-827<\/span>. <\/a><\/p>","publicationid":"65714","date":"2009-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rudwaleit M; Landew\u00e9 R; van der Heijde D; Listing J; Brandt J; Braun J; Burgos-Vargas R; Collantes-Estevez E; Davis J; Dijkmans B; Dougados M; Emery P; van der Horst-Bruinsma IE; Inman R; Khan MA; Leirisalo-Repo M; van der Linden S; Maksymowych WP; Mielants H; Olivieri I; Sturrock R; de Vlam K; Sieper J<\/span> (2009)<\/span> The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal<\/span>. Ann Rheum Dis<\/span>, 68<\/span>, (6)<\/span>, pp. 770-776<\/span>. <\/a><\/p>","publicationid":"50237","date":"2009-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dijkmans B; Emery P; Hakala M; Leirisalo-Repo M; Mola EM; Paolozzi L; Salvarani C; Sanmarti R; Sibilia J; Sieper J; Van den Bosch F; van der Heijde D; van der Linden S; Wajdula J<\/span> (2009)<\/span> Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis<\/span>. J RHEUMATOL<\/span>, 36<\/span>, (6)<\/span>, pp. 1256-1264<\/span>. <\/a><\/p>","publicationid":"3545","date":"2009-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Appel GB; Contreras G; Dooley MA; Ginzler EM; Isenberg D; Jayne D; Li L-S; Mysler E; S\u00e1nchez-Guerrero J; Solomons N; Wofsy D; Aspreva Lupus Management Study Group<\/span> (2009)<\/span> Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis<\/span>. J Am Soc Nephrol<\/span>, 20<\/span>, (5)<\/span>, pp. 1103-1112<\/span>. <\/a><\/p>","publicationid":"199728","date":"2009-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; Rehman A; Hensor EMA; Marzo-Ortega H; Emery P; McGonagle D<\/span> (2009)<\/span> Evaluation of the Diagnostic Utility of Spinal Magnetic Resonance Imaging in Axial Spondylarthritis<\/span>. ARTHRITIS RHEUM<\/span>, 60<\/span>, (5)<\/span>, pp. 1331-1341<\/span>. <\/a><\/p>","publicationid":"88600","date":"2009-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bejarano V; Conaghan PG; Proudman SM; Buch MH; Brown AK; Emery P<\/span> (2009)<\/span> Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis<\/span>. Annals of the rheumatic diseases<\/span>, 68<\/span>, (5)<\/span>, pp. 761-763<\/span>. <\/a><\/p>","publicationid":"33840","date":"2009-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Goeb V; Buch MH; Vital EM; Emery P<\/span> (2009)<\/span> Costimulation blockade in rheumatic diseases: where we are?<\/span> CURR OPIN RHEUMATOL<\/span>, 21<\/span>, (3)<\/span>, pp. 244-250<\/span>. <\/a><\/p>","publicationid":"11917","date":"2009-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; Emery P<\/span> (2009)<\/span> MRI predicts response to anti-TNF in ankylosing spondylitis<\/span>. International Journal of Clinical Rheumatology<\/span>, 4<\/span>, (2)<\/span>, pp. 123-126<\/span>. <\/a><\/p>","publicationid":"200805","date":"2009-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Combe B; Swergold G; McLay J; McCarthy T; Zerbini C; Emery P; Connors L; Kaur A; Curtis S; Laine L; Cannon CP<\/span> (2009)<\/span> Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study)<\/span>. RHEUMATOLOGY<\/span>, 48<\/span>, (4)<\/span>, pp. 425-432<\/span>. <\/a><\/p>","publicationid":"85742","date":"2009-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Van Vollenhoven R; Ostergaard M; Choy E; Combe B; Graninger W; Krueger K; Matucci-Cerinic M; Navarro F; van Riel P; Settas L; Steinfeld S<\/span> (2009)<\/span> Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe<\/span>. Ann Rheum Dis<\/span>, 68<\/span>, (4)<\/span>, pp. 456-459<\/span>. <\/a><\/p>","publicationid":"70846","date":"2009-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barkham N; Keen HI; Coates LC; O'Connor P; Hensor E; Fraser AD; Cawkwell LS; Bennett A; McGonagle D; Emery P<\/span> (2009)<\/span> Clinical and Imaging Efficacy of Infliximab in HLA-B27-Positive Patients With Magnetic Resonance Imaging-Determined Early Sacroiliitis<\/span>. ARTHRITIS RHEUM<\/span>, 60<\/span>, (4)<\/span>, pp. 946-954<\/span>. <\/a><\/p>","publicationid":"62241","date":"2009-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Westhovens R; Kremer JM; Moreland LW; Emery P; Russell AS; Li T; Aranda R; Becker JC; Qi KQ; Dougados M<\/span> (2009)<\/span> Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study<\/span>. J RHEUMATOL<\/span>, 36<\/span>, (4)<\/span>, pp. 736-742<\/span>. <\/a><\/p>","publicationid":"21326","date":"2009-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Covic T; Pallant JF; Tennant A; Cox S; Emery P; Conaghan PG<\/span> (2009)<\/span> Variability in depression prevalence in early rheumatoid arthritis: a comparison of the CES-D and HAD-D Scales<\/span>. BMC Musculoskelet Disord<\/span>, 10<\/span>, (1)<\/span>, pp. 18<\/span>. <\/a><\/p>","publicationid":"92511","date":"2009-02-07","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Doward LC; McKenna SP; Whalley D; Tennant A; Griffiths B; Emery P; Veale DJ<\/span> (2009)<\/span> The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus<\/span>. ANN RHEUM DIS<\/span>, 68<\/span>, (2)<\/span>, pp. 196-200<\/span>. <\/a><\/p>","publicationid":"112593","date":"2009-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Emery P; Peterfy CG; Tak PP; Cohen S; Genovese MC; Dougados M; Burmester GR; Greenwald M; Kvien TK; Williams S; Hagerty D; Cravets MW; Shaw T<\/span> (2009)<\/span> Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies<\/span>. ANN RHEUM DIS<\/span>, 68<\/span>, (2)<\/span>, pp. 216-221<\/span>. <\/a><\/p>","publicationid":"103396","date":"2009-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Villeneuve E; Emery P<\/span> (2009)<\/span> Rheumatoid arthritis: what has changed?<\/span> SKELETAL RADIOL<\/span>, 38<\/span>, (2)<\/span>, pp. 109-112<\/span>. <\/a><\/p>","publicationid":"65716","date":"2009-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Siddall R<\/span> (2009)<\/span> Tocilizumab \u2014 IL\u20106 inhibition for the treatment of rheumatoid arthritis<\/span>. Future Prescriber<\/span>, 10<\/span>, (1)<\/span>, pp. 5-10<\/span>. <\/a><\/p>","publicationid":"1103623","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dass S; Vital EM; Emery P<\/span> (2009)<\/span> Rituximab<\/span>. pp. 362-366<\/span>. <\/a><\/p>","publicationid":"265324","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hinks A; Ke X; Barton A; Eyre S; Bowes J; Worthington J; Thompson SD; Langefeld CD; Glass DN; Thomson W; UK Rheumatoid Arthritis Genetics Consortium; British Society of Paediatric and Adolescent Rheumatology Study Group<\/span> (2009)<\/span> Association of the IL2RA\/CD25 gene with juvenile idiopathic arthritis<\/span>. Arthritis Rheum<\/span>, 60<\/span>, (1)<\/span>, pp. 251-257<\/span>. <\/a> <\/a><\/p>","publicationid":"199151","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen J; Purcaru O; Emery P<\/span> (2009)<\/span> CERTOLIZUMAB PEGOL DEMONSTRATES SIGNIFICANT IMPROVEMENTS IN THE PRODUCTIVITY OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS, PARTICULARLY IN THE HOUSEHOLD<\/span>. VALUE IN HEALTH<\/span>, 12<\/span>, (7)<\/span>, pp. A449<\/span>. <\/a><\/p>","publicationid":"93878","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Go\u00ebb V; Smolen J; Emery P; Marzo-Ortega H<\/span> (2009)<\/span> Early inflammatory clinics. Experience with early arthritis\/back pain clinics<\/span>. Clin Exp Rheumatol<\/span>, 27<\/span>, (4 Suppl 55)<\/span>, pp. S74-S79<\/span>.<\/p>","publicationid":"88221","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Taylor P; Isaacs JD; Drost P; Dupont D; Beresniak A<\/span> (2009)<\/span> COST-EFFECTIVENESS OF BIOLOGIC THERAPEUTIC SEQUENCES FOR RHEUMATOID ARTHRITIS IN THE UK<\/span>. VALUE IN HEALTH<\/span>, 12<\/span>, (7)<\/span>, pp. A439<\/span>. <\/a><\/p>","publicationid":"61206","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Milligan CJ; Li J; Sukumar P; Majeed Y; Dallas ML; English A; Emery P; Porter KE; Smith AM; McFadzean I; Beccano-Kelly D; Bahnasi Y; Cheong A; Naylor J; Zeng FN; Liu X; Gamper N; Jiang LH; Pearson HA; Peers C; Robertson B; Beech DJ<\/span> (2009)<\/span> Robotic multiwell planar patch-clamp for native and primary mammalian cells<\/span>. NAT PROTOC<\/span>, 4<\/span>, (2)<\/span>, pp. 244-255<\/span>. <\/a><\/p>","publicationid":"59105","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Tanner SF; Rhodes LA; Tan AL; Conaghan PG; Hensor EMA; Radjenovic A; O'Connor P; Emery P; McGonagle D<\/span> (2009)<\/span> Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis<\/span>. SCAND J RHEUMATOL<\/span>, 38<\/span>, (2)<\/span>, pp. 79-83<\/span>. <\/a><\/p>","publicationid":"49928","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Potter C; Hyrich KL; Tracey A; Lunt M; Plant D; Symmons DPM; Thomson W; Worthington J; Emery P; Morgan AW; Wilson AG; Isaacs J; Barton A; BRAGGSS<\/span> (2009)<\/span> Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis<\/span>. ANN RHEUM DIS<\/span>, 68<\/span>, (1)<\/span>, pp. 69-74<\/span>. <\/a><\/p>","publicationid":"18360","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buchanan J; Emery P; Keystone EC; Smolen J; Doyle MK; Hsia EC; Rahman MU; Gathany T; Han C; Parasuraman S<\/span> (2009)<\/span> GOLIMUMAB SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED RESULTS FROM THREE PHASE 3 STUDIES<\/span>. VALUE IN HEALTH<\/span>, 12<\/span>, (3)<\/span>, pp. A69<\/span>. <\/a><\/p>","publicationid":"14399","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

MARZO-ORTEGA H<\/span> (2009)<\/span> Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence<\/span>. Ann Rheum Dis<\/span>, 68<\/span>, (11)<\/span>, pp. 1721-1727<\/span>. <\/a><\/p>","publicationid":"6998","date":"2009-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keen HI; Wakefield RJ; Grainger AJ; Hensor EMA; Emery P; Conaghan PG<\/span> (2008)<\/span> An ultrasonographic study of osteoarthritis of the hand: synovitis and its relationship to structural pathology and symptoms<\/span>. Arthritis Rheum<\/span>, 59<\/span>, (12)<\/span>, pp. 1756-1763<\/span>. <\/a><\/p>","publicationid":"78831","date":"2008-12-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Keystone EC; Kirkham B; Kavanaugh A; Fleischmann R; Mease P; Breedveld FC; Smolen JS; Kalden JR; Burmester GR; Braun J; Emery P; Winthrop K; Bresnihan B; De Benedetti F; D\u00f6rner T; Gibofsky A; Schiff MH; Sieper J; Singer N; Van Riel PLCM; Weinblatt ME; Weisman MH<\/span> (2008)<\/span> Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008<\/span>. Ann Rheum Dis<\/span>, 67 Suppl 3<\/span>, (Ann Rheum Dis 64 2007)<\/span>, pp. iii2-ii25<\/span>. <\/a><\/p>","publicationid":"1103569","date":"2008-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Crawford A; Jones EA; English A; Mundy J; Henshaw K; Corscadden D; Emery P; McGonagle D; Hatton P<\/span> (2008)<\/span> Use of synovial fluid stem cells in cartilage tissue engineering<\/span>. 8th World Biomaterials Congress 2008<\/span>, 4<\/span>, pp. 2173<\/span>.<\/p>","publicationid":"245240","date":"2008-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Freeston JE; O'Connor P; Reay N; Budgen A; Hensor EMA; Helliwell PS; Emery P; Woodburn J<\/span> (2008)<\/span> The optimal assessment of the rheumatoid arthritis hindfoot: a comparative study of clinical examination, ultrasound and high field MRI<\/span>. ANN RHEUM DIS<\/span>, 67<\/span>, (12)<\/span>, pp. 1678-1682<\/span>. <\/a><\/p>","publicationid":"71384","date":"2008-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; McInnes IB; van Vollenhoven R; Kraan MC<\/span> (2008)<\/span> Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis<\/span>. Rheumatology<\/span>, 47<\/span>, (4)<\/span>, pp. 392-398<\/span>. <\/a><\/p>","publicationid":"21247","date":"2008-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Breedveld F; Koenig AS; Robertson D<\/span> (2008)<\/span> COMET results are not stellar Reply<\/span>. LANCET<\/span>, 372<\/span>, (9652)<\/span>, pp. 1808<\/span>. <\/a><\/p>","publicationid":"96290","date":"2008-11-22","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Emery P<\/span> (2008)<\/span> The development of targeted therapies in rheumatoid arthritis<\/span>. JOURNAL OF AUTOIMMUNITY<\/span>, 31<\/span>, (3)<\/span>, pp. 219-227<\/span>. <\/a><\/p>","publicationid":"110442","date":"2008-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Heijde DVD; Mason D; Landew\u00e9 R; Vollenhoven RV; Combe B; Emery P; Strand V; Mease P; Desai C; Pavelka K<\/span> (2008)<\/span> Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study<\/span>. Arthritis Rheum<\/span>, 58<\/span>, (11)<\/span>, pp. 3319-3329<\/span>. <\/a><\/p>","publicationid":"110432","date":"2008-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Churchman SM; Church LD; Savic S; Coulthard LR; Hayward B; Nedjai B; Turner MD; Mathews RJ; Baguley E; Hitman GA; Gooi HC; Wood PMD; Emery P; McDermott MF<\/span> (2008)<\/span> A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)<\/span>. Ann Rheum Dis<\/span>, 67<\/span>, (11)<\/span>, pp. 1589-1595<\/span>. <\/a><\/p>","publicationid":"96783","date":"2008-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; McGonagle D; O'Connor P; Hensor EMA; Sivera F; Coates LC; Emery P; Marzo-Ortega H<\/span> (2008)<\/span> Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years<\/span>. Arthritis Rheum<\/span>, 58<\/span>, (11)<\/span>, pp. 3413-3418<\/span>. <\/a> <\/a><\/p>","publicationid":"94545","date":"2008-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dass S; Bowman SJ; Vital EM; Ikeda K; Pease CT; Hamburger J; Richards A; Rauz S; Emery P<\/span> (2008)<\/span> Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study<\/span>. ANN RHEUM DIS<\/span>, 67<\/span>, (11)<\/span>, pp. 1541-1544<\/span>. <\/a><\/p>","publicationid":"13153","date":"2008-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Keystone E; Tony HP; Cantagrel A; van Vollenhoven R; Sanchez A; Alecock E; Lee J; Kremer J<\/span> (2008)<\/span> IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial<\/span>. Ann Rheum Dis<\/span>, 67<\/span>, (11)<\/span>, pp. 1516-1523<\/span>. <\/a><\/p>","publicationid":"10615","date":"2008-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bejarano V; Quinn M; Conaghan PG; Reece R; Keenan AM; Walker D; Gough A; Green M; McGonagle D; Adebajo A; Jarrett S; Doherty S; Hordon L; Melsom R; Unnebrink K; Kupper H; Emery P; Yorkshire Early Arthrit Register<\/span> (2008)<\/span> Effect of the Early Use of the Anti-Tumor Necrosis Factor Adalimumab on the Prevention of Job Loss in Patients With Early Rheumatoid Arthritis<\/span>. ARTHRIT RHEUM-ARTHR<\/span>, 59<\/span>, (10)<\/span>, pp. 1467-1474<\/span>. <\/a><\/p>","publicationid":"63219","date":"2008-10-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D; EULAR; ACR<\/span> (2008)<\/span> Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR\/ACR collaborative recommendations<\/span>. Arthritis Rheum<\/span>, 59<\/span>, (10)<\/span>, pp. 1371-1377<\/span>. <\/a><\/p>","publicationid":"45936","date":"2008-10-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nam J; Villeneuve E; Emery P<\/span> (2008)<\/span> Predicting the development of rheumatoid arthritis in patients with recent-onset undifferentiated arthritis<\/span>. Future Rheumatology<\/span>, 3<\/span>, (5)<\/span>, pp. 441-444<\/span>. <\/a><\/p>","publicationid":"200567","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D<\/span> (2008)<\/span> Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR\/ACR collaborative recommendations<\/span>. Ann Rheum Dis<\/span>, 67<\/span>, (10)<\/span>, pp. 1360-1364<\/span>. <\/a><\/p>","publicationid":"107110","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dass S; Rawstron AC; Vital EM; Henshaw K; McGonagle D; Emery P<\/span> (2008)<\/span> Highly Sensitive B Cell Analysis Predicts Response to Rituximab Therapy in Rheumatoid Arthritis<\/span>. ARTHRITIS RHEUM<\/span>, 58<\/span>, (10)<\/span>, pp. 2993-2999<\/span>. <\/a><\/p>","publicationid":"95104","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown AK; Conaghan PG; Karim Z; Quinn MA; Ikeda K; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P<\/span> (2008)<\/span> An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis<\/span>. ARTHRITIS RHEUM<\/span>, 58<\/span>, (10)<\/span>, pp. 2958-2967<\/span>. <\/a><\/p>","publicationid":"58866","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barton A; Thomson W; Ke X; Eyre S; Hinks A; Bowes J; Plant D; Gibbons LJ; Wellcome Trust Case Control Consortium; YEAR Consortium; BIRAC Consortium; Wilson AG; Bax DE; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Worthington J<\/span> (2008)<\/span> Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13<\/span>. Nat Genet<\/span>, 40<\/span>, (10)<\/span>, pp. 1156-1159<\/span>. <\/a><\/p>","publicationid":"43978","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Karonitsch T; Aletaha D; Boers M; Bombardieri S; Combe B; Dougados M; Emery P; Felson D; Gomez-Reino J; Keystone E; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Richards P; van Riel P; Siegel J; Smolen JS; Sokka T; van der Heijde D; van Vollenhoven R; Ward M; Wells G; Zink A; Landewe R<\/span> (2008)<\/span> Methods of deriving EULAR\/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 67<\/span>, (10)<\/span>, pp. 1365-1373<\/span>. <\/a><\/p>","publicationid":"39163","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Vital EM; Emery P<\/span> (2008)<\/span> Abatacept in the treatment of rheumatoid arthritis<\/span>. ARTHRITIS RES THER<\/span>, 10<\/span>, (Suppl 1)<\/span>, pp. S5<\/span>. <\/a> <\/a><\/p>","publicationid":"37637","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Reece RJ; Quinn MA; English A; Cunnane G; Henshaw K; Bingham SJ; Bejarano V; Isaacs J; Emery P<\/span> (2008)<\/span> The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)<\/span>. Rheumatology (Oxford)<\/span>, 47<\/span>, (10)<\/span>, pp. 1469-1475<\/span>. <\/a><\/p>","publicationid":"36098","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Reece RJ; Quinn MA; English A; Cunnane G; Henshaw K; Bingham SJ; Bejarano V; Isaacs J; Emery P<\/span> (2008)<\/span> The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)<\/span>. Rheumatology<\/span>, 47<\/span>, (10)<\/span>, pp. 1469-1475<\/span>. <\/a><\/p>","publicationid":"2223","date":"2008-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hardy R; Rabbitt EH; Filer A; Emery P; Hewison M; Stewart PM; Gittoes NJ; Buckley CD; Raza K; Cooper MS<\/span> (2008)<\/span> Local and systemic glucocorticoid metabolism in inflammatory arthritis<\/span>. ANN RHEUM DIS<\/span>, 67<\/span>, (9)<\/span>, pp. 1204-1210<\/span>. <\/a> <\/a><\/p>","publicationid":"113565","date":"2008-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston JE; Brown AK; Hensor EMA; Emery P; Conaghan PG<\/span> (2008)<\/span> Extremity magnetic resonance imaging assessment of synovitis (without contrast) in rheumatoid arthritis may be less accurate than power Doppler ultrasound<\/span>. Ann Rheum Dis<\/span>, 67<\/span>, (9)<\/span>, pp. 1351<\/span>. <\/a><\/p>","publicationid":"107807","date":"2008-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Wakefield RJ; Tan AL; D'Agostino MA; Toumi H; Hayashi K; Emery P; Benjamin M<\/span> (2008)<\/span> Distinct topography of erosion and new bone formation in Achilles tendon enthesitis - Implications for understanding the link between inflammation and bone formation in spondylarthritis<\/span>. ARTHRITIS RHEUM<\/span>, 58<\/span>, (9)<\/span>, pp. 2694-2699<\/span>. <\/a><\/p>","publicationid":"68257","date":"2008-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Emery P<\/span> (2008)<\/span> Role of oestrogen in the development of joint symptoms?<\/span> Lancet Oncol<\/span>, 9<\/span>, (9)<\/span>, pp. 817-818<\/span>. <\/a><\/p>","publicationid":"20614","date":"2008-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Breedveld FC; Hall S; Durez P; Chang DJ; Robertson D; Singh A; Pedersen RD; Koenig AS; Freundlich B<\/span> (2008)<\/span> Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial<\/span>. Lancet<\/span>, 372<\/span>, (9636)<\/span>, pp. 375-382<\/span>. <\/a><\/p>","publicationid":"103738","date":"2008-08-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keen HI; Wakefield RJ; Grainger AJ; Hensor EMA; Emery P; Conaghan PG<\/span> (2008)<\/span> Can ultrasonography improve on radiographic assessment in osteoarthritis of the hands? A comparison between radiographic and ultrasonographic detected pathology<\/span>. ANN RHEUM DIS<\/span>, 67<\/span>, (8)<\/span>, pp. 1116-1120<\/span>. <\/a><\/p>","publicationid":"117274","date":"2008-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barton A; Thomson W; Ke X; Eyre S; Hinks A; Bowes J; Gibbons L; Plant D; Wilson AG; Marinou I; Morgan A; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Worthington J; Wellcome Trust Case Control Consor; YEAR Consortium<\/span> (2008)<\/span> Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility<\/span>. HUM MOL GENET<\/span>, 17<\/span>, (15)<\/span>, pp. 2274-2279<\/span>. <\/a><\/p>","publicationid":"112315","date":"2008-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Mackie S; Quinn M; Nizam S; Hensor E; Jarrett S; Conaghan PG; Emery P<\/span> (2008)<\/span> Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?<\/span> Ann Rheum Dis<\/span>, 67<\/span>, (8)<\/span>, pp. 1178-1180<\/span>. <\/a><\/p>","publicationid":"92140","date":"2008-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keenan AM; McKenna SP; Doward LC; Conaghan PG; Emery P; Tennant A<\/span> (2008)<\/span> Development and validation of a needs-based quality of life instrument for osteoarthritis<\/span>. ARTHRIT RHEUM-ARTHR<\/span>, 59<\/span>, (6)<\/span>, pp. 841-848<\/span>. <\/a><\/p>","publicationid":"49126","date":"2008-06-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Burmester GR; Furie R; Loveless JE; Emery P; Kremer J; Tak PP; Broder MS; Yu E; Cravets M; Magrini F; Jost F<\/span> (2008)<\/span> Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy<\/span>. Arthritis Rheum<\/span>, 59<\/span>, (6)<\/span>, pp. 785-793<\/span>. <\/a><\/p>","publicationid":"7476","date":"2008-06-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jones EA; Crawford A; English A; Henshaw K; Mundy J; Corscadden D; Chapman T; Emery P; Hatton P; McGonagle D<\/span> (2008)<\/span> Synovial fluid mesenchymal stem cells in health and early osteoarthritis - Detection and functional evaluation at the single-cell level<\/span>. ARTHRITIS RHEUM<\/span>, 58<\/span>, (6)<\/span>, pp. 1731-1740<\/span>. <\/a><\/p>","publicationid":"115476","date":"2008-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Cawkwell LS; Ng NWF; Bennett AN; Bryer DJ; Fraser AD; Emery P; Marzo-Ortega H<\/span> (2008)<\/span> Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis<\/span>. Rheumatology (Oxford)<\/span>, 47<\/span>, (6)<\/span>, pp. 897-900<\/span>. <\/a><\/p>","publicationid":"81315","date":"2008-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Tan AL; Madden J; Taylor L; Emery P<\/span> (2008)<\/span> Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritis<\/span>. RHEUMATOLOGY<\/span>, 47<\/span>, (6)<\/span>, pp. 865-867<\/span>. <\/a><\/p>","publicationid":"50264","date":"2008-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Burgoyne CH; Field SL; Brown AK; Hensor EM; English A; Bingham SL; Verburg R; Fearon U; Lawson CA; Hamlin PJ; Straszynski L; Veale D; Conaghan P; Hull MA; van Laar JM; Tennant A; Emery P; Isaacs JD; Ponchel F<\/span> (2008)<\/span> Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse<\/span>. Ann Rheum Dis<\/span>, 67<\/span>, (6)<\/span>, pp. 750-757<\/span>. <\/a><\/p>","publicationid":"30073","date":"2008-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Merkel PA; Silliman NP; Denton CP; Furst DE; Khanna D; Emery P; Hsu VM; Streisand JB; Polisson RP; Akesson A; Coppock J; van den Hoogen F; Herrick A; Mayes MD; Veale D; Seibold JR; Black CM; Korn JH; CAT-192 Research Group; Scleroderma Clinical Trials Consortium<\/span> (2008)<\/span> Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial<\/span>. Arthritis Rheum<\/span>, 59<\/span>, (5)<\/span>, pp. 699-705<\/span>. <\/a><\/p>","publicationid":"117388","date":"2008-05-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; Cawkwell LS; Ng NWF; Bennett AN; Bryer DJ; Fraser AD; Emery P; Marzo-Ortega H<\/span> (2008)<\/span> Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience<\/span>. Ann Rheum Dis<\/span>, 67<\/span>, (5)<\/span>, pp. 717-719<\/span>. <\/a><\/p>","publicationid":"83965","date":"2008-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Haroon-Rashid L; Martin SG; Gooi HC; Worthington J; Thomson W; Barrett JH; Emery P<\/span> (2008)<\/span> The shared epitope hypothesis in rheumatoid arthritis<\/span>. ARTHRITIS RHEUM<\/span>, 58<\/span>, (5)<\/span>, pp. 1275-1283<\/span>. <\/a><\/p>","publicationid":"83010","date":"2008-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Coates LC; McGonagle DG; Bennett AN; Emery P; Marzo-Ortega H<\/span> (2008)<\/span> Uveitis and tumour necrosis factor blockade in ankylosing spondylitis<\/span>. Ann Rheum Dis<\/span>, 67<\/span>, (5)<\/span>, pp. 729-730<\/span>. <\/a><\/p>","publicationid":"17289","date":"2008-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Hale G; Rebello PRUB; Richards SJ; Gooi H-C; Waldmann H; Emery P; Isaacs JD<\/span> (2008)<\/span> Anti-CD4 monoclonal antibody\/tumour necrosis factor ?? inhibitors<\/span>. Reactions Weekly<\/span>, &NA;<\/span>, (1199)<\/span>, pp. 6-7<\/span>. <\/a><\/p>","publicationid":"779143","date":"2008-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Hale G; Rebello PRUB; Richards SJ; Gooi H-C; Waldmann H; Emery P; Isaacs JD<\/span> (2008)<\/span> A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis<\/span>. QJM<\/span>, 101<\/span>, (4)<\/span>, pp. 299-306<\/span>. <\/a><\/p>","publicationid":"105272","date":"2008-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kremer JM; Genant HK; Moreland LW; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Li T; Teng J; Becker JC; Westhovens R<\/span> (2008)<\/span> Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate<\/span>. ARTHRITIS RHEUM<\/span>, 58<\/span>, (4)<\/span>, pp. 953-963<\/span>. <\/a><\/p>","publicationid":"88795","date":"2008-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Olech E; Freeston JE; Conaghan PG; Hensor EMA; Emery P; Yocum D<\/span> (2008)<\/span> Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practice<\/span>. J Rheumatol<\/span>, 35<\/span>, (4)<\/span>, pp. 580-583<\/span>.<\/p>","publicationid":"78567","date":"2008-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Tan AL; Madden J; Rawstron AC; Rehman A; Emery P; Thomas S<\/span> (2008)<\/span> Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab<\/span>. RHEUMATOLOGY<\/span>, 47<\/span>, (4)<\/span>, pp. 552-553<\/span>. <\/a><\/p>","publicationid":"77446","date":"2008-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Madden J; Taylor L; Emery P; McGonagle D<\/span> (2008)<\/span> Rituximab use in everyday clinical practice as a first line biologic therapy for the treatment of DMARD resistant rheumatoid arthritis<\/span>. RHEUMATOLOGY<\/span>, 47<\/span>, pp. II47-II48<\/span>. <\/a><\/p>","publicationid":"59057","date":"2008-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; McInnes IB; van Vollenhoven R; Kraan MC<\/span> (2008)<\/span> Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 47<\/span>, (4)<\/span>, pp. 392-398<\/span>. <\/a><\/p>","publicationid":"36281","date":"2008-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Davey R; Bamford J; Emery P<\/span> (2008)<\/span> The ACR classification criteria for headache disorders in SLE fail to classify certain prevalent headache types<\/span>. Cephalalgia<\/span>, 28<\/span>, (3)<\/span>, pp. 296-299<\/span>. <\/a><\/p>","publicationid":"70719","date":"2008-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; Tan AL; Coates LC; Emery P; Marzo-Ortega H; McGonagle D<\/span> (2008)<\/span> Sustained response to anakinra in ankylosing spondylitis [3]<\/span>. Rheumatology<\/span>, 47<\/span>, (2)<\/span>, pp. 223-224<\/span>. <\/a><\/p>","publicationid":"61983","date":"2008-02-04","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bennett AN; Tan AL; Coates LC; Emery P; Marzo-Ortega H; McGonagle D<\/span> (2008)<\/span> Sustained response to anakinra in ankylosing spondylitis<\/span>. Rheumatology (Oxford)<\/span>, 47<\/span>, (2)<\/span>, pp. 223-224<\/span>. <\/a><\/p>","publicationid":"112240","date":"2008-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Tan AL; Madden J; Emery P; McDermott MF<\/span> (2008)<\/span> Successful treatment of resistant pseudogout with anakinra<\/span>. ARTHRITIS RHEUM<\/span>, 58<\/span>, (2)<\/span>, pp. 631-633<\/span>. <\/a><\/p>","publicationid":"77115","date":"2008-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Tan AL; Madden J; Emery P; McDermott MF<\/span> (2008)<\/span> Successful treatment of resistant pseudogout with anakinra<\/span>. Arthritis and Rheumatism<\/span>, 58<\/span>, (2)<\/span>, pp. 631-633<\/span>. <\/a><\/p>","publicationid":"66015","date":"2008-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Xu SZ; Sukumar P; Zeng FN; Li J; Jairaman A; English A; Naylor J; Ciurtin C; Majeed Y; Milligan CJ; Bahnasi YM; Al-Shawaf E; Porter KE; Jiang LH; Emery P; Sivaprasadarao A; Beech DJ<\/span> (2008)<\/span> TRPC channel activation by extracellular thioredoxin<\/span>. NATURE<\/span>, 451<\/span>, (7174)<\/span>, pp. 69-U9<\/span>. <\/a><\/p>","publicationid":"60876","date":"2008-01-03","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tak PP; Thurlings RM; Rossier C; Nestorov I; Dimic A; Mircetic V; Rischmueller M; Nasonov E; Shmidt E; Emery P; Munafo A<\/span> (2008)<\/span> Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double\u2010blind, placebo\u2010controlled, dose\u2010escalating, single\u2010 and repeated\u2010dose study<\/span>. Arthritis & Rheumatism<\/span>, 58<\/span>, (1)<\/span>, pp. 61-72<\/span>. <\/a><\/p>","publicationid":"197024","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Emery P<\/span> (2008)<\/span> Early studies of SpA: The leeds experience<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 26<\/span>, (4)<\/span>, pp. 719<\/span>.<\/p>","publicationid":"122632","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Koncz T; Pan S; Lowry S<\/span> (2008)<\/span> Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study<\/span>. CLINICAL THERAPEUTICS<\/span>, 30<\/span>, (1)<\/span>, pp. 70-83<\/span>. <\/a><\/p>","publicationid":"106566","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2008)<\/span> Advances in rheumatoid arthritis : the role of IL-6 - Peer Review<\/span>. Expert Review of Clinical Immunology<\/span>.<\/p>","publicationid":"95274","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tak PP; Thurlings RM; Rossier C; Nestorov I; Dimic A; Mircetic V; Rischmueller M; Nasonov E; Shmidt E; Emery P; Munafo A<\/span> (2008)<\/span> Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study<\/span>. Arthritis Rheum<\/span>, 58<\/span>, (1)<\/span>, pp. 61-72<\/span>. <\/a><\/p>","publicationid":"86456","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Genovese M; van Vollenhoven R; Breedveld F; Emery P; Moreland L; Keystone E; Matteson E; Baptiste Y; Burke L; Reiss W; Sweetser M; Shaw T<\/span> (2008)<\/span> Safety of TNF inhibitors (TNF-is) and non-biologic DMARDs in rheumatoid arthritis (RA) patients (pts) previously treated with Rituximab (RTX)<\/span>. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY<\/span>, 37<\/span>, pp. 44<\/span>.<\/p>","publicationid":"55289","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2008)<\/span> Sexuality in Rheumatic Diseases<\/span>. Rheumatology in Practice<\/span>.<\/p>","publicationid":"53013","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Barkham N; Keen HI; Coates LC; O'Connor P; Hensor EMA; Fraser A; Cawkwell LS; McGonagle D; Emery P<\/span> (2008)<\/span> A randomized controlled trial of infliximab shows clinical and MRI efficacy in HLA B27 positive very early ankylosing spondylitis<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 26<\/span>, (4)<\/span>, pp. 745<\/span>.<\/p>","publicationid":"48613","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Breedveld FC; Hall S; Durez P; Chang DJ; Robertson D; Singh A; Pederson RD; Koenig A; Freundlich B<\/span> (2008)<\/span> Clinical Remission,Normalized Function, and Radiographic Nonprogression in Subjects With ctive EarlyRheumatoid Arthritis : Results of the Randomized, Double-blind Combination of Methotrexate And Etanercept in Active Early Rheumatoid Arthritis ( COMET ) Tr<\/span>. The Lancet<\/span>, pp. 1-111<\/span>.<\/p>","publicationid":"45078","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mathews R; Churchman S; Coulthard L; Church L; Bryer D; Nazam S; Saleem B; Cook G; Emery P; McDermott M<\/span> (2008)<\/span> Effects of TNF blockade by Infliximab on the central inflammasome component NALP3 in rheumatoid arthritis patients<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, 26<\/span>, (2)<\/span>, pp. 207<\/span>.<\/p>","publicationid":"40818","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McKenna SP; Doward LC; Emery P<\/span> (2008)<\/span> Measuring quality of life in ankylosing spondylitis<\/span>. None<\/span>.<\/p>","publicationid":"38441","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buchanan J; Emery P; Keystone EC; Smolen J; Doyle MK; Hsia EC; Rahman MU; Gathany T; Han C; Parasuraman S<\/span> (2008)<\/span> GOLIMUMAB, A HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES TIME LOST FROM WORK FOR PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED RESULTS FROMTHREE PHASE 3 STUDIES<\/span>. VALUE IN HEALTH<\/span>, 11<\/span>, (6)<\/span>, pp. A550<\/span>. <\/a><\/p>","publicationid":"38336","date":"2008-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Freeston JE; Hensor EMA; Bryer D; Quinn MA; Emery P<\/span> (2007)<\/span> Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 57<\/span>, (8)<\/span>, pp. 1564-1567<\/span>. <\/a><\/p>","publicationid":"101663","date":"2007-12-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Fleischmann R; Emery P; Furst DE; van Vollenhoven R; Bathon J; Dougados M; Baldassare A; Ferraccioli G; Chubick A; Udell J; Cravets MW; Agarwal S; Cooper S; Magrini F<\/span> (2007)<\/span> Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open\u2010label extension analysis<\/span>. Arthritis & Rheumatism<\/span>, 56<\/span>, (12)<\/span>, pp. 3896-3908<\/span>. <\/a><\/p>","publicationid":"196895","date":"2007-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston JE; Olech E; Yocum D; Hensor EMA; Emery P; Conaghan PG<\/span> (2007)<\/span> A modification of the Omeract RA MRI score for erosions for use with an extremity MRI system with reduced field of view<\/span>. ANN RHEUM DIS<\/span>, 66<\/span>, (12)<\/span>, pp. 1669-1671<\/span>. <\/a><\/p>","publicationid":"90207","date":"2007-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Aletaha D; Koeller M; Weisman MH; Emery P<\/span> (2007)<\/span> New therapies for treatment of rheumatoid arthritis<\/span>. LANCET<\/span>, 370<\/span>, (9602)<\/span>, pp. 1861-1874<\/span>. <\/a><\/p>","publicationid":"77822","date":"2007-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Thomson W; Barton A; Ke X; Eyre S; Hinks A; Bowes J; Donn R; Symmons D; Hider S; Bruce IN; Wellcome Trust Case Control Consortium; Wilson AG; Marinou I; Morgan A; Emery P; YEAR Consortium; Carter A; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Strachan D; Worthington J<\/span> (2007)<\/span> Rheumatoid arthritis association at 6q23<\/span>. Nat Genet<\/span>, 39<\/span>, (12)<\/span>, pp. 1431-1433<\/span>. <\/a><\/p>","publicationid":"54898","date":"2007-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Fleischmann R; Emery P; Furst DE; van Vollenhoven R; Bathon J; Dougados M; Baldassare A; Ferraccioli G; Chubick A; Udell J; Cravets MW; Agarwal S; Cooper S; Magrini F<\/span> (2007)<\/span> Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis<\/span>. Arthritis Rheum<\/span>, 56<\/span>, (12)<\/span>, pp. 3896-3908<\/span>. <\/a><\/p>","publicationid":"24856","date":"2007-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Tan AL; Shankaranarayana S; Madden J; Emery P; McDermott MF<\/span> (2007)<\/span> Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra<\/span>. Ann Rheum Dis<\/span>, 66<\/span>, (12)<\/span>, pp. 1683-1684<\/span>. <\/a><\/p>","publicationid":"2054","date":"2007-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Mariette X; Emery P; Peterfy CG; Tak PP; Cohen SB; Genovese MC; Williams S; Hagerty D; Cravets MW; Shaw T<\/span> (2007)<\/span> L'inhibition de\u00a0la\u00a0progression radiologique avec\u00a0le\u00a0rituximab ne\u00a0d\u00e9pend pas de\u00a0l'efficacit\u00e9 clinique : r\u00e9sultats d'une \u00e9tude chez\u00a0des\u00a0patients atteints de\u00a0polyarthrite rhumato\u00efde et\u00a0pr\u00e9sentant une\u00a0r\u00e9ponse inad\u00e9quate \u00e0\u00a0au\u00a0moins 1 anti-TNF (REFLEX)<\/span>. Revue du Rhumatisme<\/span>, 74<\/span>, (10-11)<\/span>, pp. 996<\/span>. <\/a><\/p>","publicationid":"1103615","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Dougados M; Fleischmann RM; Emery P; Chubick A; Baldassare AR; Bathon JM; Hessey E; Hagerty D; Cooper S<\/span> (2007)<\/span> Retraitement par\u00a0rituximab dans\u00a0la\u00a0polyarthrite rhumato\u00efde : maintien de\u00a0l'efficacit\u00e9 chez\u00a0des\u00a0patients ayant pr\u00e9sent\u00e9 une\u00a0r\u00e9ponse inad\u00e9quate \u00e0\u00a0au\u00a0moins un\u00a0anti-TNF<\/span>. Revue du Rhumatisme<\/span>, 74<\/span>, (10-11)<\/span>, pp. 996<\/span>. <\/a><\/p>","publicationid":"1103583","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Van Vollenhoven R; Sibilia J; Emery P; Bingham C; Keystone E; Greenwald M; Moreland LW; Sweetser M; Rowe K; Wagner B; Magrini F<\/span> (2007)<\/span> Donn\u00e9es de\u00a0tol\u00e9rance \u00e0\u00a0long terme apr\u00e8s traitement et\u00a0retraitement par\u00a0RTX dans\u00a0la\u00a0polyarthrite rhumato\u00efde<\/span>. Revue du Rhumatisme<\/span>, 74<\/span>, (10-11)<\/span>, pp. 1021<\/span>. <\/a><\/p>","publicationid":"1103564","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; Combe B; Kremer J; Moreland L; Emery P; Becker J-C; Westhovens R<\/span> (2007)<\/span> Maintien \u00e0\u00a0long terme (5\u00a0ans) de\u00a0l'efficacit\u00e9 et\u00a0de\u00a0la\u00a0tol\u00e9rance d'Abatacept chez\u00a0les\u00a0patients (pts) ayant une\u00a0polyarthrite rhumato\u00efde et\u00a0trait\u00e9s par\u00a0m\u00e9thotrexate<\/span>. Revue du Rhumatisme<\/span>, 74<\/span>, (10-11)<\/span>, pp. 1065-1066<\/span>. <\/a><\/p>","publicationid":"1103551","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tak PP; Le Loet X; Cohen SB; Emery P; Saadeh CK; de Vita S; Donohue JP; Shaw TM; Magrini F<\/span> (2007)<\/span> R\u00e9ponse clinique apr\u00e8s un\u00a0premier traitement par\u00a0rituximab : relation avec\u00a0les\u00a0taux d'autoanticorps (FR, anti-CCP) \u00e0\u00a0l'\u00e9tat basal<\/span>. Revue du Rhumatisme<\/span>, 74<\/span>, (10-11)<\/span>, pp. 1130-1131<\/span>. <\/a><\/p>","publicationid":"1103530","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

English A; Jones EA; Corscadden D; Henshaw K; Chapman T; Emery P; McGonagle D<\/span> (2007)<\/span> A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis<\/span>. RHEUMATOLOGY<\/span>, 46<\/span>, (11)<\/span>, pp. 1676-1683<\/span>. <\/a><\/p>","publicationid":"119982","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Helliwell PS; Porter G; CASPAR study grp<\/span> (2007)<\/span> Sensitivity and specificity of plain radiographic features of peripheral enthesopathy at major sites in psoriatic arthritis<\/span>. SKELETAL RADIOL<\/span>, 36<\/span>, (11)<\/span>, pp. 1061-1066<\/span>. <\/a><\/p>","publicationid":"87288","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gliddon AE; Dore CJ; Black CM; McHugh N; Moots R; Denton C; Herrick A; Barnes TM; Camilleri JP; Chakravarty K; Emery P; Griffiths B; Hopkinson N; Hickling P; Lanyon P; Laversuch C; Lawson T; Mallya R; Nisar M; Rhys-Dillon C; Sheeran T; Maddison P<\/span> (2007)<\/span> Prevention of vascular damage in scleroderma and autoimmune Raynaud\u2019s phenomenon<\/span>. Arthritis and Rheumatism<\/span>, 56<\/span>, (11)<\/span>, pp. 3837-3846<\/span>.<\/p>","publicationid":"76879","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston JE; Conaghan PG; Dass S; Vital E; Hensor EMA; Stewart SP; Emery P<\/span> (2007)<\/span> Does extremity-MRI improve erosion detection in severely damaged joints? A study of long-standing rheumatoid arthritis using three imaging modalities<\/span>. Ann Rheum Dis<\/span>, 66<\/span>, (11)<\/span>, pp. 1538-1540<\/span>. <\/a><\/p>","publicationid":"74870","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Haugeberg G; Green MJ; Conaghan PG; Quinn M; Wakefield R; Proudman SM; Stewart S; Hensor E; Emery P<\/span> (2007)<\/span> Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 66<\/span>, (11)<\/span>, pp. 1513-1517<\/span>. <\/a><\/p>","publicationid":"30477","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gliddon AE; Dor\u00e9 CJ; Black CM; McHugh N; Moots R; Denton CP; Herrick A; Barnes T; Camilleri J; Chakravarty K; Emery P; Griffiths B; Hopkinson ND; Hickling P; Lanyon P; Laversuch C; Lawson T; Mallya R; Nisar M; Rhys-Dillon C; Sheeran T; Maddison PJ<\/span> (2007)<\/span> Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril<\/span>. Arthritis Rheum<\/span>, 56<\/span>, (11)<\/span>, pp. 3837-3846<\/span>. <\/a><\/p>","publicationid":"12244","date":"2007-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; O'Connor PJ; Conaghan PG; McGonagle D; Hensor EMA; Gibbon WW; Brown C; Emery P<\/span> (2007)<\/span> Finger tendon disease in untreated early rheumatoid arthritis: a comparison of ultrasound and magnetic resonance imaging<\/span>. Arthritis Rheum<\/span>, 57<\/span>, (7)<\/span>, pp. 1158-1164<\/span>. <\/a><\/p>","publicationid":"109976","date":"2007-10-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Rhodes LA; Tan AL; Tanner SF; Conaghan PG; Hensor EMA; O'Connor P; Radjenovic A; Pease CT; Emery P; McGonagle D<\/span> (2007)<\/span> Evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritis<\/span>. ARTHRITIS RHEUM<\/span>, 56<\/span>, (10)<\/span>, pp. 3496-3501<\/span>. <\/a><\/p>","publicationid":"100708","date":"2007-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dixon WG; Watson KD; Lunt M; Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium; Silman AJ; Symmons DPM; British Society for Rheumatology Biologics Register<\/span> (2007)<\/span> Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register<\/span>. Arthritis Rheum<\/span>, 56<\/span>, (9)<\/span>, pp. 2905-2912<\/span>. <\/a><\/p>","publicationid":"196496","date":"2007-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dixon WG; Symmons DPM; Lunt M; Watson KD; Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium; Silman AJ; British Society for Rheumatology Biologics Register<\/span> (2007)<\/span> Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies<\/span>. Arthritis Rheum<\/span>, 56<\/span>, (9)<\/span>, pp. 2896-2904<\/span>. <\/a><\/p>","publicationid":"196485","date":"2007-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Grainger AJ; Farrant JM; O'Connor PJ; Tan AL; Tanner S; Emery P; McGonagle D<\/span> (2007)<\/span> MR imaging of erosions in interphalangeal joint osteoarthritis: is all osteoarthritis erosive?<\/span> Skeletal Radiol<\/span>, 36<\/span>, (8)<\/span>, pp. 737-745<\/span>. <\/a><\/p>","publicationid":"102601","date":"2007-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dass S; Vital EM; Emery P<\/span> (2007)<\/span> Development of psoriasis after B cell depletion with rituximab<\/span>. Arthritis Rheum<\/span>, 56<\/span>, (8)<\/span>, pp. 2715-2718<\/span>. <\/a><\/p>","publicationid":"83037","date":"2007-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Davey R; Bamford J; Emery P<\/span> (2007)<\/span> The validity of the inclusion of \"lupus headache\" in the Systemic Lupus Erythematosus Disease Activity Index<\/span>. Arthritis Rheum<\/span>, 56<\/span>, (8)<\/span>, pp. 2812-2813<\/span>. <\/a><\/p>","publicationid":"73880","date":"2007-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Kvien TK<\/span> (2007)<\/span> Treating rheumatoid arthritis<\/span>. BMJ<\/span>, 335<\/span>, (7610)<\/span>, pp. 56-57<\/span>. <\/a><\/p>","publicationid":"107189","date":"2007-07-14","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; O'Connor P; Emery P; McGonagle D<\/span> (2007)<\/span> Sacroiliac joint biopsies in early sacroiliitis<\/span>. RHEUMATOLOGY<\/span>, 46<\/span>, (7)<\/span>, pp. 1210-1211<\/span>. <\/a><\/p>","publicationid":"91500","date":"2007-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gabay C; Kraan M; Gomez-Reino J<\/span> (2007)<\/span> Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis<\/span>. Rheumatol Int<\/span>, 27<\/span>, (9)<\/span>, pp. 793-806<\/span>. <\/a><\/p>","publicationid":"89781","date":"2007-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Bingham SJ; Bryer D; Emery P<\/span> (2007)<\/span> Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders<\/span>. Rheumatology (Oxford)<\/span>, 46<\/span>, (7)<\/span>, pp. 1153-1156<\/span>. <\/a><\/p>","publicationid":"30420","date":"2007-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; McGonagle D; Rhodes LA; Tan AL; Conaghan PG; Connor PO; Tanner SF; Fraser A; Veale D; Emery P<\/span> (2007)<\/span> Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis<\/span>. ANN RHEUM DIS<\/span>, 66<\/span>, (6)<\/span>, pp. 778-781<\/span>. <\/a><\/p>","publicationid":"93532","date":"2007-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ikeda K; Cox S; Emery P<\/span> (2007)<\/span> Aspects of early arthritis. Biological therapy in early arthritis - Overtreatment or the way to go?<\/span> Arthritis Research and Therapy<\/span>, 9<\/span>, (2)<\/span>. <\/a><\/p>","publicationid":"196759","date":"2007-05-24","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston J; Emery P<\/span> (2007)<\/span> R\u00f4le de\u00a0l'IRM et\u00a0de\u00a0l'\u00e9chographie en\u00a0tant que crit\u00e8res substitutifs d'efficacit\u00e9 structurale des\u00a0traitements de\u00a0la\u00a0polyarthrite rhumato\u00efde<\/span>. Revue du Rhumatisme<\/span>, 74<\/span>, (5)<\/span>, pp. 440-443<\/span>. <\/a><\/p>","publicationid":"195715","date":"2007-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Baxter K; Strauss RM; Drysdale S; Griffiths B; Misbah SA; Gough A; Cunliffe WJ; Emery P<\/span> (2007)<\/span> Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study<\/span>. Br J Dermatol<\/span>, 156<\/span>, (5)<\/span>, pp. 1005-1009<\/span>. <\/a><\/p>","publicationid":"105709","date":"2007-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Karim Z; Quinn MA; Wakefield RJ; Brown AK; Green MJ; Hensor EMA; Conaghan PG; Emery P<\/span> (2007)<\/span> Response to intramuscular methyl prednisolone in inflammatory hand pain: evidence for a targeted clinical, ultrasonographic and therapeutic approach<\/span>. Ann Rheum Dis<\/span>, 66<\/span>, (5)<\/span>, pp. 690-692<\/span>. <\/a><\/p>","publicationid":"75438","date":"2007-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston J; Emery P<\/span> (2007)<\/span> The role of MRI and ultrasound as surrogate markers of structural efficacy of treatments in rheumatoid arthritis<\/span>. Joint Bone Spine<\/span>, 74<\/span>, (3)<\/span>, pp. 227-229<\/span>. <\/a><\/p>","publicationid":"66754","date":"2007-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown AK; Roberts TE; Wakefield RJ; Karim Z; Hensor E; O'Connor PJ; Emery P<\/span> (2007)<\/span> The challenges of integrating ultrasonography into routine rheumatology practice: addressing the needs of clinical rheumatologists<\/span>. RHEUMATOLOGY<\/span>, 46<\/span>, (5)<\/span>, pp. 821-829<\/span>. <\/a><\/p>","publicationid":"65247","date":"2007-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Bingham SJ; Bejarano V; Bryer D; White J; Emery P; Reece R; Quinn M<\/span> (2007)<\/span> Therapy of patients with rheumatoid arthritis: Outcome of infliximab failures switched to etanercept<\/span>. ARTHRIT RHEUM-ARTHR<\/span>, 57<\/span>, (3)<\/span>, pp. 448-453<\/span>. <\/a><\/p>","publicationid":"95142","date":"2007-04-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McQueen F; Lassere M; Bird P; Haavardsholm EA; Peterfy C; Conaghan PG; Ejbjerg B; Genant H; O'Connor P; Emery P; Ostergaard M<\/span> (2007)<\/span> Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritis<\/span>. J RHEUMATOL<\/span>, 34<\/span>, (4)<\/span>, pp. 859-861<\/span>.<\/p>","publicationid":"122220","date":"2007-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Ejbjerg B; Lassere M; Bird P; Peterfy C; Emery P; McQueen F; Haavardsholm E; O'Connor P; Edmonds J; Genant H; Ostergaard M<\/span> (2007)<\/span> A multicenter reliability study of extremity-magnetic resonance imaging in the longitudinal evaluation of rheumatoid arthritis<\/span>. J RHEUMATOL<\/span>, 34<\/span>, (4)<\/span>, pp. 857-858<\/span>.<\/p>","publicationid":"121903","date":"2007-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bird P; Ejbjerg B; Lassere M; Ostergaard M; McQueen F; Peterfy C; Haavardsholm E; O'Connor P; Genant H; Edmonds J; Emery P; Conaghan PG<\/span> (2007)<\/span> A multireader reliability study comparing conventional high-field magnetic resonance imaging with extremity low-field MRI in rheumatoid arthritis<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, 34<\/span>, (4)<\/span>, pp. 854-856<\/span>.<\/p>","publicationid":"95847","date":"2007-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

\u00d8stergaard M; McQueen F; Bird P; Peterfy C; Haavardsholm E; Ejbjerg B; Lassere M; O'Connor P; Emery P; Edmonds J; Genant H; Conaghan PG; OMERACT Magnetic Resonance Imaging Inflammatory Arthritis Group<\/span> (2007)<\/span> The OMERACT Magnetic Resonance Imaging Inflammatory Arthritis Group - advances and priorities<\/span>. J Rheumatol<\/span>, 34<\/span>, (4)<\/span>, pp. 852-853<\/span>.<\/p>","publicationid":"59508","date":"2007-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Waller ML; Tan AL; Burns A; Bury RF; Jeavons AP; Emery P; McGonagle D<\/span> (2007)<\/span> P61 High-resolution quadHIDACTM 18F-fluoride PET for the investigation of osteoarthritis of the hand<\/span>. Nuclear Medicine Communications<\/span>, 28<\/span>, (3)<\/span>, pp. A35<\/span>. <\/a><\/p>","publicationid":"366524","date":"2007-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston J; Barkham N; Hensor E; Emery P; Fraser A<\/span> (2007)<\/span> Ankylosing Spondylitis, HLA-B27 positivity and\u00a0the\u00a0need for\u00a0Biologic Therapies {lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa r\u00e9f\u00e9rence dans le m\u00eame volume de Joint Bone Spine<\/span>. Revue Du Rhumatisme Edition Francaise<\/span>, 74<\/span>, (3)<\/span>, pp. 232-236<\/span>. <\/a><\/p>","publicationid":"195602","date":"2007-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR<\/span> (2007)<\/span> Outcome measurements in scleroderma: results from a delphi exercise<\/span>. J Rheumatol<\/span>, 34<\/span>, (3)<\/span>, pp. 501-509<\/span>.<\/p>","publicationid":"83978","date":"2007-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston J; Barkham N; Hensor E; Emery P; Fraser A<\/span> (2007)<\/span> Ankylosing spondylitis, HLA-B27 positivity and the need for biologic therapies<\/span>. JOINT BONE SPINE<\/span>, 74<\/span>, (2)<\/span>, pp. 140-143<\/span>. <\/a><\/p>","publicationid":"79490","date":"2007-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown AK; Roberts TE; O'connor PJ; Wakefield RJ; Karim Z; Emery P<\/span> (2007)<\/span> The development of an evidence-based educational framework to facilitate the training of competent rheumatologist ultrasonographers<\/span>. Rheumatology (Oxford)<\/span>, 46<\/span>, (3)<\/span>, pp. 391-397<\/span>. <\/a><\/p>","publicationid":"79345","date":"2007-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2007)<\/span> Exploring the evidence for early, aggressive therapy in RA<\/span>. British Medical Journal<\/span>, (334)<\/span>, pp. S13-16<\/span>.<\/p>","publicationid":"35278","date":"2007-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Green MJ; Keenan A-M; Wakefield RJ; Proudman S; Emery P<\/span> (2007)<\/span> A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis<\/span>. Arthritis Rheum<\/span>, 57<\/span>, (1)<\/span>, pp. 154-160<\/span>. <\/a><\/p>","publicationid":"102009","date":"2007-02-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Keystone EC; Emery P; Breedveld FC; Betteridge N; Burmester GR; Dougados M; Ferraccioli G; Jaeger U; Klareskog L; Kvien TK; Martin-Mola E; Pavelka K; Working Group on the Rituximab Consensus Statement<\/span> (2007)<\/span> Consensus statement on the use of rituximab in patients with rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 66<\/span>, (2)<\/span>, pp. 143-150<\/span>. <\/a><\/p>","publicationid":"121292","date":"2007-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Benjamin M; Toumi H; Grainger AJ; Tanner SF; Emery P; McGonagle D<\/span> (2007)<\/span> The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study<\/span>. Rheumatology (Oxford)<\/span>, 46<\/span>, (2)<\/span>, pp. 253-256<\/span>. <\/a><\/p>","publicationid":"119409","date":"2007-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells AU; Matucci-Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM; Seibold JR<\/span> (2007)<\/span> Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test<\/span>. Ann Rheum Dis<\/span>, 66<\/span>, (2)<\/span>, pp. 169-173<\/span>. <\/a><\/p>","publicationid":"111050","date":"2007-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Emery P<\/span> (2007)<\/span> Rheumatological Manifestations of Malignant Haemotological Conditions<\/span>. Rheumatic Disease Topical Reviews<\/span>, 5<\/span>, (11)<\/span>, pp. 1-8<\/span>.<\/p>","publicationid":"84034","date":"2007-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Russell AS; Wallenstein GV; Li T; Martin MC; Maclean R; Blaisdell B; Gajria K; Cole JC; Becker JC; Emery P<\/span> (2007)<\/span> Abatacept improves both the physical and mental health of rheumatoid arthritis patients with inadequate response to methotrexate therapy<\/span>. Annals of the Rheumatic Diseases<\/span>, 66<\/span>, (2)<\/span>, pp. 189-194<\/span>.<\/p>","publicationid":"65157","date":"2007-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Russell AS; Wallenstein GV; Li T; Martin MC; Maclean R; Blaisdell B; Gajria K; Cole JC; Becker J-C; Emery P<\/span> (2007)<\/span> Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment<\/span>. Ann Rheum Dis<\/span>, 66<\/span>, (2)<\/span>, pp. 189-194<\/span>. <\/a><\/p>","publicationid":"3489","date":"2007-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Benjamin M; Toumi H; Grainger AJ; Tanner SF; Emery P; McGonagle D<\/span> (2007)<\/span> The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis - A high-resolution MRI and histological study<\/span>. Rheumatology<\/span>, 46<\/span>, (2)<\/span>, pp. 253-256<\/span>. <\/a><\/p>","publicationid":"2179","date":"2007-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2007)<\/span> Rituximab in Rheumatoid Arthritis<\/span>. BioDrugs<\/span>, 21<\/span>, (5)<\/span>, pp. 342<\/span>. <\/a><\/p>","publicationid":"196506","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Michaud K; Bombardier C; Emery P<\/span> (2007)<\/span> Quality of life in patients with rheumatoid arthritis: does abatacept make a difference?<\/span> Clinical and Experimental Rheumatology<\/span>, 25<\/span>, (5 Suppl 46)<\/span>, pp. S35-45<\/span>.<\/p>","publicationid":"122157","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ikeda K; Cox S; Emery P<\/span> (2007)<\/span> Aspects of early arthritis. Biological therapy in early arthritis--overtreatment or the way to go?<\/span> Arthritis Res Ther<\/span>, 9<\/span>, (3)<\/span>, pp. 211<\/span>. <\/a><\/p>","publicationid":"105427","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Combe B; Landewe R; Lukas C; Bolosiu HD; Breedveld F; Dougados M; Emery P; Ferraccioli G; Hazes JMW; Klareskog L; Machold K; Martin-Mola E; Nielsen H; Silman A; Smolen J; Yazici H<\/span> (2007)<\/span> EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)<\/span>. Ann Rheum Dis<\/span>, 66<\/span>, (1)<\/span>, pp. 34-45<\/span>. <\/a><\/p>","publicationid":"102973","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Denton C; Merkel PA; Furst DE; Khanna D; Emery P; Hsu VM; Silliman N; Streisand J; Powell J; Akesson A; Coppock J; van den Hoogen F; Herrick A; Mayes MD; Veale D; Haas J; Ledbetter S; Korn JH; Black CM; Seibold JR<\/span> (2007)<\/span> Recombinant Human Anti-Transforming Growth Factor Beta-1 Antibody Therapy in Systemic Sclerosis<\/span>. Arthritis and Rheumatism<\/span>, 56<\/span>, (1)<\/span>, pp. 323-333<\/span>.<\/p>","publicationid":"102558","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Perniok A; Rubbert A; Dougados M; Emery P; Westhovens R; Le Bars M; Becker J; Aranda R; Kremer J<\/span> (2007)<\/span> Abatacept in treatment progression leads to increasing improvement in clinical indicators of disease activity: Results of the AIM study<\/span>. ZEITSCHRIFT FUR RHEUMATOLOGIE<\/span>, 66<\/span>, pp. 79<\/span>.<\/p>","publicationid":"90640","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Michaud K; Bombardier C; Emery P<\/span> (2007)<\/span> Quality of life in patients with rheumatoid arthritis: does abatacept make a difference?<\/span> Clin Exp Rheumatol<\/span>, 25<\/span>, (5 Suppl 46)<\/span>, pp. S35-S45<\/span>.<\/p>","publicationid":"76806","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Denton CP; Merkel PA; Furst DE; Khanna D; Emery P; Hsu VM; Silliman N; Streisand J; Powell J; Akesson A; Coppock J; Hoogen FVD; Herrick A; Mayes MD; Veale D; Haas J; Ledbetter S; Korn JH; Black CM; Seibold JR; Cat-192 Study Group; Scleroderma Clinical Trials Consortium<\/span> (2007)<\/span> Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192<\/span>. Arthritis Rheum<\/span>, 56<\/span>, (1)<\/span>, pp. 323-333<\/span>. <\/a><\/p>","publicationid":"73477","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Grainger AJ; Rhodes LA; Keenan AM; Emery P; Conaghan PG<\/span> (2007)<\/span> Quantifying peri-meniscal synovitis and its relationship to meniscal pathology in osteoarthritis of the knee<\/span>. EUR RADIOL<\/span>, 17<\/span>, (1)<\/span>, pp. 119-124<\/span>. <\/a><\/p>","publicationid":"61575","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Keen HI; Emery P; McGonagle D<\/span> (2007)<\/span> Imaging inflamed synovial joints<\/span>. Methods Mol Med<\/span>, 135<\/span>, pp. 3-26<\/span>. <\/a><\/p>","publicationid":"51062","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Freeston JE; Emery P<\/span> (2007)<\/span> The future of imaging in monitoring biologic therapy<\/span>. NAT CLIN PRACT RHEUM<\/span>, 3<\/span>, (1)<\/span>, pp. 2-3<\/span>. <\/a><\/p>","publicationid":"36562","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Benjamin M; Toumi H; Suzuki D; Redman S; Emery P; McGonagle D<\/span> (2007)<\/span> Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders<\/span>. ARTHRITIS RHEUM<\/span>, 56<\/span>, (1)<\/span>, pp. 224-233<\/span>. <\/a><\/p>","publicationid":"34050","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2007)<\/span> Rituximab in rheumatoid arthritis - A viewpoint<\/span>. BIODRUGS<\/span>, 21<\/span>, (5)<\/span>, pp. 342<\/span>. <\/a><\/p>","publicationid":"22172","date":"2007-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Emery P<\/span> (2006)<\/span> Abatacept in the treatment of rheumatoid arthritis<\/span>. Therapeutics and Clinical Risk Management<\/span>, 2<\/span>, (4)<\/span>, pp. 365-375<\/span>. <\/a><\/p>","publicationid":"1039485","date":"2006-12-30","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Turner DE; Helliwell PS; Emery P; Woodburn J<\/span> (2006)<\/span> The impact of rheumatoid arthritis on foot function in the early stages of disease: a clinical case series<\/span>. BMC MUSCULOSKEL DIS<\/span>, 7<\/span>, (1)<\/span>, pp. 102<\/span>. <\/a> <\/a><\/p>","publicationid":"76304","date":"2006-12-21","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dass S; Vital EM; Emery P<\/span> (2006)<\/span> Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis<\/span>. EXPERT OPIN PHARMACO<\/span>, 7<\/span>, (18)<\/span>, pp. 2559-2570<\/span>. <\/a><\/p>","publicationid":"105157","date":"2006-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital EM; Emery P<\/span> (2006)<\/span> Abatacept in the treatment of rheumatoid arthritis<\/span>. Therapeutics and clinical risk management<\/span>, 2<\/span>, (4)<\/span>, pp. 365-375<\/span>. <\/a><\/p>","publicationid":"80892","date":"2006-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P<\/span> (2006)<\/span> Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission - Evidence from an imaging study may explain structural progression<\/span>. ARTHRITIS RHEUM<\/span>, 54<\/span>, (12)<\/span>, pp. 3761-3773<\/span>. <\/a><\/p>","publicationid":"78854","date":"2006-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Strand V; Balbir-Gurman A; Pavelka K; Emery P; Li N; Yin M; Lehane PB; Agarwal S<\/span> (2006)<\/span> Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years<\/span>. RHEUMATOLOGY<\/span>, 45<\/span>, (12)<\/span>, pp. 1505-1513<\/span>. <\/a><\/p>","publicationid":"69498","date":"2006-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pham T; Landew\u00e9 R; van der Linden S; Dougados M; Sieper J; Braun J; Davis J; Rudwaleit M; Collantes E; Burgos-Vargas R; Edmonds J; Olivieri I; van der Horst-Bruinsma I; Mielants H; Stone M; Emery P; van der Heijde D<\/span> (2006)<\/span> An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis<\/span>. Ann Rheum Dis<\/span>, 65<\/span>, (12)<\/span>, pp. 1620-1625<\/span>. <\/a><\/p>","publicationid":"51978","date":"2006-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NSL; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM<\/span> (2006)<\/span> A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma<\/span>. Arthritis Rheum<\/span>, 54<\/span>, (12)<\/span>, pp. 3962-3970<\/span>. <\/a><\/p>","publicationid":"13336","date":"2006-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jones EA; English A; Kinsey SE; Straszynski L; Emery P; Ponchel F; McGonagle D<\/span> (2006)<\/span> Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow<\/span>. CYTOM PART B-CLIN CY<\/span>, 70B<\/span>, (6)<\/span>, pp. 391-399<\/span>. <\/a><\/p>","publicationid":"91818","date":"2006-11-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Van Vollenhoven R-F; Le Lo\u00ebt X; Emery P; Bingham C; Keystone E; Greenwald M; Moreland L-W; Kim D; Cooper S; Wagner B; Ward P<\/span> (2006)<\/span> Tol\u00e9rance du\u00a0rituximab dans\u00a0la\u00a0polyarthrite rhumato\u00efde : r\u00e9sultats de\u00a0l'analyse globale de\u00a0tol\u00e9rance<\/span>. Revue du Rhumatisme<\/span>, 73<\/span>, (10-11)<\/span>, pp. 1170-1171<\/span>. <\/a><\/p>","publicationid":"1103617","date":"2006-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Breedveld F-C; Sibilia J; Genovese M; Emery P; Moreland L-W; Keystone E; Matteson E-L; Burke L; Agarwal S; Kim D; Cooper S<\/span> (2006)<\/span> Tol\u00e9rance des\u00a0anti-TNF chez\u00a0des\u00a0patients atteints de\u00a0polyarthrite rhumato\u00efde pr\u00e9c\u00e9demment trait\u00e9s par\u00a0rituximab<\/span>. Revue du Rhumatisme<\/span>, 73<\/span>, (10-11)<\/span>, pp. 1167-1168<\/span>. <\/a><\/p>","publicationid":"1103591","date":"2006-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Fleischmann R; Emery P; Chubick A; Dougados M; Baldassare A-R; Bathon J-M; Hessey E; Totoritis M; Cooper S<\/span> (2006)<\/span> Efficacit\u00e9 et\u00a0tol\u00e9rance \u00e0\u00a0long terme du\u00a0retraitement par\u00a0rituximab chez\u00a0des\u00a0patients atteints de\u00a0polyarthrite rhumato\u00efde avec\u00a0r\u00e9ponse inad\u00e9quate \u00e0\u00a0au\u00a0moins un\u00a0anti-TNF<\/span>. Revue du Rhumatisme<\/span>, 73<\/span>, (10-11)<\/span>, pp. 1168<\/span>. <\/a><\/p>","publicationid":"1103580","date":"2006-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Mariette X; Emery P; Peterfy C-G; Tak P-P; Cohen S; Genovese M; Williams S; Totoritis M; Cravets M; Shaw T<\/span> (2006)<\/span> Pr\u00e9vention des\u00a0l\u00e9sions structurales articulaires apr\u00e8s un\u00a0an de\u00a0traitement par\u00a0rituximab chez\u00a0les\u00a0patients atteints de\u00a0polyarthrite rhumato\u00efde avec\u00a0r\u00e9ponse inad\u00e9quate \u00e0\u00a0un\u00a0ou\u00a0plusieurs anti-TNF (\u00e9tude REFLEX)<\/span>. Revue du Rhumatisme<\/span>, 73<\/span>, (10-11)<\/span>, pp. 1029-1030<\/span>. <\/a><\/p>","publicationid":"1103553","date":"2006-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cox S; Emery P<\/span> (2006)<\/span> Use of prognostic markers in early rheumatoid arthritis to identify patients at risk of destructive disease<\/span>. Expert review of clinical immunology<\/span>, 2<\/span>, (6)<\/span>, pp. 853-857<\/span>. <\/a><\/p>","publicationid":"98198","date":"2006-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saleem B; Nizam S; Emery P<\/span> (2006)<\/span> Can remission be maintained with or without further drug therapy in rheumatoid arthritis?<\/span> CLIN EXP RHEUMATOL<\/span>, 24<\/span>, (6)<\/span>, pp. S33-S36<\/span>.<\/p>","publicationid":"87232","date":"2006-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Emery P; Keystone EC; Schiff MH; van Riel PLCM; Weinblatt ME; Weisman MH<\/span> (2006)<\/span> Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006<\/span>. Ann Rheum Dis<\/span>, 65 Suppl 3<\/span>, (Suppl 3)<\/span>, pp. iii2-ii15<\/span>. <\/a><\/p>","publicationid":"76764","date":"2006-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keenan AM; Tennant A; Fear J; Emery P; Conaghan PG<\/span> (2006)<\/span> Impact of multiple joint problems on daily living tasks in people in the community over age fifty-five<\/span>. ARTHRIT RHEUM-ARTHR<\/span>, 55<\/span>, (5)<\/span>, pp. 757-764<\/span>. <\/a><\/p>","publicationid":"70761","date":"2006-10-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Toumi H; Benjamin M; Grainger AJ; Tanner SF; Emery P; McGonagle D<\/span> (2006)<\/span> Combined high-resolution magnetic resonance imaging and histological examination to explore the role of ligaments and tendons in the phenotypic expression of early hand osteoarthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 65<\/span>, (10)<\/span>, pp. 1267-1272<\/span>. <\/a><\/p>","publicationid":"75121","date":"2006-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lawson CA; Brown AK; Bejarano V; Douglas SH; Burgoyne CH; Greenstein AS; Boylston AW; Emery P; Ponchel F; Isaacs JD<\/span> (2006)<\/span> Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood<\/span>. Rheumatology (Oxford)<\/span>, 45<\/span>, (10)<\/span>, pp. 1210-1217<\/span>. <\/a><\/p>","publicationid":"58359","date":"2006-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; O'Connor P; Emery P<\/span> (2006)<\/span> MR imaging findings in the hands<\/span>. Radiology<\/span>, 241<\/span>, (1)<\/span>, pp. 320-321<\/span>. <\/a><\/p>","publicationid":"52241","date":"2006-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Freeston J<\/span> (2006)<\/span> Commentary: Few clues to diagnosis<\/span>. British Medical Journal<\/span>, 333<\/span>, (7570)<\/span>, pp. 692-693<\/span>. <\/a><\/p>","publicationid":"11118","date":"2006-09-30","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Ponchel F<\/span> (2006)<\/span> Inhibiting toll-like receptors in inflammatory disease<\/span>. LANCET<\/span>, 368<\/span>, (9538)<\/span>, pp. 821-822<\/span>. <\/a><\/p>","publicationid":"72422","date":"2006-09-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Koncz T; Small M; Lowry S<\/span> (2006)<\/span> 371 ANALGESIC EFFICACY OF CELECOXIB AND DICLOFENAC IN PATIENTS WITH OSTEOARTHRITIS REQUIRING HIP REPLACEMENT SURGERY<\/span>. European Journal of Pain<\/span>, 10<\/span>, (S1)<\/span>, pp. s99b-ss99<\/span>. <\/a><\/p>","publicationid":"1103546","date":"2006-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester G-R; Cravets MW; Hessey EW; Shaw T; Totoritis MC; REFLEX Trial Group<\/span> (2006)<\/span> Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks<\/span>. Arthritis Rheum<\/span>, 54<\/span>, (9)<\/span>, pp. 2793-2806<\/span>. <\/a><\/p>","publicationid":"121082","date":"2006-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Maini RN; Taylor PC; Szechinski J; Pavelka K; Br\u00f6ll J; Balint G; Emery P; Raemen F; Petersen J; Smolen J; Thomson D; Kishimoto T; CHARISMA Study Group<\/span> (2006)<\/span> Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate<\/span>. Arthritis Rheum<\/span>, 54<\/span>, (9)<\/span>, pp. 2817-2829<\/span>. <\/a><\/p>","publicationid":"118040","date":"2006-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P<\/span> (2006)<\/span> Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis<\/span>. RHEUMATOLOGY<\/span>, 45<\/span>, (8)<\/span>, pp. 1029-1038<\/span>. <\/a><\/p>","publicationid":"117002","date":"2006-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Chinoy H; Salway F; Fertig N; Shephard N; Tait BD; Thomson W; Isenberg DA; Oddis CV; Silman AJ; Ollier WER; Cooper RG; UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC)<\/span> (2006)<\/span> In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype<\/span>. Arthritis Res Ther<\/span>, 8<\/span>, (1)<\/span>, pp. R13<\/span>. <\/a><\/p>","publicationid":"194746","date":"2006-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; van Vollenhoven RF; Furst DE; Ferraccioli G; Udell J; Rowe K; Agarwal S; Shaw T<\/span> (2006)<\/span> Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to disease-modifying anti-rheumatic drugs<\/span>. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY<\/span>, 35<\/span>, pp. 40-41<\/span>.<\/p>","publicationid":"117692","date":"2006-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; O'Connor P; Emery P<\/span> (2006)<\/span> MR imaging findings in the hands<\/span>. RADIOLOGY<\/span>, 241<\/span>, (1)<\/span>, pp. 320<\/span>. <\/a><\/p>","publicationid":"79783","date":"2006-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham C; Keystone E; Greenwald M; Moreland LW; Kim D; Cooper S; Wagner B; Ward P<\/span> (2006)<\/span> Safety of rituximab in rheumatoid arthritis: Results of a pooled analysis<\/span>. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY<\/span>, 35<\/span>, pp. 26<\/span>.<\/p>","publicationid":"74161","date":"2006-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Freeston J<\/span> (2006)<\/span> Fever of unknown origin: case outcome - Few clues to diagnosis<\/span>. BRITISH MEDICAL JOURNAL<\/span>, 333<\/span>, (7570)<\/span>, pp. 692-693<\/span>. <\/a><\/p>","publicationid":"66751","date":"2006-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Breedveld FC; van Vollenhoven RF; Genovese M; Emery P; Moreland LW; Keystone E; Matteson EL; Burke L; Agarwal S; Kim D; Cooper S<\/span> (2006)<\/span> Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab<\/span>. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY<\/span>, 35<\/span>, pp. 11<\/span>.<\/p>","publicationid":"51021","date":"2006-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Keystone E; Kvien TK; Emery P; Peterfy CD; Tak PP; Cohen S; Genovese M; Williams S; Totoritis M; Cravets M; Shaw T<\/span> (2006)<\/span> Joint structural damage prevention with rituximab in patients with rheumatoid arthritis and an inadequate response to one or more TNF inhibitors: 1 year data from the reflex study<\/span>. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY<\/span>, 35<\/span>, pp. 14<\/span>.<\/p>","publicationid":"21603","date":"2006-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Mackie SL; Vital EM; Ponchel F; Emery P<\/span> (2005)<\/span> Co-stimulatory blockade as therapy for rheumatoid arthritis<\/span>. Current rheumatology reports<\/span>, 7<\/span>, (5)<\/span>, pp. 400-406<\/span>. <\/a><\/p>","publicationid":"100777","date":"2005-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JMW; Johnson KR; Kirwan JR; Landewe RBM; Lassere MND; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; van der Heijde D; van Riel P; Wolfe F; Tugwell PS<\/span> (2005)<\/span> Minimal disease activity for rheumatoid arthritis: A preliminary definition<\/span>. J RHEUMATOL<\/span>, 32<\/span>, (10)<\/span>, pp. 2016-2024<\/span>.<\/p>","publicationid":"64281","date":"2005-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2005)<\/span> Introduction<\/span>. JCR-J CLIN RHEUMATOL<\/span>, 11<\/span>, (3)<\/span>, pp. S37-S38<\/span>. <\/a><\/p>","publicationid":"69173","date":"2005-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2005)<\/span> Adalimumab therapy: clinical findings and implications for integration into clinical guidelines for rheumatoid arthritis<\/span>. Drugs of today (Barcelona, Spain : 1998)<\/span>, 41<\/span>, (3)<\/span>, pp. 155-163<\/span>. <\/a><\/p>","publicationid":"89267","date":"2005-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown AK; O'Connor PJ; Roberts TE; Wakefield RJ; Karim Z; Emery P<\/span> (2005)<\/span> Recommendations for musculoskeletal ultrasonography by rheumatologists: Setting global standards for best practice by expert consensus<\/span>. ARTHRIT RHEUM-ARTHR<\/span>, 53<\/span>, (1)<\/span>, pp. 83-92<\/span>. <\/a><\/p>","publicationid":"109381","date":"2005-02-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ejbjerg B; McQueen F; Lassere M; Haavardsholm E; Conaghan P; O'Connor P; Bird P; Peterfy C; Edmonds J; Szkudlarek M; Genant H; Emery P; Ostergaard M<\/span> (2005)<\/span> The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the wrist joint<\/span>. ANN RHEUM DIS<\/span>, 64<\/span>, (Suppl 1)<\/span>, pp. 23-47<\/span>. <\/a> <\/a><\/p>","publicationid":"97809","date":"2005-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Davys HJ; Turner DE; Helliwell PS; Conaghan PG; Emery P; Woodburn J<\/span> (2005)<\/span> Debridement of plantar callosities in rheumatoid arthritis: a randomized controlled trial<\/span>. RHEUMATOLOGY<\/span>, 44<\/span>, (2)<\/span>, pp. 207-210<\/span>. <\/a><\/p>","publicationid":"93466","date":"2005-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan P; Bird P; Eibierg B; O'Connor P; Peterfy C; McQueen F; Lassere M; Emery P; Shnier R; Edmonds J; Ostergaard M<\/span> (2005)<\/span> The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas: the metacarpophalangeal joints<\/span>. ANN RHEUM DIS<\/span>, 64<\/span>, (Suppl 1)<\/span>, pp. 11-21<\/span>. <\/a> <\/a><\/p>","publicationid":"79980","date":"2005-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Quinn MA; Emery P<\/span> (2005)<\/span> Are early arthritis clinics necessary?<\/span> Best Pract Res Clin Rheumatol<\/span>, 19<\/span>, (1)<\/span>, pp. 1-17<\/span>. <\/a><\/p>","publicationid":"25148","date":"2005-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schiff MH<\/span> (2005)<\/span> Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade: comment on the article by Buch et al<\/span>. Arthritis Rheum<\/span>, 52<\/span>, (1)<\/span>, pp. 364-365<\/span>. <\/a><\/p>","publicationid":"191546","date":"2005-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Bingham SJ; Emery P<\/span> (2005)<\/span> Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor a blockade: comment on the article by Buch et al - Reply<\/span>. ARTHRITIS RHEUM<\/span>, 52<\/span>, (1)<\/span>, pp. 365<\/span>. <\/a><\/p>","publicationid":"103014","date":"2005-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Seto Y; Bingham SJ; Bejarano V; Bryer D; White J; Emery P<\/span> (2005)<\/span> C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept<\/span>. Arthritis Rheum<\/span>, 52<\/span>, (1)<\/span>, pp. 42-48<\/span>. <\/a><\/p>","publicationid":"101928","date":"2005-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2005)<\/span> Adalimumab therapy: Clinical findings and implications for integration into clinical guidelines for rheumatoid arthritis<\/span>. DRUGS OF TODAY<\/span>, 41<\/span>, (3)<\/span>, pp. 155-163<\/span>. <\/a><\/p>","publicationid":"91276","date":"2005-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan P; McQueen F; Peterfy C; Lassere M; Ejbjerg B; Bird P; O'Connor P; Haavardsholm E; Edmonds J; Emery P; Genant HK; Ostergaard M<\/span> (2005)<\/span> OMERACT 7 Special Interest Group. The evidence for MRI as an outcome measure in proof-of-concept rheumatoid arthritis studies<\/span>. Journal of Rheumatology<\/span>, 32<\/span>, (12)<\/span>, pp. 2465-2469<\/span>.<\/p>","publicationid":"75945","date":"2005-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Strand V; Scott DL; Emery P; Kalden JR; Smolen JS; Canon GW; Tugwell P; Crawford B<\/span> (2005)<\/span> Leflunomide Rheumatoid Arthritis Investigators. Physical function and health related quality of life:analysis of 2-year data from randomized, controlled studies of Leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis<\/span>. Journal of Rheumatology<\/span>, 32<\/span>, (4)<\/span>, pp. 590-601<\/span>.<\/p>","publicationid":"65906","date":"2005-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Vital E; Emery P<\/span> (2005)<\/span> Advances in the treatment of early rheumatoid arthritis<\/span>. American Family Physician<\/span>, 15<\/span>, (6)<\/span>, pp. 1002-1004<\/span>.<\/p>","publicationid":"28031","date":"2005-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Evangelisto A; Wakefield R; Emery P<\/span> (2004)<\/span> Imaging in early arthritis<\/span>. Best Pract Res Clin Rheumatol<\/span>, 18<\/span>, (6)<\/span>, pp. 927-943<\/span>. <\/a><\/p>","publicationid":"77155","date":"2004-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jones EA; Ponchel F; Kinsey SE; Field SL; Straszynski L; Emery P; McGonagle D<\/span> (2004)<\/span> Phenotypical, Morphological and Molecular Analysis of Fresh Human Bone Marrow Mesenchymal\/Stromal Stem Sells (MSCs) Enriched by Four Different Methods<\/span>. Blood<\/span>, 104<\/span>, (11)<\/span>, pp. 2337<\/span>. <\/a><\/p>","publicationid":"545732","date":"2004-11-16","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Saxne T; Larsson L; Geborek P<\/span> (2004)<\/span> Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al<\/span>. Arthritis Rheum<\/span>, 50<\/span>, (9)<\/span>, pp. 3049-3050<\/span>. <\/a><\/p>","publicationid":"197746","date":"2004-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bruyn GAW<\/span> (2004)<\/span> Extraarticular rheumatoid arthritis and drug-induced syndromes: understanding the role of tumor necrosis factor inhibitors<\/span>. J Rheumatol<\/span>, 31<\/span>, (7)<\/span>, pp. 1461<\/span>.<\/p>","publicationid":"193492","date":"2004-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Conaghan PG; Jarrett S; Emery P<\/span> (2004)<\/span> Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: imaging technique<\/span>. Curr Opin Rheumatol<\/span>, 16<\/span>, (4)<\/span>, pp. 435-442<\/span>. <\/a><\/p>","publicationid":"80797","date":"2004-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Brown AK; O'Connor PJ; Karim Z; Grainger A; Emery P<\/span> (2004)<\/span> Musculoskeletal ultrasonography: what is it and should training be compulsory for rheumatologists?<\/span> RHEUMATOLOGY<\/span>, 43<\/span>, (7)<\/span>, pp. 821-822<\/span>. <\/a><\/p>","publicationid":"53894","date":"2004-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Griffin AJ; Erkeller-Yuksel F<\/span> (2004)<\/span> Parenteral methotrexate should be given before biological therapy<\/span>. Rheumatology (Oxford)<\/span>, 43<\/span>, (5)<\/span>, pp. 678<\/span>. <\/a><\/p>","publicationid":"192858","date":"2004-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van de Putte BA; Atkins C; Malaise M; Sany J; Russell AS; van Riel PLCM; Settas L; Biljsma JW; Todesco S; Dougados M; Nash P; Emery P; Walter N; Kaul M; Fischkoff S; Kupper H<\/span> (2004)<\/span> Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed<\/span>. ANN RHEUM DIS<\/span>, 63<\/span>, (5)<\/span>, pp. 508-516<\/span>. <\/a><\/p>","publicationid":"112227","date":"2004-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar JM; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A<\/span> (2004)<\/span> Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR<\/span>. J RHEUMATOL<\/span>, 31<\/span>, (3)<\/span>, pp. 482-488<\/span>.<\/p>","publicationid":"108976","date":"2004-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Marzo-Ortega H; Bingham SJ; Emery P<\/span> (2004)<\/span> Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals<\/span>. RHEUMATOLOGY<\/span>, 43<\/span>, (2)<\/span>, pp. 243-244<\/span>. <\/a><\/p>","publicationid":"99297","date":"2004-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Karim Z; Wakefield RJ; Quinn M; Conaghan PG; Brown AK; Veale DJ; O'Connor P; Reece R; Emery P<\/span> (2004)<\/span> Validation and reproducibility of ultrasonography in the detection of synovitis in the knee - A comparison with arthroscopy and clinical examination<\/span>. ARTHRITIS RHEUM<\/span>, 50<\/span>, (2)<\/span>, pp. 387-394<\/span>. <\/a><\/p>","publicationid":"81271","date":"2004-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Breedveld FC; Emery P; Keystone E; Patel K; Furst DE; Kalden JR; St Clair EW; Weisman M; Smolen J; Lipsky PE; Maini RN<\/span> (2004)<\/span> Infliximab in active early rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 63<\/span>, (2)<\/span>, pp. 149-155<\/span>. <\/a><\/p>","publicationid":"60071","date":"2004-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McKenna SP; Doward LC; Whalley D; Tennant A; Emery P; Veale DJ<\/span> (2004)<\/span> Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis<\/span>. Ann Rheum Dis<\/span>, 63<\/span>, (2)<\/span>, pp. 162-169<\/span>. <\/a> <\/a><\/p>","publicationid":"14578","date":"2004-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2004)<\/span> The use of imaging and biomarkers in the assessment and follow-up of arthritis<\/span>. Arthritis Research & Therapy<\/span>, 6<\/span>, (Suppl 3)<\/span>, pp. 28<\/span>. <\/a><\/p>","publicationid":"1103475","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Emery P; Isaacs JD; Radstake TRDJ; Blom AB; Van Lent PLEM; Van Den Berg WB<\/span> (2004)<\/span> Fc\u03b3 receptors are critical modulators of inflammation within the synovium: Comment on the article by Blom et al [2] (multiple letters)<\/span>. Arthritis and Rheumatism<\/span>, 50<\/span>, (4)<\/span>, pp. 1352-1353<\/span>. <\/a><\/p>","publicationid":"192201","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Mc Gonagle D; Tan AL; Rhodes L; Tanner S; Conaghan PG; O'Connor P; Fraser A; Veale D; Emery P<\/span> (2004)<\/span> A CLINICAL AND MAGNETIC RESONANCE IMAGING ASSESSMENT OF THE EFFICACY OF INFLIXIMAB AT A DOSE OF 3 mg\/kg IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF PSORIATIC ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, 43<\/span>, pp. 130<\/span>.<\/p>","publicationid":"143393","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Benjamin M; Moriggl B; Brenner E; Emery P; McGonagle DG; Redmond AC<\/span> (2004)<\/span> The enthesis organ concept \u2013 why enthesopathies may not present as focal insertional disorders<\/span>. Arthritis and Rheumatism<\/span>, 50<\/span>, (10)<\/span>, pp. 3306-3313<\/span>. <\/a><\/p>","publicationid":"117559","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McKenna SP; Doward LC; Whalley D; Tennant A; Emery P; Veale DJ<\/span> (2004)<\/span> The Development of the PsAQoL: A quality of life instrument specific to Psoriatic Arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 63<\/span>, pp. 162-169<\/span>. <\/a><\/p>","publicationid":"74520","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bejarano V; Emery P; Conaghan P<\/span> (2004)<\/span> Adalimumab (Humira): biologic therapy for rheumatoid arthritis<\/span>. Prescriber<\/span>, 4<\/span>, pp. 48-58<\/span>.<\/p>","publicationid":"57797","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Karim Z; Brown AK; Quinn M; Wakefield RJ; Conaghan PG; Emery P; O'Connor PJ<\/span> (2004)<\/span> Ultrasound-guided steroid injections in the treatment of hip osteoarthritis: comment on the letter by Margules<\/span>. ARTHRITIS RHEUM<\/span>, 50<\/span>, (1)<\/span>, pp. 338-339<\/span>. <\/a><\/p>","publicationid":"52639","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2004)<\/span> Review of health economics modelling in rheumatoid arthritis<\/span>. PHARMACOECONOMICS<\/span>, 22<\/span>, (2)<\/span>, pp. 55-69<\/span>. <\/a><\/p>","publicationid":"45952","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; McGonagle DG; Tan AL; Evangelisto A; Emery P<\/span> (2004)<\/span> Letter \u2013 Ultrasound detection of knee patellar enthesitis<\/span>. Annals of the Rheumatic Diseases<\/span>, 63<\/span>, (6)<\/span>, pp. 753-754<\/span>.<\/p>","publicationid":"27936","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jarrett SJ; Cunnane G; Conaghan PG; Bingham SJ; Buch MH; Quinn MA; Emery P<\/span> (2004)<\/span> Extraarticular rheumatoid arthritis and drug-induced syndromes:: Understanding the role of tumor necrosis factor inhibitors -: Dr. Jarrett, et al<\/i> reply<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, 31<\/span>, (7)<\/span>, pp. 1462<\/span>.<\/p>","publicationid":"21434","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jarrett S; Cunnane G; Conaghan P; Bingham S; Buch MH; Quinn MA; Emery P<\/span> (2004)<\/span> Anti-tumor necrosis factor-alpha therapy-induced vasculitis [Reply]<\/span>. Journal of Rheumatology<\/span>, 31<\/span>, (7)<\/span>, pp. pp.1462<\/span>.<\/p>","publicationid":"20962","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham S; Buch MH; Tennant A; Emery P<\/span> (2004)<\/span> Impact of escalating conventional therapy in rheumatoid arthritis.patients referred for anti-TNF<\/span> Rheumatology<\/span>, 43<\/span>, (3)<\/span>, pp. 364-368<\/span>.<\/p>","publicationid":"7868","date":"2004-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; Emery P; Lemmel E-M; de la Serna R; Zerbini CA; Brin S; van Riel P<\/span> (2003)<\/span> Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data<\/span>. J Rheumatol<\/span>, 30<\/span>, (12)<\/span>, pp. 2572-2579<\/span>.<\/p>","publicationid":"23881","date":"2003-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Simkin PA<\/span> (2003)<\/span> Fibrillin 1 as an autoantigen in the spondylarthropathies? Comment on the conference summary by McGonagle et al<\/span>. Arthritis Rheum<\/span>, 48<\/span>, (12)<\/span>, pp. 3610-3611<\/span>. <\/a><\/p>","publicationid":"22347","date":"2003-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

van de Putte LBA; Rau R; Breedveld FC; Kalden JR; Malaise MG; van Riel PLCM; Schattenkirchner M; Emery P; Burmester GR; Zeidler H; Moutsopoulos HM; Beck K; Kupper H<\/span> (2003)<\/span> Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study<\/span>. Ann Rheum Dis<\/span>, 62<\/span>, (12)<\/span>, pp. 1168-1177<\/span>. <\/a><\/p>","publicationid":"3283","date":"2003-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kremer JM; Westhovens R; Leon M; Di Giorgio E; Alten R; Steinfeld S; Russell A; Dougados M; Emery P; Nuamah IF; Williams GR; Becker JC; Hagerty DT; Moreland LW<\/span> (2003)<\/span> Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig<\/span>. NEW ENGL J MED<\/span>, 349<\/span>, (20)<\/span>, pp. 1907-1915<\/span>. <\/a><\/p>","publicationid":"58343","date":"2003-11-13","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Emery P; Gerards AH; Dijkmans BAC; Landew\u00e9 RBM<\/span> (2003)<\/span> Cyclosporin and methotrexate therapy [1] (multiple letters)<\/span>. Annals of the Rheumatic Diseases<\/span>, 62<\/span>, (11)<\/span>, pp. 1121<\/span>. <\/a><\/p>","publicationid":"191197","date":"2003-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Suarez-Almazor ME<\/span> (2003)<\/span> Rheumatoid arthritis<\/span>. Am Fam Physician<\/span>, 68<\/span>, (9)<\/span>, pp. 1821-1823<\/span>.<\/p>","publicationid":"104961","date":"2003-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Emery P; Gerards AH; Dijkmans BAC; Landew\u00e9 RBM<\/span> (2003)<\/span> Cyclosporin and methotrexate therapy<\/span>. Annals of the Rheumatic Diseases<\/span>, 62<\/span>, (11)<\/span>, pp. 1121<\/span>. <\/a><\/p>","publicationid":"71676","date":"2003-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P<\/span> (2003)<\/span> Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol<\/span>. ARTHRITIS RHEUM<\/span>, 48<\/span>, (11)<\/span>, pp. 3039-3045<\/span>. <\/a> <\/a><\/p>","publicationid":"58481","date":"2003-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Emery P<\/span> (2003)<\/span> Cyclosporin and methotrexate therapy<\/span>. Annals of the rheumatic diseases<\/span>, 62<\/span>, (11)<\/span>, pp. 1121<\/span>. <\/a><\/p>","publicationid":"52612","date":"2003-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ<\/span> (2003)<\/span> Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans - Relationship to mediators of systemic and local inflammation<\/span>. ARTHRITIS RHEUM<\/span>, 48<\/span>, (11)<\/span>, pp. 3085-3095<\/span>. <\/a><\/p>","publicationid":"46805","date":"2003-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Dougados M; Emery P; Gibofsky A; Kavenaugh AF; Keystone EC; Klareskog L; Russell AS; van de Putte LBA; Weisman MH<\/span> (2003)<\/span> Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)<\/span>. Annals of the Rheumatic Diseases<\/span>, 62<\/span>, (Suppl II)<\/span>, pp. ii2-ii9<\/span>. <\/a><\/p>","publicationid":"20743","date":"2003-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Dougados M; Emery P; Gibofsky A; Kavanaugh AF; Keystone EC; Klareskog L; Russell AS; van de Putte LBA; Weisman MH<\/span> (2003)<\/span> Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)<\/span>. Ann Rheum Dis<\/span>, 62 Suppl 2<\/span>, (Suppl 2)<\/span>, pp. ii2-ii9<\/span>. <\/a><\/p>","publicationid":"16911","date":"2003-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kong KO; Loeuille D; Seto Y; Wakefield RJ; Emery P<\/span> (2003)<\/span> The role of ultrasonography in rheumatology<\/span>. Revista Brasileira de Reumatologia<\/span>, 43<\/span>, (5)<\/span>, pp. 4-7<\/span>. <\/a><\/p>","publicationid":"849174","date":"2003-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Appelboom T; Emery P; Tant L; Dumarey N; Schoutens A<\/span> (2003)<\/span> Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritis<\/span>. Rheumatology (Oxford)<\/span>, 42<\/span>, (10)<\/span>, pp. 1179-1182<\/span>. <\/a><\/p>","publicationid":"99580","date":"2003-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Goh E; Conaghan PG; Karim Z; Emery P<\/span> (2003)<\/span> Musculoskeletal ultrasonography in Europe: results of a rheumatologist-based survey at a EULAR meeting<\/span>. RHEUMATOLOGY<\/span>, 42<\/span>, (10)<\/span>, pp. 1251-1253<\/span>. <\/a><\/p>","publicationid":"79759","date":"2003-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; McGonagle D; Haugeberg G; Green MJ; Stewart SP; Emery P<\/span> (2003)<\/span> Bone mineral density improvement in spondyloarthropathy after treatment with etanercept<\/span>. Annals of the Rheumatic Diseases<\/span>, 62<\/span>, (10)<\/span>, pp. 1020-1021<\/span>. <\/a><\/p>","publicationid":"42353","date":"2003-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Seto Y<\/span> (2003)<\/span> Role of biologics in early arthritis<\/span>. CLIN EXP RHEUMATOL<\/span>, 21<\/span>, (5)<\/span>, pp. S191-S194<\/span>.<\/p>","publicationid":"114969","date":"2003-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Kong KO; Conaghan PG; Brown AK; O'Connor PJ; Emery P<\/span> (2003)<\/span> The role of ultrasonography and magnetic resonance imaging in early rheumatoid arthritis<\/span>. CLIN EXP RHEUMATOL<\/span>, 21<\/span>, (5)<\/span>, pp. S42-S49<\/span>.<\/p>","publicationid":"93404","date":"2003-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Quinn MA; Emery P<\/span> (2003)<\/span> Window of opportunity in early rheumatoid arthritis: Possibility of altering the disease process with early intervention<\/span>. CLIN EXP RHEUMATOL<\/span>, 21<\/span>, (5)<\/span>, pp. S154-S157<\/span>.<\/p>","publicationid":"85226","date":"2003-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham SJ; Buch MH; Lindsay S; Pollard A; White J; Emery P<\/span> (2003)<\/span> Parenteral methotrexate should be given before biological therapy<\/span>. RHEUMATOLOGY<\/span>, 42<\/span>, (8)<\/span>, pp. 1009-1010<\/span>. <\/a><\/p>","publicationid":"118878","date":"2003-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Brown A; O'Connor P; Grainger A; Karim Z; McGonagle D; Conaghan P; Emery P<\/span> (2003)<\/span> Rheumatological ultrasound<\/span>. Rheumatology (Oxford)<\/span>, 42<\/span>, (8)<\/span>, pp. 1001<\/span>. <\/a><\/p>","publicationid":"30654","date":"2003-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ali M; Veale DJ; Reece RJ; Quinn M; Henshaw K; Zanders ED; Markham AF; Emery P; Isaacs JD<\/span> (2003)<\/span> Overexpression of transcripts containing LINE-1 in the synovia of patients with rheumatoid arthritis<\/span>. ANN RHEUM DIS<\/span>, 62<\/span>, (7)<\/span>, pp. 663-666<\/span>. <\/a><\/p>","publicationid":"113969","date":"2003-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan P; Lassere M; Ostergaard M; Peterfy C; McQueen F; O'Connor P; Bird P; Ejbjerg B; Klarlund M; Shnier R; Genant H; Emery P; Edmonds J<\/span> (2003)<\/span> OMERACT rheumatoid arthritis magnetic resonance imaging studies. Exercise 4: An international multicenter longitudinal study using the RA-MRI score<\/span>. J RHEUMATOL<\/span>, 30<\/span>, (6)<\/span>, pp. 1376-1379<\/span>.<\/p>","publicationid":"120935","date":"2003-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kalden JR; Schattenkirchner M; Sorensen H; Emery P; Deighton C; Rozman B; Breedveld F<\/span> (2003)<\/span> The efficacy and safety of leflunomide in patients with active rheumatoid arthritis - A five-year followup study<\/span>. ARTHRITIS RHEUM<\/span>, 48<\/span>, (6)<\/span>, pp. 1513-1520<\/span>. <\/a><\/p>","publicationid":"108154","date":"2003-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McQueen F; Lassere M; Edmonds J; Conaghan P; Peterfy C; Bird P; O'Connor P; Ejbjerg B; Klarlund M; Stewart N; Emery P; Shnier R; Genant H; Ostergaard M<\/span> (2003)<\/span> OMERACT rheumatoid arthritis magnetic resonance imaging studies. Summary of OMERACT 6 MR imaging module<\/span>. J RHEUMATOL<\/span>, 30<\/span>, (6)<\/span>, pp. 1387-1392<\/span>.<\/p>","publicationid":"107354","date":"2003-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ostergaard M; Peterfy C; Conaghan P; McQueen F; Bird P; Ejbjerg B; Shnier R; O'Connor P; Klarlund M; Emery P; Genant H; Lassere M; Edmonds J<\/span> (2003)<\/span> OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system<\/span>. J RHEUMATOL<\/span>, 30<\/span>, (6)<\/span>, pp. 1385-1386<\/span>.<\/p>","publicationid":"100453","date":"2003-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lassere M; McQueen F; Ostergaard M; Conaghan P; Shnier R; Peterfy C; Klarlund M; Bird P; O'Connor P; Stewart N; Emery P; Genant H; Edmonds J<\/span> (2003)<\/span> OMERACT rheumatoid arthritis magnetic resonance imaging studies. Exercise 3: An international multicenter reliability study using the RA-MRI score<\/span>. J RHEUMATOL<\/span>, 30<\/span>, (6)<\/span>, pp. 1366-1375<\/span>.<\/p>","publicationid":"83329","date":"2003-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Wakefield RJ; Conaghan PG; Emery P; McGonagle D<\/span> (2003)<\/span> Imaging of the musculoskeletal system: magnetic resonance imaging, ultrasonography and computed tomography<\/span>. BEST PRACT RES CL RH<\/span>, 17<\/span>, (3)<\/span>, pp. 513-528<\/span>. <\/a><\/p>","publicationid":"59134","date":"2003-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Peterfy C; Edmonds J; Lassere M; Conaghan P; \u00d8stergaard M; McQueen F; Genant H; Klarlund M; Ejbjerg B; Stewart N; Bird P; Shnier R; O'Connor P; Emery P<\/span> (2003)<\/span> OMERACT Rheumatoid Arthritis MRI Studies Module<\/span>. J Rheumatol<\/span>, 30<\/span>, (6)<\/span>, pp. 1364-1365<\/span>.<\/p>","publicationid":"47069","date":"2003-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Suarez-Almazor M<\/span> (2003)<\/span> Rheumatoid arthritis<\/span>. Clin Evid<\/span>, 68<\/span>, (9)<\/span>, pp. 1349-1371<\/span>.<\/p>","publicationid":"18930","date":"2003-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sharp JT; Van Der Heijde D; Boers M; Boonen A; Bruynesteyn K; Emery P; Genant HK; Herborn G; Jurik A; Lassere M; McQueen F; \u00d8stergaard M; Peterfy C; Rau R; Strand V; Wassenberg S; Weissman B; Subcommittee on Healing of Erosions of the OMERACT Imaging Committee<\/span> (2003)<\/span> Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions<\/span>. J Rheumatol<\/span>, 30<\/span>, (5)<\/span>, pp. 1102-1107<\/span>.<\/p>","publicationid":"109592","date":"2003-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lawson CA; Fraser A; Veale DJ; Emery P<\/span> (2003)<\/span> Cyclosporin treatment in psoriatic arthritis: a cause of severe leg pain<\/span>. Ann Rheum Dis<\/span>, 62<\/span>, (5)<\/span>, pp. 489<\/span>. <\/a><\/p>","publicationid":"100861","date":"2003-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Tanner SF; Conaghan PG; Radjenovic A; O'Connor P; Brown AK; Emery P; McGonagle D<\/span> (2003)<\/span> Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis<\/span>. ARTHRITIS RHEUM<\/span>, 48<\/span>, (5)<\/span>, pp. 1214-1222<\/span>. <\/a><\/p>","publicationid":"63718","date":"2003-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Tanner SF; Conaghan PG; Radjenovic A; O'Connor P; Brown AK; Emery P; McGonagle D<\/span> (2003)<\/span> Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis<\/span>. Arthritis and Rheumatism<\/span>, 48<\/span>, (5)<\/span>, pp. 1214-1222<\/span>. <\/a><\/p>","publicationid":"18081","date":"2003-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wei N<\/span> (2003)<\/span> Does concomitant osteoarthritis affect histopathologic changes in patients with rheumatoid arthritis? Comment on the article by Kraan et al<\/span>. Arthritis Rheum<\/span>, 48<\/span>, (4)<\/span>, pp. 1161<\/span>. <\/a><\/p>","publicationid":"190361","date":"2003-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Keyte VH; Babbage SJ; Robinson JI; Ponchel F; Barrett JH; Bhakta BB; Bingham SJ; Buch MH; Conaghan PG; Gough A; Green M; Lawson CA; Pease CT; Markham AF; Ollier WER; Emery P; Worthington J; Isaacs JD<\/span> (2003)<\/span> FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study<\/span>. Rheumatology (Oxford, England)<\/span>, 42<\/span>, (4)<\/span>, pp. 528-533<\/span>. <\/a><\/p>","publicationid":"190354","date":"2003-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Keyte VH; Babbage SJ; Robinson JI; Ponchel F; Barrett JH; Bhakta BB; Bingham SJ; Buch MH; Conaghan PG; Gough A; Green M; Lawson CA; Pease CT; Markham AF; Ollier WER; Emery P; Worthington J; Isaacs JD<\/span> (2003)<\/span> Fc gamma RIIIA-158V and rheumatoid arthritis: a confirmation study<\/span>. RHEUMATOLOGY<\/span>, 42<\/span>, (4)<\/span>, pp. 528-533<\/span>. <\/a><\/p>","publicationid":"115257","date":"2003-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Marzo-Ortega H; Benjamin M; Emery P<\/span> (2003)<\/span> Report on the Second international Enthesitis Workshop<\/span>. Arthritis and rheumatism<\/span>, 48<\/span>, (4)<\/span>, pp. 896-905<\/span>. <\/a><\/p>","publicationid":"107249","date":"2003-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Holdsworth J; Pease C; Emery P; McGonagle D<\/span> (2003)<\/span> Successful treatment of resistant giant cell arteritis with etanercept<\/span>. ANN RHEUM DIS<\/span>, 62<\/span>, (4)<\/span>, pp. 373-374<\/span>. <\/a><\/p>","publicationid":"88071","date":"2003-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2003)<\/span> The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis<\/span>. EXPERT OPIN INV DRUG<\/span>, 12<\/span>, (4)<\/span>, pp. 673-681<\/span>. <\/a><\/p>","publicationid":"54981","date":"2003-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tan AL; Holdsworth J; Pease C; Emery P; McGonagle D<\/span> (2003)<\/span> Successful treatment of resistant giant cell arteritis with etanercept<\/span>. Ann Rheum Dis<\/span>, 62<\/span>, (4)<\/span>, pp. 373-374<\/span>. <\/a><\/p>","publicationid":"489","date":"2003-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Turner DE; Woodburn J; Helliwell PS; Cornwall MW; Emery P<\/span> (2003)<\/span> Pes planovalgus in RA: a descriptive and analytical study of foot function determined by gait analysis<\/span>. Musculoskeletal Care<\/span>, 1<\/span>, (1)<\/span>, pp. 21-33<\/span>. <\/a><\/p>","publicationid":"36210","date":"2003-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Brown AK; O'Connor PJ; Emery P<\/span> (2003)<\/span> Power Doppler sonography: improving disease activity assessment in inflammatory musculoskeletal disease<\/span>. Arthritis Rheum<\/span>, 48<\/span>, (2)<\/span>, pp. 285-288<\/span>. <\/a><\/p>","publicationid":"95076","date":"2003-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Breedveld FC; Schiff MH; Kalden JR; Emery P; Eberl G; van Riel PL; Tugwell P<\/span> (2003)<\/span> A simplified disease activity index for rheumatoid arthritis for use in clinical practice<\/span>. Rheumatology (Oxford)<\/span>, 42<\/span>, (2)<\/span>, pp. 244-257<\/span>. <\/a><\/p>","publicationid":"72081","date":"2003-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fearon U; Griosios K; Fraser A; Reece R; Emery P; Jones PF; Veale DJ<\/span> (2003)<\/span> Angiopoietins, growth factors, and vascular morphology in early arthritis<\/span>. J RHEUMATOL<\/span>, 30<\/span>, (2)<\/span>, pp. 260-268<\/span>.<\/p>","publicationid":"53853","date":"2003-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Emery P; McGonagle D<\/span> (2003)<\/span> Inhibition of tumor necrosis factor alpha and ankylosing spondylitis<\/span>. N Engl J Med<\/span>, 348<\/span>, (4)<\/span>, pp. 359-361<\/span>. <\/a><\/p>","publicationid":"1103441","date":"2003-01-23","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Asli B; Wechsler B; Lema\u00eetre C<\/span> (2003)<\/span> Inhibition of tumor necrosis factor alpha and ankylosing spondylitis<\/span>. N Engl J Med<\/span>, 348<\/span>, (4)<\/span>, pp. 359-361<\/span>. <\/a><\/p>","publicationid":"190415","date":"2003-01-23","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Schnarr S; H\u00fclsemann JL; Zeidler HK<\/span> (2003)<\/span> Unproven hypothesis that leflunomide is better than methotrexate as measured by magnetic resonance imaging: comment on the article by Reece et al<\/span>. Arthritis Rheum<\/span>, 48<\/span>, (1)<\/span>, pp. 270-271<\/span>. <\/a><\/p>","publicationid":"190261","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fernandes C; Johnson H; Reay N; South B; Emery P<\/span> (2003)<\/span> PULSED CYCLOPHOSPHAMIDE IN PATIENTS WITH SCLERODERMA AND ASSOCIATED FIBROSING ALVEOLITIS<\/span>. RHEUMATOLOGY<\/span>, 42<\/span>, pp. 141<\/span>.<\/p>","publicationid":"143078","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Bingham SJ; Rees-Evans B; Emery P<\/span> (2003)<\/span> DO PATIENTS WITH RHEUMATOID ARTHRITIS WITH HIGH DISEASE ACTIVITY ON INFLIXIMAB DEMONSTRATE IMPROVEMENT ON ETANERCEPT?<\/span> RHEUMATOLOGY<\/span>, 42<\/span>, pp. 89<\/span>.<\/p>","publicationid":"143074","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham SJ; Buch MH; Smith SL; Emery P<\/span> (2003)<\/span> OUTCOME OF ROUTINE TREATMENT OF 250 RA PATIENTS WITH ANTI-TNF AND IL-1RA AT A SINGLE CENTRE<\/span>. RHEUMATOLOGY<\/span>, 42<\/span>, pp. 88<\/span>.<\/p>","publicationid":"143073","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham SJ; Buch MH; English A; Reece R; Emery P<\/span> (2003)<\/span> RECURRENCE OF AGGRESSIVE RHEUMATOID ARTHRITIS DESPITE RITUXIMAB-INDUCED COMPLETE B CELL DEPLETION<\/span>. RHEUMATOLOGY<\/span>, 42<\/span>, pp. 86<\/span>.<\/p>","publicationid":"143072","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown AK; Wakefield RJ; Karim Z; Quinn MA; Conaghan PG; Grainger A; Roberts TE; O'Connor PJ; Emery P<\/span> (2003)<\/span> EVALUATION OF PRACTICE, TRAINING AND ASSESSMENT AMONGST EXPERTS PERFORMING MUSCULOSKELETAL ULTRASONOGRAPHY - TOWARDS THE DEVELOPMENT OF A CONSENSUS OF EDUCATIONAL STANDARDS FOR ULTRASONOGRAPHY FOR RHEUMATOLOGISTS<\/span>. RHEUMATOLOGY<\/span>, 42<\/span>, pp. 67<\/span>.<\/p>","publicationid":"142979","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Quinn MA; Conaghan PG; Greenstein A; O'Connor P; Karim Z; Fraser A; Brown C; Jarret S; Emery P<\/span> (2003)<\/span> RAPID AND SUSTAINED IMPROVEMENT WITH TNF\u03b1 BLOCKADE IN EARLY RA: RESULTS FROM A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY USING INFLIXIMAB WITH MRI OUTCOME<\/span>. RHEUMATOLOGY<\/span>, 42<\/span>, pp. 16<\/span>.<\/p>","publicationid":"142978","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kong KO; Loeuille D; Seto Y; Wakefield RJ; Emery P<\/span> (2003)<\/span> The role of ultrasonography in rheumatology<\/span>. Revista Brasileira de Reumatologia<\/span>, 43<\/span>, pp. IX-XII<\/span>.<\/p>","publicationid":"113399","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fraser A; Fearon U; Billingburst C; Ionescu M; Reece RJ; Barwick T; Emery P; Poole AR; Veale DJ<\/span> (2003)<\/span> The turnover of type II collagen and aggrecan in cartilage matrix at onset of inflammatory arthritis in humans. Relationship to mediators of systemic and local inflammation<\/span>. Arthritis and Rheumatism<\/span>, 48<\/span>, (11)<\/span>, pp. 3085-3095<\/span>. <\/a><\/p>","publicationid":"86014","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Reece RJ; Kraan MC; O'Connor PJ; Radjenovic A; Veale DJ; Ridgway JP; Gibbon WW; Breedveld FC; Tak PP<\/span> (2003)<\/span> Unproven hypothesis that leflunomide is better than methotrexate as measured by magnetic resonance imaging: comment on the article by Reece et al - Reply<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, 48<\/span>, (1)<\/span>, pp. 271<\/span>. <\/a><\/p>","publicationid":"83551","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wakefield RJ; Kong KO; Conaghan P; Brown AK; O'Connor P; Emery P<\/span> (2003)<\/span> The role of ultrasonography and magnetic resonance imaging in early rheumatoid arthritis<\/span>. Clinical and Experimental Rheumatology<\/span>, 21<\/span>, (5, Suppl 31)<\/span>, pp. S42-49<\/span>.<\/p>","publicationid":"74332","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Emery P; McGonagle D<\/span> (2003)<\/span> Inhibition of tumor necrosis factor \u03b1 and ankylosing spondylitis<\/span>. NEW ENGLAND JOURNAL OF MEDICINE<\/span>, 348<\/span>, (4)<\/span>, pp. 360<\/span>.<\/p>","publicationid":"72407","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Peterfy C; Edmonds J; Lassere M; Conaghan P; Ostergaard M; McQueen F; Genant H; Klarlund M; Ejbjerg B; Stewart N; Bird P; Shnier R; O'Connor P; Emery P<\/span> (2003)<\/span> OMERACT rheumatoid arthritis MRI studies module. Introduction to the module<\/span>. Journal of Rheumatology<\/span>, 30<\/span>, (6)<\/span>, pp. 1364-1365<\/span>.<\/p>","publicationid":"63902","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jarret S; Quinn MA; Emery P<\/span> (2003)<\/span> The evidence for early intervention in rheumatoid arthritis<\/span>. International Journal of Advances in Rheumatology<\/span>, 1<\/span>, (2)<\/span>, pp. 42-52<\/span>.<\/p>","publicationid":"61161","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kong KO; Wakefield RJ; Emery P<\/span> (2003)<\/span> Integrating imaging techniques and laboratory tests into the assessment of early RA. Review series<\/span>. Rheumatology<\/span>, 2<\/span>, pp. 4-9<\/span>.<\/p>","publicationid":"49292","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jarrett S; Cunnane G; Conaghan P; Bingham S; Buch MH; Quinn MA; Emery P<\/span> (2003)<\/span> Anti-TNF alpha therapy-induced vasculitis: Case series<\/span>. Journal of Rheumatology<\/span>, 30<\/span>, (10)<\/span>, pp. 2287-2291<\/span>.<\/p>","publicationid":"27219","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kraan MC; Reece RJ; Smeets TJM; Veale DJ; Emery P; Tak PP<\/span> (2003)<\/span> Does concomitant osteoarthritis affect histopathologic changes in patients with rheumatoid arthritis? Reply<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, 48<\/span>, (4)<\/span>, pp. 1162<\/span>. <\/a><\/p>","publicationid":"5483","date":"2003-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ponchel F; Morgan AW; Bingham SJ; Quinn M; Buch M; Verburg RJ; Henwood J; Douglas SH; Masurel A; Conaghan P; Gesinde M; Taylor J; Markham AF; Emery P; van Laar JM; Isaacs JD<\/span> (2002)<\/span> Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis<\/span>. BLOOD<\/span>, 100<\/span>, (13)<\/span>, pp. 4550-4556<\/span>. <\/a><\/p>","publicationid":"87351","date":"2002-12-15","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Braun J; van der Heijde D; Dougados M; Emery P; Khan MA; Sieper J; van der Linden S<\/span> (2002)<\/span> Staging of patients with ankylosing spondylitis: a preliminary proposal<\/span>. Ann Rheum Dis<\/span>, 61 Suppl 3<\/span>, (Suppl 3)<\/span>, pp. iii9-ii23<\/span>. <\/a><\/p>","publicationid":"1103514","date":"2002-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Olivieri I; Padula A; Scarano E<\/span> (2002)<\/span> Efficacy of tumor necrosis factor alpha blockade for enthesitis in spondylarthropathy: comment on the article by Marzo-Ortega et al<\/span>. Arthritis Rheum<\/span>, 46<\/span>, (12)<\/span>, pp. 3396-3398<\/span>. <\/a><\/p>","publicationid":"190035","date":"2002-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Jones EA; Kinsey SE; English A; Jones RA; Straszynski L; Meredith DM; Markham AF; Jack A; Emery P; McGonagle D<\/span> (2002)<\/span> Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells<\/span>. ARTHRITIS RHEUM<\/span>, 46<\/span>, (12)<\/span>, pp. 3349-3360<\/span>. <\/a><\/p>","publicationid":"119000","date":"2002-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Benjamin M; Marzo-Ortega H; Emery P<\/span> (2002)<\/span> Advances in the understanding of entheseal inflammation<\/span>. Curr Rheumatol Rep<\/span>, 4<\/span>, (6)<\/span>, pp. 500-506<\/span>. <\/a><\/p>","publicationid":"118217","date":"2002-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Woodburn J; Udupa JK; Hirsch BE; Wakefield RJ; Helliwell PS; Reay N; O'Connor P; Budgen A; Emery P<\/span> (2002)<\/span> The geometric architecture of the subtalar and midtarsal joints in rheumatoid arthritis based on magnetic resonance imaging<\/span>. Arthritis Rheum<\/span>, 46<\/span>, (12)<\/span>, pp. 3168-3177<\/span>. <\/a><\/p>","publicationid":"96784","date":"2002-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2002)<\/span> Evidence supporting the benefit of early intervention in rheumatoid arthritis<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, 29<\/span>, (SUPPL. 66)<\/span>, pp. 3-8<\/span>.<\/p>","publicationid":"104497","date":"2002-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; McGonagle D; Emery P<\/span> (2002)<\/span> Etanercept treatment in resistant spondyloarthropathy: Imaging, duration of effect and efficacy on reintroduction<\/span>. CLIN EXP RHEUMATOL<\/span>, 20<\/span>, (6)<\/span>, pp. S175-S177<\/span>.<\/p>","publicationid":"89519","date":"2002-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2002)<\/span> Is it time for a European consensus on the pharmacological management of early RA? Introduction<\/span>. J RHEUMATOL<\/span>, 29<\/span>, (SUPPL. 66)<\/span>, pp. 1-2<\/span>.<\/p>","publicationid":"81091","date":"2002-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Griffiths B; Miles S; Moss H; Robertson R; Veale D; Emery P<\/span> (2002)<\/span> Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function<\/span>. J Rheumatol<\/span>, 29<\/span>, (11)<\/span>, pp. 2371-2378<\/span>.<\/p>","publicationid":"76604","date":"2002-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; McGonagle D; Emery P<\/span> (2002)<\/span> Etanercept treatment in resistant spondyloarthropathy: Imaging, duration of effect an efficacy on reintroduction<\/span>. Clinical and Experimental Rheumatology<\/span>, 20<\/span>, (6 SUPPL. 28)<\/span>, pp. S-175-S-177<\/span>.<\/p>","publicationid":"189813","date":"2002-10-30","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Greenstein AS; Marzo-Ortega H; Emery P; O'Connor P; McGonagle D<\/span> (2002)<\/span> Magnetic resonance imaging as a predictor of progressive joint destruction in neuropathic joint disease<\/span>. ARTHRITIS RHEUM<\/span>, 46<\/span>, (10)<\/span>, pp. 2814-2816<\/span>. <\/a><\/p>","publicationid":"30896","date":"2002-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Choy EHS; Panayi GS; Emery P; Madden S; Breedveld FC; Kraan MC; Kalden JR; Rascu A; Brown JCC; Rapson N; Johnston JM<\/span> (2002)<\/span> Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial<\/span>. Rheumatology (Oxford)<\/span>, 41<\/span>, (10)<\/span>, pp. 1142-1148<\/span>. <\/a><\/p>","publicationid":"27890","date":"2002-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Emery P; McGonagle D<\/span> (2002)<\/span> The concept of disease modification in spondyloarthropathy<\/span>. J RHEUMATOL<\/span>, 29<\/span>, (8)<\/span>, pp. 1583-1585<\/span>.<\/p>","publicationid":"38509","date":"2002-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Kong SX; Ehrich EW; Watson DJ; Towheed TE<\/span> (2002)<\/span> Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review<\/span>. Clin Ther<\/span>, 24<\/span>, (8)<\/span>, pp. 1225-1291<\/span>. <\/a><\/p>","publicationid":"24575","date":"2002-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Gonagle DM; O'Connor P; Emery P<\/span> (2002)<\/span> Magnetic Resonance Imaging Advances Our Understanding of Disease Pathogenesis in Spondyloarthropathy<\/span>. Clinical Science<\/span>, 103<\/span>, (s47)<\/span>, pp. 34P<\/span>. <\/a><\/p>","publicationid":"1103626","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Greenstein A; Marzo-Ortega H; O'Connor P; Emery P; McGonagle D<\/span> (2002)<\/span> Magnetic Resonance Imaging as a Predictor of Neuropathic Joint Disease in Diabetes Mellitus<\/span>. Clinical Science<\/span>, 103<\/span>, (s47)<\/span>, pp. 34P<\/span>. <\/a><\/p>","publicationid":"1103561","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham S; Ponchel F; Veale D; Reece R; Fearon U; Isaacs J; McGonagle D; Snowden J; Morgan G; Emery P<\/span> (2002)<\/span> Highly Selected Autologous Stem Cell Transplantation in Severe Rheumatoid Arthritis with Studies of Peripheral Blood Lymphocyte (Pbl) Reconstitution, Synovial Response and Thymic Function<\/span>. Clinical Science<\/span>, 103<\/span>, (s47)<\/span>, pp. 33P<\/span>. <\/a><\/p>","publicationid":"1103525","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lawson CA; Ponchel F; Boylston AW; Emery P; Isaacs JD<\/span> (2002)<\/span> The Role of Regulatory T Cells in Rheumatoid Arthritis<\/span>. Clinical Science<\/span>, 103<\/span>, (s47)<\/span>, pp. 32P<\/span>. <\/a><\/p>","publicationid":"1103519","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Griffiths B; Markham AF; Emery P; Isaacs JD<\/span> (2002)<\/span> Linkage Disequilibrium at the Fc Gamma Receptor (Fc\u03b3r) Locus and Association of An Fc\u03b3r Haplotype with Rheumatoid Arthritis (RA)<\/span>. Clinical Science<\/span>, 103<\/span>, (s47)<\/span>, pp. 33P<\/span>. <\/a><\/p>","publicationid":"908742","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Brown AK; Quinn MA; Karim Z; Wakefield RJ; Conaghan PG; O'Connor PJ; Emery P<\/span> (2002)<\/span> Ultrasonography Detects Synovitis in Patients with Rheumatoid Arthritis despite ACR Remission<\/span>. Clinical Science<\/span>, 103<\/span>, (s47)<\/span>, pp. 35P-36P<\/span>. <\/a><\/p>","publicationid":"829474","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Quinn MA; Conaghan PG; O'Connor P; Karim Z; Wakefield BJ; Emery P<\/span> (2002)<\/span> The Use of Mri in Elucidating the Pathogenesis of Rheumatoid Arthritis (Ra) and Its Use in Understanding Response to Therapy<\/span>. Clinical Science<\/span>, 103<\/span>, (s47)<\/span>, pp. 35P<\/span>. <\/a><\/p>","publicationid":"829458","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alarc\u00f3n GS; Lopez-Ben R; Moreland LW<\/span> (2002)<\/span> High-resolution ultrasound for the study of target joints in rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 46<\/span>, (7)<\/span>, pp. 1969-1970<\/span>. <\/a><\/p>","publicationid":"189650","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Quinn MA; O'Connor P; Wakefield RJ; Karim Z; Emery P<\/span> (2002)<\/span> Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?<\/span> ARTHRITIS RHEUM<\/span>, 46<\/span>, (7)<\/span>, pp. 1971-1972<\/span>. <\/a><\/p>","publicationid":"100601","date":"2002-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Moreland LW; Alten R; Van den Bosch F; Appelboom T; Leon M; Emery P; Cohen S; Luggen M; Shergy W; Nuamah I; Becker J-C<\/span> (2002)<\/span> Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion<\/span>. Arthritis Rheum<\/span>, 46<\/span>, (6)<\/span>, pp. 1470-1479<\/span>. <\/a><\/p>","publicationid":"99314","date":"2002-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Marzo-Ortega H; O'Connor P; Gibbon W; Hawkey P; Henshaw K; Emery P<\/span> (2002)<\/span> Histological assessment of the early enthesitis lesion in spondyloarthropathy<\/span>. ANN RHEUM DIS<\/span>, 61<\/span>, (6)<\/span>, pp. 534-537<\/span>. <\/a><\/p>","publicationid":"84802","date":"2002-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Breedveld FC; Dougados M; Kalden JR; Schiff MH; Smolen JS<\/span> (2002)<\/span> Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide<\/span>. ANN RHEUM DIS<\/span>, 61<\/span>, (4)<\/span>, pp. 290-297<\/span>. <\/a><\/p>","publicationid":"114176","date":"2002-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Young A; Dixey J; Kulinskaya E; Cox N; Davies P; Devlin J; Emery P; Gough A; James D; Prouse P; Williams P; Winfield J<\/span> (2002)<\/span> Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS)<\/span>. Ann Rheum Dis<\/span>, 61<\/span>, (4)<\/span>, pp. 335-340<\/span>. <\/a><\/p>","publicationid":"113384","date":"2002-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham SJ; Snowden J; Morgan G; Emery P<\/span> (2002)<\/span> High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases<\/span>. INT IMMUNOPHARMACOL<\/span>, 2<\/span>, (4)<\/span>, pp. 399-414<\/span>. <\/a><\/p>","publicationid":"121389","date":"2002-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham S; Veale D; Fearon U; Isaacs JD; Morgan G; Emery P; McGonagle D; Reece R; Clague R; Snowden JA<\/span> (2002)<\/span> High\u2010dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short\u2010term efficacy correlates with reduction of macroscopic and histologic synovitis<\/span>. Arthritis & Rheumatism<\/span>, 46<\/span>, (3)<\/span>, pp. 837-839<\/span>. <\/a><\/p>","publicationid":"116923","date":"2002-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham S; Veale D; Fearon U; Isaacs JD; Morgan G; Emery P; McGonagle D; Reece R; Clague R; Snowden JA<\/span> (2002)<\/span> High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis<\/span>. ARTHRITIS RHEUM<\/span>, 46<\/span>, (3)<\/span>, pp. 837-839<\/span>. <\/a><\/p>","publicationid":"98357","date":"2002-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Buch M<\/span> (2002)<\/span> Treating rheumatoid arthritis with tumour necrosis factor alpha blockade<\/span>. BMJ<\/span>, 324<\/span>, (7333)<\/span>, pp. 312-313<\/span>. <\/a><\/p>","publicationid":"107858","date":"2002-02-09","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Buch M<\/span> (2002)<\/span> Treating rheumatoid arthritis with tumour necrosis factor \u03b1 blockade<\/span>. British Medical Journal<\/span>, 324<\/span>, (7333)<\/span>, pp. 312-313<\/span>. <\/a><\/p>","publicationid":"56780","date":"2002-02-09","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Nieto A; Pascual M; C\u00e1liz R; Matar\u00e1n L; Mart\u00edn J<\/span> (2002)<\/span> Association of Fcgamma receptor IIIA polymorphism with rheumatoid arthritis: comment on the article by Morgan et al<\/span>. Arthritis Rheum<\/span>, 46<\/span>, (2)<\/span>, pp. 556-559<\/span>. <\/a><\/p>","publicationid":"189623","date":"2002-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Griffiths B; Barrett JH; Markham AF; Emery P; Isaacs JD<\/span> (2002)<\/span> Reply<\/span>. Arthritis & Rheumatism<\/span>, 46<\/span>, (2)<\/span>, pp. 557-559<\/span>. <\/a><\/p>","publicationid":"56116","date":"2002-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Marzo-Ortega H; O'Connor P; Gibbon W; Pease C; Reece R; Emery P<\/span> (2002)<\/span> The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy<\/span>. Arthritis Rheum<\/span>, 46<\/span>, (2)<\/span>, pp. 489-493<\/span>. <\/a><\/p>","publicationid":"35148","date":"2002-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kraan MC; Reece RJ; Smeets TJM; Veale DJ; Emery P; Tak PP<\/span> (2002)<\/span> Comparison of knee joints with small joints: implications for pathogenesis and evaluation of treatment in rheumatoid arthritis<\/span>. Arthritis Research<\/span>, 4<\/span>, (Suppl 1)<\/span>, pp. 35<\/span>. <\/a><\/p>","publicationid":"283768","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Conaghan PG; Slade A; Draycott S; Crawshaw D; Reece R; Fraser A; Tennant A; Emery P<\/span> (2002)<\/span> THE USEFULNESS OF THE WOMAC OSTEOARTHRITIS INDEX AS A TRIAGE TOOL FOR KNEE PAIN<\/span>. RHEUMATOLOGY<\/span>, 41<\/span>, pp. 123<\/span>.<\/p>","publicationid":"143411","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Mc Gonagle D; Haugeberg G; Astin P; Conaghan PG; Emery P<\/span> (2002)<\/span> SIGNIFICANT LOSS OF BONE MASS OCCURS EARLY IN INFLAMMATORY BACK PAIN IN UNDIFFERENTIATED SPONDYLOARTHROPATHY<\/span>. RHEUMATOLOGY<\/span>, 41<\/span>, pp. 114<\/span>.<\/p>","publicationid":"143410","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham SJ; Buch MH; Lindsay S; Tennant A; Emery P<\/span> (2002)<\/span> INTENSIVE THERAPY CAN IMPROVE DISEASE ACTIVITY, QUALITY OF LIFE (RAQOL) AND DISABILITY (HAQ) EVEN IN RA PATIENTS WITH LATE 'RESISTANT' DISEASE<\/span>. RHEUMATOLOGY<\/span>, 41<\/span>, pp. 95-96<\/span>.<\/p>","publicationid":"143409","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham SJ; Buch MH; Conaghan PG; Lindsay S; Emery P<\/span> (2002)<\/span> OPEN LABEL PROSPECTIVE STUDY OF THE SAFETY AND EFFICACY OF COMBINATION THERAPY WITH LEFLUNOMIDE AND INFLIXIMAB IN PATIENTS WITH RA AND A PARTIAL RESPONSE TO LEFLUNOMIDE<\/span>. RHEUMATOLOGY<\/span>, 41<\/span>, pp. 94-95<\/span>.<\/p>","publicationid":"143408","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Bingham SJ; Lindsay S; Rees-Evans B; Emery P<\/span> (2002)<\/span> EFFICACY OF INFLIXIMAB RE-INTRODUCTION FOLLOWING PREVIOUS TWO YEARS EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, 41<\/span>, pp. 94<\/span>.<\/p>","publicationid":"143407","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham SJ; Buch MH; Lindsay S; Tennant A; Emery P<\/span> (2002)<\/span> FACTORS AFFECTING DISABILITY AND QUALITY OF LIFE IN 353 PATIENTS WITH RESISTANT RA REFERRED FOR ASSESSMENT FOR BIOLOGICAL THERAPIES<\/span>. RHEUMATOLOGY<\/span>, 41<\/span>, pp. 74-75<\/span>.<\/p>","publicationid":"143405","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; Mc Gonagle D; O'Connor P; Conaghan PG; Greenstein AS; Tan AL; Fraser A; Veale D; Emery P<\/span> (2002)<\/span> INFLIXIMAB IS EFFECTIVE IN THE TREATMENT OF RESISTANT PSORIATIC ARTHRITIS AND SKIN PSORIASIS: A CLINICAL AND MRI STUDY<\/span>. RHEUMATOLOGY<\/span>, 41<\/span>, pp. 5<\/span>.<\/p>","publicationid":"143400","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Morgan AW; Griffiths B; Barrett JH; Markham AF; Emery P; Isaacs JD<\/span> (2002)<\/span> Association of Fc\u03b3 receptor IIIA polymorphism with rheumatoid arthritis:: Comment on the article by Morgan et al -: Reply<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, 46<\/span>, (2)<\/span>, pp. 557-559<\/span>. <\/a><\/p>","publicationid":"112129","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2002)<\/span> Magnetic resonance imaging: opportunities for rheumatoid arthritis disease assessment and monitoring long-term treatment outcomes<\/span>. Arthritis Res<\/span>, 4 Suppl 2<\/span>, (Suppl 2)<\/span>, pp. S6-10<\/span>. <\/a><\/p>","publicationid":"108430","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buch MH; Emery P<\/span> (2002)<\/span> The aetiology and pathogenesis of rheumatoid arthritis<\/span>. Hospital Pharmacist<\/span>, 9<\/span>, (1)<\/span>, pp. 5-10<\/span>.<\/p>","publicationid":"38055","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; McGonagle D; Emery P<\/span> (2002)<\/span> Efficacy of tumor necrosis factor a blockade for enthesitis in spondylarthropathy: comment on the article by Marzo-Ortega et al - Reply<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, 46<\/span>, (12)<\/span>, pp. 3398<\/span>. <\/a><\/p>","publicationid":"12494","date":"2002-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Karim Z; Wakefield RJ; Conaghan PG; Lawson CA; Goh E; Quinn MA; Astin P; O'Connor P; Gibbon WW; Emery P<\/span> (2001)<\/span> The impact of ultrasonography on diagnosis and management of patients with musculoskeletal conditions<\/span>. ARTHRITIS RHEUM<\/span>, 44<\/span>, (12)<\/span>, pp. 2932-2933<\/span>. 3.0.co;2-3\"><\/a><\/p>","publicationid":"104614","date":"2001-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Camilleri JP; Amos N; Williams BD; Emery P; Williams LA; Jessop JD<\/span> (2001)<\/span> Serum soluble interleukin 2 receptor levels and radiological progression in early rheumatoid arthritis<\/span>. J RHEUMATOL<\/span>, 28<\/span>, (12)<\/span>, pp. 2576-2578<\/span>.<\/p>","publicationid":"48556","date":"2001-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Keystone EC; Breedveld FC; Kalden JR; Smolen JS; Antoni CE; Burmester GR; Crofford LJ; Kavanaugh A<\/span> (2001)<\/span> Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)<\/span>. Ann Rheum Dis<\/span>, 60 Suppl 3<\/span>, (Suppl 3)<\/span>, pp. iii2-iii5<\/span>. <\/a><\/p>","publicationid":"188990","date":"2001-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Quinn MA; Conaghan PG; Emery P<\/span> (2001)<\/span> The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?<\/span> RHEUMATOLOGY<\/span>, 40<\/span>, (11)<\/span>, pp. 1211-1220<\/span>. <\/a><\/p>","publicationid":"93943","date":"2001-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Derijk RH; Schaaf MJ; Turner G; Datson NA; Vreugdenhil E; Cidlowski J; de Kloet ER; Emery P; Sternberg EM; Detera-Wadleigh SD<\/span> (2001)<\/span> A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis<\/span>. J Rheumatol<\/span>, 28<\/span>, (11)<\/span>, pp. 2383-2388<\/span>.<\/p>","publicationid":"64078","date":"2001-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; McGonagle D; O'Connor P; Pease C; Emery P<\/span> (2001)<\/span> Subclinical vasculitis in polymyalgia rheumatica<\/span>. ANN RHEUM DIS<\/span>, 60<\/span>, (11)<\/span>, pp. 1058-1059<\/span>. <\/a><\/p>","publicationid":"48706","date":"2001-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Stockwin L; Isaacs J; Emery P<\/span> (2001)<\/span> An enthesitis based model for the pathogenesis of spondyloarthropathy. additive effects of microbial adjuvant and biomechanical factors at disease sites<\/span>. J Rheumatol<\/span>, 28<\/span>, (10)<\/span>, pp. 2155-2159<\/span>.<\/p>","publicationid":"46863","date":"2001-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Marzo-Ortega H; McGonagle D; O'Connor P; Emery P<\/span> (2001)<\/span> Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy - A clinical and magnetic resonance imaging study<\/span>. ARTHRITIS RHEUM<\/span>, 44<\/span>, (9)<\/span>, pp. 2112-2117<\/span>. 3.0.CO;2-H\"><\/a><\/p>","publicationid":"66854","date":"2001-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Fraser A; Fearon U; Reece R; Emery P; Veale DJ<\/span> (2001)<\/span> Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis<\/span>. ARTHRITIS RHEUM<\/span>, 44<\/span>, (9)<\/span>, pp. 2024-2028<\/span>. 3.0.CO;2-K\"><\/a><\/p>","publicationid":"38622","date":"2001-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Pease C; Marzo-Ortega H; O'Connor P; Gibbon W; Emery P<\/span> (2001)<\/span> Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica<\/span>. J RHEUMATOL<\/span>, 28<\/span>, (8)<\/span>, pp. 1837-1841<\/span>.<\/p>","publicationid":"109771","date":"2001-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery J; Lucassen A; Murphy M<\/span> (2001)<\/span> Common hereditary cancers and implications for primary care<\/span>. Lancet<\/span>, 358<\/span>, (9275)<\/span>, pp. 56-63<\/span>. <\/a><\/p>","publicationid":"97675","date":"2001-07-07","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Reade S; Marzo-Ortega H; Gibbon W; O'Connor P; Morgan A; Melsom R; Morgan E; Emery P<\/span> (2001)<\/span> Human immunodeficiency virus associated spondyloarthropathy: pathogenic insights based on imaging findings and response to highly active antiretroviral treatment<\/span>. ANN RHEUM DIS<\/span>, 60<\/span>, (7)<\/span>, pp. 696-698<\/span>. <\/a><\/p>","publicationid":"121079","date":"2001-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; Antoine C; Brin S; Emery P; Lemmel EM; de la Serna AR; Zerbini CA; Van Riel P<\/span> (2001)<\/span> THU0196\u2005Efficacy of and predisposing factors for response to leflunomide (lef) in patients with rheumatoid arthritis (ra)<\/span>. Annals of the Rheumatic Diseases<\/span>, 60<\/span>, pp. A433<\/span>. <\/a><\/p>","publicationid":"1103357","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Woolley JM; Chan WW<\/span> (2001)<\/span> FRI0041\u2005Improvements in functional status due to anakinra therapy in patients with rheumatoid arthritis who are not using dmards<\/span>. Annals of the Rheumatic Diseases<\/span>, 60<\/span>, pp. A461-A462<\/span>. <\/a><\/p>","publicationid":"1103356","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Breedveld F; Dougados M; Kalden J; Schiff M; Smolen J<\/span> (2001)<\/span> FRI0045\u2005Development of an evidence-based referral recommendation (err) for the optimum dmard treatment of patients with early stage rheumatoid arthritis (ra)<\/span>. Annals of the Rheumatic Diseases<\/span>, 60<\/span>, pp. A463-A464<\/span>. <\/a><\/p>","publicationid":"1103355","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Maini R; Van der Heijde D; Smolen J; Kalden J; Breedveld F; Emery P; Keystone E; Harriman G; Lipksy P<\/span> (2001)<\/span> FRI0068\u2005102-wk clinical and radiologic results from the attract trial: a 2 year, randomised, controlled, phase 3 trial of infliximab (remicade\u00ae) in pts with active ra despite mtx<\/span>. Annals of the Rheumatic Diseases<\/span>, 60<\/span>, pp. A473<\/span>. <\/a><\/p>","publicationid":"1103354","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Maini R; Breedveld F; Smolen J; Kalden J; Van der Heijde D; Han C; Harriman G<\/span> (2001)<\/span> OP0087\u2005Infliximab plus methotrexate inhibits structural damage, reduces sign and symptoms and improves disability in patients with active early rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, 60<\/span>, pp. A481-A482<\/span>. <\/a><\/p>","publicationid":"1103353","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Woolley JM; Chan WW<\/span> (2001)<\/span> SAT0245\u2005Improvement in health-related quality of life from anakinra therapy in patients with rheumatoid arthritis not using dmards<\/span>. Annals of the Rheumatic Diseases<\/span>, 60<\/span>, pp. A346-A347<\/span>. <\/a><\/p>","publicationid":"1103352","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Conaghan P; Quinn M<\/span> (2001)<\/span> Treatment of rheumatoid arthritis 2001<\/span>. J Rheumatol<\/span>, 28<\/span>, (6)<\/span>, pp. 1201-1202<\/span>.<\/p>","publicationid":"111387","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham S; Emery P<\/span> (2001)<\/span> Combination therapy in rheumatoid arthritis<\/span>. SPRINGER SEMIN IMMUN<\/span>, 23<\/span>, (1-2)<\/span>, pp. 165-183<\/span>. <\/a><\/p>","publicationid":"84037","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham S; Griffiths B; McGonagle D; Snowden JA; Morgan G; Emery P<\/span> (2001)<\/span> Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up<\/span>. Br J Haematol<\/span>, 113<\/span>, (3)<\/span>, pp. 840-841<\/span>. <\/a><\/p>","publicationid":"77102","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Reginster JY; Appelboom T; Breedveld FC; Edelmann E; Kekow J; Malaise M; Mola EM; Montecucco C; Sanda M; Sany J; Scott DL; Serni U; Seydoux G<\/span> (2001)<\/span> WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 40<\/span>, (6)<\/span>, pp. 699-702<\/span>. <\/a><\/p>","publicationid":"45119","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; K\u00f6tter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A<\/span> (2001)<\/span> Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease<\/span>. Ann Rheum Dis<\/span>, 60<\/span>, (6)<\/span>, pp. 577-584<\/span>. <\/a><\/p>","publicationid":"33334","date":"2001-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Green M; Marzo-Ortega H; Wakefield RJ; Astin P; Proudman S; Conaghan PG; Hordon L; Emery P<\/span> (2001)<\/span> Predictors of outcome in patients with oligoarthritis - Results of a protocol of intraarticular corticosteroids to all clinically active joints<\/span>. ARTHRITIS RHEUM<\/span>, 44<\/span>, (5)<\/span>, pp. 1177-1183<\/span>. 3.0.CO;2-5\"><\/a><\/p>","publicationid":"116025","date":"2001-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Ostergaard M; Kharlund M; Lassere M; Conaghan P; Peterfy C; McQueen F; O'Connor P; Shnier N; Stewart N; McGonagle D; Emery P; Genant H; Edmonds J<\/span> (2001)<\/span> Interreader agreement in the assessment of magnetic resonance images of rheumatoid arthritis wrist and finger joints - An international multicenter study<\/span>. J RHEUMATOL<\/span>, 28<\/span>, (5)<\/span>, pp. 1143-1150<\/span>.<\/p>","publicationid":"93421","date":"2001-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Albers JMC; Paimela L; Kurki P; Eberhardt KB; Emery P; van't Hof MA; Schreuder FHJM; Leirisalo-Repo M; van Riel PLCM<\/span> (2001)<\/span> Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis<\/span>. ANN RHEUM DIS<\/span>, 60<\/span>, (5)<\/span>, pp. 453-458<\/span>. <\/a><\/p>","publicationid":"47886","date":"2001-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Woolf AD<\/span> (2001)<\/span> Preface<\/span>. Best Practice & Research Clinical Rheumatology<\/span>, 15<\/span>, (1)<\/span>, pp. vii-viii<\/span>. <\/a><\/p>","publicationid":"1103597","date":"2001-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Dougados M; Antoine C; Brin S; Emery P; Lemmel EM; de la Serna AR; Zerbini CAF; Van Riel P<\/span> (2001)<\/span> Efficacy of and predisposing factors for response to leflunomide (LEF) in patients with rheumatoid arthritis (RA)<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, 28<\/span>, pp. 105<\/span>.<\/p>","publicationid":"107873","date":"2001-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2001)<\/span> Introduction - Overview of current therapies for rheumatoid arthritis<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, 28<\/span>, pp. 1-3<\/span>.<\/p>","publicationid":"65489","date":"2001-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Alldred A; Emery P<\/span> (2001)<\/span> Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis<\/span>. Expert opinion on pharmacotherapy<\/span>, 2<\/span>, (1)<\/span>, pp. 125-137<\/span>. <\/a><\/p>","publicationid":"40344","date":"2001-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hawkey CJ; Emery P; Moore A<\/span> (2001)<\/span> Selective cyclo-oxygenase inhibitors - Authors' reply<\/span>. LANCET<\/span>, 358<\/span>, (9280)<\/span>, pp. 510<\/span>. <\/a><\/p>","publicationid":"25288","date":"2001-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group<\/span> (2000)<\/span> Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group<\/span>. N Engl J Med<\/span>, 343<\/span>, (22)<\/span>, pp. 1594-1602<\/span>. <\/a><\/p>","publicationid":"1103600","date":"2000-11-30","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Breedveld FC; Burmester GR; Crofford JJ; Emery P; Feldmann M; Kalden JR; Kavanaugh AF; Keystone EC; Klareskog LG; Lipsky PE; Maini RN; Russell AS; Scott DL; Smolen JS; Van de Putte LB; Visher TL; Weisman MH<\/span> (2000)<\/span> Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000)<\/span>. Ann Rheum Dis<\/span>, 59 Suppl 1<\/span>, (Suppl 1)<\/span>, pp. i1-i2<\/span>. <\/a><\/p>","publicationid":"1103531","date":"2000-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Porter D<\/span> (2000)<\/span> Re: Bingham and Emery. Resistant rheumatoid arthritis clinics--a necessary development?<\/span> Rheumatology (Oxford)<\/span>, 39<\/span>, (10)<\/span>, pp. 1154-1155<\/span>. <\/a><\/p>","publicationid":"1103590","date":"2000-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cooper MS; Rabbitt E; Emery P; Hewison M; Stewart PM<\/span> (2000)<\/span> Inflammatory stimuli increase local cortisol production in osteoblasts in vitro and in vivo<\/span>. Bone<\/span>, 27<\/span>, (4)<\/span>, pp. 33<\/span>. <\/a><\/p>","publicationid":"1103479","date":"2000-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Emery P<\/span> (2000)<\/span> Enthesitis, osteitis, microbes, biomechanics, and immune reactivity in ankylosing spondylitis<\/span>. J Rheumatol<\/span>, 27<\/span>, (10)<\/span>, pp. 2302-2304<\/span>.<\/p>","publicationid":"1103442","date":"2000-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Smolen JS; Emery P<\/span> (2000)<\/span> Efficacy and safety of leflunomide in active rheumatoid arthritis<\/span>. Rheumatology (Oxford)<\/span>, 39 Suppl 1<\/span>, (suppl_1)<\/span>, pp. 48-56<\/span>. <\/a><\/p>","publicationid":"1103594","date":"2000-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (2000)<\/span> Assessment of Innovative Therapies: A Mode-of-Action Approach<\/span>. Arthritis Research<\/span>, 1<\/span>, (Suppl 1)<\/span>, pp. S42<\/span>. <\/a><\/p>","publicationid":"1103559","date":"2000-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Huissoon AP; Emery P; Bacon PA; Gordon J; Salmon M<\/span> (2000)<\/span> Increased expression of CD23 in rheumatoid synovitis<\/span>. Scand J Rheumatol<\/span>, 29<\/span>, (3)<\/span>, pp. 154-159<\/span>. <\/a><\/p>","publicationid":"1103513","date":"2000-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bingham S; Emery P<\/span> (2000)<\/span> Resistant rheumatoid arthritis clinics- a necessary development?<\/span> Rheumatology (Oxford)<\/span>, 39<\/span>, (1)<\/span>, pp. 2-5<\/span>. <\/a><\/p>","publicationid":"1103511","date":"2000-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Conaghan PG; Emery P<\/span> (2000)<\/span> Psoriatic arthritis - an enthesopathy-based disorder? Comment an the article by McGonagle et al - Reply<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, 43<\/span>, (3)<\/span>, pp. 713-714<\/span>. 3.0.CO;2-L\"><\/a><\/p>","publicationid":"829457","date":"2000-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Conaghan P; Emery P<\/span> (2000)<\/span> Reply<\/span>. Arthritis and Rheumatism<\/span>, 43<\/span>, (4)<\/span>, pp. 950<\/span>. 3.0.CO;2-9\"><\/a><\/p>","publicationid":"829400","date":"2000-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Furst DE; Breedveld FC; Burmester GR; Crofford L; Emery P; Feldman M; Kalden JR; Kavanaugh A; Keystone E; Lipsky PE; Maini RN; Moreland L; Smolen JS; Van De Putte L; Vischer T; Weinblatt M; Weissman M<\/span> (1999)<\/span> Access to disease modifying treatments for rheumatoid arthritis patients<\/span>. Ann Rheum Dis<\/span>, 58 Suppl 1<\/span>, (Suppl 1)<\/span>, pp. I129-I130<\/span>. <\/a><\/p>","publicationid":"1103478","date":"1999-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bresnihan B; Alvaro\u2010Gracia JM; Cobby M; Doherty M; Domljan Z; Emery P; Nuki G; Pavelka K; Rau R; Rozman B; Watt I; Williams B; Aitchison R; McCabe D; Musikic P<\/span> (1999)<\/span> Reply<\/span>. Arthritis & Rheumatism<\/span>, 42<\/span>, (8)<\/span>, pp. 1782<\/span>. 3.0.co;2-#\"><\/a><\/p>","publicationid":"1103565","date":"1999-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1999)<\/span> Vision of the future in arthritis care<\/span>. Scand J Rheumatol Suppl<\/span>, 109<\/span>, (sup109)<\/span>, pp. 3-11<\/span>. <\/a><\/p>","publicationid":"1103557","date":"1999-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1999)<\/span> Clinical aspects of COX-2 inhibitors<\/span>. Drugs Today (Barc)<\/span>, 35<\/span>, (4-5)<\/span>, pp. 267-274<\/span>. <\/a><\/p>","publicationid":"1103445","date":"1999-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1999)<\/span> Dose-loading with hydroxychloroquine is effective in early and active rheumatoid arthritis<\/span>. Clin Exp Rheumatol<\/span>, 17<\/span>, (4)<\/span>, pp. 399-400<\/span>.<\/p>","publicationid":"1103444","date":"1999-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Pincus T; Breedveld FC; Emery P<\/span> (1999)<\/span> Does partial control of inflammation prevent long-term joint damage? Clinical rationale for combination therapy with multiple disease-modifying antirheumatic drugs<\/span>. Clin Exp Rheumatol<\/span>, 17<\/span>, (6 Suppl 18)<\/span>, pp. S2-S7<\/span>.<\/p>","publicationid":"1103443","date":"1999-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Akehurst RL; Backhouse M; Emery P; Haslock I; Kirsch J; McCabe CJ; Scott DL; Whitfield M; Woolf AD<\/span> (1998)<\/span> Nabumetone compared with Ibuprofen and a weighted NSAID combination: An economic evaluation<\/span>. Journal of Medical Economics<\/span>, 1<\/span>, (1-4)<\/span>, pp. 19-37<\/span>. <\/a><\/p>","publicationid":"188175","date":"1998-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McCabe CJ; Akehurst RL; Kirsch J; Whitfield M; Backhouse M; Woolf AD; Scott DL; Emery P; Haslock M<\/span> (1998)<\/span> Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis - The impact on costs and outcomes in the UK<\/span>. PHARMACOECONOMICS<\/span>, 14<\/span>, (2)<\/span>, pp. 191-199<\/span>. <\/a><\/p>","publicationid":"65365","date":"1998-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

McGonagle D; Rawstron A; Richards S; Isaacs J; Bird H; Jack A; Morgan G; Emery P<\/span> (1997)<\/span> A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis<\/span>. Arthritis and Rheumatism<\/span>, 40<\/span>, (10)<\/span>, pp. 1838-1842<\/span>. <\/a><\/p>","publicationid":"377482","date":"1997-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gough A; Griffiths B<\/span> (1997)<\/span> Minocycline related lupus<\/span>. J Rheumatol<\/span>, 24<\/span>, (9)<\/span>, pp. 1850<\/span>.<\/p>","publicationid":"1103416","date":"1997-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Symmons DP<\/span> (1997)<\/span> What is early rheumatoid arthritis?: definition and diagnosis<\/span>. Baillieres Clin Rheumatol<\/span>, 11<\/span>, (1)<\/span>, pp. 13-26<\/span>. <\/a><\/p>","publicationid":"1103502","date":"1997-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1996)<\/span> Pirazolac<\/span>. Clinical Immunotherapeutics<\/span>, 6<\/span>, (6)<\/span>, pp. 511<\/span>. <\/a><\/p>","publicationid":"1103544","date":"1996-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Blake D; Dieppe P; Emery P; Maddison P; Nuki G; Panayi GS; Sturrock R; Williams B<\/span> (1996)<\/span> Training in rheumatology<\/span>. Br J Rheumatol<\/span>, 35<\/span>, (11)<\/span>, pp. 1190<\/span>. <\/a><\/p>","publicationid":"1103589","date":"1996-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Truscott JG; Devlin J; Emery P<\/span> (1996)<\/span> DXA scanning<\/span>. Baillieres Clin Rheumatol<\/span>, 10<\/span>, (4)<\/span>, pp. 679-698<\/span>. <\/a><\/p>","publicationid":"1103587","date":"1996-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bloem JL; Geirnaerdt MJA; Hogendoorn PCW; Chevrot A; Davies AM; H\u00e1jek M; Kurkov\u00e1 D; Herynek V; Imhof H; Masciocchi C; Maffey MV; M\u00f8ller JF; Putz R; Reiser MF; Braunschweig R; Bon\u00e9l H; St\u00e4bler A; Watt I; Adams JE; Harake MDJ; Lipscomp K; Selby PL; Aparisi F; Arana E; Lloret RM; Marti-Bonmati I; Menor F; Sanchez E; Rodrigo C; Beltran J; Cifrian C; Garci JL; Memis A; Arkun R; Akalin T; Ustu EE; Sabah D; Barile A; Rossi F; Zugaro L; Manetta R; Maurizi Enrici R; Beggs I; Bianchi S; Martinoli C; Molini L; Gandolfo N; Damiani S; Helmberger T; Sittek H; Steinborn M; Ritter MM; Geisst HC; Pistitsch C; Herrmann K; B\u00f6gl K; Kainberger F; Adlassnig KP; Kolousek G; Leitich H; Kolarz G; Bracke P; Ramon F; Stevens W; De Clarck L; De Schepper A; Sys J; Michielsen J; Martens M; Breitenseher MJ; Trattnig S; Gaebler C; Metz V; Kukla C; Gneger A; Rand T; Brossmann J; Andresen R; Preidler KW; Daenen B; DeMaeseneer M; Resnick D; Burnett S; Saifuddin A; White J; Cassar-Pullicino VN; Inman C; Griffiths J; McCall IW; Masri WE; Cs\u00f3k\u00e1si Z; Forgacs S; Czerny C; Neuhold A; Hofmann S; Tschauner C; Engel A; Recht MP; Kramer J; DeBeuckeleer L; DeSchepper A; Somerville J; Vandevenne J; De Maeseneer M; Jaovishidha S; Sartoris DJ; Elizagaray E; Saez F; Faletti C; De Stefano N; Sorrentin T; Foder\u00e0 Pierangeli L; Mona D; Foster JE; Taberner J; Keen M; Dieppe P; Freyschmidt J; Gibbon WW; O'Connor PJ; McGonagle D; Emery P; Grampp S; Lang P; Jergas M; Gl\u00fcer CC; Steiner E; Takada M; Mathur A; Genant HK; Jevtic V; Rozman B; Kos-Golja M; Demsar F; Nehrer S; Seidl G; Baldt M; Klarlund M; \u00d8stergaard M; S\u00f8rensen K; Lorenzen I; Eschberger J; Gstettner M; Schneider W; Plenk H; K\u00fchne JH; Steinborn A; D\u00fcrr HR; Scheidler J; Lienemann A; Landsiedl F; Mamdorff P; Honda G; Rosenau W; Johnston J; Mindell E; Peterfy CG; Nevitt M; Majumdar S; Lecouvet FE; Vande Berg BC; Maighem J; Michaux JL; Maldague BE; Lecoevet FE; Malghem J; Mastantuono M; Larciprete M; Bassetti E; Argento G; Amoroso M; Satragno L; Nucci F; Romanini L; Passariello R; McNally EG; Goodman TR; Merkle EM; Krammel E; Vogel J; Kr\u00e4mer S; Schulte M; Usadel S; Kern P; Brambs HJ; Mester \u00c1; Mak\u00f3 E; Papp E; Kiss K; M\u00e1rton E; D\u00e9vai T; Duffek L; B\u00e1rtfai K; N\u00e9meth L; Karlinger K; Posgay M; K\u00e1kosy T; Davies GA; Cowen AR; Fowler RC; Bury RF; Parkin GJS; Lintott DJ; Martinez D; Safadin A; Pal CR; Ostlere SJ; Phillps AJ; Athanasou N; Lemperle SM; Holmes RE; R\u00fchm S; Zanetti M; Romero J; Hodler J; Larena JA; Marti-Bonmarti L; Martin I; Tabernero G; Alonso A; Scarabino T; Guglielmi G; Giannatempo GM; Cammisa M; Salvolini U; Schmitt R; Fellner F; Heinze A; Obletter N; Schnarkowski P; Tirman PFJ; Steinbach LS; Schneider P; Ferrettiz JL; Capozza RF; Braun M; Reiners C; Zettl R; Silvestri E; Falchi M; Delucchi S; Cella R; Neumaier CE; Prato N; Migliorini S; Jessel C; Heuck A; Stevens KJ; Preston BJ; Kerslake RW; Wright W; Wallace WA; Stiskal M; Szolar D; Stenzel I; Mesaric P; Smolen J; Czembirek H; Tasker AD; Benson MK; Fleischmann D; Haller J; Rottmann B; Kontaxis G; Vanel D; Missenard G; Le Cesne A; Guinebretiere JM; Verhoek G; Duewell S; Zollinger H; Vrooman HA; Valstar ER; Brand GJ; Obermann WR; Rozing PM; Reiber JHC; Zafiroski G; Kamnar J; Zografski G; Jeftic V; Vidoevski G; Ledermann T; Zerbi A; Gambaretti R; Trenti N; Zanolla W; Allen AW; Willis CE; Radmer S; Hakim S; Banzer D; Sparmann M; Argent JD; Sampson MA; Baur A; Bartl R; Llopis E; Monton T; Vallcanera A; Serafini G; Bertolotto M; Trudell D; White LM; Garlaschi G; DiLella GM; Bray A; Parrella A; Salvia F; Parrella RE; Eszterg\u00e1lyos J; Faul S; Link J; Behrendt S; Helbich T; Steingruber I; Gahleitner A; Kettenbach J; Kreuzer S; Lomoschitz F; Kaposi PN; Reti PG; Kolenc M; Turk Z; Barovic J; Kugler C; Uggowitzer M; Gr\u00f6ll R; Raith J; Ranner G; Liskutin J; Youssefzadeh S; Montagnon C; Billiard JS; Tanji P; Peerally S; Gazielly D; Muhaz-Vives JM; Fern\u00e1ndez J; Girveni-Montilos R; Catasuz-Capellades X; Valls-Pascual R; Niitsu M; Mishima H; Itai Y; Pirronti T; Sallustio G; Cerase A; Priolo F; Poleksic L; Atanackovic M; Dimitrijevic B; Bacic G; Potsybina VV; Rangger C; Kathrein A; Klestil T; Gabl M; Daniaux H; Recondo JA; Alustiza JM; Villanua J; Barrera MC; Salvador E; Larrea JA; Martin J<\/span> (1996)<\/span> The 3rd annual congress of the European society of skeletal radiology<\/span>. European Radiology<\/span>, 6<\/span>, (5)<\/span>, pp. C3-C31<\/span>. <\/a><\/p>","publicationid":"1103552","date":"1996-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1996)<\/span> Leflunomide<\/span>. Clinical Immunotherapeutics<\/span>, 6<\/span>, (4)<\/span>, pp. 306<\/span>. <\/a><\/p>","publicationid":"1103476","date":"1996-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; van de Putte LB<\/span> (1996)<\/span> New perspectives on controlling progression of severe rheumatoid arthritis--a summary of the potential role of cyclosporin<\/span>. Br J Rheumatol<\/span>, 35 Suppl 2<\/span>, (suppl 2)<\/span>, pp. 1-3<\/span>. <\/a><\/p>","publicationid":"1103521","date":"1996-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Richardson C; Emery P<\/span> (1996)<\/span> Erratum to Clinical use of cyclosporin in rheumatoid arthritis<\/span>. Drugs<\/span>, 51<\/span>, (4)<\/span>, pp. 570<\/span>. <\/a><\/p>","publicationid":"1103536","date":"1996-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1996)<\/span> Clinical implications of selective cyclooxygenase-2 inhibition<\/span>. Scand J Rheumatol Suppl<\/span>, 102<\/span>, (sup102)<\/span>, pp. 23-28<\/span>. <\/a><\/p>","publicationid":"1103596","date":"1996-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Boivin CM; Njeh CF; Bulmer N; Devlin J; Emery P<\/span> (1996)<\/span> Comparison of finger ultrasound and bone mineral density (BMD) in rheumatoid arthritis<\/span>. Osteoporosis International<\/span>, 6<\/span>, (S1)<\/span>, pp. 197<\/span>. <\/a><\/p>","publicationid":"1103582","date":"1996-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gough A; Faint J; Salmon M; Bacon P; Emery P<\/span> (1995)<\/span> HLA-DR4 and career prospects in rheumatology: is there a link?<\/span> BMJ<\/span>, 311<\/span>, (7021)<\/span>, pp. 1665-1666<\/span>. <\/a><\/p>","publicationid":"1103446","date":"1995-12-23","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Salmon M<\/span> (1995)<\/span> Early rheumatoid arthritis: time to aim for remission?<\/span> Ann Rheum Dis<\/span>, 54<\/span>, (12)<\/span>, pp. 944-947<\/span>. <\/a><\/p>","publicationid":"1103509","date":"1995-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Reece R; Emery P<\/span> (1995)<\/span> Needle arthroscopy<\/span>. Br J Rheumatol<\/span>, 34<\/span>, (12)<\/span>, pp. 1102-1104<\/span>. <\/a><\/p>","publicationid":"1103472","date":"1995-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Griffiths B; Emery P; Akehurst R<\/span> (1995)<\/span> Economic evaluation in rheumatology: a necessity for clinical studies<\/span>. Ann Rheum Dis<\/span>, 54<\/span>, (11)<\/span>, pp. 863-864<\/span>. <\/a><\/p>","publicationid":"1103614","date":"1995-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Richardson CE; Emery P<\/span> (1995)<\/span> Innovative treatment approaches for rheumatoid arthritis. New cyclo-oxygenase and cytokine inhibitors<\/span>. Baillieres Clin Rheumatol<\/span>, 9<\/span>, (4)<\/span>, pp. 731-758<\/span>. <\/a><\/p>","publicationid":"1103576","date":"1995-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gough A; Andrews D; Bacon PA; Emery P<\/span> (1995)<\/span> Evidence of omeprazole-induced small bowel bacterial overgrowth in patients with scleroderma<\/span>. Br J Rheumatol<\/span>, 34<\/span>, (10)<\/span>, pp. 976-977<\/span>. <\/a><\/p>","publicationid":"1103449","date":"1995-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Faint J; Birley A; Gough A; Pilling D; Salmon M<\/span> (1995)<\/span> Reply<\/span>. Arthritis & Rheumatism<\/span>, 38<\/span>, (6)<\/span>, pp. 874<\/span>. <\/a><\/p>","publicationid":"1103537","date":"1995-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Waring RH; Emery P<\/span> (1995)<\/span> The genetic origin of responses to drugs<\/span>. Br Med Bull<\/span>, 51<\/span>, (2)<\/span>, pp. 449-461<\/span>. <\/a><\/p>","publicationid":"1103429","date":"1995-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kane KF; Emery P; Sheppard MC; Stewart PM<\/span> (1995)<\/span> Assessing the hypothalamo-pituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen versus the insulin tolerance test<\/span>. QJM<\/span>, 88<\/span>, (4)<\/span>, pp. 263-267<\/span>. <\/a><\/p>","publicationid":"279571","date":"1995-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Richardson C; Emery P<\/span> (1995)<\/span> Clinical use of cyclosporin in rheumatoid arthritis<\/span>. Drugs<\/span>, 50 Suppl 1<\/span>, (Supplement 1)<\/span>, pp. 26-36<\/span>. <\/a><\/p>","publicationid":"1103593","date":"1995-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1995)<\/span> Therapeutic Approaches for Early Rheumatoid Arthritis. How Early? How Aggressive?<\/span> Rheumatology<\/span>, XXXIV<\/span>, (suppl 2)<\/span>, pp. 87-90<\/span>. <\/a><\/p>","publicationid":"1103448","date":"1995-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1995)<\/span> Therapeutic Approaches for Early Rheumatoid Arthritis. How Early? How Aggressive?<\/span> Rheumatology<\/span>, XXXIV<\/span>, (suppl 4)<\/span>, pp. 87-90<\/span>. <\/a><\/p>","publicationid":"1103447","date":"1995-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Richardson C; Emery P<\/span> (1995)<\/span> New therapies for rheumatoid arthritis<\/span>. Br J Clin Pract<\/span>, 49<\/span>, (3)<\/span>, pp. 135-139<\/span>. <\/a><\/p>","publicationid":"1103428","date":"1995-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Janssen BA; Luqmani RA; Gordon C; Hemingway IH; Bacon PA; Gearing AJ; Emery P<\/span> (1994)<\/span> Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis<\/span>. Br J Rheumatol<\/span>, 33<\/span>, (12)<\/span>, pp. 1112-1116<\/span>. <\/a><\/p>","publicationid":"1103452","date":"1994-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Luqmani RA; Bacon PA; Moots RJ; Janssen BA; Pall A; Emery P; Savage C; Adu D<\/span> (1994)<\/span> Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis<\/span>. QJM<\/span>, 87<\/span>, (11)<\/span>, pp. 671-678<\/span>. <\/a><\/p>","publicationid":"1103427","date":"1994-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1994)<\/span> Assessment of rheumatoid arthritis--a clinician's viewpoint<\/span>. J Rheumatol Suppl<\/span>, 42<\/span>, pp. 20-24<\/span>.<\/p>","publicationid":"1103426","date":"1994-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

di Giovine FS; Crane A; Gough A; deVries N; VandePutte LBA; Emery P; Duff GW<\/span> (1994)<\/span> A genetic polymorphism in the IL-1 \u03b2 gene is associated with joint erosions in rheumatoid arthritis<\/span>. Cytokine<\/span>, 6<\/span>, (5)<\/span>, pp. 545<\/span>. <\/a><\/p>","publicationid":"1103603","date":"1994-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1994)<\/span> The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid disease: the key to preventing disability<\/span>. Br J Rheumatol<\/span>, 33<\/span>, (8)<\/span>, pp. 765-768<\/span>. <\/a><\/p>","publicationid":"1103451","date":"1994-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Shah P; Luqmani RA; Murray PI; Honan WP; Corridan PG; Emery P<\/span> (1994)<\/span> Posterior scleritis--an unusual manifestation of Cogan's syndrome<\/span>. Br J Rheumatol<\/span>, 33<\/span>, (8)<\/span>, pp. 774-775<\/span>. <\/a><\/p>","publicationid":"1103450","date":"1994-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Lunec J; Herbert K; Blount S; Griffiths HR; Emery P<\/span> (1994)<\/span> 8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus<\/span>. FEBS Lett<\/span>, 348<\/span>, (2)<\/span>, pp. 131-138<\/span>. <\/a><\/p>","publicationid":"1103560","date":"1994-07-11","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gough AK; Lilley J; Eyre S; Holder RL; Emery P<\/span> (1994)<\/span> Generalised bone loss in patients with early rheumatoid arthritis<\/span>. Lancet<\/span>, 344<\/span>, (8914)<\/span>, pp. 23-27<\/span>. <\/a><\/p>","publicationid":"1103332","date":"1994-07-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bradley H; Gough A; Sokhi RS; Hassell A; Waring R; Emery P<\/span> (1994)<\/span> Sulfate metabolism is abnormal in patients with rheumatoid arthritis. Confirmation by in vivo biochemical findings<\/span>. J Rheumatol<\/span>, 21<\/span>, (7)<\/span>, pp. 1192-1196<\/span>.<\/p>","publicationid":"1103421","date":"1994-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Salmon M; Pilling D; Akbar AN; Emery P<\/span> (1994)<\/span> Reply<\/span>. Arthritis & Rheumatism<\/span>, 37<\/span>, (3)<\/span>, pp. 446<\/span>. <\/a><\/p>","publicationid":"1103572","date":"1994-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Moots RJ; Elias E; Hubscher S; Salmon M; Emery P<\/span> (1994)<\/span> Liver disease in twins with Felty's syndrome<\/span>. Ann Rheum Dis<\/span>, 53<\/span>, (3)<\/span>, pp. 202-205<\/span>. <\/a><\/p>","publicationid":"1103543","date":"1994-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Luqmani RA; Bacon PA; Beaman M; Scott DG; Emery P; Lee SJ; Howie AJ; Richards N; Michael J; Adu D<\/span> (1994)<\/span> Classical versus non-renal Wegener's granulomatosis<\/span>. Q J Med<\/span>, 87<\/span>, (3)<\/span>, pp. 161-167<\/span>. <\/a><\/p>","publicationid":"1103419","date":"1994-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Menkes PCJ; Emery P<\/span> (1994)<\/span> Preface<\/span>. Scandinavian Journal of Rheumatology<\/span>, 23<\/span>, (sup100)<\/span>, pp. 1<\/span>. <\/a><\/p>","publicationid":"1103620","date":"1994-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gough A; Sheeran T; Arthur V; Panayi G; Emery P<\/span> (1994)<\/span> Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study<\/span>. Scand J Rheumatol<\/span>, 23<\/span>, (1)<\/span>, pp. 46-48<\/span>. <\/a><\/p>","publicationid":"1103599","date":"1994-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wilson AG; Gordon C; di Giovine FS; de Vries N; van de Putte LB; Emery P; Duff GW<\/span> (1994)<\/span> A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha<\/span>. Eur J Immunol<\/span>, 24<\/span>, (1)<\/span>, pp. 191-195<\/span>. <\/a><\/p>","publicationid":"1103578","date":"1994-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gough AK; Peel NF; Eastell R; Holder RL; Lilley J; Emery P<\/span> (1994)<\/span> Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 53<\/span>, (1)<\/span>, pp. 14-17<\/span>. <\/a><\/p>","publicationid":"1103568","date":"1994-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1994)<\/span> Early rheumatoid arthritis: therapeutic strategies<\/span>. Scand J Rheumatol Suppl<\/span>, 100<\/span>, (sup100)<\/span>, pp. 3-7<\/span>. <\/a><\/p>","publicationid":"1103486","date":"1994-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Luqmani R; Sheeran T; Robinson M; Richardson K; Winkles J; Emery P<\/span> (1994)<\/span> Systemic cytokine measurements: their role in monitoring the response to therapy in patients with rheumatoid arthritis<\/span>. Clin Exp Rheumatol<\/span>, 12<\/span>, (5)<\/span>, pp. 503-508<\/span>.<\/p>","publicationid":"1103425","date":"1994-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Luqmani R; Gordon C<\/span> (1994)<\/span> Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts<\/span>. Br J Clin Pract<\/span>, 48<\/span>, (2)<\/span>, pp. 82-86<\/span>. <\/a><\/p>","publicationid":"1103423","date":"1994-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Devlin J; Gough A; Huissoon A; Reece R; Emery P<\/span> (1994)<\/span> Arthritis in the elderly<\/span>. Ir Med J<\/span>, 87<\/span>, (5)<\/span>, pp. 154<\/span>.<\/p>","publicationid":"1103422","date":"1994-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gordon C; Emery P<\/span> (1993)<\/span> Cytokines and the acute phase response in SLE<\/span>. Lupus<\/span>, 2<\/span>, (6)<\/span>, pp. 345-347<\/span>. <\/a><\/p>","publicationid":"1103598","date":"1993-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Howie AJ; Bacon PA<\/span> (1993)<\/span> Relapses in patients with a systemic vasculitis<\/span>. Q J Med<\/span>, 86<\/span>, (12)<\/span>, pp. 779-789<\/span>. <\/a><\/p>","publicationid":"1103424","date":"1993-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Luqmani R; Moots R; Emery P; Bacon PA; Adu D<\/span> (1993)<\/span> Cyclophosphamide and systemic vasculitis<\/span>. Q J Med<\/span>, 86<\/span>, (12)<\/span>, pp. 843<\/span>. <\/a><\/p>","publicationid":"1103420","date":"1993-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Adu D; Berisa F; Howie AJ; Emery P; Bacon PA; McConkey B; McGonigle RJ; Michaels J; Popert AJ<\/span> (1993)<\/span> Glomerulonephritis in rheumatoid arthritis<\/span>. Br J Rheumatol<\/span>, 32<\/span>, (11)<\/span>, pp. 1008-1011<\/span>. <\/a><\/p>","publicationid":"1103459","date":"1993-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gough A; Salmon M; Devlin J<\/span> (1993)<\/span> Medical management of rheumatoid arthritis<\/span>. BMJ<\/span>, 307<\/span>, (6909)<\/span>, pp. 940<\/span>. <\/a><\/p>","publicationid":"1103588","date":"1993-10-09","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Cork MJ; Tarlow JK; Wilson AG; Blakemore AIF; Messer G; Kind P; Gordon C; Emery P; Bleehen SS; Duff GW<\/span> (1993)<\/span> Cytokine gene polymorphisms in inflammatory dermatoses<\/span>. Journal of Dermatological Science<\/span>, 6<\/span>, (1)<\/span>, pp. 18<\/span>. <\/a><\/p>","publicationid":"1103480","date":"1993-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Salmon M; Wordsworth P; Emery P; Tunn E; Bacon PA; Bell JI<\/span> (1993)<\/span> The association of HLA DR beta alleles with self-limiting and persistent forms of early symmetrical polyarthritis<\/span>. Br J Rheumatol<\/span>, 32<\/span>, (7)<\/span>, pp. 628-630<\/span>. <\/a><\/p>","publicationid":"1103454","date":"1993-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Luqmani R<\/span> (1993)<\/span> The validity of surrogate markers in rheumatic disease<\/span>. Br J Rheumatol<\/span>, 32 Suppl 3<\/span>, (suppl 3)<\/span>, pp. 3-8<\/span>. <\/a><\/p>","publicationid":"1103453","date":"1993-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Matthews N; Emery P; Pilling D; Akbar A; Salmon M<\/span> (1993)<\/span> Subpopulations of primed T helper cells in rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 36<\/span>, (5)<\/span>, pp. 603-607<\/span>. <\/a><\/p>","publicationid":"1103482","date":"1993-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Peh WC; Gough AK; Sheeran T; Evans NS; Emery P<\/span> (1993)<\/span> Pelvic insufficiency fractures in rheumatoid arthritis<\/span>. Br J Rheumatol<\/span>, 32<\/span>, (4)<\/span>, pp. 319-324<\/span>. <\/a><\/p>","publicationid":"1103455","date":"1993-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gado K; Emery P<\/span> (1993)<\/span> Modified suprascapular nerve block with bupivacaine alone effectively controls chronic shoulder pain in patients with rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 52<\/span>, (3)<\/span>, pp. 215-218<\/span>. <\/a><\/p>","publicationid":"1103573","date":"1993-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hay E; Gordon C; Emery P<\/span> (1993)<\/span> Assessment of lupus: where are we now?<\/span> Ann Rheum Dis<\/span>, 52<\/span>, (3)<\/span>, pp. 169-172<\/span>. <\/a><\/p>","publicationid":"1103528","date":"1993-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Waring RH; Emery P<\/span> (1993)<\/span> The genetic basis of responses to drugs--a rheumatological perspective<\/span>. Br J Rheumatol<\/span>, 32<\/span>, (3)<\/span>, pp. 181-188<\/span>. <\/a><\/p>","publicationid":"1103456","date":"1993-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1993)<\/span> Monotherapy in rheumatoid arthritis<\/span>. Br J Rheumatol<\/span>, 32 Suppl 1<\/span>, pp. 21-23<\/span>.<\/p>","publicationid":"1103418","date":"1993-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gordon C; Luqmani R; Fields P; Howie AJ; Emery P<\/span> (1993)<\/span> Two cases of 'Wegener's tuberculosis'<\/span>. Br J Rheumatol<\/span>, 32<\/span>, (2)<\/span>, pp. 143-149<\/span>. <\/a><\/p>","publicationid":"1103458","date":"1993-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

EMERY P; WARING R; GORDON C<\/span> (1993)<\/span> Dr de Vries' letter was shown to Dr Emery and colleagues who reply:<\/span> Rheumatology<\/span>, 32<\/span>, (2)<\/span>, pp. 172<\/span>. <\/a><\/p>","publicationid":"1103457","date":"1993-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Sheeran TP; Roobottom CA; Wanklyn PD; Winkles J; Richardson K; Emery P<\/span> (1993)<\/span> The effect of bed rest and intra-articular steroids on the acute phase response in rheumatoid arthritis<\/span>. Clin Exp Rheumatol<\/span>, 11<\/span>, (1)<\/span>, pp. 49-52<\/span>.<\/p>","publicationid":"1103417","date":"1993-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Salmon M; Bradley H; Wordsworth P; Tunn E; Bacon PA; Waring R<\/span> (1992)<\/span> Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis<\/span>. BMJ<\/span>, 305<\/span>, (6866)<\/span>, pp. 1387-1389<\/span>. <\/a><\/p>","publicationid":"1103563","date":"1992-12-05","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Clarke A; Williams P; Kill D; Cree F; Redhead R; Poland M<\/span> (1992)<\/span> Nabumetone compared with naproxen in the treatment of rheumatoid arthritis: a multicenter, double blind, randomized, parallel group trial in hospital outpatients<\/span>. J Rheumatol Suppl<\/span>, 36<\/span>, pp. 41-47<\/span>.<\/p>","publicationid":"1103440","date":"1992-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Bradley H; Arthur V; Tunn E; Waring R<\/span> (1992)<\/span> Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status<\/span>. Br J Rheumatol<\/span>, 31<\/span>, (7)<\/span>, pp. 449-451<\/span>. <\/a><\/p>","publicationid":"1103460","date":"1992-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Waring RH; Emery P<\/span> (1992)<\/span> Management of early inflammatory arthritis. Genetic factors predicting persistent disease: the role of defective enzyme systems<\/span>. Baillieres Clin Rheumatol<\/span>, 6<\/span>, (2)<\/span>, pp. 337-350<\/span>. <\/a><\/p>","publicationid":"1103625","date":"1992-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1992)<\/span> Foreword<\/span>. Bailli\u00e8re's Clinical Rheumatology<\/span>, 6<\/span>, (2)<\/span>, pp. xi-xii<\/span>. <\/a><\/p>","publicationid":"1103535","date":"1992-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Donnelly S; Scott DL; Emery P<\/span> (1992)<\/span> Management of early inflammatory arthritis. The long-term outcome and justification for early treatment<\/span>. Baillieres Clin Rheumatol<\/span>, 6<\/span>, (2)<\/span>, pp. 251-260<\/span>. <\/a><\/p>","publicationid":"1103529","date":"1992-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Teh LS; Bedwell AE; Isenberg DA; Gordon C; Emery P; Charles PJ; Harper M; Amos N; Williams BD<\/span> (1992)<\/span> Antibodies to protein P in systemic lupus erythematosus<\/span>. Ann Rheum Dis<\/span>, 51<\/span>, (4)<\/span>, pp. 489-494<\/span>. <\/a><\/p>","publicationid":"1103541","date":"1992-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gregory WL; James OF; Idle JR<\/span> (1992)<\/span> Carbocisteine polymorphism and disease<\/span>. Lancet<\/span>, 339<\/span>, (8793)<\/span>, pp. 616-617<\/span>. <\/a><\/p>","publicationid":"1103483","date":"1992-03-07","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Blann AD; Wainwright AC; Emery P<\/span> (1992)<\/span> Damage to the endothelium in Sj\u00f6gren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB autoantigens<\/span>. Ann Rheum Dis<\/span>, 51<\/span>, (3)<\/span>, pp. 389-390<\/span>. <\/a><\/p>","publicationid":"1103518","date":"1992-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Bradley H; Gough A; Arthur V; Jubb R; Waring R<\/span> (1992)<\/span> Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment<\/span>. Ann Rheum Dis<\/span>, 51<\/span>, (3)<\/span>, pp. 318-320<\/span>. <\/a><\/p>","publicationid":"1103512","date":"1992-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Blann AD; Emery P<\/span> (1992)<\/span> High von Willebrand factor antigen levels are associated with increased mortality in connective tissue diseases<\/span>. Br J Rheumatol<\/span>, 31<\/span>, (3)<\/span>, pp. 211-212<\/span>. <\/a><\/p>","publicationid":"1103461","date":"1992-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gordon C; Bradley H; Waring RH; Emery P<\/span> (1992)<\/span> Abnormal sulphur oxidation in systemic lupus erythematosus<\/span>. Lancet<\/span>, 339<\/span>, (8784)<\/span>, pp. 25-26<\/span>. <\/a><\/p>","publicationid":"1103333","date":"1992-01-04","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bradley H; Waring RH; Emery P<\/span> (1991)<\/span> Reduced thiol methyl transferase activity in red blood cell membranes from patients with rheumatoid arthritis<\/span>. J Rheumatol<\/span>, 18<\/span>, (12)<\/span>, pp. 1787-1789<\/span>.<\/p>","publicationid":"1103439","date":"1991-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Townend JN; Emery P; Davies MK; Littler WA<\/span> (1991)<\/span> Acute aortitis and aortic incompetence due to systemic rheumatological disorders<\/span>. Int J Cardiol<\/span>, 33<\/span>, (2)<\/span>, pp. 253-258<\/span>. <\/a><\/p>","publicationid":"1103609","date":"1991-11-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gordon C; Richards N; Howie AJ; Richardson K; Michael J; Adu D; Emery P<\/span> (1991)<\/span> Urinary IL-6: a marker for mesangial proliferative glomerulonephritis?<\/span> Clin Exp Immunol<\/span>, 86<\/span>, (1)<\/span>, pp. 145-149<\/span>. <\/a><\/p>","publicationid":"1103577","date":"1991-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Blann AD; Wainwright AC; Sheeran TP; Emery P<\/span> (1991)<\/span> Venostasis, subclinical vasculitis and von Willebrand factor antigen<\/span>. Br J Rheumatol<\/span>, 30<\/span>, (5)<\/span>, pp. 373-375<\/span>. <\/a><\/p>","publicationid":"1103462","date":"1991-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Macfarlane DG; Buckland-Wright JC; Emery P; Fogelman I; Clark B; Lynch J<\/span> (1991)<\/span> Comparison of clinical, radionuclide, and radiographic features of osteoarthritis of the hands<\/span>. Ann Rheum Dis<\/span>, 50<\/span>, (9)<\/span>, pp. 623-626<\/span>. <\/a><\/p>","publicationid":"1103602","date":"1991-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gough A<\/span> (1991)<\/span> Why early arthritis clinics?<\/span> Br J Rheumatol<\/span>, 30<\/span>, (4)<\/span>, pp. 241-242<\/span>. <\/a><\/p>","publicationid":"1103562","date":"1991-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Stockman A; Emery P; Doyle T; Hopper J; Tait B; Muirden K<\/span> (1991)<\/span> Relationship of progression of radiographic changes in hands and wrists, clinical features and HLA-DR antigens in rheumatoid arthritis<\/span>. J Rheumatol<\/span>, 18<\/span>, (7)<\/span>, pp. 1001-1007<\/span>.<\/p>","publicationid":"1103436","date":"1991-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Bradley H; Waring RH; Emery P; Arthur V<\/span> (1991)<\/span> Metabolism of low-dose paracetamol in patients with rheumatoid arthritis<\/span>. Xenobiotica<\/span>, 21<\/span>, (5)<\/span>, pp. 689-693<\/span>. <\/a><\/p>","publicationid":"1103488","date":"1991-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Luqmani R; Jubb R; Emery P; Reid A; Adu D<\/span> (1991)<\/span> Inner ear deafness in Wegener's granulomatosis<\/span>. J Rheumatol<\/span>, 18<\/span>, (5)<\/span>, pp. 766-768<\/span>.<\/p>","publicationid":"1103438","date":"1991-05-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Salmon M<\/span> (1991)<\/span> The immune response. 2. Systemic mediators of inflammation<\/span>. Br J Hosp Med<\/span>, 45<\/span>, (3)<\/span>, pp. 164-168<\/span>.<\/p>","publicationid":"1103437","date":"1991-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Salmon M; Emery P<\/span> (1991)<\/span> The immune response 1. The local response and understanding T cell specificity<\/span>. Br J Hosp Med<\/span>, 45<\/span>, (2)<\/span>, pp. 89-93<\/span>.<\/p>","publicationid":"1103435","date":"1991-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Buckland-Wright JC; Macfarlane DG; Fogelman I; Emery P; Lynch JA<\/span> (1991)<\/span> Techetium 99m methylene diphosphonate bone scanning in osteoarthritic hands<\/span>. Eur J Nucl Med<\/span>, 18<\/span>, (1)<\/span>, pp. 12-16<\/span>. <\/a><\/p>","publicationid":"1103555","date":"1991-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1991)<\/span> Clinical outcome in patients receiving nonsteroidal antiinflammatory drugs<\/span>. Arthritis Rheum<\/span>, 34<\/span>, (1)<\/span>, pp. 127<\/span>. <\/a><\/p>","publicationid":"1103533","date":"1991-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Wilkinson L; Emery P; Palmer R<\/span> (1990)<\/span> Immunological abnormalities in patients with leg ulcers<\/span>. Br J Rheumatol<\/span>, 29<\/span>, (6)<\/span>, pp. 490-491<\/span>. <\/a><\/p>","publicationid":"1103463","date":"1990-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Blount S; Griffiths H; Emery P; Lunec J<\/span> (1990)<\/span> Reactive oxygen species modify human DNA, eliciting a more discriminating antigen for the diagnosis of systemic lupus erythematosus<\/span>. Clin Exp Immunol<\/span>, 81<\/span>, (3)<\/span>, pp. 384-389<\/span>. <\/a><\/p>","publicationid":"1103492","date":"1990-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Rowley MJ; Tait B; Doran T; Emery P; Mackay IR<\/span> (1990)<\/span> Associations between HLA and antibodies to collagen in rheumatoid arthritis<\/span>. Ann Rheum Dis<\/span>, 49<\/span>, (8)<\/span>, pp. 578-581<\/span>. <\/a><\/p>","publicationid":"1103534","date":"1990-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1990)<\/span> Arthritis and Allied Conditions<\/span>. Annals of the Rheumatic Diseases<\/span>, 49<\/span>, (7)<\/span>, pp. 492<\/span>. <\/a><\/p>","publicationid":"1103550","date":"1990-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Bowman S; Wedderburn L; Grahame R<\/span> (1989)<\/span> Chronic shoulder pain in rheumatoid arthritis: Authors' Reply<\/span>. BMJ<\/span>, 299<\/span>, (6714)<\/span>, pp. 1530.5-1531<\/span>. <\/a><\/p>","publicationid":"1103554","date":"1989-12-16","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1989)<\/span> A patient recently presented with severe xerostomia and positive Schirmer's test 4 years after the onset of her rheumatoid arthritis. The diagnosis of secondary Sj\u00f6gren's syndrome was made<\/span>. Br J Rheumatol<\/span>, 28<\/span>, (6)<\/span>, pp. 517<\/span>. <\/a><\/p>","publicationid":"1103464","date":"1989-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Bowman S; Wedderburn L; Grahame R<\/span> (1989)<\/span> Suprascapular nerve block for chronic shoulder pain in rheumatoid arthritis<\/span>. BMJ<\/span>, 299<\/span>, (6707)<\/span>, pp. 1079-1080<\/span>. <\/a><\/p>","publicationid":"1103616","date":"1989-10-28","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Horton RC; Sheppard MC; Emery P<\/span> (1989)<\/span> Propylthiouracil-induced systemic lupus erythematosus<\/span>. Lancet<\/span>, 2<\/span>, (8662)<\/span>, pp. 568<\/span>. <\/a><\/p>","publicationid":"1103539","date":"1989-09-02","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1989)<\/span> Methotrexate--its current use in rheumatoid arthritis<\/span>. J Clin Pharm Ther<\/span>, 14<\/span>, (4)<\/span>, pp. 239-242<\/span>. <\/a><\/p>","publicationid":"1103497","date":"1989-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Tait B; Mackay IR; Board P; Coggan M; Emery P; Eckardt G<\/span> (1989)<\/span> HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis<\/span>. Gastroenterology<\/span>, 97<\/span>, (2)<\/span>, pp. 479-481<\/span>. <\/a><\/p>","publicationid":"1103477","date":"1989-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Salmon M; Kitas GD; Emery P<\/span> (1989)<\/span> Another interpretation of the role of T helper cells in the rheumatoid synovium<\/span>. Arthritis Rheum<\/span>, 32<\/span>, (6)<\/span>, pp. 795-796<\/span>. <\/a><\/p>","publicationid":"1103607","date":"1989-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kitas GD; Salmon M; Emery P<\/span> (1989)<\/span> Immune dysfunction in patients not responding to hepatitis B vaccination<\/span>. Lancet<\/span>, 1<\/span>, (8637)<\/span>, pp. 551-552<\/span>. <\/a><\/p>","publicationid":"1103538","date":"1989-03-11","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Stockman A; Rowley MJ; Emery P; Muirden KD<\/span> (1989)<\/span> Activity of rheumatoid arthritis and levels of collagen antibodies: a prospective study<\/span>. Rheumatol Int<\/span>, 8<\/span>, (6)<\/span>, pp. 239-243<\/span>. <\/a><\/p>","publicationid":"1103592","date":"1989-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Mackay IR<\/span> (1988)<\/span> Interleukin-2 inhibitor and measurement of interleukin-2 in synovial fluid of patients with rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 31<\/span>, (12)<\/span>, pp. 1590-1591<\/span>. <\/a><\/p>","publicationid":"1103548","date":"1988-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Grahame R; Watson M; Wedley J; Wood S<\/span> (1988)<\/span> Analysis of combined back clinic outcome<\/span>. Br J Rheumatol<\/span>, 27<\/span>, (6)<\/span>, pp. 494-495<\/span>. <\/a><\/p>","publicationid":"1103465","date":"1988-12-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Wood N; Gentry K; Stockman A; Mackay IR; Bernard O<\/span> (1988)<\/span> High-affinity interleukin-2 receptors on blood lymphocytes are decreased during active rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 31<\/span>, (9)<\/span>, pp. 1176-1181<\/span>. <\/a><\/p>","publicationid":"1103500","date":"1988-09-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Hertzog PJ; Emery P; Cheetham BF; Mackay IR; Linnane AW<\/span> (1988)<\/span> Interferons in rheumatoid arthritis: alterations in production and response related to disease activity<\/span>. Clin Immunol Immunopathol<\/span>, 48<\/span>, (2)<\/span>, pp. 192-201<\/span>. <\/a><\/p>","publicationid":"1103504","date":"1988-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Panayi G<\/span> (1988)<\/span> Penicillamine nephropathy<\/span>. Br Med J (Clin Res Ed)<\/span>, 296<\/span>, (6635)<\/span>, pp. 1538<\/span>. <\/a><\/p>","publicationid":"1103496","date":"1988-05-28","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gentry KC; Kelso A; Mackay IR<\/span> (1988)<\/span> Interleukin 2 inhibitor in synovial fluid<\/span>. Clin Exp Immunol<\/span>, 72<\/span>, (1)<\/span>, pp. 60-66<\/span>.<\/p>","publicationid":"1103434","date":"1988-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Lopez AF; Burns GF; Vadas MA<\/span> (1988)<\/span> Synovial fluid neutrophils of patients with rheumatoid arthritis have membrane antigen changes that reflect activation<\/span>. Ann Rheum Dis<\/span>, 47<\/span>, (1)<\/span>, pp. 34-39<\/span>. <\/a><\/p>","publicationid":"1103526","date":"1988-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Panayi GS<\/span> (1988)<\/span> Angioimmunoblastic lymphadenopathy<\/span>. Ann Rheum Dis<\/span>, 47<\/span>, (1)<\/span>, pp. 84<\/span>. <\/a><\/p>","publicationid":"1103487","date":"1988-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gentry KC; Mackay IR; Muirden KD; Rowley M<\/span> (1987)<\/span> Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis<\/span>. Arthritis Rheum<\/span>, 30<\/span>, (8)<\/span>, pp. 849-856<\/span>. <\/a><\/p>","publicationid":"1103508","date":"1987-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS<\/span> (1987)<\/span> Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study<\/span>. Br J Rheumatol<\/span>, 26<\/span>, (4)<\/span>, pp. 279-284<\/span>. <\/a><\/p>","publicationid":"1103466","date":"1987-08-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1987)<\/span> Sulphoxidation ability and thiol status in rheumatoid arthritis patients<\/span>. Br J Rheumatol<\/span>, 26<\/span>, (3)<\/span>, pp. 163-165<\/span>. <\/a><\/p>","publicationid":"1103571","date":"1987-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Panayi GS; Celinska E; Emery P; Griffin J; Welsh KI; Grahame R; Gibson T<\/span> (1987)<\/span> Seronegative and seropositive rheumatoid arthritis: similar diseases<\/span>. Br J Rheumatol<\/span>, 26<\/span>, (3)<\/span>, pp. 172-180<\/span>. <\/a><\/p>","publicationid":"1103467","date":"1987-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P<\/span> (1987)<\/span> Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus<\/span>. Arthritis Rheum<\/span>, 30<\/span>, (3)<\/span>, pp. 357-358<\/span>. <\/a><\/p>","publicationid":"1103532","date":"1987-03-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Mackay IR<\/span> (1986)<\/span> Compliance and Wilson's disease<\/span>. Lancet<\/span>, 1<\/span>, (8494)<\/span>, pp. 1388<\/span>. <\/a><\/p>","publicationid":"1103474","date":"1986-06-14","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Lythgoe S<\/span> (1986)<\/span> The effect of acupuncture on ankylosing spondylitis<\/span>. Br J Rheumatol<\/span>, 25<\/span>, (1)<\/span>, pp. 132-133<\/span>. <\/a><\/p>","publicationid":"1103470","date":"1986-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Smith GN; Panayi GS<\/span> (1986)<\/span> Lymphocytapheresis--a feasible treatment for rheumatoid arthritis<\/span>. Br J Rheumatol<\/span>, 25<\/span>, (1)<\/span>, pp. 40-43<\/span>. <\/a><\/p>","publicationid":"1103469","date":"1986-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Gibson T<\/span> (1986)<\/span> A double-blind study of the simple analgesic nefopam in rheumatoid arthritis<\/span>. Br J Rheumatol<\/span>, 25<\/span>, (1)<\/span>, pp. 72-76<\/span>. <\/a><\/p>","publicationid":"1103468","date":"1986-02-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Panayi GS; Welsh KI; Cole BC<\/span> (1985)<\/span> Relationship of HLA-DR4 to defective cellular immunity in rheumatoid arthritis using PPD, and mycoplasma and lectin mitogens<\/span>. J Rheumatol<\/span>, 12<\/span>, (5)<\/span>, pp. 859-864<\/span>.<\/p>","publicationid":"1103432","date":"1985-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Panayi GS; Welsh KI; Cole BC<\/span> (1985)<\/span> Rheumatoid factors and HLA-DR4 in RA<\/span>. J Rheumatol<\/span>, 12<\/span>, (2)<\/span>, pp. 217-222<\/span>.<\/p>","publicationid":"1103433","date":"1985-04-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

EMERY P<\/span> (1985)<\/span> REVIEWS OF BOOKS<\/span>. Rheumatology<\/span>, 24<\/span>, (3)<\/span>, pp. 306-307<\/span>. <\/a><\/p>","publicationid":"1103471","date":"1985-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH<\/span> (1984)<\/span> D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3<\/span>. J Rheumatol<\/span>, 11<\/span>, (5)<\/span>, pp. 626-632<\/span>.<\/p>","publicationid":"1103431","date":"1984-10-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Panayi GS; Nouri AM<\/span> (1984)<\/span> Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis<\/span>. Clin Exp Immunol<\/span>, 57<\/span>, (1)<\/span>, pp. 123-129<\/span>.<\/p>","publicationid":"1103430","date":"1984-07-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Panayi G; Symmons D; Brown G<\/span> (1984)<\/span> Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition<\/span>. Ann Rheum Dis<\/span>, 43<\/span>, (3)<\/span>, pp. 430-434<\/span>. <\/a><\/p>","publicationid":"1103575","date":"1984-06-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Gibson T; Simmonds HA; Rodgers AV; Huston GJ; Webster DR; Munro J; Emery P<\/span> (1983)<\/span> Gout with apparent resistance to allopurinol<\/span>. Annals of the Rheumatic Diseases<\/span>, 42<\/span>, pp. 93-94<\/span>. <\/a><\/p>","publicationid":"1103618","date":"1983-01-01","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Emery P; Grahame R<\/span> (1982)<\/span> Side effects of benoxaprofen<\/span>. BMJ<\/span>, 285<\/span>, (6335)<\/span>, pp. 137<\/span>. <\/a><\/p>","publicationid":"1103545","date":"1982-07-10","publicationtype":"Journal article","isfavourite":"0"},{"html":"

Kelly C; Emery P; Dieud\u00e9 P<\/span> Current issues in rheumatoid arthritis-associated interstitial lung disease (RA-ILD)<\/span>. The Lancet Rheumatology<\/span>.<\/p>","publicationid":"575502","date":"","publicationtype":"Journal article","isfavourite":"0"}],"conference_paper":[{"html":"

Abignano G; Karadag DT; Gundogdu O; Lettieri G; Padula MC; Padula AA; Emery P; D'Angelo S; Galdo FD<\/span> (2020)<\/span> P161\u2003Optical coherence tomography of the skin detects scleroderma changes in clinically unaffected skin: an opportunity for early detection of systemic sclerosis<\/span>. Rheumatology<\/span>, pp. keaa111.156<\/span>. <\/a> <\/a><\/p>","publicationid":"702971","date":"2020-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mahmoud K; Zayat AS; Md Yusof MY; Dutton K; Teh LS; Yee C-S; D\u2019Cruz D; Ng N; Isenberg D; Ciurtin C; Conaghan P; Emery P; Edwards C; Hensor EMA; Vital EM<\/span> (2020)<\/span> P193\u2005USEFUL I: musculoskeletal ultrasound to identify patients with lupus arthritis with better response to therapy<\/span>. Poster presentations<\/span>, pp. A124<\/span>. <\/a><\/p>","publicationid":"732948","date":"2020-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Melville A; Yusof MYM; Fitton J; Bailey L; Emery P; Buch MH; Dass S; Saleem B<\/span> (2020)<\/span> REAL-WORLD EXPERIENCE OF SWITCHING FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB IN RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 299-300<\/span>. <\/a><\/p>","publicationid":"538415","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Duquenne L; Mankia K; Garcia-Montoya L; Nam J; Di Matteo A; Emery P<\/span> (2020)<\/span> IN INDIVIDUALS AT RISK OF INFLAMMATORY ARTHRITIS, PATIENT REPORTED OUTCOMES DETERIORATE IN THE 12 WEEKS BEFORE PROGRESSION TO CLINICAL DISEASE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 74<\/span>. <\/a><\/p>","publicationid":"538414","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Garcia-Montoya L; Nam J; Mankia K; Duquenne L; Di Matteo A; Emery P<\/span> (2020)<\/span> ANTI-CCP NEGATIVE PATIENTS WITH NEW MUSCULOSKELETAL SYMPTOMS: IMPROVING REFERRALS FROM PRIMARY CARE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 516<\/span>. <\/a><\/p>","publicationid":"538413","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Iqbal K; Darby M; Lettieri G; Vital E; Beirne P; Dass S; Emery P; Kelly C<\/span> (2020)<\/span> EFFECT OF RITUXIMAB OR TUMOUR NECROSIS FACTOR INHIBITORS ON LUNG INFECTION AND 5-YEAR SURVIVAL IN RHEUMATOID ARTHRITIS-ASSOCIATED BRONCHIECTASIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 282-283<\/span>. <\/a><\/p>","publicationid":"538411","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Garcia-Montoya L; Wigston Z; Burska A; Mankia K; Vital E; Emery P<\/span> (2020)<\/span> TYPE I INTERFERON SIGNATURE PREDICTS PROGRESSION TO INFLAMMATORY ARTHRITIS IN ACPA plus AT-RISK INDIVIDUALS WITHOUT CLINICAL SYNOVITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 216-217<\/span>. <\/a><\/p>","publicationid":"538410","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Duquenne L; Mankia K; Di Matteo A; Garcia-Montoya L; Nam J; Emery P<\/span> (2020)<\/span> IN ACPA POSITIVE AT-RISK INDIVIDUALS WITHOUT CLINICAL ARTHRITIS, IS ULTRASOUND SUFFICIENTLY ACCURATE TO PREDICT PROGRESSION TO INFLAMMATORY ARTHRITIS?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 256<\/span>. <\/a><\/p>","publicationid":"538409","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mankia K; Mustufvi Z; Kang J; Tugnait A; Letton R; Duquenne L; Speirs A; Clerehugh V; Devine D; Emery P<\/span> (2020)<\/span> DISTRIBUTION AND SEVERITY OF PERIODONTITIS PREDICTS PROGRESSION TO INFLAMMATORY ARTHRITIS IN ANTI-CCP POSITIVE AT-RISK INDIVIDUALS WITHOUT CLINICAL SYNOVITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 949<\/span>. <\/a><\/p>","publicationid":"538408","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Di Matteo A; Mankia K; Duquenne L; Cipolletta E; Wakefield R; Nam J; Garcia-Montoya L; Emery P<\/span> (2020)<\/span> IN INDIVIDUALS AT-RISK OF RHEUMATOID ARTHRITIS, ULTRASOUND BONE EROSIONS AT THE V METATARSOPHALANGEAL JOINTS ARE THE MOST PREDICTIVE FOR THE DEVELOPMENT OF CLINICAL ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 876-877<\/span>. <\/a><\/p>","publicationid":"538406","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Yusof MYM; Dutton K; Teh LS; Yee CS; D'cruz D; Ng N; Isenberg D; Ciurtin C; Conaghan PG; Emery P; Edwards C; Hensor E; Vital E<\/span> (2020)<\/span> USEFUL STUDY I: A MULTICENTRE LONGITUDINAL STUDY TO TEST WHETHER ULTRASOUND CAN IDENTIFY PATIENTS WITH MUSCULOSKELETAL SYMPTOMS OF LUPUS WITH BETTER RESPONSE TO THERAPY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 111-112<\/span>. <\/a><\/p>","publicationid":"538405","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Farrow M; Biglands J; Tanner S; Hensor E; Mackie S; Emery P; Tan AL<\/span> (2020)<\/span> DIFFERENCES IN MUSCLE PROPERTIES IN GCA PATIENTS COMPARED TO HEALTHY CONTROLS AS ASSESSED BY QUANTITATIVE MRI<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 496<\/span>. <\/a><\/p>","publicationid":"538404","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Yusof MYM; Ciurtin C; Yee CS; Isenberg D; Teh LS; Dutton K; D'cruz D; Ng N; Conaghan PG; Emery P; Edwards C; Hensor E; Vital E<\/span> (2020)<\/span> USEFUL II: DERIVATION OF THE LUPUS ARTHRITIS AND MUSCULOSKELETAL DISEASE ACTIVITY SCORE (LAMDA) USING DATA FROM A MULTICENTRE LONGITUDINAL STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 901-902<\/span>. <\/a><\/p>","publicationid":"538403","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Duquenne L; Nam J; Mankia K; Garcia-Montoya L; Di Matteo A; Emery P<\/span> (2020)<\/span> VALIDATION OF RISK SCORES FOR PREDICTING PROGRESSION IN INDIVIDUALS \"AT RISK OF RHEUMATOID ARTHRITIS\"<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 588<\/span>. <\/a><\/p>","publicationid":"538401","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Karadag DT; Gundogdu O; Lettieri G; Padula MC; Padula A; Emery P; D'angelo S; Del Galdo F<\/span> (2020)<\/span> OPTICAL COHERENCE TOMOGRAPHY OF THE SKIN DETECTS SCLERODERMA CHANGES IN CLINICALLY UNAFFECTED SKIN: AN OPPORTUNITY FOR EARLY DETECTION OF SYSTEMIC SCLEROSIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 692<\/span>. <\/a> <\/a><\/p>","publicationid":"538342","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Tanaka Y; Bykerk V; Huizinga T; Citera G; Bingham C; Banerjee S; Connolly S; Zhuo J; Wong R; Huang KHG; Lozenski K; Elbez Y; Fleischmann R<\/span> (2020)<\/span> MAINTENANCE OF SDAI REMISSION AND PATIENT-REPORTED OUTCOMES (PROS) FOLLOWING DOSE DE-ESCALATION OF ABATACEPT IN MTX-NAIVE, ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA) plus PATIENTS WITH EARLY RA: RESULTS FROM AVERT-2, A RANDOMISED PHASE IIIB STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 981-982<\/span>. <\/a><\/p>","publicationid":"538216","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pachai C; Connolly S; Landis J; Tanaka Y; Bykerk V; Huizinga T; Citera G; Bingham C; Wong R; Huang KHG; Du S; Hayes W; Wu C; Fleischmann R; Emery P<\/span> (2020)<\/span> IMPACT OF BASELINE EROSION SCORE ON RESPONSE TO TREATMENT AND FUTURE RADIOLOGICAL DAMAGE IN AVERT-2, A RANDOMISED PHASE IIIB STUDY OF ABATACEPT IN MTX-NAIVE, ANTI-CITRULLINATED PROTEIN ANTIBODY-POSITIVE (ACPA plus ) PATIENTS WITH EARLY RA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 257<\/span>. <\/a><\/p>","publicationid":"538127","date":"2020-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Md Yusof MY; Wittmann M; Fernandez C; Wilson D; Edward S; Abignano G; Alase A; Laws P; Goodfield M; Emery P; Vital E<\/span> (2019)<\/span> 47\u2005Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial<\/span>. Abstracts<\/span>, pp. A34-A35<\/span>. <\/a><\/p>","publicationid":"744337","date":"2019-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Md Yusof MY; Hensor E; Conaghan P; Emery P; Vital E<\/span> (2019)<\/span> 174\u2005SLE responder index (SRI) underestimates clinical response in musculoskeletal systemic lupus erythematosus<\/span>. Abstracts<\/span>, pp. A133-A134<\/span>. <\/a><\/p>","publicationid":"732951","date":"2019-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Farrow M; Biglands J; Emery P; Buch M; Tanner S; Tan AL<\/span> (2019)<\/span> Quantitative MRI Measurements Can Distinguish Myositis From Healthy Control Muscle<\/span>. FASEB JOURNAL<\/span>, pp. 453.12<\/span>. <\/a><\/p>","publicationid":"626720","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Garcia-Montoya L; Nam J; Mankia K; Duquenne L; Pentony P; Dimatteo A; Emery P<\/span> (2019)<\/span> REFINING THE PRIMARY CARE CCP plus PATIENT PATHWAY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 213<\/span>. <\/a><\/p>","publicationid":"501834","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Farrow M; Biglands J; Emery P; Tanner S; Grainger A; Ladas A; O'connor P; Tan AL<\/span> (2019)<\/span> MUSCLES IN MYOSITIS PATIENTS WITH NORMAL MRI APPEARANCE HAVE HIGHER QUANTITATIVE T2 COMPARED TO THOSE IN HEALTHY CONTROLS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1016<\/span>. <\/a><\/p>","publicationid":"501833","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Burmester GR; Naredo E; Lagunes-Galindo I; Koenigsbauer F; Conaghan PG<\/span> (2019)<\/span> A PHASE 4 TRIAL ASSESSING THE IMPACT OF RESIDUAL INFLAMMATION AND CLINICAL CHARACTERISTICS ON THE OUTCOME OF DOSE TAPERING OF ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE IN STABLE CLINICAL REMISSION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1132-1133<\/span>. <\/a><\/p>","publicationid":"501832","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Vital E; Mcelvenny DM; Hensor E; Das S; Dass S; Rawstron AC; Buch M; Emery P; Savic S<\/span> (2019)<\/span> PREDICTING SEVERE INFECTION IN REPEAT CYCLES OF RITUXIMAB AND EFFECTS OF HYPOGAMMAGLOBULINAEMIA FOR THE TREATMENT OF RHEUMATIC AND MUSCULOSKELETAL DISEASES<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 77<\/span>. <\/a><\/p>","publicationid":"501830","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dutton K; Yusof MYM; Sabih-Ul H; Wigston Z; Emery P; Vital E<\/span> (2019)<\/span> IN PATIENTS WITH UCTD, IFN ACTIVITY IDENTIFIES PATIENTS THAT PROGRESS TO DEFINITIVE CTD CLASSIFICATION CRITERIA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 795-796<\/span>. <\/a><\/p>","publicationid":"501829","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mease PJ; Smolen JS; Behrens F; Nash P; Leage SL; Li L; Tahir H; Gooderham M; Krishnan E; Emery P; Pillai S; Helliwell P<\/span> (2019)<\/span> MULTICENTRE, RANDOMISED, OPEN-LABEL, ASSESSOR-BLINDED, PARALLEL-GROUP HEAD-TO-HEAD COMPARISON OF THE EFFICACY AND SAFETY OF IXEKIZUMAB VERSUS ADALIMUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS NAIVE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: 24-WEEK RESULTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 261-262<\/span>. <\/a><\/p>","publicationid":"501827","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hall S; Takeuchi T; Thomson G; Emery P; Combe B; Everding A; Pavelka K; Song Y; Shaw T; Friedman A; Song I-H; Mysler E<\/span> (2019)<\/span> CHARACTERIZATION OF REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH UPADACITINIB OR COMPARATORS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 362<\/span>. <\/a><\/p>","publicationid":"501826","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Garcia-Montoya L; Yusof MYM; Candelier JB; Rawstron A; Vital E; Emery P<\/span> (2019)<\/span> UNDERSTANDING THE LONG-TERM OUTCOME OF RITUXIMAB - IMPLICATIONS FOR MANAGEMENT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1143<\/span>. <\/a><\/p>","publicationid":"501825","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Duquenne L; Mankia K; Nam J; Pentony P; Garcia-Montoya L; Dimatteo A; Hunt L; Emery P<\/span> (2019)<\/span> ULTRASOUND PREDICTS IMMINENT PROGRESSION TO ARTHRITIS IN ANTI-CCP POSITIVE AT-RISK INDIVIDUALS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 304-305<\/span>. <\/a><\/p>","publicationid":"501824","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fitton J; Melville A; Dass S; Emery P; Nam J; Buch M<\/span> (2019)<\/span> JANUS KINASE INHIBITORSDEMONSTRATE EFFECTIVENESS IN A REAL-WORLD MULTI- BIOLOGIC DMARD REFRACTORY RHEUMATOID ARTHRITIS POPULATION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 358-359<\/span>. <\/a><\/p>","publicationid":"501823","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fitton J; Melville A; Naraghi K; Nam J; Dass S; Emery P; Buch M<\/span> (2019)<\/span> SINGLE CENTRE COHORT OF REFRACTORY RHEUMATOID ARTHRITIS ALSO IDENTIFIES A RARE SUBGROUP OF MULTIPLE TARGETED THERAPY CLASS NON-RESPONSE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 708<\/span>. <\/a><\/p>","publicationid":"501822","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Alfuraih AM; Tan AL; O'connor P; Emery P; Wakefield R<\/span> (2019)<\/span> MUSCLE STIFFNESS AND WEAKNESS IN RHEUMATOID ARTHRITIS - A SHEAR WAVE ELASTOGRAPHY STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1013<\/span>. <\/a><\/p>","publicationid":"501819","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Duquenne L; Mankia K; Nam J; Garcia-Montoya L; Pentony P; Dimatteo A; Hunt L; Emery P<\/span> (2019)<\/span> THE 10 YEAREXPERIENCE OF IDENTIFYING AND MONITORING INDIVIDUALS AT RISK OF RA IN AN ARTHRITIS PREVENTION CLINIC<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 2090-2091<\/span>. <\/a><\/p>","publicationid":"501818","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gul H; Ponchel F; Emery P<\/span> (2019)<\/span> ON TAPERING THERAPY FOR RA PATIENTS IN CLINICAL REMISSION; FLARE ON CS-DMARDS IS PREDICTED BY CLINICAL PARAMETERS AND ULTRASOUND, WHEREAS T-CELL ABNORMALITIES ARE PREDICTIVE FOR B-DMARD TAPERING<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1143-1144<\/span>. <\/a><\/p>","publicationid":"501817","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Alfuraih AM; Tan AL; O'connor P; Emery P; Wakefield R<\/span> (2019)<\/span> SHEAR WAVE ELASTOGRAPHY MUSCLE STIFFNESS MAY DIMINISH AFTER CORTICOSTEROID TREATMENT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 594-595<\/span>. <\/a><\/p>","publicationid":"501816","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Carriero A; Abignano G; Hutchinson M; Ballard K; Eng S; Emery P; Buch M; Del Galdo F<\/span> (2019)<\/span> SERUM INTERFERON SCORE PREDICTS CLINICAL OUTCOME AT 12 MONTHS IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS AS MEASURED BY GLOBAL RANKED COMPOSITE SCORE (GRCS) AND COMPOSITE RESPONSE INDEX IN SSC(CRISS)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 839<\/span>. <\/a><\/p>","publicationid":"501811","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Taylor PC; Emery P; Weinblatt ME; Mysler E; Rubbert-Roth A; Jia B; Sun L; Liu Y; Chen Y-F; Cardoso A; Tanaka Y<\/span> (2019)<\/span> PATIENT DISEASE TRAJECTORIES IN BARICITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 322-323<\/span>. <\/a><\/p>","publicationid":"501771","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ajaib S; Chapman A; Burska A; Mankia K; Emery P; Ponchel F<\/span> (2019)<\/span> DIFFERENCE BETWEEN PALINDROMIC RHEUMATISM AND EARLY RHEUMATOID ARTHRITIS AT THE LEVEL OF GENE EXPRESSION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A1-A2<\/span>. <\/a><\/p>","publicationid":"498798","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pitaksalee R; Burska AN; McInnes I; Emery P; Hodgett R; Ponchel F<\/span> (2019)<\/span> DIFFERENTIAL DNA METHYLATION IN PERIPHERAL NAIVE CD4+T-CELLS IN EARLY RHEUMATOID ARTHRITIS PATIENTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A62<\/span>. <\/a><\/p>","publicationid":"498797","date":"2019-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Md Yusof MY; Hensor E; Conaghan PG; Emery P; Vital E<\/span> (2018)<\/span> AB0591\u2005Sle res ponder index (SRI) underestimates clinical response in musculoskeletal systemic lupus erythematosus<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. 1448<\/span>. <\/a><\/p>","publicationid":"732952","date":"2018-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Psarras A; Alase A; Antanaviciute A; Carr I; Wittmann M; Tsokos GC; Emery P; Vital EM<\/span> (2018)<\/span> Type I IFN Production Is Induced By Non-Haematopoietic Tissue Cells but Not Plasmacytoid Dendritic Cells in Preclinical Autoimmunity and SLE<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"482777","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fautrel R; Zhu B; Taylor PC; van de Laar M; Emery P; De Leonardis F; Gaich C; Nicolay C; Kadziola Z; De La Torre I; Fleischmann R<\/span> (2018)<\/span> COMPARATIVE EFFECTIVENESS IN PAIN AND HAQ-DI IMPROVEMENT FOR BARICITINIB VERSUS ADALIMUMAB, TOCILIZUMAB, AND TOFACITINIB MONOTHERAPIES IN CSDMARD-NAIVE RHEUMATOID ARTHRITIS PATIENTS: A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 973-974<\/span>. <\/a><\/p>","publicationid":"481203","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Burmester G; Naredo E; Lagunes I; Zhang Y; Wang X; Hojnik M; Conaghan PG<\/span> (2018)<\/span> LOW INFLAMMATION ON MAGNETIC RESONANCE IMAGING IN PATIENTS WITH RHEUMATOID ARTHRITIS THAT ACHIEVED SUSTAINED CLINICAL REMISSION ON ADALIMUMAB: DATA FROM THE PREDICTRA STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 283-284<\/span>. <\/a><\/p>","publicationid":"481160","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Farrow M; Biglands J; Tanner S; Buch M; Emery P; Grainger A; Tan AL<\/span> (2018)<\/span> QUANTITATIVE MRI AND DYNAMOMETERS CAN DISTINGUISH MYOSITIS FROM HEALTHY CONTROL MUSCLE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1701-1702<\/span>. <\/a><\/p>","publicationid":"481148","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Alfuraih AM; Tan AL; O'Connor P; Emery P; Wakefield RJ<\/span> (2018)<\/span> MUSCLE ELASTOGRAPHY AS A POTENTIAL NOVEL IMAGING BIOMARKER IN MYOSITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 802-803<\/span>. <\/a><\/p>","publicationid":"481147","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Duquenne L; Pentony P; Mankia K; Nam J; Hunt L; Tan AL; Garcia-Montoya L; Emery P<\/span> (2018)<\/span> AT DIAGNOSIS OF RHEUMATOID ARTHRITIS, AT-RISK PATIENTS FOLLOWED IN CCP plus CLINIC SHOWED MILDER DISEASE ACTIVITY THAN CONVENTIONALLY REFERRED PATIENTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 935<\/span>. <\/a><\/p>","publicationid":"481146","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pentony P; Twigg S; Nam JL; Mankia K; Hunt L; Hensor EM; Emery P<\/span> (2018)<\/span> CHANGE IN FUNCTIONAL DISABILITY IN ACPA-POSITIVE ARTHRALGIA PATIENTS PRIOR TO PROGRESSION TO INFLAMMATORY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 563<\/span>. <\/a><\/p>","publicationid":"481132","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pentony P; Mankia K; Hensor EM; Nam JL; Hunt L; Garcia-Montoya L; Duquenne L; Emery P<\/span> (2018)<\/span> SEQUENTIAL ULTRASOUND SHOWS A LATE INCREASE IN INFLAMMATORY BURDEN IN ANTI-CCP POSITIVE PATIENTS WITH NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS JUST BEFORE PROGRESSION TO INFLAMMATORY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 916<\/span>. <\/a><\/p>","publicationid":"481131","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pentony P; Karkalemis K; Nam JL; Mankia K; Hunt L; Hensor EM; Emery P<\/span> (2018)<\/span> PATIENTS PRESENTING WITH NEW MUSCULOSKELETAL SYMPTOMS IN THE WRISTS, HANDS AND FEET ENRICHES DETECTION OF ANTI-CCP ANTIBODIES IN PRIMARY CARE - A NATIONAL COHORT STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 570<\/span>. <\/a><\/p>","publicationid":"481130","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mankia K; Cheng Z; Do T; Kang J; Hunt L; Meade J; Clerehugh V; Speirs A; Tugnait A; Hensor E; Devine D; Emery P<\/span> (2018)<\/span> AN INCREASED PREVALENCE OF PERIODONTAL DISEASE, PORPHYROMONAS GINGIVALIS AND AGGREGATIBACTER ACTINOMYCETEMCOMITANS IN ANTI-CCP POSITIVE INDIVIDUALS AT-RISK OF INFLAMMATORY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 222<\/span>. <\/a><\/p>","publicationid":"481128","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ahmad HA; Baker JF; Ostergaard M; Emery P; Huizinga T; Elbez Y; Banerjee S; Conaghan PG<\/span> (2018)<\/span> EXCEEDING PREDEFINED THRESHOLDS FOR MRI BONE OEDEMA AND EROSION AND HAQ-DI CAN PREDICT RELAPSE AFTER WITHDRAWAL OF ALL TREATMENT IN MTX-NAIVE PATIENTS WITH RA IN REMISSION AFTER 12 MONTHS OF ABATACEPT THERAPY IN THE AVERT TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 568-569<\/span>. <\/a><\/p>","publicationid":"481123","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hunt L; Hensor E; Naraghi K; Wakefield RJ; Emery P; Buch MH<\/span> (2018)<\/span> TOCILIZUMAB IN EARLY RHEUMATOID ARTHRITIS DELIVERS CLINICAL AND ULTRASOUND-CONFIRMED RAPID AND DEEP REMISSION WITH ABOLITION OF PD - TREMERA STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 955<\/span>. <\/a><\/p>","publicationid":"481102","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hunt L; Nam J; Hensor EM; Mankia K; Rowbotham E; Grainger AJ; Emery P<\/span> (2018)<\/span> IN ACPA POSITIVE AT-RISK INDIVIDUALS, WHICH MRI AND US FINDINGS BEST PREDICT DEVELOPMENT OF CLINICAL SYNOVITIS?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 72-73<\/span>. <\/a><\/p>","publicationid":"481100","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Lettieri G; Abignano G; Bagnato G; Eng S; Ridgeway JP; Kaftan JN; Hinton M; Kubassova O; Buch MH; Emery P; O'Connor P; Del Galdo F<\/span> (2018)<\/span> DIGITAL ARTERY VOLUME INDEX: THE FIRST OBJECTIVE, AUTOMATED, NON-INVASIVE IMAGING DIAGNOSTIC OF MACROVASCULAR INVOLVEMENT IN SSC<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 751<\/span>. <\/a><\/p>","publicationid":"481093","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bagnato G; Pigatto E; Bitto A; Irrera N; Pizzino CG; Abignano G; Ferrera A; Sciortino D; Hutichinson M; Squadrito F; Buch M; Emery P; Zanatta E; Gangemi S; Roberts WN; Saitta A; Cozzi F; Del Galdo F<\/span> (2018)<\/span> THE PREDICTOR OF MALNUTRITION IN SYSTEMIC SCLEROSIS (PREMASS) SCORE: A VALIDATED COMBINED INDEX PREDICTIVE OF FUTURE WEIGHT LOSS IN SYSTEMIC SCLEROSIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 411-412<\/span>. <\/a><\/p>","publicationid":"481091","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mankia K; D'Agostino MA; Hensor E; Rowbotham E; Hunt L; Moller I; Miguel M; Nam JL; Tan AL; Freeston J; Garcia-Montoya L; Grainger A; Emery P<\/span> (2018)<\/span> MRI INTEROSSEOUS TENDON INFLAMMATION OCCURS IN ANTI-CCP POSITIVE AT-RISK INDIVIDUALS AND MAY PRECEDE THE DEVELOPMENT OF SYNOVITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 570-571<\/span>. <\/a><\/p>","publicationid":"481088","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny YM; Savage L; Alase A; Vital E; Wittmann M; Emery P; McGonagle D<\/span> (2018)<\/span> TETHERIN, A NOVEL TYPE I INTERFERON BIOMARKER ON BLOOD LEUCOCYTES CAN CAPTURE INTERFERON STATUS AND CORRELATES WITH USTEKINUMAB (STELARA) THERAPY RESPONSE IN PSORIATIC DISEASE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 859-860<\/span>. <\/a><\/p>","publicationid":"481080","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Psarras A; Alase A; Antanaviciute A; Carr I; Wittmann M; Tsokos G; Emery P; Vital EM<\/span> (2018)<\/span> TYPE I INTERFERON IS PRODUCED BY NON-HAEMATOPOIETIC TISSUE RESIDENT CELLS BUT NOT PDCS IN PRE-CLINICAL AUTOIMMUNITY AND SLE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 139-140<\/span>. <\/a><\/p>","publicationid":"481079","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Montoya LG; Yusof MYM; Candelier J-B; Pentony P; Duquenne L; Rawstron AC; Vital EM; Emery P<\/span> (2018)<\/span> IN RA PATIENTS WITH INITIAL RESPONSE TO RITUXIMAB, EARLY DEPTH OF B CELL DEPLETION IS ASSOCIATED WITH LONG TERM MAINTENANCE OF THERAPY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 104-105<\/span>. <\/a><\/p>","publicationid":"481078","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Psarras A; Antanaviciute A; Carr I; Wittmann M; Emery P; Tsokos G; Vital EM<\/span> (2018)<\/span> TNF-A REGULATES PLASMACYTOID DENDRITIC CELLS BY SUPPRESSING IFN-A PRODUCTION AND ENHANCING TH1 AND TH17 CELL DIFFERENTIATION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 877<\/span>. <\/a><\/p>","publicationid":"481076","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mankia K; Pentony P; Hunt L; EI-Sherbiny Y; Duquenne L; Corscadden D; Do T; Meade J; Devine D; Emery P<\/span> (2018)<\/span> IGA ANTI-CCP ANTIBODIES ARE DETECTABLE IN THE SALIVA BUT NOT SPUTUM OF INDIVIDUALS AT-RISK OF DEVELOPING RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 183-184<\/span>. <\/a><\/p>","publicationid":"481072","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Twigg S; Pentony PE; Hensor EMA; Nam JL; Hunt L; Mankia K; Emery P<\/span> (2018)<\/span> CHANGE IN FUNCTION, FATIGUE AND PAIN IN ANTI-CCP POSITIVE AT-RISK INDIVIDUALS PREDICT PROGRESSION TO INFLAMMATORY ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>.<\/p>","publicationid":"467560","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; van Hoogstraten H; Jayawardena S; Mangan E; Cejas P; Verschueren P<\/span> (2018)<\/span> EFFICACY OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO PREVIOUSLY RECEIVED SARILUMAB OR TOCILIZUMAB<\/span>. RHEUMATOLOGY<\/span>, pp. key075.446<\/span>. <\/a><\/p>","publicationid":"467559","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Eng S; Buch M; Emery P; Khanna D; Del Galdo F<\/span> (2018)<\/span> CORRELATION OF THE AMERICAN COLLEGE OF RHEUMATOLOGY PROVISIONAL COMPOSITE RESPONSE INDEX IN SYSTEMIC SCLEROSIS WITH SERUM BIOMARKERS OF FIBROGENESIS IN AN OBSERVATIONAL COHORT<\/span>. RHEUMATOLOGY<\/span>.<\/p>","publicationid":"467558","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Huizinga TW; Kay J; Harigai M; Keystone E; Srnolen J; Rosase J; Emery P; Hall S; van den Bosch F; Schienberg M; Dudler J; Liao R; Meszaros G; Barry J; Kremer J<\/span> (2018)<\/span> EFFECTS OF BARICITINIB ON HAEMATOLOGICAL LABORATORY PARAMETERS IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. key075.589<\/span>. <\/a><\/p>","publicationid":"467557","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bagnato G; Pigatto E; Bitto A; Pizzino C; Irrera N; Abignano G; Hutchinson M; Ferrera A; Zanatta E; Sguadrito F; Buchi M; Emery P; Saitta A; Cozzi F; Del Galdo F<\/span> (2018)<\/span> THE PREDICTOR OF MALNUTRITION IN SYSTEMIC SCLEROSIS (PREMASS) SCORE: THE FIRST VALIDATED COMBINED INDEX PREDICTIVE OF FUTURE WEIGHT LOSS IN SYSTEMIC SCLEROSIS<\/span>. RHEUMATOLOGY<\/span>.<\/p>","publicationid":"467556","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Eng S; Bagnato G; Buch M; Emery P; Del Galdo F<\/span> (2018)<\/span> NORMALISATION OF THE AMERICAN COLLEGE OF RHEUMATOLOGY PROVISIONAL COMPOSITE RESPONSE INDEX IN SYSTEMIC SCLEROSIS NUMERATOR FOR BASELINE DATA OFFERS A MEASURE OF MAGNITUDE OF RESPONSE: RESULTS FROM A REAL-LIFE OBSERVATIONAL STUDY<\/span>. RHEUMATOLOGY<\/span>.<\/p>","publicationid":"467555","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Combe B; Balsa A; Winthrop K; Tony H-P; Genovese MC; Harigai M; Smolen JS; Emery P; Dudler J; Hall S; Zerbini CA; Van Den Bosch F; Durand F; Arthanari S; Rogai V; Zhong J; Meszaros G; Dougados M<\/span> (2018)<\/span> SAFETY SUMMARY RESULTS OF BARICITINIB FOCUSING ON SERIOUS INFECTIONS EVENTS AND PRESELECTED COMORBIDITIES<\/span>. RHEUMATOLOGY<\/span>.<\/p>","publicationid":"467554","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Daniel A; Green L; Eng S; Emery P; Del Galdo F<\/span> (2018)<\/span> MICROVASCULAR FLOW ASSESSED BY DYNAMIC OPTICAL COHERENCE TOMOGRAPHY: FIRST NON-INVASIVE QUANTITATIVE OUTCOME MEASURE OF MICROVASCULAR DISEASE IN SYSTEMIC SCLEROSIS<\/span>. RHEUMATOLOGY<\/span>.<\/p>","publicationid":"467553","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hensor EMA; McKeigue P; Buch MH; Barrett JH; Nam JL; Freeston J; Colombo M; Spiliopoulou A; Agakov F; Kelly S; Lewis MJ; Ling SF; Viatte S; Verstappen SMM; Barton A; MacGregor AJ; Pitzalis C; Emery P; Conaghan PG; Morgan AW<\/span> (2018)<\/span> VALIDITY OF A2-COMPONENT IMAGING-DERIVED DISEASE ACTIVITY SCORE (2C-DAS28) FOR IMPROVED ASSESSMENT OF SYNOVITIS IN EARLY RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. key075.194<\/span>. <\/a> <\/a><\/p>","publicationid":"467552","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; van Hoogstraten H; Jayawardena S; Mangan EK; Cejas P; Verschueren P<\/span> (2018)<\/span> EFFICACY OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WHO PREVIOUSLY RECEIVED SARILUMAB OR TOCILIZUMAB<\/span>. INTERNAL MEDICINE JOURNAL<\/span>, pp. 21<\/span>.<\/p>","publicationid":"466214","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Taylor PC; Weinblatt ME; Tanaka Y; Keystone EC; Dow ER; Higgs R; Macias WL; Rocha G; Rooney TP; Schlichting DE; Zuckerman SH; McInnes IB; Holzkaemper T<\/span> (2018)<\/span> MICROARRAY PATHWAY ANALYSIS COMPARING BARICITINIB AND ADALIMUMAB IN MODERATE TO SEVERE RHEUMATOID ARTHRITIS FROM A PHASE 3 STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A52<\/span>. <\/a><\/p>","publicationid":"465818","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Huizinga T; Kay J; Harigai M; Keystone E; Smolen J; Rosas J; Emery P; Hall S; van den Bosch F; Scheinberg M; Dudler J; Liao R; Meszaros G; Barry J; Kremer J<\/span> (2018)<\/span> EFFECTS OF BARICITINIB ON HAEMATOLOGICAL LABORATORY PARAMETERS IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. INTERNAL MEDICINE JOURNAL<\/span>, pp. 42<\/span>.<\/p>","publicationid":"465777","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ajaib S; Droop A; Mankia K; Emery P; Ponchel F<\/span> (2018)<\/span> DIFFERENCE BETWEEN PALINDROMIC RHEUMATISM AND RHEUMATOID ARTHRITIS AT THE LEVEL OF GENE EXPRESSION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A51-A52<\/span>. <\/a><\/p>","publicationid":"465759","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pitaksalee R; Burska AN; Rogers J; Xie X; Emery P; Hodgett R; Ponchel F<\/span> (2018)<\/span> ANALYSIS OF DNA METHYLATION PATTERNS IN RHEUMATOID ARTHRITIS PATIENT: A SYSTEM FOR PRIORITISING MEANINGFUL DIFFERENCE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A69<\/span>. <\/a><\/p>","publicationid":"465747","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ouboussad L; Hunt L; Wong C; Emery P; McDermott M; Aslam A; Buch M<\/span> (2018)<\/span> INVESTIGATING IL-6 INTRACELLULAR SIGNALLING IN PERIPHERAL BLOOD CELL SUBSETS IN PATIENTS AT EARLY AND LATER STAGES OF RHEUMATOID ARTHRITIS (RA)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A31-A32<\/span>. <\/a> <\/a><\/p>","publicationid":"465718","date":"2018-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gul HL; Rabin T; Ponchel F; Emery P<\/span> (2017)<\/span> 191.\u2003DEFINING TRUE REMISSION IN RHEUMATOID ARTHRITIS<\/span>. Rheumatology<\/span>. <\/a><\/p>","publicationid":"741488","date":"2017-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Burska AN; El-Jawhari JJ; Tan AL; Wakefield RJ; Marzo-Ortega H; Conaghan PG; Emery P; Ponchel F; Freeston JE<\/span> (2017)<\/span> 02.18\u2005Can rankl serum levels predict future progression to rheumatoid arthritis in early arthritis clinic patients?<\/span> Annals of the Rheumatic Diseases<\/span>, pp. A15-A16<\/span>. <\/a><\/p>","publicationid":"666880","date":"2017-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; van Keep M; Beard SM; Graham CN; Miles L; Jugl SM; Gunda P; Halliday A; Marzo-Ortega H<\/span> (2017)<\/span> COST-EFFECTIVENESS OF SECUKINUMAB FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS IN THE UK<\/span>. VALUE IN HEALTH<\/span>, pp. A534<\/span>. <\/a> <\/a><\/p>","publicationid":"453163","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Jansen D; Emery P; Smolen J; Westhovens R; Le Bars M; Connolly S; Ye J; Toes R; Huizinga T<\/span> (2017)<\/span> ASSOCIATION BETWEEN CONVERSION TO ACPA\/RF SERONEGATIVE STATUS AND CLINICAL OUTCOMES FOLLOWING TREATMENT WITH ABATACEPT IN COMBINATION WITH METHOTREXATE COMPARED WITH METHOTREXATE ALONE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AND POOR PROGNOSTIC INDICATORS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 566<\/span>. <\/a><\/p>","publicationid":"452075","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van der Heijde D; Schiff M; Tanaka Y; Klar R; Xie L; Meszaros G; Ishii T; Casillas M; Ortmann R; Emery P<\/span> (2017)<\/span> LOW RATES OF RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE OVER 2 YEARS OF BARICITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 510-511<\/span>. <\/a><\/p>","publicationid":"452074","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Vencovsky J; Keystone E; Ghil J; Cheong SY; Hong EE<\/span> (2017)<\/span> MAINTENANCE AND IMPROVEMENT IN CLINICAL EFFICACY BETWEEN WEEK 12 AND 24 IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SB4 OR REFERENCE ETANERCEPT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 834<\/span>. <\/a><\/p>","publicationid":"452073","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kvien TK; van Riel P; Rubbert-Roth A; Blanco R; Liu-Leage SS; Larsson E; Lund H; Lopez-Romero P; Zaremba-Pechmann L; Emery P<\/span> (2017)<\/span> BARICITINIB VERSUS ADALIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: ANALYSIS OF PATIENTS ACHIEVING A MODERATE EULAR RESPONSE AT WEEK 4<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 794-795<\/span>. <\/a><\/p>","publicationid":"452072","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen J; Gabay C; Aletaha D; Emery P; Sainsbury I; Zhang Y; Kavanaugh A<\/span> (2017)<\/span> THE IMPORTANCE OF SUSTAINED REMISSION FOR LONGTERM OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 242<\/span>. <\/a><\/p>","publicationid":"452071","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vencovsky J; Emery P; Keystone E; Ghil J; Cheong SY; Hong EE<\/span> (2017)<\/span> IMPACT OF ANTI-DRUG ANTIBODY AND INJECTION SITE REACTION ON EFFICACY: 24-WEEK RESULTS FROM A PHASE III STUDY COMPARING SB4 (ETANERCEPT BIOSIMILAR) WITH REFERENCE ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 137<\/span>. <\/a><\/p>","publicationid":"452070","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Curtis J; Emery P; Burmester G; Arora V; Alam J; Muram D; Klareskog L<\/span> (2017)<\/span> EFFECTS OF SMOKING ON BARICITINIB EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED ANALYSIS FROM TWO PHASE 3 CLINICAL TRIALS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 244<\/span>. <\/a><\/p>","publicationid":"452069","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; McInnes IB; Mease PJ; Schiff M; Pricop L; Shen S; Wang Z; Gaillez C<\/span> (2017)<\/span> SECUKINUMAB SUSTAINS INDIVIDUAL CLINICAL RESPONSES OVER TIME IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM A PHASE 3 TRIAL, FUTURE 2<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1329<\/span>. <\/a><\/p>","publicationid":"451688","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mankia K; D'Agostino M-A; Wakefield R; Eugenio G; Horton L; Nam J; Grainger A; Emery P<\/span> (2017)<\/span> ULTRASOUND AND MRI DURING FLARES OF PALINDROMIC RHEUMATISM REVEAL A DISTINCT PHENOTYPE EVEN IN IMMINENT RA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 518<\/span>. <\/a><\/p>","publicationid":"451529","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; Emery P; Zhang H; Wang X; Suboticki J; Sainsbury I; Kavanaugh A<\/span> (2017)<\/span> PREDICTING MAINTENANCE OF RESPONSE BASED ON DISEASE CHARACTERISTICS AND EARLY CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS UPON WITHDRAWAL OF ADALIMUMAB<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 785<\/span>. <\/a><\/p>","publicationid":"451309","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Shaw D; El-Sherbiny YM; Rawstron AC; Emery P; Vital EM<\/span> (2017)<\/span> PREDICTING AND MANAGING PRIMARY AND SECONDARY NON-RESPONSE TO RITUXIMAB USING B-CELL BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 869<\/span>. <\/a> <\/a><\/p>","publicationid":"451299","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Naraghi K; Vojinovic T; Nam J; Freeston J; Emery P; Wakefield RJ; Buch MH<\/span> (2017)<\/span> BIOLOGIC-ELIGIBLE RHEUMATOID ARTHRITIS PATIENTS DEMONSTRATE ABSENCE OF SYNOVITIS - UTILITY OF ULTRASOUND IN THE MANAGEMENT OF RA-BIOLOGIC POPULATION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1016<\/span>. <\/a> <\/a><\/p>","publicationid":"451173","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Tanaka Y; Cardillo TE; Schlichting DE; Beattie S; Chen L; Rooney TP; Smolen JS<\/span> (2017)<\/span> TEMPORARY INTERRUPTIONS OF STUDY DRUG DURING THE BARICITINIB PHASE 3 RHEUMATOID ARTHRITIS PROGRAM<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 527-528<\/span>. <\/a><\/p>","publicationid":"451170","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Green L; Eng S; Emery P; Del Galdo F<\/span> (2017)<\/span> THREE-DIMENSIONAL NAILFOLD CAPILLARY IMAGING BY DYNAMIC OPTICAL COHERENCE TOMOGRAPHY IN SYSTEMIC SCLEROSIS: A VALIDATION STUDY USING NAILFOLD VIDEO-CAPILLAROSCOPY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 627<\/span>. <\/a><\/p>","publicationid":"451160","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Daniel A; Abignano G; Eng S; Green L; Emery P; Del Galdo F<\/span> (2017)<\/span> SKIN MICROVASCULAR FLOW ASSESSED BY DYNAMIC OPTICAL COHERENCE TOMOGRAPHY: FIRST NON-INVASIVE QUANTITATIVE OUTCOME MEASURE OF MICROVASCULAR DAMAGE IN SYSTEMIC SCLEROSIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 455-456<\/span>. <\/a><\/p>","publicationid":"451159","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fent GJ; Hunt L; Mankia KS; Erhayiem B; Foley JR; Garg P; Swoboda PP; Andrews J; Greenwood P; Emery P; Plein S; Buch MH<\/span> (2017)<\/span> CARDIOVASCULAR MAGNETIC RESONANCE IMAGING CHARACTERISATION OF CARDIOVASCULAR ABNORMALITIES IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 238-239<\/span>. <\/a><\/p>","publicationid":"451149","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fisher BA; Everett CC; Rout J; O'Dywer JL; Emery P; Pitzalis C; Ng W-F; Carr A; Pease CT; Price EJ; Sutcliffe N; Makdissi J; Gendi NS; Hall FC; Ruddock SP; Fernandez C; Hulme CT; Davies KA; Edwards CJ; Lanyon PC; Moots RJ; Roussou E; Sharples LD; Bombardieri M; Bowman SJ<\/span> (2017)<\/span> EFFECT OF RITUXIMAB ON A SALIVARY GLAND ULTRASOUND SCORE IN PRIMARY SJOGREN'S SYNDROME: RESULTS OF THE TRACTISS MULTICENTRE RANDOMISED TRIAL SUB-STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1205-1206<\/span>. <\/a><\/p>","publicationid":"451126","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Roberts C; Guillard G; Bowes MA; Burlison J; Khan A; Maguire N; Gotla S; Morgan A; Parker GJ; Hodgson R; Freeston J; Vital EM; Bird P; Emery P; Conaghan PG<\/span> (2017)<\/span> QUANTITATIVE 3D IMAGING OF TENOSYNOVITIS AND BONE MARROW EDEMA BY DCE-MRI IS A SENSITIVE MEASURE OF RESPONSE TO THERAPY IN RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1010<\/span>. <\/a> <\/a><\/p>","publicationid":"451115","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Mankia KS; D'Agostino M-A; Hodgson R; Grainger A; Matsuura I; Larkman N; Conaghan PG; Emery P<\/span> (2017)<\/span> CAN WHOLE BODY MRI AT BASELINE IDENTIFY DEFINITE INFLAMMATORY ARTHRITIS PATTERNS IN UNDIFFERENTIATED ARTHRITIS?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 727-728<\/span>. <\/a> <\/a><\/p>","publicationid":"451112","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ahmad H; Baker J; Ostergaard M; Emery P; Durez P; Ye J; Banerjee S; Conaghan P<\/span> (2017)<\/span> EVALUATION OF THE IMPACT OF BASELINE LEVELS OF MRI-DETECTED INFLAMMATION ON TREATMENT RESPONSE IN EARLY, SEROPOSITIVE, MTX-NAIVE RA: DATA FROM THE AVERT TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 174<\/span>. <\/a><\/p>","publicationid":"451111","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ahmad H; Baker J; Ostergaard M; Emery P; Huizinga T; Ye J; Banerjee S; Conaghan P<\/span> (2017)<\/span> BOTH MRI AND HAQ-DI CAN PREDICT RELAPSES FOLLOWING ALL TREATMENT WITHDRAWAL IN MTX-NAIVE PATIENTS WITH RA IN REMISSION AFTER 12 MONTHS OF ABATACEPT THERAPY IN THE AVERT TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 240<\/span>. <\/a><\/p>","publicationid":"451107","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; Buch M; O'Reilly D; Sheeran T; Bishop-Bailey A; Nock G; Chitale S; Emery P<\/span> (2017)<\/span> 21ST CENTURY STATE OF RHEUMATOID ARTHRITIS MANAGEMENT IN THE UK<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 786<\/span>. <\/a> <\/a><\/p>","publicationid":"451103","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Harrison SR; Burska AN; Emery P; Marzo-Ortega H; Ponchel F<\/span> (2017)<\/span> INTERFERON-REGULATED GENES (IRG) SIGNATURES DIFFERENTIATE GROUPS OF AS PATIENTS AND ARE ASSOCIATED WITH ANTI-TNF RESPONSE: PILOT DATA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1085-1086<\/span>. <\/a><\/p>","publicationid":"451102","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Burska A; El-Jawhari J; Tan AL; Wakefield R; Marzo-Ortega H; Conaghan P; Emery P; Ponchel F; Freeston J<\/span> (2017)<\/span> CAN RANKL SERUM LEVELS PREDICT FUTURE PROGRESSION TO RHEUMATOID ARTHRITIS IN ACPA NEGATIVE PATIENTS?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 159<\/span>. <\/a><\/p>","publicationid":"451101","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny YM; Savage L; Wittmann M; Emery P; Goodfield M; McGonagle D<\/span> (2017)<\/span> GROUP 3 INNATE LYMPHOID CELLS NUMBERS IN PERIPHERAL BLOOD PREDICT USTEKINUMAB (STELARA) THERAPY RESPONSIVENESS IN PSORIATIC DISEASE CASES WITH SUBCLINICAL IMAGING ENTHESOPATHY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 771<\/span>. <\/a><\/p>","publicationid":"451094","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Twigg S; Hensor EMA; Emery P; Morgan AW; Tennant A<\/span> (2017)<\/span> THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND DISABILITY IS MEDIATED BY PAIN AND FATIGUE IN EARLY RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 227<\/span>. <\/a><\/p>","publicationid":"451092","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny YM; Yusof MYM; Hensor E; Rawstron A; Wittmann M; Emery P; Vital EM<\/span> (2017)<\/span> A NOVEL B CELL SPECIFIC IFN-I BIOMARKER IS ASSOCIATED WITH PLASMABLAST NUMBERS FOLLOWING B CELL DEPLETION THERAPY IN SLE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 152<\/span>. <\/a><\/p>","publicationid":"451091","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny YM; Yusof MYM; Psarras A; Hensor E; Tooze R; Doody G; Wittmann M; Emery P; Vital EM<\/span> (2017)<\/span> B-CELL RESPONSES TO TYPE I INTERFERON DEFINE DISEASE ACTIVITY IN SLE AND CAN BE MEASURED BY CELL SURFACE TETHERIN (CD317)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 314<\/span>. <\/a><\/p>","publicationid":"451090","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Vital EM; McElvenny D; Hensor EM; Das S; Buch MH; Emery P; Savic S<\/span> (2017)<\/span> RISK FACTORS FOR SEVERE INFECTION AND RATIONALE FOR IMMUNOGLOBULIN MONITORING DURING RITUXIMAB TREATMENT IN AUTOIMMUNE RHEUMATIC DISEASES<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 987<\/span>. <\/a> <\/a><\/p>","publicationid":"451089","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Britton J; Hensor EM; Goodfield M; Wittmann M; Emery P; Vital EM<\/span> (2017)<\/span> LASER DOPPLER IMAGING: AN OBJECTIVE OUTCOME MEASURE FOR ASSESSMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1019-1020<\/span>. <\/a> <\/a><\/p>","publicationid":"451088","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; El-Sherbiny Y; Psarras A; Hensor E; Alase A; Mohamed A; Wittmann M; Emery P; Vital EM<\/span> (2017)<\/span> PREDICTION OF CONNECTIVE TISSUE DISEASE IN AN AT-RISK COHORT USING A NOVEL INTERFERON STIMULATED GENE EXPRESSION SCORE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 91<\/span>. <\/a> <\/a><\/p>","publicationid":"451087","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; D'Agostino M-A; Hensor E; Grainger A; Emery P; McGonagle D<\/span> (2017)<\/span> CAN PAIN IN HAND OSTEOARTHRITIS BE ASSOCIATED WITH MRI COLLATERAL LIGAMENT ABNORMALITIES?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 196-197<\/span>. <\/a><\/p>","publicationid":"451086","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Bissell L-A; Dumitru RB; Eng S; Allanore Y; Avouac J; Bosello S; Denton C; Distler O; Ferraccioli G; Jordan S; Matucci-Cerinic M; Ong V; Messenger M; Hutchinson M; Buch MH; Emery P; Del Galdo F<\/span> (2017)<\/span> EUROPEAN MULTICENTRE STUDY VALIDATES ELF TEST AS BIOMARKER OF FIBROSIS IN SYSTEMIC SCLEROSIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 635<\/span>. <\/a><\/p>","publicationid":"450919","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Vencovsky J; Ghil J; Cheong SY; Hong E<\/span> (2017)<\/span> Evaluation of Radiographic Progression By Disease Activity States in Patients with Rheumatoid Arthritis Treated with SB4 or Reference Etanercept: Results from a Phase III Study<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448275","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; El-Sherbiny YM; Psarras A; Hensor EMA; Alase A; Mohamed A; Wittmann M; Emery P; Vital EM<\/span> (2017)<\/span> Prediction of Connective Tissue Disease in an at-Risk Cohort Using a Novel Interferon Stimulated Gene Expression Score<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448274","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Daniel A; Green L; Eng S; Emery P; Del Galdo F<\/span> (2017)<\/span> Microvascular Flow Assessed By Dynamic Optical Coherence Tomography: First Non-Invasive Quantitative Outcome Measure of Microvascular Disease in Systemic Sclerosis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448273","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Taylor PC; Weinblatt M; Tanaka Y; Keystone EC; Dow ER; Higgs R; Macias WL; Rocha G; Rooney TP; Schlichting DE; Zuckerman SH; McInnes IB<\/span> (2017)<\/span> Microarray Pathway Analysis Comparing Baricitinib and Adalimumab in Moderate to Severe Rheumatoid Arthritis Patients, from a Phase 3 Study<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448272","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vencovsky J; Emery P; Keystone EC; Ghil J; Cheong SY; Hong E<\/span> (2017)<\/span> Impact of Anti-Drug Antibody and Injection Site Reaction on Efficacy: 24-Week Results from a Phase III Study Comparing SB4 (etanercept biosimilar) with Reference Etanercept in Patients with Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448271","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Eugenio G; Mankia K; Pentony P; Nam JL; Hunt L; Gul H; Wakefield RJ; Emery P<\/span> (2017)<\/span> First Description of Tenosynovitis Prevalence in a Large Cohort of ACPA-Positive Patients<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448270","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kremer J; Emery P; Connelly MA; Otvos JD; Zuckerman SH; Ruotolo G; Chen L; Issa M; Macias WL; McInnes IB<\/span> (2017)<\/span> Baricitinib Reduces GlycA Levels in Phase 2 and Phase 3 Clinical Trials in Patients with Moderate to Severe Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448269","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Eng S; Buch MH; Emery P; Khanna D; Del Galdo F<\/span> (2017)<\/span> Correlation of the American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis with Serum Biomarkers of Fibrogenesis in an Observational Cohort<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448268","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dutton K; Psarras A; Yusof MYM; Emery P; El-Sherbiny YM; Vital EM<\/span> (2017)<\/span> Distinct Interferon Scores Are Separately Associated with Activity and Long Term Sequelae in SLE<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448267","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; van Hoogstraten H; Jayawardena S; Mangan EK; Cejas P; Verschueren P<\/span> (2017)<\/span> Efficacy of Sarilumab in Patients with Rheumatoid Arthritis Who Previously Received Sarilumab or Tocilizumab<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448266","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny YM; Yusof MYM; Psarras A; Hensor EMA; Kabba K; Mohamed A; Wittmann M; Emery P; Vital EM<\/span> (2017)<\/span> Novel Type I Interferon Biomarker on B Cell Predicts with Disease Activity in SLE and Can be Measured By Cell Surface Tetherin (CD317)<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448265","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Lee YC; Emery P; Bradley JD; Zhu B; Gaich CL; Cai Z; Quebe A; Cardoso A; Chen Y-F; Fleischmann R<\/span> (2017)<\/span> Remaining Pain in DMARD-Naive Rheumatoid Arthritis Patients Treated with Baricitinib and Methotrexate<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448264","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; McInnes IB; Mease PJ; Schiff M; Pricop L; Shen S; Wang Z; Gaillez C<\/span> (2017)<\/span> Secukinumab Sustains Individual Clinical Responses over Time in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, pp. S21<\/span>. <\/a><\/p>","publicationid":"448263","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fisher B; Everett C; Rout J; O'Dwyer J; Emery P; Pitzalis C; Ng W-F; Carr A; Pease C; Price E; Sutcliffe N; Makdissi J; Tappuni A; Gendi N; Hall F; Ruddock S; Fernandez C; Hulme C; Davies K; Edwards CJ; Lanyon P; Moots RJ; Roussou E; Sharples L; Bombardieri M; Bowman S<\/span> (2017)<\/span> Effect of Rituximab on a Salivary Gland Ultrasound Score in Primary Sjgren's Syndrome: Results of Multicentre Double-Blind Randomised Controlled Trial Sub-Study<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"448262","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ouboussad L; Wong C; Hunt L; Emery P; McDermott MF; Aslam A; Buch MH<\/span> (2017)<\/span> EFFECT OF TOCILIZUMAB THERAPY ON IL-6 SIGNALLING PATHWAY IN EARLY RHEUMATOID ARTHRITIS PATIENTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A40<\/span>. <\/a> <\/a><\/p>","publicationid":"443759","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Rogers JH; Burska AN; Pitaksalee R; Parmar R; Emery P; Hodgett R; Ponchel F<\/span> (2017)<\/span> DIFFERENTIAL METHYLATION PROFILE OF TNF-SIGNALLING GENES IN T-CELLS AND MONOCYTES<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A52-A53<\/span>. <\/a><\/p>","publicationid":"441871","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mankia K; D'Agostino MA; Wakefield R; Horton L; Nam J; Grainger A; Emery P<\/span> (2017)<\/span> FIRST DEMONSTRATION OF A CHANGING IMAGING PHENOTYPE DURING FLARES OF PALINDROMIC RHEUMATISM<\/span>. RHEUMATOLOGY<\/span>, pp. 156<\/span>.<\/p>","publicationid":"439146","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; van Hoogstraten H; Mangan EK; van Adelsberg J; Fan C; Kivitz A; Pinheiro GDRC; Huizinga TW<\/span> (2017)<\/span> CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 140-141<\/span>.<\/p>","publicationid":"439145","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Halliday A; Jugl S; Mokashi S; Porter B; Martin R; Sherif B; Williams N; Marzo-Ortega H<\/span> (2017)<\/span> LONG-TERM EFFICACY OF SECUKINUMAB CONDITIONAL ON RESPONSE STATUS AT WEEK 12: ANALYSIS IN TUMOUR NECROSIS FACTOR a INHIBITOR-NAIVE AND TUMOUR NECROSIS FACTOR a INHIBITOR INADEQUATE RESPONDER PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 91<\/span>.<\/p>","publicationid":"438437","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Harrison SR; Burska AN; Emery P; Marzo-Ortega H; Ponchel F<\/span> (2017)<\/span> THE EXPRESSION OF INTERFERON-RELATED GENES IS ASSOCIATED WITH RESPONSE TO INFLIXMAB IN ANKYLOSING SPONDYLITIS: PILOT DATA<\/span>. RHEUMATOLOGY<\/span>, pp. 93<\/span>. <\/a> <\/a><\/p>","publicationid":"438388","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gul HL; Rabin T; Ponchel F; Emery P<\/span> (2017)<\/span> DEFINING TRUE REMISSION IN RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 125<\/span>.<\/p>","publicationid":"438387","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mahmood FS; Coates LC; Emery P; Conaghan P; Helliwell PS<\/span> (2017)<\/span> THE KINETICS OF RESPONSE MEASURED BY SEVERAL COMPOSITE OUTCOME TOOLS IN THE TIGHT CONTROL OF INFLAMMATION IN EARLY PSORIATIC ARTHRITIS TRIAL<\/span>. RHEUMATOLOGY<\/span>, pp. 95<\/span>.<\/p>","publicationid":"438366","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Stasiuk B; Hilt J; Mosterova Z; Cheong S-Y; Ghil J<\/span> (2017)<\/span> Comparison between Continuing SB4 (Etanercept Biosimilar) and Switching from Reference Etanercept to SB4: Long-Term Safety and Efficacy of SB4 from a Phase III Study<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 877-878<\/span>.<\/p>","publicationid":"436256","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cheng Z; Do T; Mankia K; Meade JL; Hunt L; Nam J; Tugnait A; Speirs A; Clerehugh V; Emery P; Devine D<\/span> (2017)<\/span> The subgingival microbiomes in periodontitis and health of individuals with rheumatoid arthritis and at risk of developing rheumatoid arthritis<\/span>. Journal of oral microbiology<\/span>, pp. 1325216<\/span>. <\/a> <\/a><\/p>","publicationid":"436144","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Van Hoogstraten H; Mangan E; Kivitz A; Pinheiro G; Huizinga T<\/span> (2017)<\/span> CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI- CYCLIC CITRULLINATED PEPTIDE AUTOANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. INTERNAL MEDICINE JOURNAL<\/span>, pp. 29-30<\/span>.<\/p>","publicationid":"381702","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese M; Van der Heijde D; Dougados M; Chen Y; Greenwald M; Drescher E; Klar R; Xie L; De La Torre I; Rooney T; Witt S; Schlichting D; De Bono S; Emery P<\/span> (2017)<\/span> BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (CSDMARDS)<\/span>. INTERNAL MEDICINE JOURNAL<\/span>, pp. 32<\/span>.<\/p>","publicationid":"381701","date":"2017-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mariette X; Bingham C; Burmester G; Bykerk V; Emery P; Furst DE; Van Der Heijde D; Van Vollenhoven R; Vanlunen B; Arendt C; Weinblatt M<\/span> (2016)<\/span> Early response as a predictor of long-term clinical response in DMARD-naive patients with severe, active and progressive rheumatoid arthritis treated with certolizumab pegol plus optimized MTX versus optimized MTX alone<\/span>. Revue Du Rhumatisme Edition Francaise<\/span>, pp. A201-A202<\/span>. <\/a><\/p>","publicationid":"372390","date":"2016-11-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Combe B; Emery P; Burmester G; Bykerk V; Furst DE; Maldonado MA; Huizinga TW<\/span> (2016)<\/span> Abatacept plus methotrexate can effectively and safely regain the target of remission following re-treatment for flares after drug-free withdrawal in patients with early rheumatoid arthritis<\/span>. Revue Du Rhumatisme Edition Francaise<\/span>, pp. A43-A44<\/span>. <\/a><\/p>","publicationid":"372389","date":"2016-11-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Krogulec M; Alonso RB; Rossini M; Raeman F; Walker D; Ghizdavescu AP; Irto I; Rentero ML; Casillas M; De La Torre I; Dougados M; Bosio Le Goux B<\/span> (2016)<\/span> Efficacy and tolerability of baricitinib in patients with active rheumatoid arthritis and inadequate response to: Summary results from the 24-week Phase 3 RA-BUILD Study<\/span>. Revue Du Rhumatisme Edition Francaise<\/span>, pp. A126-A127<\/span>. <\/a><\/p>","publicationid":"372388","date":"2016-11-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mariette X; Emery P; Bingham C; Burmester G; Bykerk V; Furst DE; Van Der Heijde D; Van Vollenhoven R; Vanlunen B; Ecoffet C; Cioffi C; Weinblatt M<\/span> (2016)<\/span> A randomized double-blind treatment strategy study evaluating continuation or reduced-frequency dosing of certolizumab pegol versus withdrawal to maintain low disease activity in early RA patients<\/span>. Revue Du Rhumatisme Edition Francaise<\/span>, pp. A56-A57<\/span>. <\/a><\/p>","publicationid":"372387","date":"2016-11-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bertin P; Wendling D; Schaeverbeke T; Dougados M; Deschamps V; Emery P; Porter B<\/span> (2016)<\/span> Secukinumab improves physical function and quality of life in patients with active ankylosing spondylitis: 2-year data from MEASURE 1, a Phase 3 randomised trial<\/span>. Revue Du Rhumatisme Edition Francaise<\/span>, pp. A213-A214<\/span>. <\/a><\/p>","publicationid":"372386","date":"2016-11-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ahmad HA; Baker JF; \u00d8stergaard M; Ye J; Emery P; Conaghan P<\/span> (2016)<\/span> Validating MRI-detected inflammation thresholds predictive of structural damage progression in patients with rheumatoid arthritis in a randomized placebo-controlled trial<\/span>. Revue Du Rhumatisme Edition Francaise<\/span>, pp. A171-A172<\/span>. <\/a><\/p>","publicationid":"372384","date":"2016-11-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Silverman ED<\/span> (2016)<\/span> Canadian Rheumatology Association Meeting, Fairmont Chateau Lake Louise, Lake Louise, Alberta, Canada, February 17-20, 2016<\/span>. J Rheumatol<\/span>, pp. 1149-1250<\/span>. <\/a><\/p>","publicationid":"369010","date":"2016-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pu\u00e9chal X; Pagnoux C; Perrodeau \u00c9; Hamidou M; Boffa J-J; Kyndt X; Lifermann F; Papo T; Merrien D; Smail A; Delaval P; Hanrotel-Saliou C; Imbert B; Khouatra C; Lambert M; Lesk\u00e9 C; Ly KH; Pertuiset E; Roblot P; Ruivard M; Subra J-F; Viallard J-F; Terrier B; Cohen P; Mouthon L; Le Jeunne C; Ravaud P; Guillevin L; French Vasculitis Study Group<\/span> (2016)<\/span> Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis<\/span>. Arthritis Rheumatol<\/span>, pp. 690-701<\/span>. <\/a> <\/a><\/p>","publicationid":"257192","date":"2016-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bingham CIII; Emery P; Weinblatt M; Burmester G-R; Furst DE; Mariette X; van Vollenhoven R; VanLunen B; Purcaru O; Bykerk VP<\/span> (2016)<\/span> Maintenance of Improvements in Patients' Physical Function, Workplace and Household Productivity, and Reduction in Caregiver Burden with 2 Years of Certolizumab Pegol Treatment in DMARD-Naive, Early RA Patients with Severe Progressive Disease<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457928","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Weinblatt M; Bingham CIII; Burmester G-R; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; VanLunen B; Ecoffet C; Cioffi C; Emery P<\/span> (2016)<\/span> A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study Evaluating Treatment Strategies (Continuation Versus Withdrawal) for Maintaining Low Disease Activity after 1 Year of Certolizumab Pegol in DMARD-Naive Patients with Early and Progressive, Active RA<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457927","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hunt L; Musaad S; Stephenson J; Burn B; Matsuura I; Mankia K; Nam JL; Emery P<\/span> (2016)<\/span> Triggering Receptor Expressed on Myeloid Cells (TREM) As a Novel Indicator of Disease Progression in 'at-Risk' Individuals<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457926","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Emery P; Conaghan PG; Helliwell PS<\/span> (2016)<\/span> What Should be the Primary Target of 'Treat to Target' in Psa?<\/span> ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457724","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Churchman S; Boxall S; Jones E; Emery P; Giannoudis P; McGonagle D<\/span> (2016)<\/span> Transient Circulatory Existence of Multipotential Stromal Cells Is Unlikely to Contribute to the Pathogenesis of Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457692","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Savage L; Goodfield M; Hensor EMA; Emery P; McGonagle D<\/span> (2016)<\/span> Ultrasonographic Improvement of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated with Ustekinumab for Chronic Plaque Psoriasis: A 52-Week, Prospective, Open Label, Controlled Cohort Study<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457686","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hensor EMA; McKeigue P; Conaghan PG; Buch MH; Barrett JH; Nam JL; Colombo M; Spiliopoulou A; Agakov F; Kelly S; Lewis MJ; Pitzalis C; Emery P; Morgan AW<\/span> (2016)<\/span> Validity of a 2-Component Disease Activity Score for Accurate Assessment of Synovitis in Rheumatoid Arthritis<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>. <\/a><\/p>","publicationid":"457685","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Hensor EMA; Emery P; Conaghan PG; Helliwell PS<\/span> (2016)<\/span> Does Treat to Target or Achieving Remission Improve Radiographic Outcome in Psa?<\/span> ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457684","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Twigg S; Hensor EMA; Freeston JE; Tan AL; Tennant A; Emery P; Morgan A<\/span> (2016)<\/span> Greater Fatigue at Baseline and Female Gender Predict Worse Disability in Early RA Despite Treatment to Target: A Comparison of Two Observational Cohort Studies from the United Kingdom<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457599","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mankia K; D'Agostino MA; Horton L; Nam JL; Freeston JE; Grainger AJ; Emery P<\/span> (2016)<\/span> Distinct Phenotypes in Palindromic Rheumatism: Ultrasound and MRI during Palindromic Flares<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"457588","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Hunt L; Burska AN; Parmar R; Buch MH; Emery P<\/span> (2016)<\/span> CLINICAL UTILITY OF MEASURING NAIVE CD4+<\/SUP>T-CELL IN EARLY RA PATIENT TO PREDICT REMISSION ON MTX: A REPLICATION STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A32<\/span>. <\/a><\/p>","publicationid":"434573","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kremer JM; Keystone EC; Emery P; Camp HS; Friedman A; Wang L; Othman AA; Khan N; Jungerwirth S<\/span> (2016)<\/span> SAFETY AND EFFICACY OF ABT-494, A NOVEL SELECTIVE JAK1 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO ANTI-TNF BIOLOGIC THERAPY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1038-1039<\/span>. <\/a><\/p>","publicationid":"434572","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tanaka Y; Smolen J; Jones H; Szumski A; Marshall L; Emery P<\/span> (2016)<\/span> BASELINE CHARACTERISTICS AND TREATMENT OUTCOMES OF PATIENTS WHO ACHIEVE DEEP REMISSION IN RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 188-189<\/span>. <\/a><\/p>","publicationid":"434571","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gul HL; Ponchel F; Emery P<\/span> (2016)<\/span> ULTRASOUND ASSESSMENT OF CLINICAL REMISSION: POWER DOPPLER SYNOVITIS IS ASSOCIATED WITH FLARE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A44<\/span>. <\/a><\/p>","publicationid":"434570","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mariette X; Bingham C; Burmester G-R; Bykerk VP; Emery P; Furst D; van der Heijde D; van Vollenhoven R; VanLunen B; Arendt C; Weinblatt M<\/span> (2016)<\/span> EARLY RESPONSE AS A PREDICTOR OF LONG-TERM CLINICAL RESPONSE IN DMARD-NAIVE PATIENTS WITH SEVERE, ACTIVE AND PROGRESSIVE RA TREATED WITH CERTOLIZUMAB PEGOL PLUS OPTIMIZED MTX VERSUS OPTIMIZED MTX ALONE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 242<\/span>. <\/a><\/p>","publicationid":"434569","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; McInnes I; Genovese MC; Smolen JS; Kremer J; Dougados M; Schlichting DE; Rooney T; Issa M; de Bono S; Macias WL; Rogai V; Zuckerman SH; Taylor PC<\/span> (2016)<\/span> CHARACTERISATION OF CHANGES IN LYMPHOCYTE SUBSETS IN BARICITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS IN TWO PHASE 3 STUDIES<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A62<\/span>. <\/a><\/p>","publicationid":"434568","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bingham C; Emery P; Weinblatt M; Burmester G-R; Furst DE; Mariette X; van Vollenhoven R; VanLunen B; Purcaru O; Bykerk VP<\/span> (2016)<\/span> MAINTENANCE OF IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND PHYSICAL FUNCTION AT 2 YEARS IN EARLY RA PATIENTS WITH SEVERE PROGRESSIVE DISEASE WHO ACHIEVED SUSTAINED LOW DISEASE ACTIVITY FOLLOWING 1 YEAR OF INITIAL THERAPY, WITH TWO DOSING FREQUENCIES OF CERTOLIZUMAB PEGOL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 226-227<\/span>. <\/a><\/p>","publicationid":"434567","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ouboussad L; Wong C; Hunt L; Emery P; McDermott MF<\/span> (2016)<\/span> INVESTIGATING IL-6 PATHWAY SIGNALLING KINETICS IN PERIPHERAL BLOOD SINGLE CELL SUBSETS WITH TOCILIZUMAB THERAPY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A31<\/span>. <\/a> <\/a><\/p>","publicationid":"434566","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Harrison S; Burska AN; Emery P; Marzo-Ortega H; Ponchel F<\/span> (2016)<\/span> ASSOCIATION OF 20 INTERFERON RELATED GENE EXPRESSION WITH RESPONSE TO INFLIXIMAB TREATMENT IN ANKYLOSING SPONDYLITIS: PILOT DATA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A21-A22<\/span>. <\/a><\/p>","publicationid":"434565","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Burmester G; Bykerk V; Combe B; Furst DE; Maldonado MA; Huizinga TW<\/span> (2016)<\/span> ABATACEPT PLUS METHOTREXATE CAN EFFECTIVELY AND SAFELY REGAIN THE TARGET OF REMISSION FOLLOWING RE-TREATMENT FOR FLARES AFTER DRUG-FREE WITHDRAWAL IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 720-721<\/span>. <\/a><\/p>","publicationid":"434564","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; van Hoogstraten H; Mangan EK; van Adelsberg J; Fan C; Kivitz A; Pinheiro GDRC; Huizinga T<\/span> (2016)<\/span> CLINICAL RESPONSES OF SARILUMAB BASED ON RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 732<\/span>. <\/a><\/p>","publicationid":"434563","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Braun J; Baraliakos X; Deodhar A; Baeten D; Sieper J; Emery P; Talloczy Z; Martin R; Richards HB<\/span> (2016)<\/span> EFFECT OF SECUKINUMAB, AN INTERLEUKIN-17A INHIBITOR, ON SPINAL RADIOGRAPHIC CHANGES THROUGH 2 YEARS IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF THE PHASE 3 STUDY, MEASURE 1<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 52<\/span>. <\/a><\/p>","publicationid":"434562","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Lau CS; Gibofsky A; Damjanov N; Lula S; Marshall L; Jones H; Emery P<\/span> (2016)<\/span> DOSE TITRATION OF BIOLOGICS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: A SYSTEMATIC LITERATURE REVIEW<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 225-226<\/span>. <\/a><\/p>","publicationid":"434561","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Wigston Z; Buch MH; Burska A; Emery P; Ponchel F<\/span> (2016)<\/span> DYNAMICS OF T-CELL SUBSET IN EARLY RA PATIENTS TREATED WITH MTX OR MTX plus ANTI-TNF<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A30<\/span>. <\/a><\/p>","publicationid":"434560","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Burska AN; Raschke E; Olek S; Emery P<\/span> (2016)<\/span> TH17 CELLS AS A DIAGNOSTIC BIOMARKER FOR RHEUMATOID ARTHRITIS (RA): PILOT DATA USING AN EPIGENETIC QPCR ASSAY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A69<\/span>. <\/a><\/p>","publicationid":"434559","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Stasiuk B; Hilt J; Mosterova Z; Cheong SY; Ghil J<\/span> (2016)<\/span> LONG-TERM SAFETY AND EFFICACY OF SB4 (ETANERCEPT BIOSIMILAR) IN PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON BETWEEN CONTINUING SB4 AND SWITCHING FROM ETANERCEPT REFERENCE PRODUCT TO SB4<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 236<\/span>. <\/a><\/p>","publicationid":"434558","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Bingham C; Burmester G-R; Bykerk VP; Furst D; Mariette X; van der Heijde D; van Vollenhoven R; VanLunen B; Ecoffet C; Cioffi C; Weinblatt M<\/span> (2016)<\/span> A RANDOMIZED DOUBLE-BLIND TREATMENT STRATEGY STUDY EVALUATING CONTINUATION OR REDUCED-FREQUENCY DOSING OF CERTOLIZUMAB PEGOL VERSUS WITHDRAWAL TO MAINTAIN LOW DISEASE ACTIVITY IN EARLY RA PATIENTS (C-EARLY PERIOD 2)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 143-144<\/span>. <\/a><\/p>","publicationid":"434557","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Zayat AS; Mahmoud K; Yusof MYM; Cassamoali H; D'Agostino M; Emery P; Vital EM<\/span> (2016)<\/span> A PROSPECTIVE STUDY TO ASSESS RESPONSIVENESS OF CLINICAL AND ULTRASOUND OUTCOME MEASURES FOR MUSCULOSKELETAL SLE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 549<\/span>. <\/a> <\/a><\/p>","publicationid":"429612","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van der Heijde D; Dougados M; Chen Y-C; Greenwald M; Drescher E; Klar R; Xie L; de la Torre I; Rooney TP; Witt S; Schlichting D; DeBono S; Emery P<\/span> (2016)<\/span> BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CSDMARDS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 244-245<\/span>. <\/a><\/p>","publicationid":"429610","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Shaw D; Rawstron A; Emery P; Vital EM<\/span> (2016)<\/span> VALIDATION OF HIGHLY SENSITIVE FLOW CYTOMETRY AS A BIOMARKER FOR RITUXIMAB IN SLE: A RATIONALE FOR MORE INTENSIVE TREATMENT TO IMPROVE CLINICAL OUTCOMES<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 296<\/span>. <\/a> <\/a><\/p>","publicationid":"429609","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Baeten D; Deodhar A; Wei A; Geusens P; Talloczy Z; Gong Y; Porter B<\/span> (2016)<\/span> SECUKINUMAB IMPROVES PHYSICAL FUNCTION AND QUALITY OF LIFE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR DATA FROM MEASURE 1, A PHASE 3 RANDOMISED TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 818<\/span>. <\/a><\/p>","publicationid":"429608","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Iqbal K; Emery P; Dass S; Kelly C<\/span> (2016)<\/span> EFFICACY AND SAFETY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED BRONCHIECTASIS (RA-BR): RESULTS FROM A MULTICENTRE COHORT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 996<\/span>. <\/a> <\/a><\/p>","publicationid":"429604","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Zayat AS; Wong C; Cuthbert R; Ash Z; Bingham SJ; Emery P; Buch MH<\/span> (2016)<\/span> IMAGING AND HISTOPATHOLOGICAL CHANGES TO TOCILIZUMAB IN PATIENTS WITH MODERATE TO SEVERE RA: A SINGLE CENTRE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 720<\/span>. <\/a><\/p>","publicationid":"429602","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Bissell L-A; Dumitru RB; Eng S; Calder N; Messenger M; Buch M; Emery P; Del Galdo F<\/span> (2016)<\/span> COMPLEMENTARY VALUE OF ELF TEST AND NT-PROBNP IN REFLECTING FIBROSIS AND VASCULOPATHY IN SYSTEMIC SCLEROSIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 520<\/span>. <\/a><\/p>","publicationid":"429601","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Sellam J; Riviere E; Courties A; Rouzaire P-O; Tolusso B; Vital E; Emery P; Ferraciolli G; Soubrier M; Dougados M; Mariette X<\/span> (2016)<\/span> SERUM IL-33 INDEPENDENTLY PREDICTS RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: DATA FROM THE SMART AND REPLICATION COHORTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 729<\/span>. <\/a><\/p>","publicationid":"429600","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Edwards CJ; Yusof MYM; Cassamoali H; D'Agostino M; Emery P; Vital EM<\/span> (2016)<\/span> AN EVALUATION OF CLINICAL OUTCOME MEASURES FOR MUSCULOSKELETAL LUPUS USING ULTRASOUND AS A GOLD STANDARD<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 556<\/span>. <\/a> <\/a><\/p>","publicationid":"429599","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Churchman SM; Giannoudis PV; Emery P; Jones E; McGonage D<\/span> (2016)<\/span> HUMAN MESENCHYMAL STEM CELL CIRCULATION AFTER SURGICAL BONE MANIPULATION BUT ABSENCE OF MSC PERIPHERAL BLOOD CIRCULATION IN RHEUMATOID ARTHRITIS AND HEALTH<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 446<\/span>. <\/a><\/p>","publicationid":"429598","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Candelier JB; Dass S; Rawstron A; Vital EM; Emery P<\/span> (2016)<\/span> VALIDATION OF B CELL DEPLETION AS A PREDICTOR OF CLINICAL RESPONSE AND EFFICACY OF RETREATMENT OF NON-RESPONSE IN RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 731<\/span>. <\/a> <\/a><\/p>","publicationid":"429595","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ahmad HA; Baker JF; Ostergaard M; Ye J; Emery P; Conaghan PG<\/span> (2016)<\/span> VALIDATING MRI-DETECTED INFLAMMATION THRESHOLDS PREDICTIVE OF STRUCTURAL DAMAGE PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A RANDOMIZED PLACEBO-CONTROLLED TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 624<\/span>. <\/a><\/p>","publicationid":"429588","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Arumugakani G; Stephenson S; Doody G; Rawstron AC; Emery P; McGonagle D; Tooze R<\/span> (2016)<\/span> LONG-LIVED CD19-NEGATIVE HUMAN PLASMA CELLS ARE GENERATED AT THE PLASMABLAST TO PLASMA CELL TRANSITION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 133<\/span>. <\/a><\/p>","publicationid":"429577","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Arumugakani G; de Tute RM; Newton DJ; Morgan GJ; Child JA; Owen R; Emery P; Jack AS; McGonagle D; Tooze R; Rawstron AC<\/span> (2016)<\/span> NORMAL CD19-NEGATIVE PLASMA CELLS ARE BIOLOGICALLY DISTINCT FROM OTHER NORMAL PLASMA CELLS AND LIKELY TO BE INVOLVED IN LACK OF RESPONSE TO B-CELL DEPLETION FOR AUTOIMMUNE DISORDERS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 182<\/span>. <\/a><\/p>","publicationid":"429576","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Arumugakani G; Thompson J; Khukhar F; de Tute RM; Tooze R; Emery P; McGonagle D; Rawstron AC<\/span> (2016)<\/span> PREVALENCE OF MONOCLONAL B-CELL DISORDERS IN PATIENTS WITH AUTOIMMUNITY IN THE UK<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 178<\/span>. <\/a><\/p>","publicationid":"429574","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Hensor EM; Das S; Vital EM; Emery P; Savic S<\/span> (2016)<\/span> RISK FACTORS FOR SEVERE INFECTION AND OUTCOME OF SECONDARY HYPOGAMMAGLOBULINAEMIA IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS FROM 400 PATIENTS AT A SINGLE CENTRE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 845<\/span>. <\/a> <\/a><\/p>","publicationid":"429570","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Twigg S; Hensor E; Emery P; Tennant A; Morgan AW<\/span> (2016)<\/span> DISABILITY IN EARLY RHEUMATOID ARTHRITIS MAY PERSIST DESPITE IMPROVEMENT IN DISEASE ACTIVITY: EVIDENCE FROM YORKSHIRE EARLY ARTHRITIS REGISTER<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 461<\/span>. <\/a><\/p>","publicationid":"429568","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Blagojevic J; Abignano G; Hensor EM; Guiducci S; Randone SB; Bruni C; Lepri G; Romano E; Mazzotta C; Calder N; Messenger MP; Buch MH; Emery P; Matucci-Cerinic M; Del Galdo F<\/span> (2016)<\/span> A NOVEL SERUM TEST BASED ALGORITHM TO AID IN VERY EARLY DIAGNOSIS OF SYSTEMIC SCLEROSIS (VEDOSS)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 751<\/span>. <\/a><\/p>","publicationid":"429567","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Hensor EM; Emery P<\/span> (2016)<\/span> WHICH SERONEGATIVE RA PATIENTS RESPOND TO RITUXIMAB?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 502<\/span>. <\/a><\/p>","publicationid":"429565","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Inomata H; Bissell L-A; Naraghi K; Nam J; Burska A; Hensor E; Emery P; Buch M; Andrews J<\/span> (2016)<\/span> EFFICACY OF A COMPREHENSIVE CARDIOVASCULAR RISK REDUCTION PATIENT EDUCATION PROGRAMME IN PATIENTS WITH EARLY INFLAMMATORY ARTHRITIS FOLLOWING A TREAT TO TARGET THERAPEUTIC REGIME<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 475<\/span>. <\/a> <\/a><\/p>","publicationid":"429564","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dougados M; van der Heijde D; Chen Y-C; Greenwald M; Drescher E; Liu J; Beattie S; de la Torre I; Rooney T; Schlichting D; De Bono S; Emery P; Bookman A<\/span> (2016)<\/span> Baricitinib, an Oral Janus Kinase (JAK) 1\/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to cDMARD Therapy: Results of the Phase 3 RA-BUILD Study<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1188<\/span>.<\/p>","publicationid":"372103","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Taylor JC; Verstappen S; Wang J; Bongartz T; Scott I; Emery P; Pitzalis C; Barton A; Morgan AW; Barrett JH<\/span> (2016)<\/span> Genome-Wide Meta-Analysis of Response to Methotrexate in Rheumatoid Arthritis Patients on behalf of the MATURA Consortium<\/span>. GENETIC EPIDEMIOLOGY<\/span>, pp. 666-667<\/span>.<\/p>","publicationid":"371941","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny Y; Yusof MYM; Hensor E; Wittmann M; Emery P; Vital E<\/span> (2016)<\/span> SURFACE TETHERIN IS A NOVEL CELL-SPECIFIC BIOMARKER FOR INTERFERON RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 546<\/span>. <\/a> <\/a><\/p>","publicationid":"370770","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mohamed AAA; El-Sherbiny Y; Hensor EM; Yusof MYM; Goma SH; Abda EA; Abd-Allah FM; Emery P; Vital E<\/span> (2016)<\/span> TYPE I INTERFERON ACTIVITY IS ASSOCIATED WITH MUCOCUTANEOUS BUT NOT MUSCULOSKELETAL DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 547<\/span>. <\/a> <\/a><\/p>","publicationid":"370769","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; El-Sherbiny Y; Psarras A; Hensor EM; Wittmann M; Emery P; Vital EM<\/span> (2016)<\/span> INCOMPLETE AND SYSTEMIC LUPUS ERYTHEMATOSUS REVEAL A DIFFERENT PATTERN OF INTERFERON-STIMULATED GENES UP-REGULATION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 285-286<\/span>. <\/a> <\/a><\/p>","publicationid":"370765","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny YM; Yusof MYM; Hensor EM; Psarras A; Mohamed A; Wittmann M; Emery P; Vital EM<\/span> (2016)<\/span> ANALYSIS OF CELL-SPECIFIC INTERFERON RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS USING A NOVEL FLOW CYTOMETRIC ASSAY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A72-+<\/span>. <\/a><\/p>","publicationid":"370759","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Psarras A; Yusof MYM; El-Sherbiny YM; Hensor EM; Wittmann M; Emery P; Vital EM<\/span> (2016)<\/span> DISTINCT SUBSETS OF INTERFERON-STIMULATED GENES ARE ASSOCIATED WITH INCOMPLETE AND ESTABLISHED SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A72<\/span>. <\/a><\/p>","publicationid":"370758","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Mohamed AA; El-Sherbiny YM; Psarras A; Cassamoali H; Wittmann M; Vital EM; Emery P<\/span> (2016)<\/span> PATIENTS WITH EARLY INCOMPLETE LUPUS HAVE ELEVATED TYPE 1 INTERFERON ACTIVITY<\/span>. RHEUMATOLOGY<\/span>, pp. 170<\/span>.<\/p>","publicationid":"358917","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bykerk V; Burmester G; Combe B; Furst DE; Huizinga T; Wong D; Emery P<\/span> (2016)<\/span> ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION IN THE AVERT TRIAL: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 97-98<\/span>.<\/p>","publicationid":"358916","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Deodhar A; Sieper J; Andersson M; Richards H<\/span> (2016)<\/span> SECUKINUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION, QUALITY OF LIFE, FATIGUE AND WORK PRODUCTIVITY IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS TREATED FOR UP TO 52 WEEKS IN THE PHASE III MEASURE 2 STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 35<\/span>.<\/p>","publicationid":"358915","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Blagojevic J; Bissell LA; Dumitru RB; Eng S; Calder N; Messenger M; Buch M; Emery P; Del Galdo F<\/span> (2016)<\/span> COMPLEMENTARY VALUE OF THE ELF TEST AND NT-PROBNP IN REFLECTING FIBROSIS AND VASCULOPATHY IN SYSTEMIC SCLEROSIS<\/span>. RHEUMATOLOGY<\/span>, pp. 164<\/span>.<\/p>","publicationid":"358914","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery PE; Decktor D; Fan C<\/span> (2016)<\/span> CLINICAL AND RADIOGRAPHIC EFFICACY OF SARILUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH VARIED DISEASE DURATION<\/span>. RHEUMATOLOGY<\/span>, pp. 104<\/span>.<\/p>","publicationid":"358913","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Burmester G; Bykerk V; Combe B; Furst DE; Maldonado M; Huizinga T<\/span> (2016)<\/span> ABATACEPT PLUS METHOTREXATE CAN EFFECTIVELY AND SAFELY REGAIN THE TARGET OF REMISSION FOLLOWING RE-TREATMENT FOR FLARES AFTER DRUG-FREE WITHDRAWAL IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 93-94<\/span>.<\/p>","publicationid":"358912","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Cassamoali H; Rawstron AC; Hawkins T; Dunn E; Emery P; Vital EM<\/span> (2016)<\/span> HUMANIZED ANTI-CD20 ANTIBODIES IMPROVE DEPLETION AND RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH RESISTANCE TO RITUXIMAB: RESULTS FROM THE FIRST 100 PATIENTS AT A SINGLE CENTRE<\/span>. RHEUMATOLOGY<\/span>, pp. 46-47<\/span>. <\/a> <\/a><\/p>","publicationid":"358911","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Krogulec M; Blanco Alonso R; Rossini M; Raeman F; Walker D; Ghizdavescu AP; Irto I; Luz Rentero M; Casillas M; de la Torre I; Dougados M<\/span> (2016)<\/span> EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CSDMARDS: SUMMARY RESULTS FROM THE 24-WEEK PHASE III RA-BUILD STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 60<\/span>.<\/p>","publicationid":"358910","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; Buch M; O'Reilly D; Sheeran T; Keidel S; Chitale S; Emery P<\/span> (2016)<\/span> PREDICTORS OF OUTCOME AT 1-YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE UK TREAT-TO-TARGET AUDIT<\/span>. RHEUMATOLOGY<\/span>, pp. 96<\/span>.<\/p>","publicationid":"358907","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; Buch M; O'Reilly D; Sheeran T; Keidel S; Chitale S; Emery P<\/span> (2016)<\/span> THE IMPACT OF TREAT TO TARGET ON 1-YEAR REALWORLD OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 95-96<\/span>.<\/p>","publicationid":"358905","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof Y; Iqbal K; Emery P; Kelly C; Dass S<\/span> (2016)<\/span> SAFETY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS ASSOCIATED WITH BRONCHIECTASIS: RESULTS FROM A MULTICENTRE COHORT<\/span>. RHEUMATOLOGY<\/span>, pp. 103-104<\/span>.<\/p>","publicationid":"358904","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Iqbal K; Yuzaiful MYM; Emery P; Dass S; Kelly C<\/span> (2016)<\/span> EFFICACY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS ASSOCIATED WITH BRONCHIECTASIS: RESULTS FROM A MULTICENTRE COHORT<\/span>. RHEUMATOLOGY<\/span>, pp. 104<\/span>.<\/p>","publicationid":"358903","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Blagojevic J; Abignano G; Hensor EMA; Guiducci S; Randone SB; Bruni C; Lepri G; Romano E; Mazzotta C; Calder NJ; Messenger MP; Buch M; Emery P; Matucci-Cerinic M; Del Galdo F<\/span> (2016)<\/span> THE SCLERODERMA FIBROTIC SCORE: A USEFUL SERUM TEST IN THE DIAGNOSIS OF EARLY SCLERODERMA<\/span>. RHEUMATOLOGY<\/span>, pp. 49<\/span>.<\/p>","publicationid":"358901","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Latif ZP; Stack RJ; Keenan A-M; Mankia K; Gul H; Emery P; Raza K<\/span> (2016)<\/span> A QUALITATIVE EXPLORATION OF THE SYMPTOMS EXPERIENCED BY PEOPLE WITH PALINDROMIC RHEUMATISM<\/span>. RHEUMATOLOGY<\/span>, pp. 108-109<\/span>.<\/p>","publicationid":"358891","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Burmester G; Bykerk V; Combe B; Furst D; Maldonado M; Huizinga TW<\/span> (2016)<\/span> ABATACEPT PLUS METHOTREXATE CAN EFFECTIVELY AND SAFELY REGAIN THE TARGET OF REMISSION FOLLOWING RE-TREATMENT FOR FLARES AFTER DRUG-FREE WITHDRAWAL IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. INTERNAL MEDICINE JOURNAL<\/span>, pp. 42<\/span>.<\/p>","publicationid":"357250","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bykerk VP; Burmester GR; Combe BG; Furst DE; Huizinga TWJ; Wong DA; Emery P<\/span> (2016)<\/span> ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. INTERNAL MEDICINE JOURNAL<\/span>, pp. 42<\/span>.<\/p>","publicationid":"357243","date":"2016-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Burska AN; Hensor EMA; Raja R; Campbell M; Emery P; Conaghan PG<\/span> (2015)<\/span> Changes in peripheral blood immune cell composition in\u00a0osteoarthritis<\/span>. Osteoarthritis Cartilage<\/span>, pp. 1870-1878<\/span>. <\/a> <\/a><\/p>","publicationid":"319084","date":"2015-11-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Sieper J; Braun J; Baraliakos X; Baeten DL; Dougados M; Emery P; Deodhar A; Wei JC-C; Porter B; Andersson M; Mpofu S; Richards H<\/span> (2015)<\/span> SECUKINUMAB SIGNIFICANTLY IMPROVES SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: 52-WEEK DATA FROM MEASURE 2, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL WITH SUBCUTANEOUS LOADING AND MAINTENANCE DOSING<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 132-133<\/span>. <\/a><\/p>","publicationid":"441170","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Braun J; Sieper J; Aelion J; Emery P; Deodhar A; Porter B; Andersson M; Richards H<\/span> (2015)<\/span> SECUKINUMAB IMPROVES MULTIPLE PARAMETERS OF DISEASE ACTIVITY IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS THROUGH 52 WEEKS OF SUBCUTANEOUS THERAPY: DATA FROM THE PHASE 3 MEASURE 2 STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1147<\/span>. <\/a><\/p>","publicationid":"441169","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Huizinga TWJ; Connolly SE; Johnsen A; Zhu J; Furst DE; Bykerk VP; Burmester GR; Combe BG; Wong DA; Trouw LA; Toes REM; Emery P<\/span> (2015)<\/span> EFFECT OF ANTI-CYCLIC CITRULLINATED PEPTIDE 2 IMMUNOGLOBULIN M SEROSTATUS ON EFFICACY OUTCOMES FOLLOWING TREATMENT WITH ABATACEPT PLUS METHOTREXATE IN THE AVERT TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 234-235<\/span>. <\/a><\/p>","publicationid":"441167","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Fleischmann R; Xu S; Hsia EC<\/span> (2015)<\/span> TREATMENT TARGET STATUS AT 6 MONTHS AND LONG-TERM OUTCOMES AT 5 YEARS: ANALYSIS OF METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS IN THE GO-BEFORE TRIAL<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 711<\/span>. <\/a><\/p>","publicationid":"441166","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P<\/span> (2015)<\/span> IMAGING AND EARLY ARTHRITIS MANAGEMENT, DIAGNOSIS AND MONITORING<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 8<\/span>. <\/a><\/p>","publicationid":"441165","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Deodhar A; Sieper J; Emery P; Porter B; Andersson M; Richards H<\/span> (2015)<\/span> SECUKINUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION, QUALITY OF LIFE, AND WORK PRODUCTIVITY THROUGH 52 WEEKS IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS IN THE PHASE 3 MEASURE 2 STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1144<\/span>. <\/a><\/p>","publicationid":"441164","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; Kavanaugh A; Sainsbury I; Liu S; Florentinus S; Keystone EC; Emery P<\/span> (2015)<\/span> DOES ATTAINMENT OF CLINICAL REMISSION LEAD TO COMPREHENSIVE DISEASE CONTROL IN RHEUMATOID ARTHRITIS PATIENTS?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 463<\/span>. <\/a><\/p>","publicationid":"441163","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vencovsky J; Sylwestrzak A; Leszczynski P; Porawska W; Baranauskaite A; Tseluyko V; Zhdan V; Stasiuk B; Milasiene R; Rodriguez AAB; Cheong SY; Ghil J; Emery P<\/span> (2015)<\/span> A PHASE III RANDOMISED, DOUBLE-BLIND CLINICAL STUDY COMPARING SB4, AN ETANERCEPT BIOSIMILAR, WITH ETANERCEPT REFERENCE PRODUCT (ENBREL\u00ae) IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY (24-WEEK RESULTS)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 467-468<\/span>. <\/a><\/p>","publicationid":"441162","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Furst DE; Bykerk VP; Burmester GR; Combe BG; Huizinga TWJ; Alemao E; Wong DA; Emery P<\/span> (2015)<\/span> TREATMENT EFFECTS AND MINIMAL CLINICALLY IMPORTANT DIFFERENCES IN PATIENT-REPORTED OUTCOMES FOLLOWING TREATMENT AND WITHDRAWAL OF ABATACEPT, METHOTREXATE OR COMBINATION THERAPY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 1044<\/span>. <\/a><\/p>","publicationid":"441161","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Decktor DL; Nguyen D; Fan C; Kavanaugh A<\/span> (2015)<\/span> CLINICAL AND RADIOGRAPHIC EFFICACY OF SARILUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH VARIED DISEASE DURATION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 730<\/span>. <\/a><\/p>","publicationid":"441160","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Sieper J; Braun J; Baraliakos X; Baeten DL; Dougados M; Emery P; Deodhar A; Porter B; Andersson M; Richards H<\/span> (2015)<\/span> SECUKINUMAB EFFICACY IN ANTI-TNF-NAIVE PATIENTS AND PATIENTS PREVIOUSLY EXPOSED TO ANTI-TNF THERAPY: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (MEASURE 2) IN ACTIVE ANKYLOSING SPONDYLITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 272<\/span>. <\/a><\/p>","publicationid":"441159","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bykerk VP; Burmester GR; Combe BG; Furst DE; Huizinga TWJ; Wong DA; Emery P<\/span> (2015)<\/span> ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION IN THE AVERT TRIAL: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 477-478<\/span>. <\/a><\/p>","publicationid":"441158","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Kavanaugh A; Bao Y; Betts KA; Macalalad AR; Lin P; Galebach P; Garg V<\/span> (2015)<\/span> ASSESSING THE ECONOMIC IMPACT OF COMPREHENSIVE DISEASE CONTROL ON TOTAL DIRECT MEDICAL EXPENDITURES FOR RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 468<\/span>. <\/a><\/p>","publicationid":"441157","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Davies KA; Thwaites R; Emery P; Ponche FI; Sacre S<\/span> (2015)<\/span> INCREASED TOLL-LIKE RECEPTOR 5 SIGNALLING AND IL-6 PRODUCTION IN MONOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 949<\/span>. <\/a><\/p>","publicationid":"439464","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gul H; Porto MJI; Ponchel F; Hensor E; Wakefield R; Emery P<\/span> (2015)<\/span> DO THE IMMUNOLOGICAL AND ULTRASOUND CHARACTERISTICS REFLECT THE CLINICAL REMISSION PHENOTYPE IN PATIENTS WITH RHEUMATOID ARTHRITIS?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 238<\/span>. <\/a><\/p>","publicationid":"439413","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Lettieri G; Abignano G; Eng S; Britton J; Ridgway JP; Evans R; Rathbone A; O'Connor P; Emery P; Buch M; Del Galdo F<\/span> (2015)<\/span> DIGITAL ARTERY FLOW INDEX BY NON-CONTRAST MAGNETIC RESONANCE ANGIOGRAPHY OF THE HAND: A QUANTITATIVE OUTCOME MEASURE OF FIBROPROLIFERATIVE VASCULOPATHY IN RAYNAUD'S PHENOMENON OF SCLERODERMA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 596<\/span>. <\/a><\/p>","publicationid":"439400","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ouboussad L; Hunt L; Hensor EM; Nam J; Wong C; Emery P; McDermott M; Buch M<\/span> (2015)<\/span> IDENTIFICATION OF A PREDICTIVE MICRORNA SIGNATURE OF PROGRESSION FROM PRE-RA SYSTEMIC AUTOIMMUNITY TO DEVELOPMENT OF RA USING MATCHED SERUM SAMPLES<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 190<\/span>. <\/a><\/p>","publicationid":"439396","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ferreira JF; Yusof MYM; Das S; Vital EM; Emery P<\/span> (2015)<\/span> RITUXIMAB ASSOCIATED LATE ONSET NEUTROPAENIA: SAFETY OF RETREATMENT RITUXIMAB THERAPY IN 900 PATIENTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 479<\/span>. <\/a><\/p>","publicationid":"439395","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Zayat AS; Aleyan A; Hensor EM; Emery P; Vital EM<\/span> (2015)<\/span> AT PRE-CLINICAL STAGE; CONNECTIVE TISSUE DISEASE IS INDISTINGUISHABLE FROM OTHER INFLAMMATORY ARTHRITIS ON ULTRASOUND IN CCP-NEGATIVE EARLY ARTHRITIS PATIENTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 634<\/span>. <\/a><\/p>","publicationid":"439394","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Zayat AS; Yusof MYM; Wakefield RJ; Emery P; Vital EM<\/span> (2015)<\/span> DOES ULTRASOUND HAVE A ROLE IN ASSESSING MUSCULOSKELETAL SYMPTOMS OF SYSTEMIC LUPUS ERYTHEMATOSUS? A SYSTEMATIC LITERATURE REVIEW<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 877<\/span>. <\/a><\/p>","publicationid":"439393","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bowes MA; Guillard G; Vincent GR; Hensor EM; Bird P; Freeston JE; Vital EM; Emery P; Conaghan PG<\/span> (2015)<\/span> CAN WE STOP USING CONTRAST IN RA MRI CLINICAL TRIALS? QUANTITATIVE MRI DEMONSTRATES SIMILAR RESPONSIVENESS FOR CONTRAST AND CONTRAST-FREE SYNOVITIS ASSESSMENT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 873<\/span>. <\/a><\/p>","publicationid":"439392","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Roberts C; Guillard G; Bowes MA; O'Connor R; Maguire N; Morgan A; Parker GJ; Hodgson R; Vital EM; Bird P; Vincent GR; Emery P; Conaghan PG<\/span> (2015)<\/span> A NOVEL, FULLY 3-DIMENSIONAL DYNAMIC CONTRAST MRI METHOD IN THE HAND REVEALS DETAILS OF SYNOVIAL INFLAMMATION AND PROVIDES A SENSITIVE MEASURE OF CHANGE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 879<\/span>. <\/a><\/p>","publicationid":"439391","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Das S; Ferreira JF; Yusof MYM; Vital EM; Emery P<\/span> (2015)<\/span> REDUCING RITUXIMAB DOSE IN RETREATMENT RESULTS IN SIMILAR INITIAL DAS28 REDUCTION, BUT SIGNIFICANTLY SHORTER TIME TO RETREATMENT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 724-725<\/span>. <\/a><\/p>","publicationid":"439390","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Zayat AS; Edwards CJ; Yusof MYM; Mukherjee S; Conaghan PG; Wakefield RJ; Vital EM; Emery P<\/span> (2015)<\/span> THE ROLE OF MUSCULOSKELETAL ULTRASOUND IN THE STRATIFICATION OF SLE; A MULTICENTER CROSS-SECTIONAL STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 633-634<\/span>. <\/a><\/p>","publicationid":"439389","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dumitru RB; Hensor EM; Nam J; Wakefield RJ; Emery P; Buch MH<\/span> (2015)<\/span> ASSOCIATION BETWEEN POWER DOPPLER ULTRASOUND (PDUS) AND DISEASE ACTIVITY IN EARLY RHEUMATOID ARTHRITIS (RA) PATIENTS: RESULTS FROM THE IDEA STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 888<\/span>. <\/a><\/p>","publicationid":"439388","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Erhayiem B; McDiarmid A; Swoboda P; Kidambi A; Ripley D; Musa TA; Dobson LE; Garg P; Horton SC; Dumitru RB; Andrews J; Greenwood J; Emery P; Plein S; Buch MH<\/span> (2015)<\/span> TREATMENT-NAIVE, EARLY RHEUMATOID ARTHRITIS PATIENTS DEMONSTRATE VASCULAR AND MYOCARDIAL ABNORMALITIES ON CARDIAC MRI<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 130-+<\/span>. <\/a><\/p>","publicationid":"439387","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Kabia A; Dass S; Vital EM; Beirne P; Emery P<\/span> (2015)<\/span> EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH CONCOMITANT INTERSTITIAL LUNG DISEASE: 10-YEAR EXPERIENCE AT SINGLE CENTRE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 251<\/span>. <\/a><\/p>","publicationid":"439383","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Porto M-I; Andrews J; Dass S; Savic S; Vital EM; Emery P<\/span> (2015)<\/span> THE EFFECT OF CYCLOPHOSPHAMIDE AND RITUXIMAB FOR REMISSION INDUCTION AND MAINTENANCE IN SEVERE ANCA-ASSOCIATED VASCULITIS ON IMMUNOGLOBULIN LEVELS: REPEAT CYCLES ON CLINICAL RELAPSE WITH RITUXIMAB ARE ASSOCIATED WITH STABLE IGA AND IGG<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 161-162<\/span>. <\/a><\/p>","publicationid":"439382","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Jones H; Marshall L; Szumski A; Kerkmann U; Kola B<\/span> (2015)<\/span> CONTINUATION OF ETANERCEPT MONOTHERAPY AFTER ACHIEVEMENT OF REMISSION WITH ETANERCEPT AND METHOTREXATE COMBINATION THERAPY: SUBANALYSIS FROM THE COMET STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 468<\/span>. <\/a><\/p>","publicationid":"439148","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Bingham CO; Burmester G-R; Bykerk VP; Furst DE; Mariette X; Purcaru O; Coteur G; VanLunen B; Weinblatt M<\/span> (2015)<\/span> IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND WORKPLACE AND HOUSEHOLD PRODUCTIVITY FOLLOWING 52 WEEKS OF TREATMENT WITH CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN DMARD-NAIVE EARLY RHEUMATOID ARTHRITIS PATIENTS: RESULTS FROM THE C-EARLY RANDOMIZED, DOUBLE-BLIND, CONTROLLED PHASE 3 STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 712-713<\/span>. <\/a><\/p>","publicationid":"439147","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Bingham CO; Burmester G-R; Bykerk VP; Furst DE; Mariette X; van der Heijde D; Tatla D; Arendt C; Mountian I; VanLunen B; Weinblatt M<\/span> (2015)<\/span> THE FIRST STUDY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN DMARD-NAIVE EARLY RHEUMATOID ARTHRITIS PATIENTS LED TO SUSTAINED CLINICAL RESPONSE AND INHIBITION OF RADIOGRAPHIC PROGRESSION AT 52 WEEKS: THE C-EARLY RANDOMIZED, DOUBLE-BLIND, CONTROLLED PHASE 3 STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 712<\/span>. <\/a><\/p>","publicationid":"439144","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dougados M; van der Heijde D; Chen Y-C; Greenwald M; Drescher E; Liu J; Beattie S; de la Torre I; Rooney T; Schlichting D; de Bono S; Emery P<\/span> (2015)<\/span> BARICITINIB, AN ORAL JANUS KINASE (JAK)1\/JAK2 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CDMARD THERAPY: RESULTS OF THE PHASE 3 RA-BUILD STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 79<\/span>. <\/a><\/p>","publicationid":"439143","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Chambers P; Droop A; Parmar R; Halstead-Rastrick J; Emery P<\/span> (2015)<\/span> NAIVE AND MEMORY CD4+<\/SUP>T-CELL DNA METHYLATION PROFILE IN RA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A9-A10<\/span>. <\/a><\/p>","publicationid":"436446","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ouboussad L; Hunt L; Hensor EMA; Wong C; Emery P; McDermott MF; Buch MH<\/span> (2015)<\/span> IDENTIFICATION OF PREDICTIVE MICRO-RNAs OF PROGRESSION FROM PRE-RA SYSTEMIC AUTOIMMUNITY TO DEVELOPMENT OF RA USING MATCHED SERUM SAMPLES<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A75<\/span>. <\/a><\/p>","publicationid":"436440","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Shaw D; El-Sherbiny Y; Dass S; Rawstron AC; Vital EM; Emery P<\/span> (2015)<\/span> MANAGEMENT OF PRIMARY AND SECONDARY NON-RESPONSE TO B CELL DEPLETION THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS: 10-YEAR EXPERIENCE AT A SINGLE CENTRE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 338<\/span>. <\/a><\/p>","publicationid":"370763","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bowman S; Everett C; Bombardieri M; Busch R; Emery P; Hall F; Pease CT; Pitzalis C; Price E; Dawson L; Smith P; Sutcliffe N; Ng W-F; Fernandez C; Ruddock S; Sharples L; Reynolds C; Pavitt S<\/span> (2015)<\/span> Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>. <\/a> <\/a><\/p>","publicationid":"347734","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Nam JL; Hunt L; Hensor EMA; Emery P<\/span> (2015)<\/span> How to Recruit Anti-CCP Positive Patients from Primary Care<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"347664","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dumitru R; Hensor EMA; Hmamouchi I; Emery P; Dougados M; Buch MH<\/span> (2015)<\/span> Geography and Association Between Patient Reported Outcomes and Disease Activity (DAS28) Components in Patients with Rheumatoid Arthritis, Among 17 Countries<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"347663","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dumitru R; Hensor EMA; Hmamouchi I; Emery P; Dougados M; Buch MH<\/span> (2015)<\/span> Geography and the Influence of Comorbidity on the Prevalence of Depression in Patients with Rheumatoid Arthritis,a Study Across Seventeen Countries<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"347662","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gul H; Isorna Porto MJ; Hensor EMA; Ponchel F; Wakefield RJ; Emery P<\/span> (2015)<\/span> Immunological and Ultrasound Characteristics of Patients with Rheumatoid Arthritis in Clinical Remission - Can We Use These to Predict Outcomes?<\/span> ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"347661","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hensor EMA; Vital EM; Emery P<\/span> (2015)<\/span> Which Seronegative RA Patients Respond to Rituximab? - Preliminary Analysis of a Merged Clinical Trials Dataset<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"347660","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Nam JL; Hensor EMA; Hunt L; Conaghan PG; Wakefield RJ; Emery P<\/span> (2015)<\/span> Anti-CCP Positive Patients without Clinical Synovitis Progress If Ultrasound Positive<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>.<\/p>","publicationid":"347659","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Buch M; O'Reilly DT; Sheeran T; Keidel S; Emery P<\/span> (2015)<\/span> COMPLIANCE WITH TREAT TO TARGET RECOMMENDATIONS ON RHEUMATOID ARTHRITIS AND PATIENT OUTCOMES: INTERIM RESULTS OF A UK MULTICENTRE STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 97<\/span>. <\/a> <\/a><\/p>","publicationid":"341213","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ferreira JCF; Yusof MYM; Das S; Vital EM; Emery P<\/span> (2015)<\/span> RITUXIMAB-ASSOCIATED NEUTROPAENIA: SAFETY OF RETREATMENT RITUXIMAB THERAPY<\/span>. RHEUMATOLOGY<\/span>, pp. 74<\/span>.<\/p>","publicationid":"341212","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Buch M; O'Reilly DT; Sheeran T; Keidel S; Emery P<\/span> (2015)<\/span> BASELINE PATIENT CHARACTERISTICS AND TREATMENT FROM AN AUDIT OF TREAT TO TARGET RECOMMENDATIONS FOR RHEUMATOID ARTHRITIS: INTERIM RESULTS<\/span>. RHEUMATOLOGY<\/span>, pp. 97<\/span>. <\/a> <\/a><\/p>","publicationid":"341211","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Burmester GR; Bykerk VP; Combe BG; Furst DE; Karyekar CS; Wong DA; Huizinga TWJ<\/span> (2015)<\/span> PREDICTORS OF DRUG-FREE REMISSION FOLLOWING TREATMENT WITH ABATACEPT (IN COMBINATION WITH METHOTREXATE OR AS MONOTHERAPY) IN EARLY RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 28-29<\/span>.<\/p>","publicationid":"341209","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Nadesalingam K; Goodfield M; Emery P<\/span> (2015)<\/span> HALO NAEVI, VITILIGO AND DIFFUSE ALOPECIA AREATA ASSOCIATED WITH TOCILIZUMAB THERAPY<\/span>. RHEUMATOLOGY<\/span>, pp. 54<\/span>.<\/p>","publicationid":"341207","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mohamed AAA; El-Sherbiny YM; Yusof MYM; Vital EM; Emery P<\/span> (2015)<\/span> FLOW-BASED CELL-SPECIFIC INTERFERON SIGNATURE AS A BIOMARKER IN SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. RHEUMATOLOGY<\/span>, pp. 164<\/span>.<\/p>","publicationid":"341205","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Peterfy C; Burmester GR; Bykerk VP; Combe BG; DiCarlo JC; Furst DE; Huizinga TWJ; Karyekar CS; Wong DA; Conaghan P; Emery P<\/span> (2015)<\/span> SUSTAINED IMPROVEMENTS IN MAGNETIC RESONANCE IMAGING OUTCOMES WITH ABATACEPT FOLLOWING THE WITHDRAWAL OF ALL TREATMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 73-74<\/span>.<\/p>","publicationid":"341197","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kabia AR; Yusof MYM; Dass S; Vital EM; Beirne P; Emery P<\/span> (2015)<\/span> EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH CONCOMITANT INTERSTITIAL LUNG DISEASE: 10-YEAR EXPERIENCE AT SINGLE CENTRE<\/span>. RHEUMATOLOGY<\/span>, pp. 86<\/span>.<\/p>","publicationid":"341183","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny Y; Ponchel F; Rawstron AC; Emery P; Vital EM<\/span> (2015)<\/span> A PARADOXICAL RELATIONSHIP BETWEEN BAFF AND B CELLS REVEALED BY RITUXIMAB THERAPY FOR RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 81<\/span>.<\/p>","publicationid":"341181","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Zayat AS; Edwards CJ; Yusof MYM; Mukherjee S; Wakefield RJ; Emery P; Vital EM<\/span> (2015)<\/span> THE ROLE OF MUSCULOSKELETAL ULTRASOUND IN THE STRATIFICATION OF SLE: A MULTICENTRE CROSS-SECTIONAL STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 34-35<\/span>.<\/p>","publicationid":"341173","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Horton SC; Tan AL; Wakefield RJ; Freeston JE; Buch MH; Emery P<\/span> (2015)<\/span> PREDICTORS OF CLINICAL AND IMAGING REMISSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS MANAGED WITH A TREAT-TO-TARGET APPROACH: RESULTS FROM AN EARLY ARTHRITIS CLINIC<\/span>. RHEUMATOLOGY<\/span>, pp. 76<\/span>. <\/a> <\/a><\/p>","publicationid":"341172","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gul HL; Porto MJI; Ponchel F; Hensor EMA; Emery P<\/span> (2015)<\/span> DEFINING THE CHARACTERISTICS OF REMISSION AND LOW DISEASE ACTIVITY STATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: CLINICAL, IMAGING, FUNCTIONAL AND IMMUNOLOGICAL CHARACTERISTICS<\/span>. RHEUMATOLOGY<\/span>, pp. 23-24<\/span>.<\/p>","publicationid":"341170","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Strathdee JL; Taylor JC; Bongartz T; Robinson JI; Emery P; Morgan AW; Barrett JH<\/span> (2015)<\/span> Rheumatoid susceptibility SNPs and their association with disease severity at presentation and methotrexate response<\/span>. GENETIC EPIDEMIOLOGY<\/span>, pp. 582<\/span>.<\/p>","publicationid":"337409","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mohamed AAA; Yusof MYM; El-Sherbiny YM; Cassamoali H; Wittmann M; Hensor E; Vital EM; Emery P<\/span> (2015)<\/span> Increased Interferon activity is associated with progression from Early Incomplete Lupus Erythematosus to SLE<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, pp. S25<\/span>.<\/p>","publicationid":"335531","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny YM; Mohamed AAA; Yusof MYM; Taylor CF; Wittmann M; Emery P; Vital E<\/span> (2015)<\/span> An explanation for the failure of whole blood interferon signatures to represent SLE disease activity<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, pp. S75<\/span>.<\/p>","publicationid":"335530","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Zayat AS; Alayan AA; Yusof MM; Hensor EMA; Vital EM; Emery P<\/span> (2015)<\/span> At pre-clinical stage; connective tissue disease is indistinguishable from other inflammatory arthritis on ultrasound in CCP-negative early arthritis patients<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, pp. S78<\/span>.<\/p>","publicationid":"335516","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Burmester G; Bykerk V; Combe B; Karyekar C; Furst D; Huizinga T<\/span> (2015)<\/span> Induction of Clinical Remission followed by Drug-Free Withdrawal with Abatacept Combination and Monotherapy in Early RA: Results from the Avert Study over 18 Months<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1306<\/span>.<\/p>","publicationid":"331246","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Peterfy C; Burmester G; Bykerk V; Combe B; Furst D; Huizinga T; Karyekar C; Conaghan P; Emery P<\/span> (2015)<\/span> MRI Results from the Avert Study: A Randomized, Active-Controlled Trial to Evaluate Induction of Remission and Maintenance of Drug-Free Remission using Abatacept in Combination with Methotrexate or as Monotherapy in Patients with Early RA<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1305<\/span>.<\/p>","publicationid":"331245","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Erhayiem B; Bissell L-A; McDiarmid A; Kidambi A; Ripley D; Greenwood J; Sourbron S; Del Galdo F; Emery P; Andrews J; Buch M; Plein S<\/span> (2015)<\/span> CHARACTERISATION OF SUB-CLINICAL PRIMARY MYOCARDIAL DISEASE IN SYSTEMIC SCLEROSIS - PRELIMINARY FINDINGS FROM A CARDIAC MAGNETIC RESONANCE STUDY<\/span>. HEART<\/span>, pp. A48-A49<\/span>. <\/a><\/p>","publicationid":"331202","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Erhayiem B; Bissell L-A; McDiarmid A; Swoboda P; Kidambi A; Ripley D; Al Musa T; Dobson L; Garg P; Emery P; Andrews J; Greenwood J; Buch M; Plein S<\/span> (2015)<\/span> ABNORMAL LEFT VENTRICULAR GEOMETRY IS PREVALENT IN ASYMPTOMATIC PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS COMPARED WITH THOSE WITH EARLY DISEASE AND HEALTHY CONTROLS<\/span>. HEART<\/span>, pp. A47-A48<\/span>. <\/a><\/p>","publicationid":"331079","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Burska AN; Campbell M; Raja R; White D; Emery P; Conaghan PG<\/span> (2015)<\/span> SHIFT IN BLOOD IMMUNE CELL COMPOSITION IN AGEING AND OSTEOARTHRITIS PATIENTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A10-A11<\/span>. <\/a> <\/a><\/p>","publicationid":"328770","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Hunt L; Burska AN; Parmar R; Harrison S; West R; Emery P<\/span> (2015)<\/span> MULTIPARAMETER FLOW CYTOMETRY ANALYSIS: HIGH-DIMENSIONAL DATASET ANALYSIS TOWARDS A DIAGNOSTIC TEST FOR RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A79-A80<\/span>. <\/a><\/p>","publicationid":"328761","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Burska AN; Hensor EMA; Nam JL; Kozera L; Emery P; Wakefield RJ; Morgan AW<\/span> (2015)<\/span> EVALUATION OF SOLUBLE BIOMARKERS OF SYNOVIAL INFLAMMATION USING WEIGHTED JOINT COUNTS ASSESSED CLINICALLY AND ON ULTRASOUND IMAGING<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A59-A60<\/span>. <\/a><\/p>","publicationid":"328747","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coy NCN; West RM; Pavitt SH; Hyrich K; Veale D; Emery P; Buch MH<\/span> (2015)<\/span> ALIGNING CLINICAL TRIALS IN RHEUMATOID ARTHRITIS WITH REAL-LIFE POPULATIONS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 789<\/span>. <\/a> <\/a><\/p>","publicationid":"326913","date":"2015-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Wittmann M; Edward S; Goodfield M; Emery P<\/span> (2014)<\/span> Abstracts from the 3rd International Conference on Cutaneous Lupus Erythematosus<\/span>. Journal of Investigative Dermatology<\/span>, pp. 1483-1489<\/span>. <\/a><\/p>","publicationid":"286054","date":"2014-05-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hensor E; Hunt L; Parmar R; Burska A; Emery P; Ponchel F<\/span> (2014)<\/span> A1.33 Predicting the evolution of inflammatory arthritis in ACPA-positive individuals: can T-cell subsets help?<\/span> Ann Rheum Dis<\/span>, pp. A14<\/span>. <\/a><\/p>","publicationid":"279908","date":"2014-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Burska A; Parmar R; Emery P; Melado M; Sacre S; Ponchel F<\/span> (2014)<\/span> A1.3 Phenotyping B-cell may have value as RA diagnostic biomarker for patients with <12 months inflammatory arthritis<\/span>. Ann Rheum Dis<\/span>, pp. A2<\/span>. <\/a><\/p>","publicationid":"279906","date":"2014-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

James K; Lendrem D; Mitchell S; Hindmarsh V; Bowman S; Price EJ; Pease CT; Emery P; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles IP; Isenberg DA; Vadivelu S; Coady D; Dasgupta B; McHugh N; Griffiths B; Ng W-F<\/span> (2014)<\/span> THE UK PRIMARY SJOGREN'S SYNDROME REGISTRY (UKPSSR): A VALUABLE RESOURCE FOR FUTURE SJOGREN'S SYNDROM RESEARCH<\/span>. RHEUMATOLOGY<\/span>, pp. 136<\/span>.<\/p>","publicationid":"341210","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; van Vollenhoven RF; Fleischmann R; Emery P; Florentinus S; Rathmann SS; Cardoso A; Kupper H; Kavanaugh A<\/span> (2014)<\/span> EFFICACY OF ADALIMUMAB PLUS METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS NON-RESPONDERS RECEIVING METHOTREXATE MONOTHERAPY OR ADALIMUMAB COMBINATION THERAPY: RESULTS FROM THE OPTIMA TRIAL<\/span>. RHEUMATOLOGY<\/span>, pp. 89<\/span>.<\/p>","publicationid":"341208","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P<\/span> (2014)<\/span> EARLY ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 16<\/span>.<\/p>","publicationid":"341206","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham COIII; Keystone E; Fleischmann RM; Furst DE; Hessey EW; Mehbob A; Lehane PB<\/span> (2014)<\/span> LONG-TERM SAFETY OF RITUXIMAB: POOLED ANALYSIS OF THE RHEUMATOID ARTHRITIS GLOBAL CLINICAL TRIAL PROGRAMME OVER 11 YEARS<\/span>. RHEUMATOLOGY<\/span>, pp. 97-98<\/span>.<\/p>","publicationid":"341204","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante E; Churchill M; Park W; Pons-Estel B; Han C; Gathany T; Zhou Y; Xu S; Hsia EC<\/span> (2014)<\/span> FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 93<\/span>. <\/a><\/p>","publicationid":"341203","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Smolen J; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Karunaratne PM; Kavanaugh A<\/span> (2014)<\/span> WORK RELATED OUTCOMES IN EARLY RHEUMATOID ARTHRITIS PATIENTS WITH ELEVATED RISK OF EMPLOYMENT LOSS: RESULTS FROM TWO RANDOMIZED CLINICAL TRIALS (OPTIMA AND PROWD) ON THE EFFECT OF ADALIMUMAB AND METHOTREXATE COMBINATION THERAPY VERSUS METHOTREXATE MONOTHERAPY OVER 6 MONTHS OF TREATMENT<\/span>. RHEUMATOLOGY<\/span>, pp. 78<\/span>.<\/p>","publicationid":"341202","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Bissell L-A; Britton J; Woods D; Buch M; McGonagle D; Emery P; Del Galdo F<\/span> (2014)<\/span> LONGITUDINAL ASSESSMENT OF SCLERODERMA SKIN BY OPTICAL COHERENCE TOMOGRAPHY: PRELIMINARY VALIDATION OF SENSITIVITY TO CHANGE OVER-TIME<\/span>. RHEUMATOLOGY<\/span>, pp. 46-47<\/span>.<\/p>","publicationid":"341178","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Alemao E; Joo S; Banerjee S; Emery P; Weinblatt M; L'ltalien G<\/span> (2014)<\/span> IMPACT OF ANTI-IL-6 MONOCLONAL ANTIBODY, CLAZAKIZUMAB, ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE IN A PHASE IIB STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 947<\/span>. <\/a><\/p>","publicationid":"326695","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Buch M; O'Reilly D; Sheeran T; Keidel S; Emery P<\/span> (2014)<\/span> COMPLIANCE WITH TREAT TO TARGET RECOMMENDATIONS & ITS IMPACT ON CONTROL OF RHEUMATOID ARTHRITIS - INTERIM RESULTS OF A UK MULTICENTRE AUDIT<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 390<\/span>. <\/a><\/p>","publicationid":"326694","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Weinblatt M; Mease P; Mysler E; Takeuchi T; Drescher E; Berman A; Zilberstein M; Xing J; Emery P<\/span> (2014)<\/span> A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL ANTIBODY) WITH OR WITHOUT METHOTREXATE IN ADULTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 680-681<\/span>. <\/a><\/p>","publicationid":"326693","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Han C; Keystone E; Fleischmann R; Smolen J; Matteson EL; Emery P; Genovese M; Gathany T; Hsia EC<\/span> (2014)<\/span> IMPACT OF GOLIMUMAB ON PHYSICAL FUNCTION AND EMPLOYABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM 3 PHASE III CLINICAL TRIALS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 234<\/span>. <\/a><\/p>","publicationid":"326691","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gvozdenovic E; Allaart C; Wolterbeek R; Brenol C; Chopra A; Dougados M; Emery P; Ferraccioli G; Van der Heijde D; Huizinga T; Kay J; Mola E; Moots R; Da Silva J; Smolen J; Veale D; Landewe R<\/span> (2014)<\/span> ASSESSMENT OF GLOBAL DISEASE ACTIVITY IN RA BY PATIENTS AND PHYSICIANS: CULTURAL DIFFERENCES ACROSS COUNTRIES IN THE METEOR DATABASE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 336<\/span>. <\/a><\/p>","publicationid":"326690","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Pedersen R; Bukowski J; Marshall L<\/span> (2014)<\/span> EARLY RESPONSE TO ETANERCEPT-METHOTREXATE INDUCTION THERAPY PREDICTS SUSTAINED REMISSION WITH REDUCED-DOSE COMBINATION REGIMEN IN THE PRIZE STUDY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 75<\/span>. <\/a><\/p>","publicationid":"326689","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Bukowski J; Szumski A; Marshall L<\/span> (2014)<\/span> HIGH RATES OF REMISSION INDUCTION ACHIEVED WITH COMBINATION ETANERCEPT PLUS METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS UP TO ONE YEAR AFTER SYMPTOM ONSET<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 477-478<\/span>. <\/a><\/p>","publicationid":"326688","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Smolen J; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Karunaratne M; Kavanaugh A<\/span> (2014)<\/span> EFFECT OF ADALIMUMAB AND IMPACT OF DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT ON WORK INSTABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 941<\/span>. <\/a><\/p>","publicationid":"326687","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Karpouzas GA; Emery P; Fleischmann R; Xu S; Hsia EC<\/span> (2014)<\/span> DAS28(CRP) <3.2 ACHIEVED WITH OR WITHOUT A TNF INHIBITOR: DIFFERENCES IN RADIOGRAPHIC, CLINICAL, AND BIOMARKER OUTCOMES BETWEEN PLACEBO plus MTX AND GOLIMUMAB plus MTX TREATMENT AMONG MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 883<\/span>. <\/a><\/p>","publicationid":"326686","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Burmester G; Bykerk V; Combe B; Furst DE; Barre E; Karyekar CS; Wong D; Huizinga TW<\/span> (2014)<\/span> INDUCTION OF CLINICAL REMISSION FOLLOWED BY DRUG-FREE WITHDRAWAL WITH ABATACEPT COMBINATION AND MONOTHERAPY IN EARLY RA: RESULTS FROM THE AVERT STUDY OVER 18 MONTHS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 69<\/span>. <\/a><\/p>","publicationid":"326684","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Du S; Pellas T; van der Heijde D; Weinblatt M; Emery P; Zilberstein M; Conaghan P<\/span> (2014)<\/span> X-RAY AND MRI RESULTS FROM A PHASE IIB STUDY OF SUBCUTANEOUS ANTI-INTERLEUKIN-6 MONOCLONAL ANTIBODY CLAZAKIZUMAB WITH OR WITHOUT MTX IN ADULTS WITH MODERATE-TO-SEVERE ACTIVE RA AND INADEQUATE RESPONSE TO CONVENTIONAL DMARDS INCLUDING METHOTREXATE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 665-666<\/span>. <\/a><\/p>","publicationid":"326655","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Peterfy C; Burmester G; Bykerk V; Combe B; Furst DE; Huizinga TW; Karyekar CS; Wong D; Conaghan P; Emery P<\/span> (2014)<\/span> MRI RESULTS FROM THE AVERT STUDY: A RANDOMIZED, ACTIVE-CONTROLLED TRIAL TO EVALUATE INDUCTION OF REMISSION AND MAINTENANCE OF DRUG-FREE REMISSION USING ABATACEPT IN COMBINATION WITH METHOTREXATE OR AS MONOTHERAPY IN PATIENTS WITH EARLY RA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 71<\/span>. <\/a><\/p>","publicationid":"326654","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Buch MH; Rakieh C; Hensor E; Middleton E; Horton S; Das S; Pickles D; Ward J; Fechtenbaum M; Tan AL; Wakefield R; Freeston J; Emery P<\/span> (2014)<\/span> AN EXPLORATORY CLINICAL AND IMAGING STUDY EVALUATING ABATACEPT IN THE MANAGEMENT OF POOR PROGNOSIS ACPA NEGATIVE UNDIFFERENTIATED ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 678<\/span>. <\/a><\/p>","publicationid":"326572","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hunt L; Verheul M; Nam JL; Trouw L; Fechtenbaum M; Rakieh C; Hensor EM; Toes R; Buch MN; Emery P<\/span> (2014)<\/span> ANTI-CARBAMYLATED PROTEIN (ANTI-CARP) ANTIBODIES ARE PRESENT IN THE SERA OF INDIVIDUALS AT DIFFERENT STAGES OF THE INFLAMMATORY ARTHRITIS CONTINUUM<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 889-890<\/span>. <\/a><\/p>","publicationid":"326571","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bissell L-A; Erhayiem B; Hensor EMA; Plein S; Emery P; Greenwood JP; Buch MH; Andrews J<\/span> (2014)<\/span> HIGH PREVALENCE OF SUBCLINICAL CARDIOVASCULAR DISEASE AND ABNORMAL LEFT VENTRICULAR GEOMETRY DETECTED BY CMR IN ASYMPTOMATIC RHEUMATOID ARTHRITIS PATIENTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 406-407<\/span>. <\/a><\/p>","publicationid":"326570","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Yusof MYM; Vital EM; Das S; Dass S; Rawstron A; Emery P<\/span> (2014)<\/span> REPEAT CYCLES ON CLINICAL RELAPSE FOR REMISSION MAINTENANCE IN ANCA-ASSOCIATED VASCULITIS: IDENTIFYING B CELL BIOMARKERS TO GUIDE RE-TREATMENT STRATEGY<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 149-150<\/span>. <\/a><\/p>","publicationid":"326453","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Bissell L-A; Britton J; Lettieri G; Woods D; Buch MH; McGonagle D; Emery P; Del Galdo F<\/span> (2014)<\/span> LONGITUDINAL ASSESSMENT OF SCLERODERMA SKIN BY OPTICAL COHERENCE TOMOGRAPHY: PRELIMINARY VALIDATION OF SENSITIVITY TO CHANGE OVER-TIME<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 705-706<\/span>. <\/a><\/p>","publicationid":"326362","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bowes MA; Guillard G; Gill E; Vincent GR; Hensor E; Freeston JE; Vital EM; Bird P; Emery P; Conaghan PG<\/span> (2014)<\/span> Novel Quantification of MRI Provides a More Sensitive Outcome Measure Than Ramris<\/span>. ARTHRITIS & RHEUMATOLOGY<\/span>, pp. S517-S518<\/span>.<\/p>","publicationid":"319027","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Emery P; Bingham C; Maldonado M; Furst D; Tyson N; Mehbob A; Lehane P; van Vollenhoven R; Haraoui B<\/span> (2014)<\/span> Long Term Safety of Rituximab in Rheumatoid Arthritis Clinical Trials: A 10-Year Follow-Up Study<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1442<\/span>.<\/p>","publicationid":"294447","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Chalabi Y; Peterfy C; Genovese M; Emery P; Taylor P; Schlichting D; Beattie S; Macias W; Keystone E<\/span> (2014)<\/span> Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1\/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1506<\/span>.<\/p>","publicationid":"294446","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Redmond A; Alcacer-Pitarch B; Gray J; Denton C; Herrick A; Navarro-Coy N; Collie H; Loughrey L; Pavitt S; Siddle H; Wright J; Helliwell P; Emery P; Buch M<\/span> (2014)<\/span> EFFECTS OF PRESSURE RELIEVING INSOLES FOR FOOT PROBLEMS IN PEOPLE WITH SSC: THE PISCES RANDOMIZED CONTROLLED TRIAL<\/span>. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY<\/span>, pp. S45<\/span>.<\/p>","publicationid":"289881","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Parmar R; Burska A; Emery P; Mellado M; Sacre S; Ponchel F<\/span> (2014)<\/span> T-CELLS EXPRESSING TLR4 AND CXCR4 ARE ASSOCIATED WITH AN RA DIAGNOSTIC IN EARLY INFLAMMATORY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A26-A27<\/span>. <\/a> <\/a><\/p>","publicationid":"279909","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ouboussad L; Savic S; Dickie LJ; Hintze J; Wong C; Cook GP; Buch MH; Emery P; McDermott MF<\/span> (2014)<\/span> TLR-DEPENDENT XBP1 ACTIVATION INDUCES AN AUTOCRINE LOOP IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A22<\/span>. <\/a><\/p>","publicationid":"277645","date":"2014-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

McGonagle D; McKenna F; Maher T; Kavanagh R; Cunningham A-M; Lee M; Grosart R; Wakefield R; Kane D; Schmidt W; Young T; Ndosi M; Lewis M; Hale C; Bird H; Ryan S; Quinn H; McIvor E; Taylor J; Burbage G; Bond D; White J; Chagadama D; Green S; Kay L; Pace AV; Bejarano V; Emery P; Hill J; Hurley M; Porcheret M; Hart O; Oliver D; Coates L; Backhouse M; Coates L; Pickles D; Chamberlain V; Partridge K; Pickles D; Keat A; Maddison P; Taylor P; Dillon A; Chapman V; Pincus T; Shelton D; Ballestar E; Loughlin J; Tak P-P; Prinjha R; Regan L; D'Cruz D; Jones G; Lewis J; den Hollander M; Goossens M; de Jong J; Smeets R; Vlaeyen J; Ioannou J; McDonagh J; Clinch J; Pilkington C; Siebert S; Martindale J; Beevor C; Jeffries C; Deighton C; Nye A; Cook D; Taylor P; Firth J; Pickles D; Chamberlain V; Taylor P; Emery P<\/span> (2013)<\/span> Essentials in Rheumatology: Disease Management * I29. Recognition and Management of the Auto-Inflammatory Diseases<\/span>. Rheumatology<\/span>, pp. i8-i17<\/span>. <\/a> <\/a><\/p>","publicationid":"257195","date":"2013-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny YM; Churchman S; Emery P; Vital EM; Ponchel F<\/span> (2013)<\/span> A5.18\u2005Impact of Rituximab on Synovial Gene Expression<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. A37<\/span>. <\/a><\/p>","publicationid":"257401","date":"2013-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Burska A; Parmar R; El-Sherbiny Y; El Jawhari J; Emery P; Ponchel F<\/span> (2013)<\/span> A3.3\u2005An Immunological Window of Opportunity Defines the Ability of Early RA Patient to Achieve Remission with First Anti-Rheumatic Treatment<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. A14<\/span>. <\/a><\/p>","publicationid":"257400","date":"2013-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bissell L-A; Burska A; Horton SC; Donica H; Freeston JE; Buch MH; Emery P; Andrews J<\/span> (2013)<\/span> CARDIOVASCULAR RISK FACTORS ARE PREVALENT IN EARLY INFLAMMATORY ARTHRITIS REGARDLESS OF FULFILMENT OF THE ACR CRITERIA FOR RHEUMATOID ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 423<\/span>.<\/p>","publicationid":"281572","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hunt L; Nam JL; Rakieh C; Emery P; Ponchel F<\/span> (2013)<\/span> PREDICTING THE EVOLUTION OF INFLAMMATORY ARTHRITIS IN ACPA-POSITIVE INDIVIDUALS: CAN T-CELL SUBSET HELP?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 175<\/span>.<\/p>","publicationid":"281532","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese MC; Silverman GJ; Emery P; Gupta R; Gill A; Komocsar WJ; Veenhuizen M; Xie L; Berclaz P-Y; Lee C<\/span> (2013)<\/span> Efficacy and Safety Of Subcutaneous Administration Of Tabalumab, An Anti-B Cell Activating Factor Monoclonal Antibody, In Rheumatoid Arthritis: Results From a Phase 3 Multicenter, Randomized, Double-Blind Study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S733-S734<\/span>.<\/p>","publicationid":"273107","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven R; Emery P; Bingham COIII; Keystone E; Fleischmann RM; Furst DE; Hessey EW; Mehbob A; Lehane PB<\/span> (2013)<\/span> Long-Term Safety Of Rituximab: Pooled Analysis Of The Rheumatoid Arthritis Global Clinical Trial Program Over 11 Years<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S1000<\/span>.<\/p>","publicationid":"273106","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Szumski A; Bukowski J; Bananis E; Marshall L<\/span> (2013)<\/span> Characteristics of Protocol-Specified Responders\/Non-Responders Treated With Etanercept Plus Methotrexate in Period 1 of the Prize Study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S184<\/span>.<\/p>","publicationid":"273105","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Spieler W; Stopinska-Polaszewska M; Korshunov NI; Bukowski J; Pedersen R; Williams T; Gaylord S; Vlahos B<\/span> (2013)<\/span> Assessing Maintenance Of Remission After Withdrawal Of Etanercept Plus Methotrexate, Methotrexate Alone, Or Placebo In Early Rheumatoid Arthritis Patients Who Achieved Remission With Etanercept and Methotrexate: The Prize Study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S1149<\/span>.<\/p>","publicationid":"273104","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; van Vollenhoven RF; Fleischmann R; Emery P; Florentinus S; Rathmann SS; Cardoso A; Kupper H; Kavanaugh A<\/span> (2013)<\/span> Efficacy Of Adalimumab Plus Methotrexate Therapy In Rheumatoid Arthritis Non-Responders Receiving Methotrexate Monotherapy Or Adalimumab Combination Therapy: Results From The Optima Trial<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S999-S1000<\/span>.<\/p>","publicationid":"273103","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Strusberg I; Durez P; Nash P; Amante E; Churchill MA; Park W; Pons-Estel B; Han C; Gathany TA; Zhou Y; Xu S; Hsia EC<\/span> (2013)<\/span> Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Methotrexate-naive Patients With Rheumatoid Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S188-S189<\/span>.<\/p>","publicationid":"273102","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Rakieh C; Vital EM; Emery P; Martin M<\/span> (2013)<\/span> Rituximab For Treatment Of Refractory Auto-Immune Hepatitis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S684-S685<\/span>.<\/p>","publicationid":"273100","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gvozdenovic E; Wolterbeek R; Allaart CF; Brenol C; Chopra A; Dougados M; Emery P; van der Heijde D; Huizinga TWJ; Kay J; Martin Mola E; Moots RJ; Da Silva JAP; Smolen JS; Veale DJ; Landewe R<\/span> (2013)<\/span> Assessment Of Global Disease Activity In Rheumatoid Arthritis By Patients and Physicians: Cultural Differences Among Countries In The Meteor Database<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S970-S971<\/span>.<\/p>","publicationid":"273099","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Weinblatt M; Mease P; Mysler E; Takeuchi T; Drescher E; Berman A; Zilberstein M; Xing J; Emery P<\/span> (2013)<\/span> A Phase IIb Study Of The Efficacy and Safety Of Subcutaneous Clazakizumab (anti-IL-6 monoclonal antibody) With Or Without Methotrexate In Adults With Moderate-To-Severe Active Rheumatoid Arthritis and An Inadequate Response To Methotrexate<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S735-S736<\/span>.<\/p>","publicationid":"273098","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gillespie J; Abignano G; McDermott M; Emery P; Del Galdo F<\/span> (2013)<\/span> Secreted Frizzled-Related Protein 4 Can Be Induced By Transforming Growth Factor-\u03b2, Is Regulated By Caveolin-1 and Can Induce Non-Canonical Wnt Signaling In Fibroblasts<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S1157-S1158<\/span>.<\/p>","publicationid":"273047","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Liakouli V; Mavria G; Gillespie J; Scarcia M; Cipriani P; Giacomelli R; Emery P; Del Galdo F<\/span> (2013)<\/span> Pigment Epithelium Derived Factor Secreted By Activated Fibroblasts Can Contribute To Impaired Angio and Vasculogenesis In Scleroderma<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S1097<\/span>.<\/p>","publicationid":"272962","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Moverley AR; McParland L; Brown S; Collier H; Law J; Brown SR; Corrigan N; Navarro-Coy N; Emery P; Conaghan PG; Helliwell PS<\/span> (2013)<\/span> Results Of a Randomised Controlled Trial Comparing Tight Control Of Early Psoriatic Arthritis (TICOPA) With Standard Care: Tight Control Improves Outcome<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S346<\/span>.<\/p>","publicationid":"272934","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Bissell L-A; Britton J; Woods D; Buch MH; McGonagle D; Emery P; Del Galdo F<\/span> (2013)<\/span> Longitudinal Assessment Of Scleroderma Skin By Optical Coherence Tomography: Preliminary Validation Of Sensitivity To Change Over-Time<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S1111<\/span>.<\/p>","publicationid":"272892","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bissell LA; Hensor E; Mackie SL; Burska A; Nam JL; Kozera L; Keen HI; Villeneuve E; Eberl H; Donica H; Conaghan PG; Andrews J; Emery P; Morgan AW<\/span> (2013)<\/span> Improvement In Insulin Resistance Greater With The Use Of Infliximab Following Intensive Treatment Of Early Rheumatoid Arthritis<\/span>. Arthritis and Rheumatism<\/span>, pp. S1182<\/span>.<\/p>","publicationid":"272828","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Han C; Fleischmann R; Smolen J; Emery P; Genovese M; Doyle M; Hsia E<\/span> (2013)<\/span> Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Against Rheumatism: Analysis Based on Patient Reported Outcomes Analyzed from 3 Phase III Golimumab Clinical Trials of Golimumab<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 968-969<\/span>.<\/p>","publicationid":"264080","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven R; Cividino A; Emery P; Bingham C; Keystone E; Fleischmann R; Furst D; Tyson N; Mehbob A; Lehane P<\/span> (2013)<\/span> Longterm Safety of Rituximab in Rheumatoid Arthritis Clinical Trials: A 10-Year Followup Study<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 957<\/span>.<\/p>","publicationid":"264079","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kavanaugh A; Emery P; van Vollenhoven RF; Dikranian SH; Alten R; Klearman M; Musselman D; Agarwal S; Green J; Gabay C<\/span> (2013)<\/span> TOCILIZUMAB MONOTHERAPY COMPARED WITH ADALIMUMAB MONOTHERAPY IN RA: RESULTS OF A 24-WEEK STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 45<\/span>.<\/p>","publicationid":"259365","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fleischmann R; van Vollenhoven RF; Smolen J; Emery P; Florentinus S; Rathmann S; Kupper H; Kavanaugh A<\/span> (2013)<\/span> LONG-TERM OUTCOMES OF EARLY RA PATIENTS INITIATED WITH ADALIMUMAB PLUS METHOTREXATE COMPARED WITH METHOTREXATE ALONE FOLLOWING A TARGETED TREATMENT APPROACH<\/span>. RHEUMATOLOGY<\/span>, pp. 44<\/span>.<\/p>","publicationid":"259364","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ndosi M; Lewis M; Hale C; Bird H; Ryan S; Quinn H; McIvor E; Taylor J; Burbage G; Bond D; White J; Chagadama D; Green S; Kay L; Pace AV; Bejarano V; Emery P; Hill J<\/span> (2013)<\/span> THE COST-EFFECTIVENESS OF NURSE-LED CARE IN PEOPLE WITH RA<\/span>. RHEUMATOLOGY<\/span>, pp. 10<\/span>.<\/p>","publicationid":"259363","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Han C; Keystone EC; Fleischmann R; Smolen J; Emery P; Genovese M; Doyle M; Hsia EC<\/span> (2013)<\/span> VALIDATION OF REMISSION OF RHEUMATOID ARTHRITIS BY TRADITIONAL DISEASE ACTIVITY SCORE AND PROVISIONAL CRITERIA BY AMERICAN COLLEGE OF RHEUMATOLOGY AND EUROPEAN LEAGUE AGAINST RHEUMATISM: ANALYSIS BASED ON PATIENT-REPORTED OUTCOMES ANALYSED FROM THREE PHASE III GOLIMUMAB CLINICAL TRIALS<\/span>. RHEUMATOLOGY<\/span>, pp. 83<\/span>.<\/p>","publicationid":"259362","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P<\/span> (2013)<\/span> THE CHANGING FACE OF RHEUMATOID ARTHRITIS: A PALINDROMIC SHIFT<\/span>. RHEUMATOLOGY<\/span>, pp. 17<\/span>.<\/p>","publicationid":"259361","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Rakieh C; Nam JL; Hunt L; Villeneuve E; Bissell L-A; Das S; Conaghan P; McGonagle D; Wakefield RJ; Emery P<\/span> (2013)<\/span> WHAT HAPPENS TO ACPA-POSITIVE PATIENTS WITHOUT CLINICAL SYNOVITIS?<\/span> RHEUMATOLOGY<\/span>, pp. 46<\/span>.<\/p>","publicationid":"259307","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mathieson HR; Mackie SL; Bryer D; Buch M; Emery P; Marzo-Ortega H<\/span> (2013)<\/span> IS THERE CLINICAL VALUE TO ANA MONITORING IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH INFLIXIMAB? A RETROSPECTIVE AUDIT OF 70 PATIENTS<\/span>. RHEUMATOLOGY<\/span>, pp. 167<\/span>.<\/p>","publicationid":"259273","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Shuto T; Marzo-Ortega H; Thomas RC; Bingham S; Coates L; Emery P; Hamlin PJ<\/span> (2013)<\/span> CASELOAD AND IMPACT OF THE LEEDS COMBINED RHEUMATOLOGY AND GASTROENTEROLOGY CLINIC<\/span>. RHEUMATOLOGY<\/span>, pp. 166<\/span>.<\/p>","publicationid":"259272","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Redmond A; Alcacer-Pitarch B; Gray J; Denton C; Herrick A; Navarro-Coy N; Collier H; Loughrey L; Pavitt S; Siddle H; Wright J; Helliwell P; Emery P; Buch M<\/span> (2013)<\/span> SIMPLE INSOLES FOR MANAGING FOOT PROBLEMS IN PEOPLE WITH SSC: THE PISCES RANDOMIZED CONTROLLED TRIAL<\/span>. RHEUMATOLOGY<\/span>, pp. 27<\/span>.<\/p>","publicationid":"259248","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Sharif MI; Das S; Emery P; Maciver H; Shingler W; Helliwell P; Sokoll K; Vital EM<\/span> (2013)<\/span> DOSE REDUCTION IN RITUXIMAB RETREATMENT MAY DELAY ACHIEVEMENT OF OPTIMAL RESPONSES<\/span>. RHEUMATOLOGY<\/span>, pp. 94<\/span>.<\/p>","publicationid":"259247","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Coates L; Nam J; Moverley AR; Helliwell P; Hensor E; Wakefield R; Emery P; Conaghan P<\/span> (2013)<\/span> IS THERE SUB-CLINICAL JOINT DISEASE IN EARLY PSORIATIC ARTHRITIS? A CLINICAL COMPARISON WITH POWER DOPPLER ULTRASOUND<\/span>. RHEUMATOLOGY<\/span>, pp. 162<\/span>.<\/p>","publicationid":"259245","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen J; Emery P; Ferraccioli G; Samborski W; Berenbaum F; Davies O; Koetse W; Bennett B; Burkhardt H<\/span> (2013)<\/span> MAINTENANCE OF REMISSION IN RA PATIENTS WITH LOW TO MODERATE DISEASE ACTIVITY FOLLOWING WITHDRAWAL OF CERTOLIZUMAB PEGOL TREATMENT: WEEK 52 RESULTS FROM THE CERTAIN STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 85<\/span>.<\/p>","publicationid":"259237","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ouboussad L; Savic S; Dickie LJ; Hintze J; Wong CH; Cook GP; Buch M; Emery P; McDermott MF<\/span> (2013)<\/span> ACTIVATION OF THE X-BOX BINDING PROTEIN 1 AS A MEDIATOR OF INFLAMMATION IN RHEUMATOID ARTHRITIS AND EFFECTS OF PRO-INFLAMMATORY STIMULI ON REGULATION OF EXPRESSION OF MICRORNA<\/span>. RHEUMATOLOGY<\/span>, pp. 139<\/span>.<\/p>","publicationid":"259235","date":"2013-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dominique F; Van Laar J; Sont JK; Naraghi K; Marjanovic Z; Largero J; Schuerwegh A; Marijt EWA; Vonk M; Schattenberg A; Matucci M; Miniati I; Voskuyl A; Van de Loosdrecht AA; Daikeler T; Koetter I; Schmarlzing M; Martin T; Weiner S; Deligny C; Durand JM; Emery P; Machold KP; Sarrot-Reynauld F; Warnatz K; Adoue D; Constans J; Tony H-P; Del Papa N; Fassas A; Himsel A; Launay D; Monaco AL; Philippe P; Quere I; Rich E; Westhovens R; Griffiths B; Saccardi R; Van Den Hoogen FH; Fibbe WE; Socie G; Gratwohl A; Tyndall A<\/span> (2012)<\/span> Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial<\/span>. Blood<\/span>, pp. 964<\/span>. <\/a><\/p>","publicationid":"256771","date":"2012-11-16","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital E; El-Sherbiny YM; Henshaw K; Dass S; Das S; Buch M; Ponchel F; Emery P<\/span> (2012)<\/span> THU0103\u2005Synovial plasma cells predict relapse after rituximab therapy in rheumatoid arthritis<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. 189<\/span>. <\/a><\/p>","publicationid":"285996","date":"2012-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Arumugakani G; Rawstron A; Tooze R; Cherukuri A; Varghese A; Vital E; Emery P; McGonagle D<\/span> (2012)<\/span> THU0088\u2005Abnormal memory B-cell reconstitution following anti-CD20 therapy for autoimmune diseases predicts clinical relapse<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. 183<\/span>. <\/a><\/p>","publicationid":"285980","date":"2012-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ndosi M; Lewis M; Hale C; Bird H; Ryan S; Quinn H; McIvor L; Taylor J; Burbage G; Bond D; White J; Chagadama D; Green S; Kay L; Pace AV; Bejarano V; Emery P; Hill J<\/span> (2012)<\/span> OP0194-HPR\u2005Clinical outcomes of nurse-led care for people with RA: A multicentre RCT<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. 120<\/span>. <\/a> <\/a><\/p>","publicationid":"223585","date":"2012-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Churchman SM; Goeb V; Horner EA; Henshaw K; Emery P<\/span> (2012)<\/span> Pilot gene expression analysis of inflamed synovium<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. A91<\/span>. <\/a><\/p>","publicationid":"211228","date":"2012-02-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Hensor EMA; Parmar R; Nam JL; Villeneuve E; Corscadden D; Henshaw K; Emery P<\/span> (2012)<\/span> Predicting the evolution of inflammatory arthritis in ACPA-positive individuals: can T cell subset help?<\/span> Annals of the Rheumatic Diseases<\/span>, pp. A21-A22<\/span>. <\/a><\/p>","publicationid":"211227","date":"2012-02-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven RF; Shaw JW; Cifaldi MA; Signorovitch J; Wu EQ; Samuelson T; Faust E; Emery P<\/span> (2012)<\/span> Differences in Short-Term Radiographic Progression Following Early Response to Adalimumab Plus Methotrexate Vs. Methotrexate Alone<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S160-S161<\/span>.<\/p>","publicationid":"236828","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Baker J; Ostergaard M; Emery P; Hsia EC; Lu JD; Baker D; Conaghan PG<\/span> (2012)<\/span> Early Magnetic Resonance Imaging Measures Independently Predict 1- and 2-Year X-Ray Progression: Results From a Large Clinical Trial<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S692-S693<\/span>.<\/p>","publicationid":"236825","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Cuomo G; Buch MH; Rosenberg WM; Valentini G; Emery P; Del Galdo F<\/span> (2012)<\/span> Sub-Analysis of ELF Score Biomarkers Components Indicates a Specific Correlation with Different Organ Involvement in Systemic Sclerosis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S632-S633<\/span>.<\/p>","publicationid":"236824","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Cohen SB; Emery P; Kremer JM; Dougados MR; Loveless JE; Chung C; Wong P; Lehane PB; Tyrrell H<\/span> (2012)<\/span> Sustained Efficacy Responses and a Consistent Safety Profile with Rituximab Repeat Treatment Over 5 Years in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumour Necrosis Factor Inhibitors<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S548<\/span>.<\/p>","publicationid":"236819","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fleischmann R; van Vollenhoven RF; Smolen JS; Emery P; Florentinus S; Rathmann SS; Kupper H; Kavanaugh A<\/span> (2012)<\/span> Long-Term Outcomes of Early Rheumatoid Arthritis Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatment Approach<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S335-S336<\/span>.<\/p>","publicationid":"236817","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Hamoudeh M; FitzGerald OM; Combe B; Gaylord S; Williams T; Bukowski J; Pedersen R; Koenig AS; Vlahos B<\/span> (2012)<\/span> Induction of Remission in Patients with up to 12 Months of Moderate-to-Severe Rheumatoid Arthritis Symptoms Treated with Etanercept Plus Methotrexate Over 52 Weeks<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S1077<\/span>.<\/p>","publicationid":"236815","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Peterfy CG; Emery P; Genovese MC; Keystone E; Taylor P; Berclaz P-Y; DiCarlo JC; Lee CH; Schlichting DE; Beattie SD; Luchi ME; Macias W<\/span> (2012)<\/span> Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1\/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S1050-S1051<\/span>.<\/p>","publicationid":"236812","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Horton SC; Pickles D; Emery P; Buch MH; Freeston JE<\/span> (2012)<\/span> Efficacy of Methotrexate (MTX) According to Anti-Citrullinated Protein Antibody (ACPA) Status in an Early Inflammatory Arthritis Cohort<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S159<\/span>.<\/p>","publicationid":"236811","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

El-Sherbiny Y; Churchman S; Ponchel F; Emery P; Vital EM<\/span> (2012)<\/span> Synovial Gene Expression and Response to Rituximab: Preliminary Data<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S755-S756<\/span>.<\/p>","publicationid":"236810","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kavanaugh A; Emery P; van Vollenhoven RF; Dikranian AH; Alten R; Klearman M; Musselman D; Agarwal S; Green J; Gabay C<\/span> (2012)<\/span> Tocilizumab Monotherapy Compared with Adalimumab Monotherapy in Patients with Rheumatoid Arthritis: Results of a 24-Week Study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S333-S334<\/span>.<\/p>","publicationid":"236808","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Han C; Keystone E; Fleischmann R; Smolen JS; Emery P; Genovese MC; Doyle MK; Hsia EC<\/span> (2012)<\/span> Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Against Rheumatism: Patient Reported Outcomes Analyzed From 3 Phase III Golimumab Trials<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S35-S36<\/span>.<\/p>","publicationid":"236807","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kavanaugh A; van Vollenhoven RF; Emery P; Shaw JW; Cifaldi MA; Florentinus S; Smolen JS<\/span> (2012)<\/span> Patient-Reported Outcomes in Early Rheumatoid Arthritis Patients Failing to Achieve Stable Low Disease Activity: Comparing Addition of Adalimumab to Methotrexate Monotherapy with Maintenance On Adalimumab Plus Methotrexate<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S162-S163<\/span>.<\/p>","publicationid":"236806","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Strand V; Koenig AS; Pedersen R; Bananis E<\/span> (2012)<\/span> Structural Damage Is Reduced by Early Achievement of Clinical Remission<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S437<\/span>.<\/p>","publicationid":"236804","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Aydin SZ; Castillo-Gallego CJ; Woods D; Meekings A; McGonagle D; Emery P; Del Galdo F<\/span> (2012)<\/span> Optical Density Measure of the Papillary Dermis Discriminates As Abnormal Clinically Uninvolved Skin in Systemic Sclerosis and Correlates with Severity of Skin Thickness<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S304-S305<\/span>.<\/p>","publicationid":"236803","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Baeten DL; Bek S; Wei J; Brachat A; Sieper J; Emery P; Braun J; van der Heijde D; McInnes IB; van Laar JM; Landewe R; Wordsworth P; Wollenhaupt J; Kellner H; Paramarta JE; Bertolino A; Wright A; Wolfgang H<\/span> (2012)<\/span> Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions in Acute Phase Markers and Inflammatory Markers S100A8 and A9 (Calgranulin A and B)<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S942<\/span>.<\/p>","publicationid":"236799","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; Fleischmann R; Emery P; van Vollenhoven RF; Florentinus S; Faccin F; Rathmann SS; Kupper H; Kavanaugh A<\/span> (2012)<\/span> Functional Disability in Early Rheumatoid Arthritis - Contributions of Disease Activity and Structural Damage, and the Impact of Different Treatment Strategies<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S212-S213<\/span>.<\/p>","publicationid":"236797","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Rubbert-Roth A; Finckh A; Sarzi-Puttini P; Gottenberg J-E; Choquette D; Martinez Taboada V; Barile-Fabris L; Chung C; Hinsch-Gylvin L; Emery P<\/span> (2012)<\/span> Seropositive Rheumatoid Arthritis Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors Achieve Improved Clinical Effectiveness After Switching to Rituximab Versus Switching to an Alternative Tumor Necrosis Factor Inhibitor<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S203<\/span>.<\/p>","publicationid":"236793","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gillespie J; Emery P; Del Galdo F<\/span> (2012)<\/span> Secreted Frizzled-Related Protein 4 Induces a Profibrotic Phenotype in Systemic Sclerosis Fibroblasts by Activating a Non-Canonical WNT Signaling Pathway<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S972-S973<\/span>.<\/p>","publicationid":"236789","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham COIII; Keystone E; Fleischmann RM; Furst DE; Tyson N; Mehbob A; Lehane PB<\/span> (2012)<\/span> Long-Term Safety of Rituximab: 10-Year Follow-up in the Rheumatoid Arthritis Global Clinical Trial Program<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S199<\/span>.<\/p>","publicationid":"236787","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Wiland P; Spieler W; Dudler J; Gaylord S; Williams T; Pedersen R; Koenig AS; Vlahos B; Kotak S<\/span> (2012)<\/span> Impact of Etanercept-Methotrexate Therapy On Patient-Reported Outcomes in Rheumatoid Arthritis Patients with up to 12 Months of Symptoms<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S160<\/span>.<\/p>","publicationid":"236786","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Finckh A; Gottenberg J-E; Mpofu C; Bensen WG; Rubbert-Roth A; Irazoque F; Martinez Taboada V; Chung C; Hinsch-Gylvin L; Ferri C; Emery P<\/span> (2012)<\/span> Factors Influencing Choice of Rituximab Versus an Alternative Tumor Necrosis Factor Inhibitor Following Tumor Necrosis Factor Inhibitor Failure in Patients with Rheumatoid Arthritis: Sub-Analysis of a Global, Observational Comparative Effectiveness Study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S198<\/span>.<\/p>","publicationid":"236785","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Baraliakos X; Braun J; Laurent DD; Baeten D; van der Heijde D; Sieper J; Emery P; McInnes IB; van Laar J; Landewe R; Wordsworth P; Wollenhaupt J; Kellner H; Wright A; Vandenhende F; Radford K; Borah B; Wolfgang H<\/span> (2012)<\/span> Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S250-S251<\/span>.<\/p>","publicationid":"236782","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Sharif MI; Das S; Emery P; MacIver H; Shingler W; Helliwell PS; Sokoll K; Vital EM<\/span> (2012)<\/span> Dose Reduction in Rituximab Retreatment May Delay Achievement of Optimal Responses<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S206-S207<\/span>.<\/p>","publicationid":"236773","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kavanaugh A; Purcaru O; Smolen J; Emery P; Strand V; Keystone E; van Vollenhoven R; Syrotuik J<\/span> (2012)<\/span> Baseline Tender Joint Count Scores Predict Long-term Household Productivity in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol Plus Methotrexate<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1715<\/span>.<\/p>","publicationid":"220532","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Peterfy C; Haraoui B; Kavanaugh A; Smolen J; Santra S; Kupper H; Emery P<\/span> (2012)<\/span> Baseline Levels of the Inflammatory Biomarker CRP are Significantly Correlated with MRI Measures of Synovitis at Baseline and after 26 Weeks of Treatment in Patients with Early Rheumatoid Arthritis<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1741<\/span>.<\/p>","publicationid":"220528","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Sarzi-Puttini P; Moots RJ; Andrianakos A; Sheeran TP; Choquette D; Finckh A; Desjuzeur M-L; Gemmen EK; Mpofu C; Gottenberg J-E<\/span> (2012)<\/span> RELATIVE EFFICACY OF RITUXIMAB VERSUS AN ALTERNATIVE TNF INHIBITOR IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO A SINGLE PREVIOUS TNF INHIBITOR: INTERIM RESULTS FROM SWITCH-RA, A GLOBAL, COMPARATIVE-EFFECTIVENESS, OBSERVATIONAL STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 130-131<\/span>.<\/p>","publicationid":"211841","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vila J; Mitchell S; Bowman S; Price E; Pease CT; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; Hunter J; Gupta M; McLaren J; Regan M; Cooper A; Giles I; Isenberg D; Vadivelu S; Coady D; Griffiths B; Lendrem D; Foggo H; Tarn J; Ng W-F<\/span> (2012)<\/span> THE CLINICAL RELEVANCE OF ANTI-RO52 AND ANTI-RO60 IN PATIENTS IN THE UNITED KINGDOM PRIMARY SJOGREN'S SYNDROME REGISTRY (UKPSSR)<\/span>. RHEUMATOLOGY<\/span>, pp. 35<\/span>.<\/p>","publicationid":"211839","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Aydin S; Castillo-Gallego C; Woods D; Meekings A; McGonagle D; Emery P; Del Galdo F<\/span> (2012)<\/span> OPTICAL COHERENCE TOMOGRAPHY VALIDATION: A NEW QUANTITATIVE IMAGING BIOMARKER FOR AFFECTED SKIN IN SCLERODERMA<\/span>. RHEUMATOLOGY<\/span>, pp. 35<\/span>.<\/p>","publicationid":"211835","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Weinblatt ME; Fleischmann R; van Vollenhoven R; Emery P; Huizinga TWJ; Goldermann R; Duncan B; Timoshanko J; Luijtens K; Davies O; Dougados M<\/span> (2012)<\/span> CERTOLIZUMAB PEGOL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ALIGNED WITH NICE GUIDANCE FOR ANTI-TNF THERAPY: POST-HOC ANALYSES OF THE REALISTIC PHASE IIIB RANDOMIZED CONTROLLED STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 125-126<\/span>.<\/p>","publicationid":"211833","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

McInnes I; Sieper J; Braun J; Emery P; van der Heijde D; Isaacs J; Dahmen G; Wollenhaupt J; Schulze-Koops H; Gsteiger S; Bertolino A; Hueber W; Tak PP<\/span> (2012)<\/span> EFFECT OF SECUKINUMAB ON SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS OF A 24-WEEK MULTICENTRE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL<\/span>. RHEUMATOLOGY<\/span>, pp. 90-91<\/span>.<\/p>","publicationid":"211832","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Fleischmann R; Han C; van der Heijde D; Conaghan P; Xu W; Hsia E<\/span> (2012)<\/span> PREDICTORS OF RADIOGRAPHIC PROGRESSION IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON ONE-YEAR RADIOGRAPHIC DATA FROM THE GO-BEFORE GOLIMUMAB CLINICAL TRIAL<\/span>. RHEUMATOLOGY<\/span>, pp. 68-69<\/span>.<\/p>","publicationid":"211830","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Lendrem D; Mitchell S; Bowman S; Price E; Pease CT; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; Hunter J; Gupta M; McLaren J; Regan M; Cooper A; Giles I; Isenberg D; Vadivelu S; Coady D; McHugh N; Griffiths B; Foggo H; Edgar S; Ng W-F<\/span> (2012)<\/span> HOW GOOD ARE THE EULAR SJOGREN'S SYNDROME DISEASE ACTIVITY INDEX, AND EULAR SJOGREN'S SYNDROME PATIENTS REPORTED INDEX IN PREDICTING HEALTH STATUS IN PRIMARY SJOGREN'S SYNDROME?<\/span> RHEUMATOLOGY<\/span>, pp. 176<\/span>.<\/p>","publicationid":"211828","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Cuomo G; Buch MH; Rosenberg WM; Valentini G; Emery P; Del Galdo F<\/span> (2012)<\/span> ELF SCORE: A VALIDATED SERUM TEST STRONGLY PREDICTIVE OF FIBROSIS IN SYSTEMIC SCLEROSIS<\/span>. RHEUMATOLOGY<\/span>, pp. 84<\/span>.<\/p>","publicationid":"211827","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston J; Conaghan P; Grainger A; O'Connor PJ; Evans R; Emery P; Hodgson R<\/span> (2012)<\/span> USEFULNESS OF NOVEL WHOLE BODY MULTIPLE JOINT MRI IMAGING IN ESTABLISHING ACCURATE AND TIMELY DIAGNOSES IN PATIENTS PRESENTING WITH INFLAMMATORY ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 68<\/span>.<\/p>","publicationid":"211824","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Baeten D; Sieper J; Braun J; van der Heijde D; McInnes I; Van Laar J; Landewe R; Wordsworth BP; Wollenhaupt J; Kellner H; Paramarta I; Bertolino A; Wright AM; Hueber W<\/span> (2012)<\/span> EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 21<\/span>.<\/p>","publicationid":"211818","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Zayat AS; Conaghan P; Freeston J; Hensor E; Ellegard K; Terslev L; Emery P; Wakefield RJ<\/span> (2012)<\/span> ULTRASOUND DETECTED BONE EROSIONS: ARE THEY SPECIFIC FOR RHEUMATOID ARTHRITIS?<\/span> RHEUMATOLOGY<\/span>, pp. 69<\/span>.<\/p>","publicationid":"211815","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kavanaugh A; Emery P; Fleischmann R; van Vollenhoven R; Pavelka K; Durez P; Guerette B; Santra S; Redden L; Kupper H; Smolen JS<\/span> (2012)<\/span> WITHDRAWAL OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS PATIENTS WHO ATTAINED STABLE LOW DISEASE ACTIVITY WITH ADALIMUMAB PLUS METHOTREXATE: RESULTS OF A PHASE 4, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL<\/span>. RHEUMATOLOGY<\/span>, pp. 29-30<\/span>.<\/p>","publicationid":"211814","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Lendrem D; Mitchell S; Bowman S; Price E; Pease CT; Emery P; Andrews J; Bombardieri M; Sutcliffe N; Pitzalis C; Lanyon P; Hunter J; Gupta M; McLaren J; Regan M; Cooper A; Giles I; Isenberg D; Griffiths B; Foggo H; Edgar S; Vadivelu S; Coady D; McHugh N; Ng W-F<\/span> (2012)<\/span> EVALUATING HEALTH STATUS OF 620 PATIENTS WITH PRIMARY SJOGREN'S SYNDROME USING EQ-5D<\/span>. RHEUMATOLOGY<\/span>, pp. 171<\/span>.<\/p>","publicationid":"211813","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P<\/span> (2012)<\/span> CONDUCTING CLINICAL TRIALS IN RHEUMATOID ARTHRITIS: PRACTICALITIES AND POTENTIAL PITFALLS<\/span>. RHEUMATOLOGY<\/span>, pp. 1-2<\/span>.<\/p>","publicationid":"211812","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Van Laar J; Baraliakos X; Braun J; Laurent DD; Baeten D; van der Heijde D; Sieper J; Emery P; McInnes I; Landewe R; Wordsworth BP; Wollenhaupt J; Kellner H; Wright AM; Gsteiger S; Hueber W<\/span> (2012)<\/span> EARLY EFFECT OF SECUKINUMAB IN REDUCING SPINAL INFLAMMATION AS DETECTED BY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ANKYLOSING SPONDYLITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 23-24<\/span>.<\/p>","publicationid":"211810","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; Fleischmann RM; Emery P; van Vollenhoven RF; Guerette B; Santra S; Kupper H; Redden L; Kavanaugh A<\/span> (2012)<\/span> TREATING RHEUMATOID ARTHRITIS TO TARGET: OUTCOMES AND PREDICTORS IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR METHOTREXATE PLUS SUBSEQUENT ADALIMUMAB<\/span>. RHEUMATOLOGY<\/span>, pp. 114-115<\/span>.<\/p>","publicationid":"211809","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Smolen JS; Samborski W; Berenbaum F; Davies O; Ambrugeat J; Bennett B; Burkhardt H<\/span> (2012)<\/span> EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL AFTER INCOMPLETE RESPONSE TO DMARDS IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW MODERATE DISEASE ACTIVITY: RESULTS FROM CERTAIN, A PHASE IIIB STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 134<\/span>.<\/p>","publicationid":"211781","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Backhouse MR; Vinall KA; Redmond A; Helliwell P; Keenan A-M<\/span> (2012)<\/span> COMPLEX REASONING DETERMINES PATIENTS' PERCEPTION OF OUTCOME FOLLOWING FOOT SURGERY IN RHEUMATOID ARHTRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 52<\/span>. <\/a><\/p>","publicationid":"211777","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Scott N; Emery P; Buch M; Del Galdo F<\/span> (2012)<\/span> ALLOGRAFT INFLAMMATORY FACTOR-1 AND CAVEOLIN-1 COLONIC EXPRESSION IN COLLAGENOUS COLITIS ASSOCIATED WITH SSc<\/span>. RHEUMATOLOGY<\/span>, pp. 44<\/span>.<\/p>","publicationid":"210523","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Aydin S; Castillo-Gallego C; Meekings A; Woods D; Mcgoonagle D; Emery P; Del Galdo F<\/span> (2012)<\/span> OPTICAL COHERENCE TOMOGRAPHY VALIDATION: A NEW QUANTITATIVE IMAGING BIOMARKER FOR AFFECTED SKIN IN SCLERODERMA<\/span>. RHEUMATOLOGY<\/span>, pp. 114<\/span>.<\/p>","publicationid":"210522","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Hevans HL; Emery P; Del Galdo F; Buch M<\/span> (2012)<\/span> CANCER IN SSc: A SINGLE-CENTRE COHORT REPORT<\/span>. RHEUMATOLOGY<\/span>, pp. 114-115<\/span>.<\/p>","publicationid":"210520","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Del Galdo F; Emery P; Buch M<\/span> (2012)<\/span> EXTENDED COURSE CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE PULSE THERAPY CAN STABILIZE INITIALLY REFRACTORY INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SSc: A SINGLE-CENTRE EXPERIENCE<\/span>. RHEUMATOLOGY<\/span>, pp. 114<\/span>.<\/p>","publicationid":"210519","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Cuomo G; Buch M; Rosenberg WM; Valentini G; Emery P; Del Galdo F<\/span> (2012)<\/span> ELF SCORE: A VALIDATED SERUM TEST STRONGLY PREDICTIVE OF FIBROSIS IN SSc<\/span>. RHEUMATOLOGY<\/span>, pp. 14<\/span>.<\/p>","publicationid":"210513","date":"2012-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Arumugakani G; Rawstron A; Tooze R; Emery P; McGonagle D<\/span> (2011)<\/span> The Levels of Memory B-Cells with a Plasmablast-Like Phenotype Are Associated with Response to Anti-CD20 Treatment in Rheumatoid Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S681<\/span>.<\/p>","publicationid":"165333","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen J; Fleischmann RM; Emery P; van Vollenhoven RF; Guerette B; Santra S; Kupper H; Redden L; Wolfe B; Kavanaugh A<\/span> (2011)<\/span> Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S665<\/span>.<\/p>","publicationid":"165328","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Villeneuve E; Nam JL; Hensor E; Wakefield RJ; Conaghan PG; Green MJ; Gough AK; Quinn M; Reece RJ; Cox SR; Emery P<\/span> (2011)<\/span> Preliminary Results of a Multicentre Randomised Controlled Trial of Etanercept and Methotrexate to Induce Remission in Patients with Newly Diagnosed Inflammatory Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S960-S961<\/span>.<\/p>","publicationid":"165325","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Baraliakos X; Braun J; Laurent DD; Baeten D; van der Heijde D; Sieper J; Emery P; McInnes I; van Laar J; Landewe R; Wordsworth P; Wollenhaupt J; Kellner H; Wright AM; Gsteiger S; Hueber W<\/span> (2011)<\/span> Interleukin-17A Blockade with Secukinumab Reduces Spinal Inflammation in Patients with Ankylosing Spondylitis As Early As Week 6, As Detected by Magnetic Resonance Imaging<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S972<\/span>.<\/p>","publicationid":"165323","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone E; Fleischmann RM; Genovese MC; Klareskog L; Xu S; Han C; Hsia EC<\/span> (2011)<\/span> New, Provisional American College of Rheumatology and European League Against Rheumatism Remission Criteria: Results From 2 Randomized, Controlled Golimumab Trials in Patients with Rheumatoid Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S874<\/span>.<\/p>","publicationid":"165321","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Cohen SB; Emery P; Kremer JM; Dougados M; Loveless JE; Chung C; Lehane PB; Tyrrell H<\/span> (2011)<\/span> Sustained Inhibition of Structural Damage in Patients with Rheumatoid Arthritis and An Inadequate Response to Tumor Necrosis Factor Inhibitors Prior to Rituximab Treatment: 5-Year Data From the REFLEX Study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S861-S862<\/span>.<\/p>","publicationid":"165320","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen J; Emery P; Ferraccioli G; Berenbaum F; Davies O; Purcaru O; Ambrugeat J; Bennett B; Burkhardt H<\/span> (2011)<\/span> Efficacy, Safety, and Improvements in Work Productivity and Daily Activities with Certolizumab Pegol After Incomplete Response to Disease-Modifying Anti-Rheumatic Drugs in Patients with Low to Moderate Disease Activity<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S864-S865<\/span>.<\/p>","publicationid":"165318","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ash ZR; Tinazzi I; Castillo-Gallego C; Kwok C; Wilson C; Goodfield M; Gisondi P; Tan AL; Marzo-Ortega H; Wakefield RJ; Emery P; Aydin S; McGonagle D<\/span> (2011)<\/span> Nail Disease in Psoriasis Is Associated with Sonographically Determined Systemic Subclinical Enthesopathy<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S973<\/span>.<\/p>","publicationid":"165313","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone E; Fleischmann RM; Furst DE; Tyson N; Collinson N; Lehane PB<\/span> (2011)<\/span> Long-Term Safety of Rituximab in Rheumatoid Arthritis: Pooled Analysis of Patients in Clinical Trials with up to 9.5 Years of Treatment<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S857<\/span>.<\/p>","publicationid":"165312","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; Tanner S; Waller M; Hensor E; Burns A; Jeavons A; Bury R; Emery P; McGonagle D<\/span> (2011)<\/span> Regional Differences in Bone Metabolism in the DIP Joint in Psoriatic Arthritis Compared to Osteoarthritis Support the Concept of An Integrated Bone-Enthesis Nail Apparatus-A High-Resolution 18<\/SUP>F-fluoride Positron Emission Tomography<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S667<\/span>.<\/p>","publicationid":"165311","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Das S; Vital EM; Dass S; Buch MH; Rawstron A; Emery P<\/span> (2011)<\/span> B Cell Biomarkers Allow Prediction of Improving Response on Repeat Cycles of rituximab<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S881<\/span>.<\/p>","publicationid":"165307","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kavanaugh A; Emery P; Fleischmann R; van Vollenhoven RF; Pavelka K; Durez P; Guerette B; Santra S; Redden L; Kupper H; Peterson T; Smolen J<\/span> (2011)<\/span> Withdrawal of Adalimumab in Early Rheumatoid Arthritis Patients Who Attained Stable Low Disease Activity with Adalimumab Plus Methotrexate: Results of a Phase 4, Double-Blind, Placebo-Controlled Trial<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S665-S666<\/span>.<\/p>","publicationid":"165301","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Das S; Dass S; Buch MH; Ponchel F; Rawstron A; Emery P<\/span> (2011)<\/span> B Cell Repopulation and Rheumatoid Factor Predict Duration of Response to Rituximab in Rheumatoid Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S642<\/span>.<\/p>","publicationid":"165291","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Huizinga TWJ; Emery P; Westhovens R; Le Bars M; Gaillez C; Poncet C; Elegbe A; Smolen JS<\/span> (2011)<\/span> Rate of Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Seroconversion in Patients with Undifferentiated Arthritis or Early Rheumatoid Arthritis Treated with Abatacept<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S872-S873<\/span>.<\/p>","publicationid":"165290","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Kavanaugh AF; Smolen J; Cifaldi MA; Chaves L; Guerette B; Arora V; van Vollenhoven RF<\/span> (2011)<\/span> Combination Therapy with Adalimumab plus Methotrexate Significantly Improved Work Ability, Physical Function, Fatigue, and Other Patient-Reported Outcomes in Early Rheumatoid Arthritis: Results From a 26-Week Analysis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S853<\/span>.<\/p>","publicationid":"165288","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Aydin S; Buch MH; Horton S; Ikeda K; Iagnocco A; Gutierrez M; Grassi W; Naredo E; De Miguel E; Terslev L; Backhaus M; D'Agostino M-A; Batticciotto A; Karim Z; Wakefield RJ; Emery P<\/span> (2011)<\/span> Application of Ultrasound to Treat to Target Management of Rheumatoid Arthritis - Multicentre International Observational Experience<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S834-S835<\/span>.<\/p>","publicationid":"165287","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Nam JL; Villeneuve E; Das S; McGonagle D; Hodgson R; Grainger A; Wakefield RJ; Conaghan PG; Emery P<\/span> (2011)<\/span> MRI Synovitis Is Prevalent in ACPA Positive Patients with Musculoskeletal Symptoms<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S370<\/span>.<\/p>","publicationid":"165284","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kavanaugh A; Purcaru O; Smolen J; Emery P; Strand V; Keystone E; van Vollenhoven RF<\/span> (2011)<\/span> Baseline Tender Joint Count Scores Predict Long-Term Household Productivity in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol Plus Methotrexate<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S486-S487<\/span>.<\/p>","publicationid":"165283","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Nam JL; Villeneuve E; Conaghan PG; Hensor E; Keen HI; Amarasena R; Gough AK; Helliwell P; Morgan AW; Quinn M; Green MJ; Reece R; Wakefield R; Emery P<\/span> (2011)<\/span> A Preliminary Report of Remission Induction with Two Therapeutic Strategies with Infliximab or High Dose Intravenous Steroids for the Treatment of Rheumatoid Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S177-S178<\/span>.<\/p>","publicationid":"165280","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Peterfy CG; Haraoui B; Kavanaugh A; Smolen JS; Santra S; Kupper H; Nicholson TF; Emery P<\/span> (2011)<\/span> Baseline Levels of the Inflammatory Biomarker C-Reactive Protein Are Significantly Correlated with Magnetic Resonance Imaging Measures of Synovitis At Baseline and After 26 Weeks of Treatment in Patients with Early Rheumatoid Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S629-S630<\/span>.<\/p>","publicationid":"165269","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Poole CD; Emery P; Young A; Porter D; Morgan CL; Walker H; Currie CJ; Reynolds A<\/span> (2011)<\/span> Safety and Efficacy of Etanercept Over Five Years in a Large, UK Observational Cohort<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S481-S482<\/span>.<\/p>","publicationid":"165264","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Castillo-Gallego C; Aydin S; Ash ZR; Abignano G; Emery P; Marzo-Ortega H; Del Galdo F; McGonagle D<\/span> (2011)<\/span> A Comparison of Optical Coherence Tomography and Clinical Assessment of Nail Disease in Psoriasis and Psoriatic Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S74<\/span>.<\/p>","publicationid":"165260","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Sarzi-Puttini P; Moots RJ; Andrianakos AA; Sheeran TP; Choquette D; Finckh A; Desjuzeur M-L; Gemmen E; Mpofu C; Gottenberg J-E<\/span> (2011)<\/span> Relative Effectiveness of Rituximab and An Alternative TNF Inhibitor in Patients with Rheumatoid Arthritis and An Inadequate Response to a Single Previous TNF Inhibitor: Interim Results From Switch-Rheumatoid Arthritis a Global Comparative-Effectiveness Observational Study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S45<\/span>.<\/p>","publicationid":"165253","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ash ZR; Barkham N; McGonagle D; Hensor E; Emery P; Marzo-Ortega H<\/span> (2011)<\/span> Long Term Results of a Remission Induction Approach to Early Axial Spondyloarthritis: Still Looking for the Window of Opportunity<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S503<\/span>.<\/p>","publicationid":"165252","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Aydin S; Castillo-Gallego CJ; Buch MH; Emery P; Del Galdo F<\/span> (2011)<\/span> Optical Coherence Tomography: A New Imaging Technique That Allows Detailed Visualization of Affected Scleroderma Skin<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S273-S274<\/span>.<\/p>","publicationid":"165247","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Hsia EC; Xu S; Xu W; Baker DG<\/span> (2011)<\/span> Golimumab's Efficacy in Patients with Very Active Disease in Methotrexate-naive Rheumatoid Arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S470-S471<\/span>.<\/p>","publicationid":"165245","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Gallo G; Morgan CL; Currie CJ; Poole CD; Nab H<\/span> (2011)<\/span> Evaluation of the Association Between Disease Activity and Risk of Serious Infections in Subjects with Rheumatoid Arthritis When Treated with Etanercept or Disease -modifying Anti-rheumatic Drugs<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S163<\/span>.<\/p>","publicationid":"165243","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

McInnes I; Sieper J; Braun J; Emery P; van der Heijde D; Isaacs J; Dahmen G; Wollenhaupt J; Schulze-Koops H; Gsteiger S; Bertolino A; Hueber W; Tak PP<\/span> (2011)<\/span> Anti-Interleukin 17A Monoclonal Antibody Secukinumab Reduces Signs and Symptoms of Psoriatic Arthritis in a 24-Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S306<\/span>.<\/p>","publicationid":"165242","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Cuomo G; Buch MH; Rosenberg WM; Valentini G; Emery P; Del Galdo F<\/span> (2011)<\/span> ELF Score: A Validated Serum Test Strongly Predictive of Fibrosis in Systemic Sclerosis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S273<\/span>.<\/p>","publicationid":"165241","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Weinblatt M; Fleischmann RM; van Vollenhoven RF; Emery P; Huizinga TWJ; Cutolo M; Goldermann R; Duncan B; Davies O; Dougados M<\/span> (2011)<\/span> Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients with Active Rheumatoid Arthritis: Week 28 Results From a Phase IIIb Randomized Controlled Study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S490-S491<\/span>.<\/p>","publicationid":"165236","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Evans HL; Emery P; Del Galdo F; Buch MH<\/span> (2011)<\/span> Cancer in Systemic Sclerosis: Results From a Single Centre Cohort Report<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S259<\/span>.<\/p>","publicationid":"165234","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ash Z; Tinazzi I; Castillo-Gallego C; Kwok C; Wilson C; Goodfield M; Gisondi P; Tan AL; Marzo-Ortega H; Emery P; Wakefield R; McGonagle D; Aydin S<\/span> (2011)<\/span> Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than psoriasis cases with normal nails: a novel explanation for why nail disease predicts arthropathy<\/span>. BRITISH JOURNAL OF DERMATOLOGY<\/span>, pp. E4<\/span>.<\/p>","publicationid":"165208","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Aydin S; Ash Z; Tinazzi I; Castillo-Gallego C; Kwok C; Wilson C; Goodfield M; Gisondi P; Tan AL; Marzo-Ortega H; Emery P; Wakefield R; McGonagle D<\/span> (2011)<\/span> The path from psoriasis to psoriatic arthritis: a switch to a vascular phenotype at sites of subclinical enthesopathy could be relevant in the dermatological setting to predict psoriatic arthritis development<\/span>. BRITISH JOURNAL OF DERMATOLOGY<\/span>, pp. E26-E27<\/span>.<\/p>","publicationid":"165193","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Arumugakani G; Tooze R; Vital E; McGonagle D; Rawstron A; Emery P<\/span> (2011)<\/span> IDENTIFICATION OF THE PHENOTYPE OF REPOPULATING B-CELLS ASSOCIATED WITH DISEASE RELAPSE FOLLOWING B-CELL DEPLETION THERAPY IN PATIENTS WITH AUTOIMMUNE DISORDERS<\/span>. CYTOMETRY PART B-CLINICAL CYTOMETRY<\/span>, pp. 401<\/span>.<\/p>","publicationid":"156750","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven R; Blocka K; Emery P; Bingham C; Keystone E; Fleischmann R; Furst D; Macey K; Sweetser M; Lehane P; Farmer P; Long S<\/span> (2011)<\/span> Long-Term Safety of Rituximab (RTX): Rheumatoid Arthritis (RA) Clinical Trials and Retreatment Population<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1183<\/span>.<\/p>","publicationid":"146559","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese M; Cividino A; Keystone E; Breedveld F; Emery P; Cohen S; Matteson E; Burke L; Chai A; Reiss W; Sweetser M; Shaw T<\/span> (2011)<\/span> Assessing the Rate of Serious Infections in Rheumatoid Arthritis (RA) Patients who Receive Other Biologic Therapies after Discontinuing Rituximab (RTX)<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1165<\/span>.<\/p>","publicationid":"146558","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Olszynski W; Mease P; Rubbert-Roth A; Curtis J; Mueller-Ladner U; Gaylis N; Williams S; Tyrell H; Reynard M<\/span> (2011)<\/span> Treatment to Target: Retreatment with Rituximab (RTX) Provides Better Disease Control than Treatment as Needed in Patients with Rheumatoid Arthritis (RA)<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1164-1165<\/span>.<\/p>","publicationid":"146557","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Aziz AM; Dickie LJ; Emery P; Savic S; McDermott MF<\/span> (2011)<\/span> FUNCTIONAL CONSEQUENCES OF MUTATIONS IN TNFRSF1A, COMPARISON OF IN VITRO CELLULAR EVENTS TO FINDINGS FROM TISSUE SAMPLES ISOLATED FROM PATIENTS WITH TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME (TRAPS)<\/span>. ADVANCES IN TNF FAMILY RESEARCH<\/span>, pp. 785<\/span>.<\/p>","publicationid":"143869","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coulthard LR; Mathews RJ; Church LD; Cooper D; Wong C; Bryer D; Buch M; Emery P; Morgan AW; McDermott MF<\/span> (2011)<\/span> EFFECT OF INFLIXIMAB TREATMENT ON CIRCULATING MONOCYTES IN RHEUMATOID ARTHRITIS PATIENTS: DIFFERENCES BETWEEN EARLY AND LATE DISEASE<\/span>. ADVANCES IN TNF FAMILY RESEARCH<\/span>, pp. 786-787<\/span>.<\/p>","publicationid":"143494","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Parmar R; Nam J; Villeneuve E; Corscadden D; Henshaw K; Emery P<\/span> (2011)<\/span> NAIVE T CELLS PREDICT MTX INDUCED REMISSION IN EARLY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A9-A10<\/span>. <\/a><\/p>","publicationid":"139398","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Parmar R; Nam J; Villeneuve E; Corscadden D; Henshaw K; Emery P<\/span> (2011)<\/span> NAIVE T CELL REDUCTION IS A PREDICTOR OF EVOLUTION TOWARDS RA IN PATIENTS WITH <12 MONTHS INFLAMMATORY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A6-A7<\/span>. <\/a><\/p>","publicationid":"139397","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Parmar R; Nam J; Villeneuve E; Corscadden D; Henshaw K; Emery P<\/span> (2011)<\/span> REDUCTION OF NAIVE T CELL FREQUENCY AND IL-7 PREDICT THE EVOLUTION OF ACPA-POSITIVE INDIVIDUALS WITH ARTHRALGIA TOWARDS UA AND RA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A3<\/span>. <\/a><\/p>","publicationid":"139396","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Goeeb V; Aegerter P; Villeneuve E; Nam J; Conaghan PG; Fardellone P; Le Loeet X; Emery P; Vittecoq O; Ponchel F<\/span> (2011)<\/span> REDUCED IL-7 SERUM TITRES ARE ASSOCIATED WITH PROGRESSION TOWARDS RHEUMATOID ARTHRITIS IN LESS THAN 6 MONTHS INFLAMMATORY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A2<\/span>. <\/a><\/p>","publicationid":"139395","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Conaghan P; Emery P; Green M; Ibrahim G; MakIver H; Helliwell PS<\/span> (2011)<\/span> INVESTIGATING THE USE OF THE CASPAR CRITERIA IN EARLY PSORIATIC ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 144<\/span>.<\/p>","publicationid":"139380","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Conaghan P; Emery P; Green M; Ibrahim G; MakIver H; Helliwell P<\/span> (2011)<\/span> INVESTIGATING THE USE OF THE NEW RA CLASSIFICATION CRITERIA IN PSORIATIC ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 140<\/span>.<\/p>","publicationid":"139379","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven R; Emery P; Bingham CIII; Keystone E; Fleischmann RM; Furst DE; Macey KM; Sweetser MT; Lehane P; Farmer P; Long SG<\/span> (2011)<\/span> LONG-TERM SAFETY OF RITUXIMAB: FOLLOW UP OF THE RHEUMATOID ARTHRITIS CLINICAL TRIALS<\/span>. RHEUMATOLOGY<\/span>, pp. 127-128<\/span>.<\/p>","publicationid":"139378","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese MC; Breedveld FC; Emery P; Cohen SB; Keystone E; Matteson EL; Burke L; Chai A; Reiss W; Sweetser M; Shaw T<\/span> (2011)<\/span> SAFETY OF SUBSEQUENT BIOLOGIC THERAPY IN RA PATIENTS WHO DISCONTINUED RITUXIMAB<\/span>. RHEUMATOLOGY<\/span>, pp. 126<\/span>.<\/p>","publicationid":"139377","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Haraoui B; Emery P; Mozaffarian N; Guerette B; Kupper H; Patra K; Keystone E<\/span> (2011)<\/span> CHANGE IN CRP AT 12 WEEKS PREDICTS THE RISK OF RAPID RADIOGRAPHIC PROGRESSION AT TWO YEARS IN METHOTREXATE-TREATED PATIENTS WITH EARLY RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 125-126<\/span>.<\/p>","publicationid":"139376","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Fleischmann R; Emery P; Dougados M; Williams S; Reynard M<\/span> (2011)<\/span> SUSTAINED EFFICACY IS ACHIEVED WITH MULTIPLE COURSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS<\/span>. RHEUMATOLOGY<\/span>, pp. 121-122<\/span>.<\/p>","publicationid":"139375","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Atzeni F; Vital EM; Bingham SJ; Buch M; Beirne P; Emery P<\/span> (2011)<\/span> SAFETY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND CONCOMITANT LUNG DISEASE<\/span>. RHEUMATOLOGY<\/span>, pp. 121<\/span>.<\/p>","publicationid":"139374","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Fleischmann R; van der Heijde D; Keystone E; Genovese MC; Conaghan PG; Hsia EC; Xu W; Baratelle A; Beutler A; Rahman MU<\/span> (2011)<\/span> GOLIMUMAB AND RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS: RESULTS OF GO-BEFORE AND GO-FORWARD STUDIES<\/span>. RHEUMATOLOGY<\/span>, pp. 119-120<\/span>.<\/p>","publicationid":"139373","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mariette X; Matucci-Cerinic M; Pavelka K; Taylor P; Vollenhoven RV; Heatley R; Walsh C; Lawson R; Reynolds A; Emery P<\/span> (2011)<\/span> Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: A systematic review and meta-analysis<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. 115<\/span>.<\/p>","publicationid":"139372","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Matteson EL; Genovese M; Sague S; Hsia EC; Doyle MK; Fan H; Elashoff M; Rahman MU<\/span> (2011)<\/span> POST-TREATMENT CHANGES IN SERUM C-REACTIVE PROTEIN LEVELS AND CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 113-114<\/span>.<\/p>","publicationid":"139371","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Backhouse MR; Pickles DA; Mathieson HR; Edgson L; Emery P; Bird H; Helliwell P; Redmond AC<\/span> (2011)<\/span> GAIT VELOCITY EXHIBITS MORE THAN 50% DIURNAL VARIATION IN RHEUMATOID ARTHRITIS: RESULTS OF THE DIVIGN STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. 19<\/span>.<\/p>","publicationid":"139365","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Buch M<\/span> (2011)<\/span> PRACTICAL CLINICAL AND RESEARCH SESSION: BIOLOGICS - ASK THE EXPERTS - AN INTERACTIVE DISCUSSION OF YOUR COMPLEX CASES<\/span>. RHEUMATOLOGY<\/span>, pp. 6<\/span>.<\/p>","publicationid":"139363","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Dass S; Buch MH; Henshaw K; Rawstron AC; Ponchel F; Emery P<\/span> (2011)<\/span> ASSOCIATION BETWEEN CLINICAL RESPONSE AND CIRCULATING B CELL SUBSETS DURING B CELL DEPLETION THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A66-A67<\/span>. <\/a><\/p>","publicationid":"139152","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gillespie J; Tinazzi I; Colato C; Benedetti F; Biasi D; Caramaschi P; Emery P; Del Galdo F<\/span> (2011)<\/span> EPITHELIAL CELLS UNDERGOING EPITHELIAL MESENCHYMAL TRANSITION (EMT) IN SYSTEMIC SCLEROSIS LACK CAVEOLIN-1 AND MODULATE WNT SIGNALING IN THE DERMIS BY SECRETING SFRP4<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A31-A32<\/span>. <\/a><\/p>","publicationid":"139151","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Abignano G; Hermes H; Gillespie J; Jimenez SA; Emery P; Del Galdo F<\/span> (2011)<\/span> MYOFIBROBLAST SPECIFIC GENE EXPRESSION SIGNATURE IN SYSTEMIC SCLEROSIS, MORE THAN TGF-\u03b2 INDUCED ACTIVATION<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A31<\/span>. <\/a><\/p>","publicationid":"139150","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ciurtin C; Majeed Y; Naylor J; Sukumar P; English A; Emery P; Beech D<\/span> (2011)<\/span> PREGNENOLONE SULPHATE IS SIMILAR TO DEXAMETHASONE IN SUPRESSING THE UNFETTERED SECRETION OF HYALURONAN: IN VITRO STUDY ON CULTURED SYNOVIAL FIBROBLASTS FROM PATIENTS WITH LONGSTANDING RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. 50-51<\/span>.<\/p>","publicationid":"139125","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kosfeld H; Leuschner I; Harder J; Mrowietz U; Cuthbert R; Henshaw K; Emery P; Varoga D; Pufe T; Reece R; McGonagle D; Glaeser R<\/span> (2011)<\/span> Differential expression of antimicrobial peptides in synovial tissue of psoriatic arthritis indicating a diverse pathogenetic concept of skin and joint disease?<\/span> EXPERIMENTAL DERMATOLOGY<\/span>, pp. 187-188<\/span>.<\/p>","publicationid":"137723","date":"2011-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; Gomez-Reino JJ; Davies C; Alecock E; Rubbert-Roth A; Emery P<\/span> (2010)<\/span> TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: LONG-TERM EFFICACY FOR UP TO 3.5 YEARS<\/span>. RHEUMATOLOGY<\/span>, pp. I110-I111<\/span>.<\/p>","publicationid":"92308","date":"2010-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone EC; Fleischmann R; Smolen J; Strand V; Landewe R; Combe B; Mease P; Ansari Z; Goel N; van der Heijde D; Emery P<\/span> (2010)<\/span> THE EFFICACY OF CERTOLIZUMAB PEGOL ADDED TO METHOTREXATE IS SUSTAINED OVER 2 YEARS IN THE TREATMENT OF RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. I105<\/span>.<\/p>","publicationid":"74678","date":"2010-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Mease PJ; Rubbert-Roth A; Curtis JR; Muller-Ladner U; Gaylis N; Armstrong GK; Reynard M; Tyrrell H<\/span> (2010)<\/span> COMPARISON OF TWO RETREATMENT STRATEGIES WITH RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)<\/span>. RHEUMATOLOGY<\/span>, pp. I90<\/span>.<\/p>","publicationid":"42532","date":"2010-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cramb D; Grainger A; Hodgson R; Hensor E; Willis K; McGonagle D; Emery P; Jones A; Tan AL<\/span> (2010)<\/span> ANATOMICAL ABNORMALITIES IN HAND OSTEOARTHRITIS ARE AFFECTED BY SOCIAL (HOBBIES) BUT NOT OCCUPATIONAL BIOMECHANICAL FACTORS<\/span>. RHEUMATOLOGY<\/span>, pp. I80<\/span>. <\/a><\/p>","publicationid":"4857","date":"2010-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Coates LC; Helliwell PS; Hensor EM; Wakefield RJ; Emery P; Conaghan PG<\/span> (2010)<\/span> IS THERE SUB-CLINICAL JOINT DISEASE IN EARLY PSORIATIC ARTHRITIS? A CLINICAL COMPARISON WITH POWER DOPPLER ULTRASOUND<\/span>. RHEUMATOLOGY<\/span>, pp. I57<\/span>. <\/a> <\/a><\/p>","publicationid":"1538","date":"2010-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Jones D; Cook GP; Buch M; Emery P; McDermott MF<\/span> (2010)<\/span> The role of the p38 delta MAPK in the pathogenesis of rheumatoid arthritis, with a focus on IL-6 biosynthesis and responses to hypoxic stress<\/span>. IMMUNOLOGY<\/span>, pp. 146<\/span>.<\/p>","publicationid":"133751","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cooper DL; Martin SG; Kozera L; Mackie SL; Nam J; Emery P; Morgan AW<\/span> (2010)<\/span> NK cell subsets and Fc gamma receptors in rheumatoid arthritis (RA)<\/span>. IMMUNOLOGY<\/span>, pp. 182<\/span>.<\/p>","publicationid":"133525","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coulthard LR; Geiler J; Mathews RJ; Church LD; Cooper D; Wong C; Bryer D; Buch M; Emery P; Morgan AW; McDermott MF<\/span> (2010)<\/span> Differences in absolute cell counts of circulating leukocytes in RA patients and age-matched healthy controls<\/span>. IMMUNOLOGY<\/span>, pp. 172<\/span>.<\/p>","publicationid":"133524","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Robinson JI; Cooper DL; Mackie SL; Rashid LH; Martin SG; Isaacs JD; Barton A; Wilson AG; Emery P; Barrett JH; Morgan AW<\/span> (2010)<\/span> Association of FCGR3B<\/i>, but not FCGR3A<\/i> copy number, with susceptibility to rheumatoid arthritis: functional correlation with reduced neutrophil Fc\u03b3RIIIb expression<\/span>. IMMUNOLOGY<\/span>, pp. 123<\/span>.<\/p>","publicationid":"133521","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tinazzi I; Colato C; Biasi D; Emery P; Del Galdo F<\/span> (2010)<\/span> Computational Analysis of sclerodermoid-GVHD and Scleroderma skin transcriptomes reveals the main pathways involved in the immunopathogenesis of skin fibrosis<\/span>. JOURNAL OF INVESTIGATIVE DERMATOLOGY<\/span>, pp. S11<\/span>.<\/p>","publicationid":"128663","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tinazzi I; Colato C; Biasi D; Emery P; Del Galdo F<\/span> (2010)<\/span> Differential skin expression of Caveolin-1 and Allograft-inflammatory factor-1 in chronic Craft-Versus-Host Disease suggests a specific role in the pathogenesis of Scleroderma<\/span>. JOURNAL OF INVESTIGATIVE DERMATOLOGY<\/span>, pp. S10<\/span>.<\/p>","publicationid":"128662","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone E; Tony H-P; Cantagrel A; van Vollenhoven RF; Sanchez-Ortiz A; Vernon E; Roseti S; Kremer J<\/span> (2010)<\/span> OUTCOMES WITH TOCILIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO ANTI-TUMOR NECROSIS FACTOR-\u03b1 THERAPY<\/span>. JOURNAL OF CLINICAL PHARMACOLOGY<\/span>, pp. 1087<\/span>.<\/p>","publicationid":"127560","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Emery P; Haraoui B; Lavie F; Patra K; Guerette B<\/span> (2010)<\/span> Predicting the Risk of Rapid Radiographic Progression for Patients With Early Rheumatoid Arthritis: Data From PREMIER<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1328<\/span>.<\/p>","publicationid":"125082","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Russell A; Westhovens R; Kremer JM; Emery P; Li T; Aranda R; Becker J-C; Zhao CC; Dougados M<\/span> (2010)<\/span> Consistent Safety and Sustained Improvement in Disease Activity and Treatment Response over 7 Years of Abatacept Treatment in Biologic-Naive Patients with RA<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1344<\/span>.<\/p>","publicationid":"125044","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Russell A; Kremer JM; Emery P; Abud-Mendoza C; Szechinski J; Becker J-C; Wu G; Westhovens R<\/span> (2010)<\/span> Abatacept Demonstrates Consistent Safety and Sustained Improvements in Efficacy Through 5 Years of Treatment in Biologic- Naive Patients with RA<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1344<\/span>.<\/p>","publicationid":"125043","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Schiff M; Keystone E; Kvien T; Curtis J; Emery P; Luijtens K; Choy E<\/span> (2010)<\/span> DAS28 (ESR) Response at Week 12 is Predictive of Long-Term Disease Activity in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1332<\/span>.<\/p>","publicationid":"125042","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Van Vollenhoven R; Bessette L; Emery P<\/span> (2010)<\/span> Long-Term Safety of Rituximab: Long-Term Follow-up of the RA Clinical Trials and Retreatment Population<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1320<\/span>.<\/p>","publicationid":"125041","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Olszynski W; Mease P<\/span> (2010)<\/span> Retreatment with Rituximab (RTX) Based On a Treatment to Target (TT) Approach Provides Better Disease Control than Treatment as Needed (PRN) in Patients with Rheumatoid Arthritis (RA)<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1302-1303<\/span>.<\/p>","publicationid":"125040","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Fleischmann R; Emery P<\/span> (2010)<\/span> Multiple Courses of Rituximab (RTX) Produce Sustained Efficacy in Patients (pts) with Rheumatoid Arthritis (RA) with An Inadequate Response (IR) to One or More TNF Inhibitors<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1294<\/span>.<\/p>","publicationid":"125039","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kremer JM; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Becker J-C; Wu G; Westhovens R<\/span> (2010)<\/span> ABATACEPT DEMONSTRATES CONSISTENT SAFETY AND SUSTAINED IMPROVEMENTS IN EFFICACY THROUGH 5 YEARS OF TREATMENT IN BIOLOGIC-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. I104-I105<\/span>.<\/p>","publicationid":"115456","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tinazzi I; Biasi D; Benedetti F; Colato C; Emery P; Del Galdo F<\/span> (2010)<\/span> DIFFERENTIAL PATTERN OF EXPRESSION OF CAVEOLIN-1 AND AIF-1 IN CHRONIC GRAFT- VERSUS- HOST DISEASE SUGGESTS A SPECIFIC ROLE IN THE PATHOGENESIS OF SYSTEMIC SCLEROSIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A24-A25<\/span>. <\/a><\/p>","publicationid":"108830","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven R; Smolen J; Schiff M; Fleischmann R; Combe B; Goel N; Desai C; Curtis J; Keystone E; Emery P; Choy E<\/span> (2010)<\/span> SAFETY UPDATE ON CERTOLIZUMAB PEGOL (CZP) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)<\/span>. RHEUMATOLOGY<\/span>, pp. I102-I103<\/span>.<\/p>","publicationid":"98625","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese MC; Breedveld FC; Emery P; Cohen SB; Keystone EC; Matteson EL; Burke LS; Chai A; Reiss WG; Sweetser MT; Shaw TM<\/span> (2010)<\/span> AN ASSESSMENT OF THE SERIOUS INFECTION RATE IN RITUXIMAB-TREATED RHEUMATOID ARTHRITIS (RA) PATIENTS WHO SUBSEQUENTLY RECEIVED OTHER BIOLOGIC THERAPIES: A FOLLOW-UP FROM RITUXIMAB CLINICAL TRIALS<\/span>. RHEUMATOLOGY<\/span>, pp. I4<\/span>.<\/p>","publicationid":"73934","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gillespie J; Savic S; Wong C; Emery P; Grigg R; McDermott MF<\/span> (2010)<\/span> HDAC ACTIVITY: A THERAPEUTIC TARGET IN RHEUMATOID ARTHRITIS?<\/span> RHEUMATOLOGY<\/span>, pp. I11<\/span>. <\/a><\/p>","publicationid":"62401","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone EC; Fleischmann RM; Furst DE; Macey K; Sweetster MT; Lehane PB; Farmer P; Long SG<\/span> (2010)<\/span> LONG-TERM SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: LONG-TERM FOLLOW-UP OF CLINICAL TRIALS AND RETREATMENT POPULATION<\/span>. RHEUMATOLOGY<\/span>, pp. I104<\/span>.<\/p>","publicationid":"61627","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone EC; Fleischmann RM; Emery P; Dougados M; Baldassare AR; Armstrong GK; Linnik M; Reynard M; Tyrrell H<\/span> (2010)<\/span> SUSTAINED EFFICACY IS ACHIEVED WITH REPEAT COURSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS (TNF-IR)<\/span>. RHEUMATOLOGY<\/span>, pp. I98<\/span>.<\/p>","publicationid":"48547","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cuthbert R; Goeb V; Horner EA; Churchman S; Coates L; Marzo-Ortega H; Nam J; Villeneuve E; Vital E; Conaghan PG; Fardellone P; Le Loet X; Emery P; Vittecoq O; Ponchel F<\/span> (2010)<\/span> REDUCED INTERLEUKIN 7 SERUM TITRES ARE ASSOCIATED WITH PROGRESSION TOWARDS RHEUMATOID ARTHRITIS IN VERY EARLY INFLAMMATORY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A68-A69<\/span>. <\/a><\/p>","publicationid":"35567","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Coates LC; Helliwell PS; Hensor EM; Wakefield RJ; Emery P; Conaghan PG<\/span> (2010)<\/span> ACTIVE ENTHESITIS IS INFREQUENT AND CLINICALLY OVERESTIMATED COMPARED WITH OPPLER ULTRASOUND IN EARLY PSORIATIC ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. I54<\/span>.<\/p>","publicationid":"29991","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Genovese MC; Fleischmann RM; Matteson EL; Hsia EC; Xu S; Doyle MK; Rahman MU<\/span> (2010)<\/span> EFFICACY OF GOLIMUMAB, A HUMAN ANTI-TNF\u03b1 ANTIBODY, BY BASELINE CRP LEVEL IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THREE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES<\/span>. RHEUMATOLOGY<\/span>, pp. I101<\/span>.<\/p>","publicationid":"24033","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Cuthbert R; Hensor E; Parmar R; Dass S; Corscadden D; Henshaw K; Rawstron A; Ponchel F; Emery P<\/span> (2010)<\/span> HIGH SERUM B CELL ACTIVATING FACTOR PREDICTS GOOD CLINICAL RESPONSE TO RITUXIMAB IN RA: PILOT DATA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A11-A12<\/span>. <\/a><\/p>","publicationid":"19072","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van der Heijde D; Emery P; Patra K; Lavie F<\/span> (2010)<\/span> RELATIONSHIP BETWEEN BONE FORMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND CLINICAL SIGNS AND SYMPTOMS<\/span>. RHEUMATOLOGY<\/span>, pp. I18<\/span>.<\/p>","publicationid":"12446","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Isaacs JD; Olech E; Tak PP; Deodhar A; Keystone E; Emery P; Yocum D; Hessey E; Read S<\/span> (2010)<\/span> RHEUMATOID FACTOR (RF) OR ANTI-CYCLIC CITRULLINATED PEPTIDE (aCCP) SEROPOSITIVITY IN RHEUMATOID ARTHRITIS (RA) PATIENTS MAY ENHANCE CLINICAL RESPONSE TO RITUXIMAB<\/span>. RHEUMATOLOGY<\/span>, pp. I94<\/span>.<\/p>","publicationid":"2860","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cuthbert R; Parmar R; Nam J; Villeneuve E; Corscadden D; Henshaw K; Emery P; Ponchel F<\/span> (2010)<\/span> SEVERITY OF T CELL SUBSET DYSREGULATION INFLUENCES THE PROBABILITY OF ACHIEVING DRUG-INDUCED REMISSION IN EARLY ARTHRITIS<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A67-A68<\/span>. <\/a><\/p>","publicationid":"534","date":"2010-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ostergaard M; McQueen F; Wiell C; Bird P; B\u00f8yesen P; Ejbjerg B; Peterfy C; Gandjbakhch F; Duer-Jensen A; Coates L; Haavardsholm EA; Hermann K-GA; Lassere M; O'Connor P; Emery P; Genant H; Conaghan PG<\/span> (2009)<\/span> The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands<\/span>. J Rheumatol<\/span>, pp. 1816-1824<\/span>. <\/a><\/p>","publicationid":"56498","date":"2009-08-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ostergaard M; Conaghan PG; O'Connor P; Szkudlarek M; Klarlund M; Emery P; Peterfy C; Genant H; McQueen FM; Bird P; Lassere M; Ejbjerg B<\/span> (2009)<\/span> Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?<\/span> J Rheumatol<\/span>, pp. 1806-1810<\/span>. <\/a><\/p>","publicationid":"37139","date":"2009-08-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Freeston JE; Dass S; Szabo L; Ponchel F; Rawstron AC; Emery P<\/span> (2009)<\/span> RITUXIMAB IN COMBINATION WITH METHOTREXATE OR LEFLUNOMIDE IN RA: CLINICAL, IMAGING AND FLOW CYTOMETRIC OUTCOMES<\/span>. RHEUMATOLOGY<\/span>, pp. I88-I89<\/span>.<\/p>","publicationid":"122303","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone EC; Fleischmann RM; Emery P; Chubick A; Dougados MR; Baldassare AR; Bathon JM; Hessey EW; Hagerty D; Safa-Leathers S<\/span> (2009)<\/span> EFFICACY AND SAFETY OF REPEAT TREATMENT COURSES OF RITUXIMAB IN RA PATIENTS (PTS) WITH INADEQUATE RESPONSE (IR) TO TUMOUR NECROSIS FACTOR (TNF) INHIBITORS: LONG-TERM EXPERIENCE FROM THE REFLEX STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. I65-I66<\/span>.<\/p>","publicationid":"122182","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Genovese M; van Vollenhoven RF; Sasso EH<\/span> (2009)<\/span> IN PATIENTS WITH EARLY RA WHO HAD ACHIEVED A NORMAL CRP, ADALIMUMAB INHIBITED RADIOGRAPHIC PROGRESSION MORE EFFECTIVELY THAN METHOTREXATE<\/span>. RHEUMATOLOGY<\/span>, pp. I85<\/span>.<\/p>","publicationid":"112566","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Smolen J; Purcaru O; Richard L<\/span> (2009)<\/span> CERTOLIZUMAB PEGOL DEMONSTRATES SIGNIFICANT IMPROVEMENTS IN THE PRODUCTIVITY OF PATIENTS WITH ACTIVE RA, PARTICULARLY IN THE HOME<\/span>. RHEUMATOLOGY<\/span>, pp. I91<\/span>.<\/p>","publicationid":"103885","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Dass S; Ogunbambi O; Goodfield M; Emery P<\/span> (2009)<\/span> RITUXIMAB IN CUTANEOUS LUPUS: RESPONSIVENESS DEPENDS ON PATTERN OF SKIN INVOLVEMENT<\/span>. RHEUMATOLOGY<\/span>, pp. I48<\/span>.<\/p>","publicationid":"89693","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese MC; Smolen JS; Emery P; Jones G; Lee JS; Alecock E; Kremer JM<\/span> (2009)<\/span> LIPID AND INFLAMMATORY BIOMARKER PROFILES WERE EVALUATED IN FIVE TOCILIZUMAB PHASE III CLINICAL TRIALS CONDUCTED IN RHEUMATOID ARTHRITIS PATIENTS<\/span>. RHEUMATOLOGY<\/span>, pp. I90<\/span>.<\/p>","publicationid":"86636","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese MC; Breedveld FC; Emery P; Cohen SB; Keystone E; Matteson E; Baptiste Y; Burke L; Reiss W; Sweetser M; Shaw T<\/span> (2009)<\/span> SAFETY OF OTHER BIOLOGIC THERAPIES FOLLOWING RITUXIMAB TREATMENT IN RA PATIENTS<\/span>. RHEUMATOLOGY<\/span>, pp. I90-I91<\/span>.<\/p>","publicationid":"84605","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Dass S; Horner EA; Goeb V; Rawstron A; Ponchel F; Emery P<\/span> (2009)<\/span> HOW TO MANAGE NON-RESPONSE TO RITUXIMAB? PREDICTORS AND OUTCOME OF RETREATMENT PROVIDE A TREATMENT ALGORITHM<\/span>. RHEUMATOLOGY<\/span>, pp. I92-I93<\/span>.<\/p>","publicationid":"84470","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pope J; Emery P; Keystone EC<\/span> (2009)<\/span> Tocilizumab (TCZ) Rapidly and Significantly Improves Outcomes in Patients with Rheumatoid Arthritis (RA) Who Have Inadequate Response (IR) to TNF Antagonists<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 2579<\/span>.<\/p>","publicationid":"81043","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Savic S; Mathews R; Henshaw K; Churchman S; Buch M; Bryer D; Coulthard L; Emery P; McDermott MF<\/span> (2009)<\/span> ROLE OF APOPTOSIS IN THE PATHOGENESIS AND PROGRESSION OF RHEUMATOID ARTHRITIS AND NON-RESPONSE TO ANTI-TNF THERAPY<\/span>. RHEUMATOLOGY<\/span>, pp. I35<\/span>.<\/p>","publicationid":"76735","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese MC; Smolen JS; Emery P; Jones G; Lee JS; Alecock E; Kremer JM<\/span> (2009)<\/span> ANALYSIS OF LOW-DENSITY LIPOPROTEIN AND ADVERSE EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB PLUS STATINS: DATA FROM FIVE PHASE III CLINICAL TRIALS<\/span>. RHEUMATOLOGY<\/span>, pp. I81<\/span>.<\/p>","publicationid":"73194","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Fleischmann RM; Moreland LW; Hsia EC; Xu W; Rahman MU<\/span> (2009)<\/span> GOLIMUMAB, A NEW HUMAN ANTI-TNF-ALPHA MONOCLONAL ANTIBODY, IN METHOTREXATE-NAIVE ACTIVE RHEUMATOID ARTHRITIS (GO-BEFORE STUDY)<\/span>. RHEUMATOLOGY<\/span>, pp. I93<\/span>.<\/p>","publicationid":"66731","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Russell A; Westhovens R; Kremer J; Moreland L; Emery P; Li T; Aranda R; Becker JC; Tsai K; Dougados M<\/span> (2009)<\/span> Durable Impact on Diseases Activity and Consistent Safety Through 5 Years in Abatacept-Treated Rheumatoid Arthritis Patients Receiving Background Methotrexate<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 2593<\/span>.<\/p>","publicationid":"64599","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Russell A; Smolen J; Emery P; Kavanaugh A; Richard L; Purcaru O<\/span> (2009)<\/span> Certolizumab Pegol with Methotrexate Improves Performance at Work in Patients with Active Rheumatoid Arthritis<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 2580<\/span>.<\/p>","publicationid":"59921","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; Beaulieu AD; Dikranian A; Fenton I; Fisheleva E; Alecock E; Emery P<\/span> (2009)<\/span> TOCILIZUMAB IS WELL TOLERATED IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH A LOW RATE OF SERIOUS ADVERSE EVENTS<\/span>. RHEUMATOLOGY<\/span>, pp. I87<\/span>.<\/p>","publicationid":"55709","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Wakefield RJ; Conaghan PG; Hensor EM; Emery P<\/span> (2009)<\/span> POWER DOPPLER ULTRASOUND PREDICTS DEVELOPMENT OF RA IN CCP NEGATIVE PATIENTS<\/span>. RHEUMATOLOGY<\/span>, pp. I140-I141<\/span>.<\/p>","publicationid":"54929","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Parmar R; Goeb V; Saleem B; Quinn M; Conaghan PG; Ponchel F; Emery P<\/span> (2009)<\/span> LONG-TERM REMISSION AFTER TNF-BLOCKADE IN EARLY RHEUMATOID ARTHRITIS IS ASSOCIATED WITH A NORMALISATION OF IMMUNOLOGICAL STATUS<\/span>. RHEUMATOLOGY<\/span>, pp. I37<\/span>.<\/p>","publicationid":"52497","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hensor EM; Emery P; Bingham SJ; Conaghan PG; Consortium Y<\/span> (2009)<\/span> DISCREPANCIES IN CATEGORISING EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS BY DAS28(ESR) AND DAS28(CRP): CAN THEY BE REDUCED?<\/span> RHEUMATOLOGY<\/span>, pp. I137<\/span>.<\/p>","publicationid":"44956","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone E; Fleischmann R; Rowe KA; Sweetser M; Osikoya O; Kelman A; Rao RM<\/span> (2009)<\/span> LONG-TERM SAFETY OF RITUXIMAB: 6-YEAR FOLLOW-UP OF THE RA CLINICAL TRIALS AND RE-TREATMENT POPULATION<\/span>. RHEUMATOLOGY<\/span>, pp. I17-I18<\/span>.<\/p>","publicationid":"29170","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Parmar R; Goeb V; Saleem B; Conaghan P; Emery P<\/span> (2009)<\/span> BASELINE IMMUNOLOGICAL STATUS OF EARLY RHEUMATOID ARTHRITIS PATIENTS PREDICT RESPONSE TO TREATMENT<\/span>. RHEUMATOLOGY<\/span>, pp. I69<\/span>.<\/p>","publicationid":"26482","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Saleem B; Parmar R; Goeb V; Conaghan PG; Ponchel F; Emery P<\/span> (2009)<\/span> HOW CAN TNF-BLOCKERS BE STOPPED WITHOUT FLARE? NEEDS EARLY TREATMENT AND IMMUNOLOGICAL REMISSION<\/span>. RHEUMATOLOGY<\/span>, pp. I136-I137<\/span>.<\/p>","publicationid":"21821","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pope J; van Vollenhoven RF; Emery P<\/span> (2009)<\/span> Long-Term Safety of Rituximab: 6-year Follow-up of the Rheumatoid Arthritis (RA) Clinical Trials and Re-treatment Population<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 2603<\/span>.<\/p>","publicationid":"19769","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Vital EM; Dass S; Martin MF; Pease CT; Rawstron AC; Emery P<\/span> (2009)<\/span> RITUXIMAB IN SLE: HIGHLY SENSITIVE FLOW CYTOMETRY ALLOWS EARLY PREDICTION OF NON-RESPONSE AND RELAPSE<\/span>. RHEUMATOLOGY<\/span>, pp. I48-I49<\/span>.<\/p>","publicationid":"17088","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese M; Peterfy C; Emery P; Keystone E; Tak P-P; Cohen SB; DiCarlo J; Hagerty D; Cravets M; Shaw T<\/span> (2009)<\/span> EVALUATION OF JOINT DAMAGE IN RA PATIENTS TREATED WITH RITUXIMAB: COMPARISON OF GENANT- AND VAN DER HEIJDE-MODIFIED SHARP RADIOGRAPHIC SCORING<\/span>. RHEUMATOLOGY<\/span>, pp. I65<\/span>.<\/p>","publicationid":"11041","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone E; Tony HP; Law A; Woodworth T; Kremer J<\/span> (2009)<\/span> TOCILIZUMAB SIGNIFICANTLY IMPROVES PATIENT OUTCOMES REGARDLESS OF PRIOR INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR ANTAGONISTS IN RHEUMATOID ARTHRITIS<\/span>. RHEUMATOLOGY<\/span>, pp. I19<\/span>.<\/p>","publicationid":"9515","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cohen SB; Keystone EC; Genovese M; Emery P; Peterfy C; Tak P-P; Cravets MW; Shaw T; Hagerty D<\/span> (2009)<\/span> CONTINUED INHIBITION OF STRUCTURAL DAMAGE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH RITUXIMAB AT 2 YEARS: REFLEX STUDY<\/span>. RHEUMATOLOGY<\/span>, pp. I88<\/span>.<\/p>","publicationid":"7076","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Conaghan PG; Hensor EM; Keenan A-M; Emery P; Consortium Y<\/span> (2009)<\/span> PERSISTENT MODERATE DAS IS NOT A BENIGN STATE: PROGRESSIVE LOSS OF FUNCTION OCCURS IN EARLY RA DESPITE STEP-UP DMARD THERAPY<\/span>. RHEUMATOLOGY<\/span>, pp. I137<\/span>.<\/p>","publicationid":"4627","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone E; Tony HP; Cantagrel A; van Vollenhoven R; Sanchez A; Alecock E; Lee J; Kremer J<\/span> (2009)<\/span> RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE REPONSE TO TUMOUR NECROSIS FACTOR ANTAGONISTS SHOW RAPID AND SIGNIFICANT IMPROVEMENTS IN CLINICAL OUTCOME WHEN TREATED WITH TOCILIZUMAB<\/span>. RHEUMATOLOGY<\/span>, pp. I90<\/span>.<\/p>","publicationid":"179","date":"2009-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Russell A; Westhovens R; Kremer J; Moreland L; Emery P; Li T; Aranda R; Becker JC; Joshi C; Dougados M<\/span> (2008)<\/span> Maintained efficacy and safety of abatacept in rheumatoid arthritis patients receiving background methotrexate through 5 years of treatment<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1178<\/span>.<\/p>","publicationid":"114987","date":"2008-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Crawford A; Jones EA; English A; Mundy J; Henshaw K; Corscadden D; Emery P; McGonagle D; Hatton PV<\/span> (2008)<\/span> Cartilage tissue engineering using a novel source of adult stem cells<\/span>. INT J EXP PATHOL<\/span>, pp. A24<\/span>.<\/p>","publicationid":"76938","date":"2008-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven R; Haraoui B; Emery P; Bingham C; Keystone E; Greenwald M; Moreland L; Sweetser M; Rowe K; Wagner B; Magrini F<\/span> (2008)<\/span> Extended follow-up of the long-term safety of rituximab in rheumatoid arthritis<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1187-1188<\/span>.<\/p>","publicationid":"55995","date":"2008-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Khraishi M; Furst D; Ferracioli G; Udell J; van Vollenhoven R; Rowe K; Agarwal S; Shaw T<\/span> (2008)<\/span> Repeated treatment courses of rituximab produce sustained efficacy in rheumatoid arthritis patients with an inadequate response to disease-modifying anti-rheumatic drugs<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1182<\/span>.<\/p>","publicationid":"55814","date":"2008-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone EC; Pope J; Fleischmann RM; Emery P; Chubick A; Dougados MR; Baldassare AR; Bathon JM; Hessey E; Hagerty D; Cooper S<\/span> (2008)<\/span> Sustained improvement with repeated courses of rituximab in patients with rheumatoid arthritis and an inadequate response or intolerance to one or more TNF inhibitors<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1195<\/span>.<\/p>","publicationid":"50053","date":"2008-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Crawford A; Jones EA; Mundy J; English A; Henshaw K; Corscadden D; Emery P; McGonagle D<\/span> (2008)<\/span> Use of human synovial fluid-derived stem cells for cartilage tissue engineering<\/span>. TISSUE ENG PT A<\/span>, pp. 925<\/span>.<\/p>","publicationid":"119714","date":"2008-05-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

McGonagle D; Wakefield R; Tan AL; D'Agostino MA; Toumi H; Hayashi K; Emery P; Benjamin M<\/span> (2008)<\/span> Biomechanical uncoupling of bone erosion and new bone formation in spondyloarthropathy<\/span>. RHEUMATOLOGY<\/span>, pp. II4<\/span>.<\/p>","publicationid":"122245","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Barkham N; Keen H; Coates L; O'Connor P; Hensor E; Fraser A; Cawkwell L; McGonagle D; Emery P<\/span> (2008)<\/span> A randomized controlled trial of infliximab shows clinical and MRI efficacy in patients with HLA B27 positive very early ankylosing spondylitis<\/span>. RHEUMATOLOGY<\/span>, pp. II77<\/span>.<\/p>","publicationid":"115381","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone E; Fleischmann R; Chubick A; Dougados M; Baldassare A; Bathon J; Hessey E; Hagerty D; Cooper S<\/span> (2008)<\/span> Repeated treatment courses of rituximab produce sustained efficacy in patients with rheumatoid arthritis and an inadequate response or intolerance to one or more TNF inhibitors<\/span>. RHEUMATOLOGY<\/span>, pp. II45<\/span>.<\/p>","publicationid":"114950","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Furst DE; Ferraccioli G; Udell J; van Vollenhoven RF; Rowe K; Shaw T<\/span> (2008)<\/span> Repeated treatment courses of rituximab produce sustained efficacy in rheumatoid arthritis patients with an inadequate response to disease-modifying anti-rheumatic drugs<\/span>. RHEUMATOLOGY<\/span>, pp. II46<\/span>.<\/p>","publicationid":"114913","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen J; Han C; van der Heijde D; Emery P; Bathon J; Keystone E; Maini R; Kalden J; Aletaha D; Clair ES<\/span> (2008)<\/span> Infliximab inhibits radiographic progression regardless of disease activity at baseline & following treatment in patients with early active RA<\/span>. RHEUMATOLOGY<\/span>, pp. II39<\/span>.<\/p>","publicationid":"110100","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keenan AM; Conaghan PG; Pallant J; Emery P; Tennant A<\/span> (2008)<\/span> Anxiety, function and age, but not pain, directly determine quality of life in osteoarthritis: Results from a study using the OAQOL, a needs-based quality of life instrument<\/span>. RHEUMATOLOGY<\/span>, pp. II24<\/span>.<\/p>","publicationid":"106499","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bennett AN; McGonagle D; O'Connor P; Hensor E; Coates L; Emery P; Marzo-Ortega H<\/span> (2008)<\/span> Early inflammatory back pain and MRI sacroiliitis: Severity of osteitis at baseline and HLA-B27 predict ankylosing spondylitis at 8 years<\/span>. RHEUMATOLOGY<\/span>, pp. II5<\/span>.<\/p>","publicationid":"106318","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dickie LJ; Church LD; Coulthard LR; Mathews RJ; Emery P; McDermott MF<\/span> (2008)<\/span> Modulation of innate immune responses by vitamin D3<\/span>. RHEUMATOLOGY<\/span>, pp. II19<\/span>.<\/p>","publicationid":"102735","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Kremer JM; Tony HP; Genovese MC; Tak PP; Luggen M; Bombardieri S; Hessey E; Safa-Leathers S<\/span> (2008)<\/span> Repeat treatment with rituximab in active RA patients: Long-term efficacy in patients with one versus two or more prior TNF inhibitors<\/span>. RHEUMATOLOGY<\/span>, pp. II38<\/span>.<\/p>","publicationid":"97318","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Cohen S; Dougados M; Genovese M; Burmester G; Greenwald M; Kvien TK; Cravets M; Shaw T; Hagerty D<\/span> (2008)<\/span> Consistent inhibition of structural damage progression by rituximab in medically important subgroups of patients with an inadequate response to TNF inhibitors: Week 56 reflex results<\/span>. RHEUMATOLOGY<\/span>, pp. II51<\/span>.<\/p>","publicationid":"94011","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Reay N; Hill J; Hale C; Emery P; Tennant A<\/span> (2008)<\/span> A needs based quality of life measure for systemic sclerosis, the SscQol<\/span>. RHEUMATOLOGY<\/span>, pp. II9<\/span>.<\/p>","publicationid":"93837","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Vital EM; Bingham SJ; Emery P<\/span> (2008)<\/span> Rituximab in RA: 5 years of real life clinical experience<\/span>. RHEUMATOLOGY<\/span>, pp. II48<\/span>.<\/p>","publicationid":"80055","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Saleem B; Buch M; Conaghan PG; Emery P<\/span> (2008)<\/span> The absence of secondary non-response in abatacept treated RA patients<\/span>. RHEUMATOLOGY<\/span>, pp. II37<\/span>.<\/p>","publicationid":"71021","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Breedveld F; Hall S; Durez P; Pedersen R; Robertson D; Koenig AS; Freundlich B<\/span> (2008)<\/span> Remission rates in subjects with active early rheumatoid arthritis - 1 year results of the comet trial<\/span>. RHEUMATOLOGY<\/span>, pp. II10-II11<\/span>.<\/p>","publicationid":"69708","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Kremer J; Moreland L; Russell A; Li T; Aranda R; Becker JC; Tsai K; Dougados M; Westhovens R<\/span> (2008)<\/span> Long-term efficacy and safety of abatacept through 5 years of treatment in rheumatoid arthritis patients with an inadequate response to methotrexate<\/span>. RHEUMATOLOGY<\/span>, pp. II48<\/span>.<\/p>","publicationid":"68883","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Pritchard C; Zhou X; Genovese M; Schiff M<\/span> (2008)<\/span> The efficacy and safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial<\/span>. RHEUMATOLOGY<\/span>, pp. II45<\/span>.<\/p>","publicationid":"68314","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Davys HJ; Butland D; Emery P; Helliwell PS<\/span> (2008)<\/span> Use of foot orthoses in patients with rheumatic diseases: Audit of patient reported outcomes<\/span>. RHEUMATOLOGY<\/span>, pp. II145<\/span>.<\/p>","publicationid":"66393","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Churchman SM; Jones EA; English A; Emery P; McGonagle D; Ponchel F<\/span> (2008)<\/span> Inflammation reduces the chondrogenic ability of mesenchymal stem cells in RA - A molecular study<\/span>. RHEUMATOLOGY<\/span>, pp. II60<\/span>.<\/p>","publicationid":"38959","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Saleem B; Parmer R; Conaghan PG; Emery P; Ponchel F<\/span> (2008)<\/span> Using T-cell subsets and T regulatory cells to define immunological remission post TNF-blockade<\/span>. RHEUMATOLOGY<\/span>, pp. II115<\/span>.<\/p>","publicationid":"36755","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone E; Peterfy CG; Tak PP; Cohen SB; Genovese MC; Williams S; Hagerty D; Cravets MW; Shaw TM<\/span> (2008)<\/span> Inhibition of radiographic progression with rituximab is not dependent on clinical efficacy: Results from a study in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (reflex)<\/span>. RHEUMATOLOGY<\/span>, pp. II50<\/span>.<\/p>","publicationid":"36491","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Barkham N; Coates L; Keen H; Hensor E; Fraser A; Redmond A; Cawkswell L; Emery P<\/span> (2008)<\/span> A double blind placebo controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis<\/span>. RHEUMATOLOGY<\/span>, pp. II72<\/span>. <\/a><\/p>","publicationid":"33745","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Genovese MC; Breedveld F; Moreland L; Keystone E; Matteson EL; Baptiste Y; Reiss W; Sweetser M; Shaw T<\/span> (2008)<\/span> Safety of tnf inhibitors and non-biologic DMARDs in rheumatoid arthritis patients previously treated with rituximab<\/span>. RHEUMATOLOGY<\/span>, pp. II48-II49<\/span>.<\/p>","publicationid":"29348","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Genovese M; van Vollenhoven R; Patra K; Sasso E<\/span> (2008)<\/span> Radiographic progression and clinical status are differentially related for adalimumab plus methotrexate (MTX) vs. monotherapy with adalimumab or MTX: Subanalysis of premier<\/span>. RHEUMATOLOGY<\/span>, pp. II115-II116<\/span>.<\/p>","publicationid":"24797","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; van Vollenhoven RF; Binghamlll CO; Keystone EC; Greenwald M; Moreland LW; Sweetser M; Rowe K; Wagner B; Magrini F<\/span> (2008)<\/span> Extended follow-up of the long-term safety of rituximab in rheumatoid arthritis<\/span>. RHEUMATOLOGY<\/span>, pp. II16<\/span>.<\/p>","publicationid":"10410","date":"2008-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Churchman SM; Jones EA; English A; Emery P; McGonagle D; Ponchel F<\/span> (2008)<\/span> The loss of chondrogenic potential of synovium derived mesenchymal stem cells in rheumatoid arthritis may be linked to inflammation driven dysregulation of SOX9 expression<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A46-A47<\/span>.<\/p>","publicationid":"121575","date":"2008-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mathews R; Churchman S; Church L; Coulthard L; Bryer D; Nizam S; Saleem B; Cook GP; Emery P; McDermott MF<\/span> (2008)<\/span> Effects of TNF blockade by infliximab on inflammasome regulators in rheumatoid arthritis patients<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A25-A26<\/span>.<\/p>","publicationid":"104700","date":"2008-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ponchel F; Saleem B; Parmar R; Emery P<\/span> (2008)<\/span> Using T-cell subset and Treg to define immunological remission post TNF-blockade<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A21<\/span>.<\/p>","publicationid":"74128","date":"2008-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coulthard L; Church L; Mathews R; Bryer D; Nizam S; Saleem B; Morgan A; Emery P; McDermott MF<\/span> (2008)<\/span> Investigation of the effects of infliximab (remicade) on peripheral blood cells of rheumatoid arthritis patients 2 hours after infusion<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A18-A19<\/span>.<\/p>","publicationid":"57121","date":"2008-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Burgoyne C; Vital E; Dass S; Corscadden D; Emery P; Ponchel F<\/span> (2008)<\/span> Alteration of B cell phenotype following depletion with rituximab in rheumatoid arthritis<\/span>. ANN RHEUM DIS<\/span>, pp. A5-A6<\/span>.<\/p>","publicationid":"47561","date":"2008-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ostergaard M; Wiell C; Bird P; Lassere M; Conaghan P; Boyesen P; Gandjbakhch F; Duer-Jensen A; Peterfy C; Hermann KG; Haavardsholm E; Ejbjerg B; Anandarajah A; Emery P; Genant H; McQueen F<\/span> (2008)<\/span> Peripheral psoriatic arthritis: MRI definitions of key pathologies and development of a MRI scoring system<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S696<\/span>.<\/p>","publicationid":"121338","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Durez P; Emery P; Hall S; Koenig A; Sato R; Singh A; Robertson D; Freundlich B<\/span> (2008)<\/span> Assessment of patient-reported outcomes from a double-blind trial of etanercept and methotrexate combination in early active rheumatoid arthritis: The COMET trial<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S457<\/span>.<\/p>","publicationid":"119672","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese MC; Smolen JS; Emery P; Jones G; Lee JS; Alecock E; Kremer JM<\/span> (2008)<\/span> Lipid and inflammatory biomarker profiles in patients receiving tocilizumab for rheumatoid arthritis: Analysis of five phase 3 clinical trials<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S531-S532<\/span>.<\/p>","publicationid":"118506","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; Beaulieu AD; Dikranian A; Fenton I; Fisheleva E; Alecock E; Emery P<\/span> (2008)<\/span> Safety of tocilizumab in patients with rheumatoid arthritis: Pooled analysis of five phase 3 clinical trials<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S784<\/span>.<\/p>","publicationid":"116061","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Wakefield RJ; Conaghan PG; Hensor EMA; Emery P<\/span> (2008)<\/span> Predicting RA in CCP negative patients: Power Doppler Ultrasound as a surrogate for auto-antibodies in very early inflammatory arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S758-S759<\/span>.<\/p>","publicationid":"111893","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Jones DL; Coulthard LR; Scott GB; Cook GC; Emery P; McDermott MF<\/span> (2008)<\/span> Validation of antibodies against the four isoforms of p38 MAPK for immunohistochemistry of synovial tissue: a role for p38\u03b4 in non-response to anti-TNF therapy in rheumatoid arthritis patients<\/span>. IMMUNOLOGY<\/span>, pp. 111<\/span>.<\/p>","publicationid":"104691","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Buchanan J; Emery P; Keystone EC; Smolen J; Doyle MK; Hsia EC; Rahman MU; Gathany T; Han C; Parasuraman S<\/span> (2008)<\/span> Golimumab significantly reduces time lost from work for patients with rheumatoid arthritis: Pooled results from three phase 3 studies<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S472-S473<\/span>.<\/p>","publicationid":"93084","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cohen S; Keystone E; Genovese M; Emery P; Peterfy C; Tak P; Cravets M; Shaw T; Hagerty D<\/span> (2008)<\/span> Continued inhibition of structural damage in rheumatoid arthritis patients treated with rituximab at 2 years: REFLEX study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S303-S304<\/span>.<\/p>","publicationid":"86212","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen J; Emery P; Kavanaugh A; Richard L; Purcaru O<\/span> (2008)<\/span> Certolizumab pegol with methotrexate improves performance at work in patients with active rheumatoid arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S527-S528<\/span>.<\/p>","publicationid":"85509","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Belch J; Fiorentino D; Denton C; Herrick A; Sule S; Steen V; Rothfield N; Scheja A; Shapiro L; Shanahan J; Emery P; Chung L; Gregory JK<\/span> (2008)<\/span> MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S622<\/span>.<\/p>","publicationid":"85274","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Saleem B; Parmer R; Corsadden D; Conaghan PG; Emery P<\/span> (2008)<\/span> Stopping TNF-blockade Therapy in Early RA: Predictors of Sustained Remission<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. 3974<\/span>.<\/p>","publicationid":"77633","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Smolen J; Kavanaugh A; Richard L; Purcaru O<\/span> (2008)<\/span> Combination therapy with certolizumab pegol plus methotrexate improves household productivity<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S527<\/span>.<\/p>","publicationid":"77015","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Fleischmann RM; Emery P; Moreland LW; Hsia EC; Strusberg I; Durez P; Nasi P; Amante E; Churchill M; Park W; Pons-Estel B; Xu W; Rahman MU<\/span> (2008)<\/span> Golimumab, a new human Anti-TNF-\u03b1 monoclonal antibody, administered subcutaneously everv 4 weeks in methotrexate-naive patients with active rheumatoid arthritis:: A randomized, double-blind, placebo-controlled, GO-BEFORE study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S530<\/span>.<\/p>","publicationid":"75137","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Breedveld FC; Hall S; Durez P; Chang DJ; Pedersen R; Koenig AS; Robertson D; Freundlich B<\/span> (2008)<\/span> Clinical remission, radiographic non-progression, and normalized function with the combination of etanercept and methotrexate in the treatment of early active rheumatoid arthritis: 1-year results of the COMET trial<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S617<\/span>.<\/p>","publicationid":"74390","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bennett AN; McGonagle DG; O'Connor P; Hensor EMA; Coates LC; Sivera F; Emery P; Marzo-Ortega H<\/span> (2008)<\/span> Severity of baseline MRI sacroiliitis and HLA-B27 status in early inflammatory back pain predicts radiographic Ankylosing spondylitis at 8 years<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S609<\/span>.<\/p>","publicationid":"73924","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kremer JM; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Zhao C; Becker J-C; Westhovens R<\/span> (2008)<\/span> Safety and efficacy of abatacept over 4 years of treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate in the AIM trial<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S308-S309<\/span>.<\/p>","publicationid":"73504","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone E; Tony HP; Cantagrel A; van Vollenhoven R; Sanchez A; Alecock E; Lee J; Kremer J<\/span> (2008)<\/span> Tociluzumab (TCZ) rapidly and significantly improves outcomes in patients with rheumatoid arthritis (RA) who have inadequate response (IR) to TNF antagonists<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S617-S618<\/span>.<\/p>","publicationid":"71723","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cooper DL; Martin S; Mackie S; Emery P; Morgan A<\/span> (2008)<\/span> Characterisation of the immunological phenotype of human monocyte subsets in early and established rheumatoid arthritis<\/span>. IMMUNOLOGY<\/span>, pp. 39<\/span>.<\/p>","publicationid":"62919","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Genovese M; van Vollenhoven R; Ozol-Godfrey A; Sasso EH<\/span> (2008)<\/span> Adalimumab inhibited radiographic progression more effectively than methotrexate in early RA patients who had achieved a normal c-reactive protein concentration<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S536<\/span>.<\/p>","publicationid":"55235","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bennett AN; Rehman A; Hensor EMA; Marzo-Ortega H; Emery P; Cgonagle DGI<\/span> (2008)<\/span> The diagnostic utility of MRI in spondyloarthropathy<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S354-S355<\/span>.<\/p>","publicationid":"51047","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese MC; Smolen JS; Emery P; Jones G; Lee JS; Alecock E; Kremer JM<\/span> (2008)<\/span> Concomitant use of statins in tocilizumab-treated patients with rheumatoid arthritis with elevated low density lipoprotein cholesterol: Analysis of five phase 3 clinical trials<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S785-S786<\/span>.<\/p>","publicationid":"41028","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham CO; Keystone E; Fleischmann R; Furst DE; Rowe KA; Sweetser M; Osikoya O; Kelman A; Rao R<\/span> (2008)<\/span> Long-term safety of rituximab: 6-year follow-up of the RA clinical trials and re-treatment population<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S300-S301<\/span>.<\/p>","publicationid":"37747","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Rothfield N; Shapiro L; Fiorentino D; Chung L; Denton C; Herrick A; Baron M; Shanahan J; Hsu V; Belch J; Steen V; Scheja A; Martin R; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Sule S; Emery P; Wigey FM<\/span> (2008)<\/span> Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S821<\/span>.<\/p>","publicationid":"35544","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Herrick A; Denton C; Fiorentino D; Sule S; Rothfield N; Belch J; Shapiro L; Scheja A; Shanahan J; Steen V; Chung L; Emery P; Wigley F; Gregory J<\/span> (2008)<\/span> Comparison of responders and non-responders to MQX-503, a novel investigational topical nitroglycerin formulation, in treatment of scieroderma-related and non-scleroderma-related Raynaud'S phenomenon<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S822<\/span>.<\/p>","publicationid":"28454","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone E; Tony HP; Law A; Woodworth T; Kremer J<\/span> (2008)<\/span> Patients achieve significant improvement in rheumatoid arthritis (RA) outcomes with tociluzumab (TCZ) regardless of prior inadequate response (IR) to TNF antagonists<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S533<\/span>.<\/p>","publicationid":"20863","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Rigby WF; Cornbe B; Catim K; Szczepaski LJ; Roschmann RA; Chen A; Annstrong GK; Douglass W; Tyrrell H<\/span> (2008)<\/span> Efficacy and safety of rituximab (RTX) as first-line biologic therapy in patients (pts) with active rheumatoid arthritis (RA): Results of a phase III Randomized controlled study (SERENE)<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S302<\/span>.<\/p>","publicationid":"18046","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kremer J; Pope J; Ton HP; Burmester GR; Hall S; Euller-Ziegler L; Woodworth T; Alecock E; Emery P<\/span> (2008)<\/span> Tociluzumab (TCZ) improves quality of life (QOL) in patients with rheumatoid arthritis (RA) who had inadequate response (IR) to TNF antagonists<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S533-S534<\/span>.<\/p>","publicationid":"12004","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Maxwell J; Marinou I; Barton A; Moore DJ; Worthington J; Martin SG; Consortium YEAR; Emery P; Morgan AW; Wilson AG<\/span> (2008)<\/span> Association of rs6920220 at 6q23 with radiological damage in seropositive<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S212-S213<\/span>.<\/p>","publicationid":"5633","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone EC; Fleischmarm RM; Emery P; Chubick A; Dougados MR; Baldassare AR; Bathon JM; Hessey E; Hagerty D; Safa-Leathers S<\/span> (2008)<\/span> Efficacy and safety of repeat treatment courses of rituximab (RTX) in RA patients (pts) with inadequate response (IR) to tumor necrosis factor (TNF) inhibitors: Long-term experience from the REFLEX 2 study<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S303<\/span>.<\/p>","publicationid":"5499","date":"2008-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Breedveld F; Hall S; Durez P; Pedersen R; Robertson D; Freundlich B; Chang DJ<\/span> (2007)<\/span> Remission rates in subjects with active early rheumatoid arthritis 1 year results of the COMET trial: Combination of methotrexate and etanercept in active early rheumatoid arthritis<\/span>. ARTHRITIS RHEUM<\/span>, pp. 4310-4311<\/span>.<\/p>","publicationid":"73866","date":"2007-12-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Denton CP; Fiorentino D; Herrick A; Sule S; Rothfield N; Belch J; Shapiro L; Scheja A; Shanahan J; Steen V; Emery P; Chung L; Gregory J; Batson E; Dooley T; Gilbert A; Dechow F; Wigley FM<\/span> (2007)<\/span> A multi-center crossover study of MQX-503, a topical formulation of nitroglycerin, in patients with Raynaud's phenomenon<\/span>. ARTHRITIS RHEUM<\/span>, pp. 4238<\/span>.<\/p>","publicationid":"51926","date":"2007-12-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Barkham N; Keen H; Coates L; O'Connor P; Hensor E; Fraser A; Cawkwell L; McGonagle D; Emery P<\/span> (2007)<\/span> A randomised controlled trial of infliximab shows clinical and MRI efficacy in patients with HLA B27 positive very early ankylosing spondylitis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. 4237-4238<\/span>.<\/p>","publicationid":"46140","date":"2007-12-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Sieper J; Emery P; Keystone EC; Schiff MH; Mease P; van Riel P; Fleischmann R; Weisman MH; Weinblatt ME<\/span> (2007)<\/span> Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007<\/span>. ANN RHEUM DIS<\/span>, pp. 2-22<\/span>. <\/a><\/p>","publicationid":"88703","date":"2007-11-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Pountos I; Corscadden D; Emery P; Giannoudis PV<\/span> (2007)<\/span> Mesenchymal stem cell tissue engineering: Techniques for isolation, expansion and application<\/span>. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED<\/span>, pp. S23-S33<\/span>. <\/a><\/p>","publicationid":"75432","date":"2007-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ke X; Thomson W; Barton A; Eyre S; Hinks A; Bowes J; Donn R; Hider S; Bruce IN; Wilson AG; Morgan A; Emery P; Carter A; Steer S; Hocking L; Reid DM; Strachan D; Wordsworth P; Worthington J<\/span> (2007)<\/span> Whole genome association studies of rheumatoid arthritis and replication of identified susceptibility loci<\/span>. GENET EPIDEMIOL<\/span>, pp. 633<\/span>.<\/p>","publicationid":"20200","date":"2007-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gilworth G; Emery P; Gossec L; Vlieland T; Breedveld FC; Heuber A; Schett G; Tennant A<\/span> (2007)<\/span> Adaptation and cross-cultural validation of the RA-WIS<\/span>. ANN RHEUM DIS<\/span>, pp. 28<\/span>.<\/p>","publicationid":"121118","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Marzo-Ortega H; Bryer DJ; Bennett AN; Fraser AD; Emery P<\/span> (2007)<\/span> Non-response to biologic drugs in psoriatic arthritis - Switching should always be considered<\/span>. ANN RHEUM DIS<\/span>, pp. 392<\/span>.<\/p>","publicationid":"120737","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ikeda K; Brown AK; Mark QA; Stewart S; Conaghan PG; Karim Z; Hensor EM; Wakefield RJ; Peterfy CG; O'Connor PJ; Emery P<\/span> (2007)<\/span> Hand bone densitometry in rheumatoid arthritis (RA): Is hand dual energy X ray absorptiometry (DXA) a sensitive measure for assessing disease activity of RA in remission?<\/span> ANN RHEUM DIS<\/span>, pp. 330<\/span>.<\/p>","publicationid":"114930","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Dass S; Vital EM; Hensor EMA; Stewart SP; Emery P; Conaghan PG<\/span> (2007)<\/span> Examining the utility of e-MRI with a reduced field of view: An imaging comparison study in severe rheumatoid arthritis<\/span>. ANN RHEUM DIS<\/span>, pp. 564<\/span>.<\/p>","publicationid":"114002","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Laar JM; Farge D; Bocelli-Tyndall C; Sont JK; Saccardi R; Miniatis I; Matucci-Cerinics M; Machold K; Arfi S; Adoue D; Sarrot-Reynauld' F; Constans J; Roblot P; Quere I; Durand J; Sibilia J; Himsel A; Kaltwasser J; Peter H; Koetter I; Kleinert S; Tony H; Weiner S; Fassas A; Voskuyl AE; Vonk M; Van den Hoogen F; Dass S; Emery P; Villiger P; Daikeler T; Gratwohl A; Tyndall A<\/span> (2007)<\/span> Autologous stem cell transplantation for severe systemic sclerosis: Update on the astis trial<\/span>. ANN RHEUM DIS<\/span>, pp. 227<\/span>.<\/p>","publicationid":"104861","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ikeda K; Brown AK; Conaghan PG; Karim Z; Quinn MA; Peterfy CG; Hensor EM; Wakefield RJ; O'Connor PJ; Emery P<\/span> (2007)<\/span> An explanation of structural deterioration in RA patients in clinical remission on DMARDS: The significance of sub-clinical inflammation detectable with imaging<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 95<\/span>.<\/p>","publicationid":"104466","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Bowman SJ; Vital EM; Ikeda K; Pease CT; Emery P<\/span> (2007)<\/span> Safety and efficacy of rituximab in Sjogren's syndrome: results of a randomised, placebo controlled trial<\/span>. ANN RHEUM DIS<\/span>, pp. 70<\/span>.<\/p>","publicationid":"104334","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Brown AK; Freeston JE; Vital EM; Rawstron AC; Emery P<\/span> (2007)<\/span> Rituximab therapy improves imaging synovitis before clinical response in RA<\/span>. ANN RHEUM DIS<\/span>, pp. 123<\/span>.<\/p>","publicationid":"101861","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Marzo-Omega H; Bryer DJ; Cawkwell LS; Pickles DA; Fraser AD; Emery P<\/span> (2007)<\/span> Sustained response to long-term biologics in ankylosing spondylitis: The majority of patients continue on the same drug after two years<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 392<\/span>.<\/p>","publicationid":"99824","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Saleem B; Keen HI; Nizam S; Hensor E; Wakefield R; Conaghan PG; Emery P<\/span> (2007)<\/span> Delay in instituting TNF blocking therapy results in inferior imaging remission<\/span>. ANN RHEUM DIS<\/span>, pp. 186<\/span>.<\/p>","publicationid":"97589","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Furst DE; Ferraccioli G; Udell J; van Vollenhoven RF; Rowe K; Agarwal S; Shaw T<\/span> (2007)<\/span> Sustained efficacy of repeat treatment courses of rituximab in rheumatoid arthritis patients with an inadequate response to disease-modifying anti-rheumatic drugs<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 430<\/span>.<\/p>","publicationid":"94974","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan A; Waller ML; Hensor EMA; Tanner SF; Jeavons AR; Emery P; McGonagle D<\/span> (2007)<\/span> Further evidence for the importance of ligaments and tendons in the phenotypic expression of hand osteoarthritis - A combined high-resolution positron emission tomography and high-resolution magnetic resonance imaging study<\/span>. ANN RHEUM DIS<\/span>, pp. 511<\/span>.<\/p>","publicationid":"90893","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Saleem B; Keen HI; Conaghan PG; Nizam S; Hensor E; Wakefield R; Emery P<\/span> (2007)<\/span> Does a new threshold of DAS 28 predict imaging assessed remission in RA?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 186<\/span>.<\/p>","publicationid":"86247","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven R; Haraoui B; Emery P; Bingham C; Keystone E; Greenwald M; Moreland LW; Kim D; Cooper S; Wagner B; Ward P<\/span> (2007)<\/span> Safety of rituximab in rheumatoid arthritis: Results of a pooled analysis<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1606<\/span>.<\/p>","publicationid":"81279","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Pope JE; Emery P; Peterfy CG; Tak PP; Cohen S; Genovese M; Williams S; Totoritis M; Cravets M; Shaw T<\/span> (2007)<\/span> Prevention of joint structural damage at 1 year with rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (Reflex study)<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1619<\/span>.<\/p>","publicationid":"78166","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dougados M; Emery P; Westhovens R; Le Bars M; Vratsanos G; Teng J; Beckers J; Aranda R; Kremer J<\/span> (2007)<\/span> Abatacept provides increasing improvements in clinical measures of disease activity over time: Results from the aim trial<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 429<\/span>.<\/p>","publicationid":"75394","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Breedveld F; Martin-Mola E; Pavelka K; Szczepanski L; Hagerty D; Magrini F; Behrendt C; Kelman A<\/span> (2007)<\/span> Relationship between peripheral B cell levels and loss of EULAR response in rheumatoid arthritis patients treated with rituximab<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 124<\/span>.<\/p>","publicationid":"74984","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Bykerk VP; Ferraccioli G; Udell J; van Vollenhoven RF; Rowe K; Agarwal S; Shaw T<\/span> (2007)<\/span> Long-term efficacy and safety of a repeat treatment course of rituximab in ra patients with an inadequate response to disease-modifying antirheumatic drugs<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1611-1612<\/span>.<\/p>","publicationid":"73796","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keenan A; McKenna SP; Doward LC; Conaghan P; Emery P; Tennant A<\/span> (2007)<\/span> OAQol: Development and preliminary validation of a needs-based quality of life measure for osteoarthritis<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 640<\/span>.<\/p>","publicationid":"71291","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mease PJ; Keystone E; Kaell A; Emery P; Clair EWS; Dougados M; Cravets M; Shaw T; Behrendt C; Yocum D<\/span> (2007)<\/span> Predicting outcome of a second course of rituximab for rheumatoid arthritis<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 434<\/span>.<\/p>","publicationid":"71212","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Yocum D; Olech E; Hensor EMA; Emery P; Conaghan PG<\/span> (2007)<\/span> A modification of the EULAR-OMERACT RA MRI score for use with an extremity MRI system with reduced field of view: RAMRIS-RV<\/span>. ANN RHEUM DIS<\/span>, pp. 564-565<\/span>.<\/p>","publicationid":"66188","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tak PP; Cohen SB; Emery P; Saadeh CK; Vita S; Donohue JP; Shaw TM; Magrini F<\/span> (2007)<\/span> Clinical response following the first treatment course with rituximab: Effect of baseline autoantibody status (RF, anti-CCP)<\/span>. ANN RHEUM DIS<\/span>, pp. 338<\/span>.<\/p>","publicationid":"63742","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Crawford A; Jones EA; English A; Mundy J; Henshaw K; Corscadden D; Emery P; McGonagle D; Hatton PV<\/span> (2007)<\/span> Potential of synovial fluid stem cells for cartilage engineering<\/span>. TISSUE ENG<\/span>, pp. 1745<\/span>.<\/p>","publicationid":"63060","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Burgoyne CH; Vital EM; Reece RJ; Rawstron AC; Ponchel F; Emery P<\/span> (2007)<\/span> Reduction in synovial B cell levels after Rituximab in RA predicts clinical response<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 90<\/span>.<\/p>","publicationid":"59416","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Fleischmann RM; Emery P; Chubick A; Dougadoss M; Baldassare AR; Bathon JM; Hessey E; Hagerty D; Coopers S<\/span> (2007)<\/span> Repeated treatment courses of rituximab in rheumatoid arthritis: Sustained efficacy in patients with an inadequate response to one or more TNF inhibitors<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 432<\/span>.<\/p>","publicationid":"58229","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Saleem B; Nizam S; Mackie S; Quinn M; Jarrett S; Hensor E; Conaghan PG; Emery P<\/span> (2007)<\/span> The long term outcome of evolving RA is not influenced by a short course of TNF antagonist therapy<\/span>. ANN RHEUM DIS<\/span>, pp. 186-187<\/span>.<\/p>","publicationid":"56658","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Davys HJ; Turner DE; Butland D; Emery P; Helliwell PS<\/span> (2007)<\/span> Longitudinal data for the leeds foot impact scale<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 278<\/span>.<\/p>","publicationid":"54780","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bejarano V; Quinn MA; Conaghan PG; Reece R; Keenan A; Walker D; Gough A; Green M; McGonagle D; Adebajo A; Jarrett S; Doherty SM; Hordon L; Melsom R; Emery P<\/span> (2007)<\/span> Improved work stability and reduced job loss with adalimumab plus methotrexate in early rheumatoid arthritis: Results of the prevention of work disability (PROWD) study<\/span>. ANN RHEUM DIS<\/span>, pp. 176<\/span>.<\/p>","publicationid":"45021","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Pope JE; Fleischmann R; Emery P; Chubick A; Dougados M; Baldassare AR; Bathon JM; Hessey E; Totoritis M; Cooper S<\/span> (2007)<\/span> Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1617-1618<\/span>.<\/p>","publicationid":"37469","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keenan A; McKenna SP; Doward LC; Conaghan PC; Emery P; Tennant A<\/span> (2007)<\/span> OAQol: Development and preliminary validation of a needs-based quality of life measure for osteoarthritis<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 120-121<\/span>.<\/p>","publicationid":"30154","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Breedveld FC; Khraishi MM; Genovese M; Emery P; Moreland LW; Keystone E; Matteson EL; Burke L; Agarwal S; Kim D; Cooper S<\/span> (2007)<\/span> Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1602<\/span>.<\/p>","publicationid":"22939","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Emery P; Peterfy CG; Tak PP; Cohen SB; Genoveses MC; Williams S; Hagerty D; Cravetss MW; Shaw T<\/span> (2007)<\/span> Inhibition of radiographic progression with rituximab is not dependent on clinical efficacy: Results from a study in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (reflex)<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 431-432<\/span>.<\/p>","publicationid":"16739","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Genovese M; Van Vollenhoven R; Patra K; Sasso E<\/span> (2007)<\/span> Less progression of joint erosion (JE) and joint space narrowing (JSN) with adalimumab plus mtx vs. mtx monotherapy at all levels of clinical response: Subanalysis of premier<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 169<\/span>.<\/p>","publicationid":"16161","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cohen S; Cividino A; Emery P; Greenwald M; Dougados M; Furie R; Burmester GR; Williams S; Cravets M; Magrini F<\/span> (2007)<\/span> Prolonged efficacy of rituximab in rheumatoid arthritis patients and inadequate response to one or more TNF inhibitors: 1-year follow-up of a subset of patients receiving a single course in a controlled trial (reflex study)<\/span>. JOURNAL OF RHEUMATOLOGY<\/span>, pp. 1604-1605<\/span>.<\/p>","publicationid":"9732","date":"2007-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keenan AM; McKenna SP; Doward LC; Conaghan PG; Emery P; Tennant A<\/span> (2007)<\/span> OAQoL: Development and preliminary validation of a needs-based quality of life measure for osteoarthritis<\/span>. RHEUMATOLOGY<\/span>, pp. I62-I63<\/span>.<\/p>","publicationid":"119216","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bejarano V; Quinn M; Conaghan PG; Keenan AM; Reece R; Walker D; Gough AK; Emery P<\/span> (2007)<\/span> Improved work stability and reduced job loss with adalimumab plus methotrexate in early rheumatoid arthritis: Results of the prevention of work disability (PROWD) study<\/span>. RHEUMATOLOGY<\/span>, pp. I8<\/span>.<\/p>","publicationid":"115212","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Ostergaard M; McQueen F; Bird P; Peterfy C; Haavardsholm E; Ejbjerg B; Lassere M; O'Connor P; Emery P; Edmonds J; Genant H; Conaghan PG<\/span> (2007)<\/span> The OMERACT MRI inflammatory arthritis group - Advances and priorities<\/span>. J RHEUMATOL<\/span>, pp. 852-853<\/span>.<\/p>","publicationid":"114994","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Churchman S; Field S; Burgoyne C; Brown A; ElSayed N; Emery P; Ponchel F<\/span> (2007)<\/span> Circulating levels of IL-7 in RA<\/span>. RHEUMATOLOGY<\/span>, pp. I45<\/span>.<\/p>","publicationid":"114363","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coulthard LR; Church LD; Mathews RJ; Churchman S; Dickie L; Buch M; Reece R; English A; Morgan AW; Gay S; Emery P; McDermott MF<\/span> (2007)<\/span> Investigation of the role of P38 mapk alpha and delta isoforms in non-response to TNF blockade in the synovium of rheumatoid arthritis patients<\/span>. RHEUMATOLOGY<\/span>, pp. I44<\/span>.<\/p>","publicationid":"107414","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; Waller ML; Hensor EM; Tanner SF; Jeavons AP; Emery P; McGonagle D<\/span> (2007)<\/span> Further evidence for the importance of ligaments and tendons in the phenotypic expression of hand osteoarthritis - A combined high-resolution positron emission tomography and high-resolution magnetic resonance imaging study<\/span>. RHEUMATOLOGY<\/span>, pp. I15<\/span>.<\/p>","publicationid":"105462","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Churchman SM; Church LD; Hayward B; Savic S; Gooi HC; Emery P; McDermott MF<\/span> (2007)<\/span> A novel splice mutation in TNFRSF1A in a 16 year old male and his mother, both of whom have TNF-receptor associated periodic syndrome (TRAPS)<\/span>. RHEUMATOLOGY<\/span>, pp. I48<\/span>.<\/p>","publicationid":"98429","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Bowman SJ; Vital EM; Ikeda K; Pease CT; Emery P<\/span> (2007)<\/span> Reduction of fatigue in Sjogren's syndrome with rituximab: Results of a randomized, placebo-controlled study<\/span>. RHEUMATOLOGY<\/span>, pp. I5<\/span>.<\/p>","publicationid":"97174","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Reay N; Denton C; Tennant A; Hale C; Hill J; Emery P<\/span> (2007)<\/span> A study of levels of fatigue in diffuse and limited systemic sclerosis<\/span>. RHEUMATOLOGY<\/span>, pp. I23<\/span>.<\/p>","publicationid":"96498","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Keystone EC; Genovese M; van Vollenhoven RF; Breedveld C; Sasso EH; Patra K<\/span> (2007)<\/span> Do patients with early rheumatoid arthritis who discontinue methotrexate after 6 months of therapy experience increased radiographic progression? A subanalysis of premier<\/span>. RHEUMATOLOGY<\/span>, pp. I29<\/span>.<\/p>","publicationid":"94153","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Marzo-Ortega H; Coates LC; Bryer DJ; Bennett AN; Fraser AD; Emery P<\/span> (2007)<\/span> Non-response and switching in ankylosing spondylitis: A rare occurrence<\/span>. RHEUMATOLOGY<\/span>, pp. I59<\/span>.<\/p>","publicationid":"90566","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Laar J; Farge D; Bocelli-Tyndall C; Sont J; Saccardi R; Miniati I; Matucci-Cerinic M; Machold K; Arfi S; Adoue D; Sarrot-Reynauld F; Constans J; Roblot P; Quere I; Durand J; Sibilia J; Himsel A; Kaltwasser J; Peter H; Koetter I; Kleinert S; Tony H; Fassas A; Voskuyl A; Vonk M; van den Hoogen F; Villiger P; Weiner S; Dass S; Emery P; Gratwohl A; Tyndall A<\/span> (2007)<\/span> Autologous stem cell transplantation for severe systemic sclerosis: update on the ASTIS-trial<\/span>. BONE MARROW TRANSPL<\/span>, pp. S96<\/span>.<\/p>","publicationid":"90102","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Marzo-Ortega H; Bryer DJ; Cawkwell LS; Pickles DA; Fraser AD; Emery P<\/span> (2007)<\/span> Sustained response to biological therapies over 2 years in resistant psoriatic arthritis<\/span>. RHEUMATOLOGY<\/span>, pp. I58<\/span>.<\/p>","publicationid":"89852","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Marzo-Ortega H; Bryer DJ; Bennett A; Fraser AD; Emery P<\/span> (2007)<\/span> Non-response to biologic drugs in psoriatic arthritis-'switching' should always be considered<\/span>. RHEUMATOLOGY<\/span>, pp. I54<\/span>.<\/p>","publicationid":"84323","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Freeston JE; Olech E; Conaghan PG; Emery P; Yocum D<\/span> (2007)<\/span> Using extremity MRI in the diagnosis and monitoring of early RA: The optimal joint combination to be scanned in clinical practice<\/span>. RHEUMATOLOGY<\/span>, pp. I85<\/span>.<\/p>","publicationid":"83460","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Field S; Jones E; English A; Reece R; Emery P; Ponchel F<\/span> (2007)<\/span> The regulation of IL-7 production in synovial stromal cells in RA is different from health<\/span>. RHEUMATOLOGY<\/span>, pp. I45<\/span>.<\/p>","publicationid":"82861","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Burgoyne CH; Rawstron AC; Vital EM; Reece RJ; Ponchel F; Emery P<\/span> (2007)<\/span> Predicting response to rituximab in RA: Different effects of B cell depletion in blood and synovium<\/span>. RHEUMATOLOGY<\/span>, pp. I17<\/span>.<\/p>","publicationid":"78537","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coates LC; Marzo-Ortega H; Bryer DJ; Cawkwell LS; Pickles DA; Fraser AD; Emery P<\/span> (2007)<\/span> Sustained response to long-term biologics in ankylosing spondylitis - The majority of patients continue on the same drug after 2 years<\/span>. RHEUMATOLOGY<\/span>, pp. I58<\/span>.<\/p>","publicationid":"78126","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Russell A; Becker JC; Aranda R; Li T; Teng J; Schmidely N; LeBars M; Moreland LW; Westhovens R; Kremer JM<\/span> (2007)<\/span> Abatacept (Aba) provides long-term efficacy and significant sustained benefits in clinical and patient (Pt)-reported outcomes (PROs) through 2 yrs in rheumatoid arthritis (RA) pts with an inadequate response to Methotrexate (MTX): The long-term extension (LTE) of the aim BA in inadequate responders to MTX) trial<\/span>. RHEUMATOLOGY<\/span>, pp. I40<\/span>.<\/p>","publicationid":"59701","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Conaghan PG; Rhodes LA; Hensor EMA; Thomas C; Emery P; Grainger AJ<\/span> (2007)<\/span> A MRI study of the extent of 'Gold Standard'-evaluated synovitis and its relationship to pain in osteoarthritis of the knee<\/span>. RHEUMATOLOGY<\/span>, pp. I14<\/span>.<\/p>","publicationid":"52747","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mathews R; Churchman S; Church L; Coulthard L; Dickie L; Nizam S; Bryer D; Saleem B; Emery P; McDermott M<\/span> (2007)<\/span> Different effects of TNF blockade by infliximab and etanercept on NALP3 and inflammasome regulators in rheumatoid arthritis patients<\/span>. RHEUMATOLOGY<\/span>, pp. I35<\/span>.<\/p>","publicationid":"49834","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Li T; Teng J; Schiff M; Luggen M<\/span> (2007)<\/span> Abatacept provided clinically meaningful improvements in multiple aspects of health-related quality of life (HRQoL) and physical function through 2 years of treatment in patients with active rheumatoid arthritis (RA): Results from the aim and attain trials<\/span>. RHEUMATOLOGY<\/span>, pp. I39<\/span>.<\/p>","publicationid":"33490","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hammond T; Emery P; Aranda R; Becker JC; Zhou Y; Dougados M; Westhovens R<\/span> (2007)<\/span> Abatacept (Aba) provides sustained clinical benefit through 3 yrs in rheumatoid arthritis (RA) patients (Pts) with inadequate responses to methotrexate (MTX)<\/span>. RHEUMATOLOGY<\/span>, pp. I42<\/span>.<\/p>","publicationid":"26005","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Field SL; Jones E; English A; Reece R; Emery P; McGonagle D; Ponchel F<\/span> (2007)<\/span> Mesenchymal stem cells repair capabilities are defectives in RA in relation with in vivo exposure to inflammation<\/span>. RHEUMATOLOGY<\/span>, pp. I19<\/span>.<\/p>","publicationid":"20710","date":"2007-04-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Jones E; Field S; English A; Reece R; Emery P; McGonagle D; Ponchel F<\/span> (2007)<\/span> Mesenchymal stem cell repair capabilities are defective in rheumatoid arthritis in relation with in vivo exposure to inflammation - art. no. P29<\/span>. ARTHRITIS RES THER<\/span>, pp. P29<\/span>. <\/a><\/p>","publicationid":"118955","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P<\/span> (2007)<\/span> Clinical trials: Which is the target population?<\/span> ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A3<\/span>.<\/p>","publicationid":"106116","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Field S; Jones E; English A; Burgoyne C; Churchman S; Reece R; Emery P; Ponchel F<\/span> (2007)<\/span> The regulation of IL-7 production in synovial stromal cells in RA is promiscuous<\/span>. ANN RHEUM DIS<\/span>, pp. A9<\/span>.<\/p>","publicationid":"105738","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Jones E; Kinsey S; English A; Field S; Jones R; Rawstron A; Strazsynski L; Rundlett S; Jain S; Deans R; Emery P; McGonagle D; Ponchel F<\/span> (2007)<\/span> Genomics analysis of freshly-purified human marrow stromal cells (MSCs): Comparison with hematopoietic lineage cells and culture-expanded MSCs<\/span>. ANN RHEUM DIS<\/span>, pp. A8-A9<\/span>.<\/p>","publicationid":"95607","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mathews R; Churchman S; Church L; Coulthard L; Dickie L; Nizam S; Bryer D; Saleem B; Emery P; McDermott M<\/span> (2007)<\/span> Different effect of TNF blockade by infliximab and etanercept on NALP3 and NALP3 inflammasome regulators in rheumatoid arthritis patients<\/span>. ANN RHEUM DIS<\/span>, pp. A21<\/span>.<\/p>","publicationid":"91050","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Churchman S; Field S; Burgoyne C; Brown A; ElSayed N; Emery P; Ponchel F<\/span> (2007)<\/span> Circulating levels of interleukin-7 in RA<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A9<\/span>.<\/p>","publicationid":"88634","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Coulthard LR; Church LD; Mathews RJ; Churchman S; Dickie L; Buch M; Reece R; English A; Morgan AW; Gay S; Emery P; McDermott MF<\/span> (2007)<\/span> Investigation of the role of the p38 MAPK alpha and delta isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients - art. no. P20<\/span>. ARTHRITIS RES THER<\/span>, pp. P20<\/span>. <\/a><\/p>","publicationid":"79924","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Burgoyne CH; Dass S; Vital EM; English A; Coulthard LR; Reece RJ; Rawstron AC; Ponchel F; Emery P<\/span> (2007)<\/span> Synovial B-lymphocyte reduction predicts clinical response in rheumatoid arthritis patients treated with rituximab<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A59<\/span>.<\/p>","publicationid":"79303","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tak PP; Thurlings RM; Dimic A; Mircetic V; Rischmueller M; Nasanov E; Shmidt E; Emery P; Rossier C; Nesterov I; Hill J; Munafo A<\/span> (2007)<\/span> A phase Ib study to investigate atacicept (TACI-Ig) in patients with rheumatoid arthritis<\/span>. ANN RHEUM DIS<\/span>, pp. A10<\/span>.<\/p>","publicationid":"62515","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Jones E; Field S; English A; Reece R; Emery P; McGonagle D; Ponchel F<\/span> (2007)<\/span> Mesenchymal stem cells repair capabilities are defectives in RA in relation with in vivo exposure to inflammation<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A8<\/span>.<\/p>","publicationid":"37036","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Jones E; English A; Crawford A; Mundy J; Henshaw K; Corscadden D; Emery P; Hutton P; McGonagle D<\/span> (2007)<\/span> Comparative analysis of mesenchymal stem cells from normal bone marrow and synovial fluid: Implications for cartilage regeneration strategies<\/span>. ANN RHEUM DIS<\/span>, pp. A20-A21<\/span>.<\/p>","publicationid":"36906","date":"2007-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Davey RJ; Emery P; Bamford J<\/span> (2007)<\/span> Stroke secondary to SLE is associated with increased cerebrovascular reactivity<\/span>. J NEUROL NEUROSUR PS<\/span>, pp. 212<\/span>.<\/p>","publicationid":"109912","date":"2007-02-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Field S; Jones E; English A; Burgoyne C; Churchman S; Reece R; Emery P; Ponchel F<\/span> (2007)<\/span> The regulation of IL-7 production in synovial stromal cells in rheumatoid arthritis is promiscuous<\/span>. ARTHRITIS RESEARCH & THERAPY<\/span>, pp. P28<\/span>. <\/a><\/p>","publicationid":"96453","date":"2007-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Churchman S; Field S; Burgoyne C; Brown A; Emery P; Ponchel F<\/span> (2007)<\/span> Circulating levels of IL-7 in rheumatoid arthritis<\/span>. ARTHRITIS RESEARCH & THERAPY<\/span>, pp. P27<\/span>. <\/a><\/p>","publicationid":"48926","date":"2007-01-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Brown AK; Conaghan PG; Karim Z; Quinn MA; Peterfy CG; Hensor EMA; Ikeda K; Wakefield RJ; O'Connor PJ; Emery P<\/span> (2006)<\/span> The relevance of sub-clinical synovitis in the longitudinal assessment of RA: MRI-detected inflammation predicts structural progression in patients in apparent clinical remission<\/span>. ARTHRITIS RHEUM<\/span>, pp. 4034<\/span>.<\/p>","publicationid":"102164","date":"2006-12-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tak PP; Thurlings RM; Dimic A; Mircetic V; Rischmueller M; Nasanov E; Shmidt E; Emery P; Rossier C; Nesterov I; Hill J; Munafo A<\/span> (2006)<\/span> A phase lb study to investigate atacicept (TACI-Ig) in patients with rheumatoid arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. 4051<\/span>.<\/p>","publicationid":"92463","date":"2006-12-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Bejarano V; Quinn M; Conaghan PG; Keenan AM; Reece RJ; Walker D; Gough AK; Emery P<\/span> (2006)<\/span> Adalimumab plus methotrexate improves work stability and reduces job loss in early rheumatoid arthritis (RA): Results of the pevention of work disability (PROWD) study<\/span>. ARTHRITIS RHEUM<\/span>, pp. 4037-4038<\/span>.<\/p>","publicationid":"89638","date":"2006-12-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Jones EA; Kinsey SE; English A; Field S; Rawstron A; Jones RA; Strazsynskj L; Rundlett S; Jain S; Deans R; Emery P; Ponchel F; McGonagle D<\/span> (2006)<\/span> Genomics analysis of freshly-purified human marrow stromal cells (MSCs): Comparison with hematopoietic lineage cells and culture expanded MSCs<\/span>. BLOOD<\/span>, pp. 726A-727A<\/span>. <\/a><\/p>","publicationid":"68782","date":"2006-11-16","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Wakefield RJ; Freeston JE; Hensor EMA; Bryer D; Quinn MA; Emery P<\/span> (2006)<\/span> Delay in imaging versus clinical response provides rationale for prolonged treatment with anti-TNF in early rheumatoid arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S544<\/span>.<\/p>","publicationid":"121039","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Conaghan PG; Rhodes L; Hensor EM; Thomas C; Emery P; Grainger AJ<\/span> (2006)<\/span> A MRI study of the extent of \"Gold standard\"-evaluated synovitis and its relationship to pain in osteoarthritis of the knee<\/span>. ARTHRITIS RHEUM<\/span>, pp. S822<\/span>.<\/p>","publicationid":"120006","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Marzo-Ortega H; Rhodes LA; Tanner SF; Tan AL; Conaghan PG; Hensor E; Radjenovic A; O'Connor P; Pease C; Emery P; McGonagle D<\/span> (2006)<\/span> Is polymyalgia rheumatica primarily a synovial\/tenosynovial based disease or is the epicentre of inflammation in the extracapsular tissues?: Results from a comprehensive MRI assessment<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S622<\/span>.<\/p>","publicationid":"113315","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Smolen JS; Han C; van der Heijde D; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Aletaha D; Baker D; Han J; Bala M; Clair EW<\/span> (2006)<\/span> Infliximab inhibits radiographic progression regardless of disease activity at baseline and following treatment in patients with early active rheumatoid arthritis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S231<\/span>.<\/p>","publicationid":"111074","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Breedveld F; Martin-Mola E; Pavelka K; Szczepanski L; Kim D; Magrini F; Behrendt C; Kelman A<\/span> (2006)<\/span> Relationship between peripheral B cell return and loss of EULAR response in RA patients treated with rituximab<\/span>. ARTHRITIS RHEUM<\/span>, pp. S66<\/span>.<\/p>","publicationid":"110377","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone EC; Genovese M; Van Vollenhoven RF; Emery P; Breedveld FC; Sasso E; Patra K<\/span> (2006)<\/span> Radiographic progression in patients with early rheumatoid arthritis who discontinued methotrexate after 6 months of therapy: PREMIER subanalysis<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S132-S133<\/span>.<\/p>","publicationid":"103043","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keen H; Cawkwell LS; Barkham N; Pickles D; O'Connor P; Grainger A; Fraser A; Emery P<\/span> (2006)<\/span> The role of MRI imaging in the diagnosis of early inflammatory back pain<\/span>. ARTHRITIS RHEUM<\/span>, pp. S136<\/span>.<\/p>","publicationid":"97237","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Rawstron AC; Vital EM; Jain S; Bingham SJ; McGonagle D; Emery P<\/span> (2006)<\/span> Highly sensitive B cell analysis predicts response to rituximab therapy in RA<\/span>. ARTHRITIS RHEUM<\/span>, pp. S832<\/span>.<\/p>","publicationid":"92315","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Furst DE; Ferraccioli G; Udell J; van Vollenhoven RF; Rowe K; Agarwal S; Shaw T<\/span> (2006)<\/span> Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to disease-modifying anti-rheumatic drugs<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S228<\/span>.<\/p>","publicationid":"84898","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Kremer J; Westhovens R; Russell A; Emery P; Aranda R; Becker JC; Teng J; Schmidely N; Le Bars M; Moreland L<\/span> (2006)<\/span> Long-term efficacy of abatacept through 2 years of treatment in rheumatoid arthritis patients in the AIM trial<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S247<\/span>.<\/p>","publicationid":"79513","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Rawstron AC; Vital EM; Jain S; Sultan S; Pease C; Emery P<\/span> (2006)<\/span> Cell depletion after rituximab in connective tissue diseases predicts outcome but is often incomplete: Results of ffigh sensitivity analysis<\/span>. ARTHRITIS RHEUM<\/span>, pp. S260<\/span>.<\/p>","publicationid":"76977","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Conaghan PG; Hensor EM; Rhodes L; Canvin J; Thomas C; Emery P; Grainger AJ<\/span> (2006)<\/span> The short-term natural history of synovitis and bone marrow lesions in painful osteoarthritis of the knee: A MRI study employing contrast agent<\/span>. ARTHRITIS RHEUM<\/span>, pp. S158-S159<\/span>.<\/p>","publicationid":"73636","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; Benjamin M; Toumi H; Grainger AJ; Tanner SF; Emery P; McGonagle D<\/span> (2006)<\/span> The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis: A high-resolution MRI and histology study<\/span>. ARTHRITIS RHEUM<\/span>, pp. S808<\/span>.<\/p>","publicationid":"73358","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mease P; Keystone E; Kaell A; Emery P; Clair EW; Dougados M; Cravets M; Shaw T; Behrendt C; Yocum D<\/span> (2006)<\/span> Recent disease activity affects outcome of second course of rituximab for RA<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S236<\/span>.<\/p>","publicationid":"71830","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Quinn M; Cox S; Conaghan PG; Keenan AM; Hensor EA; Emery P; YEAR Grp<\/span> (2006)<\/span> A comparison of 12 months two standardized therapies on disease activity in an early rheumatoid arthritis: Results of the Yorkshire Early Arthritis Register<\/span>. ARTHRITIS RHEUM<\/span>, pp. S370<\/span>.<\/p>","publicationid":"70217","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Coulthard L; Rawstron AC; English A; Vital EM; Reece R; Bingham SJ; McDermott M; Emery P<\/span> (2006)<\/span> B cell levels in synovium predict efficacy of rituximab in RA better than those in peripheral blood<\/span>. ARTHRITIS RHEUM<\/span>, pp. S778-S779<\/span>.<\/p>","publicationid":"58166","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese M; Emery P; Ruderman E; Keystone E; Boling E; van Vollenhoven RF; McCabe D; Magrini F; Agarwal S; Cooper S<\/span> (2006)<\/span> B-cell depletion\/repletion patterns, immunoglobulins, and infection rates with repeated rituximab courses<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S779-S780<\/span>.<\/p>","publicationid":"53730","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; Waller ML; Bury RF; Tanner SF; Jeavons AP; Emery P; McGonagle D<\/span> (2006)<\/span> A qualitative assessment of regional bone metabolism and inflammation using high-resolution F-18-Fluoride positron emission tomography and high-resolution MRI in small joint psoriatic arthritis and osteoarthritis<\/span>. ARTHRITIS RHEUM<\/span>, pp. S623-S624<\/span>.<\/p>","publicationid":"47414","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Emery P; Peterfy CG; Tak PP; Cohen SB; Genovese MC; Williams S; Totoritis MC; Cravets MW; Shaw T<\/span> (2006)<\/span> Inhibition of joint structural damage with rituximab is not dependant on clinical response in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (REFLEX study)<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S542-S543<\/span>.<\/p>","publicationid":"46624","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Genovese M; Breedveld FC; Emery P; Moreland LW; Keystone E; Matteson EL; Burke L; Agarwal S; Kim D; Cooper S<\/span> (2006)<\/span> TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab<\/span>. ARTHRITIS RHEUM<\/span>, pp. S329<\/span>.<\/p>","publicationid":"41354","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Fleischmann RM; Emery P; Chubick A; Dougados M; Baldassare AR; Bathon JM; Hessey E; Totoritis M; Cooper S<\/span> (2006)<\/span> Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors<\/span>. ARTHRITIS RHEUM<\/span>, pp. S328<\/span>.<\/p>","publicationid":"31987","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tak PP; Cohen S; Emery P; Saadeh CK; De Vita S; Donohue JP; McCabe DP; Shaw T; Magrini F<\/span> (2006)<\/span> Baseline autoantibody status (RF, anti-CCP) and clinical response following the first treatment course with rituximab<\/span>. ARTHRITIS AND RHEUMATISM<\/span>, pp. S368-S369<\/span>.<\/p>","publicationid":"28295","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Luggen M; Emery P; Li T; McCann T; Teng J; Schiff M<\/span> (2006)<\/span> Abatacept provided clinically meaningful improvements in multiple aspects of health related quality of life (HRQoL) and physical function through 2 years of treatment in patients with active rheumatoid arthritis (RA): Results from the AIM and ATTAIN trials<\/span>. ARTHRITIS RHEUM<\/span>, pp. S423-S424<\/span>.<\/p>","publicationid":"20676","date":"2006-09-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cohen S; Emery P; Greenwald M; Dougados M; Furie R; Burmester G; Williams S; Cravets M; Magrini F<\/span> (2006)<\/span> Prolonged efficacy of rituximab in rheumatoid arthritis patients with inadequate response to one or more TNF inhibitors: 1-year follow-up of a subset of patients receiving a single course in a controlled trial (Reflex study)<\/span>. ANN RHEUM DIS<\/span>, pp. 183<\/span>.<\/p>","publicationid":"119615","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Rawstron AC; Vital EM; Jain S; Pease CT; Emery P<\/span> (2006)<\/span> Peripheral blood B cells often persist after rituximab therapy in connective tissue diseases: Results from high sensitivity flow cytometry<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 63-64<\/span>.<\/p>","publicationid":"113792","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Redmond AC; Barkham N; Keen HI; Cawkwell L; Pickles DA; Fraser A; Emery P<\/span> (2006)<\/span> Gait parameters are valid outcome measures for studies of ankylosing spondylitis<\/span>. ANN RHEUM DIS<\/span>, pp. 539<\/span>.<\/p>","publicationid":"110648","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Furst DE; Ferraccioli G; Udell J; Van Vollenhoven RF; Rowe K; Agarwa S; Shaw T<\/span> (2006)<\/span> Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to disease-modifying anti-rheumatic drugs<\/span>. ANN RHEUM DIS<\/span>, pp. 58<\/span>.<\/p>","publicationid":"97545","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Davys HJ; Turner DE; Helliwell PS; Emery P<\/span> (2006)<\/span> Foot ulceration in patients with rheumatic diseases<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 669<\/span>.<\/p>","publicationid":"95718","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Emery P; Peterfy CG; Tak PP; Cohen S; Genovese M; Williams S; Totoritis M; Cravets M; Shaw T<\/span> (2006)<\/span> Prevention of joint structural damage at 1 year with rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (reflex study)<\/span>. ANN RHEUM DIS<\/span>, pp. 58<\/span>.<\/p>","publicationid":"89709","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Cohen SB; Greenwald M; Dougados M; Emery P; Furie R; Shaw T; Totoritis M<\/span> (2006)<\/span> Efficacy and safety of rituximab in active RA patients who experienced inadequate responses to one or more TNF inhibitors<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 108-109<\/span>.<\/p>","publicationid":"86939","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan A; Grainger AJ; Toumi H; Benjamin M; Tanner SF; Emery P; McGonagle D<\/span> (2006)<\/span> Distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis - Are they the same? A high-resolution mri and histology study<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 68<\/span>.<\/p>","publicationid":"85260","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Breedveld FC; Genovese M; Emery P; Moreland LW; Keystone E; Matteson EL; Burke L; Agarwal S; Kim D; Cooper S<\/span> (2006)<\/span> Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 178-179<\/span>.<\/p>","publicationid":"84281","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan A; Waller M; Grainger A; Tanner S; Emery P; Benjamin M; McGonagle D<\/span> (2006)<\/span> High-resolution PET & high-resolution MRI assessment of hand osteoarthritis<\/span>. ANN RHEUM DIS<\/span>, pp. 21-22<\/span>.<\/p>","publicationid":"78957","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Quinn M; Conaghan PG; Keenan A; Hensor E; Emery P<\/span> (2006)<\/span> Quality of life (QOL) in recently diagnosed rheumatoid arthritis: Results from the Yorkshire early arthritis register<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 486<\/span>.<\/p>","publicationid":"75081","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Emery P; Fleischmann R; Martin-Mola E; Schechtman J; Van Vollenhoven RF; Alloway J; Mitchell V; Garg J; Shaw T<\/span> (2006)<\/span> Prolonged efficacy of rituximab in rheumatoid arthritis patients with with an inadequate response to methotrexate: 1 year follow-up of a subset of patients receiving a single course in a controlled trial (DANCER trial)<\/span>. ANN RHEUM DIS<\/span>, pp. 190<\/span>.<\/p>","publicationid":"69518","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Conaghan PG; Quinn M; Hensor E; Keenan A; Emery P<\/span> (2006)<\/span> PISA: Predictive capacity in an early RA cohort<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 146<\/span>.<\/p>","publicationid":"67783","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Coulthard L; Rawstron AC; English A; Vital EM; Reece R; Bingham SJ; McDermott M; Emery P<\/span> (2006)<\/span> Response to rituximab therapy in RA correlates with variable B cell expression in peripheral blood and synovium<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 186<\/span>.<\/p>","publicationid":"57354","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

van Vollenhoven RF; Emery P; Bingham C; Keystone E; Greenwalds M; Moreland LW; Kim D; Cooper S; Wagner B; Ward P<\/span> (2006)<\/span> Safety of rituximab in rheumatoid arthritis: Results of a pooled analysis<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 332<\/span>.<\/p>","publicationid":"57109","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Gomez-Reino JJ; Dasgupta B; Haugeberg G; Descalzo MA; Hutchings A; Conaghans P; Pampin EP; Hollywood J; Morton S; Carmona L; Lamping D; Proudman S; Pease C; Stewarts S; Chakravarty K; Emery P; Silverman B; Hazleman B; Scott DGI; Choy E; Bourke B; Gendl N<\/span> (2006)<\/span> Mortality rate is reduced in ra patients treated with TNF antagonists. Data from biobadaser<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 318<\/span>.<\/p>","publicationid":"50825","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Dass S; Rawstron AC; Vital EM; Jain S; Bingham SJ; McGonagle D; Emery P<\/span> (2006)<\/span> Specific peripheral blood B-lineage cells predict response to rituximab therapy in RA: A study with high sensitivity flow cytometry<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 185<\/span>.<\/p>","publicationid":"49814","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Keystone E; Fleischmann R; Emery P; Chubick A; Dougados M; Baldassares AR; Bathon JM; Hessey E; Totoritis M; Cooper S<\/span> (2006)<\/span> Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors<\/span>. ANN RHEUM DIS<\/span>, pp. 323-324<\/span>.<\/p>","publicationid":"38185","date":"2006-07-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Hoyles RK; Ellis RW; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM<\/span> (2005)<\/span> Fibrosing Alveolitis in scleroderma trial (FAST) - A multi-centre prospective randomised double-blind placebo-controlled trial<\/span>. ARTHRITIS RHEUM<\/span>, pp. 4110<\/span>.<\/p>","publicationid":"42027","date":"2005-12-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Marzo-Ortega H; Green M; Keenan AM; Wakefield R; Proudman S; Emery P<\/span> (2005)<\/span> A randomised trial of intra-articular corticosteroids versus conservative treatment in early oligoarthritis over 12 months<\/span>. RHEUMATOLOGY<\/span>, pp. I90<\/span>.<\/p>","publicationid":"119549","date":"2005-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Tan AL; Madden J; Sutton L; Muralikuttan K; Emery P; Conaghan PG; McGonagle D<\/span> (2005)<\/span> An open label study of pamidronate for spinal osteoarthritis associated with MRI determined bone oedema<\/span>. RHEUMATOLOGY<\/span>, pp. I48-I49<\/span>.<\/p>","publicationid":"74697","date":"2005-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Rhodes LA; Tan AL; Tanner SF; Radjenovic A; Marzo-Ortega H; O'Connor P; Emery P; McGonagle D<\/span> (2005)<\/span> A study of the differences in synovial volumes in early and late inflammatory arthritis using dynamic enhanced MRI<\/span>. RHEUMATOLOGY<\/span>, pp. I97<\/span>.<\/p>","publicationid":"49863","date":"2005-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Lawson CA; Brown AK; Field SL; Burgoyne C; Emery P; Isaacs JD; Ponchel F<\/span> (2005)<\/span> A role for IL-7 in regulating CD4(+)CD25(high) regulatory T cells<\/span>. RHEUMATOLOGY<\/span>, pp. I20<\/span>.<\/p>","publicationid":"34579","date":"2005-03-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Mackie S; Robinson JI; Barrett JH; Lawson CA; Martin S; Haroon-Rashid L; Cooper D; Bowman SJ; Pease CT; Conaghan PG; Green M; Quinn M; Isaacs JD; Emery P; Morgan AW<\/span> (2005)<\/span> Association of FCGR3A and FCGR3B haplotypes with rheumatoid arthritis and primary Sjogren's syndrome<\/span>. ARTHRITIS RES THER<\/span>, pp. S45<\/span>. <\/a> <\/a><\/p>","publicationid":"107034","date":"2005-02-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Brown A; Ponchel F; Isaacs J; Emery P<\/span> (2005)<\/span> The persistence of abnormal T-cell differentiation patterns predicts relapse in rheumatoid arthritis patients with controlled disease<\/span>. ARTHRITIS RESEARCH & THERAPY<\/span>, pp. S20<\/span>. <\/a><\/p>","publicationid":"82377","date":"2005-02-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Buch MH; Snow K; Field S; Emery P; Isaacs J; Ponchel F<\/span> (2005)<\/span> The signalling signature downstream of the notch receptor in CD4(+)CD25(high) regulatory T cells in RA defines anergic cells: insight into resistance to anti-tumour necrosis factor therapies<\/span>. ARTHRITIS RESEARCH & THERAPY<\/span>, pp. S11<\/span>. <\/a><\/p>","publicationid":"62018","date":"2005-02-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Brown AK; Karim Z; Quinn MA; Wakefield RW; Conaghan PG; O'Connor P; Emery P<\/span> (2001)<\/span> AB0202\u2005The increasing use of ultrasonography to guide corticosteroid injections<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. A267-A268<\/span>. <\/a><\/p>","publicationid":"944246","date":"2001-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Lassere MN; McQueen F; Ostergaard M; Conaghan P; Shnier R; Peterfy C; Klarlund M; Stewart N; O'Connor P; Bird P; Edmonds J; Emery P; Genant H<\/span> (2001)<\/span> THU0185\u2005Reliability of ra mri scoring<\/span>. Annals of the Rheumatic Diseases<\/span>, pp. A428<\/span>. <\/a><\/p>","publicationid":"829429","date":"2001-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Karim Z; Brown AK; Connor PJO; Quinn M; Jackson G; Wakefield RJ; Conaghan PG; Emery P<\/span> (2001)<\/span> AB0200\u2005Do ultrasound-guided corticosteroid injections provide short-term relief of symptoms in patients waiting total hip replacement?<\/span> Annals of the Rheumatic Diseases<\/span>, pp. A267<\/span>. <\/a><\/p>","publicationid":"829428","date":"2001-06-01","publicationtype":"Conference paper","isfavourite":"0"},{"html":"

Willison HJ; Lastovica AJ; Prendergast MM; Moran AP; Walsh C; Flitcroft I; Eustace P; McMahon C; Smith J; Smith OP; Lakshmandass G; Taylor MRH; Holland CV; Cox D; Good B; Kearns GM; Gaffney P; Shark K; Frauenshuh M; Ortmann W; Messner R; King R; Rich S; Behrens T; Mahmud N; Molloy A; McPartlin J; Scott JM; Weir DG; Walsh KM; Thorburn D; Mills P; Morris AJ; Good T; Cameron S; McCruden EAB; Bennett MW; O\u2019Connell J; Brady C; Roche D; Collins JK; Shanahan F; O\u2019Sullivant GC; Henry M; Koston S; McMahon K; MacNee W; FitzGerald MX; O\u2019Connor CM; McGonagle D; Gibbon W; O\u2019Connor P; Emery P; Murphy M; Watson R; Casey E; Naidu E; Murphy M; Watson R; Barnes L; McCann S; Murphy M; Watson R; Barnes L; Sweeney E; Barrett EJ; Graham H; Cunningham RT; Johnston CF; Curry WJ; Buchanan KD; Courtney CH; McAllister AS; McCance DR; Hadden DR; Bell PM; Leslie H; Sheridan B; Atkinson AB; Kilbane MT; Smith DF; Murray MJ; Shering SG; McDermott EWM; O\u2019Higgins NJ; Smyth PPA; McEneny J; Trimble ER; Young IS; Sharpe P; Mercer C; McMaster D; Young IS; Evans AE; Young IS; Cundick J; Hasselwander O; McMaster D; McGeough J; Savage D; Maxwell AP; Evans AE; Kee F; Larkin CJ; Watson RGP; Johnston C; Ardill JES; Buchanan KD; McNamara DA; Walsh TN; Bouchier-Hayes DJ; Madden C; Timon C; Gardiner N; Lawler M; O\u2019Riordan J; Duggan C; McCann SR; Gowing H; Braakman E; Lawler M; Byrne C; Martens ACM; Hagenbeek A; McCann SR; Kinsella N; Cusack S; Lawler M; Baker H; White B; Smith OP; Lawler M; Gardiner N; Molloy K; Gowing H; Wogan A; McCann SR; McElwaine S; Lawler M; Hollywood D; McCann SR; Mcmahon C; Merry C; Ryan M; Smith O; Mulcahy FM; Murphy C; Briones J; Gardiner N; McCann SR; Lawler M; White B; Lawler M; Cusack S; Kinsella N; Smith OP; Lavin P; McCaffrey M; Gillen P; White B; Smith OP; Thompson L; Lalloz M; Layton M; Barnes L; Corish C; Kennedy NP; Flood P; Mulligan S; McNamara E; Kennedy NP; Flood P; Mathias PM; Ball E; Duiculescu D; Calistru P; O\u2019Gorman N; Kennedy NP; Abuzakouk M; Feighery C; Brannigan M; Pender S; Keeling F; Varghese J; Lee M; Colreavy M; Gaffney R; Hone S; Herzig M; Walsh M; Dolan C; Wogan A; Lawler M; McCann SR; Hollywood D; Donovan D; Harmey J; Bouchier-Hayes DJ; Haverty A; Wang JH; Harmey JH; Redmond HP; Bouchier-Hayes DJ; McGreal G; Shering SG; Moriarty MJ; Shortt A; Kilbane MT; Smith DF; McDermott EWM; O\u2019Higgins NJ; Smyth PPA; McNamara DA; Harmey J; Wang JH; Donovan D; Walsh TN; Bouchier-Hayes DJ; Kay E; Pidgeon G; Harmey J; McNamara DA; Bouchier-Hayes DJ; Dunne P; Lambkin H; Russell JM; O\u2019Neill AJ; Dunne BM; O\u2019Donovan M; Lawler M; Gaffney EF; Gillan JE; Cotter TG; Horan J; Jones D; Biswas SK; Mulkerrin EC; Brady H; O\u2019Donnell J; Neary J; Healy E; Watson A; Keogh B; Ryan M; Cassidy C; Ward S; Stokes E; Keoghan F; Barrett A; O\u2019Connell P; Ryall N; O\u2019Connell PA; Jenkinson A; O\u2019Brien T; O\u2019Connell PG; Harrison R; Barrett T; Bailey DMD; Butler A; Barton DE; Byrne C; McElwaine S; McCann SR; Lawler M; Cusack S; Lawler M; White B; Smith OP; Daly G; Gill M; Heron S; Hawi Z; Fitzgerald M; Hawi Z; Mynett-Johnson L; Shiels D; Kendler K; McKeon P; Gill M; Straub R; Walsh D; Ryan F; Barton DE; McCabe D; Murphy R; Segurado R; Mulcahy T; Larson B; Comerford C; O\u2019Connell R; O\u2019Mahony E; Gill M; Donnelly J; Minahan F; O\u2019Neill D; Farrell Z; O\u2019Neill D; Jones D; Horan J; Glynn C; Biswas SK; Mulkerrin E; Brady H; Lennox SE; Murphy A; Rea IM; McNulty H; McMeel C; O\u2019Neill D; McEvoy H; Freaney R; McKenna MJ; Crowe M; Keating D; Colreavy M; Hone S; Norman G; Widda S; Viani L; Galvin; Nolan CM; Hardiman O; Hardiman O; Brett F; Droogan O; Gallagher P; Harmey M; King M; Murphy J; Perryrnan R; Sukumaran S; Walsh J; Farrell MA; Hughes G; Cunningham C; Walsh JB; Coakley D; O\u2019Neill D; Hurson M; Flood P; McMonagle P; Hardiman O; Ryan F; O\u2019Sullivan S; Merry C; Dodd P; Redmond J; Mulcahy FM; Browne R; Keating S; O\u2019Connor J; Cassidy BP; Smyth R; Sheppard NP; Cullivan R; Crown J; Walsh N; Denihan A; Bruce I; Radic A; Coakley D; Lawlor BA; Bridges PK; O\u2019Doherty M; Farrington A; O\u2019Doherty M; Farragher B; Fahy S; Kelly R; Carey T; Owens J; Gallagher O; Sloan D; McDonough C; Casey P; Horgan A; Elneihum A; O\u2019Neill C; McMonagle T; Quinn J; Meagher D; Murphy P; Kinsella A; Mullaney J; Waddington JL; Rooney S; Rooney S; Bamford L; Sloan D; O\u2019Connor JJ; Franklin R; O\u2019Brien K; Fitzpatrick G; Laffey JG; Boylan JF; Laffey J; Coleman M; Boylan J; Laffey JG; McShane AJ; Boylan JF; Loughrey JPR; Gardiner J; McGinley J; Leonard I; Carey M; Neligan P; O\u2019Rourke J; Cunningham A; Fennessy F; Kelly C; Bouchier-Hayes D; Fennessy F; Wang JH; Kelly C; Bouchier-Hayes D; Fennessy F; Wang JH; Kelly C; Bouchier-Hayes DJ; Kellett J; Laffey J; Murphy D; Regan J; O\u2019Keeffe D; Mahmud A; Hemeryck L; Feely J; Mahmud A; Hemeryck L; Hall M; Feely J; Menown IBA; Mathew TP; Nesbitt GS; Syme M; Young IS; Adgey AAJ; Menown IBA; Turtle F; Allen J; Anderson J; Adgey AAJ; O\u2019Hanlon R; Codd MB; Walkin S; McCann HA; Sugrue DD; Rasheed AM; Chen G; Kelly C; Bouchier-Hayes DJ; Leahy A; Rasheed AM; Kay E; Jina S; Bouchier-Hayes DJ; Leahy A; McDowell I; Rasheed AM; Wang JH; Wo Q; Kelly C; Bouchier-Hayes DJ; Leahy A; Shuhaibar MN; McGovern E; Turtle F; Menown IBA; Manoharan G; Kirkpatrick R; Campbell NPS; Walkin S; Codd MB; O\u2019Hanlon R; McCarthy C; McCann HA; Sugrue DD; Wen Y; Killalea S; Hall M; Hemeryck L; Feely J; Fahy CJ; Griffith A; McGinley J; McCabe D; Fraser A; Casey E; Ryan T; Murphy R; Browne M; Fenton J; Hughes J; Timon CI; Fenton J; Curran A; Smyth D; Viani L; Walsh M; Hughes JP; Fenton J; Lee P; Kelly A; Timon CI; Hughes JP; Fenton J; Shine N; Blayney A; McShane DP; Timon CI; Hussey J; Howlett M; Langton A; McEvoy A; Slevin J; Fitzpatrick C; Turner MJ; Enright F; Goggin N; Costigan C; Duff D; Osizlok P; Wood F; Watson R; Fitzsimons RB; Flanagan N; Enright F; Barnes L; Watson R; Molloy E; Griffin E; Deasy PF; Sheridan M; White MJ; Moore R; Gray A; Hill J; Glasgow JFT; Middleton B; Slattery D; Donoghue V; McMahon A; Murphy J; Slattery D; McCarthy A; Oslislok P; Duff D; Colreavy M; Keogh I; Hone S; Walsh M; Henry M; Koston S; McMahon K; MacNee W; FitzGerald MX; O\u2019Connor CM; Russell KJ; Henry M; Fitzgerald MX; O\u2019Connor CM; Kavanagh PV; McNamara SM; Feely J; Barry M; O\u2019Brien JE; McCormick P; Molony C; Doyle RM; Walsh JB; Coakley D; Codd MB; O\u2019Connell PR; Dowey LC; McGlynn H; Thurnham DI; Elborn SJ; Flynn L; Carton J; Byrne B; O\u2019Farrelly C; Kelehan P; O\u2019Herlihy C; O\u2019Hara AM; Moran AP; Orren A; Fernie BA; Merry C; Clarke S; Courtney G; de Gascun C; Mulcahy FM; Merry C; Ryan M; Barry M; Mulcahy FM; Merry C; Ryan M; Barry M; Mulcahy FM; Byrne M; Moylett E; Murphy H; Butler K; Nourse C; Thaker H; Barry C; Russell J; Sheehan G; Boyle B; Hone R; Conboy B; Butler C; Moris D; Cormican M; Flynn J; McCormack O; Corbally N; Murray A; Kirrane S; O\u2019Keane C; Hone R; Lynch SM; Cryan B; Whyte D; Morris D; Butler C; Cormican M; Flynn J; Corbett-Feeney G; Murray A; Corbally N; Hone R; Mackle T; Colreavy M; Perkins J; Saidlear C; Young A; Eustace P; Wrigley M; Clifford J; Waddington JL; Tighe O; Croke DT; Drago J; Sibley DR; Feely J; Kelly A; Carvalho M; Hennessy M; Kelly M; Feely J; Hughes C; Hanlon M; Feely J; Sabra K; Keane T; Egan D; Ryan M; Maerry C; Ryan M; Barry M; Mulcahy FM; Maerry C; Ryan M; Barry M; Mulcahy FM; Sharma SC; Williams D; Kelly A; Carvalho M; Feely J; Williams D; Kelly A; Carvalho M; Feely J; Codd MB; Mahon NG; McCann HA; Sugrue DD; Sayers GM; Johnson Z; McNamara SM; Kavanagh PV; Feely J<\/span> (1998)<\/span> National Scientific Medical meeting. 27-28 March 1998. Abstracts<\/span>. Ir J Med Sci<\/span>, pp. 1-46<\/span>. <\/a><\/p>","publicationid":"188255","date":"1998-01-01","publicationtype":"Conference paper","isfavourite":"0"}],"presentation_conference_workshop_etc_":[{"html":"

Yusof MYM; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital E; Emery P<\/span> (2022)<\/span> BREAKTHROUGH INFECTIONS AND PREDICTING SEVERE COVID OUTCOMES DURING RITUXIMAB THERAPY IN AUTOIMMUNE RHEUMATIC DISEASES<\/span>. EULAR 2022 European Congress of Rheumatology<\/span>, pp. 164<\/span>. <\/a> <\/a><\/p>","publicationid":"596603","date":"2022-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Arnold JE; Vital EMJ; Dass S; Aslam A; Rawstron AC; Savic S; Emery P; Yusof Y<\/span> (2021)<\/span> A PROPOSAL FOR INDIVIDUALLY TAILORED RITUXIMAB TREATMENT BASED ON CLINICAL AND B-CELL BIOMARKERS FOR REMISSION MAINTENANCE IN ANCA ASSOCIATED VASCULITIS<\/span>. British Society for Rheumatology Annual Conference 2021<\/span>, pp. 113<\/span>. <\/a> <\/a><\/p>","publicationid":"563290","date":"2021-04-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Arnold J; Vital E; Dass S; Aslam A; Rawstron A; Savic S; Emery P; Yusof MYM<\/span> (2021)<\/span> A PERSONALISED RITUXIMAB RETREATMENT APPROACH BASED ON CLINICAL AND B-CELL BIOMARKERS IN ANCA-ASSOCIATED VASCULITIS<\/span>. EULAR 2021<\/span>, pp. 30<\/span>. <\/a> <\/a><\/p>","publicationid":"568359","date":"2021-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Dubash S; Alabas OA; Michelena X; Garcia-Montoya L; Wakefield R; Tan A-L; Helliwell P; Emery P; McGonagle D; Marzo-Ortega H<\/span> (2021)<\/span> DACTYLITIS IS ASSOCIATED WITH GREATER DISEASE SEVERITY, CRP, ULTRASOUND DETERMINED SYNOVITIS, AND EROSIVE DAMAGE IN DMARD-NAIVE EARLY PsA<\/span>. British Society for Rheumatology Annual Conference 2021<\/span>, pp. 6<\/span>. <\/a> <\/a><\/p>","publicationid":"563295","date":"2021-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Farrow M; Biglands J; Tanner S; Hensor E; Buch MH; Emery P; Tan AL<\/span> (2020)<\/span> MUSCLE DETERIORATION DUE TO RHEUMATOID ARTHRITIS: ASSESSMENT BY QUANTITATIVE MRI AND STRENGTH TESTING<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. 204<\/span>. <\/a><\/p>","publicationid":"538535","date":"2020-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Dubash S; Alabas O; Michelena X; Garcia-Montoya L; De Marco G; Merashli M; Wakefield R; Helliwell P; Mcgonagle D; Tan AL; Emery P; Marzo-Ortega H<\/span> (2020)<\/span> SWOLLEN JOINTS ARE ASSOCIATED WITH ULTRASOUND POWER DOPPLER SYNOVITIS, WHEREAS TENDER JOINTS IN THE ABSENCE OF SWELLING ARE NOT: AN ANALYSIS OF AGREEMENT AND CORRELATION IN VERY EARLY DMARD NAIVE PSORIATIC ARTHRITIS<\/span>. European League Against Rheumatism (EULAR) 2020<\/span>, pp. 1148<\/span>. <\/a> <\/a><\/p>","publicationid":"538138","date":"2020-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Dubash S; Alabas O; Michelena X; De Marco G; Garcia-Montoya L; Wakefield R; Tan AL; Helliwell P; Emery P; Mcgonagle D; Marzo-Ortega H<\/span> (2020)<\/span> DACTYLITIS IS ASSOCIATED WITH DISEASE SEVERITY AND ULTRASOUND DEFINED EROSIVE DAMAGE IN VERY EARLY, DMARD NAIVE PSORIATIC ARTHRITIS<\/span>. EULAR<\/span>, pp. 1155-1156<\/span>. <\/a> <\/a><\/p>","publicationid":"538134","date":"2020-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Di Matteo A; Mankia K; Duquenne L; Mahler M; Corscadden D; Mbara K; Garcia-Montoya L; Nam J; Emery P<\/span> (2020)<\/span> THIRD GENERATION APCA IMPROVE PREDICTION OF CLINICAL ARTHRITIS IN AT-RISK INDIVIDUALS WITH POSITIVE SECOND GENERATION ACPA<\/span>. British Society for Rheumatology Annual Conference 2020<\/span>, pp. keaa111.233<\/span>. <\/a> <\/a><\/p>","publicationid":"529236","date":"2020-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Yusof MYM; Robinson J; El-Sherbiny Y; Rawstron AC; Emery P; Morgan A; Vital E<\/span> (2019)<\/span> THE EFFECT OF FCGR3A POLYMORPHISM ON THE INITIAL DEPTH OF B-CELL DEPLETION BY RITUXIMAB, FUNCTIONAL NK-CELL MEDIATED KILLING AND CLINICAL RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS<\/span>. Annual European Congress of Rheumatology, EULAR 2019<\/span>, pp. 1069-1070<\/span>. <\/a> <\/a><\/p>","publicationid":"501828","date":"2019-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Perez-Witzke D; Tiede C; Robinson JI; Tomlinson D; Emery P; Ponchel F<\/span> (2019)<\/span> IDENTIFICATION OF AFFIMERS THAT BIND TO THE IL-7R AND INHIBITS THE IL-7 SIGNALLING CASCADE<\/span>. ANNALS OF THE RHEUMATIC DISEASES<\/span>, pp. A61-A62<\/span>. <\/a><\/p>","publicationid":"498795","date":"2019-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Dutton K; Psarras A; El-Sherbiny Y; Yusof MYM; Emery P; Vital E<\/span> (2018)<\/span> IN SLE PATIENTS IN SUSTAINED LOW DISEASE ACTIVITY, NOVEL INTERFERON ASSAYS PREDICT FLARES AND GLUCOCORTICOID REQUIREMENTS<\/span>. Annual European Congress of Rheumatology, EULAR 2018<\/span>, pp. 112-113<\/span>. <\/a> <\/a><\/p>","publicationid":"481082","date":"2018-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Elies J; Liakouli V; Abignano G; Esteves F; Emery P; Denton C; Giacomelli R; Mavria G; Del Galdo F<\/span> (2017)<\/span> SCLERODERMA FIBROBLASTS SUPPRESS ANGIOGENESIS VIA TGF-\u03b2\/CAVEOLIN-DEPENDENT SECRETION OF PIGMENTED EPITHELIUM DERIVED FACTOR: TGF-\u03b2 RECEPTOR INHIBITORS AS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF SCLERODERMA<\/span>. 37th SEF National Meeting with guest society: the British Pharmacology Society<\/span>, pp. 51<\/span>. <\/a> <\/a><\/p>","publicationid":"438143","date":"2017-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Merashli M; De Marco G; Tan AL; Emery P; Mcgonagle D; Helliwell P; Marzo-Ortega H<\/span> (2016)<\/span> BASELINE CLINICAL CHARACTERISTICS OF THE LEEDS SPARRO EARLY PSORIATIC ARTHRITIS COHORT: HIGH DISEASE AND RADIOGRAPHIC INVOLVEMENT ARE SEEN EARLY EVEN IN THE PRESENCE OF PRESERVED QUALITY OF LIFE<\/span>. Annual European Congress of Rheumatology 2016<\/span>, pp. 1144<\/span>. <\/a> <\/a><\/p>","publicationid":"429575","date":"2016-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Merashli M; Horton L; Hensor E; De Marco G; D'agostino MA; Tan AL; Emery P; Mcgonagle D; Marzo-Ortega H<\/span> (2016)<\/span> HIGH PREVALENCE OF US DETERMINED SUBCLINICAL SYNOVITIS IN EARLY PSORIATIC ARTHRITIS CORRELATES BETTER WITH THE SJC RATHER THAN TJC: RESULTS FROM THE LEEDS SPARRO COHORT<\/span>. European League Against Rheumatism Annual Congress 2016<\/span>, pp. 607<\/span>. <\/a> <\/a><\/p>","publicationid":"429569","date":"2016-01-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"},{"html":"

Md Yusof MY; Vital E; Dass S; Pease C; Martin M; Savic S; Buch M; Emery P<\/span> (2013)<\/span> FRI0334\u2005Safety of rituximab for remission maintenance in relapsing anca\u2013associated vasculitis: repeat cycles on clinical relapse are associated with low rates of hypogammaglobulinaemia<\/span>. Annual European Congress of Rheumatology EULAR<\/span>, pp. A487<\/span>. <\/a> <\/a><\/p>","publicationid":"281368","date":"2013-06-01","publicationtype":"Presentation (conference\/workshop etc)","isfavourite":"0"}],"book":[{"html":"

Emery P<\/span> (2011)<\/span> Pocket Reference to Early Rheumatoid Arthritis<\/span>. Springer Healthcare Ltd<\/a>. <\/a><\/p>","publicationid":"1103499","date":"2011-01-01","publicationtype":"Book","isfavourite":"0"},{"html":"

Emery P<\/span> (2003)<\/span> Pocket Pharma: Adalimumab and Rheumatoid Arthritis<\/span>. Science Press<\/span>.<\/p>","publicationid":"5378","date":"2003-01-01","publicationtype":"Book","isfavourite":"0"},{"html":"

Emery P; Marzo-Ortega H; Conaghan P<\/span> (2001)<\/span> Visual diagnosis self-tests. Rheumatology<\/span>.<\/p>","publicationid":"96973","date":"2001-01-01","publicationtype":"Book","isfavourite":"0"},{"html":"

Adu D; Emery P; Madaio M<\/span> (2001)<\/span> Rheumatology and the Kidney<\/span>. Oxford University Press<\/span>.<\/p>","publicationid":"37311","date":"2001-01-01","publicationtype":"Book","isfavourite":"0"},{"html":"

Vane JR; Botting R; Emery P; Hawkey CJ<\/span> (1999)<\/span> Clinician's Manual on Cox-2 Inhibition - Second Edition<\/span>. Second<\/span>, Science Press<\/span>.<\/p>","publicationid":"105979","date":"1999-01-01","publicationtype":"Book","isfavourite":"0"},{"html":"

Vane JR; Botting R; Emery P<\/span> (1999)<\/span> Clinician's Manual on Cox-2 Inhibition and Arthritis<\/span>. Science Press<\/span>.<\/p>","publicationid":"96829","date":"1999-01-01","publicationtype":"Book","isfavourite":"0"}],"chapter":[{"html":"

Deane KD; Aletaha D; Bathon JM; Emery P; Fragoulis GE; Holers VM; Huizinga TWJ; Kolfenbach JR; O\u2019Dell JR; Pearson DW; Park E; Smolen J; Tanaka Y; Taylor PC; van der Helm-van Mil A; van Vollenhoven RF; St. Clair EW<\/span> (2023)<\/span> Rheumatoid Arthritis<\/span>. A Clinician S Pearls and Myths in Rheumatology Second Edition<\/span>, Springer International Publishing<\/a>, pp. 1-23<\/span>. <\/a><\/p>","publicationid":"630637","date":"2023-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Coates L; Savage L; Emery P<\/span> (2016)<\/span> Pathogenesis of psoriasis and psoriatic arthritis<\/span>. Handbook of Psoriasis and Psoriatic Arthritis<\/span>, Springer International Publishing<\/a>, pp. 7-16<\/span>. <\/a><\/p>","publicationid":"1103570","date":"2016-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Bissell L-A; Adu D; Emery P<\/span> (2015)<\/span> The patient with rheumatoid arthritis, mixed connective tissue disease, Sj\u00f6gren syndrome, or polymyositis<\/span>. In: Remuzzi G ed<\/span> Oxford Textbook of Clinical Nephrology<\/span>, Oxford University Press<\/a>. <\/a> <\/a><\/p>","publicationid":"321010","date":"2015-10-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Vital EM; Dass S; Emery P<\/span> (2015)<\/span> 60 B-cell depletion<\/span>. Rheumatology<\/span>, Elsevier<\/span>, pp. 472-478<\/span>. <\/a><\/p>","publicationid":"762544","date":"2015-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Vital EM; Dass S; Emery P<\/span> (2015)<\/span> B-cell depletion<\/span>. Rheumatology Sixth Edition<\/span>, 1-2<\/span>, Elsevier<\/a>, pp. 472-478<\/span>. <\/a><\/p>","publicationid":"340225","date":"2015-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Grainger AJ; Rowbotham EL<\/span> (2013)<\/span> Rheumatoid arthritis<\/span>. In: Mackay IR; Rose N eds<\/span> Evidence Based Rheumatology<\/span>, 17<\/span>, Thieme<\/span>, pp. 69-73<\/span>. <\/a><\/p>","publicationid":"133145","date":"2013-02-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Bingham S; Emery P<\/span> (2012)<\/span> Renal toxicity of anti-rheumatic drugs<\/span>. Rheumatology and the Kidney<\/span>, Oxford University Press<\/a>, pp. 385-398<\/span>. <\/a><\/p>","publicationid":"1103394","date":"2012-04-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Nizam S; Karim Z; Emery P<\/span> (2012)<\/span> Rheumatological complications of renal disease and transplantation<\/span>. Rheumatology and the Kidney<\/span>, Oxford University Press<\/a>, pp. 441-454<\/span>. <\/a><\/p>","publicationid":"1103393","date":"2012-04-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Nishikawa M; Owaki H; Fuji T; Soliman MM; Ashcroft DM; Watson KD; Lunt M; Symmons D; Hyrich KL; Atkinson F; Malik S; Heycock C; Saravanan V; Rynne M; Hamilton J; Kelly C; Burmester G; Kary S; Unnebrink K; Guerette B; Oezer U; Kupper H; Dennison E; Jameson K; Hyrich K; Watson K; Landewe R; Keystone E; Smolen J; Goldring M; Guerette B; Patra K; Cifaldi M; van der Heijde D; Lloyd LA; Owen C; Breslin A; Ahmad Y; Emery P; Matteson EL; Genovese M; Sague S; Hsia EC; Doyle MK; Fan H; Elashoff M; Kirkham B; Wasco MC; Bathon J; Hsia EC; Fleischmann R; Genovese MC; Matteson EL; Liu H; Fleischmann R; Goldman J; Leirisalo-Repo M; Zanetakis E; El-Kadi H; Kellner H; Bolce R; Wang J; Dehoratius R; Decktor D; Kremer J; Taylor P; Mendelsohn A; Baker D; Kim L; Ritchlin C; Taylor P; Mariette X; Matucci Cerenic M; Pavelka K; van Vollenhoven R; Heatley R; Walsh C; Lawson R; Reynolds A; Emery P; Iaremenko O; Mikitenko G; Smolen J; van Vollenhoven R; Kavanaugh A; Luijtens K; van der Heijde D; Curtis J; van der Heijde D; Schiff M; Keystone E; Landewe R; Kvien T; Curtis J; Khanna D; Luijtens K; Furst D; Behrens F; Koehm M; Scharbatke EC; Kleinert S; Weyer G; Tony H-P; Burkhardt H; Blunn KJ; Williams RB; Young A; McDowell J; Keystone E; Weinblatt M; Haraoui B; Guerette B; Mozaffarian N; Patra K; Kavanaugh A; Khraishi M; Alten R; Gomez-Reino J; Rizzo W; Schechtman J; Kahan A; Vernon E; Taylor M; Smolen J; Hogan V; Holweg C; Kummerfeld S; Teng O; Townsend M; van Laar JM; Gullick NJ; De Silva C; Kirkham BW; van der Heijde D; Landewe R; Guerette B; Roy S; Patra K; Keystone E; Emery P; Fleischmann R; van der Heijde D; Keystone E; Genovese MC; Conaghan PG; Hsia EC; Xu W; Baratelle A; Beutler A; Rahman MU; Nikiphorou E; Kiely P; Walsh DA; Williams R; Young A; Shah D; Knight GD; Hutchinson DG; Dass S; Atzeni F; Vital EM; Bingham SJ; Buch M; Beirne P; Emery P; Keystone E; Fleischmann R; Emery P; Dougados M; Williams S; Reynard M; Blackler L; Gullick NJ; Zain A; Oakley S; Rees J; Jones T; Mistlin A; Panayi G; Kirkham BW; Westhovens R; Durez P; Genant H; Robles M; Becker J-C; Covucci A; Bathon J; Genovese MC; Schiff M; Luggen M; Le Bars M; Becker J-C; Aranda R; Li T; Elegbe A; Dougados M; Smolen J; van Vollenhoven R; Kavanaugh A; Fichtner A; Strand V; Vencovsky J; van der Heijde D; Davies R; Galloway J; Watson KD; Lunt M; Hochberg M; Westhovens R; Aranda R; Kelly S; Khan N; Qi K; Pappu R; Delaet I; Luo A; Torbeyns A; Moreland L; Cohen R; Gujrathi S; Weinblatt M; Bykerk VP; Alvaro-Gracia J; Andres Roman Ivorra J; Nurmohamed MT; Pavelka K; Bernasconi C; Stancati A; Sibilia J; Ostor A; Strangfeld A; Eveslage M; Listing J; Herzer P; Liebhaber A; Krummel-Lorenz B; Zink A; Haraoui B; Emery P; Mozaffarian N; Guerette B; Kupper H; Patra K; Keystone E; Genovese MC; Breedveld FC; Emery P; Cohen SB; Keystone E; Matteson EL; Burke L; Chai A; Reiss W; Sweetser M; Shaw T; Ellis SD; Ehrenstein MR; Notley CA; Yazici Y; Curtis J; Ince A; Baraf H; Malamet R; Chung CY; Kavanaugh A; Hughes C; Faurholm B; Dell'Accio F; Manzo A; Seed M; Eltawil N; Marrelli A; Gould D; Subang C; Al-Kashi A; De Bari C; Winyard P; Chernajovsky Y; Nissim A; van Vollenhoven R; Emery P; Bingham C; Keystone E; Fleischmann RM; Furst DE; Macey KM; Sweetser MT; Lehane P; Farmer P; Long SG; Kremer JM; Furst DE; Burgos-Vargas R; Dudler J; Mela CM; Vernon E; Fleischmann RM; Wegner N; Lugli H; Quirke A-M; Guo Y; Potempa J; Venables P<\/span> (2011)<\/span> Rheumatoid arthritis - treatment: 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis<\/span>. In: Isenberg D; Maddison P; Woo P; Glass D; Breedveld F eds<\/span> Oxford Textbook of Rheumatology, third edition<\/span>, 50<\/span>, Oxford University Press (OUP)<\/a>, pp. iii111-iii129<\/span>. <\/a><\/p>","publicationid":"8883","date":"2011-04-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Dass S; Vital EM; Emery P<\/span> (2011)<\/span> Rituximab<\/span>. Rheumatology<\/span>, Elsevier<\/a>, pp. 563-570.e1<\/span>. <\/a><\/p>","publicationid":"1039522","date":"2011-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Suarez-Almazor ME; Osiri M; Emery P<\/span> (2009)<\/span> Rheumatoid arthritis<\/span>. In: Bishop T; Sham PC eds<\/span> Evidence Based Rheumatology<\/span>, Wiley<\/a>, pp. 243-314<\/span>. <\/a><\/p>","publicationid":"164774","date":"2009-08-03","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Vital EM; Dass S; Emery P<\/span> (2009)<\/span> B cell targets in rheumatoid arthritis<\/span>. New Therapeutic Targets in Rheumatoid Arthritis<\/span>, Birkh\u00e4user Basel<\/a>, pp. 1-26<\/span>. <\/a><\/p>","publicationid":"1039524","date":"2009-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Dass S; Vital EM; Emery P<\/span> (2009)<\/span> CHAPTER 10I Rituximab<\/span>. Rheumatoid Arthritis<\/span>, Elsevier<\/span>, pp. 362-366<\/span>. <\/a><\/p>","publicationid":"762322","date":"2009-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Emery P<\/span> (2007)<\/span> Early Arthritis<\/span>. In: Smolen JF; Lipsky PE eds<\/span> Targeted Therapies in Rheumatology<\/span>, Martin Dunitz<\/span>, pp. 509-513<\/span>.<\/p>","publicationid":"100980","date":"2007-10-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Tan AL; Keen HI; Emery P; McGonagle D<\/span> (2007)<\/span> Imaging Inflamed Synovial Joints<\/span>. Arthritis Research<\/span>, 135<\/span>, Springer Nature<\/span>, pp. 3-26<\/span>. <\/a><\/p>","publicationid":"1103395","date":"2007-07-06","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Keen HI; Emery P; Conaghan P<\/span> (2006)<\/span> Ultrasound and Alternative Imaging Outcomes<\/span>. In: Moskowitz RW; Altman RD; Buckwalter JA; Goldberg VM; Hochberg MC eds<\/span> Osteoarthritis: Diagnosis and Medical\/Surgical Management, 4th Edition<\/span>, Osteoarthritis: Diagnosis and Medical\/Surgical Management, 4th Edition<\/span>, pp. 193-199<\/span>.<\/p>","publicationid":"34142","date":"2006-12-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

McGonagle D; Ai LT; Wakefield R; Emery P<\/span> (2006)<\/span> Imaging in Ankylosing Spondylitis<\/span>. Ankylosing Spondylitis<\/span>, Taylor & Francis<\/span>, pp. 71-82<\/span>. <\/a><\/p>","publicationid":"762142","date":"2006-01-13","publicationtype":"Chapter","isfavourite":"0"},{"html":"

McGonagle D; Tan A; Wakefield R; Emery P<\/span> (2006)<\/span> Imaging in Ankylosing Spondylitis<\/span>. In: Royen V; BJ; BAC D eds<\/span> Ankylosing Spondylitis<\/span>, New York<\/span>: CRC Press<\/a>, pp. 71-81<\/span>. <\/a><\/p>","publicationid":"5368","date":"2006-01-13","publicationtype":"Chapter","isfavourite":"0"},{"html":"

MACKIE S; QUINN M; EMERY P<\/span> (2006)<\/span> CHAPTER 32 Rheumatoid Arthritis<\/span>. The Autoimmune Diseases<\/span>, Elsevier<\/span>, pp. 417-436<\/span>. <\/a><\/p>","publicationid":"762104","date":"2006-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Emery P<\/span> (2005)<\/span> Preface, Early Rheumatoid Arthritis<\/span>. In: Emery P ed<\/span> Rheumatic Disease Clinics of North America<\/span>, Rheumatic Disease Clinics of North America<\/span>, pp. xiii-xiv<\/span>.<\/p>","publicationid":"103800","date":"2005-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Wakefield RJ; Conaghan P; Emery P<\/span> (2004)<\/span> Ultrasonography and MRI<\/span>. In: Haynes BF; Pisetsky DS; St CEW eds<\/span> RA, Rheumatoid Arthritis<\/span>, RA, Rheumatoid Arthritis<\/span>, pp. 98-106<\/span>.<\/p>","publicationid":"95967","date":"2004-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Conaghan P; Marzo-Ortega H; Emery P<\/span> (2004)<\/span> New Treatments in Arthritis<\/span>. Current Medical Literature<\/span>, Current Medical Literature<\/span>.<\/p>","publicationid":"6244","date":"2004-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Suarez\u2010Almazor ME; Osiri M; Emery P<\/span> (2003)<\/span> Rheumatoid Arthritis<\/span>. Evidence\u2010Based Rheumatology<\/span>, Wiley<\/a>, pp. 243-314<\/span>. <\/a><\/p>","publicationid":"1103604","date":"2003-12-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Conaghan P; Karim Z; Green MJ; McGonagle DG; Emery P<\/span> (2003)<\/span> The use of imaging in the assessment of common rheumatological clinical problems: multiple peripheral joint swelling<\/span>. In: Isenberg D; Renton P eds<\/span> Imaging in Rheumatology<\/span>, Imaging in Rheumatology<\/span>, pp. 147-159<\/span>.<\/p>","publicationid":"113228","date":"2003-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Quinn MA; Green MJ; Emery P<\/span> (2003)<\/span> Evaluation and management of early inflammatory polyarthritis<\/span>. Rheumatology 3rd Edition<\/span>, Rheumatology 3rd Edition<\/span>, pp. 885-891<\/span>.<\/p>","publicationid":"110820","date":"2003-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Bingham S; Emery P<\/span> (2002)<\/span> Combination therapy in rheumatoid arthritis<\/span>. Combination Treatment in Autoimmune Diseases<\/span>, Springer Berlin Heidelberg<\/a>, pp. 165-183<\/span>. <\/a><\/p>","publicationid":"1103495","date":"2002-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Emery P; Scott DL; Strand V<\/span> (2001)<\/span> Leflunomide: An Immunomodulatory Drug for the Treatment of Rheumatoid Arthritis<\/span>. Modern Therapeutics in Rheumatic Diseases<\/span>, Humana Press<\/a>, pp. 121-133<\/span>. <\/a><\/p>","publicationid":"1103396","date":"2001-11-13","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Marzo-Ortega H; Strauss RM; Emery P<\/span> (2001)<\/span> Tetracyclines and autoimmunity<\/span>. Tetracyclines in Biology, Chemistry and Medicine<\/span>, Birkh\u00e4user Basel<\/a>, pp. 311-324<\/span>. <\/a><\/p>","publicationid":"1103608","date":"2001-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Bingham S; Emery P<\/span> (2001)<\/span> Renal Toxicity of Anti-Rheumatic Drugs<\/span>. In: Adu; Madaio; Emery eds<\/span> Rheumatology and the Kidney<\/span>, Rheumatology and the Kidney<\/span>, pp. 445-461<\/span>.<\/p>","publicationid":"53259","date":"2001-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Luqmani RA; Pall A; Adu D; Moots RJ; Richards N; Howie AJ; Michael J; Emery P; Bacon PA<\/span> (1996)<\/span> Therapy of vasculitis<\/span>. The Vasculitides<\/span>, Springer US<\/a>, pp. 315-331<\/span>. <\/a><\/p>","publicationid":"1103498","date":"1996-01-01","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Moots RJ; Emery P<\/span> (1995)<\/span> The role of the endothelium in rheumatoid arthritis and scleroderma<\/span>. Immunological Aspects of the Vascular Endothelium<\/span>, Cambridge University Press<\/a>, pp. 153-172<\/span>. <\/a><\/p>","publicationid":"1103493","date":"1995-09-07","publicationtype":"Chapter","isfavourite":"0"},{"html":"

Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Bacon PA<\/span> (1993)<\/span> Necrotizing vasculitis--relapse despite cytotoxic therapy<\/span>. Advances in Experimental Medicine and Biology<\/span>, Advances in Experimental Medicine and Biology<\/span>, 336<\/span>, Springer US<\/a>, pp. 477-481<\/span>. <\/a><\/p>","publicationid":"1103549","date":"1993-01-01","publicationtype":"Chapter","isfavourite":"0"}],"conference_abstract":[{"html":"

Tan Y; Bhatt T; Sutcliffe M; Fitton J; Emery P; Aslam A; Menon M; Plant D; Buch M<\/span> (2024)<\/span> SINGLE-CELL ANALYSIS OF PERIPHERAL BLOOD MONONUCLEAR CELLS IDENTIFIES IMMUNE SIGNATURES AT DIFFERENT STAGES OF ACTIVE RHEUMATOID ARTHRITIS<\/span>. pp. 14-15<\/span>. <\/a><\/p>","publicationid":"1054118","date":"2024-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Harnden K; Sidhu N; Rowbotham E; Duquenne L; Sharrack S; Howell K; Bertham D; Emery P; Bridgewood C; Mankia K<\/span> (2024)<\/span> Whole-Body MRI Reveals Distinct Imaging Phenotypes in Patients with Arthralgia or Inflammatory Arthritis after Exposure to Immune Checkpoint Inhibitors<\/span>. pp. 419-420<\/span>. <\/a><\/p>","publicationid":"1031342","date":"2024-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Shukla RR; Wakefield RJ; Tan AL; Emery P; Plant D; Buch M<\/span> (2024)<\/span> INFLAMMATORY PROTEOMIC SIGNATURE OF CONCORDANCE\/DISCORDANCE BETWEEN DISEASE ACTIVITY AND JOINT INFLAMMATION IDENTIFIES FIBROBLAST GROWTH FACTOR-5 AND ADENOSINE DEAMINASE AS KEY PROTEINS<\/span>. pp. 735<\/span>. <\/a><\/p>","publicationid":"984309","date":"2024-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

De Marco G; Hensor E; Helliwell PS; Sultan S; Dubash SR; Michelena X; Coates LC; L. Tan A; Emery P; Mcgonagle D; Marzo-Ortega H<\/span> (2024)<\/span> ATREATMENT STRATEGY COMBININGTNF- INHIBITOR, METHOTREXATE AND STEROIDS IS NOT SUPERIOR TO METHOTREXATE AND STEROIDS IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE GOLMEPSA RANDOMISED, DOUBLE-BLIND CLINICAL TRIAL<\/span>. pp. 153-154<\/span>. <\/a> <\/a><\/p>","publicationid":"806148","date":"2024-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Duquenne L; Eroglu DS; Wu J; DI Matteo A; Harnden K; Nam J; Thornton L; Chowdhury R; Garcia-Montoya L; Mankia K; Emery P<\/span> (2024)<\/span> WHICH BIOMARKERS INDICATE IMMINENT PROGRESSION TO INFLAMMATORY ARTHRITIS IN HIGH RISK CCP POSITIVE PERSONS?<\/span> pp. 596-597<\/span>. <\/a><\/p>","publicationid":"757500","date":"2024-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

De Marco G; Hensor EMA; McGonagle DG; Tan AL; Coates LC; Emery P; Helliwell PS; Ortega HM<\/span> (2024)<\/span> THE PSORIATIC ARTHRITIS DISEASE ACTIVITY SCORE DEMONSTRATES EXCELLENT TEST-RETEST RELIABILITY IN EARLY, UNTREATED PSORIATIC ARTHRITIS<\/span>. pp. keae163.299-i159<\/span>. <\/a> <\/a><\/p>","publicationid":"671534","date":"2024-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Siddle HJ; Wilson M; Nam JL; Garcia-Montoya L; Duquenne L; Mankia K; Emery P; Hensor EMA<\/span> (2024)<\/span> DEVELOPING A MULTIVARIABLE PREDICTION MODEL TO IDENTIFY ANTI-CCP POSITIVE INDIVIDUALS AMONG THOSE WITH NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS IN PRIMARY CARE<\/span>. pp. I2<\/span>. <\/a> <\/a><\/p>","publicationid":"662040","date":"2024-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Duquenne L; Harnden K; Garcia-Montoya L; Di Matteo A; Chowdhury R; Nam J; Sidhu N; Mankia K; Emery P<\/span> (2023)<\/span> IN ANTI-CCP POSITIVE AT RISK INDIVIDUALS, WHICH BIOMARKERS CHANGE PRIOR TO PROGRESSION TO INFLAMMATORY ARTHRITIS?<\/span> pp. 840-841<\/span>. <\/a><\/p>","publicationid":"645862","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Di Matteo A; De Lorenzis E; Duquenne L; Nam J; Garcia-Montoya L; Harnden K; Chowdhury R; Emery P; Mankia K<\/span> (2023)<\/span> A REDUCED ULTRASOUND SCANNING PROTOCOL OF 3 JOINTS BILATERALLY IMPROVES PREDICTION OF INFLAMMATORY ARTHRITIS PROGRESSION IN ANTI-CCP ANTIBODIES POSITIVE INDIVIDUALS WITH MUSCULOSKELETAL SYMPTOMS<\/span>. pp. 80-81<\/span>. <\/a><\/p>","publicationid":"645861","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Van Ouwerkerk L; Verschueren P; Boers M; Emery P; De Jong P; Landewe RBM; Lems W; Smolen J; Huizinga T; Allaart C; Bergstra SA<\/span> (2023)<\/span> INITIAL GLUCOCORTICOID BRIDGING IN RHEUMATOID ARTHRITIS: DOES IT AFFECT GLUCOCORTICOID USE OVER TIME?<\/span> pp. 145<\/span>. <\/a><\/p>","publicationid":"645860","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Tuttle J; Drescher E; Simon-Campos JA; Emery P; Greenwald M; Kivitz A; Rha H; Yachi P; Kiley C; Nirula A<\/span> (2023)<\/span> A PHASE 2 TRIAL OF PERESOLIMAB FOR ADULTS WITH RHEUMATOID ARTHRITIS<\/span>. pp. 397<\/span>. <\/a><\/p>","publicationid":"645859","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Harnden K; Di Matteo A; Almeida DE; De Lorenzis E; Duquenne L; Garcia-Montoya L; Nam J; Emery P; Mankia K<\/span> (2023)<\/span> AN INCREASE IN ULTRASOUND JOINT INFLAMMATION OCCURS WHEN ANTI-CCP POSITIVE AT-RISK INDIVIDUALS WITH SUBCLINICAL SYNOVITIS PROGRESS TO INFLAMMATORY ARTHRITIS<\/span>. pp. 488-489<\/span>. <\/a><\/p>","publicationid":"645858","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Sparks J; Dieude P; Hoffmann-Vold AM; Burmester GR; Walsh S; Kreuter M; Stock C; Sambevski S; Alves M; Emery P<\/span> (2023)<\/span> DESIGN OF A PROSPECTIVE MULTI-NATIONAL CROSS-SECTIONAL STUDY ON SCREENING FOR INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) GUIDED BY RISK FACTORS<\/span>. pp. 1316-1317<\/span>. <\/a><\/p>","publicationid":"645856","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Buch MH; Aletaha D; Caporali R; Combe B; Schulze-Koops H; Gottenberg JE; Tanaka Y; Blanco R; Takeuchi T; Omoruyi EVE; Van Beneden K; Rajendran V; Watson C; De Leonardis F; Emery P<\/span> (2023)<\/span> EFFICACY OF FILGOTINIB (FIL) IN PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA): WEEK (W) 156 RESULTS FROM A LONG-TERM EXTENSION (LTE) STUDY<\/span>. pp. 729-730<\/span>. <\/a><\/p>","publicationid":"645855","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Mustufvi Z; Letton R; Harnden K; Chowdhury R; Tugnait A; Emery P; Pavitt S; Mankia K<\/span> (2023)<\/span> ANTI-CCP plus AT-RISK INDIVIDUALS HAVE A MILD PHENOTYPE OF PERIODONTAL DISEASE, WHICH IS TREATABLE WITH A COURSE OF NON-SURGICAL PERIODONTAL THERAPY<\/span>. pp. 1176<\/span>. <\/a><\/p>","publicationid":"645654","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

David P; Di Matteo A; Hen O; Dass S; Emery P; Saleem B; Mcgonagle D<\/span> (2023)<\/span> REAL WORLD \"POLY-REFRACTORY RA\": A RARE BUT UNMET CLINICAL CHALLENGE<\/span>. pp. 88-89<\/span>. <\/a><\/p>","publicationid":"645365","date":"2023-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Cooles F; Tarn J; Lendrem D; Naamane N; Lin A; Millar B; Maney N; Thalayasingam N; Bondet V; Duffy D; Barnes M; Smith G; Ng S; Watson D; Henkin R; Cope A; Reynard L; Pratt A; Consortium RM; Isaacs J<\/span> (2022)<\/span> OP0012\u2005INTERFERON-\u03b1 MEDIATED THERAPEUTIC RESISTANCE IN EARLY RA IMPLICATES EPIGENETIC REPROGRAMMING<\/span>. pp. 7-8<\/span>. <\/a><\/p>","publicationid":"591969","date":"2022-06-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Carter LM; Alase A; Wigston Z; Psarras A; Burska A; Yusof MYM; Reynolds JA; Wittmann M; Bruce I; Vital EM<\/span> (2022)<\/span> OA09\u2003Gene expression analysis reveals distinct ancestry-specific profiles associated with response to rituximab in SLE<\/span>. pp. keac132.008-i5<\/span>. <\/a> <\/a><\/p>","publicationid":"592915","date":"2022-04-23","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Pontarini E; Chowdhury F; Sciacca E; Grigoriadou S; Murray-Brown W; Rivellese F; Lucchesi D; Goldmann K; Fossati-Jimack L; Jaworska E; Ghirardi GM; Nerviani A; Emery P; Ng WF; Sutcliffe N; Tappuni A; Lewis M; Arends S; De Wolff L; Bootsma H; Pitzalis C; Bowman SJ; Bombardieri M<\/span> (2022)<\/span> CLINICAL RESPONSE TO RITUXIMAB IS ASSOCIATED WITH PREVENTION OF B-CELL DRIVEN SALIVARY GLAND INFLAMMATION AND EPITHELIAL RESTORATION AS REVEALED BY MOLECULAR PATHOLOGY: RESULTS FROM THE TRACTISS TRIAL IN PRIMARY SJOGREN'S SYNDROME<\/span>. pp. 299-300<\/span>. <\/a><\/p>","publicationid":"596918","date":"2022-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Duquenne L; Harnden K; Garcia-Montoya L; Sidhu N; Nam J; Mankia K; Emery P<\/span> (2022)<\/span> ANTI-CCP POSITIVE INDIVIDUALS AT RISK OF PROGRESSION TO INFLAMMATORY ARTHRITIS: WHAT HAPPENS TO BIOMARKERS PRIOR TO PROGRESSION?<\/span> pp. 524-525<\/span>. <\/a><\/p>","publicationid":"596917","date":"2022-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Combe B; Tanaka Y; Emery P; Pechonkina A; Kuo A; Gong Q; Van Beneden K; Rajendran V; Schulze-Koops H<\/span> (2022)<\/span> CLINICAL OUTCOMES UP TO WEEK (W) 48 IN THE ONGOING FILGOTINIB (FIL) LONG-TERM EXTENSION (LTE) TRIAL OF RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS) WITH INADEQUATE RESPONSE (IR) TO METHOTREXATE (MTX) INITIALLY TREATED WITH FIL OR ADALIMUMAB (ADA) DURING THE PHASE 3 PARENT STUDY (PS)<\/span>. pp. 615-616<\/span>. <\/a><\/p>","publicationid":"596916","date":"2022-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Emery P; Fleischmann R; Wong R; Lozenski K; Tanaka Y; Bykerk V; Bingham C; Huizinga T; Citera G; Elbez Y; Perera V; Murthy B; Maxwell K; Passarell J; Hedrich W; Williams D<\/span> (2022)<\/span> ABSENCE OF ASSOCIATION BETWEEN ABATACEPT EXPOSURE LEVELS AND INITIAL INFECTION IN PATIENTS WITH RA: A POST HOC ANALYSIS OF THE RANDOMIZED, PLACEBO-CONTROLLED AVERT-2 STUDY<\/span>. pp. 556-557<\/span>. <\/a><\/p>","publicationid":"596915","date":"2022-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Shukla R; Burska A; Emery P; Plant D; Buch MH<\/span> (2022)<\/span> EFFECT OF EARLY ETANERCEPT TREATMENT ON CIRCULATING LIPOPROTEINS DIFFERS TO TREATMENT WITH METHOTREXATE AND IS MODULATED BY CLINICAL DISEASE ACTIVITY<\/span>. pp. 342-343<\/span>. <\/a><\/p>","publicationid":"596914","date":"2022-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Shukla R; Wakefield R; Emery P; Plant D; Buch MH<\/span> (2022)<\/span> DISCORDANCE BETWEEN DAS28ESR AND PRESENCE OF ULTRASOUND POWER DOPPLER DURING EARLY TREATMENT IS ASSOCIATED WITH DISTINCT CLINICAL AND IMAGING PHENOTYPES AT PRESENTATION<\/span>. pp. 55<\/span>. <\/a><\/p>","publicationid":"596633","date":"2022-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Yusof MYM; Teh LS; Khan S; Yee CS; D'cruz D; Ng N; Isenberg D; Ciurtin C; Conaghan PG; Emery P; Edwards CJ; Hensor E; Vital E<\/span> (2022)<\/span> DERIVATION AND INDEPENDENT VALIDATION OF THE LUPUS ARTHRITIS AND MUSCULOSKELETAL DISEASE ACTIVITY SCORE (LAMDA): A MORE SENSITIVE, SPECIFIC AND RESPONSIVE TOOL FOR LUPUS ARTHRITIS<\/span>. pp. 1412<\/span>. <\/a><\/p>","publicationid":"596618","date":"2022-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Yusof MYM; Robinson J; Davies V; Wild D; Morgan M; Taylor J; El-Sherbiny Y; Morris D; Liu L; Rawstron A; Buch MH; Plant D; Cordell H; Isaacs J; Bruce IN; Emery P; Barton A; Vyse T; Barrett J; Vital E; Morgan A<\/span> (2022)<\/span> COMPREHENSIVE GENETIC AND FUNCTIONAL ANALYSES OF FC GAMMA RECEPTORS EXPLAIN RESPONSE TO RITUXIMAB THERAPY FOR AUTOIMMUNE RHEUMATIC DISEASES<\/span>. pp. 126-127<\/span>. <\/a><\/p>","publicationid":"596264","date":"2022-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Garcia-Montoya L; Mankia K; Duquenne L; Nam J; Di Matteo A; Peill J; Mumba E; Emery P<\/span> (2021)<\/span> WORK ABSENCE DUE TO MUSCULOSKELETAL SYMPTOMS IN PATIENTS AT-RISK OF RHEUMATOID ARTHRITIS IS COMPARABLE TO THOSE WITH ESTABLISHED DISEASE<\/span>. pp. 482<\/span>. <\/a><\/p>","publicationid":"568556","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Garcia-Montoya L; Yusof MYM; Eugenio G; Candelier JB; Das S; Vital E; Emery P<\/span> (2021)<\/span> LONG-TERM EFFECTIVENESS OF THE RITUXIMAB HALF DOSE REGIMEN FOLLOWING A RESPONSE TO THE LICENSED DOSE IN RHEUMATOID ARTHRITIS<\/span>. pp. 557-558<\/span>. <\/a><\/p>","publicationid":"568555","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Emery P; Downie B; Liu J; Hawtin R; Curtis JR; Burmester GR<\/span> (2021)<\/span> FILGOTINIB DEMONSTRATES CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS INDEPENDENT OF SMOKING STATUS: A POST-HOC SUBGROUP ANALYSIS OF THREE PHASE 3 CLINICAL TRIALS<\/span>. pp. 502<\/span>. <\/a><\/p>","publicationid":"568554","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Di Matteo A; Mankia K; Duquenne L; Cipolletta E; Nam J; Garcia-Montoya L; Wakefield R; Mahler M; Emery P<\/span> (2021)<\/span> IS IT POSSIBLE TO IDENTIFY INDIVIDUALS AT IMMINENT-RISK OF SUB-CLINICAL JOINT INVOLVEMENT?<\/span> pp. 463-464<\/span>. <\/a><\/p>","publicationid":"568553","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Curtis J; Karis E; Bykerk V; Kricorian G; Yen P; Emery P; Haraoui P; Collier D; Stolshek B<\/span> (2021)<\/span> EFFECT OF WITHDRAWING ETANERCEPT OR METHOTREXATE ON PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS IN REMISSION ON COMBINATION THERAPY: RESULTS FROM THE SEAM-RA TRIAL<\/span>. pp. 66<\/span>. <\/a><\/p>","publicationid":"568552","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Hutchinson M; Abignano G; Blagojevic J; Bosello SL; Allanore Y; Denton C; Distler O; Emery P; Matucci-Cerinic M; Del Galdo F<\/span> (2021)<\/span> A COMBINED CLINICAL AND BIOMARKER ALGORITHM TO PREDICT FVC DECLINE IN SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE: RESULTS FROM AN INTERNATIONAL MULTICENTRE OBSERVATIONAL COHORT<\/span>. pp. 163-164<\/span>. <\/a><\/p>","publicationid":"568388","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Yusof MYM; Dutton K; Teh LS; Yee CS; D'cruz D; Ng N; Isenberg D; Ciurtin C; Conaghan PG; Emery P; Edwards CJ; Hensor E; Vital E<\/span> (2021)<\/span> THE ARTHRITIS COMPONENT OF THE SLEDAI SHOULD ONLY BE SCORED IF THERE IS JOINT SWELLING<\/span>. pp. 625<\/span>. <\/a><\/p>","publicationid":"568377","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Gul H; Ponchel F; Emery P<\/span> (2021)<\/span> IN RA PATIENTS IN REMISSION, WHICH BIOMARKERS PREDICT SUCCESSFUL TAPERING OF CSDMARDS?<\/span> pp. 110<\/span>. <\/a><\/p>","publicationid":"568375","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Pontarini E; Chowdhury F; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Goldmann K; Fossati-Jimack L; Emery P; Ng WF; Sutcliffe N; Everett C; Fernandez C; Tappuni A; Lewis M; Pitzalis C; Bowman SJ; Bombardieri M<\/span> (2021)<\/span> RITUXIMAB PREVENTS THE PROGRESSION OF B-CELL DRIVEN INFLAMMATORY INFILTRATE IN THE MINOR SALIVARY GLANDS OF PRIMARY SJOGREN'S SYNDROME BY DOWNREGULATING IMMUNOLOGICAL PATHWAYS KEY IN ECTOPIC GERMINAL CENTRE ORGANIZATION: RESULTS FROM THE TRACTISS TRIAL<\/span>. pp. 79-80<\/span>. <\/a><\/p>","publicationid":"568361","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Pepple S; Arnold J; Vital E; Rawstron A; Pease C; Dass S; Emery P; Yusof MYM<\/span> (2021)<\/span> IDENTIFYING PREDICTORS OF SHORT-TERM RESPONSE TO RITUXIMAB IN PRIMARY SJOGREN'S SYNDROME<\/span>. pp. 1173<\/span>. <\/a><\/p>","publicationid":"568360","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Pitaksalee R; Emery P; Hodgett R; Ponchel F<\/span> (2021)<\/span> DIFFERENTIAL METHYLATION OF THE TNF GENE PROMOTER, POTENTIAL FOR THE DEVELOPMENT OF A DIAGNOSTIC BIOMARKER FOR RA<\/span>. <\/a><\/p>","publicationid":"563298","date":"2021-01-01","publicationtype":"Conference abstract","isfavourite":"0"},{"html":"

Ponchel F; Hunt L; van Delft M; Emery P; Trouw L<\/span> (2019)<\/span> ANTI-CARBAMYLATED PROTEIN ANTIBODIES : ARE THEY USEFUL FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS?<\/span> pp. A14<\/span>. <\/a><\/p>","publicationid":"498796","date":"2019-01-01","publicationtype":"Conference abstract","isfavourite":"0"}],"preprint":[{"html":"

Pitaksalee R; Parmar R; Hotgett R; Emery P; Ponchel F<\/span> (2023)<\/span> DNA-hypomethylation in the TNF-alpha gene predicts rheumatoid arthritis classification in patients with early inflammatory symptoms<\/span>. Research Square Platform LLC<\/span>. <\/a><\/p>","publicationid":"1103343","date":"2023-05-23","publicationtype":"Preprint","isfavourite":"0"},{"html":"

Fairfax B; Taylor C; Watson R; Tong O; Ye W; Nassiri I; Gilchrist J; Aires AVDL; Sharma P; Koturan S; Cooper R; Woodcock V; Jungkurth E; Shine B; Coupe N; Payne M; Naranbhai V; Groha S; Emery P; Mankia K; Freedman M; Choueiri T; Middleton M; Gusev A<\/span> (2022)<\/span> Genetic variation at IL7 provides mechanistic insights into toxicity to immune checkpoint blockade<\/span>. Springer Science and Business Media LLC<\/span>. <\/a><\/p>","publicationid":"1103349","date":"2022-04-12","publicationtype":"Preprint","isfavourite":"0"},{"html":"

Garcia-Montoya L; Nam JL; Duquenne L; Di Matteo A; Villota-Eraso C; Hartley C; Mankia K; Emery P<\/span> (2021)<\/span> Prioritising Referrals To\u00a0Rheumatology For\u00a0Individuals At-Risk of an Inflammatory Arthritis: Guidance Based on Results of a 10-Year National Primary Care Study<\/span>. SSRN Electronic Journal<\/span>. <\/a><\/p>","publicationid":"757504","date":"2021-01-01","publicationtype":"Preprint","isfavourite":"0"},{"html":"

Robinson J; Md Yusof MY; Davies V; Wild D; Morgan M; Taylor J; El-Sherbiny Y; Morris D; Liu L; Rawstron A; Buch M; Plant D; Cordell H; Isaacs J; Bruce I; Emery P; Barton A; Vyse T; Barrett J; Vital E; Morgan A; MASTERPLANS Consortia<\/span> (2021)<\/span> Comprehensive genetic and functional analysis of Fc\u03b3Rs in rituximab therapy for autoimmunity reveals a key role for Fc\u03b3RIIIa on NK cells<\/span>. medRxiv<\/span>. <\/a> <\/a><\/p>","publicationid":"568023","date":"2021-01-01","publicationtype":"Preprint","isfavourite":"0"},{"html":"

Mahmoud K; Zayat A; Md Yusof MY; Dutton K; Teh LS; Yee C-S; D\u2019Cruz D; Ng N; Isenberg D; Ciurtin C; Conaghan P; Emery P; Edwards C; Hensor EMA; Vital E<\/span> (2020)<\/span> Ultrasound to identify lupus patients with inflammatory joint symptoms with a better response to therapy: The USEFUL longitudinal multicentre study<\/span>. medRxiv<\/span>. <\/a><\/p>","publicationid":"613240","date":"2020-01-01","publicationtype":"Preprint","isfavourite":"0"},{"html":"

Al-Laith M; Jasenecova M; Abraham S; Bosworth A; Bruce IN; Buckley CD; Ciurtin C; D\u2019Agostino M-A; Emery P; Gaston H; Isaacs JD; Filer A; Fisher BA; Huizinga TWJ; Ho P; Jacklin C; Lempp H; McInnes IB; Pratt AG; \u00d6stor A; Raza K; Taylor PC; Schaardenburg DV; Shivapatham D; Wright AJ; Vasconcelos JC; Kelly J; Murphy C; Prevost AT; Cope AP<\/span> (2019)<\/span> Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double blind, parallel group placebo-controlled clinical trial Protocol<\/span>. Springer Science and Business Media LLC<\/span>. <\/a><\/p>","publicationid":"1103367","date":"2019-03-28","publicationtype":"Preprint","isfavourite":"0"},{"html":"

El-Sherbiny Y; Yusof MYM; Psarras A; Hensor E; Kabba K; Dutton K; Mohamed AAA; Elewaut D; McGonagle D; Tooze R; Doody G; Wittmann M; Emery P; Vital E<\/span> (2019)<\/span> B cell tetherin: a flow-cytometric cell-specific assay for response to Type-I interferon predicts clinical features and flares in SLE<\/span>. bioRxiv<\/span>. <\/a><\/p>","publicationid":"571405","date":"2019-01-01","publicationtype":"Preprint","isfavourite":"0"},{"html":"

Al-Laith M; Jasenecova M; Abraham S; Bosworth A; Bruce IN; Buckley CD; Ciurtin C; D\u2019Agostino M-A; Emery P; Gaston H; Isaacs JD; Filer A; Fisher BA; Huizinga TWJ; Ho P; Jacklin C; Lempp H; McInnes IB; Pratt AG; \u00d6stor A; Raza K; Taylor PC; Schaardenburg DV; Shivapatham D; Wright AJ; Vasconcelos JC; Kelly J; Murphy C; Prevost AT; Cope AP<\/span> (2018)<\/span> Arthritis Prevention in the Pre-Clinical Phase of RA with Abatacept (the APIPPRA Study): A Multi-Centre, Randomised, Double Blind, Parallel Group Placebo-Controlled Clinical Trial<\/span>. Springer Science and Business Media LLC<\/span>. <\/a><\/p>","publicationid":"1103366","date":"2018-12-19","publicationtype":"Preprint","isfavourite":"0"}],"report":[],"internet_publication":[],"performance":[],"composition":[],"exhibition":[],"poster":[{"html":"

El-Sherbiny YM; Md Yosuf MY; Mohamed A; Hensor E; Psarras A; Wittmann M; Emery P; Vital EM<\/span> (2016)<\/span> 09.06 Analysis of Cell-Specific Interferon Response in Systemic Lupus Erythematosus Using a Novel Flow Cytometric Assay<\/span>.<\/p>","publicationid":"360235","date":"2016-02-27","publicationtype":"Poster","isfavourite":"0"},{"html":"

Harrison S; Burksa A; Parmar R; Emery P; Ponchel F<\/span> (2014)<\/span> A1.9 Pilot work towards discovery of novel diagnostic biomarker for rheumatoid arthritis using combinations of chemokine receptor expression on peripheral blood cell-subsets<\/span>.<\/p>","publicationid":"279907","date":"2014-03-01","publicationtype":"Poster","isfavourite":"0"},{"html":"

Burska A; Hensor E; Nam JL; Kozera L; Wakefield RJ; Emery P; Morgan AW<\/span> (2014)<\/span> Evaluation of Metalloproteinase-3 As a Soluble Biomarker of Synovitis Using Weighted Joint Counts Assessed Clinically and on Ultrasound Imaging<\/span>.<\/p>","publicationid":"319029","date":"2014-01-01","publicationtype":"Poster","isfavourite":"0"},{"html":"

Hunt L; Burska A; Hensor EMA; Nam JL; Ponchel F; Emery P<\/span> (2014)<\/span> Predicting the Evolution of Inflammatory Arthritis in ACPA-Positive Individuals: Can T-Cell Subsets Model Help?<\/span><\/p>","publicationid":"319026","date":"2014-01-01","publicationtype":"Poster","isfavourite":"0"},{"html":"

Vital E; Israelsson L; Nogueira L; Malmstrom V; El-Sherbiny Y; Rawston AC; Serre G; Klareskog L; Ponchel F; Emery P<\/span> (2014)<\/span> ACPA FINE SPECIFICITY IS ASSOCIATED WITH INCREASED PLASMABLAST NUMBERS AND WORSE CLINICAL RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS<\/span>.<\/p>","publicationid":"280923","date":"2014-01-01","publicationtype":"Poster","isfavourite":"0"},{"html":"

Churchman SM; El-Jawhari J; Goeb V; Vital E; El-Sherbini Y; Conaghan PG; Emery P; Ponchel F<\/span> (2014)<\/span> IL-7 DRIVES THE TISSUE ARCHITECTURE OF THE RA SYNOVIUM PROVIDING A NICHE FOR B-CELLS TO MATURE<\/span>.<\/p>","publicationid":"280922","date":"2014-01-01","publicationtype":"Poster","isfavourite":"0"},{"html":"

Vital EM; Israelsson L; Nogueira L; Malmstrom V; El-Sherbiny Y; Rawstron A; Serre G; Klareskog L; Ponchel F; Emery P<\/span> (2013)<\/span> ACPA FINE SPECIFICITY IS ASSOCIATED WITH INCREASED PLASMABLAST NUMBERS AND WORSE CLINICAL RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS<\/span>.<\/p>","publicationid":"281340","date":"2013-01-01","publicationtype":"Poster","isfavourite":"0"},{"html":"

Vital EM; El-Sherbiny Y; Freeston J; Brown A; Reece R; Dass S; Buch M; Ponchel F; Emery P<\/span> (2013)<\/span> SYNOVIAL B CELL STATUS DETERMINES INTENSITY OF RITUXIMAB THERAPY REQUIRED IN RHEUMATOID ARTHRITIS<\/span>.<\/p>","publicationid":"281339","date":"2013-01-01","publicationtype":"Poster","isfavourite":"0"}],"artefact":[],"design":[],"patent":[],"scholarly_edition":[],"software_code":[],"thesis_dissertation":[],"other":[{"html":"

Emery P; Bingham C; Burmester GR; Bykerk VP; Furst D; Mariette X; Purcaru O; VanLunen B; Weinblatt M<\/span> (2015)<\/span> Improvements in Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study<\/span>. United States<\/span>, 18<\/span>, (7)<\/span>. <\/a><\/p>","publicationid":"338072","date":"2015-11-01","publicationtype":"Other","isfavourite":"0"},{"html":"

Emery P; Bingham C; Burmester G; Bykerk V; Furst D; Mariette X; Purcaru O; Coteur G; Vanlunen B; Weinblatt M<\/span> (2015)<\/span> Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study<\/span>. United States<\/span>, 18<\/span>, (7)<\/span>. <\/a><\/p>","publicationid":"338071","date":"2015-11-01","publicationtype":"Other","isfavourite":"0"},{"html":"

Wylie A; Deodhar A; Baeten D; Braun J; Baraliakos X; Sieper J; Dougados M; Emery P; Porter B; Martin R; Mpofu S; Richards H<\/span> (2015)<\/span> SECUKINUMAB, A MONOCLONAL ANTIBODY TO INTERLEUKIN-17A, SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION AND QUALITY OF LIFE IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH INTRAVENOUS LOADING AND SUBCUTANEOUS MAINTENANCE DOSING<\/span>. 45<\/span>.<\/p>","publicationid":"326696","date":"2015-01-01","publicationtype":"Other","isfavourite":"0"},{"html":"

Collins A; Baeten D; Braun J; Baraliakos X; Sieper J; Dougados M; Emery P; Deodhar A; Porter B; Martin R; Mpofu S; Richards H<\/span> (2015)<\/span> SECUKINUMAB, A MONOCLONAL ANTIBODY TO INTERLEUKIN-17A, SIGNIFICANTLY IMPROVES SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF A 52-WEEK PHASE 3 RANDOMIZED PLACEBO-CONTROLLED TRIAL WITH INTRAVENOUS LOADING AND SUBCUTANEOUS MAINTENANCE DOSING<\/span>. 45<\/span>.<\/p>","publicationid":"326692","date":"2015-01-01","publicationtype":"Other","isfavourite":"0"},{"html":"

Chadha P; Sieper J; Braun J; Baraliakos X; Baeten D; Dougados M; Emery P; Deodhar A; Porter B; Andersson M; Mpofu S; Richards H<\/span> (2015)<\/span> SECUKINUMAB, A MONOCLONAL ANTIBODY TO INTERLEUKIN-17A, SIGNIFICANTLY IMPROVES SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH SUBCUTANEOUS LOADING AND MAINTENANCE DOSING<\/span>. 45<\/span>.<\/p>","publicationid":"326685","date":"2015-01-01","publicationtype":"Other","isfavourite":"0"},{"html":"

Wakefield RJ; Conaghan P; O'Connor P; Emery P<\/span> (2004)<\/span> A comparison of ultrasound and MRI in inflammatory joint disease<\/span>. RAD Magazine<\/span>.<\/p>","publicationid":"34119","date":"2004-01-01","publicationtype":"Other","isfavourite":"0"},{"html":"

Churchman SM; Savic S; Church LD; Emery P; McDermott MF<\/span> Mutated TNFR1 in tumor necrosis factor receptor associated periodic syndrome (TRAPS) patients is expressed on the cell surface and causes translocation of the p65 subunit of NF-kappaB to the nucleus<\/span>.<\/p>","publicationid":"118487","date":"","publicationtype":"Other","isfavourite":"0"}],"dataset":[],"media":[],"working_paper":[]}}